Clustering O 0 3.051355179195525e-06
of O 0 1.8475988383670483e-07
missense O 0 4.9326877160638105e-06
mutations O 0 6.903660754176144e-09
in O 0 8.653099348165938e-10
the O 0 9.771500231181562e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 4.475349442145671e-07
in O 0 3.4292741979413677e-09
a O 0 3.612801724450776e-10
sporadic B-Disease 0 1.6828098523546942e-06
T I-Disease 1 0.7614641189575195
- I-Disease 0 0.0003883940225932747
cell I-Disease 0 3.864960672217421e-05
leukaemia I-Disease 0 0.0021726181730628014
. O 0 4.310983570121607e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.2138101232703775e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.883708963429825e-11
is O 0 1.2899088264531344e-12
a O 0 5.123512291510535e-12
recessive B-Disease 0 9.350546115172165e-09
multi I-Disease 0 5.732729732699227e-06
- I-Disease 1 0.9984350800514221
system I-Disease 0 0.006504466291517019
disorder I-Disease 0 2.79785326711135e-05
caused O 0 1.599891952253074e-08
by O 0 4.5834150363965875e-10
mutations O 0 2.588990133389757e-10
in O 0 8.776446236424817e-11
the O 0 4.963752742170868e-10
ATM O 0 3.153958871848772e-08
gene O 0 1.2017460637725463e-10
at O 0 5.578204564926637e-10
11q22 O 0 2.370344276414471e-07
- O 0 8.325413318743813e-07
q23 O 0 1.671928657742683e-05
( O 0 1.081906786382092e-09
ref O 0 6.49557989618188e-07
. O 0 8.272593721159183e-10
3 O 0 5.351326937130807e-09
) O 0 2.2783394615366603e-10
. O 0 9.713760462659593e-09

The O 0 1.7905611571222835e-07
risk O 0 6.696558330077096e-08
of O 0 1.5960454291530368e-08
cancer B-Disease 0 5.358560883905739e-07
, O 0 1.5819659471283387e-10
especially O 0 1.6262028168512188e-08
lymphoid B-Disease 0 7.544385880464688e-05
neoplasias I-Disease 0 0.014149188064038754
, O 0 1.5310817891300843e-10
is O 0 3.712537655770065e-12
substantially O 0 1.7272110408583785e-09
elevated O 0 1.518928456789581e-06
in O 0 1.1115298903519033e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9481310248374939
and O 0 1.5564569078030388e-10
has O 0 5.717980776365206e-12
long O 0 1.8028504036871063e-11
been O 0 1.2493650211609086e-11
associated O 0 3.9069364410337926e-10
with O 0 2.1237198666312906e-09
chromosomal O 1 0.9999985694885254
instability O 1 0.9999998807907104
. O 0 2.9691780127905076e-06

By O 0 1.7641130511947267e-07
analysing O 0 4.711420842795633e-06
tumour B-Disease 1 0.9999988079071045
DNA O 0 3.3737126159394393e-07
from O 0 6.477131719861973e-09
patients O 0 1.2035250129827091e-08
with O 0 4.159259048286401e-11
sporadic B-Disease 0 1.632448288546584e-06
T I-Disease 0 0.0009031558874994516
- I-Disease 0 6.667329671472544e-06
cell I-Disease 0 1.14179681531823e-06
prolymphocytic I-Disease 0 0.00019310727657284588
leukaemia I-Disease 1 0.733153760433197
( O 0 2.9220439956567645e-10
T B-Disease 0 1.3658582531661523e-07
- I-Disease 0 6.796943807785283e-08
PLL I-Disease 0 1.1713835874616052e-06
) O 0 3.4503903206806186e-11
, O 0 5.3201562079385756e-12
a O 0 1.6922971704524947e-11
rare O 0 1.4161738448592587e-09
clonal B-Disease 0 2.712509683533426e-07
malignancy I-Disease 0 1.5716840096047235e-07
with O 0 1.8133272661202682e-11
similarities O 0 1.784704606322407e-10
to O 0 1.0669973932175836e-10
a O 0 1.0757974511221846e-09
mature B-Disease 0 2.0351342300273245e-07
T I-Disease 0 5.502894282471971e-07
- I-Disease 0 8.278077956447305e-08
cell I-Disease 0 2.8851687261521874e-08
leukaemia I-Disease 0 2.816158541918412e-07
seen O 0 7.126373102739336e-11
in O 0 3.3615575600887126e-11
A B-Disease 0 0.0006293230107985437
- I-Disease 0 0.00047989081940613687
T I-Disease 1 1.0
, O 0 3.711307650089424e-11
we O 0 2.3124286773618108e-12
demonstrate O 0 4.663996619469479e-12
a O 0 6.179613027887387e-13
high O 0 4.204981501887417e-11
frequency O 0 4.711835782655882e-11
of O 0 2.7549090786394004e-10
ATM O 0 1.2826124020648422e-06
mutations O 0 1.592967713293092e-08
in O 0 3.417770244595886e-08
T B-Disease 0 0.00013784848852083087
- I-Disease 0 4.9880178266903386e-05
PLL I-Disease 0 0.000811235629953444
. O 0 4.403126183660788e-07

In O 0 3.3286404743648745e-08
marked O 0 1.3956954703076008e-08
contrast O 0 8.125320860585816e-09
to O 0 2.5022808824992637e-10
the O 0 2.6028796895616324e-09
ATM O 0 2.524108708712447e-07
mutation O 0 4.668309072641819e-10
pattern O 0 3.1528610278108715e-10
in O 0 3.5270117382246724e-10
A B-Disease 1 0.999995231628418
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
, O 0 1.4931772485127226e-10
the O 0 3.651519017711102e-11
most O 0 4.8888892066611955e-12
frequent O 0 1.9695263215463443e-12
nucleotide O 0 2.927275435937737e-11
changes O 0 3.2404454120005255e-11
in O 0 1.6021134419119676e-10
this O 0 1.5814267673164295e-09
leukaemia B-Disease 0 0.0005024909041821957
were O 0 1.1939194166643574e-07
missense O 0 9.68218137131771e-06
mutations O 0 1.9034629872294317e-07
. O 0 1.6519163636985468e-07

These O 0 1.3951236610409978e-07
clustered O 0 1.5106753892268898e-07
in O 0 3.1831456914765965e-10
the O 0 3.1937638644841115e-10
region O 0 4.4477224681038763e-10
corresponding O 0 2.360014961233503e-10
to O 0 1.9315521404550395e-10
the O 0 2.2003896482658547e-09
kinase O 0 3.361035005866597e-09
domain O 0 6.478980685287183e-10
, O 0 4.979498150620154e-12
which O 0 2.3305699817927072e-12
is O 0 5.0943563603689235e-12
highly O 0 5.627533439245269e-10
conserved O 0 1.867161536495132e-09
in O 0 3.8596298379545146e-10
ATM O 0 8.819675940685556e-07
- O 0 4.273366371876364e-08
related O 0 2.2928849929826356e-08
proteins O 0 3.000017734233751e-10
in O 0 2.3822660510930405e-10
mouse O 0 3.5434797318600886e-09
, O 0 1.9693245298380013e-11
yeast O 0 3.238596590904308e-08
and O 0 3.719461183493422e-09
Drosophila O 0 2.5703698725010327e-07
. O 0 2.3144323790802446e-08

The O 0 8.61667714957548e-08
resulting O 0 4.416297727516394e-08
amino O 0 1.6198320906823938e-08
- O 0 2.586519975977808e-08
acid O 0 1.5831780331154732e-08
substitutions O 0 3.479268428918658e-08
are O 0 1.175518710150314e-10
predicted O 0 2.977019075700582e-09
to O 0 3.2976474328982874e-10
interfere O 0 5.082950504942119e-09
with O 0 5.516435641617079e-10
ATP O 0 0.161308154463768
binding O 0 1.395294049189033e-07
or O 0 6.421628562236492e-09
substrate O 0 3.526128011799301e-07
recognition O 0 1.2948987659910927e-07
. O 0 1.1498049445890501e-07

Two O 0 5.062122454546625e-08
of O 0 7.560414161389417e-08
seventeen O 0 6.832303256487648e-07
mutated O 0 4.2454357185306435e-07
T B-Disease 0 3.725989017766551e-06
- I-Disease 0 5.433396950138558e-07
PLL I-Disease 0 2.7958258215221576e-06
samples O 0 5.874368547154063e-09
had O 0 9.947178497560216e-11
a O 0 9.807406622930337e-12
previously O 0 2.6360028049232653e-10
reported O 0 1.15580989223929e-09
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
allele O 0 1.162866510640015e-06
. O 0 5.2339004241730436e-08

In O 0 2.9345191165930373e-08
contrast O 0 1.8642303700744378e-08
, O 0 1.3623957517694407e-10
no O 0 7.143643315776771e-11
mutations O 0 1.0433068298176806e-10
were O 0 1.8159171388809625e-10
detected O 0 1.4125400848996605e-09
in O 0 4.805834064036674e-10
the O 0 2.7501800836660095e-09
p53 O 0 9.446770032894847e-10
gene O 0 7.703507276524135e-11
, O 0 6.124466819107388e-12
suggesting O 0 4.718931842506713e-11
that O 0 2.2215898825422853e-12
this O 0 1.016849937585107e-09
tumour B-Disease 1 1.0
suppressor O 0 1.5833335055503994e-05
is O 0 2.0261873776017403e-11
not O 0 2.615696504879028e-12
frequently O 0 8.222874638141864e-12
altered O 0 3.00470787140128e-10
in O 0 1.9579547705372846e-10
this O 0 3.996805109096613e-09
leukaemia B-Disease 0 0.004032333847135305
. O 0 9.42269977599608e-08

Occasional O 0 5.718685315514449e-06
missense O 0 2.6565170628600754e-05
mutations O 0 8.552149921570162e-08
in O 0 1.0544469297713022e-08
ATM O 0 9.826560926740058e-06
were O 0 1.6931391400021312e-08
also O 0 1.132101357104176e-10
found O 0 1.235493235496321e-10
in O 0 6.75011713191509e-10
tumour B-Disease 1 0.9999992847442627
DNA O 0 5.934056090950435e-08
from O 0 1.3639799290032784e-09
patients O 0 1.8293228043475551e-09
with O 0 1.851407048503173e-11
B B-Disease 0 4.488277045311406e-05
- I-Disease 0 6.369859306687431e-08
cell I-Disease 0 3.1202958439280337e-07
non I-Disease 0 3.160154165016138e-06
- I-Disease 0 0.018381938338279724
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9035375714302063
( O 0 1.9031227982413412e-10
B B-Disease 0 2.7161078719473153e-07
- I-Disease 0 1.7799800522411147e-09
NHL I-Disease 0 1.357198868845444e-07
) O 0 8.097676175433666e-12
and O 0 1.8326737696860995e-11
a O 0 1.737751331720716e-10
B B-Disease 0 2.3498316750192316e-06
- I-Disease 0 6.188392376316187e-08
NHL I-Disease 0 5.794040589535143e-06
cell O 0 1.397458078145064e-07
line O 0 1.3256253339477553e-07
. O 0 3.4864562792336073e-08

The O 0 7.773758525786434e-09
evidence O 0 1.0767252645038639e-09
of O 0 1.2161328610815758e-09
a O 0 5.815023115807172e-11
significant O 0 6.025486776195521e-10
proportion O 0 4.045793033924383e-09
of O 0 4.030004774335794e-09
loss O 0 1.8165668080882824e-08
- O 0 3.2918755721311754e-08
of O 0 5.851603646078729e-08
- O 0 1.6764039045824575e-08
function O 0 1.249222530974592e-10
mutations O 0 2.3137049567911738e-11
and O 0 1.6998468604922934e-12
a O 0 1.431933456357004e-12
complete O 0 2.155916140056391e-10
absence O 0 2.232829476866982e-09
of O 0 4.975041489885257e-10
the O 0 6.694493570602589e-11
normal O 0 7.132587576119676e-11
copy O 0 2.0730120398049223e-10
of O 0 1.468522803360628e-10
ATM O 0 1.4638373180275721e-08
in O 0 4.1959925117796004e-11
the O 0 1.0696402791277038e-10
majority O 0 8.186010203026228e-11
of O 0 2.5081068333321355e-09
mutated O 0 6.587109055544715e-06
tumours B-Disease 1 1.0
establishes O 0 4.187028324054154e-08
somatic O 0 1.4198397479958658e-07
inactivation O 0 2.1213269008057978e-07
of O 0 4.318410906645198e-10
this O 0 1.8767857060120186e-11
gene O 0 3.112682334105443e-11
in O 0 2.2438245705913573e-11
the O 0 2.606117543990649e-10
pathogenesis O 0 1.5196790172922192e-06
of O 0 1.2739890031809864e-08
sporadic B-Disease 0 9.547379704599734e-07
T I-Disease 0 0.00010791807289933786
- I-Disease 0 8.975164746516384e-06
PLL I-Disease 0 3.270856905146502e-05
and O 0 2.401051024669698e-10
suggests O 0 1.5863259317239198e-10
that O 0 9.858659028028072e-13
ATM O 0 1.9903156456280158e-08
acts O 0 1.3615696070612415e-10
as O 0 2.0315180648822206e-09
a O 0 1.1990638704162393e-08
tumour B-Disease 1 0.9999998807907104
suppressor O 0 8.629399962956086e-05
. O 0 2.1131413063812943e-07

As O 0 2.455653032029659e-07
constitutional O 0 3.235951453461894e-07
DNA O 0 2.185650593844457e-08
was O 0 1.0122386262523264e-09
not O 0 5.5145571269121785e-12
available O 0 5.984902157196714e-11
, O 0 1.2284667207096422e-11
a O 0 2.2622570483576965e-10
putative O 0 1.690241515461821e-05
hereditary O 1 0.9999998807907104
predisposition O 1 0.9999678134918213
to O 0 1.9790119040408172e-05
T B-Disease 1 0.9999994039535522
- I-Disease 1 0.9910456538200378
PLL I-Disease 0 0.0031359221320599318
will O 0 4.720581148198733e-10
require O 0 1.405406901966444e-10
further O 0 2.6815821785319827e-10
investigation O 0 1.0663429028667792e-09
. O 0 1.0042443543412105e-09
. O 0 1.0731582733569667e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 4.622929736797232e-06
kinase O 0 7.8522660373892e-08
is O 0 3.7448988354782387e-11
involved O 0 1.0878298262184671e-11
in O 0 8.042111247774653e-12
the O 0 2.5158611305364786e-11
modulation O 0 3.6728531327412384e-10
of O 0 2.9323674044512416e-10
the O 0 1.744680067083948e-09
Ca2 O 0 1.4712774110137161e-08
+ O 0 2.5035244988202976e-08
homeostasis O 0 6.21341911255513e-08
in O 0 4.851702595232155e-09
skeletal O 0 5.800868052574515e-07
muscle O 0 1.2326767091508373e-06
cells O 0 2.999013759108493e-06
. O 0 3.3328910831187386e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.942732498922851e-05
DM B-Disease 1 1.0
) O 0 1.072538236002174e-08
, O 0 6.533431434752046e-11
the O 0 1.1412199657501176e-10
most O 0 2.9670534917869418e-09
prevalent O 1 0.9999775886535645
muscular B-Disease 1 0.9999934434890747
disorder I-Disease 1 0.9999978542327881
in O 0 5.748226499235898e-07
adults O 0 1.3879914106951219e-08
, O 0 2.1775693227754633e-12
is O 0 3.473742832011545e-13
caused O 0 5.1626945773985966e-11
by O 0 6.625773263380097e-10
( O 0 2.0637568043380128e-10
CTG O 0 1.30012921317757e-07
) O 0 5.118179317864513e-12
n O 0 4.7844391642959394e-11
- O 0 2.543587007686199e-10
repeat O 0 1.3613125904310408e-10
expansion O 0 1.030841634275248e-09
in O 0 2.1931430629895665e-11
a O 0 7.16965679534165e-12
gene O 0 5.387234061626778e-12
encoding O 0 4.350421134446947e-10
a O 0 2.8878913149732455e-10
protein O 0 3.5674592169243624e-09
kinase O 0 3.743233634168064e-08
( O 0 1.7116855710597179e-09
DM B-Disease 1 1.0
protein O 0 7.488183939585724e-08
kinase O 0 5.993841867280025e-09
; O 0 7.840671167880231e-11
DMPK O 0 1.5367893865914084e-05
) O 0 4.3946957184459734e-11
and O 0 1.7284155010011126e-11
involves O 0 1.0332584787775545e-10
changes O 0 4.671854569870959e-10
in O 0 4.350672266895117e-09
cytoarchitecture O 0 3.2977830414893106e-05
and O 0 5.881367570736984e-08
ion O 0 5.33822139914264e-06
homeostasis O 0 1.771373354131356e-05
. O 0 1.0383605513197836e-06

To O 0 1.8858166583868297e-08
obtain O 0 2.622695483012194e-08
clues O 0 4.926623020651277e-08
to O 0 6.163446142348761e-11
the O 0 2.5418847582336923e-10
normal O 0 1.0783283155291201e-09
biological O 0 1.6462029517327892e-09
role O 0 6.702980948070092e-10
of O 0 4.588554247675347e-08
DMPK O 1 1.0
in O 0 8.323037036461756e-06
cellular O 0 1.9195010736439144e-07
ion O 0 8.902535597599126e-08
homeostasis O 0 4.70666918772622e-08
, O 0 2.6834853783519463e-10
we O 0 1.166635538174532e-10
have O 0 2.5319253638134143e-11
compared O 0 2.5542497006370013e-09
the O 0 3.034508422317117e-09
resting O 0 1.2388339598601306e-07
[ O 0 8.818836771951055e-10
Ca2 O 0 2.1571626429572888e-10
+ O 0 1.5413723075674568e-10
] O 0 2.0110264842276848e-10
i O 0 3.554306501896143e-11
, O 0 8.988318444570764e-13
the O 0 3.015084275997948e-12
amplitude O 0 1.0468988870249163e-10
and O 0 1.7940036609043197e-11
shape O 0 9.334218953327422e-10
of O 0 1.1740134420179515e-09
depolarization O 0 3.870020037766153e-08
- O 0 4.7265508840155235e-08
induced O 0 4.546033949281991e-08
Ca2 O 0 8.951326346817723e-10
+ O 0 2.0383170151738739e-10
transients O 0 1.7389923945287933e-09
, O 0 1.328050408359871e-12
and O 0 1.873129906390658e-12
the O 0 1.2922243136648248e-11
content O 0 1.3975640089647356e-10
of O 0 6.490706860873274e-10
ATP O 0 1.8621374692884274e-05
- O 0 1.8606677087973367e-07
driven O 0 1.0985890241954621e-07
ion O 0 7.455761874552991e-08
pumps O 0 5.769170474678731e-09
in O 0 4.746529835841784e-10
cultured O 0 1.860435219214196e-07
skeletal O 0 8.914361870893117e-08
muscle O 0 2.13827910933162e-09
cells O 0 1.9907282489128875e-09
of O 0 1.940422933444097e-09
wild O 0 1.2126243120746949e-08
- O 0 3.882777710462193e-10
type O 0 1.3169334511786701e-09
and O 0 1.2705031471327288e-10
DMPK O 0 1.2872253137174994e-05
[ O 0 1.8205314589181398e-08
- O 0 4.800168653673609e-07
/ O 0 2.2435215214500204e-06
- O 0 8.912476187106222e-05
] O 0 1.9834617432934465e-06
knockout O 0 0.00020958711684215814
mice O 0 2.193201282807422e-07
. O 0 9.291060365512749e-09

In O 0 4.045780315209413e-07
vitro O 0 2.3002912712399848e-06
- O 0 1.34751735458849e-06
differentiated O 0 2.4447199393762276e-06
DMPK O 0 0.007708679419010878
[ O 0 6.743765368355525e-08
- O 0 9.106181408924385e-08
/ O 0 6.87769343699074e-08
- O 0 1.5507932005220937e-07
] O 0 1.3580800484191968e-08
myotubes O 0 1.184781766028209e-07
exhibit O 0 4.774076689528783e-10
a O 0 4.177115250914021e-11
higher O 0 9.611475171311668e-09
resting O 0 9.295211356175059e-08
[ O 0 5.516403445149365e-10
Ca2 O 0 1.973506913444112e-10
+ O 0 3.2032079766430854e-10
] O 0 2.4934715403546193e-10
i O 0 3.5947772536459865e-11
than O 0 8.431436972211603e-12
do O 0 1.7904452226380485e-11
wild O 0 1.577365904559258e-09
- O 0 8.808179741137678e-10
type O 0 1.205388144853714e-08
myotubes O 0 1.019180331240932e-06
because O 0 1.2918164316033653e-09
of O 0 3.6996128383037785e-10
an O 0 1.9449032228474605e-12
altered O 0 5.170896488770893e-10
open O 0 8.323589040237778e-10
probability O 0 9.578925846964736e-11
of O 0 1.4875062293029373e-10
voltage O 0 6.846673272775661e-08
- O 0 5.179943585176261e-08
dependent O 0 6.274643027381899e-09
l O 0 7.192317852400265e-10
- O 0 1.1084109186043634e-09
type O 0 1.0893549395873947e-09
Ca2 O 0 5.717245010750105e-10
+ O 0 1.0872874822709377e-09
and O 0 3.176522656023195e-10
Na O 0 1.3482021188337967e-07
+ O 0 1.726684928371469e-08
channels O 0 5.981770190288671e-09
. O 0 6.648233519257474e-09

The O 0 1.6823862551973434e-06
mutant O 0 3.1770523492014036e-06
myotubes O 0 2.1928381102043204e-05
exhibit O 0 6.100054150692813e-08
smaller O 0 5.1566177994288864e-09
and O 0 4.2763703689274735e-10
slower O 0 6.639340455194542e-08
Ca2 O 0 1.1509948549814908e-08
+ O 0 1.6254266821391639e-09
responses O 0 1.5821771670587736e-10
upon O 0 3.832092976274737e-10
triggering O 0 1.8120913658492555e-09
by O 0 6.974887334365576e-11
acetylcholine O 0 1.4692855820896966e-09
or O 0 9.816025769993075e-10
high O 0 3.5409684073783865e-08
external O 0 2.122400921678036e-08
K O 0 5.461965884023812e-07
+ O 0 1.8360527320737674e-08
. O 0 5.249684686958744e-09

In O 0 3.261918735120162e-08
addition O 0 6.817169051487326e-09
, O 0 4.4988121561395644e-10
we O 0 6.369996197186367e-11
observed O 0 6.772036403868142e-11
that O 0 8.746957693740731e-13
these O 0 3.901721654098189e-11
Ca2 O 0 1.9982566712428707e-09
+ O 0 4.3501495738951235e-09
transients O 0 2.7777479871815558e-08
partially O 0 2.850889246897026e-10
result O 0 1.6020882537270964e-11
from O 0 3.097733528023561e-11
an O 0 1.0019412599940325e-12
influx O 0 8.298443876508799e-11
of O 0 1.0271474643053224e-10
extracellular O 0 1.6082919718218847e-10
Ca2 O 0 1.7931528484282921e-10
+ O 0 1.6141800396329842e-10
through O 0 3.188193459235933e-11
the O 0 1.0198580868703289e-10
l O 0 1.1359456708603943e-09
- O 0 8.637488946305893e-09
type O 0 1.2872766852467521e-08
Ca2 O 0 9.863418526379064e-09
+ O 0 1.359557266766842e-08
channel O 0 2.3595030373968484e-09
. O 0 3.6993677010599413e-09

Neither O 0 2.017855877056718e-06
the O 0 3.180466734420406e-08
content O 0 1.540036720371063e-08
nor O 0 8.586240163310777e-09
the O 0 3.8842593030885553e-10
activity O 0 5.580183537468031e-10
of O 0 3.2313880460321798e-09
Na O 0 5.833806540067599e-07
+ O 0 2.6568017119643628e-08
/ O 0 4.455011648474283e-08
K O 0 9.508964637916506e-08
+ O 0 2.8989910472176916e-09
ATPase O 0 4.9586548200863945e-09
and O 0 1.629383433732201e-10
sarcoplasmic O 0 7.785914846181186e-08
reticulum O 0 2.5700947148266096e-08
Ca2 O 0 4.234685047066478e-09
+ O 0 1.9903487746830706e-09
- O 0 3.890697541919508e-09
ATPase O 0 2.2130546284415686e-09
are O 0 1.1203786162705676e-11
affected O 0 1.154905754363611e-10
by O 0 6.929250506715334e-10
DMPK O 1 0.9988501071929932
absence O 0 0.00011220168380532414
. O 0 1.6446273320980254e-06

In O 0 4.4487368455747855e-08
conclusion O 0 1.2550505346098362e-07
, O 0 9.211141849263527e-10
our O 0 1.523990100782413e-10
data O 0 5.0775574716999117e-11
suggest O 0 3.466598189061365e-11
that O 0 5.0045206693993816e-12
DMPK O 0 0.23399251699447632
is O 0 5.1386842697676016e-11
involved O 0 8.53070912520959e-12
in O 0 6.78386210054005e-12
modulating O 0 8.011758478865261e-10
the O 0 9.736084161104941e-11
initial O 0 1.6092736865314095e-10
events O 0 9.862011381145397e-12
of O 0 2.883700916944676e-11
excitation O 0 1.4207062193349884e-08
- O 0 7.360695519764704e-08
contraction O 0 1.774631641637825e-08
coupling O 0 3.835687323316961e-08
in O 0 3.6212755016862275e-09
skeletal O 0 6.225792503755656e-08
muscle O 0 1.4281394733473007e-08
. O 0 1.0986284770808652e-08
. O 0 6.014113296259893e-08

Constitutional O 0 0.001071360195055604
RB1 O 1 0.9880120754241943
- O 0 0.0066586947068572044
gene O 0 2.896174748912017e-07
mutations O 0 4.116190766012551e-08
in O 0 3.5723277669319486e-09
patients O 0 8.034292164893486e-08
with O 0 8.90093165839545e-10
isolated O 0 3.490506514935987e-06
unilateral B-Disease 0 1.790970236470457e-05
retinoblastoma I-Disease 1 1.0
. O 0 0.010046031326055527

In O 0 8.844888554904173e-08
most O 0 1.227232004907819e-08
patients O 0 1.505688018710316e-08
with O 0 1.374543395771255e-10
isolated O 0 3.5386023000683053e-07
unilateral B-Disease 0 1.037366564560216e-05
retinoblastoma I-Disease 1 1.0
, O 0 2.7208855044591473e-06
tumor B-Disease 1 0.8374906778335571
development O 0 1.126485038582814e-08
is O 0 1.3867720340121625e-11
initiated O 0 1.7810387886729728e-10
by O 0 1.2740113651543705e-11
somatic O 0 4.797795050137665e-09
inactivation O 0 2.4099730211446513e-08
of O 0 1.2587010600473292e-10
both O 0 1.8948852903433178e-11
alleles O 0 1.3445780600029877e-10
of O 0 5.448486661840946e-10
the O 0 1.037695351868706e-08
RB1 O 0 7.257766264956445e-05
gene O 0 5.799004654249984e-08
. O 0 1.266563458557357e-07

However O 0 4.669070676754927e-07
, O 0 1.143678485249211e-09
some O 0 1.0308844750062107e-10
of O 0 7.582299788033708e-10
these O 0 2.533831366946515e-09
patients O 0 6.147136133449749e-08
can O 0 1.2383958303274767e-09
transmit O 0 9.042936710557115e-08
retinoblastoma B-Disease 0 0.0438709631562233
predisposition O 0 0.00022891315165907145
to O 0 1.1121814225134585e-07
their O 0 1.0981999594150693e-06
offspring O 0 6.085445875214646e-06
. O 0 9.615347806857244e-08

To O 0 2.223085271424452e-09
determine O 0 1.0277456663487783e-09
the O 0 3.1031635594480633e-10
frequency O 0 7.495764564602325e-10
and O 0 8.927961148152974e-11
nature O 0 4.028266054056928e-10
of O 0 1.4735120901221421e-09
constitutional O 0 1.4887906218064018e-05
RB1 O 1 0.9966894388198853
- O 0 8.382703526876867e-05
gene O 0 2.0197928662923914e-08
mutations O 0 1.938920801691779e-09
in O 0 1.9386756089367907e-10
patients O 0 3.540074899888168e-09
with O 0 5.633265381943531e-11
isolated O 0 8.375945270699958e-08
unilateral B-Disease 0 4.655296095279482e-07
retinoblastoma I-Disease 1 0.9999972581863403
, O 0 2.5579566909073037e-08
we O 0 5.113803269729544e-10
analyzed O 0 1.3817121891079864e-09
DNA O 0 7.027933235370654e-10
from O 0 3.8389330603294525e-10
peripheral O 0 3.751961799025594e-07
blood O 0 4.1682074680693404e-08
and O 0 2.3906561175124352e-09
from O 0 1.652271919283521e-08
tumor B-Disease 0 5.651580977428239e-06
tissue O 0 5.197386485633615e-07
. O 0 8.661000805432195e-08

The O 0 1.3460214276506122e-08
analysis O 0 3.0669535799887626e-09
of O 0 1.4223579114513996e-07
tumors B-Disease 1 1.0
from O 0 5.362855404200673e-07
54 O 0 5.237515665612591e-07
( O 0 1.1689363366151895e-10
71 O 0 6.944283814647179e-09
% O 0 2.2282451925259572e-11
) O 0 1.9491144809258287e-12
of O 0 5.297095539980035e-10
76 O 0 5.188912837184034e-07
informative O 0 6.131163843292597e-08
patients O 0 2.4445929724947746e-08
showed O 0 3.387213287631141e-10
loss O 0 1.9359791547657323e-09
of O 0 9.77401271029521e-09
constitutional O 0 1.6109579519252293e-05
heterozygosity O 1 0.8283789157867432
( O 0 4.048249380161906e-08
LOH O 0 0.001476406934671104
) O 0 3.5789482488723934e-10
at O 0 8.817832686247584e-09
intragenic O 0 2.3198765575216385e-06
loci O 0 1.6519841210538289e-06
. O 0 3.334296252432978e-07

Three O 0 4.227448258120603e-08
of O 0 2.4164997114439757e-08
13 O 0 2.4800209530440043e-07
uninformative O 0 0.253630131483078
patients O 0 9.889814828056842e-05
had O 0 4.865939473575054e-08
constitutional O 0 5.002535090170568e-06
deletions O 0 2.9448883651639335e-05
. O 0 7.666383680771105e-06

For O 0 3.087221784880967e-07
39 O 0 2.6492648430576082e-06
randomly O 0 2.3818512318030116e-07
selected O 0 5.789616352558369e-06
tumors B-Disease 1 1.0
, O 0 3.111903268404603e-08
SSCP O 1 0.9999998807907104
, O 0 7.715914307482308e-08
hetero O 0 2.2172314402268967e-06
- O 0 2.0755381413550822e-08
duplex O 0 5.870314012668132e-09
analysis O 0 7.759100306703459e-11
, O 0 5.0268873265368885e-12
sequencing O 0 1.1343109784789362e-09
, O 0 1.0581160947431556e-11
and O 0 2.696207493380065e-11
Southern O 0 9.877684226111683e-10
blot O 0 1.1839421887316348e-08
analysis O 0 5.6747519877609065e-11
were O 0 8.366385362279516e-11
used O 0 9.578999399240118e-11
to O 0 6.175592814905428e-10
identify O 0 4.425108457439819e-08
mutations O 0 2.9780639465570857e-07
. O 0 4.4517165065371955e-07

Mutations O 0 2.8799132678614114e-07
were O 0 8.68423821742681e-09
detected O 0 1.1337967009694694e-08
in O 0 1.218580125694757e-09
21 O 0 1.8082875641312057e-08
( O 0 8.759889341680704e-11
91 O 0 3.8410757241535975e-08
% O 0 4.674490308720358e-11
) O 0 4.680233197523753e-12
of O 0 2.676197929929458e-09
23 O 0 4.477324546314776e-05
tumors B-Disease 1 1.0
with O 0 5.890084139537066e-05
LOH O 1 1.0
. O 0 0.0009532156400382519

In O 0 1.8221247444216715e-07
6 O 0 2.027931031989283e-07
( O 0 2.9723085104294e-10
38 O 0 4.056301516897065e-09
% O 0 5.6629881339809174e-11
) O 0 1.2595769913192889e-11
of O 0 5.835572469692352e-09
16 O 0 1.571305801917333e-05
tumors B-Disease 1 1.0
without O 1 0.9999312162399292
LOH O 1 1.0
, O 0 3.49379036812536e-09
one O 0 8.863148409643529e-11
mutation O 0 2.553390138215761e-11
was O 0 2.6582574683131632e-11
detected O 0 1.1795299459382846e-10
, O 0 2.7744592647621635e-12
and O 0 8.995217765095376e-12
in O 0 2.424752343355152e-10
9 O 0 6.2206377826612425e-09
( O 0 1.081536336183797e-11
56 O 0 2.723821168615359e-10
% O 0 2.8562909416135485e-12
) O 0 5.781584521032113e-13
of O 0 2.597571879814353e-10
the O 0 2.3453935682482552e-07
tumors B-Disease 1 1.0
without O 1 0.9737840294837952
LOH O 1 1.0
, O 0 1.1049623438452727e-08
both O 0 2.14519513264122e-09
mutations O 0 5.020839299874069e-09
were O 0 3.977966844814773e-09
found O 0 2.2504833552261516e-09
. O 0 2.8306438082381646e-08

Thus O 0 6.063930868549505e-08
, O 0 2.161231471564662e-10
a O 0 9.103385580078172e-12
total O 0 3.302643575286979e-11
of O 0 2.428987844194097e-10
45 O 0 1.575519714691609e-09
mutations O 0 3.3205838079197747e-10
were O 0 6.675829333779859e-10
identified O 0 1.5780702300460803e-09
in O 0 2.5016152704893102e-08
tumors B-Disease 1 1.0
of O 0 2.4648230464663357e-05
36 O 0 0.00016824765771161765
patients O 0 3.12074480461888e-05
. O 0 1.3860686465250183e-07

Thirty O 0 7.936992915347219e-06
- O 0 6.22104948888591e-07
nine O 0 8.079869218136082e-09
of O 0 1.7073423785873842e-09
the O 0 1.6138730352110997e-09
mutations O 0 8.475624091452971e-10
- O 0 2.8480060976221466e-08
including O 0 3.950768601157506e-09
34 O 0 3.6006632342378e-08
small O 0 1.0294701757729285e-09
mutations O 0 2.427677225913527e-10
, O 0 6.037689792570688e-11
2 O 0 4.702485068008855e-09
large O 0 9.802199052444394e-10
structural O 0 1.6152595705420936e-08
alterations O 0 5.396765118348412e-06
, O 0 1.532631799250339e-08
and O 0 3.437750351054092e-08
hypermethylation O 1 0.5707836151123047
in O 0 3.5817893717648985e-07
3 O 0 1.6778228655311977e-06
tumors O 1 0.999992847442627
- O 0 7.96442467532188e-09
were O 0 4.79173811740452e-10
not O 0 8.820006357213028e-12
detected O 0 3.907555112814265e-10
in O 0 3.44817334407832e-11
the O 0 3.714057117409908e-10
corresponding O 0 5.846479744775479e-09
peripheral O 0 4.2412775655975565e-06
blood O 0 1.0439113395932509e-07
DNA O 0 1.6411085823619942e-07
. O 0 4.364429884162746e-08

In O 0 3.5644112017507723e-07
6 O 0 2.424528986466612e-07
( O 0 2.580751723435526e-10
17 O 0 1.0405448724881694e-09
% O 0 6.593090223078191e-12
) O 0 7.980557404155264e-13
of O 0 8.79658984542786e-11
the O 0 3.620640010026932e-09
36 O 0 9.857535587798338e-08
patients O 0 1.553229651563015e-07
, O 0 2.3349227065705414e-11
a O 0 3.6239251183234344e-11
mutation O 0 3.305878348847102e-10
was O 0 8.798138884102968e-10
detected O 0 2.7592543805354808e-09
in O 0 2.45431758250092e-10
constitutional O 0 1.0455488919092204e-08
DNA O 0 4.913407902762401e-09
, O 0 1.0447519585565779e-11
and O 0 1.0679456451112568e-11
1 O 0 3.9372333171527885e-10
of O 0 2.3164084539395446e-10
these O 0 1.3455067615630867e-10
mutations O 0 9.028550823630965e-11
is O 0 2.4928982489402784e-12
known O 0 2.4894310571288436e-11
to O 0 7.036886264660813e-12
be O 0 2.5255296118298354e-11
associated O 0 7.394798662296864e-10
with O 0 1.0000483080530032e-10
reduced O 0 3.8977336203060986e-07
expressivity O 0 3.967058000853285e-05
. O 0 3.7157371934881667e-07

The O 0 2.4001332477041615e-08
presence O 0 6.286858811321849e-10
of O 0 2.357658734908341e-09
a O 0 3.7377934081206377e-10
constitutional O 0 8.543296559082592e-08
mutation O 0 1.435079943767903e-09
was O 0 2.9993940664496677e-10
not O 0 2.5413874563812167e-12
associated O 0 3.454433614158425e-11
with O 0 1.1812645046155312e-12
an O 0 7.311675678974006e-13
early O 0 1.3265847087495786e-08
age O 0 1.2950119199217625e-08
at O 0 4.286237142991922e-09
treatment O 0 6.429830818888149e-07
. O 0 1.658470409893198e-07

In O 0 7.35626031200809e-08
1 O 0 2.730222377067548e-07
patient O 0 3.2100740554596996e-07
, O 0 5.18404985605514e-10
somatic O 0 1.512893049948616e-05
mosaicism O 0 0.04024958238005638
was O 0 3.2456322074381205e-09
demonstrated O 0 3.4502142809422764e-10
by O 0 4.56886915453647e-12
molecular O 0 2.7283694400970226e-11
analysis O 0 4.335663772447873e-12
of O 0 3.2662653831616595e-11
DNA O 0 9.171713943878501e-10
and O 0 1.4021189764790165e-10
RNA O 0 6.618526171564554e-09
from O 0 4.9308699345829154e-09
peripheral O 0 1.064796197169926e-05
blood O 0 1.4873950249238987e-06
. O 0 4.414815748532419e-07

In O 0 1.9475675117064384e-07
2 O 0 1.9802966733095673e-07
patients O 0 1.0757794655091857e-08
without O 0 1.1629924800971025e-09
a O 0 6.051920076188821e-10
detectable O 0 3.019414862137637e-06
mutation O 0 5.91635824775949e-08
in O 0 4.126754049593728e-09
peripheral O 0 4.116515356145101e-06
blood O 0 1.769051038991165e-07
, O 0 4.801545827604059e-10
mosaicism O 0 4.0394138522970024e-06
was O 0 1.198441457184174e-09
suggested O 0 1.3960241296295806e-10
because O 0 1.9815057580863105e-11
1 O 0 5.075845854740635e-10
of O 0 2.2245688624522586e-10
the O 0 4.367158634721591e-09
patients O 0 4.0256898614643433e-07
showed O 0 1.7148292386082176e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 3.832396444636288e-08
the O 0 9.623380314849328e-09
other O 0 8.383273519818601e-10
later O 0 9.408473111705007e-09
developed O 0 7.65528511692537e-08
bilateral B-Disease 0 3.620349389166222e-06
retinoblastoma I-Disease 0 0.031638383865356445
. O 0 4.8325869101972785e-06

In O 0 1.8448885086286282e-08
conclusion O 0 3.35474759083354e-08
, O 0 4.680434373405262e-10
our O 0 2.4800106412925516e-10
results O 0 3.7302155808660586e-10
emphasize O 0 3.878262988532555e-10
that O 0 1.0773686630327628e-12
the O 0 9.018946700578567e-11
manifestation O 0 8.5224812096385e-08
and O 0 1.5782748441495187e-09
transmissibility O 0 8.372593583771959e-06
of O 0 3.713508434088908e-08
retinoblastoma B-Disease 0 1.96751216208213e-06
depend O 0 1.1957705048359912e-08
on O 0 1.3523822062211366e-09
the O 0 1.0377379511261609e-10
nature O 0 2.3714478297742758e-11
of O 0 5.245275394583082e-11
the O 0 8.88586357272736e-11
first O 0 1.7280767095062544e-10
mutation O 0 2.4758785299727748e-11
, O 0 7.313627784985566e-13
its O 0 1.2057260571907147e-12
time O 0 2.8998449475015065e-11
in O 0 3.106869275737445e-11
development O 0 2.5843968631811265e-10
, O 0 2.592401987522308e-12
and O 0 2.658687072581989e-12
the O 0 1.9131231321356523e-11
number O 0 1.2727920280231064e-11
and O 0 8.27132373010242e-12
types O 0 3.0182056853789163e-10
of O 0 2.3551854910763836e-10
cells O 0 5.157635429853258e-11
that O 0 1.5945513139048462e-12
are O 0 1.9091790648406715e-11
affected O 0 1.0767888802831749e-09
. O 0 1.7028088938886299e-09
. O 0 2.9411085122887926e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999988079071045
of I-Disease 0 0.0001678475528024137
the I-Disease 0 1.735674914016272e-06
fifth I-Disease 0 2.1143096091691405e-06
component I-Disease 0 9.516040933021941e-08
of I-Disease 0 1.1852842263238017e-08
complement I-Disease 0 6.379951145163432e-08
in O 0 1.630792780815682e-07
man O 0 6.930206950528373e-07
. O 0 1.8589295791571203e-07

I O 0 0.004334559198468924
. O 0 1.2824501027353108e-05

Clinical O 0 3.808283508988097e-05
, O 0 8.610085977522886e-09
immunochemical O 0 0.004403939004987478
, O 0 1.3524938502484929e-08
and O 0 3.1533677891104617e-09
family O 0 3.925694880280162e-09
studies O 0 2.8604498769624342e-09
. O 0 1.045949815647873e-08

The O 0 5.5288282396759314e-08
first O 0 1.0766066260714524e-08
recognized O 0 8.297898368425649e-09
human O 0 4.180235713135971e-09
kindred O 0 0.00034584783134050667
with O 0 2.467255555416159e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9759885668754578
the I-Disease 0 1.102097712646355e-06
fifth I-Disease 0 2.919298935921688e-07
component I-Disease 0 1.614132472127494e-08
of I-Disease 0 2.4138188337019528e-08
complement I-Disease 0 8.279403118649498e-07
( O 0 3.0634414116548214e-08
C5 O 1 0.6258077621459961
) O 0 4.0800277045782707e-10
is O 0 1.379960035130523e-10
described O 0 6.530360696643811e-09
. O 0 6.143760344912153e-08

The O 0 6.78013577726233e-07
proband O 0 0.00016232958296313882
, O 0 2.5468651632110095e-09
a O 0 2.2827849333051375e-10
20 O 0 3.6781599987989466e-10
- O 0 4.665914321577702e-10
year O 0 1.0380155623934684e-09
- O 0 2.1224575874612128e-08
old O 0 2.6626253202266525e-08
black O 0 2.1811671913063435e-10
female O 0 9.844044850104705e-12
with O 0 3.018353969541643e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9927911758422852
age O 0 0.0013902949867770076
11 O 0 7.9209456771423e-09
, O 0 8.93276563829204e-11
lacked O 0 7.597783024948512e-08
serum O 0 8.534257744940987e-08
hemolytic O 0 2.233188752143178e-05
complement O 0 8.35449842639946e-09
activity O 0 2.7087565523942203e-09
, O 0 1.7253325504396066e-11
even O 0 3.130030609699297e-11
during O 0 1.7116529305027939e-09
remission O 0 4.033044547213649e-07
. O 0 4.8926118267900165e-08

C5 O 0 0.025377821177244186
was O 0 1.0461402553119115e-06
undetectable O 0 2.73844148068747e-06
in O 0 3.98597199691153e-09
her O 0 1.031675161966561e-10
serum O 0 1.0375246217719791e-09
by O 0 6.692118387219281e-11
both O 0 5.198942387707461e-10
immunodiffusion O 0 0.00019368482753634453
and O 0 1.3508365270809009e-07
hemolytic O 1 0.9999990463256836
assays O 0 0.00016637190128676593
. O 0 1.2565168390210602e-06

Other O 0 1.5829666466515846e-08
complement O 0 7.652172229200005e-09
components O 0 2.0181140314434742e-08
were O 0 1.0522605009555264e-09
normal O 0 3.7321512547094926e-10
during O 0 1.430022322779223e-09
remission O 0 2.0757249785674503e-07
of O 0 1.5488615190406563e-07
lupus O 1 0.6086244583129883
, O 0 3.0814131246614807e-09
but O 0 2.1175809550300073e-08
C1 O 0 7.15966452844441e-05
, O 0 2.836214374468682e-09
C4 O 0 1.5409661500598304e-05
, O 0 4.625234917288168e-10
C2 O 0 3.1427569524566934e-07
, O 0 2.011655564349013e-10
and O 0 2.366407736431597e-09
C3 O 0 0.03106064535677433
levels O 0 2.3508400772698224e-06
fell O 0 5.557169424719177e-05
during O 0 5.484818643708422e-07
exacerbations O 0 0.0034836428239941597
. O 0 2.9160007670725463e-06

A O 0 4.919843377138022e-06
younger O 0 1.0758799362520222e-06
half O 0 5.849193129847663e-08
- O 0 7.906059181550518e-06
sister O 0 4.804024342774937e-07
, O 0 2.7018717818627636e-10
who O 0 5.532744401515188e-11
had O 0 8.674301277267205e-10
no O 0 6.2764620167854446e-09
underlying O 1 0.9983497858047485
disease O 0 0.057764433324337006
, O 0 1.1299571001099906e-10
was O 0 3.3662768128550624e-09
also O 0 3.312516927422848e-11
found O 0 2.6969071073579265e-11
to O 0 7.388648026740441e-11
lack O 0 1.4162982324705808e-06
immunochemically O 1 0.8385592699050903
detectable O 0 0.26259031891822815
C5 O 0 0.0009890642249956727
. O 0 6.655441779912508e-07

By O 0 4.3701859908651386e-07
hemolytic O 1 0.9579629898071289
assay O 0 1.566860191815067e-05
, O 0 6.150698617091166e-09
she O 0 6.941111574398917e-11
exhibited O 0 2.04852856899862e-10
1 O 0 6.152854892249593e-10
- O 0 9.446174953353648e-10
2 O 0 6.450104339528195e-10
% O 0 4.0106442472653825e-12
of O 0 7.884637387434168e-12
the O 0 7.415274644317904e-11
normal O 0 3.454232899713361e-09
serum O 0 7.007406566117425e-08
C5 O 0 4.788984142578556e-07
level O 0 1.920341663463887e-09
and O 0 1.4663137024029105e-11
normal O 0 6.235694599565633e-11
concentrations O 0 4.064508729584304e-10
of O 0 1.1641503733228475e-10
other O 0 1.7824286491219254e-10
complement O 0 7.515495781262871e-09
components O 0 2.6888761794907623e-07
. O 0 3.597259023990773e-07

C5 O 0 0.00014811755681876093
levels O 0 2.0093305863611022e-07
of O 0 1.604977839519961e-08
other O 0 1.386545989134902e-09
family O 0 1.2189445286470146e-10
members O 0 7.419572768674332e-12
were O 0 2.1411183936947964e-10
either O 0 8.768047399243528e-11
normal O 0 1.6373754574416921e-09
or O 0 6.346637798637644e-11
approximately O 0 2.8893550746422747e-11
half O 0 1.2162552909256164e-10
- O 0 1.1833636293090422e-09
normal O 0 3.310770546605113e-09
, O 0 1.0802128289078006e-11
consistent O 0 1.510233743617917e-10
with O 0 5.018725452582418e-12
autosomal O 0 1.7000187924054444e-08
codominant O 0 6.607289719795517e-07
inheritance O 0 3.659019398583041e-08
of O 0 7.461160578259296e-10
the O 0 1.3011687283182027e-09
gene O 0 1.730476384409485e-08
determining O 0 2.923142528743483e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 7.139517038012855e-06

Normal O 0 3.4077911550411955e-05
hemolytic O 1 0.6504812836647034
titers O 0 0.0003974633291363716
were O 0 3.684384708435573e-08
restored O 0 5.547610015810278e-08
to O 0 4.346365489737991e-10
both O 0 4.33304103708565e-09
homozygous O 0 0.0001314138062298298
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 5.3990230952649654e-08
C5D B-Disease 1 1.0
) O 0 1.7434026444718143e-09
sera O 0 2.473454996376745e-09
by O 0 6.123625911902408e-12
addition O 0 4.9837002580321865e-11
of O 0 1.2542059613096512e-09
highly O 0 1.65016228947934e-06
purified O 0 5.906625301577151e-05
human O 0 2.97394564086062e-07
C5 O 0 0.00024462526198476553
. O 0 4.573900866944314e-07

In O 0 2.242741885538635e-07
specific O 0 2.895191357765725e-07
C5 O 0 0.0006969184032641351
titrations O 0 1.750229057506658e-05
, O 0 3.9011879837680397e-10
however O 0 5.568605576655727e-10
, O 0 1.6598184632288238e-11
it O 0 4.654683322807829e-12
was O 0 7.321064310339409e-10
noted O 0 9.747250923064499e-11
that O 0 1.5582792218041264e-12
when O 0 6.557476783797256e-11
limited O 0 8.323457895142994e-11
amounts O 0 3.305052620472537e-10
of O 0 1.804296934082572e-09
C5 O 0 1.5386104905701359e-06
were O 0 2.092254813845784e-09
assayed O 0 5.179634499086205e-09
in O 0 2.824997701045273e-11
the O 0 2.3123373008027137e-11
presence O 0 1.8554512093427178e-11
of O 0 2.5895183219937223e-10
low O 0 6.154996157192727e-08
dilutions O 0 8.569989404350054e-06
of O 0 3.678851356880841e-08
either O 0 6.952954123562449e-08
C5D B-Disease 1 1.0
serum O 0 4.782151563631487e-07
, O 0 1.538147664792433e-10
curving O 0 1.0275046369301322e-09
rather O 0 2.3822646980087292e-11
than O 0 2.618177159449675e-12
linear O 0 1.4657636215886782e-10
dose O 0 8.77397798859647e-09
- O 0 1.6013016468363617e-09
response O 0 3.1060534699811626e-10
plots O 0 1.98250216243423e-09
were O 0 2.0134752198863737e-10
consistently O 0 5.491919072286855e-11
obtained O 0 2.690325739962418e-11
, O 0 9.892191232818703e-12
suggesting O 0 4.120554175646163e-10
some O 0 1.3128949316598693e-10
inhibitory O 0 3.375233958990975e-08
effect O 0 1.5768365813073615e-07
. O 0 4.664290997880016e-07

Further O 0 5.208118736277356e-08
studies O 0 2.4055675229561757e-09
suggested O 0 2.7668420332638277e-10
that O 0 8.22814559542362e-12
low O 0 5.939457636827683e-08
dilutions O 0 0.0012980333995074034
of O 0 2.31820240514935e-06
C5D B-Disease 1 1.0
serum O 0 1.2480721807150985e-06
contain O 0 1.1752008255427882e-09
a O 0 1.9002492288033856e-11
factor O 0 7.013899461227879e-10
( O 0 3.927973397932494e-12
or O 0 1.7207478497649475e-11
factors O 0 8.886987257206158e-10
) O 0 1.48618964357361e-11
interfering O 0 2.0280674362105344e-10
at O 0 4.107183482204846e-10
some O 0 9.035476533636455e-11
step O 0 5.0288324615621605e-09
in O 0 1.2503149626752474e-09
the O 0 5.098077515697241e-09
hemolytic O 0 0.0007051722495816648
assay O 0 2.798899231493124e-06
of O 0 1.2322113889240427e-06
C5 O 0 5.703119313693605e-06
, O 0 6.4185332396271555e-12
rather O 0 6.080191471830032e-12
than O 0 2.9658042514923988e-12
a O 0 7.394061751764269e-11
true O 0 2.7257989643203473e-08
C5 O 0 4.0585910028312355e-05
inhibitor O 0 6.33328511412401e-07
or O 0 1.3843138191305115e-08
inactivator O 0 1.3791076526104007e-05
. O 0 2.847075393219711e-07

Of O 0 3.4427114314894425e-07
clinical O 0 1.6957521438598633e-05
interest O 0 1.6535037161702348e-07
are O 0 1.726518511491193e-10
( O 0 1.2728115436622112e-11
a O 0 1.1994874711540593e-11
) O 0 1.3976107597624132e-12
the O 0 8.588553479516037e-12
documentation O 0 8.157179931522762e-10
of O 0 2.5512214563150337e-09
membranous O 1 0.9999669790267944
glomerulonephritis B-Disease 1 1.0
, O 0 3.252789326779748e-07
vasculitis B-Disease 1 1.0
, O 0 3.689412864105179e-08
and O 0 4.6123247443574655e-07
arthritis B-Disease 1 1.0
in O 0 1.3534491927202907e-07
an O 0 1.4092078892691262e-10
individual O 0 5.556799020922654e-09
lacking O 0 1.9682704078149982e-05
C5 O 0 4.549936784314923e-05
( O 0 3.058771985697817e-11
and O 0 3.032850706685686e-11
its O 0 3.1987187204540746e-11
biologic O 0 1.4499370593057392e-07
functions O 0 6.258464579911305e-11
) O 0 4.6546655418922e-12
, O 0 4.4444617257333174e-12
and O 0 2.2203201083259572e-11
( O 0 1.2956893370719147e-11
b O 0 3.879951915308766e-09
) O 0 3.5226515714831264e-12
a O 0 3.511664917188462e-11
remarkable O 0 2.086420591851379e-09
propensity O 0 4.34937170723515e-08
to O 0 9.553203783596587e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999998807907104
in O 0 2.824245004529047e-10
the O 0 5.535340588669335e-11
proband O 0 1.1730000970544552e-08
, O 0 3.1312591408649837e-12
even O 0 1.4240455602915203e-12
during O 0 1.2178470037982336e-11
periods O 0 4.813686671489847e-10
of O 0 2.5069479825390317e-10
low O 0 6.603823266004838e-09
- O 0 7.607214858040834e-10
dose O 0 1.3606936022370064e-08
or O 0 4.774839204579884e-11
alternate O 0 1.7100083571364166e-09
- O 0 3.193686648472749e-09
day O 0 1.2639421065330225e-08
corticosteroid O 0 3.2508432923350483e-06
therapy O 0 1.1628497986748698e-06
. O 0 2.0011070134273723e-08

Other O 0 3.124666747567062e-08
observations O 0 1.4985397811528856e-08
indicate O 0 5.407024827874807e-10
that O 0 8.087905345455226e-12
the O 0 5.838467487251364e-09
C5D B-Disease 1 1.0
state O 0 1.1397767174514684e-08
is O 0 6.291869802943495e-11
compatible O 0 2.9791946687396376e-09
with O 0 7.049110860996022e-12
normal O 0 7.254233325149073e-10
coagulation O 0 1.8902101217577183e-08
function O 0 3.1223985202943894e-11
and O 0 7.871954824101302e-12
the O 0 1.831171325683556e-11
capacity O 0 1.47550249796069e-10
to O 0 1.4716800000869057e-10
mount O 0 9.295625318372913e-07
a O 0 2.0952949597585757e-08
neutrophilic O 0 0.002187074162065983
leukocytosis O 0 0.00017902626132126898
during O 0 2.2613999135501217e-06
pyogenic B-Disease 0 0.000196596491150558
infection I-Disease 0 2.1423722955660196e-06
. O 0 1.918182945814806e-08
. O 0 6.622721571147849e-08

Susceptibility O 0 0.0005147384945303202
to O 0 3.0571079605579143e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9786307215690613
twins O 0 1.4164807907945942e-05
: O 0 5.0120314148971445e-11
the O 0 6.960813175860281e-11
role O 0 4.8919510803324684e-11
of O 0 1.7517215455953306e-10
genes O 0 2.794559028629351e-10
, O 0 1.1606783589801495e-10
HLA O 1 0.909519374370575
, O 0 4.677848330914003e-09
and O 0 1.7525412232544113e-09
the O 0 1.8270432278200133e-08
environment O 0 4.2048515069836867e-07
. O 0 1.2993569953323458e-07

OBJECTIVE O 0 7.394618478429038e-06
To O 0 1.5985124335315959e-09
determine O 0 9.599305794694146e-10
the O 0 2.9684896207804456e-10
relative O 0 1.0532770211568732e-08
effects O 0 2.4219446004281053e-08
of O 0 1.1589009751844515e-08
genetic O 0 6.120227880046514e-08
and O 0 1.322288945004857e-10
environmental O 0 3.940315629336055e-09
factors O 0 4.5658421488070644e-10
in O 0 8.209495583333393e-11
susceptibility O 0 1.1654583431663923e-07
to O 0 1.6481916986776923e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9997547268867493
AS B-Disease 1 1.0
) O 0 2.6643933281889076e-08
. O 0 5.857555152033456e-08

METHODS O 0 0.0001670382625889033
Twins O 0 3.077965084230527e-05
with O 0 3.6144973125651347e-10
AS B-Disease 1 0.9999676942825317
were O 0 6.460076917846891e-10
identified O 0 1.1374381471418449e-11
from O 0 1.9794762617236783e-12
the O 0 1.262590899886451e-11
Royal O 0 1.4881831766899722e-08
National O 0 3.1148945645043113e-09
Hospital O 0 1.6098822470667074e-06
for O 0 7.175386063096312e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 1.6342800108759548e-06
. O 0 3.036183500171319e-07

Clinical O 0 4.128993532503955e-05
and O 0 1.461622112230998e-08
radiographic O 0 9.308140761277173e-06
examinations O 0 3.332558844704181e-05
were O 0 1.8911547883249114e-08
performed O 0 3.261728664938346e-10
to O 0 1.6716628081780982e-11
establish O 0 1.791888748492454e-09
diagnoses O 1 0.8869374394416809
, O 0 3.2883029632557736e-09
and O 0 5.459120711037713e-09
disease O 0 3.953669818201888e-07
severity O 0 9.98769451143744e-07
was O 0 4.11043021841806e-09
assessed O 0 1.7925793072137708e-09
using O 0 3.150034399990176e-11
a O 0 1.3427628800521951e-11
combination O 0 5.260527569106443e-10
of O 0 2.2184936110392073e-09
validated O 0 1.0880472700591781e-06
scoring O 0 6.425417495847796e-07
systems O 0 1.0641256267263088e-06
. O 0 8.870095058455263e-08

HLA O 0 0.0038232591468840837
typing O 0 1.2635030088858912e-06
for O 0 1.7595255030755652e-08
HLA O 0 5.460864122142084e-05
- O 0 4.650921255233698e-06
B27 O 0 3.858872332784813e-06
, O 0 4.298384148615497e-10
HLA O 0 2.741206230894022e-07
- O 0 3.9232642023989683e-08
B60 O 0 2.273510943950896e-07
, O 0 5.568018615620396e-11
and O 0 1.3012971256110006e-10
HLA O 0 0.0008971008937805891
- O 1 0.8838942646980286
DR1 O 1 0.9999638795852661
was O 0 4.287692867421811e-09
performed O 0 1.3049956948396613e-10
by O 0 2.4061018802368217e-11
polymerase O 0 2.1571717745416663e-09
chain O 0 4.251695107093667e-10
reaction O 0 1.935896859484032e-10
with O 0 5.516029907143283e-12
sequence O 0 8.268073725670178e-12
- O 0 1.1449176329225708e-10
specific O 0 8.55840329161417e-11
primers O 0 1.008236960586828e-08
, O 0 1.9558932598529033e-11
and O 0 3.998806494265317e-11
zygosity O 0 1.9816417307083611e-07
was O 0 7.732057660803093e-09
assessed O 0 5.888371745754739e-08
using O 0 1.5100825478953084e-08
microsatellite O 0 6.3863340074021835e-06
markers O 0 9.535560252516007e-07
. O 0 2.3179451602572954e-07

Genetic O 0 6.482290245912736e-06
and O 0 4.777012119205892e-09
environmental O 0 1.6326330509741638e-08
variance O 0 3.522401481603765e-09
components O 0 2.4264851461452963e-08
were O 0 4.090751737351184e-09
assessed O 0 1.791958048613651e-08
with O 0 6.384483219878945e-11
the O 0 5.719778428669997e-09
program O 0 1.1347783823723034e-09
Mx O 0 8.36344149490742e-09
, O 0 1.064090113765681e-12
using O 0 1.0493688166676729e-12
data O 0 4.0245601989896684e-12
from O 0 1.2633585583926576e-12
this O 0 3.052336161601943e-12
and O 0 4.824288971777557e-12
previous O 0 1.3017936728587642e-10
studies O 0 6.319146594879754e-11
of O 0 1.4315525154184883e-10
twins O 0 6.711110245305463e-08
with O 0 2.642990548640256e-10
AS B-Disease 1 1.0
. O 0 4.5982793039911485e-07

RESULTS O 0 8.271675142168533e-06
Six O 0 3.797680037109785e-08
of O 0 1.717527275957309e-08
8 O 0 8.255355510300433e-07
monozygotic O 0 0.0003316556103527546
( O 0 1.4984340879209412e-08
MZ O 0 0.0019341581501066685
) O 0 2.1140407202580036e-09
twin O 0 6.55932410609239e-08
pairs O 0 6.921034301221596e-10
were O 0 5.456733398467861e-10
disease O 0 6.6304157719798695e-09
concordant O 0 2.079383421005332e-06
, O 0 5.85306803024821e-11
compared O 0 2.646824703855799e-10
with O 0 4.839661223859926e-12
4 O 0 5.709028805256366e-10
of O 0 1.3286141631319026e-10
15 O 0 1.7703903620880368e-10
B27 O 0 1.3074934912538083e-08
- O 0 3.2595537380331052e-09
positive O 0 2.4063522285899808e-09
dizygotic O 0 6.669432650596718e-07
( O 0 8.281367258611283e-11
DZ O 0 2.469009814376477e-07
) O 0 5.94838275858045e-11
twin O 0 6.258315643492551e-09
pairs O 0 1.2894255108086838e-10
( O 0 1.1269861779905632e-11
27 O 0 2.2523556353348795e-09
% O 0 3.8485353792694355e-11
) O 0 1.496034958241299e-12
and O 0 1.5895477642469125e-11
4 O 0 8.305953702603119e-10
of O 0 1.3508844043386148e-09
32 O 0 5.158135607530312e-08
DZ O 0 6.520688475575298e-05
twin O 0 1.271940277547401e-07
pairs O 0 3.208980581259624e-10
overall O 0 5.0992055022902605e-09
( O 0 1.86468965268638e-11
12 O 0 1.8086097897107578e-10
. O 0 3.6678736436979165e-11
5 O 0 5.580694795170871e-10
% O 0 4.875203712950693e-11
) O 0 4.2176727388376634e-11
. O 0 6.616052594665689e-09

Nonsignificant O 0 0.0005777780315838754
increases O 0 5.342671443031577e-07
in O 0 2.1239547898233013e-09
similarity O 0 2.530508247389207e-09
with O 0 4.237307033028159e-11
regard O 0 1.1140153688415921e-08
to O 0 6.630801463458624e-11
age O 0 3.046159946507032e-08
at O 0 5.465830454909337e-09
disease O 0 8.260363060230702e-09
onset O 0 1.1147251370857703e-06
and O 0 2.4031221457221363e-10
all O 0 2.890281070033751e-11
of O 0 4.424184352203042e-10
the O 0 1.433898000335887e-09
disease O 0 8.718360255954849e-09
severity O 0 2.4645746776741362e-08
scores O 0 1.4810861426184374e-09
assessed O 0 2.6292152899287657e-09
were O 0 2.2958890344426663e-10
noted O 0 1.4280672477884337e-10
in O 0 3.421360694755293e-10
disease O 0 5.309381378992839e-08
- O 0 1.4258308738135383e-06
concordant O 0 0.006847789976745844
MZ O 1 0.9614499807357788
twins O 0 5.990787030896172e-07
compared O 0 1.8298602633137762e-09
with O 0 2.5418653293307614e-10
concordant O 0 0.00016855806461535394
DZ O 1 0.9921951293945312
twins O 0 4.7323912440333515e-05
. O 0 1.4008004711740796e-07

HLA O 0 0.010405604727566242
- O 0 0.0001316711859544739
B27 O 0 2.6203555535175838e-05
and O 0 4.168555278738495e-09
B60 O 0 5.060945227342017e-07
were O 0 5.033090055839295e-10
associated O 0 9.373499892939563e-11
with O 0 1.4016210067580026e-11
the O 0 3.815531890438706e-09
disease O 0 5.196816346142441e-07
in O 0 1.7294197185435678e-09
probands O 0 8.126381726469845e-05
, O 0 3.687585306555441e-11
and O 0 5.517597663484697e-12
the O 0 1.494455774408987e-11
rate O 0 9.67156355002885e-11
of O 0 4.990197144394415e-11
disease O 0 2.0901975261722328e-08
concordance O 0 2.646171104458972e-08
was O 0 1.3583040248121847e-10
significantly O 0 2.376797092473737e-10
increased O 0 1.007478989123456e-09
among O 0 6.534783825173918e-09
DZ O 0 3.7434876958286623e-06
twin O 0 1.5890288196374058e-08
pairs O 0 2.79143600595555e-11
in O 0 3.274091501387355e-12
which O 0 1.5733462709749402e-12
the O 0 9.473000162074641e-11
co O 0 1.245091363344386e-09
- O 0 1.9051659805313648e-08
twin O 0 1.5962006827408004e-08
was O 0 4.0425204850258467e-10
positive O 0 5.169868005916456e-11
for O 0 3.012211660657904e-11
both O 0 3.6128983138539184e-10
B27 O 0 2.316103291377658e-06
and O 0 5.851290652003627e-08
DR1 O 0 0.005027480889111757
. O 0 3.080812973621505e-07

Additive O 0 6.010019205859862e-06
genetic O 0 2.770867126855592e-07
effects O 0 2.5157547156595683e-08
were O 0 3.619286870204519e-09
estimated O 0 1.0369069491922289e-10
to O 0 4.7994282159624646e-11
contribute O 0 6.405220798200162e-10
97 O 0 9.49738208078088e-08
% O 0 3.0140737128370176e-11
of O 0 1.284713915111757e-11
the O 0 3.52027539063382e-11
population O 0 5.586258886025597e-12
variance O 0 1.7438216426413078e-09
. O 0 4.000735387421628e-08

CONCLUSION O 0 3.282837860751897e-05
Susceptibility O 0 4.1653904190752655e-05
to O 0 1.5792151586424552e-08
AS B-Disease 1 1.0
is O 0 1.1263383559168005e-09
largely O 0 5.602614816524465e-09
genetically O 0 1.9002801554535154e-09
determined O 0 1.1862379967197967e-09
, O 0 8.686776124811058e-12
and O 0 1.1245769940271266e-11
the O 0 3.40814571009318e-10
environmental O 0 1.860933274144827e-08
trigger O 0 6.267750207733513e-10
for O 0 7.553455777520313e-11
the O 0 6.4788117093428355e-09
disease O 0 3.2379395520365506e-07
is O 0 1.9479495794172408e-10
probably O 0 2.1655703008605087e-08
ubiquitous O 0 3.656996341305785e-07
. O 0 9.090874897310641e-08

HLA O 0 0.0010110301664099097
- O 0 2.223720912297722e-05
B27 O 0 5.7247311815444846e-06
accounts O 0 1.3726996206386843e-09
for O 0 1.006705829809107e-11
a O 0 3.156572225826437e-11
minority O 0 2.4995557706963822e-11
of O 0 3.2531592003559595e-11
the O 0 6.236744454213294e-10
overall O 0 2.199828941229498e-07
genetic O 0 1.020205786517181e-07
susceptibility O 0 1.2452983355615288e-06
to O 0 1.1468508809286959e-08
AS B-Disease 1 1.0
. O 0 2.305823545611929e-05

Cell O 0 4.630968817309622e-07
cycle O 0 3.322766417568346e-08
- O 0 2.462084580656665e-08
dependent O 0 6.380338479772263e-09
colocalization O 0 3.858375805521064e-07
of O 0 2.4743718185504804e-08
BARD1 O 1 0.9999998807907104
and O 0 1.1843152236679089e-07
BRCA1 O 0 2.03077910043703e-08
proteins O 0 2.460578442387007e-11
in O 0 3.9706099519420945e-11
discrete O 0 2.676157073722152e-09
nuclear O 0 1.1458466531166778e-07
domains O 0 2.0537265754683176e-07
. O 0 1.76447315425321e-07

Germ O 0 0.000709377636667341
- O 0 9.330368811788503e-06
line O 0 5.22282675774477e-07
mutations O 0 6.425904697238138e-09
of O 0 3.55674467655831e-09
the O 0 2.6200606129123116e-08
BRCA1 O 0 4.544707721265695e-08
gene O 0 4.1129685768304114e-10
predispose O 0 3.038030982338569e-08
women O 0 9.553308838450292e-11
to O 0 7.650540791159788e-12
early O 0 3.5015457342524314e-06
- O 0 0.2507360875606537
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999170303344727
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 2.768905937866606e-10
compromising O 0 1.040535480001381e-08
the O 0 7.521199218984975e-10
genes O 0 2.3617260924702066e-10
presumptive O 0 5.7649717888352825e-08
function O 0 1.5898367344835407e-10
as O 0 3.6665395719559513e-10
a O 0 1.108937497384943e-09
tumor B-Disease 0 9.90944840850716e-07
suppressor O 0 4.507870926317992e-06
. O 0 7.091008313864222e-08

Although O 0 6.664976126558031e-07
the O 0 3.7936185748321805e-08
biochemical O 0 3.7024512948846677e-06
properties O 0 1.4470308542513521e-06
of O 0 4.782658038493537e-07
BRCA1 O 0 3.8269698166004673e-07
polypeptides O 0 4.701139921792219e-09
are O 0 1.3113625636773651e-11
not O 0 9.323550612116982e-12
understood O 0 7.051148553927078e-10
, O 0 6.0679686102182995e-12
their O 0 1.1976289751580715e-11
expression O 0 1.985315384311903e-11
pattern O 0 3.886576824263521e-11
and O 0 1.5130643266081378e-11
subcellular O 0 9.445801474328164e-09
localization O 0 8.876522628042949e-09
suggest O 0 2.1472201794381363e-10
a O 0 2.0285152030341536e-11
role O 0 1.074025382519217e-10
in O 0 3.6053809937541814e-10
cell O 0 1.7755592551793598e-08
- O 0 8.282702523843e-09
cycle O 0 2.187927883312568e-08
regulation O 0 2.4697561684661196e-07
. O 0 2.771444940208312e-08

When O 0 5.925539880990982e-07
resting O 0 2.5624331101425923e-06
cells O 0 3.5094722683481905e-09
are O 0 3.1120647725479955e-11
induced O 0 1.390768056275249e-09
to O 0 4.2399906502454954e-11
proliferate O 0 7.632842802252071e-09
, O 0 2.3334088133930564e-11
the O 0 9.292327324272875e-11
steady O 0 6.49495457416549e-10
- O 0 3.674848272905429e-11
state O 0 7.477621820350944e-12
levels O 0 2.340881100071357e-10
of O 0 1.6298155880445364e-10
BRCA1 O 0 3.6313024809331296e-10
increase O 0 1.2991538400619618e-11
in O 0 7.035306365255067e-11
late O 0 2.3744868826724996e-07
G1 O 0 1.7320770950846054e-07
and O 0 4.200203726489882e-11
reach O 0 3.228132344768042e-11
a O 0 1.2923320183086395e-12
maximum O 0 1.5023388089119294e-10
during O 0 5.289506610495209e-09
S O 0 1.7304818129559862e-06
phase O 0 2.385966809015372e-06
. O 0 1.511400142817365e-07

Moreover O 0 6.853447303001303e-07
, O 0 3.289137406881082e-09
in O 0 7.4444188591371585e-09
S O 0 8.015586900000926e-06
phase O 0 5.522406354430132e-06
cells O 0 3.1804546551938984e-08
, O 0 2.6319435519894796e-10
BRCA1 O 0 3.352609079243507e-09
polypeptides O 0 1.419938722158065e-09
are O 0 3.2407420497149175e-11
hyperphosphorylated O 0 1.239461511204354e-07
and O 0 7.388948342068602e-10
accumulate O 0 1.2584046693575601e-08
into O 0 1.2113615666109467e-09
discrete O 0 2.1254555448990686e-08
subnuclear O 0 2.995869181177113e-06
foci O 0 8.505390724167228e-06
termed O 0 1.0215751444775378e-06
" O 0 3.7398370977825834e-07
BRCA1 O 0 4.2506212594162207e-07
nuclear O 0 2.958198592750705e-07
dots O 0 3.659302478808968e-07
. O 0 7.914621136251299e-08

" O 0 3.67917054973077e-05
BRCA1 O 0 5.3693813242716715e-05
associates O 0 1.9560759767500713e-07
in O 0 2.3183721609143504e-09
vivo O 0 7.969195969792509e-09
with O 0 2.656908894282939e-11
a O 0 1.0845989661945055e-09
structurally O 0 1.6903856021599495e-06
related O 0 2.7468638563732384e-06
protein O 0 3.754431645575096e-06
termed O 0 7.677542271267157e-06
BARD1 O 1 0.9999972581863403
. O 0 5.380208222049987e-06

Here O 0 3.5320954339113086e-07
we O 0 9.596706762593499e-10
show O 0 5.977144473812146e-11
that O 0 9.81054430401751e-13
the O 0 1.3824363875869494e-10
steady O 0 2.831549439363812e-09
- O 0 1.9387644267787607e-10
state O 0 1.044722121312791e-11
levels O 0 1.5552967247423055e-10
of O 0 8.019843122930581e-11
BARD1 O 0 3.12943484459538e-05
, O 0 3.7492085824819554e-11
unlike O 0 2.6030869126891787e-10
those O 0 2.6479443637761335e-11
of O 0 8.389239858352937e-10
BRCA1 O 0 4.523198260386607e-09
, O 0 9.232116807145196e-12
remain O 0 1.3537648779760048e-10
relatively O 0 6.546778397176212e-11
constant O 0 8.46817060917715e-11
during O 0 1.3061317583051846e-09
cell O 0 1.9567469422554495e-08
cycle O 0 2.388861553015431e-08
progression O 0 2.516981680855679e-07
. O 0 2.2125870913214385e-08

However O 0 2.669434877589083e-07
, O 0 9.356003971561222e-09
immunostaining O 0 1.1158291272295173e-05
revealed O 0 4.0746190421714346e-08
that O 0 1.218029455074543e-09
BARD1 O 1 0.9999916553497314
resides O 0 3.1076271511665254e-07
within O 0 2.0414161028270428e-08
BRCA1 O 0 1.7947559882713904e-08
nuclear O 0 1.8870041529339687e-08
dots O 0 1.9740802326140283e-09
during O 0 3.2687428319633227e-09
S O 0 8.83342465840542e-08
phase O 0 4.6438916712077116e-08
of O 0 1.1090389717693938e-09
the O 0 6.594502027779114e-11
cell O 0 2.0488596930157144e-11
cycle O 0 7.84380806834184e-12
, O 0 2.2330377022310166e-13
but O 0 6.591427165365815e-13
not O 0 1.415582928654402e-12
during O 0 8.22611423423325e-10
the O 0 6.649603090380651e-09
G1 O 0 2.069805987048312e-06
phase O 0 7.703604865128e-07
. O 0 6.360680515626882e-08

Nevertheless O 0 1.2215045899210963e-05
, O 0 5.4759862422315564e-08
BARD1 O 0 0.00045798096107319
polypeptides O 0 2.396110971858434e-07
are O 0 1.5096290884031305e-10
found O 0 5.212284423516955e-11
exclusively O 0 9.941924367096178e-11
in O 0 1.0248924972589002e-11
the O 0 4.191113081586373e-11
nuclear O 0 8.272408535958675e-09
fractions O 0 1.0066271016739847e-07
of O 0 8.075262236673098e-09
both O 0 3.705220019689648e-10
G1 O 0 1.557302482524392e-07
- O 0 1.2896187229216594e-08
and O 0 5.104097144936759e-10
S O 0 2.2306984703845956e-07
- O 0 2.503209373116988e-08
phase O 0 1.987137352443824e-07
cells O 0 9.928727173758034e-09
. O 0 1.2315695130382665e-09

Therefore O 0 2.2930517218355817e-07
, O 0 2.1886530365833323e-09
progression O 0 1.685399908524232e-08
to O 0 2.4073654181222537e-10
S O 0 1.6026092453103047e-07
phase O 0 4.5930725889320456e-08
is O 0 5.835619747845966e-12
accompanied O 0 8.493027461864422e-12
by O 0 1.8018249652723695e-12
the O 0 1.1672024458064811e-11
aggregation O 0 2.5926319424662836e-10
of O 0 2.984123781413217e-10
nuclear O 0 2.8009449692945054e-07
BARD1 O 0 0.006540429778397083
polypeptides O 0 7.33333365587896e-07
into O 0 1.0669114658412582e-07
BRCA1 O 0 2.0174718429188943e-07
nuclear O 0 2.8117250394643634e-07
dots O 0 8.133399660437135e-07
. O 0 1.2948937921919423e-07

This O 0 1.357898682385894e-08
cell O 0 1.139194250043829e-08
cycle O 0 3.7090612803325484e-09
- O 0 6.063523461108389e-09
dependent O 0 3.057841757581059e-09
colocalization O 0 1.6244797507170006e-07
of O 0 1.4234347922581492e-08
BARD1 O 1 0.9999324083328247
and O 0 1.5854807244863878e-08
BRCA1 O 0 4.0516621169217615e-09
indicates O 0 9.113813870254006e-11
a O 0 2.3615345789984588e-12
role O 0 2.079481899175395e-11
for O 0 2.8049079725533943e-10
BARD1 O 1 0.9999892711639404
in O 0 1.1845149856526405e-05
BRCA1 O 0 1.5954108675941825e-05
- O 0 2.696785486477893e-06
mediated O 0 3.7616634926962433e-06
tumor B-Disease 0 0.00019714386144187301
suppression O 0 2.0449528165045194e-05
. O 0 4.126229384837643e-07

Ethnic O 0 1.9880548052242375e-07
differences O 0 9.999256889159369e-08
in O 0 6.80539846698025e-09
the O 0 3.312888097184441e-08
HFE O 0 0.0004021594359073788
codon O 0 3.2725895380281145e-06
282 O 0 3.858989657601342e-06
( O 0 2.2843552827112035e-08
Cys O 0 0.002815728075802326
/ O 0 1.6965268514468335e-05
Tyr O 0 6.972772825974971e-05
) O 0 7.542637625590487e-09
polymorphism O 0 4.4559129719345947e-07
. O 0 1.011004542306182e-07

Recent O 0 2.6279741405232926e-07
studies O 0 1.0285011953214962e-08
have O 0 1.0356616952922337e-10
shown O 0 2.9318808492106996e-10
that O 0 1.1085293794010909e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.12701743841171265
HH B-Disease 1 1.0
) O 0 3.9495987036453073e-10
is O 0 9.701008225893037e-12
likely O 0 4.390339133908405e-11
to O 0 2.14146365570822e-12
be O 0 4.164654732186079e-12
caused O 0 2.599871706809864e-10
by O 0 2.1053921106517492e-10
homozygosity O 0 2.793033218040364e-07
for O 0 1.6207141184665375e-10
a O 0 2.468128479371501e-10
Cys282Tyr O 0 5.474576028063893e-07
mutation O 0 1.5659328278516682e-09
in O 0 2.5458149477408654e-10
the O 0 3.732274045376016e-09
HFE O 0 0.0002819504588842392
gene O 0 1.0800912519925987e-07
located O 0 4.5962362804630175e-08
4 O 0 1.5822519117136835e-07
. O 0 9.766078079564977e-08

5 O 0 8.46227521833498e-06
Mb O 0 2.4191796910599805e-05
telomeric O 0 2.7541338567971252e-05
to O 0 9.740109163658417e-08
HLA O 1 0.9998753070831299
- O 0 0.136932373046875
A O 0 1.4605982869397849e-05
. O 0 3.7636016259057214e-07

Population O 0 4.7377581857688256e-09
studies O 0 2.0969639913381855e-10
of O 0 2.0103044229280442e-11
this O 0 1.3332184314873707e-11
polymorphism O 0 2.146459676666268e-09
are O 0 5.6511271356862736e-12
facilitated O 0 3.735268344629006e-11
by O 0 7.684938622964932e-12
the O 0 4.932257033352094e-11
fact O 0 1.1105937350319728e-11
that O 0 8.52688254206202e-13
the O 0 3.561678452168593e-10
Cys282Tyr O 0 5.023250196245499e-06
mutation O 0 5.27564214536369e-09
creates O 0 6.68163857575621e-10
a O 0 3.004306525777878e-10
Rsal O 0 4.6368031689780764e-06
restriction O 0 1.2807679468096467e-06
site O 0 3.3670431776045007e-07
. O 0 6.32185646054495e-08

We O 0 1.2533336146702823e-08
have O 0 9.971246744955309e-11
studied O 0 1.1834268009991433e-09
the O 0 9.264299882794091e-10
codon O 0 1.1774265828989883e-07
282 O 0 6.008415311953286e-07
( O 0 8.18765766297247e-09
Cys O 0 0.001953964587301016
/ O 0 6.313448466244154e-06
Tyr O 0 1.0497627954464406e-05
) O 0 1.5418956389456895e-10
polymorphism O 0 1.5334321590287914e-09
in O 0 5.123163004938647e-11
different O 0 5.615939657754865e-11
ethnic O 0 2.4458404745963946e-10
groups O 0 2.0624738028551803e-10
. O 0 5.361297628070361e-09

In O 0 1.4513877211186355e-08
agreement O 0 8.10490519143059e-09
with O 0 1.7295045950938004e-10
previous O 0 3.863493347466829e-08
observations O 0 4.5022073180689404e-08
the O 0 7.937583035300122e-09
Tyr O 0 5.780204446637072e-06
allele O 0 9.141434276216387e-09
appeared O 0 1.4271857029513058e-09
to O 0 6.042352382329419e-12
be O 0 2.45918962277214e-11
rare O 0 1.794549842060178e-09
or O 0 4.5685774607839846e-10
absent O 0 5.027971639037787e-08
in O 0 1.1408332056817017e-09
Asiatic O 0 2.266055929567301e-07
( O 0 6.6910938595343694e-12
Indian O 0 1.4400311498796725e-10
, O 0 7.408089766625103e-12
Chinese O 0 9.705347636668193e-10
) O 0 1.2813569649772205e-10
populations O 0 1.800535942564352e-09
. O 0 4.4794039588680334e-09

The O 0 6.809166563925828e-08
highest O 0 4.5493560918430376e-08
allele O 0 1.0807662542688945e-09
frequency O 0 7.633100818082994e-10
( O 0 1.515140790608882e-11
7 O 0 2.1771852376506473e-10
. O 0 1.152304380386271e-11
5 O 0 1.7401129148719718e-10
% O 0 5.090043837807645e-12
) O 0 6.328946156215765e-13
was O 0 1.9662478589754784e-10
found O 0 1.0236095304705373e-10
in O 0 3.5595069114435773e-09
Swedes O 0 2.9462817110470496e-05
. O 0 8.31658098832122e-07

Saamis O 0 0.1730363368988037
( O 0 2.2919405040511265e-08
2 O 0 2.756383565838405e-08
% O 0 1.9479531876420708e-10
) O 0 9.665103786749007e-12
and O 0 1.3782082419755426e-10
Mordvinians O 0 4.3494303099578246e-05
( O 0 5.81705308921876e-11
1 O 0 2.1111152825881163e-09
. O 0 2.2070791375061738e-11
8 O 0 2.6000501751610727e-10
% O 0 4.699626972304305e-12
) O 0 6.204060160573677e-13
had O 0 1.70196287618829e-11
significantly O 0 5.436548988768664e-10
lower O 0 1.813620542634453e-08
frequencies O 0 1.2040456409678768e-09
of O 0 1.7418105846545018e-09
the O 0 2.2908478669592114e-08
Tyr O 0 2.1868925614398904e-05
allele O 0 2.8085841563552094e-07
. O 0 8.162635367625626e-08

Comparisons O 0 1.3254082205094164e-06
with O 0 2.9888647112841227e-09
allele O 0 1.1146232381520349e-08
frequencies O 0 3.433822781673257e-09
based O 0 4.139720233276023e-10
on O 0 2.951963673503144e-10
prevalence O 0 1.7108434668955397e-09
estimates O 0 6.675571206926634e-11
of O 0 7.257969780738449e-10
HH B-Disease 1 1.0
showed O 0 6.059722181817051e-07
some O 0 1.0030440922292883e-09
disagreements O 0 1.1775596497898277e-08
with O 0 1.8710205260119572e-11
the O 0 5.008631842606803e-10
RFLP O 0 1.9462082434529293e-07
data O 0 9.581087034860047e-10
, O 0 3.153064268013317e-11
particularly O 0 9.510262577450135e-10
in O 0 2.168111246092508e-09
Finns O 0 2.5826655019045575e-06
. O 0 5.3096645302730394e-08

The O 0 9.876371223072056e-07
newly O 0 3.8065095395722892e-06
described O 0 6.786565904803865e-07
HFE O 0 0.48413699865341187
marker O 0 1.5228780512188678e-06
provides O 0 1.8865416173685645e-10
a O 0 7.20128817688348e-12
new O 0 5.829526444900424e-11
approach O 0 3.9240985461042044e-10
to O 0 8.145791333125096e-12
the O 0 4.141226597753622e-11
screening O 0 3.869206288698024e-09
of O 0 4.306281109478505e-09
HH B-Disease 1 0.9999982118606567
as O 0 4.029773847946672e-09
well O 0 3.185834929197995e-11
as O 0 1.055199222270431e-12
studies O 0 9.034277774662425e-13
of O 0 1.127576981438394e-12
the O 0 1.9137800719160047e-11
relationship O 0 4.148388924041235e-11
between O 0 4.805485454006941e-10
the O 0 7.886337272111632e-08
HFE O 1 0.9373084902763367
Tyr O 0 3.8674785173498094e-05
allele O 0 1.974288110773159e-08
and O 0 2.447343161460225e-10
different O 0 2.190172931904044e-09
disorders O 0 4.5388082071440294e-05
including O 0 7.672166475458653e-07
cancer B-Disease 1 0.9999982118606567

Autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9803918600082397
associated O 0 2.9590298211701338e-08
with O 0 3.314054031200442e-10
a O 0 2.202757976021985e-09
missense O 0 1.5866793035002047e-07
mutation O 0 1.0088463398005842e-09
encoding O 0 1.2018504413902065e-08
Gly23 O 0 4.19321713707177e-06
- O 0 7.415511618091841e-07
- O 0 4.3542530647755484e-07
> O 0 6.373650762725447e-07
Val O 0 1.7375053573687183e-07
in O 0 5.344757969538705e-09
neurophysin O 0 9.90336702670902e-05
II O 1 1.0
. O 0 7.848401764931623e-06

Autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.5856846264105116e-07
ADNDI B-Disease 1 1.0
) O 0 1.7099691662636474e-09
is O 0 9.214493751352748e-11
an O 0 9.984434806709075e-11
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.4412558812182397e-05
by O 0 3.142256232990803e-08
progressive O 1 0.7999472618103027
degeneration O 1 0.9999995231628418
of O 0 1.6474560879942146e-06
the O 0 1.0021691565498259e-07
magnocellular O 0 1.208873868563387e-06
neurons O 0 1.7837448185176186e-10
of O 0 9.81042330705506e-11
the O 0 5.495243149411522e-10
hypothalamus O 0 1.5661418828472051e-09
leading O 0 2.1049031406761287e-09
to O 0 1.2500044055396842e-10
decreased O 0 5.579551043410902e-08
ability O 0 7.85798148772443e-10
to O 0 2.8341201607773314e-10
produce O 0 8.29715407490994e-09
the O 0 3.451053842695728e-08
hormone O 0 9.647256860034759e-08
arginine O 0 2.466809121415281e-07
vasopressin O 0 6.241105552362569e-07
( O 0 1.1342725869667447e-08
AVP O 0 3.053331238334067e-05
) O 0 1.5720384993755943e-08
. O 0 9.87750468084414e-08

Affected O 0 1.6538804175070254e-06
individuals O 0 1.1186180870481621e-09
are O 0 3.7742559078068894e-11
not O 0 1.0418233636899643e-10
symptomatic O 0 3.747474011106533e-06
at O 0 8.751481317403886e-09
birth O 0 5.310150896775667e-08
, O 0 1.931945228794696e-11
but O 0 6.804923985415101e-11
usually O 0 4.096404548903365e-09
develop O 0 2.556047888901958e-07
diabetes B-Disease 1 0.9999994039535522
insipidus I-Disease 0 0.016656266525387764
at O 0 2.1095505786661306e-08
1 O 0 1.7061233847925905e-07
- O 0 3.907250061274681e-07
6 O 0 2.4581578372817603e-07
yr O 0 1.2326039495746954e-06
of O 0 3.2764704283039237e-09
age O 0 4.966532429762083e-08
. O 0 3.848115426308141e-08

The O 0 6.457815970861702e-08
genetic O 0 2.6819837017910686e-08
locus O 0 4.936685282785902e-09
of O 0 1.556131223878765e-09
the O 0 1.025584328573359e-08
disease O 0 8.251632834799238e-07
is O 0 2.6355201354633095e-10
the O 0 2.3176395913537817e-08
AVP O 0 0.0015445903409272432
- O 0 4.666364930017153e-06
neurophysin O 1 0.7674453854560852
II O 1 1.0
( O 0 1.662241366773287e-08
NPII O 1 0.9923742413520813
) O 0 3.231435674599936e-10
gene O 0 2.512270946830597e-10
, O 0 2.1415586318185298e-11
and O 0 9.975146403329305e-11
mutations O 0 2.877565130621207e-10
that O 0 1.54384022926779e-11
cause O 0 5.5224628425776245e-08
ADNDI B-Disease 1 0.9999994039535522
have O 0 2.820359501498615e-09
been O 0 2.458721837239608e-10
found O 0 1.0241928832810387e-11
in O 0 5.763981306139421e-12
both O 0 1.4246188864003306e-12
the O 0 1.0551233498024004e-11
signal O 0 4.9857729056412836e-11
peptide O 0 3.195261416566453e-11
of O 0 1.3774723028880942e-10
the O 0 1.96030236487843e-09
prepro O 0 0.00024608548847027123
- O 0 0.08273844420909882
AVP O 1 0.8364471197128296
- O 0 1.4702258340548724e-05
NPII O 0 0.16480199992656708
precursor O 0 1.7165502868010662e-06
and O 0 2.618445460456087e-09
within O 0 1.4763203992629315e-08
NPII O 1 0.9479485154151917
itself O 0 2.916068240210734e-07
. O 0 1.1037916181066976e-07

An O 0 1.5338425640720743e-08
affected O 0 3.1096789143703063e-07
girl O 0 2.0529198252461356e-07
who O 0 1.437890223554561e-10
presented O 0 1.4157930383618123e-09
at O 0 8.802805151475468e-10
9 O 0 5.462585939142173e-10
months O 0 3.27321919568746e-11
of O 0 7.62020863076529e-11
age O 0 4.858693891662824e-09
and O 0 3.8756876180601196e-11
her O 0 1.2349978678605211e-11
similarly O 0 1.235700708424048e-10
affected O 0 7.245507527287032e-10
younger O 0 2.1188416354789297e-08
brother O 0 5.181640450047098e-09
and O 0 2.2471709215654556e-10
father O 0 3.499539547036079e-09
were O 0 8.201861412260314e-10
all O 0 1.870945585957795e-11
found O 0 4.500420869302246e-12
to O 0 3.4670326505559235e-12
have O 0 9.613478416103938e-12
a O 0 5.6060191211404486e-11
novel O 0 2.31510348669417e-08
missense O 0 1.1891126661112139e-07
mutation O 0 9.767076036837352e-10
( O 0 1.6824939011450546e-11
G1758 O 0 1.6183435036509763e-08
- O 0 7.898768750180807e-09
- O 0 1.6956406057033746e-08
> O 0 4.978976519964817e-08
T O 0 7.766319143343026e-09
) O 0 3.004458227345852e-12
encoding O 0 1.0240762404745141e-10
the O 0 9.659911759385409e-11
amino O 0 5.6679910764856345e-11
acid O 0 1.4427582739617861e-10
substitution O 0 1.1485977502445621e-08
Gly23 O 0 1.1486348512335098e-06
- O 0 1.6890838594463276e-07
- O 0 2.993824921304622e-07
> O 0 9.311498274655605e-07
Val O 0 4.371478325992939e-07
within O 0 1.0261678085043968e-07
NPII O 1 0.8991575837135315
. O 0 1.5517786096097552e-06

The O 0 2.91489783421639e-07
mutation O 0 4.514452456305662e-08
was O 0 4.061774916408467e-09
confirmed O 0 9.201677197978597e-10
by O 0 1.2140209670885582e-10
restriction O 0 4.194734160023472e-08
endonuclease O 0 3.8793993439867336e-07
analysis O 0 1.491251921947878e-08
. O 0 5.0868514733792836e-08

A O 0 8.654445082356688e-06
T1 O 0 0.0010865218937397003
- O 0 9.835353012022097e-07
weighted O 0 3.4076359156642866e-07
magnetic O 0 8.23392021231939e-09
resonance O 0 3.983646301719546e-09
imaging O 0 2.6216552484470412e-08
of O 0 1.3377646546075539e-08
the O 0 1.116801058742567e-06
fathers O 0 0.00010865853255381808
pituitary O 0 6.350937383103883e-06
gland O 0 1.878389923604118e-07
demonstrates O 0 1.2369540947076985e-08
an O 0 2.895933215452118e-10
attenuated O 0 3.6571468626789283e-06
posterior O 0 9.309278539149091e-07
pituitary O 0 6.267462595133111e-05
bright O 0 0.0018715729238465428
spot O 0 2.5787283448153175e-05
. O 0 1.5501869654599432e-07

This O 0 8.26331287839821e-08
mutation O 0 8.291841879781714e-08
may O 0 1.5880281534208507e-09
be O 0 2.033742479978784e-10
valuable O 0 4.793505148370514e-09
for O 0 3.571513224054357e-11
developing O 0 1.0021300456131144e-09
models O 0 1.6779192479887683e-09
of O 0 1.7561090359663467e-08
dominantly B-Disease 1 0.9993139505386353
inherited I-Disease 1 0.9999983310699463
neurodegeneration I-Disease 1 1.0
, O 0 3.3367879570533887e-09
as O 0 9.589162797141171e-11
the O 0 2.986046826469746e-11
early O 0 1.7269211616266489e-09
age O 0 2.005564048168651e-10
of O 0 7.940905571990342e-11
onset O 0 1.467935589971603e-06
of O 0 1.5414626375331864e-07
symptoms O 0 0.012218769639730453
suggests O 0 1.2395111603780151e-09
that O 0 1.0069223016148654e-12
this O 0 9.230813162453e-12
mutation O 0 6.480165015698702e-11
may O 0 1.741204229410709e-11
be O 0 1.985712982932597e-11
particularly O 0 9.0241825123627e-10
deleterious O 0 1.415577699503956e-08
to O 0 8.904599280157299e-10
the O 0 8.018508879104047e-08
magnocellular O 0 9.217917977366596e-05
neuron O 0 7.519792575294559e-07
. O 0 1.6663014079654204e-08
. O 0 5.342976550082312e-08

Frequent O 0 1.65493602821698e-07
inactivation O 0 2.8048687454429455e-05
of O 0 5.473581495607505e-06
PTEN O 1 0.9999997615814209
/ O 1 0.9970334768295288
MMAC1 O 1 1.0
in O 0 0.00013406708603724837
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.884919220174197e-05

Sporadic B-Disease 1 0.9999996423721313
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.1223591656062126e-07
the O 0 2.7833165106017077e-08
most O 0 1.008835237570338e-08
common O 0 5.2133362515860426e-08
male B-Disease 0 1.7473309465998454e-09
cancer I-Disease 0 9.618256191501473e-10
in O 0 9.072011371291655e-12
the O 0 6.761710635849738e-11
Western O 0 5.937767166841468e-09
world O 0 3.8890758669030134e-11
, O 0 9.208562731788383e-13
yet O 0 1.001284558738158e-11
many O 0 7.900047803433008e-13
of O 0 6.479815382182119e-12
the O 0 3.473282425558999e-11
major O 0 1.1665225452262007e-09
genetic O 0 1.7651134720519934e-10
events O 0 8.930647887872567e-12
involved O 0 7.60024682078253e-12
in O 0 1.1943554652227295e-11
the O 0 6.929774809538713e-11
progression O 0 2.5688682292468457e-09
of O 0 1.498349638806573e-10
this O 0 2.115963793070108e-10
often O 0 1.0264395555736883e-08
fatal O 0 2.2380301743396558e-05
cancer B-Disease 1 0.630249559879303
remain O 0 1.5823077603727143e-07
to O 0 1.113900083282715e-09
be O 0 2.9933790557379325e-08
elucidated O 0 0.00017960039258468896
. O 0 7.518236770920339e-07

Numerous O 0 7.521434781665448e-07
cytogenetic O 0 5.362800584407523e-05
and O 0 1.5672842579306234e-08
allelotype O 0 0.00010493529407540336
studies O 0 2.873838411687757e-08
have O 0 6.848531464154206e-11
reported O 0 7.264890772296084e-11
frequent O 0 1.885771677700987e-10
loss O 0 2.8834689302925653e-08
of O 0 4.3681319539246033e-07
heterozygosity O 1 0.9929119944572449
on O 0 2.6530422019277466e-06
chromosomal O 0 4.964279014529893e-07
arm O 0 7.930228775876458e-07
10q O 0 2.506339478713926e-05
in O 0 1.111071014747722e-06
sporadic B-Disease 1 0.9999858140945435
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5598230675095692e-05

Deletion O 0 1.607930698810378e-06
mapping O 0 4.949293241907071e-08
studies O 0 3.7789993356796e-09
have O 0 1.690307616097897e-10
unambiguously O 0 1.7760867221383592e-09
identified O 0 2.7789745504769314e-10
a O 0 3.2088075252456605e-11
region O 0 5.080011411529028e-10
of O 0 8.744385771031205e-10
chromosome O 0 3.137695381294492e-10
10q23 O 0 1.881440780948651e-08
to O 0 1.2122385560642268e-11
be O 0 5.7066274448958065e-12
the O 0 8.493842434953436e-11
minimal O 0 1.8109382438069588e-08
area O 0 1.789573822463808e-08
of O 0 7.719193284572157e-09
loss O 0 2.550236104070791e-06
. O 0 6.913004995112715e-07

A O 0 2.922983412645408e-06
new O 0 6.526191782540991e-07
tumor B-Disease 0 8.144374078256078e-06
suppressor O 0 4.974813236913178e-06
gene O 0 1.1971078350825337e-08
, O 0 2.7253608259059092e-09
PTEN O 0 0.034742459654808044
/ O 0 2.4291526642628014e-05
MMAC1 O 1 1.0
, O 0 4.494800531773535e-09
was O 0 5.055030882772371e-08
isolated O 0 3.991426744676119e-09
recently O 0 2.4350693683672375e-10
at O 0 2.625385464583019e-10
this O 0 3.792455238738057e-11
region O 0 9.773859499517812e-10
of O 0 8.540503304566016e-10
chromosome O 0 1.5278726894774053e-10
10q23 O 0 2.473531779401128e-08
and O 0 1.9884002430692327e-11
found O 0 3.6204687251656376e-12
to O 0 6.015016501374759e-13
be O 0 1.6596341271754578e-12
inactivated O 0 7.849023653250242e-10
by O 0 3.8405351815429256e-11
mutation O 0 1.0339490374988713e-09
in O 0 2.7521585010958916e-09
three O 0 5.52735208714239e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 4.153330337430816e-06
lines O 0 3.013239080473795e-08
. O 0 4.022910715661965e-08

We O 0 2.9696195724682184e-06
screened O 0 6.335093348752707e-05
80 O 0 2.6792624339577742e-05
prostate B-Disease 1 0.9999892711639404
tumors I-Disease 1 1.0
by O 0 1.4011687810011608e-08
microsatellite O 0 6.436217176997161e-07
analysis O 0 6.304378130650434e-10
and O 0 6.217618087056564e-11
found O 0 2.9070110901807666e-11
chromosome O 0 7.030128562623972e-11
10q23 O 0 4.7347434417588374e-08
to O 0 2.81087431108773e-10
be O 0 1.5682553033968816e-09
deleted O 0 8.58270343684353e-09
in O 0 2.0660497757063467e-09
23 O 0 1.8227202858156488e-08
cases O 0 6.289260667813323e-09
. O 0 3.5973204859374164e-08

We O 0 3.677504523125208e-08
then O 0 8.299239628861699e-10
proceeded O 0 1.8699202186667208e-09
with O 0 6.791302546368949e-13
sequence O 0 6.265923110232441e-13
analysis O 0 2.973337288186828e-12
of O 0 4.816669285645503e-11
the O 0 2.6039672640365552e-09
entire O 0 3.9289560049837746e-07
PTEN O 1 0.7952817678451538
/ O 0 4.4443138904171064e-05
MMAC1 O 1 0.9992068409919739
coding O 0 2.1395780436250789e-07
region O 0 5.464892094408924e-09
and O 0 1.3446396773808544e-10
tested O 0 1.8154747705168006e-09
for O 0 1.642297686732519e-10
homozygous O 0 3.0006885864963806e-09
deletion O 0 9.834221215143657e-10
with O 0 3.625362857140324e-11
new O 0 1.3543137278304584e-08
intragenic O 0 2.012303411902394e-05
markers O 0 7.437495952444806e-08
in O 0 2.9907223919600767e-10
these O 0 3.212530935714497e-11
23 O 0 1.9020848784911948e-10
cases O 0 2.8435942836524397e-11
with O 0 3.177078738980654e-11
10q23 O 0 8.111950592137873e-06
loss O 0 4.108969278604491e-06
of O 0 2.8404276690707775e-06
heterozygosity O 0 0.45216310024261475
. O 0 2.2033364075468853e-06

The O 0 2.592321690642052e-09
identification O 0 7.991567962939428e-10
of O 0 6.605079816424109e-10
the O 0 6.647976613649575e-10
second O 0 1.2675561933406243e-08
mutational O 0 7.368378760475025e-07
event O 0 2.066940618661306e-09
in O 0 1.1219017381769447e-10
10 O 0 1.8683291025389792e-10
( O 0 1.6943384195666766e-11
43 O 0 5.4490509882043625e-09
% O 0 2.2816806222181185e-09
) O 0 1.1693098933562851e-08
tumors B-Disease 1 1.0
establishes O 0 4.1567553125787526e-05
PTEN O 1 0.9999933242797852
/ O 0 0.00022022827761247754
MMAC1 O 1 0.9999685287475586
as O 0 1.1933228849514421e-09
a O 0 2.7206733393958515e-11
main O 0 3.4467478871036406e-10
inactivation O 0 6.788622997078164e-09
target O 0 2.3278268201920582e-10
of O 0 1.1020845347431418e-09
10q O 0 8.485258149448782e-06
loss O 0 3.905769972334383e-06
in O 0 7.341570267271891e-07
sporadic B-Disease 1 0.9999421834945679
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.220162328598235e-08
. O 0 5.03262498341428e-08

Risk O 0 6.697562639601529e-06
reversals O 0 7.440361287081032e-07
in O 0 2.80717871170566e-09
predictive O 0 4.8608281844053636e-08
testing O 0 4.134118967158429e-07
for O 0 1.934181000251556e-06
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.1813699428748805e-06

The O 0 2.634175899629554e-08
first O 0 1.7319152778583202e-09
predictive O 0 1.0568026453938728e-08
testing O 0 1.0010038664631793e-07
for O 0 1.0259618647978641e-06
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.60934979074068e-09
HD B-Disease 0 8.052146768022794e-06
) O 0 1.4422623685617086e-11
was O 0 3.1315611215276817e-10
based O 0 1.154309009487875e-10
on O 0 2.0156577795749087e-10
analysis O 0 1.932502907697753e-10
of O 0 7.443647920268859e-10
linked O 0 2.5477215004343634e-08
polymorphic O 0 8.901449177756149e-08
DNA O 0 8.867282907942808e-09
markers O 0 2.4800497211430184e-09
to O 0 2.637671331351399e-11
estimate O 0 2.116008201991093e-10
the O 0 2.126547028746817e-11
likelihood O 0 5.045066031605927e-10
of O 0 5.407035374993541e-10
inheriting O 0 5.3063946126030714e-08
the O 0 5.591757279432841e-09
mutation O 0 2.5080588716974717e-09
for O 0 3.0905011882964573e-09
HD B-Disease 0 4.272807200322859e-05
. O 0 4.395213863972458e-07

Limits O 0 1.1856503761009662e-06
to O 0 4.011338816667376e-09
accuracy O 0 1.240474887254095e-07
included O 0 2.206644644786593e-08
recombination O 0 6.144905917437882e-09
between O 0 1.5409526987752997e-09
the O 0 1.814574712710737e-09
DNA O 0 3.1699995961531613e-09
markers O 0 5.865512520131233e-09
and O 0 5.382871232084696e-11
the O 0 3.1090169327896433e-10
mutation O 0 4.5010092875052976e-10
, O 0 1.9347958998827686e-11
pedigree O 0 5.4018216566475985e-09
structure O 0 1.6345609310519649e-09
, O 0 3.770586620710503e-11
and O 0 2.5718953008957435e-11
whether O 0 1.548588340893886e-11
DNA O 0 7.952030700586477e-11
samples O 0 7.553916520075532e-11
were O 0 1.4309184913352535e-11
available O 0 3.4611539329043595e-11
from O 0 2.6384322504569013e-10
family O 0 4.31794933142271e-10
members O 0 2.429900725076095e-10
. O 0 1.8121095735068593e-08

With O 0 2.8802846774311774e-09
direct O 0 2.638911977825842e-09
tests O 0 2.176272939635737e-09
for O 0 3.7570205280168523e-10
the O 0 6.487641091013074e-09
HD B-Disease 0 6.256723281694576e-06
mutation O 0 1.6195160768006645e-09
, O 0 2.674194893304005e-11
we O 0 9.831285958938896e-12
have O 0 2.7960812918476075e-12
assessed O 0 1.4558395600161589e-09
the O 0 1.2837936269605166e-10
accuracy O 0 2.57683763216221e-09
of O 0 2.2173714253614918e-10
results O 0 1.8925602751629356e-10
obtained O 0 4.0007594459545714e-11
by O 0 1.2695819222308113e-11
linkage O 0 2.12703493707167e-10
approaches O 0 1.0298413233300607e-09
when O 0 3.482842139690412e-11
requested O 0 2.8512153749105096e-10
to O 0 2.0958804136661513e-10
do O 0 6.511013950216693e-11
so O 0 2.8802103063663154e-11
by O 0 3.753107893911256e-11
the O 0 4.3305109498348315e-10
test O 0 9.49630951652125e-09
individuals O 0 1.8881110563917503e-10
. O 0 1.1187787585242859e-08

For O 0 2.7332802687851654e-08
six O 0 2.9097542153522227e-09
such O 0 2.534661369679725e-10
individuals O 0 4.3301452701260956e-11
, O 0 1.9988951466265448e-11
there O 0 8.867810999402259e-12
was O 0 3.691577321607298e-10
significant O 0 7.852317684964305e-10
disparity O 0 5.311224526849401e-08
between O 0 8.672729201464335e-10
the O 0 7.3658323884728816e-09
tests O 0 1.0663234917274167e-07
. O 0 6.55323404430419e-08

Three O 0 9.80916539106147e-08
went O 0 6.723639955907856e-08
from O 0 6.803824725842844e-10
a O 0 1.7421318554422527e-10
decreased O 0 1.3126576448030391e-07
risk O 0 8.204025014890703e-09
to O 0 2.2653129372329772e-11
an O 0 8.762755061494931e-13
increased O 0 1.224976370339803e-10
risk O 0 8.959764041804874e-10
, O 0 2.5202496339860048e-12
while O 0 1.1129899953055133e-11
in O 0 1.3454649720745504e-11
another O 0 2.957253886215483e-11
three O 0 1.9682469196147245e-11
the O 0 7.855464057016093e-10
risk O 0 1.2776098401445779e-08
was O 0 1.1287497159173654e-08
decreased O 0 5.528337396754068e-07
. O 0 1.5637883166164102e-07

Knowledge O 0 1.364167474093847e-06
of O 0 3.8821003300881785e-08
the O 0 9.079347940144089e-09
potential O 0 1.0398985672566141e-08
reasons O 0 3.6286318394473938e-09
for O 0 2.1285596549236452e-11
these O 0 8.465824395675892e-12
changes O 0 5.666845118157404e-11
in O 0 1.4284322336077793e-10
results O 0 9.109091259063007e-10
and O 0 1.1459706794614277e-10
impact O 0 3.3386724496153874e-09
of O 0 7.440099092370644e-10
these O 0 4.3416759076819744e-10
risk O 0 3.2260183413512777e-09
reversals O 0 3.9290156905735785e-08
on O 0 1.6963911164680212e-08
both O 0 1.118114711928797e-09
patients O 0 1.4989005592269677e-07
and O 0 5.248460555051793e-10
the O 0 1.3899095208103063e-08
counseling O 0 2.9345692098559084e-08
team O 0 4.8645400207991685e-11
can O 0 4.988357817092837e-12
assist O 0 1.539339211653612e-10
in O 0 3.956525732040639e-11
the O 0 1.5061979441455264e-10
development O 0 4.3057529763856905e-10
of O 0 1.6604970176636868e-10
strategies O 0 6.389846429755153e-10
for O 0 8.970801532171002e-12
the O 0 6.564308818735043e-11
prevention O 0 1.02600050677637e-09
and O 0 2.7494996297089402e-12
, O 0 2.449566970704614e-13
where O 0 6.244495480596524e-13
necessary O 0 6.260076484965182e-11
, O 0 6.405715367863163e-12
management O 0 6.275473890537953e-11
of O 0 1.6449999695744566e-10
a O 0 1.2405797222836412e-10
risk O 0 1.766431334537799e-09
reversal O 0 1.3205480042799422e-09
in O 0 9.538960593635792e-11
any O 0 1.116986572680112e-10
predictive O 0 2.8347704184028544e-09
testing O 0 1.3628755013428417e-08
program O 0 7.439489579930125e-10
. O 0 3.0655250560229774e-10
. O 0 7.774114685332734e-09

A O 0 4.790683192368306e-07
novel O 0 2.052823901976808e-07
common O 0 6.599997703915506e-08
missense O 0 9.599036729923682e-07
mutation O 0 5.51679546489936e-09
G301C O 0 8.658804517835961e-08
in O 0 1.3837157808449518e-10
the O 0 1.077562969409307e-10
N O 0 9.261195366150332e-09
- O 0 2.1952095252686377e-08
acetylgalactosamine O 0 2.707911335164681e-06
- O 0 1.1941504851620266e-07
6 O 0 3.737091347488786e-08
- O 0 1.8378361943405253e-08
sulfate O 0 1.4262617753502127e-07
sulfatase O 0 4.729923603008501e-06
gene O 0 1.9584495802860147e-08
in O 0 2.7873808150502555e-08
mucopolysaccharidosis B-Disease 0 0.26979178190231323
IVA I-Disease 1 0.9999996423721313
. O 0 1.0930385542451404e-05

Mucopolysaccharidosis B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
( O 0 0.0007184328860603273
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.2386609959946782e-08
is O 0 2.792502340476233e-10
an O 0 2.9092256381701986e-10
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 4.638040991267189e-06
by O 0 8.44838421443228e-09
a O 0 1.2952520478393126e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 6.237011973553308e-08
N O 0 4.774810236085614e-08
- O 0 3.0273010764858554e-08
acetylgalactosamine O 0 1.6942090041993652e-06
- O 0 1.7513599459562101e-07
6 O 0 3.442159268729483e-08
- O 0 2.279102417901413e-08
sulfate O 0 2.3065622656304186e-07
sulfatase O 0 9.663448145147413e-05
( O 0 6.678150477057443e-09
GALNS O 1 0.9988859295845032
) O 0 1.2945475802439432e-08
. O 0 1.0163912378402529e-07

In O 0 4.6759954130948245e-08
previous O 0 7.815895486373847e-08
studies O 0 7.632348086872298e-09
, O 0 1.0366024011387864e-10
we O 0 4.5329361791912604e-11
have O 0 8.28858422868839e-12
found O 0 2.7983126232866695e-11
two O 0 1.644566254010993e-11
common O 0 5.869978281225485e-09
mutations O 0 1.7509274030658162e-09
in O 0 1.7490647818974026e-09
Caucasians O 0 8.918409122316007e-08
and O 0 1.1904192909195643e-10
Japanese O 0 1.4360983868755284e-07
, O 0 2.5489341193285497e-10
respectively O 0 1.092418333570322e-08
. O 0 5.8560363669357685e-08

To O 0 6.682778064259765e-08
characterize O 0 4.61163892850891e-07
the O 0 1.2999568355098745e-07
mutational O 0 0.00015192809223663062
spectrum O 0 3.611693728089449e-06
in O 0 5.601756836171035e-10
various O 0 2.660023590284055e-10
ethnic O 0 6.321533574382698e-11
groups O 0 3.6843071996028876e-12
, O 0 2.8429311856037476e-12
mutations O 0 1.156265187762795e-11
in O 0 8.492141018168198e-11
the O 0 7.451294692373267e-09
GALNS O 1 0.9997252821922302
gene O 0 1.7509147909322564e-08
in O 0 1.2135545013336468e-08
Colombian O 0 7.165951387833047e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.8638914227485657
were O 0 4.810440046298936e-09
investigated O 0 5.182193785202571e-09
, O 0 1.2859500964079729e-10
and O 0 4.628376570892101e-10
genetic O 0 2.6153722743060825e-08
backgrounds O 0 3.0269603712440585e-08
were O 0 3.0175799636822376e-09
extensively O 0 4.1155898133915514e-10
analyzed O 0 4.421122357101126e-10
to O 0 5.076550638194455e-11
identify O 0 4.1040823517413116e-10
racial O 0 2.3961466144584165e-10
origin O 0 1.2006652339024981e-09
, O 0 7.984580878417358e-12
based O 0 3.0851505378182154e-11
on O 0 7.818821978755608e-11
mitochondrial O 0 4.0654546396012847e-10
DNA O 0 1.2904619595133227e-09
( O 0 4.292909083769558e-11
mtDNA O 0 1.07525577330847e-09
) O 0 1.1112553238712408e-10
lineages O 0 2.083224437399167e-08
. O 0 1.5439660216998163e-08

Three O 0 1.2995024007977918e-06
novel O 0 1.4321297385322396e-05
missense O 0 8.882001566234976e-05
mutations O 0 3.452529142577987e-07
never O 0 2.7180735884257956e-08
identified O 0 2.1105193148684975e-09
previously O 0 1.1840137759122626e-09
in O 0 2.612039473604e-10
other O 0 2.4418317368102294e-10
populations O 0 7.513353134092071e-11
and O 0 2.290154177408965e-11
found O 0 1.2627625334271642e-10
in O 0 3.599265885334546e-10
16 O 0 4.022601807207593e-09
out O 0 1.552294404127963e-10
of O 0 1.6668061375568755e-09
19 O 0 1.839140573167697e-08
Colombian O 0 1.0038603193152085e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 4.906545996163914e-07
alleles O 0 5.5041411428646825e-09
account O 0 2.5799590241959436e-10
for O 0 5.393973601108826e-10
84 O 0 4.490869400797237e-07
. O 0 1.154053066443339e-07

2 O 0 1.5594054048051476e-07
% O 0 7.507726662581149e-10
of O 0 2.6104657324665936e-10
the O 0 6.663998242117941e-10
alleles O 0 1.194192744691236e-09
in O 0 1.970546642526827e-10
this O 0 1.4657021429886896e-10
study O 0 1.7071698499293575e-09
. O 0 6.430502352827716e-09

The O 0 2.5546734150339034e-07
G301C O 0 6.962296083656838e-06
and O 0 1.4997750596990045e-08
S162F O 0 2.7855476218974218e-06
mutations O 0 4.404249409617478e-09
account O 0 5.032120831138798e-10
for O 0 1.6770425048662219e-09
68 O 0 1.2263753887964413e-06
. O 0 1.7950698349977756e-07

4 O 0 1.347536363027757e-05
% O 0 7.083573905219964e-08
and O 0 1.1216182649320672e-08
10 O 0 7.464953455382783e-08
. O 0 1.385249390750687e-07

5 O 0 2.838822581452405e-07
% O 0 1.9862111955148976e-09
of O 0 7.5725881121258e-10
mutations O 0 5.922799473090379e-10
, O 0 4.080181331689303e-11
respectively O 0 3.8328185070213294e-09
, O 0 9.247171084414418e-11
whereas O 0 3.0316966714849514e-09
the O 0 5.210917919384883e-09
remaining O 0 3.1731278795632534e-06
F69V O 1 0.9404286742210388
is O 0 1.8241895494153226e-10
limited O 0 1.329719528930795e-10
to O 0 6.9878000955037045e-12
a O 0 8.727618627801803e-11
single O 0 3.4007316962458845e-09
allele O 0 5.5771355533806855e-08
. O 0 1.9231064740665715e-08

The O 0 1.185880620369062e-07
skewed O 0 2.2994987602942274e-07
prevalence O 0 5.852317741528168e-08
of O 0 1.943234018142448e-09
G301C O 0 4.865828486799728e-07
in O 0 4.98948549143563e-10
only O 0 7.541046953551955e-11
Colombian O 0 1.3303188550750633e-09
patients O 0 2.5882307408409133e-09
and O 0 2.007683429228191e-11
haplotype O 0 1.8655374467435593e-10
analysis O 0 2.367118653867628e-11
by O 0 1.559975065790198e-11
restriction O 0 2.1873840516661858e-09
fragment O 0 1.6942884872861441e-09
length O 0 5.392307711460376e-10
polymorphisms O 0 2.598286474864153e-09
in O 0 3.5735459036345674e-10
the O 0 5.18963227946756e-09
GALNS O 0 9.50251123867929e-05
gene O 0 1.5165561029206742e-09
suggest O 0 1.242651814781226e-10
that O 0 2.048452336575468e-12
G301C O 0 3.6880408060824266e-08
originated O 0 1.8491326247982443e-09
from O 0 5.3106189584761765e-11
a O 0 4.3624506784745165e-11
common O 0 4.851961499241497e-09
ancestor O 0 6.920386681485979e-07
. O 0 2.0949916290646797e-07

Investigation O 0 4.140412102060509e-07
of O 0 8.344483859445972e-08
the O 0 1.0974053665790962e-08
genetic O 0 4.385598106892985e-09
background O 0 2.334585302854464e-10
by O 0 1.9770926215634255e-11
means O 0 8.718887833936151e-10
of O 0 2.7155746540330483e-09
mtDNA O 0 7.14416470426471e-10
lineages O 0 1.1251139603318805e-10
indicate O 0 4.3452008484379245e-12
that O 0 3.586021453741428e-13
all O 0 1.6836528698993547e-11
our O 0 1.5266725383877855e-10
patients O 0 5.86851955919343e-10
are O 0 2.727904924518243e-12
probably O 0 1.9017984409508415e-10
of O 0 1.9740038770255097e-10
native O 0 2.534222609540393e-09
American O 0 9.407952639151063e-09
descent O 0 5.013109785068082e-07

Low O 0 4.6576232648476434e-07
frequency O 0 1.3318505409642967e-08
of O 0 2.1681120898620065e-08
BRCA1 O 0 9.747317335495609e-07
germline O 0 4.0539876522416307e-07
mutations O 0 1.1016557666110316e-09
in O 0 8.221529707030939e-11
45 O 0 2.781553209985077e-09
German O 1 0.9977801442146301
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.9828837594104698e-07
. O 0 4.342177106764211e-08

In O 0 9.593196459434239e-09
this O 0 1.0716844078828558e-10
study O 0 1.005077479576677e-10
we O 0 2.6295122763225764e-12
investigated O 0 2.787734210141224e-10
45 O 0 2.1749035905571645e-09
German O 1 0.998256504535675
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.454288214996495e-10
for O 0 1.5714614332029697e-10
germline O 0 2.6906940675530677e-08
mutations O 0 4.397783526233212e-10
in O 0 2.0982801607338786e-10
the O 0 8.656537708873202e-09
BRCA1 O 0 1.181586242182675e-07
gene O 0 7.548955238689814e-09
. O 0 3.094814715609573e-08

We O 0 6.288315290703395e-08
identified O 0 5.1171451076470476e-08
four O 0 1.0662091654012329e-08
germline O 0 2.082276751025347e-06
mutations O 0 1.863305953975214e-08
in O 0 2.616922678555511e-09
three O 0 7.85945530878962e-09
breast B-Disease 1 0.9861288666725159
cancer I-Disease 0 0.11194860935211182
families O 0 1.1004692712646147e-09
and O 0 6.191255286225328e-10
in O 0 2.5819900884016533e-08
one O 0 0.0001177580634248443
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.9552164332026223e-09
. O 0 1.0769047979752866e-11
among O 0 2.589990071369397e-12
these O 0 7.407605887195523e-13
were O 0 3.1312785697679146e-11
one O 0 3.869106424136959e-11
frameshift O 0 5.158348859168882e-09
mutation O 0 9.481459367632894e-11
, O 0 8.565093946588664e-12
one O 0 4.727354965816666e-11
nonsense O 0 5.5956941302781615e-09
mutation O 0 5.057224639060109e-10
, O 0 7.927675009511415e-12
one O 0 1.7307313568415417e-11
novel O 0 1.5096470740161294e-09
splice O 0 5.7146561260879025e-08
site O 0 3.0745326284886687e-09
mutation O 0 2.941605015127635e-10
, O 0 7.399744011982179e-12
and O 0 6.707811389672358e-11
one O 0 1.2576841790234994e-09
missense O 0 2.6405682547192555e-06
mutation O 0 1.5537629849404766e-07
. O 0 1.4380033519501012e-07

The O 0 1.5890824442976736e-06
missense O 0 1.593080014572479e-05
mutation O 0 8.024858288990799e-08
was O 0 2.5466722064493297e-08
also O 0 1.9111037752317372e-10
found O 0 3.505817580684578e-10
in O 0 7.688553127493947e-10
2 O 0 1.6023388127450744e-07
. O 0 5.778589340366125e-08

8 O 0 2.9256952416290005e-07
% O 0 6.727854384713794e-10
of O 0 1.0889929930035791e-10
the O 0 1.681243616546979e-10
general O 0 1.1248576292643975e-08
population O 0 2.879979761616358e-11
, O 0 4.475255235836251e-12
suggesting O 0 2.5028666639226316e-11
that O 0 5.213581844888682e-13
it O 0 2.9689623155804146e-12
is O 0 1.2319863879062254e-11
not O 0 1.3920782582221847e-10
disease O 0 4.923739282958195e-08
associated O 0 5.418521098476958e-08
. O 0 2.603279085633403e-07

The O 0 3.6918979873235e-08
average O 0 1.2811530503142876e-08
age O 0 4.3026684437563745e-09
of O 0 6.96515956022381e-10
disease O 0 1.7360611082040123e-07
onset O 0 0.0004079511563759297
in O 0 4.877756865084848e-09
those O 0 4.4135983756632413e-10
families O 0 1.527121068489734e-10
harbouring O 0 1.8676468371836563e-08
causative O 0 4.1000884465347553e-08
mutations O 0 5.406728398327232e-09
was O 0 6.6175287471992306e-09
between O 0 4.86975304525572e-09
32 O 0 3.369468402070197e-07
. O 0 1.6143302161708561e-07

3 O 0 9.160075933323242e-06
and O 0 1.4781680590658652e-07
37 O 0 1.8330421198697877e-06
. O 0 2.986487572798069e-07

4 O 0 5.653908488056913e-07
years O 0 3.139247306549464e-09
, O 0 7.838368148993524e-11
whereas O 0 2.550900157771707e-09
the O 0 1.0686681539695542e-09
family O 0 3.8533995438960744e-10
harbouring O 0 2.7615774556011274e-08
the O 0 4.588630808655125e-09
missense O 0 2.530817084789305e-07
mutation O 0 1.78927950233998e-09
had O 0 1.0757741919498187e-10
an O 0 7.345306004061247e-13
average O 0 7.710312943665087e-11
age O 0 1.5859205615420535e-10
of O 0 2.2097171314960917e-10
onset O 0 3.977134383603698e-06
of O 0 1.6977269297058228e-06
51 O 0 3.7832749057997717e-06
. O 0 4.6385889618250076e-07

2 O 0 1.0362126886320766e-05
years O 0 3.8946458857935795e-07
. O 0 1.0022682772614644e-06

These O 0 8.919055716205548e-08
findings O 0 4.732991953915189e-08
show O 0 4.6226772409951877e-10
that O 0 1.9700232764541248e-11
BRCA1 O 0 1.519330616872594e-08
is O 0 1.4756255245496064e-11
implicated O 0 1.9369827963799935e-10
in O 0 7.47490194741296e-11
a O 0 1.116847499899043e-11
small O 0 1.0774308528693766e-11
fraction O 0 2.9217098185263524e-10
of O 0 2.209118065366056e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7508863803250563e-10
suggesting O 0 1.2125854140232484e-11
the O 0 3.2483152452578157e-12
involvement O 0 6.491109299372466e-12
of O 0 5.131710681394175e-11
another O 0 3.876931553570273e-10
susceptibility O 0 7.323109940671202e-08
gene O 0 6.977236122196473e-09
( O 0 1.4292941274973714e-09
s O 0 1.2278405847609974e-06
) O 0 8.656095928927243e-08

Paternal O 0 0.0002622643078211695
transmission O 0 5.696356311091222e-05
of O 0 0.0003825924650300294
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9329692125320435

We O 0 3.019412275762079e-08
report O 0 2.645709207271807e-10
a O 0 1.8019977870986637e-11
rare O 0 2.9296448600391045e-10
case O 0 1.1438682223641194e-09
of O 0 1.8015262170933966e-08
paternally O 1 0.9999978542327881
transmitted O 1 0.9999995231628418
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.080732540183817e-06
DM B-Disease 1 1.0
) O 0 6.321277368215306e-08
. O 0 1.0677256767621657e-07

The O 0 1.3992449510169536e-07
proband O 0 8.874172635842115e-06
is O 0 2.0101213749068592e-10
a O 0 3.35506240844996e-11
23 O 0 4.803927811103392e-10
year O 0 4.027981836962624e-10
old O 0 1.7404221352990135e-06
, O 0 7.382854505522118e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 5.5748764680174645e-06
who O 0 1.579962471964791e-08
suffers O 0 0.00018821867706719786
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999960660934448

He O 0 7.349076902585239e-09
presented O 0 2.236389384790982e-08
with O 0 7.64795116126038e-10
respiratory O 1 1.0
and O 0 6.036443664925173e-07
feeding O 0 1.1163750968989916e-05
difficulties O 0 3.1409143730343203e-07
at O 0 1.6403183167312818e-07
birth O 0 7.594154794787755e-06
. O 0 2.2035243318896391e-07

His O 0 1.6167658714039135e-06
two O 0 1.9374250825876516e-07
sibs O 1 0.9999969005584717
suffer O 0 2.112628408212913e-06
from O 0 7.994562878366196e-08
childhood O 0 2.715470145631116e-05
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
. O 0 0.003844548249617219

Their O 0 1.7770457816368435e-07
late O 0 1.5356450603576377e-05
father O 0 2.3457558029349457e-07
had O 0 1.279950700983079e-09
the O 0 9.509077553149226e-11
adult O 0 4.683557361384594e-11
type O 0 8.255156280778664e-11
of O 0 2.8588023059938905e-09
DM B-Disease 1 1.0
, O 0 2.5404611747603667e-09
with O 0 4.594239572108805e-11
onset O 0 4.436582912603626e-06
around O 0 3.2954359241443854e-09
30 O 0 2.7178910233516262e-09
years O 0 1.4016197091848426e-09
. O 0 8.043518739953015e-09

Only O 0 1.891327805481069e-08
six O 0 4.7759890486887e-10
other O 0 8.200789873569203e-12
cases O 0 1.4080303763208679e-11
of O 0 1.843943886470356e-10
paternal O 0 7.76267711444234e-07
transmission O 0 2.28527619583474e-06
of O 0 0.026964988559484482
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 3.526778891682625e-05
been O 0 1.533304327949736e-08
reported O 0 7.954279457322855e-10
recently O 0 3.5497911277104777e-09
. O 0 1.1351036555140581e-08

We O 0 1.6539303260287852e-08
review O 0 6.765743076897479e-09
the O 0 7.521773204288706e-10
sex O 0 8.757918001922604e-11
related O 0 8.73113692456684e-10
effects O 0 4.41034408993346e-09
on O 0 8.244589899675248e-09
transmission O 0 1.9421626973326056e-07
of O 0 1.2781945315509802e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999710321426392

Decreased O 0 2.457654090903816e-06
fertility O 0 5.03085459513386e-07
of O 0 2.811079591324983e-09
males O 0 1.3203609039447173e-10
with O 0 6.755957772386356e-12
adult O 0 1.4077738974549447e-09
onset O 0 2.2409971279557794e-05
DM B-Disease 1 1.0
and O 0 4.123766217389857e-08
contraction O 0 1.1088512330559297e-08
of O 0 2.0212524987073266e-09
the O 0 2.941038246273564e-10
repeat O 0 2.4273622001302897e-10
upon O 0 4.706494083350776e-10
male O 0 4.935776787284851e-11
transmission O 0 1.3736201412428706e-11
contribute O 0 1.2886398762304574e-12
to O 0 1.148148633459134e-12
the O 0 3.229801495696627e-11
almost O 0 1.5507902254019434e-11
absent O 0 1.4622145161347078e-10
occurrence O 0 9.400530701086929e-12
of O 0 6.188927148542689e-11
paternal O 0 2.622005190744403e-08
transmission O 0 4.1873640554968006e-08
of O 0 8.818206964633646e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.012333514168858528

Also O 0 1.0192601429537262e-08
the O 0 5.656333179615558e-09
fathers O 0 2.548013178227393e-08
of O 0 2.603593451944164e-10
the O 0 1.007321559498564e-09
reported O 0 8.707890408743424e-09
congenitally O 0 0.004695686046034098
affected O 0 1.8189369654919574e-07
children O 0 5.177508421994048e-10
showed O 0 3.1879745371332646e-11
, O 0 2.6934511478809986e-12
on O 0 4.5816320182190395e-10
average O 0 5.704851702148517e-09
, O 0 4.2275652423207077e-10
shorter O 0 2.8459319310059072e-06
CTG O 0 0.0001894217130029574
repeat O 0 1.299300009804938e-07
lengths O 0 6.310693834166159e-07
and O 0 1.5407521092303256e-10
hence O 0 2.781224361925183e-09
less O 0 2.217419137195975e-09
severe O 0 8.579893062687916e-08
clinical O 0 4.336814072303241e-07
symptoms O 0 9.414490165227107e-08
than O 0 1.261862003776315e-10
the O 0 1.0201095523854065e-09
mothers O 0 3.828944106221144e-10
of O 0 3.164849285419713e-11
children O 0 6.147631015362975e-11
with O 0 2.170253143862766e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.43972983956336975

We O 0 3.496652212220397e-08
conclude O 0 5.03027379750165e-08
that O 0 5.153170945515484e-11
paternal O 0 5.453399012367299e-07
transmission O 0 1.0425816299175494e-06
of O 0 5.156573388376273e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 7.447105190294678e-07
rare O 0 8.730141054513751e-09
and O 0 2.433085503905641e-11
preferentially O 0 2.7803408880755498e-11
occurs O 0 1.3887036052345758e-12
with O 0 2.0449532909042056e-13
onset O 0 1.1342725869667447e-08
of O 0 1.393436406260662e-07
DM B-Disease 1 1.0
past O 0 7.49682897094317e-07
30 O 0 3.715249441427204e-09
years O 0 1.0598335403733117e-10
in O 0 3.222497269028679e-11
the O 0 2.1694337992705925e-10
father O 0 5.685385939813159e-09
. O 0 1.2147256533978634e-09
. O 0 2.191210413116096e-08

The O 0 6.869734988868004e-06
RB1 O 0 0.0003457354032434523
gene O 0 3.979205942528097e-08
mutation O 0 6.9456080886709515e-09
in O 0 2.2354319784145815e-10
a O 0 5.586381912614513e-10
child O 0 3.38180079495487e-08
with O 0 1.0682285278562631e-08
ectopic B-Disease 1 0.956657886505127
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.000740183109883219

The O 0 8.240871466114186e-06
RB1 O 0 0.0004405075451359153
gene O 0 4.825320232271224e-08
mutation O 0 8.876709145511086e-09
was O 0 1.749565381459206e-09
investigated O 0 6.6363750050868475e-09
in O 0 3.741390308675818e-09
a O 0 1.2786678382781247e-08
child O 0 6.096379365772009e-07
with O 0 1.2956814288145324e-08
ectopic B-Disease 0 0.000997652648948133
intracranial I-Disease 1 0.9999972581863403
retinoblastoma I-Disease 0 0.0002147480408893898
using O 0 1.934938209657844e-09
DNA O 0 3.5613792470634564e-10
obtained O 0 4.134880632333804e-11
from O 0 6.838728194846766e-11
both O 0 6.257235007911532e-11
the O 0 6.965800825042834e-09
pineal B-Disease 0 0.013569257222115993
and I-Disease 0 2.7918714451402593e-08
retinal I-Disease 0 0.25114747881889343
tumours I-Disease 1 1.0
of O 0 2.5010124318214366e-06
the O 0 9.915366945278947e-07
patient O 0 6.16506940787076e-06
. O 0 5.434263172787723e-08

A O 0 7.624333306921471e-07
nonsense O 0 5.522103947441792e-07
mutation O 0 9.917767940237354e-09
in O 0 3.0488962465824443e-09
exon O 0 1.5173330325524148e-07
17 O 0 1.1637341756909336e-08
( O 0 1.5431696198664469e-10
codon O 0 2.6358396354453362e-08
556 O 0 5.261405178202949e-08
) O 0 5.510417122600586e-11
of O 0 2.1479873435481522e-09
the O 0 5.079667531049381e-08
RB1 O 0 3.975821891799569e-05
gene O 0 2.6095607896792217e-09
was O 0 2.267787957421774e-09
found O 0 4.2273531897230043e-11
to O 0 4.100682467200745e-12
be O 0 1.596426636718551e-11
present O 0 7.63774710144105e-10
homozygously O 0 5.639017399516888e-05
in O 0 9.444108606260215e-09
both O 0 6.866859858511987e-10
the O 0 2.8454851808135118e-09
retinal B-Disease 0 1.0250885225104867e-06
and I-Disease 0 7.52183737517953e-08
the I-Disease 0 2.5456372895860113e-05
pineal I-Disease 1 0.9999994039535522
tumours I-Disease 1 1.0
. O 0 1.8517388525651768e-05

The O 0 1.0959745999628012e-08
same O 0 5.774297706651055e-10
mutation O 0 3.520344571406042e-10
was O 0 6.856599177318401e-10
present O 0 3.534540715666168e-10
heterozygously O 0 1.3732026218349347e-06
in O 0 1.1558407564393747e-09
the O 0 2.070621174521392e-10
DNA O 0 1.5245715800915605e-10
from O 0 2.933020493145477e-11
the O 0 9.420315222330444e-11
constitutional O 0 2.377378516271733e-09
cells O 0 1.0404967859534153e-10
of O 0 1.1165200014540133e-10
the O 0 3.9613981539510235e-10
patient O 0 4.361816863251988e-08
, O 0 1.9869519224391397e-11
proving O 0 7.190072981444473e-09
it O 0 3.746997503939475e-12
to O 0 1.1658473665632219e-11
be O 0 1.0142092721210361e-10
of O 0 6.4596368254399295e-09
germline O 0 3.7568167954304954e-07
origin O 0 2.381573338539056e-08
. O 0 3.715662089120997e-08

The O 0 7.542928415205097e-08
initial O 0 2.105308425370822e-07
mutation O 0 1.4789640623291689e-08
was O 0 3.871879261652111e-09
shown O 0 9.090168895387052e-11
to O 0 2.5781671936231376e-11
have O 0 4.7803615232933083e-11
occurred O 0 9.137408163439886e-09
in O 0 3.9755224112703047e-10
the O 0 1.925895221077667e-09
paternally O 0 9.947996204573428e-07
derived O 0 8.205051926779561e-07
RB1 O 0 0.00015837186947464943
allele O 0 6.565194325958146e-07
. O 0 1.0376957959579158e-07

The O 0 4.4788677655560605e-08
mutation O 0 1.410101146959164e-09
is O 0 1.543831208705715e-11
in O 0 1.5637345585073348e-11
an O 0 5.958004814336781e-13
area O 0 2.917594499329823e-10
of O 0 3.520189972849863e-10
the O 0 1.4196274156219602e-09
gene O 0 1.6027858207312562e-10
that O 0 1.0946901371489126e-11
encodes O 0 3.519832689202751e-11
the O 0 6.556875875585177e-11
protein O 0 9.837856224104158e-11
- O 0 1.0226323121642622e-09
binding O 0 2.089204143018719e-09
region O 0 7.764600518100906e-09
known O 0 1.974392649373158e-09
as O 0 4.533024511310657e-10
the O 0 7.30731208875568e-09
pocket O 0 1.2298643014219124e-05
region O 0 1.4414367477399992e-08
and O 0 9.387460808696346e-10
has O 0 3.595078748586111e-11
been O 0 9.430310698999023e-11
detected O 0 2.139111332510879e-09
in O 0 8.394437922554232e-11
other O 0 4.276238044220726e-11
cases O 0 3.993481101360885e-10
of O 0 1.1664273991129903e-08
retinoblastoma B-Disease 0 0.0027480190619826317
. O 0 1.2582982833464484e-07
. O 0 1.1873720495714224e-07

Low O 0 1.9637184323073598e-06
levels O 0 1.9278367346942105e-08
of O 0 1.6516377154829343e-09
beta O 0 2.1860632415382497e-08
hexosaminidase O 0 2.5058566279767547e-06
A O 0 2.9118822908458242e-08
in O 0 1.0000870132031991e-09
healthy O 0 1.9246171323317185e-09
individuals O 0 1.1621525139796085e-12
with O 0 2.3529662593335665e-11
apparent O 0 8.456061914330348e-05
deficiency O 1 0.9999854564666748
of O 0 9.607382526155561e-05
this O 0 4.911639450710936e-08
enzyme O 0 4.789121135218011e-07
. O 0 6.360037474451019e-08

Appreciable O 0 2.3047088689054362e-05
beta O 0 1.5029328324089875e-06
hexosaminidase O 0 0.00010635633225319907
A O 0 1.0828448466781992e-05
( O 0 2.2692084655773215e-08
hex O 0 5.5979348871915136e-06
A O 0 4.277508836025845e-08
) O 0 1.0650901688391556e-10
activity O 0 7.488277220524253e-10
has O 0 7.488326798921197e-12
been O 0 6.288630727269151e-11
detected O 0 1.488308054575782e-08
in O 0 9.354613084155972e-09
cultured O 0 2.6955596695188433e-05
skin O 0 1.2755307579936925e-05
fibroblasts O 0 2.0157231119810604e-06
and O 0 1.668986016056806e-08
melanoma B-Disease 0 0.000248744705459103
tissue O 0 5.760201915450125e-08
from O 0 8.82486528297477e-09
healthy O 0 9.882230145308313e-09
individuals O 0 4.1561962205172165e-12
previously O 0 5.5229383566501866e-11
reported O 0 2.6292527183224834e-11
as O 0 7.129571932829037e-10
having O 0 1.0149886264798624e-07
deficiency B-Disease 0 0.006552517879754305
of I-Disease 0 1.0943766937998589e-05
hex I-Disease 0 6.4953910623444244e-06
A I-Disease 0 6.710403344101223e-09
activity O 0 2.515627428589795e-10
indistinguishable O 0 7.396445261820261e-11
from O 0 5.587396322524751e-13
that O 0 3.146684708589184e-14
of O 0 7.274399832501999e-12
patients O 0 2.1700885532993652e-09
with O 0 9.873394546389136e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.077253627585378e-08
TSD B-Disease 1 0.9940800070762634
) O 0 1.4439986095737822e-08
. O 0 1.4666871095414535e-07

Identification O 0 3.136732686925825e-07
and O 0 8.630671288756275e-09
quantitation O 0 0.0003620967618189752
of O 0 3.279671000200324e-05
hex O 0 0.023470180109143257
A O 0 8.759916454437189e-07
, O 0 4.827422905862022e-10
amounting O 0 5.3132183097659436e-09
to O 0 1.3393675057926657e-09
3 O 0 2.3637751667138218e-07
. O 0 4.8485041759249725e-08

5 O 0 2.6756183615361806e-06
% O 0 1.4784599500217155e-07
- O 0 1.388944383506896e-06
6 O 0 1.7993596657106536e-06
. O 0 2.7199621399631724e-07

9 O 0 7.427869377352181e-07
% O 0 2.450894376337942e-09
of O 0 4.920495122462398e-10
total O 0 5.677991965491458e-10
beta O 0 1.4827743477496824e-08
hexosaminidase O 0 7.399235641969426e-07
activity O 0 6.213238368246721e-09
, O 0 2.622551481534785e-11
has O 0 1.8371805812766873e-12
been O 0 4.271670690780827e-12
obtained O 0 6.322667389646597e-11
by O 0 8.677594198758243e-10
cellulose O 0 6.196144568093587e-06
acetate O 0 6.351261276904552e-07
gel O 0 3.9916920968607883e-07
electrophoresis O 0 2.3643742963486147e-08
, O 0 8.446220944868799e-10
DEAE O 0 5.993528611725196e-05
- O 0 1.9894316949375934e-07
cellulose O 0 4.5308249241315934e-07
ion O 0 1.5516957319050562e-07
- O 0 8.941096041326091e-08
exchange O 0 5.1101615383686294e-08
chromatography O 0 1.2239947011494223e-07
, O 0 1.966472817915843e-10
radial O 0 1.3372035034819874e-08
immunodiffusion O 0 4.56383713753894e-06
, O 0 1.7581625044726934e-09
and O 0 3.599267772713688e-09
radioimmunoassay O 0 7.515340257668868e-05
. O 0 1.0220653621217934e-06

Previous O 0 6.50764923193492e-05
family O 0 4.050736635008434e-08
studies O 0 9.54118561935502e-10
suggested O 0 1.758792139705534e-10
that O 0 1.547592349410154e-12
these O 0 1.5264331465481007e-11
individuals O 0 3.826750114704902e-12
may O 0 4.592776506329166e-11
be O 0 3.0574768411506525e-11
compound O 0 5.270552883018809e-09
heterozygotes O 0 8.802440554234181e-09
for O 0 2.21679098688643e-11
the O 0 2.2418879253027768e-10
common O 0 1.22253149825724e-08
mutant O 0 2.044510694076962e-07
TSD B-Disease 0 7.380063379969215e-06
gene O 0 6.98604785132062e-10
and O 0 2.5047099810882045e-11
a O 0 4.1098378172899075e-11
rare O 0 1.017531392477622e-08
( O 0 2.444974223081431e-09
allelic O 0 3.5636908251035493e-06
) O 0 5.059571428489562e-09
mutant O 0 1.7153739406694513e-07
gene O 0 1.143317085450235e-08
. O 0 4.853555779504859e-08

Thus O 0 4.127048214286333e-07
, O 0 2.9971707338205533e-09
the O 0 3.2318752118953853e-09
postulated O 0 4.5143059423935483e-07
rate O 0 2.7536932734051334e-08
mutant O 0 4.5810835125337235e-09
gene O 0 1.4651457824754743e-10
appears O 0 1.5888454441004285e-10
to O 0 2.999162116573695e-12
code O 0 6.034696353740543e-11
for O 0 3.673446963281535e-11
the O 0 9.430579928082494e-11
expression O 0 4.345833068408744e-11
of O 0 5.996053653589684e-11
low O 0 1.2273203564561186e-09
amounts O 0 4.918656038022107e-10
of O 0 4.650998253197258e-09
hex O 0 8.348841220140457e-06
A O 0 1.8344587715546368e-06
. O 0 4.127197712477937e-07

Heterozygotes O 0 0.00021678161283489317
for O 0 5.3694158452799456e-08
the O 0 5.198511843218512e-08
rare O 0 6.626954274224772e-08
mutant O 0 3.378048418767321e-08
may O 0 1.7771430160795632e-10
be O 0 2.7940460708975046e-11
indistinguishable O 0 9.444499626809488e-10
from O 0 3.457617525626233e-11
heterozygotes O 0 9.02487506948546e-09
for O 0 9.384644450438628e-11
the O 0 3.9923482297865576e-09
common O 0 1.009226025416865e-06
TSD B-Disease 1 0.9957166314125061
mutant O 0 5.048415005148854e-06
. O 0 9.122295807628689e-08

However O 0 1.197058026036757e-07
, O 0 6.702226551524859e-10
direct O 0 8.343442048364125e-10
visualization O 0 1.2303965490900737e-07
and O 0 4.332346925650654e-09
quantitation O 0 0.06411445140838623
of O 0 0.005324908532202244
hex O 0 6.623342778766528e-05
A O 0 6.50059783779966e-09
by O 0 2.394957496210104e-11
the O 0 2.0819661966653413e-11
methods O 0 4.7885767573419e-10
described O 0 8.358713027289966e-11
may O 0 5.535794739275346e-11
prevent O 0 1.1730012794419764e-10
false O 0 5.056790541857481e-10
- O 0 1.9047072807865106e-09
positive O 0 3.650385826947655e-10
prenatal O 0 2.3730985176939612e-08
diagnosis O 0 5.5381160990464195e-08
of O 0 1.52072221482058e-08
TSD B-Disease 1 0.9992929697036743
in O 0 1.0454236587520427e-07
fetuses O 0 6.865582236059709e-08
having O 0 8.329397588324738e-11
the O 0 1.7159841325664615e-09
incomplete O 0 2.5835628548520617e-05
hex B-Disease 0 0.0007429519901052117
A I-Disease 0 7.904707217676332e-07
deficiency I-Disease 0 4.362881895758619e-07
of O 0 2.2060206994467535e-09
the O 0 4.692671806694193e-10
type O 0 3.571462459106556e-09
described O 0 3.4592945175049294e-10
in O 0 1.9048732036175409e-10
the O 0 3.346622756694728e-09
four O 0 1.0959704255242286e-08
healthy O 0 2.922984663200623e-07
individuals O 0 1.1776450925538029e-08

The O 0 3.968370947404765e-06
tumor B-Disease 0 4.198735041427426e-05
suppressor O 0 2.5410799935343675e-05
gene O 0 8.445245924804112e-08
Smad4 O 0 0.00019411799439694732
/ O 0 1.6853731494848034e-06
Dpc4 O 0 1.534869079478085e-05
is O 0 5.7973594674853857e-11
required O 0 6.954124776026305e-11
for O 0 8.522338390548612e-11
gastrulation O 0 5.350615310817375e-07
and O 0 9.65403590402758e-11
later O 0 1.0740054401381371e-09
for O 0 1.0184235399446351e-10
anterior O 0 1.140974648095039e-09
development O 0 2.915999219865739e-09
of O 0 3.0175915100016937e-09
the O 0 1.6758443521780464e-08
mouse O 0 1.1160999946469019e-07
embryo O 0 9.773177822580692e-08
. O 0 2.2505272312400848e-08

Mutations O 0 5.477547802001936e-07
in O 0 5.933114000100659e-09
the O 0 4.305059064790839e-08
SMAD4 O 1 0.9999982118606567
/ O 0 0.0502631701529026
DPC4 O 1 0.9999666213989258
tumor B-Disease 0 7.14301859261468e-05
suppressor O 0 4.959144348504196e-07
gene O 0 4.35604247117638e-10
, O 0 1.1361025835376903e-11
a O 0 2.574545611422341e-11
key O 0 6.784599548836923e-08
signal O 0 6.012484732309531e-08
transducer O 0 9.657770050353065e-08
in O 0 2.2656954090649606e-09
most O 0 2.5414932380840582e-09
TGFbeta O 0 3.125188595731743e-05
- O 0 3.1994471783036715e-07
related O 0 4.688869523761241e-07
pathways O 0 5.6068159004496465e-09
, O 0 1.3310123402748841e-12
are O 0 8.303307450245254e-14
involved O 0 4.2287440910060425e-13
in O 0 7.0121798992350826e-12
50 O 0 3.2174260478079475e-10
% O 0 2.892951989075243e-10
of O 0 1.351892109369146e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.00040713720954954624

Homozygous O 0 0.000480977090774104
Smad4 O 1 0.6229164600372314
mutant O 0 0.00021256928448565304
mice O 0 5.711648555006832e-06
die O 0 7.655036426967854e-08
before O 0 1.3391074915602985e-08
day O 0 1.0240503200975581e-07
7 O 0 4.5103556089998165e-07
. O 0 4.6531567932106555e-08

5 O 0 2.280521357533871e-06
of O 0 3.0948859830459696e-07
embryogenesis O 0 9.980193863157183e-05
. O 0 1.7481638678873423e-06

Mutant O 0 2.097865399264265e-05
embryos O 0 2.395811691258132e-07
have O 0 2.2298449198210335e-10
reduced O 0 1.2229295354160286e-09
size O 0 1.4260211900207764e-09
, O 0 2.4093360639909633e-10
fail O 0 1.9325195665942374e-08
to O 0 7.655920342131139e-10
gastrulate O 0 2.1956211639917456e-05
or O 0 4.432329170356297e-09
express O 0 6.00406779849294e-10
a O 0 3.503716761166231e-11
mesodermal O 0 1.8720055550147663e-07
marker O 0 1.9456789956961984e-08
, O 0 3.820144547916904e-11
and O 0 5.533693989145938e-11
show O 0 3.4515176827731864e-10
abnormal O 0 7.299623128176336e-09
visceral O 0 8.692293818057806e-07
endoderm O 0 0.00042211738764308393
development O 0 1.1663071290968219e-06
. O 0 1.7434076937661303e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.953221726580523e-06
the O 0 3.492956750505982e-07
Smad4 O 1 0.995311439037323
- O 0 0.0015523110050708055
deficient O 0 3.3267413073190255e-06
embryos O 0 8.029171993939599e-09
results O 0 2.567407397791044e-10
from O 0 3.7828178089949205e-11
reduced O 0 1.888558420759523e-09
cell O 0 2.6965703003867247e-09
proliferation O 0 2.4090343053728702e-09
rather O 0 9.64597360320063e-11
than O 0 5.870957886511263e-11
increased O 0 9.267114187139214e-09
apoptosis O 0 9.217034744324337e-07
. O 0 1.8570973736586893e-07

Aggregation O 0 5.9938606682408135e-06
of O 0 5.975774115540844e-07
mutant O 0 7.826627552276477e-06
Smad4 O 0 0.003368140896782279
ES O 0 1.0777226634672843e-05
cells O 0 8.601020451415309e-10
with O 0 5.003165416683775e-12
wild O 0 1.6556781501364526e-09
- O 0 4.567444755743111e-10
type O 0 9.219547791872174e-09
tetraploid O 0 2.053759089903906e-06
morulae O 0 1.7089785615098663e-05
rescues O 0 5.458513783196395e-07
the O 0 1.7304335742096555e-08
gastrulation B-Disease 0 2.2805368644185364e-05
defect I-Disease 0 2.046907638941775e-06
. O 0 2.89746196813212e-07

These O 0 3.126908865169753e-08
results O 0 1.0059261867922942e-08
indicate O 0 2.77256972935902e-09
that O 0 3.302693882267782e-11
Smad4 O 0 2.2235014967009192e-06
is O 0 4.607763129382825e-11
initially O 0 6.10778858045613e-11
required O 0 1.9340948981261263e-11
for O 0 9.110611570717353e-12
the O 0 7.822193587303516e-11
differentiation O 0 6.68049116026026e-10
of O 0 2.3224161482815475e-10
the O 0 2.2949390998672214e-10
visceral O 0 1.4152968574876468e-08
endoderm O 0 2.0798962907520036e-07
and O 0 4.3957688183882127e-11
that O 0 1.2808597498609187e-12
the O 0 1.208056849000272e-10
gastrulation B-Disease 0 1.443913788534701e-07
defect I-Disease 0 3.1662352739658672e-09
in O 0 1.9187371136375475e-10
the O 0 3.2407065919670686e-10
epiblast O 0 5.084592089588114e-07
is O 0 2.7313113576399317e-11
secondary O 0 1.195054633029713e-08
and O 0 4.038110124060523e-11
non O 0 3.1271888190076425e-08
- O 0 1.7347535674616665e-07
cell O 0 4.2923713294840127e-07
autonomous O 0 1.626258594455976e-08
. O 0 2.1579054987341806e-08

Rescued O 0 0.00030716153560206294
embryos O 0 6.415738880605204e-06
show O 0 4.671270659173388e-08
severe O 0 1.3556973499362357e-06
anterior O 0 1.722910496937402e-06
truncations O 1 0.9982057809829712
, O 0 9.158922509300282e-09
indicating O 0 1.1725282078600685e-08
a O 0 1.4096863953927397e-10
second O 0 4.142953091701429e-09
important O 0 5.462471586170636e-10
role O 0 1.25242663462366e-10
for O 0 1.3686290989411987e-09
Smad4 O 0 0.00029417022597044706
in O 0 4.76208619204499e-08
anterior O 0 6.705876387513854e-08
patterning O 0 1.617896487005055e-06
during O 0 1.735519276735431e-06
embryogenesis O 0 3.477494101389311e-05
. O 0 3.4652487101993756e-07

Prevalence O 0 1.024232551571913e-05
of O 0 1.1909933306242237e-07
p16 O 0 3.3367311971232994e-06
and O 0 8.687489128078596e-08
CDK4 O 1 0.9999948740005493
germline O 0 0.00014727425877936184
mutations O 0 3.984157359582241e-08
in O 0 1.7530962237444214e-09
48 O 0 4.9922892486620185e-08
melanoma B-Disease 1 0.9895081520080566
- O 0 0.0004605459689628333
prone O 0 0.04081019014120102
families O 0 2.574680912914573e-09
in O 0 1.3952555777407838e-09
France O 0 3.138267246072246e-08
. O 0 1.0748588863407349e-07

The O 0 7.615489039380918e-07
French O 0 9.210246207658201e-05
Familial B-Disease 1 0.9994420409202576
Melanoma I-Disease 1 1.0
Study O 0 6.353239768941421e-06
Group O 0 2.2316426040447368e-08
. O 0 3.349811095176847e-08

Germline O 0 0.0005894477944821119
mutations O 0 3.1262530342246464e-07
in O 0 4.541594655904646e-09
the O 0 1.034659646848013e-08
p16 O 0 6.071732059353963e-07
and O 0 1.5568504707630382e-08
CDK4 O 1 0.9990655779838562
genes O 0 1.9167675446851717e-08
have O 0 9.075720730500336e-11
been O 0 5.846228362527128e-11
reported O 0 3.2002015620813395e-11
in O 0 2.469102006186219e-11
a O 0 7.534606272230349e-11
subset O 0 2.2494116791449414e-08
of O 0 1.6960933990617377e-08
melanoma B-Disease 0 0.03562961518764496
pedigrees O 0 3.9884119473754254e-07
, O 0 3.733238718162113e-11
but O 0 3.860548339340575e-11
their O 0 4.541520631784479e-11
prevalence O 0 4.94519314386821e-10
is O 0 1.3882004270063253e-12
not O 0 9.605010363455957e-12
well O 0 4.85886775258848e-10
known O 0 1.2686784067739154e-08
. O 0 8.176893118161388e-08

We O 0 5.961179994073973e-08
searched O 0 1.8630896647664485e-07
for O 0 1.2182501674118384e-09
such O 0 3.617625310425865e-08
germline O 0 4.869173062616028e-05
mutations O 0 2.283157485294396e-08
in O 0 2.397089637895533e-09
48 O 0 2.9491470598941305e-08
French O 0 1.4005255479787593e-06
melanoma B-Disease 1 0.9999997615814209
- O 1 0.9717146158218384
prone O 1 0.9097030162811279
families O 0 9.577669768390251e-10
selected O 0 2.5762664224160403e-10
according O 0 6.539087847590164e-12
to O 0 3.562632610795702e-12
two O 0 4.5700982061192e-12
major O 0 2.6879074521701796e-09
criteria O 0 1.9709702314685273e-07
families O 0 1.435343944394818e-11
with O 0 3.318198309436998e-13
at O 0 5.921271112319104e-11
least O 0 1.4175802892646416e-11
three O 0 1.659400568343461e-11
affected O 0 1.092361534560382e-09
members O 0 5.477179473856175e-11
( O 0 1.028890080773115e-11
n O 0 1.8749762853431662e-10
= O 0 1.0183866250290663e-10
20 O 0 8.18521431189545e-11
) O 0 1.0809377481643678e-12
or O 0 1.418321363133579e-11
families O 0 7.43437603145658e-12
with O 0 1.3316623194772892e-12
two O 0 2.1562399435404167e-11
affected O 0 1.9714350152355564e-09
members O 0 2.0063742334208712e-11
, O 0 7.0771860594120994e-12
one O 0 6.3057428202617505e-12
of O 0 4.915371235036936e-11
them O 0 6.795892841526818e-12
affected O 0 3.383950411550707e-11
before O 0 1.5848442003196794e-10
the O 0 1.0932259958407187e-10
age O 0 4.3947065431204635e-10
of O 0 1.9313532717557536e-10
50 O 0 5.483673515271903e-10
( O 0 4.432685555416649e-12
n O 0 1.0226513386113467e-10
= O 0 2.16166848310273e-10
28 O 0 1.0827304608440613e-09
) O 0 4.645919933488063e-12
, O 0 3.951614209463106e-12
and O 0 6.182670261173362e-12
one O 0 6.788975197985492e-12
additional O 0 7.940541973949777e-11
minor O 0 1.4353001631661755e-07
criterion O 0 0.04255588725209236
. O 0 1.7358519244226045e-06

Sixteen O 0 3.700113666127436e-05
different O 0 3.477869086054852e-07
p16 O 0 1.7133599612861872e-05
germline O 0 4.546048330666963e-06
mutations O 0 1.1270287814113544e-08
were O 0 2.053274439361985e-09
found O 0 7.665296869463489e-11
in O 0 4.529634306527086e-11
21 O 0 7.902109522284206e-10
families O 0 2.412029603826582e-11
, O 0 4.009267310506326e-12
while O 0 4.791059562969657e-11
one O 0 9.54391080054684e-11
germline O 0 1.622701617520761e-08
mutation O 0 3.7198280566919095e-10
, O 0 2.481911551277527e-11
Arg24His O 0 1.4427427004193305e-06
, O 0 6.39378064382079e-11
was O 0 8.70144400977324e-10
detected O 0 2.380722730066509e-09
in O 0 3.8607270158586005e-10
the O 0 1.0878398626346097e-08
CDK4 O 1 0.5497459769248962
gene O 0 2.993305372456234e-07
. O 0 2.9104757004461135e-07

The O 0 2.859632886043073e-08
frequency O 0 9.5607921579699e-09
of O 0 5.656171087053963e-09
p16 O 0 1.0895013957679112e-07
gene O 0 1.0390732718690288e-09
mutation O 0 2.0864593386349384e-10
in O 0 1.7434682864081452e-10
our O 0 1.519120385040651e-10
sample O 0 2.8391464179655657e-10
( O 0 3.4342567852008177e-12
44 O 0 1.94051053004074e-10
% O 0 5.986486046466455e-12
) O 0 4.684320964974675e-13
is O 0 2.091549372931767e-12
among O 0 1.4760703076488468e-11
the O 0 1.4655001170926774e-11
highest O 0 1.0263138117139192e-09
rates O 0 4.262087627271427e-10
yet O 0 2.8789635606041308e-11
reported O 0 9.657861316236804e-12
and O 0 9.162892666836342e-12
the O 0 1.881223510302732e-10
CDK4 O 0 1.1903116501343902e-05
mutation O 0 4.203812575820365e-10
is O 0 2.5993833821513768e-12
the O 0 8.89488049188314e-12
second O 0 4.0117345556645034e-10
mutation O 0 8.055194011813427e-11
detected O 0 8.182018396141189e-10
in O 0 1.0831595342875033e-10
this O 0 3.532592829369463e-10
gene O 0 9.792000987829397e-09
worldwide O 0 1.674722760469649e-08
. O 0 1.7852876510460192e-07

In O 0 1.9362238035114387e-08
summary O 0 4.955385790594846e-08
, O 0 9.305243797719243e-10
our O 0 7.935171408846031e-10
results O 0 9.740026563065385e-10
show O 0 1.0630159946733997e-10
frequent O 0 2.63346861678615e-11
involvement O 0 1.3085849071003963e-10
of O 0 1.1135559141450813e-09
the O 0 1.5552121368500593e-08
p16 O 0 2.1731368349264812e-07
gene O 0 5.968880056883563e-09
in O 0 3.029159367784473e-09
familial B-Disease 0 7.048612360449624e-07
melanoma I-Disease 0 0.3483666777610779
and O 0 1.8635103182784718e-10
confirm O 0 1.646465880300596e-10
the O 0 1.7320267442499926e-10
role O 0 6.455935092075649e-11
of O 0 1.0458576227279082e-09
the O 0 1.5265227304439577e-08
CDK4 O 1 0.965755820274353
gene O 0 4.73768579922762e-09
as O 0 6.188492496228548e-10
a O 0 2.526139297742702e-09
melanoma B-Disease 0 0.028759175911545753
- O 0 1.2473351489461493e-05
predisposing O 0 2.804133328027092e-05
gene O 0 1.4660278324640785e-08
. O 0 5.748487463819174e-09
. O 0 3.060025122181287e-08

Progression O 0 1.506509397586342e-05
of O 0 7.726671356067527e-07
somatic O 0 0.0008018325315788388
CTG O 0 0.00011012684262823313
repeat O 0 5.661462765260694e-08
length O 0 3.801729597796566e-09
heterogeneity O 0 2.809762200683963e-08
in O 0 1.2720355324624677e-10
the O 0 1.8744648888624482e-10
blood O 0 5.872853314770055e-10
cells O 0 1.0035225983529017e-09
of O 0 7.279823410755171e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999905824661255
. O 0 9.019902904583432e-07

The O 0 1.432859786376639e-08
genetic O 0 8.991542621572535e-09
basis O 0 7.1724990391430765e-09
of O 0 1.2133077689213678e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1904066923307255e-06
DM B-Disease 1 1.0
) O 0 1.7804001328780572e-10
is O 0 3.5737122896367657e-12
the O 0 4.937092401569032e-12
expansion O 0 3.4539937576738566e-10
of O 0 1.3345420601940106e-10
an O 0 4.794624766657485e-11
unstable O 0 1.6278296754990151e-07
CTG O 0 3.2528589599678526e-06
repeat O 0 5.662918134419215e-09
in O 0 4.276223819488223e-10
the O 0 7.833230175613437e-10
34 O 0 5.951509507440278e-09
UTR O 0 4.9907623179024085e-05
of O 0 2.0877222173254495e-09
the O 0 2.9413387281351788e-08
DM B-Disease 1 1.0
protein O 0 4.471330896649306e-07
kinase O 0 4.372303408217704e-08
gene O 0 8.647126903404967e-10
on O 0 2.544029875650722e-09
chromosome O 0 3.980099361200473e-09
19 O 0 7.798919909873803e-08
. O 0 1.68006167200474e-07

One O 0 1.7781010441808576e-08
of O 0 2.843401958330105e-09
the O 0 1.6589213336359876e-09
principal O 0 7.639673782477985e-09
features O 0 8.71768629506775e-11
of O 0 4.0404779522162926e-10
the O 0 3.1271593314841084e-08
DM B-Disease 1 1.0
mutation O 0 7.363166787399678e-08
is O 0 1.854064471396022e-11
an O 0 7.154517321465714e-13
extraordinarily O 0 3.1430380520447443e-10
high O 0 1.2449440367490183e-09
level O 0 1.914059355456743e-09
of O 0 4.957274146732971e-09
somatic O 0 5.290717581374338e-06
mosaicism O 0 4.71626708531403e-06
, O 0 3.7079186943067555e-11
due O 0 3.2477314171330818e-09
to O 0 3.881472573907807e-11
an O 0 5.0077481224264364e-12
extremely O 0 5.180491591261216e-10
high O 0 4.708020084898124e-10
degree O 0 1.6903698440984272e-09
of O 0 1.4494173639079122e-09
somatic O 0 8.695892574905884e-07
instability O 0 4.159255162505815e-09
both O 0 9.45765410431676e-11
within O 0 2.7120017342951996e-10
and O 0 4.40427035119928e-11
between O 0 3.482890087447288e-10
different O 0 4.493549088380178e-09
tissues O 0 6.082738082113792e-07
. O 0 1.8519826028295938e-07

This O 0 8.725018574295973e-08
instability O 0 1.8916171029559337e-07
appears O 0 6.327764534574953e-09
to O 0 4.8559746501641854e-11
be O 0 8.274735757707319e-11
biased O 0 1.317305264869617e-09
towards O 0 4.2107539677260775e-10
further O 0 7.383182260012333e-11
expansion O 0 3.1081883733463656e-09
and O 0 2.788126153563386e-11
continuous O 0 1.5667835084887116e-10
throughout O 0 3.485653085610885e-11
the O 0 1.517568154474347e-10
life O 0 1.620837769555905e-10
of O 0 1.1802613053557565e-10
an O 0 4.075372418005374e-12
individual O 0 1.3612263226325805e-11
, O 0 1.96693247626889e-12
features O 0 7.959279936520236e-12
that O 0 2.1162188483785788e-13
could O 0 4.606513087646036e-12
be O 0 2.578485602117153e-12
associated O 0 3.888289690223701e-11
with O 0 5.930061563325095e-12
the O 0 1.9204444701159673e-09
progressive O 0 8.366698693862418e-07
nature O 0 1.2724874487446414e-09
of O 0 3.5735066017394956e-09
the O 0 4.129921293838379e-08
disease O 0 2.501225026207976e-06
. O 0 1.9173293708263373e-07

Although O 0 1.0441164732810648e-07
increasing O 0 1.0118645477064092e-08
measured O 0 1.284338591034384e-08
allele O 0 4.593709412858971e-09
size O 0 1.8114035826855002e-09
between O 0 3.0014499774466685e-09
patients O 0 1.8595179653857485e-06
clearly O 0 6.180592926341433e-09
correlates O 0 4.343268411588497e-09
with O 0 5.9408164151952825e-12
an O 0 8.315071721443079e-13
increased O 0 3.191186551121383e-11
severity O 0 3.394622183350293e-08
of O 0 1.012629091690087e-08
symptoms O 0 2.0950246835127473e-06
and O 0 1.4281952009920218e-10
an O 0 9.955786195448013e-13
earlier O 0 4.6242360635107005e-11
age O 0 1.2225721823799773e-10
of O 0 2.4312532889703142e-11
onset O 0 1.9003174145382218e-08
, O 0 6.00165707062561e-12
this O 0 1.5354083022361964e-12
correlation O 0 2.6156464147386593e-12
is O 0 2.967358888987526e-13
not O 0 5.823619581360462e-13
precise O 0 3.511713697612606e-10
and O 0 5.957204868289878e-11
measured O 0 4.88149631827639e-10
allele O 0 2.2462452731186744e-10
length O 0 4.715962689805231e-11
cannot O 0 9.624816568742922e-12
be O 0 2.584926630383455e-12
used O 0 9.251787704001035e-12
as O 0 8.39264074903312e-12
an O 0 3.0651929562239277e-13
accurate O 0 2.509196461719654e-10
predictor O 0 9.260597977345242e-08
of O 0 7.30811688942623e-10
age O 0 7.74684938420478e-09
of O 0 2.4915141061399027e-09
onset O 0 6.830096390331164e-05
. O 0 9.386399710820115e-07

In O 0 1.6052778661901357e-08
order O 0 1.2685857919692012e-09
to O 0 4.003248080253208e-11
further O 0 1.0455418475441292e-10
characterize O 0 9.211128748631836e-09
the O 0 3.2848239683858083e-09
dynamics O 0 1.0994421728582893e-07
of O 0 2.9902316782681737e-06
DM B-Disease 1 1.0
CTG O 1 0.9999734163284302
repeat O 0 1.7456699197282433e-06
somatic O 0 3.985035164077999e-06
instability O 0 4.420702914842423e-09
, O 0 5.148236871532763e-12
we O 0 2.1080901781156403e-12
have O 0 1.1681952063677392e-12
studied O 0 6.326768969833196e-11
repeat O 0 2.6990685728089936e-11
length O 0 1.0548053749892539e-11
changes O 0 1.2614908249941603e-11
over O 0 1.3117736064049978e-10
time O 0 9.047759208513639e-10
in O 0 4.686036891854428e-09
111 O 0 2.357178345846478e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 5.343782163436117e-07
with O 0 2.6304066563787032e-11
varying O 0 2.3939277227214006e-09
clinical O 0 2.6518554463450528e-08
severity O 0 3.7081369441693823e-07
and O 0 2.2265915333719022e-08
CTG O 0 1.7795994153857464e-06
repeat O 0 1.7044465838722545e-09
size O 0 2.2320491288585487e-10
over O 0 2.4871433038087254e-11
time O 0 7.658453732295456e-12
intervals O 0 6.053522266791234e-11
of O 0 5.093290719737631e-11
1 O 0 3.720269869944559e-09
- O 0 8.68142269183636e-09
7 O 0 8.68592753278108e-09
years O 0 1.7133089391663248e-09
. O 0 7.982948524443145e-09

We O 0 5.9584181144600734e-08
have O 0 4.0366185394269394e-10
found O 0 5.6876361259616814e-11
a O 0 4.6336541374703e-12
direct O 0 5.687690249334132e-11
progression O 0 4.9837622917436875e-09
of O 0 6.984955391864389e-10
the O 0 3.318424979248391e-10
size O 0 5.688312043616861e-10
heterogeneity O 0 3.740355580816868e-09
over O 0 1.3417753019773215e-10
time O 0 1.9252258121049692e-10
related O 0 4.369892003808218e-09
to O 0 4.11414569079227e-10
initial O 0 5.531275348857889e-08
CTG O 0 4.6349319404725975e-07
repeat O 0 1.9679211038514666e-10
size O 0 1.344342137610255e-10
and O 0 3.3251309691784137e-12
the O 0 4.873797546101066e-12
time O 0 1.2665489317054135e-11
interval O 0 2.868085768881201e-10
and O 0 1.7945617214465415e-11
always O 0 1.7434816090844407e-10
biased O 0 5.359771515500711e-10
towards O 0 9.821512492180773e-10
further O 0 2.2030941515538416e-09
expansion O 0 4.807796472050541e-07
. O 0 2.1047161169462925e-07

Attempts O 0 3.3977968882936693e-07
to O 0 2.661507014778408e-09
mathematically O 0 1.4776169621200097e-07
model O 0 1.0312945164514531e-08
the O 0 6.189239787346423e-09
dynamics O 0 1.2166397311830224e-07
have O 0 1.0756332491368426e-09
proved O 0 1.5769357730732736e-07
only O 0 3.955192562354881e-10
partially O 0 5.882351494790328e-09
successful O 0 1.4708221307557778e-09
suggesting O 0 2.937651788492701e-10
that O 0 7.170583029257604e-13
individual O 0 4.397963764002366e-12
specific O 0 1.56609256812823e-11
genetic O 0 1.0185405852070062e-09
and O 0 1.333804039438391e-10
/ O 0 7.150482161932814e-08
or O 0 1.4955922056358872e-09
environmental O 0 7.350664077421243e-08
factors O 0 3.883935395521121e-09
also O 0 2.454700158416312e-11
play O 0 3.0253063942886627e-10
a O 0 7.536417323539268e-11
role O 0 1.3532646114811087e-09
in O 0 3.4653535152529e-08
somatic O 0 0.00015848955081310123
mosaicism O 0 0.0002602894383016974
. O 0 2.3773027990614537e-08
. O 0 5.652216472640248e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 2.816114829329308e-06
Palestinian O 0 3.0037535907467827e-06
Arabs O 0 1.1740094123524614e-06
. O 0 1.7934527818397328e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9996176958084106
AGU B-Disease 1 1.0
) O 0 2.2312935499257947e-08
is O 0 2.0068191552979897e-10
a O 0 1.75476452812795e-10
rare O 0 1.1321180437562361e-07
disorder B-Disease 1 0.9686115384101868
of I-Disease 0 0.013112339191138744
glycoprotein I-Disease 0 4.712261579697952e-05
metabolism I-Disease 0 2.8099448172724806e-06
caused O 0 2.933666864990414e-09
by O 0 1.0708916392543344e-10
the O 0 8.037951637618335e-09
deficiency B-Disease 0 1.1768117929022992e-06
of I-Disease 0 1.5321056423545087e-08
the I-Disease 0 1.671136118375216e-08
lysosomal I-Disease 0 3.44413115271891e-06
enzyme I-Disease 0 3.7198603308752354e-08
aspartylglucosaminidase I-Disease 0 1.0852205377887003e-05
( O 0 1.9890318281312602e-09
AGA O 0 0.0013678290415555239
) O 0 3.03932767842241e-09
. O 0 2.9215009078598086e-08

AGU B-Disease 1 1.0
is O 0 2.0920417682646075e-06
inherited O 0 0.020853133872151375
as O 0 2.8009367269987706e-07
an O 0 5.836463312647311e-09
autosomal O 0 0.31946679949760437
recessive O 0 0.03449616581201553
trait O 0 3.211021748938947e-06
and O 0 6.252585671440158e-10
occurs O 0 2.257742777456162e-11
with O 0 6.880851682704303e-13
a O 0 2.305426682891465e-12
high O 0 3.25754451191429e-10
frequency O 0 1.0727560506573752e-10
in O 0 3.148436719668801e-11
Finland O 0 6.136528507560968e-10
because O 0 3.919720450995534e-11
of O 0 5.138863223841383e-10
a O 0 1.1294921664628532e-09
founder O 0 9.602500483651966e-08
effect O 0 5.015491311155529e-08
. O 0 8.54993160714912e-08

While O 0 4.192970664007589e-07
very O 0 1.3484934946461635e-08
few O 0 3.31189617952532e-08
patients O 0 3.935713834835042e-07
with O 0 2.4032482670577338e-08
AGU B-Disease 1 1.0
have O 0 1.5274584086455434e-07
been O 0 2.02340499910747e-09
reported O 0 8.113944238719029e-11
from O 0 9.797708477865541e-11
non O 0 3.7209795245018995e-09
- O 0 1.3625368611158706e-09
Finnish O 0 4.670753739333122e-08
origin O 0 5.702542882346506e-10
, O 0 2.4839196671733177e-11
we O 0 2.425178113885096e-10
diagnosed O 0 0.00015019830607343465
the O 0 2.314744165232696e-07
disorder O 1 0.9786351323127747
in O 0 1.3987353497668664e-07
8 O 0 1.8423098424591444e-07
patients O 0 1.1433214375244916e-08
originating O 0 3.422973016142805e-10
from O 0 6.987296852223324e-11
3 O 0 6.564938592745762e-10
unrelated O 0 8.964858855264879e-10
families O 0 1.2412795617755545e-11
, O 0 6.729178846087702e-13
all O 0 1.2149370051672825e-12
Palestinian O 0 1.4901016531787548e-10
Arabs O 0 8.17480735881837e-11
from O 0 1.180017628749086e-11
the O 0 2.410921115525433e-11
region O 0 1.3885116667555764e-10
of O 0 4.97893337669808e-10
Jerusalem O 0 3.076897883147467e-06
. O 0 1.1652716125354345e-07

The O 0 2.282139206499778e-07
clinical O 0 1.4518229363602586e-05
diagnosis O 1 0.9961762428283691
of O 1 0.9999902248382568
AGU B-Disease 1 1.0
is O 0 4.6275690834818306e-08
often O 0 3.9652536809597905e-10
difficult O 0 4.0513817300968924e-10
, O 0 5.057546829251303e-12
in O 0 9.157371042012308e-12
particular O 0 6.251437562054818e-11
early O 0 6.6541074872361605e-09
in O 0 2.70066469187924e-11
the O 0 4.0497726699895154e-11
course O 0 1.306381003374213e-09
of O 0 5.341307604544987e-11
the O 0 3.95062316194128e-10
disease O 0 9.317751903381577e-09
, O 0 3.923630517710386e-12
and O 0 6.623567579827627e-12
most O 0 1.0532312869071525e-11
of O 0 7.65071894726077e-11
the O 0 6.820494724557591e-10
patients O 0 2.2711741820558018e-08
are O 0 1.7431748752794185e-11
diagnosed O 0 3.1567619629413457e-09
after O 0 5.767605837370127e-10
the O 0 2.855781999766549e-10
age O 0 1.9077321944394043e-09
of O 0 5.114125234406686e-10
5 O 0 2.44282993833167e-09
years O 0 2.293443657208627e-09
. O 0 1.4176879226113215e-08

However O 0 4.142102341120335e-07
, O 0 2.038154756078825e-09
since O 0 5.829710048033121e-09
these O 0 2.3807364968320144e-09
patients O 0 2.062047244066889e-08
excrete O 0 1.9795709960135355e-08
early O 0 6.583072753585384e-09
large O 0 4.98700941653496e-11
amounts O 0 3.730611999874789e-11
of O 0 3.1683539125637594e-10
aspartylglucosamine O 0 4.323848315834766e-06
in O 0 2.5843585049756257e-09
urine O 0 3.0172979670339828e-09
, O 0 1.7830014808345451e-12
biochemical O 0 8.427582243175635e-11
screening O 0 1.3395385911607605e-09
is O 0 1.7646684460914663e-11
easy O 0 7.590286732472862e-10
by O 0 7.558936809815009e-10
urine O 0 1.7457985279634158e-07
chromatography O 0 9.822567790251924e-07
. O 0 7.85456855112443e-09
. O 0 4.7645485778957664e-08

Detection O 0 4.339753559179371e-06
of O 0 8.590831157562206e-08
heterozygous O 0 7.456014472495553e-09
carriers O 0 1.1068729266483501e-09
of O 0 5.274169989633037e-10
the O 0 1.1381207087879375e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.8082055198174203e-07
ATM O 0 1.2306481039559003e-05
) O 0 6.74216169005426e-11
gene O 0 4.523141930445895e-11
by O 0 2.0430226954637476e-10
G2 O 0 5.0113162615161855e-06
phase O 0 3.7134381614123413e-07
chromosomal O 0 9.472018547285188e-08
radiosensitivity O 0 5.823555511597078e-06
of O 0 2.5540668957546586e-07
peripheral O 0 0.000858429295476526
blood O 0 1.7332124116364866e-05
lymphocytes O 0 2.6783345674630255e-06
. O 0 8.869858447724255e-08

In O 0 3.650415237643756e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.015589448623359203
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.3266117921139085e-09
patients O 0 7.544280578031248e-08
, O 0 8.958866634656282e-12
mutations O 0 2.9345425395232994e-11
in O 0 2.977936300330164e-11
a O 0 1.8351186889531412e-11
single O 0 7.501367582651852e-11
gene O 0 5.2978309239559707e-11
, O 0 8.77326163106762e-12
ATM O 0 1.7450002331997894e-08
, O 0 1.38442447610021e-12
result O 0 3.180194996232899e-11
in O 0 3.8221581455388787e-10
an O 0 4.059025560110285e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 9.790898758410549e-09
embraces O 0 6.190479240331115e-09
a O 0 1.0402462745362495e-11
variety O 0 1.5096981997864134e-10
of O 0 1.9924176197783083e-10
clinical O 0 2.160528822514607e-08
features O 0 3.229599365717206e-10
and O 0 9.878509121818979e-11
manifests O 0 1.3914551733051894e-09
extreme O 0 1.4918720481205128e-08
radiosensitivity O 0 9.495948347648664e-07
and O 0 1.0148135665133395e-09
a O 0 4.541410303371407e-10
strong O 0 4.311787371591436e-09
pre O 0 5.782928383268882e-06
- O 0 1.0168658945985953e-06
disposition O 0 4.31897678936366e-05
to O 0 5.434564087636318e-08
malignancy B-Disease 0 0.00021592325356323272
. O 0 3.078114048093994e-07

Heterozygotes O 0 1.4094873222347815e-05
for O 0 2.3595672971055137e-08
the O 0 8.987105104552029e-08
ATM O 0 2.6475854610907845e-06
gene O 0 7.207547891852073e-10
have O 0 1.6213131531772618e-11
no O 0 1.29957026043237e-11
clinical O 0 1.4120551394825043e-09
expression O 0 6.044165168361815e-11
of O 0 4.45397274617676e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.597762588900764e-09
may O 0 1.8005796853515221e-10
be O 0 1.5729667568464833e-10
cancer B-Disease 0 4.284465759951672e-08
prone O 0 3.2124116700060767e-09
with O 0 4.135533061833119e-12
a O 0 1.717296305159266e-10
moderate O 0 5.0348237579100896e-08
increase O 0 1.1754901496630055e-09
in O 0 2.9939541956736093e-09
in O 0 8.868941137052389e-09
vitro O 0 4.868706469096651e-07
radiosensitivity O 0 6.550605576194357e-06
. O 0 2.974359745167021e-07

We O 0 1.5585951018692867e-07
performed O 0 1.0035694231191883e-07
a O 0 5.280373471805433e-09
blind O 0 4.800818231842641e-08
chromosomal O 0 1.0905884195722138e-08
analysis O 0 7.260244405671301e-09
on O 0 8.362010106566231e-08
G2 O 0 2.023692286456935e-05
- O 0 9.408853429704322e-08
phase O 0 7.184659693848516e-07
lymphocytes O 0 5.185595064460813e-09
from O 0 9.990760302391877e-11
7 O 0 1.5997507762932628e-09
unrelated O 0 1.407414984555544e-08
A B-Disease 1 0.9999972581863403
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.35278093814849854
, O 0 1.3821199740249313e-10
13 O 0 3.0072591639118684e-10
obligate O 0 1.2848965225131792e-09
A B-Disease 1 0.9999651908874512
- I-Disease 1 0.9999911785125732
T I-Disease 1 1.0
heterozygotes O 0 2.4815049073367845e-06
( O 0 2.960526962469956e-11
parents O 0 2.2320947173914973e-11
of O 0 3.811794196256768e-12
the O 0 3.250014493638709e-11
patients O 0 5.862702545655907e-10
) O 0 2.456535192277287e-12
, O 0 1.0188582616477149e-11
and O 0 5.114786025273155e-11
14 O 0 3.461564923590288e-10
normal O 0 3.2562708085492886e-10
controls O 0 3.904656598052725e-10
following O 0 1.3740696358510718e-09
X O 0 1.4124943845672533e-06
- O 0 8.963874620349088e-08
irradiation O 0 1.1728612889783108e-06
with O 0 1.3101533746784355e-10
1 O 0 1.1666054788861402e-08
Gy O 0 1.7518570984975668e-06
in O 0 1.565220696109204e-11
order O 0 1.0276212172866117e-11
to O 0 7.548929363554446e-12
evaluate O 0 2.287404848866359e-10
this O 0 2.866618400987342e-11
cytogenetic O 0 1.58720595777595e-07
method O 0 1.7162763654710034e-08
as O 0 5.485629728241292e-10
a O 0 5.5046606162179046e-11
tool O 0 1.5974792599848797e-09
for O 0 2.3915156313614183e-11
detection O 0 5.416877613129145e-08
of O 0 5.5125912723497095e-08
ATM O 0 0.0002328175469301641
carriers O 0 8.417792400905455e-07
. O 0 8.791671746166685e-08

Both O 0 3.793611824676191e-07
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 0.0003675767220556736
and O 0 2.9315803118379336e-09
heterozygotes O 0 1.391419175433839e-07
showed O 0 2.960133249629848e-10
significantly O 0 1.4559056737972753e-10
increased O 0 6.581182820930565e-11
levels O 0 2.0307189263490955e-10
of O 0 2.5528459901558165e-10
radiation O 0 9.771602890396025e-06
- O 0 4.2909348962894e-07
induced O 0 5.768887604062911e-06
chromatid O 0 6.705441251142474e-07
damage O 0 1.0840245145971039e-08
relative O 0 4.045044743605786e-09
to O 0 2.0088517654892613e-11
that O 0 3.4928522747723623e-12
of O 0 3.7614947268060916e-10
normal O 0 2.4144590327068727e-08
controls O 0 9.625825470038762e-08
. O 0 1.349219473922858e-07

These O 0 2.183683633916189e-08
results O 0 3.750694688164913e-08
show O 0 7.112322397695436e-10
that O 0 1.706266378187493e-11
the O 0 3.861877928557078e-09
G2 O 0 0.000582235399633646
- O 0 9.841376140684588e-07
phase O 0 3.0903784136171453e-06
chromosomal O 0 1.9152363250896087e-08
radiosensitivity O 0 2.221467809704336e-07
assay O 0 4.2608383488129675e-09
can O 0 7.768351933945539e-12
be O 0 1.4478732882766687e-12
used O 0 2.942342767001116e-12
for O 0 1.9654360604304255e-12
the O 0 1.799600225782516e-11
detection O 0 8.396527917398089e-09
of O 0 3.1018647206337846e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00014121367712505162
. O 0 2.677869588296744e-07

In O 0 2.503456073554844e-07
combination O 0 3.3660799658719043e-07
with O 0 1.3121095321366738e-09
molecular O 0 1.405734764148292e-07
genetic O 0 1.1933235732897174e-08
analyses O 0 1.5419964194407498e-09
, O 0 4.610152103817766e-12
this O 0 2.1586174688004167e-12
test O 0 1.010477368446061e-09
may O 0 6.154306925187925e-11
be O 0 5.325882096451906e-12
of O 0 2.7369120858544704e-11
value O 0 6.53475190626196e-11
in O 0 1.13097855733435e-11
studies O 0 1.2675156063624016e-11
of O 0 2.5238203887889554e-11
familial B-Disease 0 9.137704815032066e-09
and I-Disease 0 7.246699240681664e-09
sporadic I-Disease 0 2.134750957338838e-06
cancers I-Disease 0 8.353643352165818e-06
aimed O 0 1.501257607117168e-08
at O 0 1.1550034262342024e-09
determination O 0 3.494348421728688e-10
of O 0 3.870769260672091e-10
the O 0 1.3161494116786798e-10
potential O 0 3.3434821578026686e-10
involvement O 0 8.086659813999475e-11
of O 0 1.186797105034998e-09
ATM O 0 8.9076629592455e-06
mutations O 0 8.172897913993893e-09
in O 0 1.7303765087461898e-09
tumor B-Disease 0 3.853988346236292e-06
risk O 0 1.3231657547407849e-08
or O 0 3.334203468874364e-10
development O 0 8.741305457249382e-09
. O 0 2.050926095620298e-09
. O 0 2.898201678647183e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.0229918245840963e-08
identification O 0 2.3846222774182024e-09
and O 0 5.390204341898519e-12
detection O 0 1.0546595818894389e-09
of O 0 2.9068698559342465e-09
founder O 0 1.3772181262083905e-07
- O 0 1.8727698147813499e-07
effect O 0 2.0316359439220832e-07
mutations O 0 2.273062627011768e-09
in O 0 4.36732316977384e-10
the O 0 1.910353875089754e-09
ATM O 0 5.986600513097073e-07
gene O 0 6.866335833244364e-10
in O 0 3.3288274914333726e-10
ethnic O 0 1.537385774241784e-09
populations O 0 5.324488849822728e-09
. O 0 7.421848025046529e-09

To O 0 1.2942241056634884e-08
facilitate O 0 1.4082098154233336e-08
the O 0 2.342441129954409e-09
evaluation O 0 1.8488766784230393e-07
of O 0 3.520526661304757e-07
ATM O 0 0.265927255153656
heterozygotes O 0 2.3080101527739316e-05
for O 0 4.1626360136604035e-09
susceptibility O 0 9.601563988326234e-07
to O 0 3.8334452279187303e-10
other O 0 2.761407547069439e-09
diseases O 0 0.0013257229002192616
, O 0 1.2444140162770623e-10
such O 0 5.524756652164342e-09
as O 0 2.465081252012169e-06
breast B-Disease 1 0.9998136162757874
cancer I-Disease 0 1.876053102023434e-05
, O 0 5.549442849694941e-11
we O 0 4.2465708033345706e-11
have O 0 1.814375559516801e-11
attempted O 0 3.8308139993503687e-10
to O 0 3.6871207476085743e-11
define O 0 3.0961044839017404e-10
the O 0 5.222955401507079e-10
most O 0 2.103722196444835e-10
common O 0 2.686271205476487e-10
mutations O 0 1.3070326071451532e-11
and O 0 2.6795447371358305e-12
their O 0 3.1278805500550844e-12
frequencies O 0 8.924488231754069e-11
in O 0 1.3437788659587113e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.707069365395e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 9.762158859061287e-10
homozygotes O 0 9.719991567180841e-08
from O 0 5.949327142040772e-10
10 O 0 9.726622840489085e-10
ethnic O 0 3.30311139551398e-10
populations O 0 3.1379603360193187e-09
. O 0 6.805709773516355e-09

Both O 0 3.340725811540324e-07
genomic O 0 5.438176344796375e-07
mutations O 0 2.200575366373414e-08
and O 0 8.130215389812179e-10
their O 0 4.3951170480838186e-10
effects O 0 1.114661429824082e-08
on O 0 3.1544644230052654e-08
cDNA O 0 1.0427989849404184e-07
were O 0 4.147839405277409e-09
characterized O 0 2.9521297406631675e-08
. O 0 1.129724793713649e-07

Protein O 0 2.6806932851286547e-07
- O 0 6.265484842060687e-08
truncation O 0 2.2640836050413782e-07
testing O 0 3.23130961987772e-08
of O 0 7.969621407255545e-09
the O 0 7.800791124168427e-09
entire O 0 1.155028073185349e-08
ATM O 0 1.9057661404531245e-07
cDNA O 0 8.330994560878935e-09
detected O 0 3.4539298088276382e-09
92 O 0 3.563040706922038e-08
( O 0 4.7655223517351075e-11
66 O 0 3.6038840800500793e-09
% O 0 9.332647155080309e-11
) O 0 3.972200693369565e-11
truncating O 0 1.3047038294189406e-07
mutations O 0 6.103101579668646e-09
in O 0 3.283690208633061e-09
140 O 0 6.377639749644004e-08
mutant O 0 1.201799335603937e-07
alleles O 0 4.392716235201988e-08
screened O 0 2.42458895627351e-07
. O 0 6.7705094863868e-08

The O 0 8.865238214639248e-07
haplotyping O 0 0.0007458902546204627
of O 0 2.6957286536344327e-06
patients O 0 1.1176801308465656e-05
with O 0 1.0063363475865117e-09
identical O 0 3.3311147262793384e-07
mutations O 0 7.605115648345873e-09
indicates O 0 2.0692050295423314e-09
that O 0 3.882492417839334e-12
almost O 0 1.3441619345355704e-11
all O 0 3.134163067963769e-12
of O 0 1.7716121972211063e-11
these O 0 6.776865527080567e-12
represent O 0 3.3867316503316536e-12
common O 0 8.030863474228767e-11
ancestry O 0 5.0947090296515896e-11
and O 0 1.6527727537268833e-12
that O 0 3.7610295737164345e-13
very O 0 1.056092366336081e-10
few O 0 2.702007062538314e-09
spontaneously O 0 2.3125554093894607e-07
recurring O 0 1.6140239722517435e-07
ATM O 0 2.1970308807794936e-05
mutations O 0 7.11995724600456e-08
exist O 0 2.8528559070650772e-08
. O 0 1.0041476627975499e-07

Assays O 0 2.4221330932050478e-06
requiring O 0 1.2788829906185128e-07
minimal O 0 2.670397520887491e-07
amounts O 0 1.7043305433617206e-08
of O 0 3.6233345213076973e-09
genomic O 0 5.346286968688219e-09
DNA O 0 2.2655830544948685e-09
were O 0 1.4361579980803896e-10
designed O 0 4.497267835912311e-10
to O 0 2.2980346792156325e-11
allow O 0 4.278342957686476e-11
rapid O 0 2.4431188183626773e-09
screening O 0 2.8912669591818485e-08
for O 0 4.634940486969441e-10
common O 0 3.679272353451779e-08
ethnic O 0 4.651033780334046e-09
mutations O 0 1.563271823101786e-08
. O 0 3.795587133481604e-08

These O 0 1.468847017349617e-07
rapid O 0 4.554770214326709e-07
assays O 0 7.090338840498589e-07
detected O 0 4.2963029045495205e-07
mutations O 0 1.1363860963342631e-08
in O 0 1.242924985156435e-09
76 O 0 4.212035520367863e-08
% O 0 1.6702231264709155e-10
of O 0 4.413093501742793e-10
Costa O 0 1.1138878264205232e-08
Rican O 0 5.8736600294651e-07
patients O 0 3.709353961767192e-07
( O 0 1.0238920822303044e-11
3 O 0 4.1065648104243735e-10
) O 0 2.1803912841900086e-12
, O 0 4.154214732626782e-12
50 O 0 2.0941491596371264e-11
% O 0 8.156358618019444e-13
of O 0 1.3509139119849412e-11
Norwegian O 0 2.115984614192712e-07
patients O 0 8.264053263928872e-08
( O 0 7.869252992287468e-12
1 O 0 6.996262458258684e-10
) O 0 5.138005472471452e-12
, O 0 4.063101417817183e-12
25 O 0 3.177139107357618e-11
% O 0 2.0058221576746416e-12
of O 0 2.2937781882226282e-11
Polish O 0 1.3299106740305433e-06
patients O 0 1.1603779057622887e-05
( O 0 2.2293207210810628e-11
4 O 0 1.0518952375804247e-09
) O 0 2.401717496755551e-12
, O 0 2.6682987416815074e-12
and O 0 3.152064330033677e-12
14 O 0 3.794083103247914e-11
% O 0 2.1733992643796496e-12
of O 0 2.5202655934419838e-11
Italian O 0 5.888550731469877e-07
patients O 0 3.232486415072344e-05
( O 0 1.1074778247244232e-11
1 O 0 1.0733235411564124e-09
) O 0 4.107100944061859e-12
, O 0 4.695809713295418e-12
as O 0 1.796349180516188e-11
well O 0 2.362179896131522e-11
as O 0 3.1881143558454283e-11
in O 0 1.5949452869534753e-10
patients O 0 1.4225004507650851e-09
of O 0 1.7286481135414533e-09
Amish O 0 1.4356687643157784e-06
/ O 0 2.114977917244687e-07
Mennonite O 0 3.449376322350872e-07
and O 0 9.118717586575897e-11
Irish O 0 8.580935961788327e-09
English O 0 1.829958939936205e-08
backgrounds O 0 6.825758447348562e-08
. O 0 3.0377414361737465e-08

Additional O 0 7.263363244192078e-08
mutations O 0 2.3501081969357074e-08
were O 0 2.1743147282649034e-09
observed O 0 4.794343810843316e-10
in O 0 1.32866995183889e-10
Japanese O 0 1.5814478615538974e-07
, O 0 2.2193008542004122e-10
Utah O 0 5.913008038760381e-08
Mormon O 0 1.6400704794250487e-08
, O 0 1.0325841744152076e-11
and O 0 1.2463374950144601e-11
African O 0 1.367370799920664e-10
American O 0 8.897231285054374e-10
patients O 0 2.7104324118454315e-08
. O 0 2.688385691840267e-08

These O 0 2.716467228935926e-08
assays O 0 5.7576972523065706e-08
should O 0 1.885059747186446e-10
facilitate O 0 3.001362491872328e-10
screening O 0 7.905400778440708e-09
for O 0 1.1230562035891012e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
heterozygotes O 0 9.857945997282513e-07
in O 0 1.8316193006739923e-10
the O 0 4.8624625159643386e-11
populations O 0 1.033488572499408e-11
studied O 0 9.518332649838257e-11
. O 0 1.468707655494228e-10
. O 0 1.3059656467362402e-08

The O 0 1.791057911759708e-06
von B-Disease 1 0.9999747276306152
Hippel I-Disease 1 0.9999994039535522
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.999997615814209
tumor I-Disease 0 0.007793995551764965
suppressor O 0 2.1288446987455245e-06
gene O 0 5.809493996977722e-10
is O 0 2.3582576863523386e-12
required O 0 1.564188015223955e-11
for O 0 1.2080516274826092e-11
cell O 0 4.754721061317468e-10
cycle O 0 6.523397932944874e-10
exit O 0 3.964514494469995e-09
upon O 0 1.155937789931727e-09
serum O 0 1.469376087470664e-08
withdrawal O 0 2.4052154046216856e-08
. O 0 9.463875016990642e-08

The O 0 1.4050118402053613e-08
inactivation O 0 1.154565325123258e-06
of O 0 8.165543796678776e-09
the O 0 4.2739856098705786e-08
von B-Disease 1 0.9999972581863403
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 8.519911034454708e-07
VHL I-Disease 1 1.0
) I-Disease 0 2.1075642564483132e-07
tumor I-Disease 0 0.00033754087053239346
suppressor O 0 4.865580558544025e-05
gene O 0 2.3390759551489282e-08
predisposes O 0 2.2141665567687596e-07
affected O 0 5.630456989536015e-09
individuals O 0 3.4206738136477455e-11
to O 0 1.341557837042373e-10
the O 0 3.790035520978563e-07
human O 1 0.987873375415802
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.4659844171927006e-10
is O 0 8.313834104663187e-13
associated O 0 8.276183557920369e-12
with O 0 8.23103391001112e-12
sporadic B-Disease 0 4.159982381679583e-06
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 3.375800616822744e-08
RCC B-Disease 0 0.3318649232387543
) O 0 3.210586241308988e-09
and O 0 5.7400981745558965e-08
brain B-Disease 0 3.2212351470661815e-06
hemangioblastomas I-Disease 0 0.0004600694519467652
. O 0 4.647928562917514e-06

VHL O 1 0.9892260432243347
- O 0 0.00033604426425881684
negative O 0 4.306161372369388e-06
786 O 0 5.0281003495911136e-05
- O 0 8.619094842288177e-06
0 O 0 6.700468020426342e-07
RCC B-Disease 0 8.213638466258999e-06
cells O 0 3.2613634015632442e-09
are O 0 6.446263661752383e-11
tumorigenic O 0 8.601793524576351e-06
in O 0 2.4747404836489295e-07
nude O 0 3.335129576953477e-07
mice O 0 1.8094319376160684e-09
which O 0 1.3220781891129518e-12
is O 0 1.5198028382665263e-12
suppressed O 0 2.965795942166949e-10
by O 0 1.1591120424592205e-10
the O 0 1.3773547857809376e-09
reintroduction O 0 2.2814995759290468e-07
of O 0 1.8761085129881394e-08
VHL B-Disease 0 0.007447462994605303
. O 0 1.4040467704035109e-06

Remarkably O 0 1.0764817488961853e-05
, O 0 2.380076968844236e-10
this O 0 1.3045221153307196e-11
occurs O 0 7.76613356956446e-11
without O 0 2.7656180123791785e-10
affecting O 0 7.832752779712848e-10
the O 0 2.0208544559974229e-10
growth O 0 4.0503927989377075e-10
rate O 0 3.933045278348146e-10
and O 0 8.628813809308244e-12
cell O 0 1.0748021223028204e-10
cycle O 0 6.632318999555409e-11
profile O 0 1.1052668502653518e-10
of O 0 1.1503812485935683e-10
these O 0 8.977756038586193e-11
cells O 0 6.546856945455204e-10
in O 0 1.4887495403126394e-10
culture O 0 9.814064227953168e-09
. O 0 1.2978876640090675e-08

The O 0 2.106753527186811e-06
786 O 0 9.553807103657164e-06
- O 0 4.287997512619768e-07
0 O 0 1.8417663838476983e-08
cell O 0 1.2570150476065578e-09
line O 0 5.0404902474099345e-09
, O 0 4.949106402474257e-11
like O 0 5.468100416905486e-10
many O 0 5.793559521016789e-10
cancer B-Disease 0 2.1536621375162213e-08
cells O 0 1.2356983492001206e-10
, O 0 4.589972065621728e-12
fails O 0 1.351012496320081e-10
to O 0 2.4328674491647106e-11
exit O 0 2.578558477850379e-09
the O 0 1.4026700634328648e-10
cell O 0 1.192958232199004e-10
cycle O 0 2.9379474547619466e-11
upon O 0 1.2950969463521034e-10
serum O 0 3.808348303380171e-09
withdrawal O 0 1.0039634013025989e-08
. O 0 4.261710273567587e-08

Here O 0 3.179448242462968e-07
, O 0 5.596481056358016e-10
it O 0 1.8747035174238036e-11
is O 0 2.8306434887021004e-12
shown O 0 1.5815571508676074e-12
that O 0 3.219188967045622e-13
reintroduction O 0 2.1233148572719074e-09
of O 0 1.3287865252564757e-10
the O 0 7.914900956862425e-10
wild O 0 2.4808647580698562e-08
- O 0 8.874761370236683e-09
type O 0 8.008787233393377e-08
VHL B-Disease 0 0.00013493151345755905
gene O 0 3.5317930802136743e-09
restores O 0 1.0766312286136781e-08
the O 0 7.458655915115742e-10
ability O 0 3.6973765715764273e-10
of O 0 2.6568473643351354e-08
VHL O 1 1.0
- O 1 1.0
negative O 1 0.9867695569992065
RCC B-Disease 1 0.9999918937683105
cancer I-Disease 0 1.1464394447102677e-06
cells O 0 1.2705611562857655e-10
to O 0 1.1051588463817374e-11
exit O 0 9.221038377305035e-10
the O 0 7.875473190255278e-11
cell O 0 1.4090842381797586e-10
cycle O 0 9.857089450227008e-11
and O 0 3.628157843604818e-11
enter O 0 2.0098166686466357e-08
G0 O 0 0.00013627523730974644
/ O 0 1.9554940422494838e-07
quiescence O 0 9.160503964267264e-07
in O 0 1.8458061745718624e-09
low O 0 4.345756465795603e-08
serum O 0 6.534848751016398e-08
. O 0 2.94256192745479e-08

Both O 0 2.282077048221254e-06
VHL O 1 0.9997878670692444
- O 0 0.0002439579548081383
positive O 0 2.5535601366755145e-07
and O 0 4.740544667924951e-08
VHL O 1 0.9999990463256836
- O 0 0.023764071986079216
negative O 0 4.70775648864219e-06
RCC B-Disease 0 0.00010934590682154521
cells O 0 1.5837036571042518e-08
exit O 0 7.211002461815497e-09
the O 0 1.886879819057441e-10
cell O 0 2.564852219499869e-10
cycle O 0 1.2397989579415736e-10
by O 0 4.6627184752123796e-11
contact O 0 1.4764238720488265e-09
inhibition O 0 2.958996958568605e-07
. O 0 3.708794906742696e-07

The O 0 2.591196789580863e-06
cyclin O 0 1.5066172636579722e-05
- O 0 1.1072830830016755e-06
dependent O 0 1.1584284465016026e-07
kinase O 0 1.2076057487320213e-07
inhibitor O 0 2.703019674754614e-07
, O 0 6.281656861339968e-10
p27 O 0 6.53040672204952e-07
, O 0 1.8689777503411165e-10
accumulates O 0 2.0492447738718056e-09
upon O 0 2.487177686028019e-10
serum O 0 3.20093590522319e-10
withdrawal O 0 3.426755268431947e-10
, O 0 6.242140918738537e-12
only O 0 3.5354002711485144e-12
in O 0 4.714512200770793e-12
the O 0 7.541130046806455e-12
presence O 0 9.365935978167261e-12
of O 0 2.1824082541144207e-09
VHL B-Disease 1 0.99997878074646
, O 0 3.005223569996218e-10
as O 0 1.1740414196381721e-11
a O 0 1.0879310690173338e-12
result O 0 4.966295170244495e-12
of O 0 1.2944790205027257e-11
the O 0 3.696697808974747e-11
stabilization O 0 3.0958935415270616e-09
of O 0 2.107434227127669e-09
the O 0 8.312234456298029e-09
protein O 0 2.8269100837974293e-08
. O 0 2.6053498913825024e-08

We O 0 1.674895244718755e-08
propose O 0 1.4803187120548955e-08
that O 0 2.497087432662415e-11
the O 0 1.0589045196240932e-09
loss O 0 2.21580531700738e-08
of O 0 2.0240815246097554e-08
wild O 0 5.273668080008065e-07
- O 0 2.9669534384879626e-08
type O 0 1.2857434228408238e-07
VHL B-Disease 0 0.000274437916232273
gene O 0 9.761284003317883e-10
results O 0 6.810875197160726e-10
in O 0 5.860911062027796e-11
a O 0 1.5825174504158213e-11
specific O 0 8.300031217878256e-10
cellular O 0 3.119462377298987e-08
defect O 0 9.488850594152609e-09
in O 0 4.52644088877463e-10
serum O 0 1.446253250492191e-08
- O 0 1.305996022438194e-07
dependent O 0 9.119665911327957e-09
growth O 0 4.520194774038089e-10
control O 0 2.1348792178521592e-10
, O 0 9.683407721505777e-12
which O 0 3.035257808980951e-11
may O 0 9.084163643535703e-09
initiate O 0 1.6240522882071673e-07
tumor B-Disease 0 4.620073923433665e-06
formation O 0 2.197906070477984e-07
. O 0 1.6330555752119835e-07

This O 0 6.880183534008211e-09
is O 0 4.1869602229738234e-10
corrected O 0 4.27854285334206e-09
by O 0 1.6618215137320647e-10
the O 0 4.928667474146664e-10
reintroduction O 0 2.9792474265377678e-08
of O 0 7.755509012774553e-10
wild O 0 3.996639463821339e-08
- O 0 1.6530062652009292e-08
type O 0 4.910224902232585e-07
VHL B-Disease 1 0.9999765157699585
, O 0 1.5271343301037632e-08
implicating O 0 3.150020575048984e-06
VHL B-Disease 1 0.9999996423721313
as O 0 1.3275521837385895e-07
the O 0 1.3537558629650448e-08
first O 0 1.8558955483527484e-09
tumor B-Disease 0 3.5604184489557156e-08
suppressor O 0 2.330516757353962e-08
involved O 0 5.169473876742714e-11
in O 0 4.193232219784626e-11
the O 0 1.4922547919571372e-10
regulation O 0 1.070316901774504e-08
of O 0 7.944711555296635e-10
cell O 0 7.354009068372136e-10
cycle O 0 1.9897136716018338e-10
exit O 0 5.780534939603399e-10
, O 0 3.638105170854916e-13
which O 0 2.597374626576304e-13
is O 0 3.947408806076469e-13
consistent O 0 6.72472078022679e-11
with O 0 1.260374183492674e-12
its O 0 8.06684857801443e-11
gatekeeper O 0 3.900624268027286e-09
function O 0 3.314886906635728e-11
in O 0 1.1642037334169686e-10
the O 0 1.9822186114737406e-09
kidney O 0 2.913732259912649e-06
. O 0 3.2119091830651314e-09
. O 0 1.880543720744754e-08

Piebaldism B-Disease 1 1.0
with O 0 0.03315446153283119
deafness B-Disease 1 1.0
: O 0 1.5574563860809576e-08
molecular O 0 6.351779546776015e-09
evidence O 0 1.8513657273899753e-10
for O 0 1.5313117093795903e-11
an O 0 5.3829943974514904e-11
expanded O 0 9.862960723694414e-06
syndrome O 1 0.9999997615814209
. O 0 3.640139402705245e-05

In O 0 2.033604751261464e-08
a O 0 9.87195880597369e-10
South O 0 8.704486020860713e-09
African O 0 7.541051116888298e-10
girl O 0 1.3658674191674436e-09
of O 0 2.610027471927623e-10
Xhosa O 0 9.042295801009459e-07
stock O 0 7.016728886810597e-08
with O 0 1.156739461161127e-11
severe O 0 1.2475687753976672e-06
piebaldism B-Disease 1 0.9999998807907104
and O 0 0.0010146691929548979
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 6.671520225154381e-08
identified O 0 5.388235968517563e-10
a O 0 1.11009387446237e-11
novel O 0 3.037946560979776e-10
missense O 0 3.6885736687253257e-09
substitution O 0 1.6286859860770164e-08
at O 0 1.8256908207447964e-09
a O 0 8.108993337918591e-11
highly O 0 3.0646498672126654e-09
conserved O 0 1.7410831665287674e-09
residue O 0 1.4201155806858878e-08
in O 0 1.8611445717908737e-10
the O 0 1.3523403230575326e-10
intracellular O 0 1.449549230647662e-10
kinase O 0 6.261680063346375e-10
domain O 0 1.749564382258484e-10
of O 0 3.283125160624678e-10
the O 0 9.826708335936019e-09
KIT O 0 0.3018982410430908
proto O 0 2.810464684444014e-05
- O 0 1.8859172996599227e-05
oncogene O 0 9.102443982555997e-06
, O 0 1.328858134641564e-09
R796G O 0 1.3623422319142264e-06
. O 0 1.1225046847584963e-07

Though O 0 2.4190376279875636e-06
auditory B-Disease 0 7.066311809467152e-05
anomalies I-Disease 0 1.4458058103627991e-05
have O 0 2.2342521166507368e-09
been O 0 1.0646173942419068e-09
observed O 0 2.254409992019646e-09
in O 0 1.545350070131235e-09
mice O 0 2.768036022615661e-09
with O 0 2.0340088988102245e-11
dominant O 0 2.0627494450309314e-06
white O 0 7.453570560755907e-07
spotting O 0 0.1883244663476944
( O 0 2.7634941002219193e-09
W O 0 4.493920641834848e-06
) O 0 4.476179496504251e-11
due O 0 1.9214755297980446e-07
to O 0 1.0396051131067452e-08
KIT O 1 1.0
mutations O 0 5.50309641766944e-06
, O 0 4.437804079771013e-08
deafness B-Disease 1 1.0
is O 0 5.589640555969666e-11
not O 0 1.0033148790944413e-11
typical O 0 1.8510698529539127e-09
in O 0 3.2893804347011724e-10
human O 0 1.079237810230893e-09
piebaldism B-Disease 0 6.8907315835531335e-06
. O 0 2.952384363652527e-07

Thus O 0 4.2480195361349615e-08
, O 0 1.4694921668390037e-10
the O 0 8.841739146392413e-11
occurrence O 0 1.4455032726345962e-08
of O 0 5.744333248003386e-05
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.0009429603815078735
this O 0 2.378912888900686e-08
patient O 0 1.43882772363213e-07
extends O 0 5.846354511618301e-10
considerably O 0 1.878349031869675e-09
the O 0 1.5001970499195494e-10
phenotypic O 0 3.089275280032666e-09
range O 0 1.3349125360662129e-08
of O 0 3.5305807166707837e-09
piebaldism B-Disease 0 2.296455704708933e-06
due O 0 6.133562351351429e-07
to O 0 1.5297406008585313e-08
KIT O 0 0.0007217494421638548
gene O 0 6.425132870191419e-09
mutation O 0 2.2641013508462038e-09
in O 0 1.2818311689866135e-10
humans O 0 5.050496132419369e-10
and O 0 6.467471003190894e-11
tightens O 0 1.434894603136172e-08
the O 0 1.1190065540844785e-09
clinical O 0 2.6198456737347442e-08
similarity O 0 1.2388210457459081e-09
between O 0 9.50047263081899e-10
piebaldism B-Disease 0 2.513750223442912e-05
and O 0 2.219042727347187e-10
the O 0 2.6434330419045082e-11
various O 0 1.0076394579838777e-11
forms O 0 4.933915498384067e-10
of O 0 3.442343654569413e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999152421951294
. O 0 4.37791136675969e-08
. O 0 6.62310029042601e-08

Cycloheximide O 0 7.633892528247088e-05
facilitates O 0 3.597052966597403e-08
the O 0 1.5767763761331821e-09
identification O 0 1.4409446968954853e-08
of O 0 1.0614570555844693e-08
aberrant O 0 7.659257050818269e-08
transcripts O 0 7.502291232697189e-09
resulting O 0 1.2359228085401242e-09
from O 0 8.116549654602068e-10
a O 0 4.517643203971744e-10
novel O 0 3.905301326767585e-08
splice O 0 5.773355837845884e-07
- O 0 2.671420773481259e-08
site O 0 3.3417177913719343e-09
mutation O 0 2.5281624016493254e-10
in O 0 5.884791959287483e-11
COL17A1 O 0 0.004364609252661467
in O 0 8.257649009024703e-10
a O 0 3.7703581923231866e-10
patient O 0 2.1526517457459704e-08
with O 0 5.464910191044225e-10
generalized O 1 0.7261177897453308
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999986886978149
bullosa I-Disease 1 0.9771157503128052
. O 0 6.480497631855542e-06

Patients O 0 2.117345320584718e-05
with O 0 2.181868374862006e-08
generalized O 0 0.44056200981140137
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
often O 0 7.327091822162402e-08
show O 0 1.0606996392326096e-09
decreased O 0 1.7240414651453762e-09
expression O 0 1.7700459153946468e-10
of O 0 3.5062724945689183e-10
type O 0 4.964127242601535e-07
XVII O 1 1.0
collagen O 0 3.43534611602081e-06
, O 0 1.2330643173186218e-09
a O 0 5.625054311231281e-10
transmembrane O 0 7.226300002827202e-09
hemidesmosomal O 0 9.792826460852666e-08
protein O 0 8.045172306125892e-10
encoded O 0 2.803271503815097e-10
by O 0 1.9246320093202485e-09
COL17A1 O 0 0.003057870315387845
. O 0 1.525450784356508e-06

This O 0 1.3756358718808315e-08
report O 0 1.3599923409657322e-09
documents O 0 1.2324347764547383e-08
a O 0 1.2815067895743937e-09
novel O 0 8.069599743976141e-08
splice O 0 2.192449528592988e-06
- O 0 8.325232414563288e-08
site O 0 1.18024230388869e-08
mutation O 0 8.217332925219978e-10
in O 0 1.4707933482238644e-10
COL17A1 O 1 0.9456444978713989
in O 0 2.0454724580787342e-09
a O 0 3.627896871805092e-10
patient O 0 2.391364439802146e-08
with O 0 3.2941646632700383e-10
generalized O 1 0.9995577931404114
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.2435893714427948
, O 0 2.729791670486037e-10
and O 0 1.2775932221875674e-11
applies O 0 1.000479490920192e-10
a O 0 5.296666317350374e-12
new O 0 9.534813216749427e-11
methodology O 0 1.6740767661005407e-09
to O 0 3.389370381579049e-11
define O 0 4.775661532896436e-10
and O 0 2.470064153214935e-10
characterize O 0 9.967815017830617e-09
the O 0 5.457621465865259e-09
resulting O 0 5.2532232786006716e-08
mRNA O 0 1.9996672051547648e-07
splice O 0 1.0051409162770142e-06
variants O 0 1.4118208468971716e-07
. O 0 9.421388114105866e-08

Mutational O 0 2.1447094695759006e-05
analysis O 0 2.0739472361697153e-08
of O 0 9.868935535450873e-08
COL17A1 O 1 0.9999594688415527
identified O 0 4.354045302079612e-07
a O 0 6.1987259769580305e-09
maternally O 0 2.441062633806723e-06
inherited O 0 8.974497177405283e-06
G O 0 0.00016064780356828123
- O 0 5.344057285583403e-07
to O 0 8.645432814091691e-09
- O 0 2.7616713850875385e-05
T O 0 1.1717035704350565e-05
transversion O 0 6.503166787297232e-07
at O 0 6.166224197912129e-10
the O 0 6.529694146495402e-11
- O 0 2.1158265417486888e-10
1 O 0 7.285486658403784e-10
position O 0 6.224669668597471e-10
of O 0 1.500466639825504e-09
exon O 0 1.393433706198266e-07
32 O 0 3.6779532308628404e-08
. O 0 2.959153988513208e-08

This O 0 5.161215810289832e-08
acceptor O 0 3.6720379625876376e-07
splice O 0 2.3333470835495973e-06
- O 0 6.57878231891118e-08
site O 0 7.768244714156936e-09
mutation O 0 7.176778615836099e-10
led O 0 1.866263393823786e-10
to O 0 8.50632151522257e-12
the O 0 8.709177129473389e-11
formation O 0 1.9851280619320733e-09
of O 0 8.677747409535641e-09
aberrant O 0 1.6167145844292463e-08
transcripts O 0 2.9487856600951545e-09
present O 0 9.313193272131315e-11
at O 0 3.5574572176955144e-09
extremely O 0 3.447698659897469e-08
low O 0 2.1004251493650372e-07
levels O 0 1.3103462492836115e-07
. O 0 7.525195400148732e-08

Based O 0 2.4551235355829704e-07
on O 0 6.209473468743454e-08
our O 0 1.543161598505094e-09
recent O 0 3.2748942446758633e-10
finding O 0 6.804720120712204e-10
that O 0 1.2872796578689005e-11
cycloheximide O 0 9.039777978614438e-06
stabilized O 0 0.00032836131867952645
mutant O 0 2.4647731606819434e-06
COL17A1 O 0 0.0003332755877636373
transcripts O 0 9.517764709698895e-08
in O 0 1.2377676661401438e-09
keratinocytes O 0 4.3636557478521354e-08
homozygous O 0 3.795672220974211e-09
for O 0 3.843231982658679e-11
a O 0 1.5266783670586648e-10
frameshift O 0 7.622283959562992e-08
mutation O 0 1.2314238517774356e-09
, O 0 1.6323782603411274e-11
the O 0 1.0009318374137877e-10
effects O 0 5.705047101400851e-09
of O 0 1.572116659076528e-08
the O 0 3.907864254415472e-08
splice O 0 1.412437768522068e-06
- O 0 1.0307168452072801e-07
site O 0 5.5162696632748975e-09
mutation O 0 1.213942280031688e-10
on O 0 6.692118387219281e-11
splicing O 0 3.450926877590632e-09
of O 0 3.894914613056244e-09
COL17A1 O 0 0.0018858300754800439
transcripts O 0 3.886278676645816e-08
were O 0 6.949897879415801e-10
determined O 0 2.8131375007234283e-10
using O 0 8.573042276083243e-11
reverse O 0 2.4685626875964317e-09
transcriptase O 0 1.2720750008909931e-09
polymerase O 0 5.681892178976966e-10
chain O 0 8.063603257335572e-11
reaction O 0 1.2677967009544489e-10
of O 0 5.704239303128134e-10
total O 0 1.252840053922455e-10
RNA O 0 2.639756191413767e-10
from O 0 4.5017285038584376e-11
keratinocytes O 0 1.354931278285676e-08
incubated O 0 4.5771386680826254e-08
for O 0 3.9516484529045215e-10
2 O 0 2.8536774721032998e-08
. O 0 2.254720676830857e-08

5 O 0 8.780876328273735e-07
h O 0 1.460489897908701e-07
in O 0 6.213495828966131e-10
the O 0 3.685041993772842e-10
presence O 0 1.5301475364548622e-10
or O 0 2.938756182846447e-10
absence O 0 4.9278543912123496e-08
of O 0 2.1469441335852935e-08
10 O 0 1.1029956503705307e-08
microg O 0 1.167490154330153e-06
cycloheximide O 0 4.918778358842246e-06
per O 0 3.0764704206376337e-07
ml O 0 1.2731997230730485e-05
. O 0 4.2166738012383576e-07

Using O 0 1.1249127185308794e-09
this O 0 1.6054967078016347e-10
approach O 0 5.206331010754184e-08
, O 0 7.063680196317534e-10
an O 0 1.091280191212185e-10
abnormally O 0 8.12417724205261e-08
spliced O 0 1.499471835586519e-08
transcript O 0 2.4317113656024958e-08
was O 0 2.2658164233746447e-09
identified O 0 1.3318517122495876e-10
that O 0 6.972990978029725e-13
contains O 0 1.3190563225018437e-11
an O 0 7.506970305798388e-13
extra O 0 2.0463299110762279e-10
264 O 0 2.9712214910659895e-09
bases O 0 4.3678063943453083e-10
upstream O 0 3.669389014859803e-09
from O 0 6.856389900278259e-10
exon O 0 2.694268452785309e-08
32 O 0 1.366524005064207e-09
, O 0 4.3133439528442175e-12
resulting O 0 9.48692235880344e-11
in O 0 7.576195920622197e-11
a O 0 2.1631821334189283e-10
premature O 0 4.756721239118633e-08
termination O 0 2.113113026780411e-07
codon O 0 1.729612648659895e-07
27 O 0 1.149924457877205e-07
bp O 0 3.6468890129981446e-08
downstream O 0 2.3040552576958362e-08
from O 0 7.259451373364811e-10
the O 0 9.534877776218309e-09
cryptic O 0 2.266540832351893e-06
splice O 0 1.7707923689158633e-05
site O 0 1.5011409004728193e-06
. O 0 3.0596112310377066e-07

Three O 0 1.3272509136186272e-07
other O 0 3.9400900320174514e-09
splice O 0 6.160199745863792e-07
variants O 0 2.0659562949276733e-08
, O 0 5.749797860055139e-11
including O 0 2.4150584310156376e-11
one O 0 9.880500931314096e-12
derived O 0 1.0649764403680706e-10
from O 0 1.4293152772459905e-10
the O 0 3.999380826513743e-10
skipping O 0 2.7903329424816548e-08
of O 0 5.883282749863383e-09
exon O 0 5.15217664087686e-08
32 O 0 4.667011221926032e-09
, O 0 7.528041384707862e-11
were O 0 1.924485015791788e-09
also O 0 5.354305332438969e-10
identified O 0 1.3024656020377279e-08
. O 0 5.565627247960947e-08

These O 0 1.0654610527183195e-08
results O 0 3.847232754594643e-09
indicate O 0 1.110624481270861e-09
the O 0 2.3050375497213338e-10
usefulness O 0 1.5958688592832004e-08
of O 0 7.06362635050084e-10
cycloheximide O 0 8.461996685582562e-07
treatment O 0 2.1366622604546137e-07
in O 0 1.7742304847523371e-10
evaluating O 0 1.7092257609263584e-09
the O 0 1.8352001862620426e-10
abnormal O 0 1.0490976143362474e-10
processing O 0 4.394549169006723e-09
of O 0 5.62348079213848e-09
mRNA O 0 3.576793305981596e-09
due O 0 2.0395713562493256e-08
to O 0 5.006607350921399e-10
splice O 0 3.8429485016422404e-07
- O 0 1.9849018428885756e-08
site O 0 2.5380975099409397e-09
mutations O 0 6.13286296746729e-11
, O 0 1.7755556139947837e-12
because O 0 6.258237678080647e-11
( O 0 4.9645738908754566e-11
i O 0 9.139268786206856e-10
) O 0 3.546220955774615e-11
aberrant O 0 2.4608530768688297e-09
splicing O 0 2.5244148993408544e-09
often O 0 7.555891329280584e-11
generates O 0 1.9607379955766113e-11
a O 0 7.817282411670678e-12
premature O 0 4.810834841606493e-09
termination O 0 2.250467190378913e-08
codon O 0 8.845475463203911e-09
, O 0 1.5897669292108674e-10
( O 0 1.4580057647317624e-11
ii O 0 4.191975051526242e-07
) O 0 1.0588919324705515e-10
transcripts O 0 1.6712691230935661e-09
with O 0 2.8703771998150884e-11
premature O 0 5.1152618141259154e-08
termination O 0 4.420165566898504e-08
codons O 0 2.3376742763758784e-09
can O 0 2.620491323934715e-11
occur O 0 4.009927112580414e-11
at O 0 4.0849645888130226e-10
low O 0 4.815635890054182e-09
or O 0 3.501138268191539e-11
undetectable O 0 4.73768579922762e-09
levels O 0 6.10970218861695e-10
due O 0 2.4335986559265166e-09
to O 0 1.8625614939260515e-10
nonsense O 0 3.485186184093436e-08
- O 0 4.674931552983708e-09
mediated O 0 3.383379576504808e-09
mRNA O 0 4.777401252376023e-10
decay O 0 1.6892675036572768e-09
, O 0 3.9550676102229065e-12
and O 0 2.5820047055286066e-12
( O 0 2.4448026068879525e-12
iii O 0 3.957165617407554e-08
) O 0 1.666079600670667e-11
the O 0 1.2459387688235068e-10
levels O 0 1.3342831284290924e-09
of O 0 1.9860586786268897e-10
these O 0 7.36152735991702e-11
transcripts O 0 4.935383768334134e-10
can O 0 5.473981077447343e-12
be O 0 1.0691176242916267e-11
increased O 0 7.599384455048153e-10
by O 0 3.738550802268037e-09
cycloheximide O 0 0.00012830074410885572
. O 0 1.5176005945249926e-06

A O 0 1.4618320847148425e-06
deletion O 0 3.57163855824183e-07
mutation O 0 3.5898356287589195e-08
in O 0 2.833802525969986e-09
COL17A1 O 1 0.9682229161262512
in O 0 2.3910347035638324e-09
five O 0 2.166861412522536e-10
Austrian O 0 8.264905204669049e-08
families O 0 5.4108391378537846e-11
with O 0 2.9996900796636083e-11
generalized O 0 0.00011498555250000209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999990463256836
bullosa I-Disease 0 0.0021564634516835213
represents O 0 3.978072982135927e-09
propagation O 0 1.1547659717336956e-08
of O 0 3.533320580562105e-10
an O 0 4.333846823079135e-11
ancestral O 0 1.224237564656505e-07
allele O 0 1.6556575133108709e-07
. O 0 7.798652035262421e-08

Patients O 0 2.7386364308767952e-05
with O 0 2.147410782527004e-08
generalized O 1 0.957514226436615
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999861717224121
, O 0 2.810286003906981e-09
a O 0 8.171440607496194e-11
usually O 0 2.225010037326669e-10
nonlethal O 0 2.3540231097740616e-07
form O 0 5.5363389428464416e-09
of O 0 6.358157520480745e-07
junctional B-Disease 1 0.999982476234436
epidermolysis I-Disease 1 0.9997554421424866
bullosa I-Disease 0 0.0018411752535030246
, O 0 7.388045730749582e-10
have O 0 7.016411063265338e-11
generalized O 0 2.044365743358867e-08
blistering B-Disease 0 1.3686725424122415e-06
, O 0 1.3002515508730994e-08
nail B-Disease 1 0.9999908208847046
dystrophy I-Disease 1 1.0
, O 0 1.6618981817373424e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999982118606567
, O 0 3.8457969253613555e-08
and O 0 1.5926144669720088e-06
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9154403209686279

Skin B-Disease 1 0.999998927116394
fragility I-Disease 1 0.8625498414039612
in O 0 8.823943886682173e-08
most O 0 1.676697114483261e-09
cases O 0 5.689787530016588e-10
is O 0 1.0317809107096565e-11
due O 0 6.4391554310816446e-09
to O 0 2.6861585178394876e-10
mutations O 0 6.342357750099836e-10
in O 0 6.364482552090323e-11
the O 0 9.969287895206236e-11
gene O 0 3.659655911647519e-11
encoding O 0 5.6356999067475044e-09
type O 0 4.583328973239986e-06
XVII O 1 1.0
collagen O 0 0.0007480250205844641
( O 0 6.486813930450808e-08
COL17A1 O 1 0.9995031356811523
) O 0 1.9776988935404916e-08
. O 0 9.47478326907003e-08

Recently O 0 2.029789584412356e-06
, O 0 2.9276296942271074e-09
we O 0 3.0552282925810914e-10
reported O 0 1.3135310894529795e-10
five O 0 2.4075158533420904e-11
Austrian O 0 4.0853734617485316e-08
families O 0 1.055957335460711e-10
with O 0 6.928189272281671e-11
generalized O 0 0.0002925603184849024
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999967813491821
who O 0 8.762977188325749e-08
share O 0 6.744072411635216e-09
the O 0 1.1577824254871416e-09
same O 0 1.5474006076487967e-08
COL17A1 O 1 0.8917285203933716
mutation O 0 1.3647791092807893e-06
. O 0 1.1449007075725603e-07

Affected O 0 3.289238293291419e-06
individuals O 0 2.899129158961955e-09
in O 0 1.8385398758979932e-09
three O 0 3.2176836195496605e-10
families O 0 5.9728368084766e-11
are O 0 3.559895433991045e-12
homozygous O 0 3.1684248974483964e-11
for O 0 1.8655292588487526e-11
4003delTC O 0 2.206602367493815e-08
, O 0 4.484460025544479e-11
whereas O 0 1.0220473356525872e-09
those O 0 4.604178496792066e-11
in O 0 1.0881998080414235e-10
two O 0 2.8756651573869085e-11
others O 0 2.1120487303516455e-10
are O 0 7.530152890122821e-11
compound O 0 9.009983870100768e-08
heterozygotes O 0 2.467614422130282e-06
. O 0 3.183920682658936e-07

To O 0 1.3296397760598211e-08
determine O 0 2.0828738733769114e-09
if O 0 7.045296984697913e-11
the O 0 1.1638306984806945e-10
occurrence O 0 3.7502331795558064e-10
of O 0 4.961395738689589e-10
4003delTC O 0 5.937928548860327e-08
in O 0 1.4126093350608215e-10
these O 0 2.0474219541988248e-11
unrelated O 0 7.879804586607975e-10
families O 0 1.8684984115502346e-12
signifies O 0 1.2529254543591772e-11
propagation O 0 3.675663662328077e-10
of O 0 2.7528803889231845e-11
an O 0 1.2425533692239643e-12
ancestral O 0 1.6325730767263735e-09
allele O 0 5.433666849796737e-10
or O 0 1.0255422205895925e-10
a O 0 8.914965987649737e-10
mutational O 0 1.87800051207887e-05
hot O 0 7.864948565838858e-05
spot O 0 2.8271753649278253e-07
, O 0 1.7951068409516324e-10
haplotypes O 0 6.722470580200479e-09
were O 0 2.626296957686236e-10
determined O 0 8.035250242954817e-10
for O 0 1.007711136757905e-10
polymorphisms O 0 9.891791385996385e-09
both O 0 7.676156932312495e-10
within O 0 6.345821645936667e-09
and O 0 7.645125421618104e-09
flanking O 0 1.6783265891717747e-05
COL17A1 O 1 0.9999947547912598
. O 0 6.273511644394603e-06

Five O 0 1.5966139699230553e-06
intragenic O 0 2.852014404197689e-05
polymorphisms O 0 4.711707788374042e-07
were O 0 1.609269162372584e-08
chosen O 0 5.9649307715403665e-09
based O 0 2.2149675427129978e-09
on O 0 1.5735595937371727e-08
their O 0 9.052200766745955e-09
informativeness O 0 8.26875984785147e-05
. O 0 7.40481254979386e-07

One O 0 1.851197950486494e-08
of O 0 1.8104538979102358e-09
these O 0 1.5577013290357655e-10
, O 0 1.8751899338864675e-11
not O 0 1.289838114787445e-11
previously O 0 2.6399274433153153e-10
reported O 0 4.599509315084127e-11
, O 0 1.5420890259187914e-11
was O 0 4.475057213682021e-09
2988 O 0 1.0159662906517042e-06
A O 0 7.438559634920239e-08
or O 0 4.771949058124392e-09
C O 0 3.7175275338086067e-06
that O 0 1.2677912539227343e-11
introduces O 0 4.6089082550437865e-10
a O 0 6.84924643043483e-12
new O 0 8.327141753916578e-11
restriction O 0 3.775613155454494e-09
site O 0 8.406907947566822e-10
for O 0 1.6647179468254336e-10
Eco0109 O 0 2.7288322144158883e-06
I O 0 2.828334118021303e-06
. O 0 7.89337946116575e-08

All O 0 2.172417268297977e-08
the O 0 4.319887558779101e-09
4003delTC O 0 2.3785598557424237e-07
alleles O 0 5.235025746230804e-09
showed O 0 3.391434633126522e-10
the O 0 4.6819496196670585e-11
same O 0 4.1531469235911445e-11
haplotype O 0 1.308051444937064e-09
for O 0 4.1689172947112496e-11
these O 0 1.883083133868979e-10
five O 0 7.699045290188167e-10
polymorphic O 0 2.0529003563751758e-07
markers O 0 3.15515677584699e-07
. O 0 1.1023062285175911e-07

Fourteen O 0 3.408662450965494e-05
microsatellite O 0 3.366642340552062e-05
polymorphisms O 0 6.802448524467763e-07
were O 0 9.929162381183687e-09
selected O 0 4.745101644942906e-09
based O 0 6.515489259228957e-10
on O 0 4.160445321588213e-09
their O 0 9.730333205837383e-10
high O 0 5.653854984188911e-08
heterozygosity O 0 2.695343027880881e-06
and O 0 5.649667400575709e-10
their O 0 1.3307470403400856e-10
location O 0 6.675421881929822e-10
within O 0 7.200031681975361e-10
10q23 O 0 3.864636255457299e-07
- O 0 4.5566423523268895e-07
q25 O 0 8.471884029859211e-06
near O 0 1.5456507753697224e-06
COL17A1 O 0 0.024563852697610855
. O 0 9.291769629271585e-07

Three O 0 1.0827913143884871e-07
families O 0 9.634822717430325e-09
shared O 0 8.723683109224112e-09
microsatellite O 0 1.3882159919376136e-06
polymorphisms O 0 1.123545771974932e-07
covering O 0 2.5089118338428307e-08
at O 0 6.300066246467395e-09
most O 0 1.0301065556106437e-09
19 O 0 1.6850840722781868e-09
cM O 0 3.508401569263242e-09
, O 0 1.9623129510204507e-11
whereas O 0 5.46862222172706e-10
the O 0 1.3185067482268664e-09
others O 0 6.727585155630322e-10
shared O 0 7.266530155369821e-10
smaller O 0 5.178891204771219e-10
regions O 0 5.415570214495347e-10
consistent O 0 7.084837161386304e-10
with O 0 7.390617631775065e-12
cross O 0 3.0600397216140607e-10
- O 0 2.759875439295456e-09
over O 0 9.723983424025917e-11
events O 0 8.454754257813946e-12
during O 0 1.623067479028517e-11
passage O 0 8.789110411688839e-11
of O 0 1.0708339596987582e-11
this O 0 9.584367154091833e-12
mutation O 0 8.237854842718662e-11
through O 0 6.17898371357839e-11
several O 0 4.3031583851771416e-10
generations O 0 2.443744584468277e-08
. O 0 2.8687452413578285e-08

These O 0 3.7321193246953044e-08
results O 0 1.125235193910612e-08
indicate O 0 9.3922603028318e-10
that O 0 8.779756435761676e-12
4003delTC O 0 1.0402795069808235e-08
occurs O 0 1.9831514208590306e-10
on O 0 9.732871453227432e-11
a O 0 1.118250110565544e-11
single O 0 6.747513658922344e-11
ancestral O 0 6.6092415984542185e-09
allele O 0 3.1846596471041266e-09
. O 0 6.556416520808739e-10
. O 0 6.688679832222988e-09

The O 0 2.146917040590779e-06
haptoglobin O 0 7.849415123928338e-05
- O 0 2.443403218421736e-06
gene O 0 6.799715457361799e-09
deletion O 0 5.326835417207576e-09
responsible O 0 5.927761059787429e-10
for O 0 1.2745983157813612e-09
anhaptoglobinemia B-Disease 1 0.9565385580062866
. O 0 8.353491466550622e-06

We O 0 7.597174089823966e-08
have O 0 4.2199196914616266e-10
found O 0 1.338636285153072e-10
an O 0 1.260201751979162e-11
allelic O 0 6.51073790436385e-08
deletion O 0 1.1651377640475857e-08
of O 0 2.6259691310315247e-08
the O 0 2.34970102042098e-07
haptoglobin O 0 0.0013574083568528295
( O 0 1.2778089697462747e-09
Hp O 0 7.12887100462467e-08
) O 0 8.663350592463814e-11
gene O 0 1.49022114093178e-10
from O 0 1.1997307314270955e-10
an O 0 9.276349653697391e-12
individual O 0 8.783580113247424e-11
with O 0 2.4056442948783285e-10
anhaptoglobinemia B-Disease 0 0.0952431708574295
. O 0 7.085504876158666e-06

The O 0 1.332869146608573e-06
Hp O 0 4.767603059008252e-06
gene O 0 2.0965462255162493e-08
cluster O 0 7.562159254348444e-08
consists O 0 9.956750979256412e-10
of O 0 2.736015858317842e-10
coding O 0 7.015775960184101e-09
regions O 0 2.3350596123350442e-08
of O 0 3.92879854871353e-07
the O 0 6.106085379542492e-07
alpha O 0 3.5811473253488657e-07
chain O 0 6.92078339081803e-10
and O 0 3.249481586586889e-11
beta O 0 2.559008005498242e-10
chain O 0 8.633362080789908e-11
of O 0 1.7900704529782985e-10
the O 0 1.669593352460197e-09
haptoglobin O 0 4.855213546761661e-07
gene O 0 7.182667238758711e-10
( O 0 2.921006145295557e-11
Hp O 0 3.3962204160076226e-09
) O 0 9.096894244831066e-12
and O 0 3.0140966111869005e-11
of O 0 8.382250449301409e-10
the O 0 3.233336487440397e-09
alpha O 0 1.5107394446545186e-08
chain O 0 5.757779253379169e-10
and O 0 4.685576926455326e-11
beta O 0 9.641950571293023e-10
chain O 0 1.4778402113169165e-10
of O 0 1.684900136078582e-10
the O 0 6.525650575461839e-10
haptoglobin O 0 3.2467826827087265e-07
- O 0 1.5727403379628413e-08
related O 0 4.113310225761779e-08
gene O 0 4.470535497347328e-09
( O 0 1.2317660780247763e-10
Hpr O 0 1.717176019155886e-07
) O 0 3.360685688069687e-11
, O 0 3.4652756358832804e-11
in O 0 2.521690078971517e-10
tandem O 0 1.5204989267658675e-08
from O 0 5.321744711572762e-10
the O 0 4.1193932709404635e-09
5 O 0 3.689265071216141e-08
side O 0 8.399975826023365e-08
. O 0 1.3813048838073883e-07

Southern O 0 1.1085658115916885e-05
blot O 0 1.1232516044401564e-05
and O 0 5.8483649034712926e-09
PCR O 0 1.2692029827121587e-07
analyses O 0 6.960315435122766e-09
have O 0 3.1016474111300596e-11
indicated O 0 5.318292334299812e-11
that O 0 5.975587863069065e-13
the O 0 2.4409923735091432e-11
individual O 0 3.4097804874760884e-12
with O 0 3.6663476074561e-12
anhaptoglobinemia B-Disease 0 1.9222118226025486e-06
was O 0 2.7086700882250625e-08
homozygous O 0 8.877228951931215e-10
for O 0 8.542975354908222e-11
the O 0 4.401392028619e-10
gene O 0 7.666101087266952e-11
deletion O 0 2.1642675152033775e-10
and O 0 6.565335775032821e-11
that O 0 6.4118762382880945e-12
the O 0 4.50208287317011e-10
gene O 0 1.1671340283125886e-10
deletion O 0 4.939904596490408e-10
was O 0 1.1857946846660639e-09
included O 0 2.8132288165672037e-10
at O 0 6.271253516487718e-10
least O 0 1.3785386894504814e-11
from O 0 4.671513176290887e-11
the O 0 6.537236862946827e-10
promoter O 0 1.1622616824524812e-07
region O 0 3.3894316242566447e-09
of O 0 1.666183813142652e-08
Hp O 0 1.2919769005748094e-06
to O 0 1.1560854318304337e-07
Hpr O 0 2.3944598069647327e-05
alpha O 0 2.6999735780464107e-08
but O 0 1.0197491462360375e-10
not O 0 2.3726104414478755e-11
to O 0 6.448603873110414e-10
Hpr O 0 4.9787286116043106e-06
beta O 0 2.1823497320383467e-07
( O 0 2.115964958804284e-09
Hpdel O 0 8.266249096777756e-06
) O 0 5.178577566766762e-09
. O 0 5.5420258604499395e-08

In O 0 3.0042809129327e-08
addition O 0 2.9334765727639933e-09
, O 0 2.6587759771601327e-10
we O 0 1.0638517150551863e-10
found O 0 1.0830211727430594e-10
seven O 0 7.907111077010143e-11
individuals O 0 3.502792890811013e-12
with O 0 2.4550842261938932e-11
hypohaptoglobinemia B-Disease 1 0.6792771220207214
in O 0 1.811500141002398e-07
three O 0 6.417388842550054e-10
families O 0 4.5356343680857947e-11
, O 0 1.0096878845164414e-12
and O 0 3.808153445361562e-12
the O 0 1.0565073815804737e-10
genotypes O 0 9.27512466830649e-09
of O 0 2.081785632768174e-09
six O 0 3.030041773044445e-10
of O 0 5.479126041763038e-10
the O 0 5.885760767654347e-10
seven O 0 9.000387934943177e-11
individuals O 0 1.4007009527944314e-12
were O 0 2.553453455622634e-11
found O 0 7.344400261566353e-12
to O 0 1.5258275545826372e-11
be O 0 1.4807585158038705e-09
Hp2 O 0 0.0013702595606446266
/ O 0 6.462029705289751e-05
Hpdel O 0 0.003490505740046501
. O 0 1.6603551102889469e-06

The O 0 6.513426455967419e-07
phenotypes O 0 2.079419346046052e-06
and O 0 5.11765962940558e-09
genotypes O 0 2.972476806917257e-07
in O 0 3.428762274104713e-10
one O 0 9.1372898830544e-12
of O 0 2.3153163414280087e-11
these O 0 1.9551102056758474e-11
three O 0 1.331046037278405e-11
families O 0 9.111202244060923e-12
showed O 0 5.094475882816418e-11
the O 0 1.6347595499510703e-10
father O 0 1.5161396582641373e-09
to O 0 7.023614329026984e-11
be O 0 7.012377789550328e-09
hypohaptoglobinemic B-Disease 0 0.11119061708450317
( O 0 1.368308022442477e-09
Hp2 O 0 2.0165805381111568e-06
) O 0 4.590193156128741e-11
and O 0 2.168738660879299e-10
Hp2 O 0 1.9229910321882926e-06
/ O 0 7.078536157223425e-08
Hpdel O 0 1.1237166290811729e-05
, O 0 3.1217806117922464e-10
the O 0 1.5993815161152725e-09
mother O 0 9.041600246284531e-10
to O 0 4.038541723261346e-11
be O 0 4.791190222341868e-10
Hp2 O 0 1.2479764336603694e-05
- O 0 1.0730828847727025e-07
1 O 0 1.850407294057277e-08
and O 0 1.9408843976442824e-10
Hp1 O 0 1.1642068784567527e-06
/ O 0 2.0135846767743715e-08
Hp2 O 0 2.461709982526372e-06
, O 0 2.704871222836136e-11
one O 0 6.299960553235451e-12
of O 0 5.77444897453816e-11
the O 0 3.546791194075638e-10
two O 0 1.0936159616781183e-10
children O 0 6.035041910656957e-11
to O 0 5.857443002854623e-12
be O 0 4.4468065341085605e-10
hypohaptoglobinemic B-Disease 0 0.0005306215607561171
( O 0 1.4162359063263352e-09
Hp2 O 0 9.157699423667509e-06
) O 0 1.3843150237224933e-10
and O 0 5.610621411911154e-10
Hp2 O 0 4.411756890476681e-05
/ O 0 5.405657930168672e-07
Hpdel O 0 0.0006968741654418409
, O 0 4.208835224783769e-10
and O 0 1.2811028626824594e-10
the O 0 5.922901058497132e-10
other O 0 1.662642523658775e-10
child O 0 2.611441618505239e-10
to O 0 1.4577027085405092e-11
be O 0 3.0079130852733726e-10
Hp1 O 0 1.2195734598208219e-05
and O 0 6.269953001236672e-09
Hp1 O 0 0.00018458081467542797
/ O 0 9.6372127700306e-07
Hpdel O 0 2.8637419745791703e-05
, O 0 1.0090343144364411e-10
showing O 0 1.2592989151460898e-10
an O 0 6.488819030703308e-12
anomalous O 0 6.956456388707011e-08
inheritance O 0 5.476915134750016e-07
of O 0 5.415058694779873e-07
Hp O 0 1.2062309906468727e-05
phenotypes O 0 2.3182421955425525e-06
in O 0 1.2105808577800303e-09
the O 0 7.625374220943115e-10
child O 0 5.903412203522862e-10
with O 0 7.243113053778671e-11
Hp1 O 0 0.00033486931351944804
. O 0 1.3586975455837091e-06

The O 0 1.0305295745638432e-06
Hp2 O 0 0.0014555305242538452
/ O 0 1.8354758140048943e-05
Hpdel O 0 0.00039830151945352554
individuals O 0 2.2438484403863868e-09
had O 0 1.1806671196268326e-09
an O 0 1.1347122894078687e-11
extremely O 0 3.4534817228148995e-09
low O 0 3.43306503225449e-08
level O 0 1.0237100944721078e-08
of O 0 2.27875016634016e-08
Hp O 0 1.6534246469745995e-06
( O 0 1.1285726797538587e-09
mean O 0 1.3196749470978375e-08
+ O 0 3.10521386381879e-09
/ O 0 4.455876556619387e-09
- O 0 2.68472177822332e-08
SD O 0 5.81658468945534e-07
= O 0 1.876100608200204e-09
0 O 0 1.9501213976980125e-09
. O 0 8.977088516992637e-11
049 O 0 2.556498301942156e-08
+ O 0 5.637783018208609e-10
/ O 0 1.1708983782554583e-09
- O 0 3.3941480737098573e-09
0 O 0 2.9320164074420063e-09
. O 0 1.6314484485580039e-10
043 O 0 1.4199589770669263e-07
mg O 0 8.900583736703993e-08
/ O 0 8.795760564339616e-09
ml O 0 3.306701401584178e-08
; O 0 7.869887380662632e-11
n O 0 1.743398481135472e-10
= O 0 9.940617079484682e-11
6 O 0 3.41574657447552e-10
) O 0 1.5816143967423146e-12
, O 0 2.49535309949922e-12
compared O 0 5.730189586716783e-11
with O 0 6.951084239453786e-12
the O 0 1.6299999128221998e-09
level O 0 1.2160202800259867e-07
( O 0 2.7823994844244915e-11
1 O 0 1.4355507893526465e-09
. O 0 5.3259254645388054e-11
64 O 0 8.007068896809244e-10
+ O 0 1.2779644009697222e-10
/ O 0 4.2685227574779105e-10
- O 0 1.5979698675394616e-09
1 O 0 8.485895874876803e-10
. O 0 4.906697617657052e-11
07 O 0 9.846501392019036e-09
mg O 0 7.73687034438808e-08
/ O 0 6.120902895645486e-09
ml O 0 1.7653308148624092e-08
) O 0 7.506717469851765e-12
obtained O 0 1.4453087338051063e-10
from O 0 5.087137933124097e-10
52 O 0 6.274764530189714e-08
healthy O 0 3.460248265696464e-08
volunteers O 0 2.763921314041795e-09
having O 0 5.821784165860322e-10
phenotype O 0 7.206426744232886e-08
Hp2 O 0 3.5757150271820137e-06
, O 0 2.2151522283131442e-10
whereas O 0 1.668612803484848e-09
the O 0 3.4649472180348084e-10
serum O 0 7.131588652953269e-09
Hp O 0 9.157140823390364e-09
level O 0 3.754686783707939e-09
of O 0 3.7647673867269305e-10
an O 0 3.986437048519864e-12
individual O 0 9.388973105928233e-12
with O 0 2.2120520692947565e-11
Hp1 O 0 4.0571510908193886e-05
/ O 0 2.8793442652386148e-06
Hpdel O 0 0.00011483576236059889
was O 0 2.4128434006343014e-07
0 O 0 1.684449415506606e-07
. O 0 1.2484140832214052e-08

50 O 0 1.3869033637092798e-06
mg O 0 9.579288416716736e-06
/ O 0 7.27085534890648e-07
ml O 0 5.564508228417253e-06
, O 0 2.754341754673817e-10
which O 0 1.1388969628489676e-11
was O 0 2.0393788047190498e-10
approximately O 0 9.543232523667733e-12
half O 0 3.101156137441663e-11
the O 0 6.681787761975144e-11
level O 0 5.877529574149776e-09
of O 0 4.340221071430506e-09
Hp O 0 7.848566951906832e-08
in O 0 3.967986828001813e-09
control O 0 3.961855554734939e-08
sera O 0 9.80919878657005e-09
from O 0 2.4504914764023056e-10
the O 0 1.247480230226472e-09
Hp1 O 0 9.232173397322185e-06
phenotype O 0 7.183577821479048e-08
( O 0 3.336059206660025e-11
1 O 0 7.561892778618073e-10
. O 0 4.305495890366551e-11
26 O 0 7.806368884644144e-10
+ O 0 3.097344880576003e-10
/ O 0 9.635809927743821e-10
- O 0 4.1939482997577215e-09
0 O 0 1.481120115442991e-09
. O 0 2.963182130222286e-11
33 O 0 4.5277187554759735e-10
mg O 0 8.640059334652506e-09
/ O 0 2.35863928388369e-09
ml O 0 1.4241680723614536e-08
; O 0 8.014491154062497e-11
n O 0 2.6356056226362057e-10
= O 0 1.7174994759727724e-10
9 O 0 7.506896215758729e-10
) O 0 6.63330241429394e-12
, O 0 1.8750003286105432e-11
showing O 0 1.5892516469495632e-10
a O 0 1.3259661424402935e-10
gene O 0 1.248980252555043e-09
- O 0 4.8709075883834885e-08
dosage O 0 2.1536396161536686e-05
effect O 0 2.6320074084651424e-06
. O 0 5.754891390097328e-07

The O 0 2.1928373428181658e-07
other O 0 1.3712348589933754e-08
allele O 0 1.4344293752799331e-08
( O 0 2.746907701300927e-10
Hp2 O 0 7.747398171886744e-07
) O 0 3.9774242927004266e-11
of O 0 3.16887377449504e-10
individuals O 0 7.0019424286416054e-12
with O 0 6.432679389156704e-11
Hp2 O 1 0.9999767541885376
/ O 0 0.02259245328605175
Hpdel O 1 0.9972236156463623
was O 0 5.885362241997427e-08
found O 0 4.8726935680809547e-11
to O 0 2.723215750122243e-12
have O 0 8.875221738091632e-12
, O 0 4.489447008593217e-12
in O 0 2.5268450526416686e-11
all O 0 8.652353139515512e-11
exons O 0 6.517080208823245e-10
, O 0 3.0521208390504873e-12
no O 0 8.174710040831368e-12
mutation O 0 3.205651022408773e-11
, O 0 1.8336168087357274e-12
by O 0 2.4293433584232638e-11
DNA O 0 8.301713094738261e-09
sequencing O 0 1.4699301686960098e-07
. O 0 3.928010983145214e-08

On O 0 1.3196867598708195e-07
the O 0 9.67739888224628e-10
basis O 0 6.125921991895211e-10
of O 0 2.190953252156902e-10
the O 0 1.1464035276631535e-10
present O 0 6.679876790594008e-11
study O 0 4.876226505912129e-11
, O 0 7.93638483924386e-13
the O 0 7.931577269970624e-12
mechanism O 0 2.9502245091350687e-10
of O 0 5.705458328009172e-10
anhaptoglobinemia B-Disease 0 3.214615844626678e-06
and O 0 2.6867991165246963e-10
the O 0 4.5029499573523424e-10
mechanism O 0 1.5761539851055772e-09
of O 0 7.899427223456712e-10
anomalous O 0 2.9017979841228225e-07
inheritance O 0 5.239858751338033e-07
of O 0 1.124072994684866e-07
Hp O 0 1.9996282389911357e-06
phenotypes O 0 2.8975664463359863e-06
were O 0 4.7589534091230234e-08
well O 0 8.823132446877935e-09
explained O 0 1.0304337649813533e-07
. O 0 5.813778614083276e-08

However O 0 1.2837428187140176e-07
, O 0 5.191926333303343e-10
the O 0 3.004111681637056e-10
mechanism O 0 7.311704131041097e-09
of O 0 1.7986765854516307e-08
hypohaptoglobinemia B-Disease 0 0.040880028158426285
remains O 0 3.375775850145146e-05
unknown O 0 1.6879814211279154e-05

ATM O 0 0.001195370452478528
mutations O 0 7.032276698737405e-07
and O 0 8.84464856909517e-09
phenotypes O 0 4.8789042921271175e-06
in O 0 7.778876920383482e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.480562670825748e-07
in O 0 1.635670210387019e-10
the O 0 2.6354285073693084e-11
British O 0 2.0723794902366421e-10
Isles O 0 6.340377556313115e-09
: O 0 1.7346176578447725e-11
expression O 0 4.059021521674033e-11
of O 0 7.62775606566457e-11
mutant O 0 1.995202447702127e-09
ATM O 0 2.028715506696699e-08
and O 0 8.860642254637785e-12
the O 0 2.1426208030028704e-11
risk O 0 1.2027183415863618e-10
of O 0 7.424916237397383e-10
leukemia B-Disease 1 0.9999617338180542
, O 0 1.19553149602325e-07
lymphoma B-Disease 1 1.0
, O 0 5.389690045376483e-07
and O 0 1.9120097931590863e-06
breast B-Disease 1 0.9970728158950806
cancer I-Disease 0 0.00029690726660192013
. O 0 7.842803597668535e-07

We O 0 2.427022138817847e-08
report O 0 7.393501921804102e-10
the O 0 6.232035443254347e-10
spectrum O 0 4.3224115842122046e-08
of O 0 5.497342581151088e-09
59 O 0 9.28975296687895e-08
ATM O 0 6.055921062397829e-07
mutations O 0 5.910577582923793e-10
observed O 0 6.794266815823846e-10
in O 0 3.100906553754612e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.8822665374027565e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.250403445344887e-10
patients O 0 3.124296155121442e-09
in O 0 9.714931983872965e-12
the O 0 1.541292926621196e-10
British O 0 8.318117750150122e-09
Isles O 0 6.084333108447026e-07
. O 0 9.577313164754742e-08

Of O 0 2.367225351918023e-05
51 O 0 2.0044983102707192e-05
ATM O 0 0.00016730348579585552
mutations O 0 4.406738796092213e-08
identified O 0 3.475877363712243e-09
in O 0 1.0078539114388718e-09
families O 0 2.1567964081370405e-10
native O 0 5.1030825398701296e-11
to O 0 4.15832906303093e-12
the O 0 1.2146231243015393e-10
British O 0 5.506504141550295e-09
Isles O 0 2.343835063811639e-07
, O 0 1.5954837451204185e-10
11 O 0 4.951677401443533e-10
were O 0 4.600671843491e-09
founder O 0 6.127609708528325e-08
mutations O 0 9.397169709046693e-10
, O 0 6.66661378878608e-11
and O 0 1.4567834438761196e-10
2 O 0 5.01316455014944e-09
of O 0 1.3593983716475577e-09
these O 0 3.281290517076485e-10
11 O 0 1.0054418408955712e-10
conferred O 0 3.02084512959766e-09
a O 0 9.995487076919218e-11
milder O 0 1.7141782109320047e-06
clinical O 0 2.5228331423932104e-07
phenotype O 0 5.96737770308664e-09
with O 0 4.322815543023051e-12
respect O 0 1.0079071605106904e-10
to O 0 1.0683699758207155e-10
both O 0 3.484860755520458e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.3051920859652455e-06
cellular O 0 2.9759371500404086e-07
features O 0 4.387162633179287e-09
. O 0 1.5889591864493013e-08

We O 0 9.613583706880036e-09
report O 0 4.865944314147441e-10
, O 0 8.1262725715181e-11
in O 0 8.849482951989174e-11
two O 0 7.492016035337556e-11
A B-Disease 1 0.9999912977218628
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
families O 0 5.430768279524045e-09
, O 0 7.391152793967404e-12
an O 0 1.7712261778796146e-12
ATM O 0 4.3089531942541726e-08
mutation O 0 9.614936624657844e-10
( O 0 2.5625378555216294e-11
7271T O 0 5.372417177795796e-08
- O 0 5.826878179959749e-08
- O 0 1.0963157848209448e-07
> O 0 6.100392369035035e-08
G O 0 6.80423255516871e-08
) O 0 1.2016692979219257e-12
that O 0 1.1395347014088453e-13
may O 0 4.921288203341145e-12
be O 0 3.5744009748567285e-12
associated O 0 4.896226479811361e-11
with O 0 3.0481645853230876e-12
an O 0 6.954688019054911e-13
increased O 0 3.598291109518925e-10
risk O 0 7.2133694573039975e-09
of O 0 1.373269071791583e-07
breast B-Disease 1 0.9988895058631897
cancer I-Disease 0 9.782288543647155e-06
in O 0 3.9664356243918064e-09
both O 0 4.730245972695002e-09
homozygotes O 0 6.171848667690938e-07
and O 0 9.881415685697448e-10
heterozygotes O 0 4.950473453391169e-08
( O 0 1.4489404467910028e-11
relative O 0 5.194504826278035e-09
risk O 0 5.308241624035759e-10
12 O 0 2.756979020079875e-11
. O 0 5.15251990379495e-12
7 O 0 1.66177058225081e-10
; O 0 2.8700214080301656e-11
P O 0 1.747715856481591e-07
= O 0 3.9454878253408765e-10
. O 0 1.0542568207316805e-10
0025 O 0 2.792654285599383e-08
) O 0 2.1098359604537764e-12
, O 0 4.345215051486384e-13
although O 0 6.011533285055215e-12
there O 0 2.0584120345723544e-12
is O 0 8.468501507680193e-13
a O 0 7.989410348574477e-12
less O 0 4.2225063445755495e-09
severe O 0 0.004904684145003557
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
phenotype O 0 3.1340723349870814e-09
in O 0 3.603361370136532e-13
terms O 0 7.873452324141939e-13
of O 0 5.414870483423651e-13
the O 0 2.1865968237444466e-12
degree O 0 9.66236757271588e-10
of O 0 1.198839783000949e-08
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 6.211544678080827e-05

This O 0 5.28347925410344e-08
mutation O 0 4.3863781939990076e-08
( O 0 4.3676401384473706e-10
7271T O 0 1.2110946556731506e-07
- O 0 3.5953174659653087e-08
- O 0 4.835546718595651e-08
> O 0 1.1317639803110069e-07
G O 0 1.9198360234895517e-07
) O 0 8.530807137085983e-12
also O 0 6.614587892174451e-13
allows O 0 5.767255705120544e-13
expression O 0 7.219799411095629e-12
of O 0 2.6004755640518518e-11
full O 0 1.9248733162946507e-10
- O 0 1.0631219238277367e-09
length O 0 9.170350034892749e-10
ATM O 0 2.077031169278598e-08
protein O 0 2.8144028774157448e-11
at O 0 1.5463245267577364e-11
a O 0 1.612790521791918e-12
level O 0 4.433102149259405e-11
comparable O 0 4.985452051187167e-10
with O 0 9.900756429981339e-13
that O 0 3.028779050479047e-12
in O 0 3.4631500445136965e-10
unaffected O 0 2.1421055862447247e-07
individuals O 0 2.287365713504741e-10
. O 0 1.4127616410064547e-08

In O 0 9.811500056855493e-09
addition O 0 1.1945481270814184e-09
, O 0 7.665428708447664e-11
we O 0 1.7244147082484673e-11
have O 0 4.418226635244382e-12
studied O 0 1.3432152057291091e-09
18 O 0 3.1469027383934645e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.4156159460544586
, O 0 2.609537152337138e-12
in O 0 1.872044186335131e-12
15 O 0 8.320660133120938e-12
families O 0 2.1072301889524248e-12
, O 0 7.953645879930915e-13
who O 0 8.192754634428479e-12
developed O 0 6.729786150572181e-08
leukemia B-Disease 1 1.0
, O 0 5.705175681214314e-06
lymphoma B-Disease 1 1.0
, O 0 7.078994599396538e-07
preleukemic O 1 0.980316698551178
T O 0 6.648514681728557e-05
- O 0 2.231634681493233e-07
cell O 0 8.57648529972721e-09
proliferation O 0 4.239518069937276e-09
, O 0 1.2015895223260742e-11
or O 0 5.90195137206706e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.1260561311464699e-07
mostly O 0 3.852445917829073e-09
in O 0 3.9166508924992627e-10
childhood O 0 6.286911968800268e-08
. O 0 2.297350043534152e-08

A O 0 8.831165359879378e-06
wide O 0 2.1605017082038103e-06
variety O 0 8.357768876976479e-08
of O 0 9.381866306057418e-08
ATM O 0 1.2949340089107864e-05
mutation O 0 1.1210664396799075e-08
types O 0 8.432445852690762e-09
, O 0 8.141290419594327e-11
including O 0 1.2457873621585236e-09
missense O 0 8.773544095674879e-07
mutations O 0 5.217929643919206e-09
and O 0 8.092650993773987e-10
in O 0 1.9740200585260936e-09
- O 0 4.101895356711793e-08
frame O 0 2.4473829185467366e-08
deletions O 0 5.523660639994432e-09
, O 0 7.207778124351805e-11
were O 0 1.1225508300682918e-09
seen O 0 8.33935309696443e-10
in O 0 3.0071387047136966e-10
these O 0 2.0554531410255095e-09
patients O 0 1.5436737044183246e-07
. O 0 2.837644252906557e-08

We O 0 1.0992116017405351e-07
also O 0 8.323160494150272e-10
show O 0 6.72102790089113e-11
that O 0 6.140441345496572e-13
25 O 0 5.411633641205782e-11
% O 0 5.0095344539258235e-12
of O 0 3.7299576621796504e-11
all O 0 3.1879579531768343e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0005698386230506003
carried O 0 2.904363416433853e-10
in O 0 7.304602062108145e-11
- O 0 1.3687675437523694e-09
frame O 0 1.047481124061278e-08
deletions O 0 4.82332325191237e-08
or O 0 3.324750608157956e-08
missense O 0 5.66864355278085e-06
mutations O 0 4.083953619726799e-09
, O 0 2.94647743703802e-11
many O 0 8.796082785755832e-12
of O 0 2.67546037407973e-11
which O 0 3.7920847018035886e-12
were O 0 4.68400387920731e-11
also O 0 7.093994445692142e-13
associated O 0 4.498095472482699e-12
with O 0 1.7999289125131268e-12
expression O 0 2.9311594818004494e-10
of O 0 4.4599919313270675e-09
mutant O 0 9.784984911220818e-08
ATM O 0 1.1815079687949037e-06
protein O 0 2.6537628983192008e-08
. O 0 3.2026978402655004e-08

The O 0 8.994184668154048e-07
DMPK O 1 0.8652072548866272
gene O 0 2.578939302111394e-07
of O 0 3.7740031189059664e-07
severely O 1 0.9999954700469971
affected O 1 0.999998927116394
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998618364334106
is O 0 6.167400479206719e-10
hypermethylated O 0 7.315026664400648e-07
proximal O 0 2.244882807644899e-06
to O 0 1.4588082963840066e-09
the O 0 3.499060596823256e-08
largely O 0 2.053526912959569e-07
expanded O 0 1.3783521524146636e-07
CTG O 0 4.8166355554712936e-05
repeat O 0 1.2328695220276131e-06
. O 0 4.966746018908452e-07

Using O 0 1.5486385507301748e-07
methylation O 0 1.1974204880971229e-06
- O 0 3.144554739265004e-06
sensitive O 0 1.0895715831793495e-06
restriction O 0 1.4721032925990585e-07
enzymes O 0 1.1414083012084575e-08
, O 0 1.0497882424465033e-10
we O 0 3.48888556933602e-11
characterized O 0 1.0237598963014349e-10
the O 0 1.0650658133215529e-10
methylation O 0 4.5622991495797294e-10
pattern O 0 9.155773361690933e-10
on O 0 5.869079666709354e-10
the O 0 2.023994583044697e-10
5 O 0 1.5001168363060202e-10
side O 0 8.045029920022984e-11
of O 0 2.675155374998184e-10
the O 0 6.507718364190396e-09
CTG O 0 2.7935577691096114e-06
repeat O 0 1.927210613317243e-09
in O 0 1.764645651824992e-10
the O 0 3.3814939737197847e-10
DMPK O 0 1.6598579577475903e-06
gene O 0 7.912677457699857e-11
of O 0 6.053579165721246e-11
normal O 0 3.161333417267542e-10
individuals O 0 2.5856168334864593e-12
and O 0 6.915643405158711e-12
of O 0 1.8468203633048574e-09
patients O 0 6.169171342662594e-07
affected O 0 3.15404307116296e-08
with O 0 9.483949980904072e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 6.686588172044594e-09
showing O 0 7.554612491134094e-10
expansions O 0 1.610017563713484e-09
of O 0 1.4729754083120383e-09
the O 0 3.62720653512838e-09
repetitive O 0 4.063667802256532e-08
sequence O 0 3.594383235494547e-09
. O 0 2.2362870666370327e-08

The O 0 5.858750569132098e-07
gene O 0 2.5484700572064867e-08
segment O 0 1.2278055905312613e-08
analyzed O 0 2.3862327669377237e-09
corresponds O 0 1.703322149992914e-09
to O 0 1.795935622439515e-10
the O 0 3.5831710931688576e-09
genomic O 0 8.362297165831478e-08
SacI O 0 4.635056939150672e-06
- O 0 3.8053148188055275e-08
HindIII O 0 3.929432068616734e-07
fragment O 0 7.708409022200158e-09
carrying O 0 1.6930415958071876e-09
exons O 0 6.6427072731300996e-09
11 O 0 1.2545241512285088e-09
- O 0 1.2629805645758552e-08
15 O 0 1.6098772093187108e-08
. O 0 2.4709006396506084e-08

There O 0 3.046467966782984e-08
is O 0 1.1602937499688437e-09
constitutive O 0 3.465268605395977e-07
methylation O 0 4.3518824099919584e-07
in O 0 1.2956448358636408e-07
intron O 0 2.612765456433408e-06
12 O 0 6.228188631496323e-09
at O 0 8.128323569778217e-10
restriction O 0 5.7573865674953595e-09
sites O 0 1.5167355149614536e-09
of O 0 1.7762866733050942e-09
SacII O 0 3.494952034088783e-05
and O 0 1.7112881778302835e-08
HhaI O 0 4.2296229366911575e-05
, O 0 4.083982874103498e-10
localized O 0 7.563641268859556e-09
1 O 0 4.1968450936735735e-09
, O 0 3.153100003316922e-11
159 O 0 2.3249968617022887e-09
- O 0 1.7946216734898712e-09
1 O 0 5.478146380966109e-09
, O 0 6.314784806171758e-11
232 O 0 5.2317918886046755e-09
bp O 0 5.15406117784778e-09
upstream O 0 4.858073499036664e-09
of O 0 1.9914954130229034e-09
the O 0 3.3941883970101117e-08
CTG O 0 3.04263176076347e-05
repeat O 0 2.9273799384554877e-08
, O 0 1.3789970554345388e-10
whereas O 0 5.083820586726517e-10
most O 0 4.103516831888143e-11
, O 0 1.3702177413532635e-12
if O 0 5.929606306832869e-13
not O 0 1.7742556555899736e-12
all O 0 8.244011376334903e-12
, O 0 2.4523404140719407e-12
of O 0 2.790807689112551e-11
the O 0 9.432829517486141e-11
other O 0 1.3422251157746423e-11
sites O 0 1.0903210279078479e-10
of O 0 1.724142495440617e-10
SacII O 0 5.6420976761728525e-06
, O 0 7.517656497313396e-10
HhaI O 0 1.1343880942149553e-05
, O 0 3.771106482641784e-10
and O 0 7.576257399222186e-10
HpaII O 0 1.2105917448934633e-05
in O 0 1.3181045144250447e-09
this O 0 1.9988656563274532e-10
region O 0 4.975366341142262e-09
are O 0 1.974357899392487e-10
unmethylated O 0 1.0459363153358936e-07
, O 0 1.6784231990363274e-11
in O 0 1.5046667037332817e-11
normal O 0 2.2894652840221852e-10
individuals O 0 1.6809469398013088e-12
and O 0 7.15147819435602e-12
most O 0 5.231128377691796e-11
of O 0 1.0208647260867565e-09
the O 0 4.435756295606552e-08
patients O 0 5.377917204896221e-07
. O 0 3.400071690862205e-08

In O 0 1.6705275385220375e-08
a O 0 1.8470695806183102e-10
number O 0 1.414016542744534e-10
of O 0 3.006578097597412e-09
young O 0 3.674790605145972e-08
and O 0 1.7366456050993406e-09
severely O 0 4.072244337294251e-06
affected O 0 3.45948677704655e-07
patients O 0 3.2537586776015814e-06
, O 0 5.2484176726874665e-11
however O 0 1.7005759023192013e-09
, O 0 6.48644679634991e-11
complete O 0 4.5484754851443654e-10
methylation O 0 5.050045714938278e-09
of O 0 1.2425599438259383e-09
these O 0 3.7541244418681785e-11
restriction O 0 7.37091609970264e-10
sites O 0 2.2542283317772416e-10
was O 0 2.593433245934307e-10
found O 0 1.6837232996724794e-11
in O 0 3.219781732899385e-11
the O 0 6.147095055197838e-10
mutated O 0 6.609256786305195e-08
allele O 0 9.0140240160963e-08
. O 0 3.608866094850782e-08

In O 0 5.3028131219434727e-08
most O 0 1.1630501006720806e-09
of O 0 4.122731600553209e-10
these O 0 2.3221814748897174e-10
patients O 0 3.4220737354928588e-09
, O 0 8.298372297481371e-13
the O 0 6.2601924512295515e-12
onset O 0 2.06989341222652e-07
of O 0 4.725829683138727e-08
the O 0 1.7199783997057239e-06
disease O 1 0.9990948438644409
was O 0 1.8481820006854832e-05
congenital O 1 1.0
. O 0 1.9020717445528135e-05

Preliminary O 0 3.814955107372953e-06
in O 0 2.390940778695949e-07
vivo O 0 1.793399633243098e-06
footprinting O 0 5.947950194240548e-05
data O 0 1.4886317067919208e-08
gave O 0 3.4432079409896232e-09
evidence O 0 1.322778886425624e-09
for O 0 2.8745919533612607e-10
protein O 0 2.083112127237996e-09
- O 0 1.3021252520672988e-08
DNA O 0 6.369746952117339e-09
contact O 0 2.4963173195224897e-10
in O 0 3.0799895966993063e-10
normal O 0 1.583836528595839e-08
genes O 0 7.106545907298312e-10
at O 0 5.559170901392463e-10
an O 0 3.047334953820702e-11
Sp1 O 0 1.3843354906839522e-07
consensus O 0 3.1869884509205804e-08
binding O 0 3.880025634117601e-09
site O 0 1.442314001565137e-08
upstream O 0 3.2042788422614876e-09
of O 0 5.465202179699702e-10
the O 0 4.956271837386339e-09
CTG O 0 2.3444124508387176e-06
repeat O 0 1.374122038377834e-09
and O 0 3.886109836703788e-11
for O 0 3.5911362859103457e-12
a O 0 8.322814551257884e-13
significant O 0 5.191604958432183e-12
reduction O 0 1.760376150405918e-10
of O 0 2.1205859290773788e-10
this O 0 2.6251037801849897e-11
interaction O 0 9.992551230908475e-11
in O 0 1.7723218725951284e-11
cells O 0 8.087026708014644e-12
with O 0 5.329629424420668e-13
a O 0 1.479549399663327e-10
hypermethylated O 0 1.6368321666959673e-05
DMPK O 1 0.9853513240814209
gene O 0 5.792306012608606e-08
. O 0 6.6061791592630925e-09
. O 0 2.9408617763238e-08

The O 0 3.156102684442885e-05
hemochromatosis B-Disease 1 1.0
gene O 0 4.0134383993972733e-07
product O 0 1.2163717144630937e-07
complexes O 0 3.446081109359511e-08
with O 0 8.586084621065027e-11
the O 0 1.938939231393988e-09
transferrin O 0 7.340652814491477e-07
receptor O 0 2.58472478975591e-08
and O 0 3.8883657405008876e-10
lowers O 0 5.107644973634251e-09
its O 0 4.36275876536385e-11
affinity O 0 2.883774052886423e-10
for O 0 4.9148463077131055e-11
ligand O 0 6.541070973753449e-08
binding O 0 8.261390149755243e-08
. O 0 1.1727946969131153e-07

We O 0 2.4371541940126917e-07
recently O 0 2.58702321787041e-08
reported O 0 7.506896215758729e-10
the O 0 4.859080915409209e-10
positional O 0 7.25482109942277e-08
cloning O 0 3.846442098165426e-08
of O 0 3.4802274950784806e-10
a O 0 1.4219789234992675e-10
candidate O 0 1.5591950841553626e-08
gene O 0 2.2022119683384744e-09
for O 0 3.43398838253961e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 0.9999998807907104
. O 0 7.98371183918789e-06

The O 0 9.069849227216764e-08
gene O 0 5.521772483696452e-10
product O 0 1.1165780522404134e-09
, O 0 2.792117578809261e-11
a O 0 1.0591781791913224e-11
member O 0 6.779283297925209e-12
of O 0 1.2206614885545974e-10
the O 0 6.317486533902184e-10
major O 0 1.918787404520117e-07
histocompatibility O 1 0.9997236132621765
complex O 0 6.827204288128996e-06
class O 0 1.1726493909236524e-07
I O 0 1.7651254680117745e-08
- O 0 5.424246829477397e-09
like O 0 3.7844075095883056e-10
family O 0 2.298573831271966e-11
, O 0 1.3879409774264495e-12
was O 0 1.3723114311581242e-10
found O 0 2.0604674216828656e-11
to O 0 1.484679566787772e-11
have O 0 6.702964572280479e-11
a O 0 2.3052838804549225e-10
mutation O 0 1.3971943602086867e-09
, O 0 2.6122090601710113e-10
Cys O 0 2.348236421312322e-06
- O 0 9.881311058279607e-08
282 O 0 8.19811560859307e-08
- O 0 4.86335096638868e-08
- O 0 6.730658697051695e-08
> O 0 3.886991066792689e-07
Tyr O 0 2.3481961761717685e-06
( O 0 3.8604747870651934e-11
C282Y O 0 8.56291837436629e-09
) O 0 3.852359403699879e-12
, O 0 1.2160150273873849e-12
in O 0 2.9624404058320453e-12
85 O 0 4.0152406399762697e-10
% O 0 1.696446802479379e-11
of O 0 1.3260066655806924e-10
patient O 0 8.920417116087265e-08
chromosomes O 0 2.659093034651505e-08
. O 0 8.800479633919167e-08

This O 0 3.331473052980982e-08
mutation O 0 2.9842976090321827e-08
eliminates O 0 6.229711857486109e-08
the O 0 2.4919704078030236e-09
ability O 0 2.0189061533670838e-09
of O 0 2.3682467542585073e-08
HFE O 1 0.9957315325737
to O 0 6.1098917036872535e-09
associate O 0 2.849406488536488e-09
with O 0 2.5332005590406048e-11
beta2 O 0 7.273314622580074e-06
- O 0 6.0074467000958975e-06
microglobulin O 0 0.27098336815834045
( O 0 1.6292446280985473e-09
beta2m O 0 7.759436812193599e-06
) O 0 2.5893159838474844e-10
and O 0 1.7893811432578843e-10
prevents O 0 7.619515018930656e-10
cell O 0 1.1667033561479911e-08
- O 0 1.2121110337659502e-08
surface O 0 1.9207334389648167e-07
expression O 0 1.5962456245688372e-07
. O 0 1.2346787059414055e-07

A O 0 2.3381180653814226e-06
second O 0 5.678744514625578e-07
mutation O 0 5.189850327269596e-09
that O 0 5.737919254317214e-12
has O 0 2.4487694857966424e-12
no O 0 2.0769200161779855e-12
effect O 0 1.345958622334109e-10
on O 0 5.4812607785947876e-09
beta2m O 0 6.159736221889034e-05
association O 0 8.184831479240984e-09
, O 0 1.1714451630950862e-10
H63D O 0 0.00588652677834034
, O 0 1.6512052836148428e-10
was O 0 1.6992725004882914e-09
found O 0 6.121129991765173e-11
in O 0 4.132420794444869e-11
eight O 0 1.066598614984926e-10
out O 0 3.003313917004924e-11
of O 0 1.0160298158368164e-09
nine O 0 8.23572676722506e-09
patients O 0 6.0197575812992454e-09
heterozygous O 0 1.7254717099568495e-10
for O 0 3.6968671179860024e-11
the O 0 4.69254857193846e-09
C282Y O 0 8.916093975130934e-06
mutant O 0 1.4334715388031327e-06
. O 0 9.508347886821866e-08

In O 0 3.483981547702797e-09
this O 0 4.297234790229254e-11
report O 0 7.78673514556516e-11
, O 0 2.3124344453173684e-11
we O 0 1.4787192303966634e-11
demonstrate O 0 3.573900064779423e-10
in O 0 6.939089858271075e-10
cultured O 0 2.952674265088717e-07
293 O 0 2.0007335876925936e-07
cells O 0 2.4395811593080907e-08
overexpressing O 0 6.608146918551938e-07
wild O 0 2.7040915284715084e-08
- O 0 1.2693949003050875e-08
type O 0 8.432514420064763e-08
or O 0 1.0681917572696875e-08
mutant O 0 5.440853669824719e-07
HFE O 0 1.2603483810380567e-05
proteins O 0 7.586317685159827e-11
that O 0 3.736563575912344e-12
both O 0 9.964416444740998e-12
the O 0 2.3595289611044734e-10
wild O 0 1.508099423119802e-08
- O 0 4.520714025346706e-09
type O 0 4.597849567744561e-08
and O 0 5.684062998057016e-09
H63D O 1 0.9562702178955078
HFE O 0 0.00016126969421748072
proteins O 0 3.736025655509678e-10
form O 0 2.4668578291198173e-10
stable O 0 6.827679532861453e-10
complexes O 0 3.3927333165095774e-11
with O 0 9.159777970835226e-13
the O 0 1.741713301361969e-10
transferrin O 0 1.6611566877600126e-07
receptor O 0 4.838766898274116e-08
( O 0 7.169458915434745e-10
TfR O 0 1.101082830246014e-06
) O 0 7.202037299869346e-10
. O 0 1.4861352148898277e-08

The O 0 2.440524156099855e-07
C282Y O 0 5.257450538920239e-06
mutation O 0 3.9468165624612084e-08
nearly O 0 3.485362276567372e-10
completely O 0 1.5644811834913952e-10
prevents O 0 2.1905633557084414e-11
the O 0 5.732922817025532e-11
association O 0 2.1254532855952135e-10
of O 0 2.8785479555537563e-10
the O 0 2.6574693556824514e-09
mutant O 0 7.24843118860008e-08
HFE O 0 5.437406343844486e-06
protein O 0 1.678328920284855e-09
with O 0 3.902614689743622e-11
the O 0 5.730971697204268e-09
TfR O 0 1.8360360627411865e-05
. O 0 7.097489884699826e-08

Studies O 0 2.8677831664936093e-07
on O 0 1.845212338480451e-08
cell O 0 1.0207503287062991e-08
- O 0 4.080838778008911e-09
associated O 0 2.3356776512883926e-09
transferrin O 0 1.3363235211727442e-06
at O 0 2.3456927067400102e-08
37 O 0 2.8829614251435487e-09
degrees O 0 1.8822662539719204e-08
C O 0 6.95754422963546e-08
suggest O 0 1.6332823982168065e-10
that O 0 2.1116960177008925e-12
the O 0 1.0973043584883158e-09
overexpressed O 0 7.243779123200511e-07
wild O 0 1.1896424467749966e-07
- O 0 1.701459240166514e-08
type O 0 6.142307285017523e-08
HFE O 0 8.107665962597821e-06
protein O 0 8.32929059058074e-10
decreases O 0 9.147290702671285e-10
the O 0 2.4386747829452382e-11
affinity O 0 1.2093755163977704e-10
of O 0 1.4710851981014628e-10
the O 0 1.963528006854176e-09
TfR O 0 1.1700448112605955e-06
for O 0 1.3782404106876811e-09
transferrin O 0 4.312606051826151e-06
. O 0 3.034336657492531e-07

The O 0 0.00011609833018155769
overexpressed O 0 0.00854547694325447
H63D O 1 0.9954608082771301
protein O 0 4.6796355235301235e-08
does O 0 1.5760780180951173e-10
not O 0 1.2270194409136348e-11
have O 0 3.132459786350794e-12
this O 0 1.2464652790825093e-12
effect O 0 3.2344449341081827e-10
, O 0 2.1455406895576346e-11
providing O 0 2.193389914140198e-11
the O 0 7.0718691319582305e-12
first O 0 3.4313365950694452e-12
direct O 0 2.3809825638876347e-12
evidence O 0 2.50665998374755e-11
for O 0 2.9740860382071466e-12
a O 0 1.2194811133126038e-11
functional O 0 3.973993134565035e-09
consequence O 0 6.121766649158644e-09
of O 0 7.534842971779199e-09
the O 0 8.301590526116343e-08
H63D O 0 0.38322702050209045
mutation O 0 5.60672162919218e-07
. O 0 7.898304232867304e-08

Addition O 0 9.340175211036694e-08
of O 0 9.067133532880689e-08
soluble O 0 0.00044182385317981243
wild O 0 3.5452403608360328e-06
- O 0 3.030120296898531e-07
type O 0 3.040195451831096e-06
HFE O 1 0.9999967813491821
/ O 0 0.007540536113083363
beta2m O 1 0.7642014622688293
heterodimers O 0 0.0001106659256038256
to O 0 1.1697649959785394e-08
cultured O 0 1.996966858541782e-07
cells O 0 1.4428690464640681e-09
also O 0 7.51977126400849e-12
decreased O 0 2.539689569758252e-10
the O 0 4.3090451345983993e-11
apparent O 0 8.291518027725431e-10
affinity O 0 4.5385267766206994e-10
of O 0 5.365377031552043e-10
the O 0 8.979884058568643e-10
TfR O 0 4.571737832748113e-08
for O 0 4.247006392399388e-12
its O 0 3.917423677113341e-12
ligand O 0 5.885176235231881e-10
under O 0 1.37474853723063e-09
steady O 0 3.234014833708443e-09
- O 0 7.461384288198758e-11
state O 0 5.918716905473076e-12
conditions O 0 2.54483545347739e-09
, O 0 9.934016283186242e-12
both O 0 1.1291335054453011e-11
in O 0 1.7862573920002234e-10
293 O 0 6.423221510232224e-09
cells O 0 3.2137090211215025e-10
and O 0 6.055531076576415e-11
in O 0 1.628188361912919e-09
HeLa O 0 3.871390163112665e-06
cells O 0 2.2787894238263107e-08
. O 0 1.5885621706956954e-08

Furthermore O 0 8.530569743925298e-07
, O 0 1.7444005129263473e-09
at O 0 1.2590402054257765e-09
4 O 0 9.655531929553263e-10
degrees O 0 5.204325503882501e-08
C O 0 3.526413934196171e-07
, O 0 1.0916918410930343e-11
the O 0 5.323204030349693e-11
added O 0 1.8129962808810518e-10
soluble O 0 1.139857630505503e-07
complex O 0 3.00291169708089e-08
of O 0 2.7427953241954128e-08
HFE O 0 0.0015437344554811716
/ O 0 1.2655724503929378e-06
beta2m O 0 1.860814791143639e-06
inhibited O 0 1.1714015535346789e-08
binding O 0 1.38732902943417e-09
of O 0 1.8904324772250902e-09
transferrin O 0 2.819090241246158e-07
to O 0 8.047616795181511e-09
HeLa O 0 3.957429726142436e-06
cell O 0 2.0964503022469216e-08
TfR O 0 1.8385782141194795e-07
in O 0 4.673527537191191e-11
a O 0 2.720943088896366e-11
concentration O 0 3.494904987633163e-08
- O 0 7.062581630634668e-08
dependent O 0 9.385750132651083e-08
manner O 0 2.7299776661493524e-07
. O 0 2.6722725010586146e-07

Scatchard O 0 0.00016585332923568785
plots O 0 8.491309699820704e-07
of O 0 3.029097328521857e-08
these O 0 7.67375551991023e-10
data O 0 7.161409243394701e-10
indicate O 0 6.70191957485855e-10
that O 0 8.453110607320458e-12
the O 0 1.0370023728611955e-09
added O 0 2.391080444752447e-09
heterodimer O 0 2.1648931536333293e-08
substantially O 0 4.840527090266278e-09
reduced O 0 3.164387640808286e-09
the O 0 4.152982679972439e-10
affinity O 0 1.5881462811506708e-09
of O 0 1.999568288724163e-09
TfR O 0 1.8742899783319444e-06
for O 0 2.05066785774477e-09
transferrin O 0 3.4799770673998864e-06
. O 0 3.57718420218589e-07

These O 0 2.6062593860842753e-08
results O 0 1.1248490139337264e-08
establish O 0 3.4932439163526396e-09
a O 0 9.80159564623051e-11
molecular O 0 2.8839843846384383e-09
link O 0 2.7326689799878068e-09
between O 0 1.5471233183461663e-08
HFE O 1 1.0
and O 0 1.1928517551496043e-07
a O 0 4.8198631752427445e-09
key O 0 1.7536764573833352e-07
protein O 0 1.1704562874470525e-09
involved O 0 1.000838301123963e-10
in O 0 9.714010845707222e-11
iron O 0 2.6633750849214266e-07
transport O 0 8.656706995679997e-08
, O 0 8.268898066265962e-11
the O 0 7.844893068487124e-10
TfR O 0 3.372830974512908e-07
, O 0 1.1307542575889062e-11
and O 0 1.0459522137296062e-11
raise O 0 6.086657566850562e-11
the O 0 4.2646230297149756e-11
possibility O 0 1.385625225669429e-10
that O 0 1.4092763414574883e-12
alterations O 0 6.846696543050257e-09
in O 0 1.4618715959979767e-10
this O 0 1.1743146385856384e-11
regulatory O 0 2.6760551552484912e-09
mechanism O 0 1.7794845597052245e-09
may O 0 6.190381540704948e-10
play O 0 2.1392569660161342e-10
a O 0 6.074951305889975e-12
role O 0 2.09548767227119e-11
in O 0 5.2761198188200353e-11
the O 0 2.0030115344127353e-09
pathogenesis O 0 0.06535162031650543
of O 0 6.737485819030553e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9174493551254272
. O 0 1.948299086507177e-06

Genomic O 0 6.443243023568357e-07
organization O 0 4.031757594447072e-09
of O 0 7.12663839053107e-09
the O 0 3.591000279357104e-07
UBE3A O 1 0.9999997615814209
/ O 0 0.20204252004623413
E6 O 0 0.2689862549304962
- O 0 4.052973508805735e-06
AP O 0 4.705175342678558e-06
gene O 0 1.6302050820371505e-09
and O 0 9.822219426691703e-11
related O 0 6.220071213647316e-08
pseudogenes O 0 1.6695879821782e-05
. O 0 8.687172226018447e-07

The O 0 1.406741012033308e-05
UBE3A O 0 0.002592977602034807
gene O 0 9.324492822315733e-08
encodes O 0 1.0421343787925252e-08
the O 0 3.0743642298602936e-08
E6 O 0 0.00015060300938785076
- O 0 5.621141554001952e-06
AP O 0 1.8937751519843005e-05
ubiquitin O 0 2.853389844403864e-07
- O 0 4.07708398597606e-07
protein O 0 1.5181826906740525e-09
ligase O 0 9.394056199596434e-09
and O 0 6.29021723597134e-10
has O 0 9.940649865758378e-12
recently O 0 8.317078969977132e-11
been O 0 1.067843816843217e-11
shown O 0 3.34222883743851e-12
to O 0 3.0244381218208494e-12
be O 0 1.0627079077840662e-10
mutated O 0 2.056032599284663e-06
in O 0 4.455410817172378e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0788508802652359
who O 0 2.743048843623086e-10
lack O 0 2.6009245868152675e-09
15q11 O 0 3.4263737802575633e-07
- O 0 1.0165075536860968e-07
q13 O 0 7.125730121515517e-07
deletions O 0 4.409008980132967e-08
or O 0 3.3336582383469704e-09
chromosome O 0 1.4877291398818215e-08
15 O 0 3.321150998658595e-08
paternal O 0 8.946254638431128e-06
uniparental B-Disease 1 0.9534602165222168
disomy I-Disease 1 0.773530125617981
. O 0 2.1881940483581275e-05

Previous O 0 5.111984137329273e-05
UBE3A O 0 0.0007751494995318353
cDNA O 0 4.5913253643448115e-07
analysis O 0 4.966264732786385e-09
has O 0 4.967206854167294e-11
shown O 0 3.11533125685326e-11
a O 0 2.913916677393935e-11
coding O 0 7.126231160725638e-09
region O 0 2.3150932282334225e-09
of O 0 4.0521102029345e-09
approximately O 0 1.9485524305196122e-09
2 O 0 2.7920419753968417e-08
. O 0 1.2783875291688673e-08

6 O 0 5.563527156482451e-05
kb O 0 4.3712600017897785e-05
and O 0 1.0011104834006801e-08
a O 0 2.990261815938311e-09
3 O 0 1.5252661000886292e-07
- O 0 1.4240262089515454e-06
untranslated O 1 0.9999182224273682
region O 0 8.212013113961802e-08
( O 0 2.489375372505265e-10
UTR O 0 8.727133536012843e-05
) O 0 2.8389336020895328e-11
of O 0 4.507401119013821e-10
< O 0 1.66006479673797e-08
50 O 0 3.08009706628809e-09
bp O 0 8.748839985806001e-10
, O 0 1.110428502620886e-11
whereas O 0 1.0761128793612684e-10
Northern O 0 2.1698351448939945e-10
analysis O 0 5.4920550746073715e-11
has O 0 7.135019138015952e-12
indicated O 0 3.008818194594198e-11
mRNA O 0 6.630927751327675e-11
sizes O 0 3.195518849530288e-10
of O 0 7.170648519405631e-10
5 O 0 1.9487950808638743e-08
- O 0 3.2550576634093886e-07
8 O 0 3.036328450889414e-07
kb O 0 6.2585963860328775e-06
. O 0 3.2138356687028136e-07

We O 0 2.5919578661159903e-07
have O 0 1.504306568200775e-09
analyzed O 0 5.154886739688891e-09
additional O 0 1.6980348238604392e-09
cDNA O 0 1.9599525558078312e-07
clones O 0 1.5860530311329057e-07
and O 0 1.72075201310129e-10
provide O 0 1.0714509141029893e-11
evidence O 0 4.755162583136574e-11
for O 0 8.531815878787263e-12
an O 0 4.06137363323511e-12
additional O 0 9.665592770602416e-10
0 O 0 9.51095984191852e-08
. O 0 2.490289574552662e-08

5 O 0 7.0954033617454115e-06
kb O 0 1.4518325770040974e-05
of O 0 2.4740796789046726e-07
5 O 0 8.054021236603148e-07
- O 0 2.38366510529886e-06
UTR O 1 0.999842643737793
and O 0 1.3797659681458185e-09
> O 0 4.401740838488877e-08
2 O 0 1.1318823212036477e-08
kb O 0 6.01596070737287e-08
of O 0 4.560970268130404e-09
3 O 0 9.880535571937799e-07
- O 0 2.233244049421046e-05
UTR O 1 0.9999508857727051
. O 0 9.485322038926824e-07

We O 0 2.1251391757459714e-08
have O 0 7.759529824236111e-11
established O 0 2.933346343603205e-10
the O 0 1.0092730123867355e-10
genomic O 0 1.1734874183488841e-09
organization O 0 1.277204036975732e-10
of O 0 9.495761954525506e-10
UBE3A O 0 0.00014981096319388598
and O 0 6.697332133320799e-10
the O 0 2.261044823592684e-10
sequence O 0 5.266277344762038e-11
of O 0 1.2326082377001057e-09
intron O 0 7.870917215768714e-07
- O 0 2.547397116359207e-06
exon O 0 2.7547444005904254e-06
borders O 0 7.877347485418795e-08
. O 0 1.8692153957999835e-07

We O 0 3.842069133952464e-07
have O 0 5.1640784981543675e-09
also O 0 6.956529796653399e-10
mapped O 0 8.279638308295034e-09
two O 0 4.2482253825859573e-10
highly O 0 3.075402332797239e-08
homologous O 0 1.0553604212759637e-08
processed O 0 2.7696677307176287e-07
pseudogenes O 0 1.9391789010114735e-06
, O 0 1.8718042671395096e-09
UBE3AP1 O 0 0.29925811290740967
and O 0 3.0362986791487856e-08
UBE3AP2 O 1 0.999962329864502
, O 0 6.479277669946271e-10
to O 0 7.437272325772071e-11
chromosomes O 0 1.1996711957174e-10
2 O 0 2.0737475625587365e-10
and O 0 2.073983866590634e-11
21 O 0 4.191770541783768e-10
, O 0 7.1989536727656844e-12
respectively O 0 3.3659861009560643e-10
, O 0 8.458174265146834e-12
and O 0 1.7152527662100958e-11
determined O 0 5.099066724412182e-10
their O 0 2.8967067633445254e-10
genomic O 0 5.727692986567945e-09
organization O 0 1.7839975052780233e-09
. O 0 1.2097620682993693e-08

These O 0 6.47449098778452e-08
results O 0 3.176501905954865e-08
will O 0 2.4776750096044964e-10
form O 0 1.6432188942872017e-10
the O 0 8.361137476819991e-11
basis O 0 5.8121292501045474e-11
for O 0 1.1608897437093146e-12
studies O 0 4.76037828947562e-12
of O 0 5.3462685667415855e-12
mutation O 0 7.028586046509133e-11
and O 0 1.254489984114926e-10
imprinting O 0 2.986986089581478e-07
of O 0 1.564786430208187e-06
UBE3A O 1 0.999972939491272
. O 0 1.4702145563205704e-05

Mutation O 0 2.6466436793270987e-06
spectrum O 0 2.6453642476553796e-06
and O 0 7.133111878943055e-09
genotype O 0 2.3485456495109247e-06
- O 0 6.94241862220224e-07
phenotype O 0 1.2064040788573038e-07
analyses O 0 9.910293696790973e-10
in O 0 4.2788833587437125e-10
Cowden B-Disease 1 0.9727405309677124
disease I-Disease 0 5.31998466613004e-07
and O 0 2.3473205601476366e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.029020285121419e-09
two O 0 2.087057415778304e-09
hamartoma B-Disease 1 0.9992334842681885
syndromes I-Disease 1 0.9967122077941895
with O 0 1.407427703270514e-06
germline O 1 0.9999021291732788
PTEN O 1 0.9998127818107605
mutation O 0 3.7477348087122664e-06
. O 0 1.878902367025148e-07

The O 0 9.534241689834744e-05
tumour B-Disease 1 1.0
suppressor O 1 0.9924265146255493
gene O 0 1.3747378034167923e-05
PTEN O 0 0.020380664616823196
, O 0 1.3004343157874132e-09
which O 0 1.246704267598986e-10
maps O 0 5.32951816012428e-09
to O 0 2.7010846892494556e-09
10q23 O 0 7.870717672631145e-05
. O 0 1.978126874746522e-06

3 O 0 7.186331458797213e-07
and O 0 3.095350420423415e-09
encodes O 0 9.301410752726724e-10
a O 0 2.09233352865823e-10
403 O 0 6.1072351620339305e-09
amino O 0 5.958060156352474e-10
acid O 0 2.887231786985467e-09
dual O 0 1.121201176346176e-08
specificity O 0 4.9171415383852946e-08
phosphatase O 0 1.2710984265140723e-05
( O 0 2.927473596869845e-09
protein O 0 4.107977069622848e-09
tyrosine O 0 1.2272577620819902e-08
phosphatase O 0 6.66224977408092e-08
; O 0 5.56676760243846e-10
PTPase O 0 1.647390149628336e-06
) O 0 8.203281109953053e-11
, O 0 2.8823755882090296e-11
was O 0 5.706698447127678e-10
shown O 0 4.6691525645847776e-11
recently O 0 1.198774551847137e-10
to O 0 6.02380575975836e-11
play O 0 2.8002855589903675e-09
a O 0 6.94523383248935e-10
broad O 0 1.7547385766647494e-07
role O 0 3.443300311545272e-09
in O 0 4.494765892815167e-09
human O 0 1.2521413239596768e-08
malignancy B-Disease 0 7.692022336414084e-05
. O 0 1.7161855225822364e-07

Somatic O 0 0.05116890370845795
PTEN O 0 0.008720044046640396
deletions O 0 4.1811017581494525e-06
and O 0 1.9725604261111584e-08
mutations O 0 4.921755447639953e-09
were O 0 9.185544547207769e-10
observed O 0 7.144927427482628e-10
in O 0 3.1688993651357578e-09
sporadic B-Disease 0 0.015170756727457047
breast I-Disease 1 1.0
, I-Disease 0 8.153110684361309e-07
brain I-Disease 1 0.999962329864502
, I-Disease 0 5.707955779143958e-07
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 1.2694850681782555e-07
lines O 0 3.094073608433945e-10
and O 0 1.2209868532897517e-11
in O 0 5.104523401189276e-11
several O 0 3.081717381281379e-10
primary O 0 2.3282848360395292e-07
tumours B-Disease 1 0.5821667313575745
such O 0 1.0640470726741569e-09
as O 0 1.0188561816448782e-07
endometrial B-Disease 1 0.9999500513076782
carcinomas I-Disease 1 1.0
, O 0 1.6286869140458293e-05
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999910593032837
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9995484948158264

In O 0 3.1653492271743744e-08
addition O 0 1.0649327641942818e-08
, O 0 7.030403814667352e-09
PTEN O 0 0.18223419785499573
was O 0 4.6356788629964285e-08
identified O 0 2.0307160397692314e-09
as O 0 3.1200900196814985e-10
the O 0 8.86227313756649e-10
susceptibility O 0 4.452369850582727e-08
gene O 0 9.983068816055152e-10
for O 0 6.908794647486616e-10
two O 0 7.37431236075281e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
( O 0 1.919349568169082e-09
CD B-Disease 0 6.127912911324529e-06
; O 0 1.1922906217876061e-08
MIM O 0 0.00010844613279914483
158350 O 0 3.5397670217207633e-07
) O 0 3.2919771075778925e-11
and O 0 1.1510749298171419e-10
Bannayan B-Disease 0 8.974736374511849e-06
- I-Disease 0 0.00016304082237184048
Zonana I-Disease 1 0.9981162548065186
( I-Disease 0 6.631465598871955e-09
BZS I-Disease 0 0.0005373229505494237
) I-Disease 0 4.132154896030471e-10
or I-Disease 0 1.4227636846442238e-09
Ruvalcaba I-Disease 0 2.5189870029862504e-06
- I-Disease 0 8.387197567572002e-07
Riley I-Disease 0 9.581764970789663e-06
- I-Disease 1 0.9966519474983215
Smith I-Disease 1 0.9999836683273315
syndrome I-Disease 1 1.0
( O 0 1.946037713196347e-07
MIM O 1 0.999993085861206
153480 O 0 0.00017601053696125746
) O 0 1.0680634154880408e-08
. O 0 1.0547530138182992e-07

Constitutive O 0 1.0742061022028793e-05
DNA O 0 6.027573249411944e-07
from O 0 1.60704853868765e-08
37 O 0 1.0305339515070955e-07
CD B-Disease 0 1.0017112117566285e-06
families O 0 3.8947342573258936e-10
and O 0 1.1838099944760927e-10
seven O 0 3.690628469499302e-09
BZS B-Disease 1 0.999729573726654
families O 0 2.4399615661252483e-09
was O 0 3.9420595676631365e-09
screened O 0 3.3397949295022045e-08
for O 0 1.8525684097880912e-08
germline O 0 0.0003788263420574367
PTEN O 0 0.08962766826152802
mutations O 0 3.902080607076641e-06
. O 0 5.65600089430518e-07

PTEN O 0 0.00814413744956255
mutations O 0 3.608811312005855e-07
were O 0 9.861575556158186e-09
identified O 0 5.322414731168124e-10
in O 0 1.0257769633703617e-10
30 O 0 1.144490280324817e-09
of O 0 5.27780574799408e-09
37 O 0 1.7991762035762804e-07
( O 0 2.6385177376297975e-10
81 O 0 3.260009577843448e-07
% O 0 1.4909461165668603e-10
) O 0 1.486643273762578e-11
CD B-Disease 0 1.5358895666395256e-07
families O 0 1.0173091535836676e-10
, O 0 9.527354599692117e-12
including O 0 1.3029215206739053e-10
missense O 0 5.00876126352523e-07
and O 0 8.851398725084891e-09
nonsense O 0 3.3370304208801826e-06
point O 0 1.4910648360455525e-07
mutations O 0 1.56781565507913e-09
, O 0 4.6264592851175124e-11
deletions O 0 2.0254784516282598e-09
, O 0 2.260561876576972e-10
insertions O 0 1.1488256568270572e-08
, O 0 6.035282690275423e-11
a O 0 1.9793122696398768e-10
deletion O 0 2.3259028480993038e-08
/ O 0 2.0711492254577024e-07
insertion O 0 3.7025253618594434e-07
and O 0 3.653809699244448e-08
splice O 0 2.982830483233556e-05
site O 0 8.687752028890827e-07
mutations O 0 1.4340291443204478e-07
. O 0 7.231376741856366e-08

These O 0 9.666965894439272e-08
mutations O 0 1.6380946377125838e-08
were O 0 3.941443171839865e-09
scattered O 0 7.300064441828624e-10
over O 0 9.379294563238716e-11
the O 0 7.539784907528713e-10
entire O 0 1.291796669633527e-09
length O 0 4.313150392398768e-10
of O 0 1.4507235412963837e-08
PTEN O 0 1.1983847798546776e-05
, O 0 1.3652696161103872e-11
with O 0 2.7768615857258483e-13
the O 0 1.3001206014551236e-11
exception O 0 2.2318692033396204e-11
of O 0 1.5470177222587367e-11
the O 0 1.5201458147817704e-11
first O 0 2.528273423951788e-10
, O 0 3.563823888774742e-11
fourth O 0 1.6438349348391057e-08
and O 0 5.217678511471036e-10
last O 0 2.0358363883588027e-08
exons O 0 3.0835730058242916e-07
. O 0 7.621397202228763e-08

A O 0 5.895135927858064e-06
hot O 0 0.0004368869122117758
spot O 0 3.142105697406805e-06
for O 0 1.883049094431044e-08
PTEN O 0 0.00019957359472755343
mutation O 0 2.364613216343514e-08
in O 0 1.6664120083831335e-09
CD B-Disease 0 4.2883328887910466e-07
was O 0 3.3136955401857904e-09
identified O 0 6.471558289256052e-10
in O 0 1.4842138629234114e-09
exon O 0 3.399643944135278e-08
5 O 0 4.484950189009851e-10
that O 0 9.260610941280722e-13
contains O 0 4.795136857027593e-11
the O 0 9.876591766655451e-10
PTPase O 0 3.553821807145141e-05
core O 0 4.031224307254888e-06
motif O 0 2.8577722410716433e-09
, O 0 3.633606219730079e-12
with O 0 9.694251694794542e-13
13 O 0 1.6580727069115397e-10
of O 0 3.5650427054889633e-10
30 O 0 2.5411490689464244e-09
( O 0 2.083102093597411e-11
43 O 0 1.3501502138524302e-09
% O 0 1.9549759380788068e-11
) O 0 5.775030193638786e-12
CD B-Disease 0 4.8070027958146966e-08
mutations O 0 6.714714340105843e-10
identified O 0 4.4707124113863017e-10
in O 0 3.2675442906970886e-10
this O 0 3.2041871378396536e-09
exon O 0 1.4913237009750446e-06
. O 0 1.481053573115787e-07

Seven O 0 3.121397469385556e-07
of O 0 7.94276502347202e-08
30 O 0 1.0489470270158563e-07
( O 0 3.1382998977314003e-10
23 O 0 3.4441407503749133e-09
% O 0 2.2333340038427352e-11
) O 0 1.394580306270099e-12
were O 0 1.4361579980803896e-10
within O 0 2.1234555780402786e-10
the O 0 2.3338828647467835e-09
core O 0 4.845097691941191e-07
motif O 0 1.0943947970076806e-09
, O 0 8.537138877773298e-12
the O 0 1.1136296745872798e-10
majority O 0 6.384726081165581e-11
( O 0 6.117905227559506e-12
five O 0 5.3036446762133593e-11
of O 0 3.539600557100897e-10
seven O 0 1.1139696109996322e-10
) O 0 2.282095085820446e-12
of O 0 4.770087796979183e-11
which O 0 4.582862214719263e-11
were O 0 1.60029482998425e-08
missense O 0 5.642424980578653e-07
mutations O 0 2.5955129157040346e-09
, O 0 7.55538687169377e-11
possibly O 0 5.6375921708706755e-09
pointing O 0 2.7661626322839084e-09
to O 0 3.071751186745075e-11
the O 0 4.1028300201695345e-10
functional O 0 1.258162285466824e-08
significance O 0 1.828054330133e-08
of O 0 2.8048132705293938e-09
this O 0 1.352758904893392e-09
region O 0 6.389633000480899e-08
. O 0 7.67328032225123e-08

Germline O 0 0.030351141467690468
PTEN O 0 0.0029302167240530252
mutations O 0 1.2161362406004628e-07
were O 0 4.368525097220299e-09
identified O 0 2.2443950864481366e-10
in O 0 5.939596037229933e-11
four O 0 3.590021682708944e-11
of O 0 7.421731007539734e-10
seven O 0 1.9603996204153873e-09
( O 0 1.4250850499664125e-10
57 O 0 3.1572390923884086e-08
% O 0 3.1068117523069816e-10
) O 0 3.0771593606537806e-10
BZS B-Disease 1 0.7024762034416199
families O 0 7.504723953388748e-09
studied O 0 9.517982846318773e-08
. O 0 6.881550973503181e-08

Interestingly O 0 4.764989625982707e-06
, O 0 6.378002126439242e-09
none O 0 9.655905408578747e-09
of O 0 1.143645844692287e-09
these O 0 4.083063609439108e-10
mutations O 0 3.1955554868901004e-10
was O 0 4.3576878216988746e-10
observed O 0 3.3604949378762683e-10
in O 0 1.8922065303517144e-10
the O 0 6.074636349495677e-09
PTPase O 0 0.0011310557601973414
core O 0 0.00015839979459997267
motif O 0 1.2194977898616344e-06
. O 0 9.794601396606595e-08

It O 0 6.592320467291302e-09
is O 0 3.3070704508197935e-10
also O 0 2.9819150620946644e-11
worthy O 0 6.093179738542176e-09
of O 0 7.895205322849819e-11
note O 0 9.387741972677333e-11
that O 0 1.6603867803235972e-13
a O 0 2.6059460579014315e-12
single O 0 5.207236725146558e-11
nonsense O 0 2.391554509983962e-09
point O 0 5.163228733451319e-10
mutation O 0 2.789477156206477e-11
, O 0 3.3313267509132993e-12
R233X O 0 1.1287992762731847e-08
, O 0 2.0084380339402408e-11
was O 0 3.9290265485547593e-10
observed O 0 4.736292469331715e-10
in O 0 5.481237130844363e-10
the O 0 5.166758132446603e-09
germline O 0 4.270881248658043e-08
DNA O 0 1.253916415144829e-09
from O 0 1.055325132837126e-10
two O 0 2.1671497929531824e-11
unrelated O 0 9.21801834863345e-09
CD B-Disease 0 9.90157104752143e-07
families O 0 3.3567282287094713e-10
and O 0 2.012941341389407e-10
one O 0 5.253921742109924e-09
BZS B-Disease 1 0.9999943971633911
family O 0 1.0632405889055008e-07
. O 0 1.1114158837699506e-07

Genotype O 0 6.168248364701867e-05
- O 0 4.039067334815627e-06
phenotype O 0 1.951903669805688e-07
studies O 0 5.522846624472777e-10
were O 0 4.612810480808527e-11
not O 0 3.883603074544828e-12
performed O 0 1.5402056019464538e-10
on O 0 1.2506101709774953e-10
this O 0 4.218533508626443e-11
small O 0 2.6796087571057114e-10
group O 0 4.449179913379453e-11
of O 0 1.997304321932347e-09
BZS B-Disease 1 0.9999998807907104
families O 0 2.891869144150405e-07
. O 0 2.0979446446744987e-07

However O 0 1.3691786193703592e-07
, O 0 2.3941744142774724e-09
genotype O 0 3.155457761749858e-07
- O 0 5.201546926514311e-08
phenotype O 0 4.8641577876651354e-08
analysis O 0 1.154492279553665e-09
inthe O 0 1.7511389387436793e-06
group O 0 1.1228972612853383e-10
of O 0 7.042854632821616e-10
CD B-Disease 0 0.0003220380749553442
families O 0 7.1955835734272e-10
revealed O 0 1.8543554192174128e-10
two O 0 3.3054526997478018e-12
possible O 0 8.368875037412238e-11
associations O 0 9.635254399897875e-11
worthy O 0 6.710735966919401e-09
of O 0 2.513334818043944e-10
follow O 0 4.465990910418327e-10
- O 0 2.2776889263553812e-09
up O 0 1.8254947553586476e-10
in O 0 4.6144737336772934e-11
independent O 0 7.388183120848879e-11
analyses O 0 8.707088383630435e-10
. O 0 2.883434158107434e-09

The O 0 7.104722499207128e-08
first O 0 9.270030965069509e-09
was O 0 1.7184971667916216e-08
an O 0 2.8050136866020203e-11
association O 0 2.7087032616890383e-10
noted O 0 8.247759419877099e-11
in O 0 2.088297763880309e-11
the O 0 5.812073392008621e-11
group O 0 2.097149927673958e-12
of O 0 3.0359527392054275e-11
CD B-Disease 0 2.3360977138509043e-05
families O 0 1.1617531381347135e-09
with O 0 3.731726039291061e-09
breast B-Disease 1 0.9999908208847046
disease I-Disease 0 0.3933693468570709
. O 0 1.0222613127552904e-05

A O 0 2.3307840990582918e-07
correlation O 0 3.4635347923028803e-09
was O 0 1.7038355171195008e-09
observed O 0 2.905155560561923e-10
between O 0 6.682986108952349e-11
the O 0 2.8332874935088626e-10
presence O 0 7.484050046357993e-10
/ O 0 2.660445659330435e-07
absence O 0 1.038077357407019e-06
of O 0 4.6318429980374276e-08
a O 0 5.429484417618369e-09
PTEN O 0 6.050360752851702e-06
mutation O 0 4.860925550964623e-10
and O 0 6.158906717956825e-12
the O 0 8.096271049418124e-12
type O 0 4.585740953633177e-10
of O 0 3.4190204001305347e-09
breast O 0 4.781226152772433e-07
involvement O 0 7.055456663351833e-09
( O 0 2.1805941496921832e-09
unaffected O 0 9.592131391400471e-05
versus O 0 0.0035295223351567984
benign O 1 0.9836645722389221
versus O 0 0.0015045847976580262
malignant O 0 0.0010389448143541813
) O 0 1.6724595042205692e-08
. O 0 1.0893850088677937e-07

Specifically O 0 1.0308838938044573e-07
and O 0 2.2954258493967927e-09
more O 0 3.5886252303107824e-11
directly O 0 1.0167737485300421e-10
, O 0 7.410435980126362e-12
an O 0 3.036512664575386e-12
association O 0 2.4935001285975034e-10
was O 0 9.736609296595589e-10
also O 0 7.1489142730585264e-12
observed O 0 1.85975262967375e-11
between O 0 7.1937924367437844e-12
the O 0 2.6536677369404238e-11
presence O 0 1.7169810712092115e-11
of O 0 5.677602277209814e-10
a O 0 1.6485667941879e-08
PTEN O 1 0.9999879598617554
mutation O 0 2.1425343220471404e-05
and O 0 2.1334867597033735e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.8327351808547974
. O 0 6.670376478723483e-06

Secondly O 0 3.0086966944509186e-05
, O 0 9.087612440339399e-09
there O 0 1.0426985941336397e-09
appeared O 0 1.1224544627097544e-09
to O 0 1.4742471132755952e-11
be O 0 5.038168840454382e-11
an O 0 8.397288420169957e-11
interdependent O 0 1.2800495596820838e-07
association O 0 1.2282905359484175e-08
between O 0 2.9561006975598048e-09
mutations O 0 1.0421661755799505e-08
upstream O 0 1.1251451326188544e-08
and O 0 3.5170543560836265e-11
within O 0 3.444040608258092e-10
the O 0 5.674974268288224e-09
PTPase O 0 0.002919214777648449
core O 0 2.7028931071981788e-05
motif O 0 9.173782622440285e-09
, O 0 2.235187729349164e-11
the O 0 1.7382685568723133e-10
core O 0 1.5128126307217826e-08
motif O 0 4.028857525373297e-10
containing O 0 5.154350557479148e-11
the O 0 1.1554081302822539e-10
majority O 0 9.662749766992107e-11
of O 0 3.278195714884191e-09
missense O 0 4.027824900276755e-07
mutations O 0 2.2196660065532114e-09
, O 0 1.5621724400172177e-11
and O 0 1.0029168467928784e-11
the O 0 3.295709191664109e-11
involvement O 0 1.6584704096156422e-11
of O 0 8.423259312273501e-11
all O 0 3.432143458326209e-11
major O 0 2.1110558634518384e-08
organ O 0 3.6457145142776426e-06
systems O 1 0.9678325057029724
( O 0 2.484757288812034e-08
central O 0 8.246592915384099e-05
nervous O 0 1.4140674466034397e-05
system O 0 2.798098648781888e-06
, O 0 4.4398928977784635e-09
thyroid O 1 0.9884672164916992
, O 0 1.2205647408336517e-06
breast O 1 1.0
, O 0 1.441907784283103e-06
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 0.9999998807907104
) O 0 3.565202533195588e-08
. O 0 8.204809205381025e-07

However O 0 3.1064215022524877e-07
, O 0 1.759866918860098e-09
these O 0 1.5851041312853198e-10
observations O 0 1.3877577975662803e-09
would O 0 5.7189541297075763e-11
need O 0 8.893765585105129e-11
to O 0 1.2937138339774723e-11
be O 0 1.3959063072110922e-11
confirmed O 0 5.623668197785037e-11
by O 0 1.8860081898997016e-11
studying O 0 8.99307711632602e-11
a O 0 1.5725362635318763e-12
larger O 0 3.39107734947941e-11
number O 0 3.2870331456713586e-11
of O 0 9.3646412846482e-10
CD B-Disease 0 4.053940938320011e-05
families O 0 2.031220702747305e-08
. O 0 1.8837027937479434e-08

Molecular O 0 0.0012470887741073966
defects O 0 0.005126009229570627
leading O 0 3.753611679258029e-07
to O 0 2.4688723287979997e-10
human O 0 7.300356985595613e-10
complement B-Disease 0 7.100561106199166e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.71284830342256e-10
an O 0 1.393997981283257e-12
African O 0 1.790807259427485e-11
- O 0 6.638030125571959e-10
American O 0 4.876293813182997e-10
family O 0 4.5483192212536494e-10
. O 0 7.134989488122301e-09

Complement B-Disease 0 2.0412704543559812e-05
component I-Disease 1 0.9999997615814209
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.9647952598234042e-08
C6D B-Disease 1 0.8457275032997131
) O 0 5.183170004308124e-10
was O 0 5.91353774836989e-08
diagnosed O 0 5.641473762807436e-06
in O 0 2.6509892059323192e-09
a O 0 2.781365970871974e-10
16 O 0 1.7382162376122778e-09
- O 0 5.540878866838739e-10
year O 0 6.217693027110727e-10
- O 0 2.831063605768236e-09
old O 0 4.436964129439502e-09
African O 0 3.27298813052046e-11
- O 0 7.151550185380273e-11
American O 0 1.4327701351735112e-11
male O 0 8.89342245680158e-12
with O 0 1.288842036567539e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.7298959846812068e-06

The O 0 6.133930696705647e-07
patients O 0 4.023419933218975e-06
father O 0 1.2058082177190954e-07
and O 0 3.3709093294476133e-09
two O 0 3.857475228130625e-09
brothers O 0 1.387033989885822e-07
also O 0 3.2326810672778095e-10
had O 0 1.0418501616982212e-08
C6D B-Disease 1 0.9999997615814209
, O 0 3.204809195800351e-10
but O 0 6.704217042630134e-11
gave O 0 7.324971185163065e-11
no O 0 5.393577511697556e-12
history O 0 1.789701858934123e-10
of O 0 6.963034038243165e-10
meningitis B-Disease 1 0.9999358654022217
or O 0 6.377828820625098e-10
other O 0 1.0532724692424722e-09
neisserial B-Disease 0 1.4759291843802202e-05
infection I-Disease 0 8.012039870664012e-06
. O 0 2.2548117328824446e-07

By O 0 2.0877511275330107e-08
using O 0 9.785765087144682e-09
exon O 0 1.8538061397066485e-07
- O 0 5.5359481443417735e-09
specific O 0 7.032117110838954e-10
polymerase O 0 5.8632867450114645e-09
chain O 0 6.803188568049734e-10
reaction O 0 6.005934638508847e-10
( O 0 2.351073155604233e-11
PCR O 0 9.305071380083518e-09
) O 0 4.9754280556646435e-11
/ O 0 8.409168916756471e-10
single O 0 1.1580821718260026e-10
- O 0 8.752378821696993e-10
strand O 0 4.896322791658747e-10
conformation O 0 6.211502145969661e-11
polymorphism O 0 3.551040364535574e-11
as O 0 3.5450832807509824e-12
a O 0 1.6793444889903753e-12
screening O 0 4.393407304625896e-10
step O 0 3.8580474925886676e-10
and O 0 2.2412368835822427e-11
nucleotide O 0 2.341801197403015e-10
sequencing O 0 7.331446560954191e-10
of O 0 2.8960214781825755e-10
target O 0 1.086232326308334e-09
exons O 0 2.1621562318330234e-09
, O 0 5.8589066757874786e-12
we O 0 1.9560043688915396e-12
determined O 0 1.345883387376956e-11
that O 0 4.820359064162949e-13
the O 0 8.059251876968432e-11
proband O 0 6.983382832004281e-07
was O 0 1.9001351603264993e-09
a O 0 7.065778517834076e-11
compound O 0 2.99256832647643e-08
heterozygote O 0 4.844686145588639e-07
for O 0 1.1743785943707508e-09
two O 0 6.103462180107044e-09
C6 O 0 0.0007593731279484928
gene O 0 1.358544210461332e-07
mutations O 0 8.096147752212346e-08
. O 0 1.4397309655578283e-07

The O 0 4.911732887080689e-08
first O 0 8.452961886007415e-09
, O 0 3.799479897370617e-10
1195delC O 0 1.1578065794992654e-07
located O 0 3.919784052897057e-09
in O 0 5.092749000290553e-10
exon O 0 5.889775422929233e-08
7 O 0 1.615765121698587e-08
, O 0 1.7190684639678544e-11
is O 0 3.981330889968326e-12
a O 0 4.978956916895649e-12
novel O 0 3.003848281224464e-10
mutation O 0 2.6558449883751223e-11
, O 0 1.0322803809664771e-12
while O 0 2.3953035735435613e-12
the O 0 1.6862365670444746e-11
second O 0 7.753142572397564e-10
, O 0 2.5186314839276136e-11
1936delG O 0 7.41553707328535e-09
in O 0 1.1088676643566941e-09
exon O 0 1.1822497647528962e-08
12 O 0 7.839089377625896e-10
, O 0 1.5097289737808772e-11
has O 0 2.218651044133546e-12
been O 0 1.247747911936603e-11
described O 0 5.128696772827013e-11
before O 0 1.463183352257147e-09
to O 0 3.203342313629065e-10
cause O 0 2.725646481849253e-07
C6D B-Disease 1 0.9999963045120239
in O 0 4.7749351139714236e-09
an O 0 2.1287506479783502e-11
unrelated O 0 2.305047486217404e-09
African O 0 2.1817164741477768e-10
- O 0 1.3533214548999695e-09
American O 0 5.737476049816337e-10
individual O 0 6.311609013209818e-10
. O 0 6.857335144161425e-09

Both O 0 2.0549727253182937e-07
mutations O 0 3.388625202660478e-08
result O 0 7.517732214523676e-09
in O 0 9.318675608938065e-09
premature O 0 1.3732078514294699e-06
termination O 0 1.0984848586303997e-06
codons O 0 1.113778239414387e-06
and O 0 7.560443293641583e-08
C6 O 0 0.00017738011956680566
null O 0 6.987625511101214e-06
alleles O 0 1.2973065111054893e-07
. O 0 1.2625065437532612e-07

Allele O 0 2.8227353254806076e-07
- O 0 2.6798156582685806e-08
specific O 0 6.99177993279676e-10
PCR O 0 4.4533635445986874e-08
indicated O 0 1.6681928061146323e-09
that O 0 6.746223371600912e-12
the O 0 4.665096087208553e-10
probands O 0 5.701426925952546e-05
two O 0 5.737457176024918e-09
brothers O 0 2.8165336729557566e-08
also O 0 7.276346192242045e-11
inherited O 0 1.1770431740387721e-08
the O 0 5.448842710364943e-09
1195delC O 0 9.849435400610673e-08
mutation O 0 8.008993468422432e-10
from O 0 1.6193822671706215e-10
their O 0 1.5874247749625425e-10
heterozygous O 0 6.538770080943834e-10
mother O 0 4.265484840337841e-11
and O 0 3.93056637584821e-12
the O 0 4.170857756391477e-11
1936delG O 0 4.657798591267692e-09
mutation O 0 1.223885714995987e-10
from O 0 9.044890530995886e-11
their O 0 1.8362820985995398e-10
homozygous O 0 2.6254669549530263e-09
father O 0 7.3758141816426814e-09
. O 0 2.0605481765301192e-09
. O 0 4.1211084322867464e-08

PAX6 O 1 0.9941284656524658
mutations O 0 6.005766408634372e-05
reviewed O 0 4.8493719077669084e-05
. O 0 6.438196578528732e-06

Mutations O 0 1.8818172975443304e-05
in O 0 2.373135430389084e-07
PAX6 O 1 0.987711489200592
are O 0 1.0859900756443608e-09
responsible O 0 3.306817875081691e-10
for O 0 1.4492229638563003e-10
human O 0 5.299301442107662e-09
aniridia B-Disease 1 1.0
and O 0 3.8176995076355524e-06
have O 0 1.4815382254340648e-09
also O 0 2.4887425453812284e-11
been O 0 2.940706012033445e-11
found O 0 1.5129722127915635e-11
in O 0 2.12860840065332e-11
patients O 0 6.952456943487562e-10
with O 0 4.4192906278883726e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.965136320336569e-08
with O 0 6.917522910043772e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 7.570095021947054e-07
with O 0 1.0849392850786899e-07
autosomal B-Disease 1 0.9999977350234985
dominant I-Disease 1 0.9999994039535522
keratitis I-Disease 1 0.9999995231628418
, O 0 5.5764628470456046e-09
and O 0 2.0581130133479064e-09
with O 0 1.211172762083379e-08
isolated B-Disease 1 0.9947269558906555
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9999755620956421

No O 0 9.681524915094997e-08
locus O 0 8.470056656051383e-08
other O 0 3.9782832583767913e-10
than O 0 2.576000801557399e-10
chromosome O 0 2.9787117217239256e-09
11p13 O 0 1.1141447657792014e-06
has O 0 2.9732044604102725e-10
been O 0 4.5593848141400883e-10
implicated O 0 3.5422362820725084e-09
in O 0 1.10136850750564e-08
aniridia B-Disease 1 1.0
, O 0 1.329426790874777e-08
and O 0 8.221099356831019e-09
PAX6 O 1 0.9155122637748718
is O 0 4.126287367345327e-10
clearly O 0 4.1436462594468537e-10
the O 0 6.678475134025419e-11
major O 0 5.521975321443051e-09
, O 0 1.182153246820361e-11
if O 0 4.304057110715576e-12
not O 0 3.434243774774748e-12
only O 0 1.937085214454015e-11
, O 0 2.940862831035673e-11
gene O 0 1.6715107076237246e-10
responsible O 0 1.6821234405384189e-09
. O 0 1.461075100905873e-07

Twenty O 0 3.077106157434173e-06
- O 0 4.0752877339400584e-07
eight O 0 9.687783020240204e-09
percent O 0 1.2601261145661624e-09
of O 0 5.282446147170106e-10
identified O 0 1.7672613594754694e-08
PAX6 O 0 0.43368908762931824
mutations O 0 1.4410546533838442e-08
are O 0 3.507717172279712e-10
C O 0 7.201493872344145e-07
- O 0 9.161983172134569e-08
T O 0 9.206003426243115e-08
changes O 0 1.5414612919428805e-09
at O 0 1.1597943938568278e-08
CpG O 0 2.2481383155081858e-07
dinucleotides O 0 7.576985581181361e-07
, O 0 7.801854995381774e-11
20 O 0 1.9306166387789148e-10
% O 0 1.0798873947837073e-11
are O 0 1.3814280665561118e-12
splicing O 0 3.1682891865614238e-09
errors O 0 5.1334119177681714e-08
, O 0 1.5484118154329707e-10
and O 0 8.351334901401941e-11
more O 0 1.3079703119200925e-11
than O 0 3.407142623590431e-11
30 O 0 4.5086651079273565e-10
% O 0 4.5253512742648994e-11
are O 0 7.554561143319205e-12
deletion O 0 7.246627187207366e-10
or O 0 3.7400968433409787e-10
insertion O 0 3.691756944590452e-08
events O 0 3.7052164003625876e-08
. O 0 2.0379853538088355e-07

There O 0 2.0460898753071888e-08
is O 0 5.056559060356847e-10
a O 0 7.391047773808168e-10
noticeably O 0 5.270355245556857e-07
elevated O 0 1.1289090480204322e-06
level O 0 9.985092752629043e-09
of O 0 8.908829784992633e-10
mutation O 0 2.4330451542375897e-10
in O 0 4.327238914414444e-11
the O 0 1.3899027762054317e-10
paired O 0 1.5327179803126256e-10
domain O 0 4.9988756190000316e-11
compared O 0 1.1902989704992706e-10
with O 0 1.4573989801439091e-12
the O 0 1.7485536629724407e-10
rest O 0 1.2578592611944828e-09
of O 0 4.356125737903227e-10
the O 0 4.088668958956987e-09
gene O 0 3.6467271424811543e-09
. O 0 2.165913315366197e-08

Increased O 0 3.8424465742536995e-07
mutation O 0 3.5601196657353285e-08
in O 0 1.0934183558575228e-09
the O 0 5.673816083628935e-09
homeodomain O 0 1.1377316013749805e-06
is O 0 1.5115998730497182e-10
accounted O 0 5.149243809121629e-10
for O 0 7.999443989159527e-12
by O 0 9.806345319107734e-11
the O 0 5.197497543463214e-09
hypermutable O 0 9.462200068810489e-06
CpG O 0 3.0874857657181565e-06
dinucleotide O 0 1.2424668511812342e-06
in O 0 4.467724679102503e-08
codon O 0 5.188789486965106e-07
240 O 0 3.475014693776757e-07
. O 0 6.580414435575221e-08

Very O 0 3.122221983176132e-07
nearly O 0 6.291540177727484e-09
all O 0 4.124312280584519e-10
mutations O 0 1.1857358428457587e-09
appear O 0 2.315367009231295e-09
to O 0 3.392579828176423e-10
cause O 0 8.67457430331342e-08
loss O 0 1.1911864561398033e-07
of O 0 9.290546110207742e-09
function O 0 1.8001367063646967e-10
of O 0 3.3278754751897566e-10
the O 0 1.770451008020757e-10
mutant O 0 6.190924994875502e-10
allele O 0 4.8951995235135826e-11
, O 0 1.8987736730147198e-12
and O 0 1.6714610381537987e-12
more O 0 1.0220497408466866e-12
than O 0 5.242692131118831e-12
80 O 0 1.1359211488093379e-10
% O 0 5.804193931036039e-12
of O 0 4.247056872852539e-11
exonic O 0 1.439398715774587e-07
substitutions O 0 2.6061352187412012e-08
result O 0 1.0793968385769404e-08
in O 0 1.03097201886726e-08
nonsense O 0 3.0855557042741566e-07
codons O 0 2.1553515239247645e-07
. O 0 9.133926681670346e-08

In O 0 1.3202959792124602e-07
a O 0 1.94838145617382e-09
gene O 0 5.660949486951949e-10
with O 0 3.998959149931203e-11
such O 0 1.2416697892092543e-08
extraordinarily O 0 2.243923972855555e-06
high O 0 2.5010288595694874e-07
sequence O 0 9.466899486554325e-10
conservation O 0 4.30567270726101e-09
throughout O 0 6.481128828061955e-11
evolution O 0 2.6756555304707774e-10
, O 0 8.276909539695065e-12
there O 0 6.291654003343083e-11
are O 0 4.225074179409205e-10
presumed O 0 9.990142189053586e-07
undiscovered O 0 0.00011753762373700738
missense O 0 4.611137683241395e-06
mutations O 0 1.4141096293940336e-08
, O 0 1.1820094902859068e-10
these O 0 5.893463494999196e-11
are O 0 3.692209385453005e-11
hypothesized O 0 1.1090431906168874e-09
to O 0 1.1627212387343988e-10
exist O 0 7.261153900373074e-10
in O 0 5.946207415341576e-10
as O 0 3.793356295744843e-09
- O 0 8.375960902640145e-08
yet O 0 1.1072239125553551e-08
unidentified O 0 7.61433316398552e-09
phenotypes O 0 2.734708992591095e-08
. O 0 8.827621966744914e-10
. O 0 1.3267921872284205e-08

Genetic O 0 5.7292972996947356e-06
heterogeneity O 0 1.5846136420805124e-06
and O 0 3.995615838192634e-09
penetrance O 0 5.959878421890608e-07
analysis O 0 4.6313258783570177e-10
of O 0 2.2333233040683353e-09
the O 0 1.0048584897504043e-07
BRCA1 O 0 5.731144483434036e-06
and O 0 1.4800751557686453e-07
BRCA2 O 0 1.3505288734450005e-05
genes O 0 1.6025122562268734e-08
in O 0 6.850513756262444e-08
breast B-Disease 1 0.9944426417350769
cancer I-Disease 1 0.8095541596412659
families O 0 1.003293803591987e-07
. O 0 9.966779543901794e-07

The O 0 0.0005215932033024728
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0001296025438932702
Consortium O 0 3.0128539947327226e-06
. O 0 1.3497987083610496e-07

The O 0 4.795263208734468e-08
contribution O 0 6.854592271565707e-08
of O 0 1.3228293482825393e-07
BRCA1 O 0 6.430844678106951e-06
and O 0 1.7338157931590104e-07
BRCA2 O 0 0.0006519464077427983
to O 0 7.637752901246131e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.76129015017068e-05
assessed O 0 2.0509041576133313e-07
by O 0 1.572415531114757e-09
linkage O 0 7.570020166269842e-09
and O 0 4.278653126243981e-11
mutation O 0 1.8225575562635932e-11
analysis O 0 9.667095249299429e-12
in O 0 1.271908706829139e-11
237 O 0 8.909373239163187e-10
families O 0 7.538742199941773e-12
, O 0 5.712723588451041e-13
each O 0 1.0021681157460979e-13
with O 0 4.5077038889757004e-13
at O 0 2.698441747828184e-10
least O 0 2.5006240134128888e-11
four O 0 1.111929038427606e-11
cases O 0 1.82424172989748e-10
of O 0 7.945401847564426e-08
breast B-Disease 0 0.00634476263076067
cancer I-Disease 0 6.143279307480043e-08
, O 0 3.5583881761308556e-12
collected O 0 2.8846855459896403e-11
by O 0 2.484113956202627e-11
the O 0 9.06965880176358e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999997615814209
Linkage O 0 1.9911210813461366e-07
Consortium O 0 4.1994251631649604e-08
. O 0 3.3990910086600934e-09

Families O 0 2.4538334031376507e-08
were O 0 6.15372308665485e-10
included O 0 1.246200226345806e-10
without O 0 1.7500784155188853e-10
regard O 0 3.5431417799713927e-09
to O 0 1.8134240636902277e-11
the O 0 1.281880157577575e-10
occurrence O 0 1.401804983203192e-08
of O 0 3.3727678783179726e-06
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 7.478320185327902e-07
other I-Disease 0 1.5909051853668643e-06
cancers I-Disease 1 0.935899019241333
. O 0 2.422445049887756e-06

Overall O 0 0.00020450747979339212
, O 0 7.304751648007368e-08
disease O 0 1.900077586469706e-05
was O 0 3.870456453114457e-07
linked O 0 1.1219626685488038e-06
to O 0 7.998558970712111e-08
BRCA1 O 0 3.5992329685541335e-06
in O 0 2.2821373679704493e-09
an O 0 3.3137095498125824e-12
estimated O 0 4.791459329994696e-12
52 O 0 3.169911902412004e-11
% O 0 2.5616620370066956e-12
of O 0 4.228579292275825e-11
families O 0 2.92972174298356e-11
, O 0 3.763315700733294e-11
to O 0 8.049669264487136e-10
BRCA2 O 0 4.0906689946496044e-07
in O 0 1.7291590381773858e-09
32 O 0 9.249856991466743e-10
% O 0 6.990826320607546e-12
of O 0 2.0414675158675344e-11
families O 0 6.950951533107874e-12
, O 0 1.316966717970769e-12
and O 0 6.0325065255606436e-12
to O 0 2.5295987526874342e-11
neither O 0 1.322057574526525e-09
gene O 0 1.3656843711462585e-10
in O 0 2.2804871879777977e-10
16 O 0 1.4394221370395144e-09
% O 0 2.5136642767265016e-11
( O 0 1.0067168453031794e-12
95 O 0 1.2213189348742048e-09
% O 0 6.242013156354531e-11
confidence O 0 1.3092820161375585e-09
interval O 0 1.8524589862067842e-08
[ O 0 8.729080036573578e-08
CI O 0 0.000394989998312667
] O 0 4.273958964517988e-09
6 O 0 1.4934201653105106e-09
% O 0 2.7912229819127e-11
- O 0 3.7150774123695385e-10
28 O 0 8.829070252680538e-10
% O 0 2.998214176930247e-11
) O 0 3.760285485765458e-12
, O 0 1.912896924194385e-11
suggesting O 0 2.209549654352827e-09
other O 0 6.620319403793928e-09
predisposition O 0 8.324886584887281e-05
genes O 0 2.0884317564195953e-06
. O 0 1.1936965620407136e-06

The O 0 2.0126138622345024e-07
majority O 0 1.1509837527512445e-08
( O 0 5.252015489176642e-10
81 O 0 7.762219667029058e-08
% O 0 6.428264170965647e-11
) O 0 4.153747224650006e-12
of O 0 6.35218821987138e-10
the O 0 2.5834194730123272e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.614647328819558e-10
were O 0 9.293744940297444e-11
due O 0 1.1463210380924238e-09
to O 0 2.5630916833385697e-10
BRCA1 O 0 2.2556487788705226e-09
, O 0 3.235194664247265e-12
with O 0 6.160936561264152e-13
most O 0 9.29863894216787e-11
others O 0 4.4270691279546526e-11
( O 0 1.8753321378434107e-12
14 O 0 8.280450630726577e-11
% O 0 6.679286897876002e-12
) O 0 1.8336378422578736e-12
due O 0 1.6842879091427676e-08
to O 0 7.621862607720686e-08
BRCA2 O 0 0.00010210707841906697
. O 0 1.2884480611319304e-06

Conversely O 0 3.2031737191573484e-06
, O 0 1.4787067126320608e-09
the O 0 8.055597855438634e-10
majority O 0 1.7371945548738665e-10
of O 0 9.412417512066895e-10
families O 0 1.1030955315849411e-10
with O 0 2.155508063705902e-11
male B-Disease 0 2.077565008917759e-09
and I-Disease 0 5.265144431554347e-10
female I-Disease 0 3.5286147337387774e-09
breast I-Disease 0 1.491629404881678e-06
cancer I-Disease 0 5.169797034909607e-08
were O 0 1.6435016680915737e-09
due O 0 1.8977331137648434e-06
to O 0 1.7860759271570714e-07
BRCA2 O 0 3.2261111755360616e-06
( O 0 2.0706646119972305e-10
76 O 0 6.038550282028154e-08
% O 0 2.6973767663918125e-10
) O 0 8.766876113952549e-11
. O 0 7.658874423555062e-09

The O 0 5.256551389720698e-07
largest O 0 2.0339118123047228e-07
proportion O 0 1.3747492921822868e-08
( O 0 1.1521995163521481e-10
67 O 0 5.45367795368179e-09
% O 0 1.2956596733004755e-11
) O 0 8.444403488093444e-13
of O 0 2.4647414664791256e-10
families O 0 5.4289711615140845e-11
due O 0 4.2189018500948805e-08
to O 0 9.587851623749089e-10
other O 0 1.9893011682370343e-09
genes O 0 4.1562636665659625e-10
was O 0 1.0257696914095504e-09
found O 0 6.300973631745421e-11
in O 0 3.4614842242541854e-11
families O 0 7.823785889982116e-12
with O 0 9.52177356058903e-13
four O 0 2.6476262154906394e-11
or O 0 2.6136927691600143e-11
five O 0 2.243871755069904e-11
cases O 0 1.145441866357011e-10
of O 0 5.344250197936162e-08
female O 0 3.573474884888128e-07
breast B-Disease 0 0.0005664690397679806
cancer I-Disease 0 5.660425586029305e-07
only O 0 4.339492321037142e-09
. O 0 9.571542847197634e-08

These O 0 4.4978644808679746e-08
estimates O 0 8.636335202538703e-09
were O 0 9.303504633351167e-10
not O 0 4.912371898146972e-11
substantially O 0 2.1200987632141732e-08
affected O 0 2.0961132829455664e-09
either O 0 1.0028638336434526e-10
by O 0 2.5788114699221154e-11
changing O 0 5.595189866980377e-10
the O 0 3.0092503489065336e-10
assumed O 0 1.5155730004323686e-09
penetrance O 0 8.287224773084745e-08
model O 0 1.5721877133501039e-09
for O 0 5.12855258261169e-10
BRCA1 O 0 8.362899706071403e-09
or O 0 1.1435683129612517e-11
by O 0 1.7065007393290976e-11
including O 0 2.2871519955725006e-10
or O 0 9.070901363372741e-09
excluding O 0 1.4809288586548064e-05
BRCA1 O 0 1.4845425084786257e-06
mutation O 0 2.4837103040908914e-08
data O 0 1.3586293867717814e-08
. O 0 4.600340730576136e-08

Among O 0 3.186186745551822e-07
those O 0 2.1564479091296107e-09
families O 0 1.5760177884960314e-10
with O 0 4.812050410918367e-11
disease O 0 3.3981834803853417e-06
due O 0 0.12052340060472488
to O 0 4.092095906571558e-08
BRCA1 O 0 4.119245744504951e-08
that O 0 5.159285759032128e-12
were O 0 4.973691597465191e-11
tested O 0 6.616701631045885e-11
by O 0 1.131487785410723e-11
one O 0 9.290089530988865e-12
of O 0 1.597456195101543e-11
the O 0 2.486602763973611e-11
standard O 0 2.6498353511428263e-10
screening O 0 4.107058027003063e-10
methods O 0 3.59895002688404e-10
, O 0 1.6383984446921573e-11
mutations O 0 5.506950104261499e-11
were O 0 2.4722088265427544e-10
detected O 0 1.405488059269544e-09
in O 0 1.9756687952288132e-10
the O 0 6.340495350976028e-10
coding O 0 1.5780882156590792e-09
sequence O 0 7.896515386018876e-11
or O 0 7.346910579908439e-11
splice O 0 2.4330660153282224e-08
sites O 0 1.1590949311468535e-09
in O 0 3.107604451546564e-11
an O 0 5.900700934813319e-13
estimated O 0 1.718756907631569e-11
63 O 0 8.705361986827143e-10
% O 0 4.4017924721861945e-11
( O 0 1.2139369370833819e-11
95 O 0 4.335936765187398e-08
% O 0 3.6419725013558946e-09
CI O 0 3.429830394452438e-05
51 O 0 8.210067292679923e-09
% O 0 1.9694983144358247e-10
- O 0 8.070858648068224e-09
77 O 0 2.2234425856026974e-08
% O 0 3.24059529210885e-10
) O 0 1.2947759531201086e-10
. O 0 1.3051911551542617e-08

The O 0 6.382592943054988e-08
estimated O 0 8.69096128397473e-10
sensitivity O 0 4.761838479083735e-09
was O 0 2.2844848235337167e-09
identical O 0 3.4817079774818183e-10
for O 0 1.0944897765874373e-11
direct O 0 8.955966523949144e-11
sequencing O 0 5.257380308876236e-09
and O 0 1.041616723429506e-10
other O 0 1.4292227124013124e-10
techniques O 0 3.175859575321738e-08
. O 0 6.910817518246404e-08

The O 0 6.230508233784349e-07
penetrance O 0 0.00014695400022901595
of O 0 3.520607606333215e-06
BRCA2 O 0 1.1879811609105673e-05
was O 0 2.8450946043534486e-09
estimated O 0 1.625301108976185e-11
by O 0 1.1494354947017005e-11
maximizing O 0 2.2024398305120485e-08
the O 0 1.1043724157389079e-08
LOD O 1 0.9999216794967651
score O 0 7.114200570867979e-07
in O 0 2.267071330663839e-08
BRCA2 O 0 1.1694910284631987e-07
- O 0 1.2570636975794969e-08
mutation O 0 4.735244418796469e-10
families O 0 1.3580831771664581e-11
, O 0 4.5262098648073124e-13
over O 0 2.439985713476034e-12
all O 0 2.3862028672438917e-11
possible O 0 2.8916404826162534e-09
penetrance O 0 6.303454938461073e-06
functions O 0 1.167041574490213e-08
. O 0 3.668620962571367e-08

The O 0 3.3527644660580336e-08
estimated O 0 1.0141188999668316e-09
cumulative O 0 1.0715261566929257e-08
risk O 0 9.416084800761837e-09
of O 0 3.037294860064321e-08
breast B-Disease 0 0.0001027563339448534
cancer I-Disease 0 3.516732022035285e-06
reached O 0 2.584784795089945e-07
28 O 0 7.380884170515856e-08
% O 0 2.1780575953922465e-10
( O 0 4.415463220747151e-12
95 O 0 6.358506610126824e-09
% O 0 2.734241999480247e-10
CI O 0 1.6839014733704971e-06
9 O 0 1.132935745218333e-09
% O 0 1.914875549791084e-11
- O 0 1.8221101016901997e-10
44 O 0 1.4849832474794766e-10
% O 0 1.3148533910961602e-12
) O 0 5.595626704503996e-14
by O 0 1.6574260410309738e-12
age O 0 3.1307009762393534e-10
50 O 0 4.0009121016204574e-11
years O 0 1.7409684804903236e-11
and O 0 1.9698768657927523e-11
84 O 0 4.157074240396241e-09
% O 0 4.4652989639182294e-11
( O 0 4.247038484783694e-12
95 O 0 5.583582929347131e-09
% O 0 7.255741563128026e-10
CI O 0 4.263037681084825e-06
43 O 0 2.7157247561859776e-09
% O 0 2.6796429658526577e-11
- O 0 4.111321838529136e-10
95 O 0 1.6206284092490364e-09
% O 0 5.1732984215902e-12
) O 0 1.3454841895580577e-13
by O 0 6.358194352962254e-12
age O 0 3.991876162956487e-09
70 O 0 2.9710911508828985e-09
years O 0 5.198330654820893e-09
. O 0 4.897243144341701e-08

The O 0 2.9886439278925536e-06
corresponding O 1 0.998634397983551
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.5278943465091288e-05
were O 0 5.4881468258827226e-08
0 O 0 2.786318589187431e-07
. O 0 4.519440821582066e-08

4 O 0 1.862391172835487e-06
% O 0 1.367927726647622e-08
( O 0 4.774659556616712e-10
95 O 0 1.328418335333481e-07
% O 0 6.015694165029117e-09
CI O 0 2.0392157239257358e-05
0 O 0 4.9210422403689336e-09
% O 0 4.589869456728124e-11
- O 0 1.734569016198506e-10
1 O 0 2.3218581224337953e-10
% O 0 2.3461623269160903e-12
) O 0 7.072832852164299e-14
by O 0 2.0088392754802342e-12
age O 0 5.076417619598317e-10
50 O 0 8.71875072139261e-11
years O 0 3.582948868152691e-11
and O 0 3.748786697732598e-11
27 O 0 2.5981528040119883e-09
% O 0 3.912870721878292e-11
( O 0 2.2885547623641145e-12
95 O 0 1.956798278968108e-09
% O 0 1.5883425130702733e-10
CI O 0 3.637077554685675e-07
0 O 0 5.71777902802495e-10
% O 0 1.0474335808419166e-11
- O 0 1.147851952376655e-10
47 O 0 2.889329331345891e-10
% O 0 2.257909571118377e-12
) O 0 9.421594906154629e-14
by O 0 5.757136087303216e-12
age O 0 6.8869843161678546e-09
70 O 0 4.042769230494514e-09
years O 0 3.8672438584796964e-09
. O 0 4.2312560566415414e-08

The O 0 2.6034231837002153e-07
lifetime O 0 7.757629987281689e-07
risk O 0 3.1092696417545085e-07
of O 0 2.520287125662435e-06
breast B-Disease 1 0.9999983310699463
cancer I-Disease 0 0.00023618467093911022
appears O 0 6.084632353520192e-09
similar O 0 1.0390336369070496e-09
to O 0 2.9677255097837474e-10
the O 0 2.148541611290966e-08
risk O 0 5.748611542344406e-08
in O 0 1.3879138949235426e-09
BRCA1 O 0 1.2737867427503602e-09
carriers O 0 7.553210834565505e-11
, O 0 9.347691891370413e-13
but O 0 2.119370868039483e-12
there O 0 2.4534679843313256e-12
was O 0 5.665677996202767e-11
some O 0 4.544897878183685e-12
suggestion O 0 6.825609522032039e-10
of O 0 3.869189968419562e-10
a O 0 6.084860948440962e-10
lower O 0 1.3352088217288838e-06
risk O 0 4.327121772007558e-08
in O 0 4.866957947768924e-09
BRCA2 O 0 1.8857159389540357e-08
carriers O 0 5.029424654523496e-10
< O 0 5.772395894609872e-09
50 O 0 3.0726199362618445e-10
years O 0 1.594059433063233e-11
of O 0 2.0520832255677135e-10
age O 0 4.533652031568636e-08
. O 0 1.00567902450166e-07

Eye B-Disease 1 0.9999444484710693
movement I-Disease 0 2.9894647468609037e-06
abnormalities I-Disease 0 1.6912855471673538e-06
correlate O 0 2.999934878289423e-08
with O 0 3.6022326788121006e-10
genotype O 0 7.299713161046384e-06
in O 0 2.700256906962295e-08
autosomal O 0 0.19479356706142426
dominant O 1 0.9999679327011108
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999985694885254
. O 0 3.300383696114295e-06

We O 0 7.974901450324978e-08
compared O 0 2.0531665256839915e-07
horizontal O 0 9.528388318358338e-07
eye O 0 5.428646909422241e-05
movements O 0 2.0612536388853187e-07
( O 0 2.163880630234871e-09
visually O 0 7.210095187559773e-09
guided O 0 4.623519700430734e-08
saccades O 0 3.049250096864853e-07
, O 0 4.4615552918791934e-10
antisaccades O 0 4.39163159171585e-07
, O 0 1.26660515409327e-10
and O 0 5.023918434043928e-11
smooth O 0 5.380605405669314e-10
pursuit O 0 6.20471141132839e-09
) O 0 9.873417187999944e-12
in O 0 5.900977623207737e-11
control O 0 3.2743465716578157e-09
subjects O 0 4.940814335441246e-08
( O 0 2.109137170469566e-11
n O 0 6.511141070753013e-10
= O 0 4.889267324337254e-10
14 O 0 7.274489344233359e-10
) O 0 1.767420411413756e-11
and O 0 1.482543809938619e-10
patients O 0 1.830216422860076e-09
with O 0 2.7829340394636137e-12
three O 0 2.032977258759061e-11
forms O 0 1.5115948492905318e-09
of O 0 1.0637172209726486e-07
autosomal O 0 2.5150282453978434e-05
dominant O 0 6.803534779464826e-05
cerebellar B-Disease 0 0.0015034826938062906
ataxias I-Disease 0 4.1066494304686785e-05
type I-Disease 0 1.6559604773647152e-05
I I-Disease 0 3.226880289730616e-05
spinocerebellar B-Disease 0 0.0008286940865218639
ataxias I-Disease 0 1.2409886039677076e-05
1 I-Disease 0 1.2705145024938247e-07
and I-Disease 0 1.1445928649322923e-09
2 I-Disease 0 1.2223635437180747e-08
( O 0 1.1688895684702771e-10
SCA1 B-Disease 0 5.075156150269322e-05
, O 0 2.2028492918657605e-10
n O 0 3.6699049354993463e-10
= O 0 1.6616502618305162e-10
11 O 0 1.370966812297425e-10
; O 0 4.855863627861723e-11
SCA2 B-Disease 0 6.202328222570941e-06
, O 0 2.0599970340651197e-10
n O 0 3.150288363507059e-10
= O 0 3.258060210509228e-10
10 O 0 1.208808192432187e-10
) O 0 9.370384676521404e-12
and O 0 7.578453975476407e-10
SCA3 B-Disease 1 1.0
/ O 0 0.00015370565233752131
Machado B-Disease 0 7.666271812922787e-07
- I-Disease 0 8.485351941089903e-07
Joseph I-Disease 0 0.0003087351506110281
disease I-Disease 0 3.8402162317652255e-05
( O 0 1.1754318629542126e-09
MJD B-Disease 1 1.0
) O 0 1.7351158287937096e-09
( O 0 6.703795157880776e-11
n O 0 1.3408294474714921e-09
= O 0 1.7166814636482286e-09
16 O 0 5.841140904294662e-09
) O 0 3.817582638898642e-10
. O 0 2.34994690373469e-08

In O 0 6.631688620473142e-07
SCA1 B-Disease 0 0.0005476173246279359
, O 0 4.824921795432147e-09
saccade O 0 1.6959843662789353e-07
amplitude O 0 2.7842299132885273e-08
was O 0 3.83524634273158e-09
significantly O 0 5.406748826430885e-09
increased O 0 1.3742504911817832e-09
, O 0 1.4974468887096748e-10
resulting O 0 5.011071113614207e-09
in O 0 9.281318824605478e-09
hypermetria B-Disease 0 5.996965046506375e-05
. O 0 7.262019039444567e-07

The O 0 2.2599785154397978e-07
smooth O 0 3.5491032690515567e-07
pursuit O 0 6.18319336354034e-06
gain O 0 2.53235270974983e-06
was O 0 5.001286353945034e-07
decreased O 0 8.691384209669195e-06
. O 0 2.5754269472599844e-07

In O 0 5.338687856237812e-07
SCA2 B-Disease 0 0.0006503793993033469
, O 0 6.357900428355379e-09
saccade O 0 2.0557371271934244e-07
velocity O 0 5.7374382578245786e-08
was O 0 4.801495734341188e-08
markedly O 0 3.9169271985883825e-06
decreased O 0 4.773626642418094e-06
. O 0 5.933133593316597e-07

The O 0 9.413287216375466e-08
percentage O 0 7.917142852420511e-08
of O 0 4.141309517535774e-09
errors O 0 1.4407352182388422e-06
in O 0 8.88674165366865e-08
antisaccades O 1 0.5682479739189148
was O 0 6.294039422982678e-08
greatly O 0 9.313575688452147e-09
increased O 0 9.786226273789111e-10
and O 0 1.1047104897521365e-10
was O 0 4.295531985665235e-10
significantly O 0 1.023936158084382e-09
correlated O 0 1.0110982051614315e-09
with O 0 7.311986086055988e-12
age O 0 1.7393448459301908e-08
at O 0 2.511890073719769e-08
disease O 0 2.4500505446667376e-07
onset O 0 1.1417508176236879e-05
. O 0 6.257213840399345e-07

In O 0 1.92075297889005e-08
addition O 0 1.6083969711644386e-09
, O 0 1.0316909132557228e-10
a O 0 1.365350367488194e-11
correlation O 0 2.7316709658165017e-11
between O 0 7.81824049944646e-11
smooth O 0 5.924576385041291e-09
pursuit O 0 6.514588335448934e-08
gain O 0 4.4628678530500565e-09
and O 0 1.3615949513712255e-11
the O 0 2.279503148738815e-11
number O 0 4.680556636715849e-11
of O 0 1.0132507055615747e-09
trinucleotide O 0 1.3038147699262481e-06
repeats O 0 1.8725327954882687e-09
was O 0 9.258969591030564e-09
found O 0 2.9185365235662175e-09
. O 0 2.0381440535288675e-08

In O 0 4.825522410101257e-06
SCA3 B-Disease 1 1.0
, O 0 5.820218689223111e-07
gaze B-Disease 0 3.397018735995516e-05
- I-Disease 0 1.5458790585398674e-05
evoked I-Disease 0 1.8830218323273584e-05
nystagmus I-Disease 0 9.691002560430206e-06
was O 0 1.1986409198527781e-08
often O 0 8.049542976618085e-11
present O 0 4.387191998578288e-11
as O 0 1.0053324839276456e-10
was O 0 9.039479720307497e-10
saccade O 0 3.7063685454086226e-08
hypometria O 0 2.2081567863097007e-07
and O 0 3.972626672066326e-10
smooth O 0 7.131588652953269e-09
pursuit O 0 2.763470092759235e-07
gain O 0 3.271976254382025e-07
was O 0 1.3722925018555543e-07
markedly O 0 1.0606378054944798e-05
decreased O 0 6.865569503133884e-06
. O 0 4.0630754938320024e-07

Three O 0 2.004063404115186e-08
major O 0 7.081682440457371e-08
criteria O 0 3.6217855381437403e-07
, O 0 1.0471888911567362e-09
saccade O 0 4.842330625365321e-08
amplitude O 0 5.169734862420228e-09
, O 0 4.6312707141504816e-11
saccade O 0 3.830757488998415e-09
velocity O 0 1.9576569254553533e-09
, O 0 2.8884955191599282e-11
and O 0 2.0570002298714307e-11
presence O 0 9.808964751556459e-11
of O 0 3.2392019733151756e-08
gaze B-Disease 0 2.5655659555923194e-05
- I-Disease 0 1.0837912668648642e-05
evoked I-Disease 0 3.068610567424912e-06
nystagmus I-Disease 0 2.3603939780514338e-07
, O 0 8.687620935143858e-12
permitted O 0 1.9997760392076458e-11
the O 0 1.5072056450127214e-11
correct O 0 8.940469198304157e-11
assignment O 0 1.568036256394123e-10
of O 0 1.5209324077947173e-10
90 O 0 4.445839807409868e-10
% O 0 6.71989634076775e-12
of O 0 3.9479849944790146e-11
the O 0 7.106681354507316e-10
SCA1 B-Disease 0 0.03263312950730324
, O 0 5.259624402675911e-10
90 O 0 1.3147800626001072e-09
% O 0 7.485727315792445e-12
of O 0 2.5765008182521143e-11
the O 0 2.825667477779348e-10
SCA2 B-Disease 0 0.015877127647399902
, O 0 2.9304383919459553e-10
and O 0 7.974677168620659e-11
93 O 0 1.4680193727301116e-09
% O 0 2.7188149735041245e-12
of O 0 5.403070785919839e-12
the O 0 7.478638541780214e-11
patients O 0 4.973127243346198e-09
with O 0 2.91751095504722e-10
SCA3 B-Disease 1 1.0
to O 0 5.092826995678479e-07
their O 0 1.6706954397704976e-07
genetically O 0 1.3196367945056409e-06
confirmed O 0 3.5650188578983943e-08
patient O 0 2.7248740934737725e-06
group O 0 1.0193713928519088e-11
and O 0 4.657240738892288e-12
, O 0 2.1083074522310064e-12
therefore O 0 1.1303968178166812e-10
, O 0 1.3617456121051141e-11
may O 0 4.5003056836634414e-10
help O 0 4.395368513598896e-10
orient O 0 3.680732731936587e-07
diagnoses O 0 1.8348961248193518e-06
of O 0 8.089016034773522e-08
SCA1 B-Disease 1 0.9997686743736267
, O 0 1.8706978188731682e-09
SCA2 B-Disease 0 0.014302932657301426
, O 0 2.718019143088668e-10
and O 0 4.3305109498348315e-10
SCA3 B-Disease 1 1.0
at O 0 1.207892523780174e-07
early O 0 4.030360685192136e-07
clinical O 0 4.4696172096792e-08
stages O 0 5.3162692026376135e-09
of O 0 1.2360028556201996e-09
the O 0 2.161085177476707e-08
diseases O 0 3.7640500067936955e-06
. O 0 6.1824083630313e-09
. O 0 4.900326189272164e-08

Genetic O 0 3.817634421920957e-07
basis O 0 7.561737902506138e-09
and O 0 1.645411029649324e-10
molecular O 0 3.944225390739575e-09
mechanism O 0 1.4360828082260468e-08
for O 0 5.678333891978582e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.00020899003720842302

Ventricular B-Disease 1 0.9999969005584717
fibrillation I-Disease 0 0.4372546374797821
causes O 0 3.348189352436748e-07
more O 0 1.4957055038955502e-10
than O 0 6.033798460869377e-11
300 O 0 3.1439614800454763e-10
, O 0 1.5460178276471837e-11
000 O 0 8.073302582012332e-10
sudden O 0 2.905803930808304e-10
deaths O 0 5.1410761064962784e-11
each O 0 2.552512238032656e-12
year O 0 2.467304971442985e-10
in O 0 1.5814448639517309e-09
the O 0 3.9520291039707445e-08
USA O 0 2.2776777086619404e-07
alone O 0 5.7383982010605905e-09
. O 0 6.816752939897697e-09

In O 0 9.458371152959444e-08
approximately O 0 1.3283919519935239e-09
5 O 0 7.763652831727086e-09
- O 0 2.7273332037225373e-08
12 O 0 2.1996091614795432e-09
% O 0 2.18669804485927e-11
of O 0 1.067888659445071e-11
these O 0 4.4448351249615214e-12
cases O 0 3.680600269007073e-11
, O 0 4.858270036267598e-12
there O 0 9.009760819356227e-12
are O 0 1.0120792225121189e-11
no O 0 2.1100916847149875e-10
demonstrable O 0 1.8874416127800941e-06
cardiac O 0 0.0006310130702331662
or O 0 1.4066904086007526e-08
non O 0 1.3672654858964961e-05
- O 0 5.2554805733961985e-05
cardiac O 0 0.003108463017269969
causes O 0 2.292289025263017e-09
to O 0 2.3073942062579178e-11
account O 0 3.048160682195267e-11
for O 0 3.4396992198981735e-11
the O 0 4.843528689235654e-09
episode O 0 1.9316783728129394e-09
, O 0 3.461937984547414e-12
which O 0 5.262546583402472e-13
is O 0 1.5478926734119325e-13
therefore O 0 5.31925328436933e-12
classified O 0 1.40702685613725e-10
as O 0 1.9230945724757476e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.7646057131059933e-06
IVF B-Disease 1 1.0
) O 0 2.7063100205282353e-08
. O 0 1.1513366615645282e-07

A O 0 2.437250032016891e-06
distinct O 0 9.460499228453045e-08
group O 0 9.661021982410034e-10
of O 0 1.3205580273734085e-07
IVF B-Disease 1 1.0
patients O 1 0.9999591112136841
has O 0 5.6959954114477185e-11
been O 0 1.4794471203671833e-11
found O 0 3.1418721790910098e-12
to O 0 1.0390639086990672e-12
present O 0 1.752997400017442e-11
with O 0 1.6602998489934073e-11
a O 0 6.678363417833566e-10
characteristic O 0 1.0188328758431453e-07
electrocardiographic O 0 1.8800126781570725e-05
pattern O 0 6.474256224464625e-07
. O 0 2.1813779937929212e-07

Because O 0 8.375418047990024e-08
of O 0 2.6122114249460537e-08
the O 0 4.996449920469104e-09
small O 0 1.4175730034260425e-10
size O 0 1.5654423590749644e-10
of O 0 4.561193922558715e-10
most O 0 5.817056281109956e-10
pedigrees O 0 2.4626011452255625e-08
and O 0 6.959020859564902e-11
the O 0 1.0086110419083028e-10
high O 0 2.717263747342713e-09
incidence O 0 7.98632604492866e-10
of O 0 5.538554059825174e-10
sudden B-Disease 0 3.870977760556116e-09
death I-Disease 0 8.351023872421592e-09
, O 0 2.6590788598790382e-11
however O 0 1.2027503992761979e-10
, O 0 5.482883244645187e-12
molecular O 0 2.023159764719118e-11
genetic O 0 1.2133998666952195e-11
studies O 0 2.8079029986555204e-12
of O 0 8.427067377247965e-11
IVF B-Disease 1 1.0
have O 0 5.536885394619162e-10
not O 0 5.664403321392619e-11
yet O 0 1.402349791845836e-09
been O 0 6.249104012034934e-10
done O 0 7.813939717493668e-09
. O 0 3.563258132999181e-08

Because O 0 1.211582639371045e-05
IVF B-Disease 1 1.0
causes O 0 0.22000481188297272
cardiac O 1 1.0
rhythm O 1 0.9824281334877014
disturbance O 0 0.0003620809002313763
, O 0 2.1097576463624534e-10
we O 0 6.489762893746587e-11
investigated O 0 3.269896575730513e-09
whether O 0 4.632856764885673e-09
malfunction O 0 0.009317911230027676
of O 0 2.237177056940709e-07
ion O 0 4.123387498111697e-06
channels O 0 4.808614839646452e-09
could O 0 1.555931494756635e-10
cause O 0 3.6626133237405156e-09
the O 0 1.6682627501651837e-09
disorder O 0 2.0020193503000883e-08
by O 0 2.0046614368496307e-10
studying O 0 2.4711630519647088e-09
mutations O 0 3.7654192264202635e-11
in O 0 3.1824459734153265e-11
the O 0 4.3332953891805914e-10
cardiac O 0 2.442072570829623e-07
sodium O 0 1.7088506183426944e-06
channel O 0 1.057480503163788e-07
gene O 0 3.573978446524961e-08
SCN5A O 0 0.0019494579173624516
. O 0 2.374177256569965e-06

We O 0 9.682503332442138e-08
have O 0 9.41342226390418e-10
now O 0 3.5382707874731523e-10
identified O 0 4.725536073557635e-10
a O 0 3.253433911165615e-10
missense O 0 6.144873623270541e-07
mutation O 0 4.390946273247209e-09
, O 0 3.986849739234799e-11
a O 0 6.512081845988504e-11
splice O 0 1.4589822683319653e-07
- O 0 2.8917579442122587e-08
donor O 0 3.217531796551043e-09
mutation O 0 2.607559446143881e-10
, O 0 9.862552398029467e-13
and O 0 1.6948999712398938e-12
a O 0 1.5856023091731508e-11
frameshift O 0 4.208491777291101e-09
mutation O 0 7.335219237569746e-11
in O 0 3.982001187119444e-11
the O 0 8.744031193552715e-11
coding O 0 1.0308259801306008e-09
region O 0 6.390321605209692e-10
of O 0 4.303620571022293e-09
SCN5A O 1 0.9965421557426453
in O 0 1.6742884412224157e-08
three O 0 7.871696183769927e-09
IVF B-Disease 1 1.0
families O 0 7.783877542522077e-09
. O 0 1.321906850648702e-08

We O 0 6.12178041592415e-08
show O 0 5.557347915186028e-10
that O 0 4.982670959857716e-12
sodium O 0 4.324768099195353e-09
channels O 0 2.779382557438481e-10
with O 0 4.451393247062452e-12
the O 0 2.152404476873926e-09
missense O 0 7.846537073419313e-07
mutation O 0 8.63907079207138e-09
recover O 0 1.5856290502824777e-08
from O 0 9.989769428342399e-11
inactivation O 0 3.920235371879244e-07
more O 0 2.174088513384742e-11
rapidly O 0 1.12397768869954e-09
than O 0 1.1248601876345798e-11
normal O 0 1.4881335053118505e-10
and O 0 7.23110026717988e-12
that O 0 2.1581235062906323e-12
the O 0 8.572620946445397e-10
frameshift O 0 4.3764504908949675e-08
mutation O 0 2.2249251052652852e-10
causes O 0 1.0471145478474497e-10
the O 0 1.7007177610661728e-10
sodium O 0 5.550485848715425e-09
channel O 0 1.2333084553617368e-10
to O 0 8.298454805266697e-12
be O 0 8.98270624549724e-11
non O 0 9.85529808872343e-08
- O 0 2.0791186727819877e-07
functional O 0 4.66556770106763e-07
. O 0 4.4505107155146106e-08

Our O 0 1.2236108659635647e-07
results O 0 8.214641411541379e-09
indicate O 0 2.556072686843436e-09
that O 0 4.696627114997298e-11
mutations O 0 1.3745231619566312e-09
in O 0 8.028876452570444e-10
cardiac O 0 8.402088838010968e-07
ion O 0 9.728149734655744e-07
- O 0 0.00023344902729149908
channel O 0 1.2834790119597983e-08
genes O 0 5.8451472828569e-11
contribute O 0 4.148070342074872e-12
to O 0 6.333067317093599e-12
the O 0 1.8243880017809744e-10
risk O 0 2.3308002194966093e-09
of O 0 3.3691736067709144e-09
developing O 0 1.3577842992162914e-06
IVF B-Disease 1 1.0
. O 0 3.2342200029233936e-08
. O 0 2.713153257616341e-08

Molecular O 0 3.695999112096615e-06
heterogeneity O 0 5.55579617866897e-06
in O 0 2.2966409574110003e-07
mucopolysaccharidosis B-Disease 1 0.9999912977218628
IVA I-Disease 1 1.0
in O 0 2.2441882663315482e-07
Australia O 0 2.038104129908902e-09
and O 0 7.66504845706173e-11
Northern O 0 1.0877313494361829e-09
Ireland O 0 1.9498760384095704e-09
: O 0 1.5274881359772507e-10
nine O 0 1.0524792148913775e-09
novel O 0 8.832877207431977e-10
mutations O 0 4.677629464322486e-11
including O 0 2.057137619970728e-11
T312S O 0 1.1852858960992307e-07
, O 0 5.70555304391096e-11
a O 0 3.3398412507823494e-11
common O 0 2.651677100118377e-09
allele O 0 1.432656770994356e-09
that O 0 1.5304328984666604e-11
confers O 0 8.19864443002416e-09
a O 0 1.4933289049778864e-09
mild O 0 8.387314665014856e-06
phenotype O 0 4.588114461512305e-05
. O 0 4.912651547783753e-07

Mucopolysaccharidosis B-Disease 1 0.9999995231628418
IVA I-Disease 1 1.0
( O 0 0.0020551281049847603
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.612208031635646e-09
is O 0 8.013634894554755e-11
an O 0 8.928813938213764e-11
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.038294067257084e-05
by O 0 3.609237708701585e-08
a O 0 5.108568643663602e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 6.105886285467932e-08
N O 0 5.8369675315361746e-08
- O 0 7.200862484069148e-08
acetylgalactosamine O 0 4.012675162812229e-06
- O 0 3.67994317684861e-07
6 O 0 6.62004353557677e-08
- O 0 4.3735632004882063e-08
sulfate O 0 4.6140758058754727e-07
sulfatase O 0 0.00013345615298021585
( O 0 8.334300360957059e-09
GALNS O 1 0.9823399782180786
) O 0 1.6452965212465642e-08
. O 0 1.1419891876585098e-07

Previous O 0 4.919994012198003e-07
studies O 0 1.001540095302289e-08
of O 0 2.3558335282558573e-09
patients O 0 8.752248703558507e-09
from O 0 2.4438806880966446e-11
a O 0 1.008679771652421e-11
British O 0 1.4048877616801292e-09
- O 0 3.607186727094813e-08
Irish O 0 2.737297499777469e-08
population O 0 8.551153708735715e-12
showed O 0 2.1046513056649507e-12
that O 0 8.083101245628943e-14
the O 0 4.415734791707315e-11
I113F O 0 6.731583113150919e-08
mutation O 0 1.830096768573597e-10
is O 0 8.986003672932508e-13
the O 0 3.553111580997803e-12
most O 0 2.9785366881251996e-12
common O 0 3.2706108654689814e-11
single O 0 8.772546578050822e-11
mutation O 0 1.1848677594628043e-09
among O 0 4.0863068484497944e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.5069219470024109
and O 0 3.382964741671657e-10
produces O 0 2.3239049573575699e-10
a O 0 1.2612749733520445e-10
severe O 0 1.99395162781002e-06
clinical O 0 0.00028516509337350726
phenotype O 0 2.937775025202427e-05
. O 0 1.8918515820587345e-07

We O 0 7.297217763380104e-08
studied O 0 6.995387735742042e-08
mutations O 0 5.351163512301582e-09
in O 0 9.208735440857652e-10
the O 0 6.4651839437601666e-09
GALNS O 0 0.049791090190410614
gene O 0 2.0437915804194517e-09
from O 0 8.187045485996691e-10
23 O 0 4.800952968508909e-09
additional O 0 7.780211142005555e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.9999972581863403
( O 0 6.191725604454135e-11
15 O 0 1.9882569202156475e-10
from O 0 3.240878052035434e-11
Australia O 0 6.21000958989093e-11
, O 0 1.850583488532953e-12
8 O 0 3.086981018030066e-11
from O 0 2.777711914647707e-11
Northern O 0 8.044481747404575e-10
Ireland O 0 6.692250087425577e-10
) O 0 1.0673389255755339e-11
, O 0 4.719190316304633e-12
with O 0 1.757854820906568e-12
various O 0 9.92459447957117e-10
clinical O 0 5.9004501963499933e-05
phenotypes O 0 0.006444523576647043
( O 0 4.136991194059192e-09
severe O 0 0.002104870742186904
, O 0 1.7578540845164525e-09
16 O 0 6.863796198075534e-10
cases O 0 1.442246599925312e-10
; O 0 2.5039649173552725e-11
intermediate O 0 3.4479860460123746e-06
, O 0 1.8789634778637598e-11
4 O 0 7.685939384938223e-11
cases O 0 1.98501232812065e-11
; O 0 4.639953699037136e-11
mild O 0 2.00498857338971e-06
, O 0 1.6492295307202198e-09
3 O 0 8.901716697096163e-09
cases O 0 2.5701718531223605e-09
) O 0 5.088340859771279e-10
. O 0 3.2737609956257074e-08

We O 0 1.9116565397325758e-07
found O 0 9.535423117768005e-09
two O 0 5.396649793709685e-10
common O 0 9.993589955570314e-09
mutations O 0 1.0935142791268504e-09
that O 0 9.729358811660926e-12
together O 0 4.0471161144584045e-11
accounted O 0 2.5686524018908585e-09
for O 0 1.7607859614798826e-10
32 O 0 2.030444923306618e-09
% O 0 1.390474801271635e-11
of O 0 3.221440475487114e-11
the O 0 2.3527879644547056e-10
44 O 0 1.6133436808729584e-09
unrelated O 0 6.203102476121103e-09
alleles O 0 8.733201939392643e-10
in O 0 3.541734683309983e-10
these O 0 1.116727266214923e-09
patients O 0 5.077177789303278e-08
. O 0 2.664901721516344e-08

One O 0 3.760651878792487e-08
is O 0 3.556797079085072e-10
the O 0 1.2517753500418394e-09
T312S O 0 8.027473654692585e-07
mutation O 0 3.20884741000782e-09
, O 0 1.4926497537981476e-11
a O 0 2.367750787102274e-11
novel O 0 4.266449860068633e-09
mutation O 0 5.11662268110058e-10
found O 0 1.660990268936846e-11
exclusively O 0 5.4586571374137804e-11
in O 0 1.3493746398030027e-10
milder O 1 0.9601258635520935
patients O 1 0.9999738931655884
. O 0 3.3937469652300933e-06

The O 0 1.584270705734525e-07
other O 0 1.0724947596685297e-09
is O 0 2.5530053765487892e-11
the O 0 7.920801514682552e-11
previously O 0 2.356951578352806e-10
described O 0 4.0707928694594386e-10
I113F O 0 3.087954780767177e-07
that O 0 3.8072114905141063e-11
produces O 0 9.221882701915263e-10
a O 0 7.767825827009744e-10
severe O 0 2.2036088921595365e-05
phenotype O 0 0.0015649988781660795
. O 0 1.2849139920945163e-06

The O 0 5.056342615716858e-07
I113F O 0 1.1338688636897132e-05
and O 0 1.4193139996621085e-08
T312S O 0 2.7563869480218273e-06
mutations O 0 2.8914530769696967e-09
accounted O 0 4.025626054726672e-09
for O 0 2.7889573983586047e-10
8 O 0 1.6293137505840605e-08
( O 0 2.3916526745160205e-11
18 O 0 2.684775735062317e-10
% O 0 1.1358988402654369e-11
) O 0 1.0468159542323385e-12
and O 0 5.0924552769116005e-11
6 O 0 1.1660337584373792e-08
( O 0 2.4855168270776495e-11
14 O 0 4.645127060776133e-10
% O 0 7.70016862772227e-12
) O 0 3.490093684974799e-13
of O 0 3.232531256558424e-11
44 O 0 7.970423210323929e-10
unrelated O 0 3.759258682123345e-09
alleles O 0 8.696184328194079e-10
, O 0 2.823938027862738e-10
respectively O 0 2.0553287072289095e-08
. O 0 5.595995844487334e-08

The O 0 2.4108953766699415e-07
relatively O 0 1.2920837377805583e-07
high O 0 1.5222377669488196e-07
residual O 0 3.423846010264242e-06
GALNS O 0 0.024555865675210953
activity O 0 6.45796376375074e-08
seen O 0 2.9176570048861095e-09
when O 0 4.524628172131173e-10
the O 0 1.493083989778654e-09
T312S O 0 3.5728274383473035e-07
mutant O 0 5.040204342776633e-08
cDNA O 0 5.522705137650519e-08
is O 0 6.939328556221369e-10
overexpressed O 0 5.468085078064178e-07
in O 0 4.3755443712711894e-10
mutant O 0 1.9155386166147537e-09
cells O 0 5.487154827732432e-11
provides O 0 6.414686490319177e-13
an O 0 2.3481027235441876e-14
explanation O 0 9.30720518016459e-12
for O 0 6.330313877256355e-12
the O 0 9.00585328533765e-10
mild O 0 6.568932440131903e-05
phenotype O 0 5.586010047409218e-06
in O 0 4.392202601621875e-09
patients O 0 1.991324438677111e-09
with O 0 3.056151685887354e-12
this O 0 2.8789814976448724e-10
mutation O 0 2.409917776446946e-08
. O 0 4.737507453000944e-08

The O 0 1.6926708923392653e-08
distribution O 0 1.394268589471892e-09
and O 0 7.670079155142062e-11
relative O 0 1.0721307175387551e-09
frequencies O 0 2.0217026663882365e-10
of O 0 1.8540548263334955e-10
the O 0 1.1176755077002554e-09
I113F O 0 5.701405711988627e-07
and O 0 2.54976684210817e-09
T312S O 0 6.673225243503111e-07
mutations O 0 2.2549389022685773e-09
in O 0 1.6259281421238114e-10
Australia O 0 1.1471844307830992e-10
corresponded O 0 6.566587551493086e-11
to O 0 2.073904936672477e-11
those O 0 5.746892545177573e-11
observed O 0 3.4934685699816725e-10
in O 0 4.609294612656356e-10
Northern O 0 6.695112908516876e-09
Ireland O 0 1.5011307752388348e-09
and O 0 1.20839782624671e-10
are O 0 1.606941836540532e-11
unique O 0 3.2166391078503054e-11
to O 0 9.666615598258321e-12
these O 0 1.161338178401472e-10
two O 0 3.649813090644827e-11
populations O 0 1.0200156691508866e-10
, O 0 2.9651706437427983e-12
suggesting O 0 5.231148153539422e-11
that O 0 2.671848419594225e-12
both O 0 3.941153306485923e-11
mutations O 0 1.46361811559359e-10
were O 0 7.84113773910633e-10
probably O 0 6.165212784736696e-10
introduced O 0 2.688803624195657e-10
to O 0 1.8128984424770067e-11
Australia O 0 3.079811752848549e-11
by O 0 1.6430112478871273e-11
Irish O 0 3.0274438511668222e-09
migrants O 0 1.10794526331226e-10
during O 0 5.038649358857228e-11
the O 0 1.3224603356842835e-10
19th O 0 2.3336043852850707e-07
century O 0 4.016752882307628e-06
. O 0 4.192550875359302e-07

Haplotype O 0 1.823348270590941e-06
analysis O 0 1.501956425897788e-08
using O 0 1.5825078136799675e-08
6 O 0 4.58731165053905e-07
RFLPs O 0 3.305821883259341e-05
provides O 0 7.038396532266233e-10
additional O 0 6.391635137825702e-11
data O 0 5.462948149403957e-11
that O 0 1.727761922247495e-12
the O 0 3.375488222268075e-10
I113F O 0 2.0713586934562045e-07
mutation O 0 1.230273438679319e-09
originated O 0 2.3752336208993086e-10
from O 0 1.4625011271474087e-11
a O 0 2.5178054086083534e-11
common O 0 4.805882358738245e-09
ancestor O 0 5.777834530817927e-07
. O 0 2.084809125335596e-07

The O 0 1.1782840374507941e-06
other O 0 2.993915870774799e-08
9 O 0 6.000805115036201e-07
novel O 0 2.7524129109224305e-07
mutations O 0 6.0172782312406525e-09
identified O 0 6.203513258640214e-10
in O 0 1.2045732467047543e-10
these O 0 1.5283740939509016e-10
23 O 0 9.435609626962105e-09
patients O 0 8.498226122810593e-09
were O 0 1.4381042190425575e-10
each O 0 2.269818447780958e-12
limited O 0 5.3505661706809704e-11
to O 0 2.7641501934572155e-11
a O 0 7.412026548081485e-10
single O 0 3.278697491282401e-08
family O 0 6.029766463910846e-09
. O 0 3.0999249389651595e-08

These O 0 2.423307776666661e-08
data O 0 2.9348645735893797e-09
provide O 0 5.1115479904328964e-11
further O 0 3.046742372281308e-11
evidence O 0 4.0041511772948013e-10
for O 0 8.540433638071221e-11
extensive O 0 5.78929046923804e-08
allelic O 0 4.266592441126704e-06
heterogeneity O 0 3.7864149362576427e-06
in O 0 8.931821184887667e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.43713974054549e-09
British O 0 2.3492734424479522e-09
- O 0 1.4025832051345333e-08
Irish O 0 2.8030285648128483e-08
patients O 0 9.53191392483177e-09
and O 0 6.753819292021346e-12
provide O 0 1.5613136868444788e-12
evidence O 0 1.0354044011062769e-11
for O 0 2.97174021501867e-11
their O 0 6.754367620764867e-10
transmission O 0 1.3615132354871662e-09
to O 0 2.0293201147270068e-11
Australia O 0 1.0888012713650141e-11
by O 0 3.4640977152750052e-12
British O 0 5.297560723427353e-10
- O 0 9.030971526158282e-09
Irish O 0 1.3042753543857089e-08
migrants O 0 3.1410365974871013e-10
. O 0 5.5848981689310406e-11
. O 0 1.556745732322895e-09

Identification O 0 5.589360512203712e-07
of O 0 2.16538524000498e-07
constitutional O 0 0.0009464509785175323
WT1 O 1 0.9999997615814209
mutations O 0 2.2369220005202806e-06
, O 0 1.2625560597001595e-09
in O 0 1.1644307740255044e-09
patients O 0 2.4017499100636996e-08
with O 0 3.162606010409519e-10
isolated O 0 0.0001006190650514327
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.527753644760878e-09
and O 0 2.6766852623261173e-11
analysis O 0 2.2381100445167945e-11
of O 0 4.0054193295446794e-10
genotype O 0 2.2864591642246523e-07
/ O 0 3.581286733833622e-08
phenotype O 0 3.5383536101107893e-09
correlations O 0 1.0413545026288773e-10
by O 0 1.3634992657510225e-12
use O 0 1.4722351809881573e-11
of O 0 2.76429934498168e-10
a O 0 1.099126789583238e-09
computerized O 0 3.3064227409340674e-06
mutation O 0 6.802532936944772e-08
database O 0 4.3251251469200724e-08
. O 0 3.7029838750868294e-08

Constitutional O 0 1.0901580935751554e-05
mutations O 0 2.2205844629752391e-07
of O 0 1.0810681771999953e-07
the O 0 2.3090889555987815e-07
WT1 O 0 0.00019869829702656716
gene O 0 1.0554972895704395e-08
, O 0 2.1860985244259723e-10
encoding O 0 6.339506697372599e-09
a O 0 6.817351128063365e-09
zinc O 0 9.229694842360914e-05
- O 0 6.80912344250828e-05
finger O 0 1.0523783657845343e-06
transcription O 0 1.8899456222243316e-07
factor O 0 1.6542079706027835e-08
involved O 0 2.898386530780783e-10
in O 0 4.773259565382659e-09
renal O 1 1.0
and O 0 3.1815682177693816e-07
gonadal O 1 0.7395792603492737
development O 0 1.0756203892015037e-06
, O 0 9.791692456850853e-11
are O 0 9.545653330278459e-12
found O 0 1.0713487388902543e-11
in O 0 1.0386622117941613e-11
most O 0 1.2330543530669758e-10
patients O 0 1.0431679964284513e-09
with O 0 1.1148453687992443e-10
Denys B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5354736149220116e-07
DDS B-Disease 1 1.0
) O 0 5.11573450268088e-10
, O 0 9.057407601709144e-11
or O 0 6.360410864658661e-09
diffuse B-Disease 1 0.9999985694885254
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 8.113598255476973e-07
DMS B-Disease 1 0.5247763991355896
) O 0 5.261447874604919e-11
associated O 0 2.1960532003983957e-10
with O 0 7.33558283561031e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 6.756988000233832e-07
/ O 0 0.00031884314375929534
or O 0 1.7156239664473105e-06
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9995254278182983
( O 0 1.2524446368900044e-08
WT B-Disease 1 1.0
) O 0 8.73577121751623e-09
. O 0 4.430082611861508e-08

Most O 0 3.1074674211595266e-07
mutations O 0 9.223702335248163e-08
in O 0 6.343222480609256e-08
DDS B-Disease 1 1.0
patients O 1 0.9999961853027344
lie O 0 4.306381526930636e-07
in O 0 3.900921807797886e-09
exon O 0 1.0638228076231826e-07
8 O 0 1.387099501926059e-08
or O 0 8.921616778678754e-10
exon O 0 1.2859041476076527e-07
9 O 0 1.7905502858184263e-08
, O 0 4.953802368312665e-10
encoding O 0 4.438049927557586e-07
zinc O 0 0.031614039093256
finger O 0 0.00018676475156098604
2 O 0 0.00013942665827926248
or O 0 7.972679441081709e-07
zinc O 0 0.0030689965933561325
finger O 0 1.5980459693309967e-06
3 O 0 6.861458956564093e-08
, O 0 5.616764345295344e-11
respectively O 0 4.98444452379232e-10
, O 0 7.906925982015256e-12
with O 0 2.950907747323317e-12
a O 0 1.007803354657888e-10
hot O 0 9.292574759456329e-06
spot O 0 9.44360749599582e-08
( O 0 2.0225114985561454e-11
R394W O 0 1.894837531324356e-08
) O 0 3.409834220535757e-11
in O 0 1.2650724912077749e-09
exon O 0 2.2192740800619504e-07
9 O 0 1.6225847332407284e-07
. O 0 1.391222923530222e-07

We O 0 3.105322221585993e-08
analyzed O 0 1.555437734168663e-08
a O 0 4.1623643420862777e-10
series O 0 6.107488403905847e-10
of O 0 5.915020695468343e-10
24 O 0 1.0313968346054025e-08
patients O 0 6.353793224889159e-08
, O 0 3.63795590874183e-11
10 O 0 8.857908850856688e-11
with O 0 8.121934375049378e-11
isolated B-Disease 0 2.0316321752034128e-05
DMS I-Disease 1 1.0
( O 0 5.366193363443017e-06
IDMS B-Disease 1 1.0
) O 0 2.7351823028709532e-09
, O 0 1.2977749430653773e-10
10 O 0 1.4712421558815691e-10
with O 0 6.347412873086711e-11
DDS B-Disease 1 1.0
, O 0 1.7125085793878725e-09
and O 0 2.7825439175011013e-10
4 O 0 4.213109860984332e-09
with O 0 1.9079640645180973e-10
urogenital B-Disease 0 0.013635924085974693
abnormalities I-Disease 0 0.00015021163562778383
and O 0 3.224451745609258e-07
/ O 0 0.00014983696746639907
or O 0 1.1178741260664538e-05
WT B-Disease 1 1.0
. O 0 1.1291082273601205e-06

We O 0 8.685200327818166e-07
report O 0 4.740870451769297e-07
WT1 O 1 0.8859665989875793
heterozygous O 0 1.296158075092535e-06
mutations O 0 1.4734566455842923e-08
in O 0 5.612419418099535e-10
16 O 0 1.6534382751842713e-08
patients O 0 1.0704659381133297e-08
, O 0 2.4606018611539326e-11
4 O 0 2.1853325815612834e-09
of O 0 3.3331242210721257e-09
whom O 0 6.100762117711156e-09
presented O 0 8.202542289836856e-08
with O 0 2.0115772159101653e-08
IDMS B-Disease 1 0.9999948740005493
. O 0 6.850618774478789e-06

One O 0 8.523001326921076e-08
male O 0 9.212218543552808e-09
and O 0 2.254202519091919e-10
two O 0 2.2533513943656658e-10
female O 0 7.649691546873782e-09
IDMS B-Disease 1 0.999997615814209
patients O 0 0.0009041864541359246
with O 0 3.286461947027419e-07
WT1 O 1 1.0
mutations O 0 5.933939610258676e-05
underwent O 0 0.00014810542052146047
normal O 0 6.8540430220309645e-06
puberty O 0 7.195564830908552e-05
. O 0 2.1723472798385046e-07

Two O 0 4.3964172391497414e-07
mutations O 0 6.208171043908806e-08
associated O 0 2.0412487700127713e-08
with O 0 5.8189009166653705e-09
IDMS B-Disease 1 0.9999998807907104
are O 0 9.80552750107222e-10
different O 0 3.560847797179356e-11
from O 0 3.4128404963196246e-11
those O 0 1.593056415949423e-11
described O 0 8.347978419642743e-10
in O 0 2.194497916718774e-08
DDS B-Disease 1 1.0
patients O 1 0.9996509552001953
. O 0 3.4542748039712023e-07

No O 0 1.1314923540339805e-05
WT1 O 0 0.006639351136982441
mutations O 0 1.9516151894549694e-07
were O 0 7.471388840940563e-09
detected O 0 7.462444884254182e-09
in O 0 2.7460222984387883e-10
the O 0 1.7763442938800722e-09
six O 0 3.2695286478201524e-09
other O 0 2.309158730895433e-08
IDMS B-Disease 1 1.0
patients O 1 0.9990668892860413
, O 0 8.010674346081714e-10
suggesting O 0 4.061147418354949e-09
genetic O 0 1.7579287359126283e-08
heterogeneity O 0 1.4039916607089253e-07
of O 0 1.1782089082146285e-08
this O 0 1.3586604730164709e-08
disease O 0 2.9272399842739105e-05
. O 0 3.614611614466412e-07

We O 0 1.895096772841498e-07
analyzed O 0 4.3018829387619917e-07
genotype O 0 7.4925428634742275e-06
/ O 0 1.0728840607043821e-06
phenotype O 0 2.599537936021079e-07
correlations O 0 1.8279775915175378e-08
, O 0 1.1468798133407176e-11
on O 0 1.6503290053981878e-11
the O 0 5.8998942883969896e-12
basis O 0 2.0767864858384222e-11
of O 0 2.4803025952535585e-11
the O 0 8.24184678838158e-11
constitution O 0 3.6713193596327187e-10
of O 0 6.733391177959902e-09
a O 0 8.268653317600183e-09
WT1 O 0 9.202125511365011e-05
mutation O 0 7.299177262609646e-09
database O 0 1.3270446963531413e-09
of O 0 1.117117065518869e-09
84 O 0 3.798882630690059e-08
germ O 0 0.00011178368731634691
- O 0 9.76530554908095e-06
line O 0 1.2314041669014841e-05
mutations O 0 5.181244766561122e-09
, O 0 1.8713667768177622e-11
to O 0 1.113176825023876e-11
compare O 0 3.987992991394407e-10
the O 0 4.641564563256928e-11
distribution O 0 2.6946601200394937e-11
and O 0 4.617323884348323e-12
type O 0 7.527456435951763e-10
of O 0 1.5832618549538324e-09
mutations O 0 2.7050170436915266e-10
, O 0 3.4595681354387953e-12
according O 0 2.097250845212173e-11
to O 0 1.0440945850953565e-11
the O 0 9.335001660559783e-10
different O 0 9.780465326514332e-09
symptoms O 0 5.191225136513822e-05
. O 0 1.6756242757764994e-06

This O 0 2.8189251821686412e-08
demonstrated O 0 2.1462361132762453e-07
( O 0 1.996290077688201e-10
1 O 0 4.138198672620774e-09
) O 0 4.06593300694702e-11
the O 0 5.209901399183536e-10
association O 0 3.453941022080187e-10
between O 0 4.555308075193665e-10
mutations O 0 2.017912947849254e-09
in O 0 6.768504867693537e-09
exons O 0 4.0955708158207926e-08
8 O 0 5.131079117148829e-09
and O 0 1.903435048467017e-10
9 O 0 1.3470180526553577e-08
and O 0 9.615486185055033e-10
DMS B-Disease 0 0.03478560596704483
; O 0 5.733781449634989e-09
( O 0 3.231521994440101e-10
2 O 0 5.495612409589512e-09
) O 0 2.4496021530651113e-11
among O 0 1.833401902517906e-10
patients O 0 6.081020686998784e-10
with O 0 1.3935652978802615e-11
DMS B-Disease 0 5.93352087889798e-05
, O 0 7.59193402588565e-11
a O 0 1.3226766903962073e-11
higher O 0 2.4669047360426077e-10
frequency O 0 9.429627217949488e-11
of O 0 4.0571040971215666e-10
exon O 0 1.768320068151752e-08
8 O 0 3.865879616427037e-09
mutations O 0 9.466520900502928e-10
among O 0 2.7808089164693683e-10
46 O 0 4.944638920534317e-09
, O 0 9.59187507199033e-10
XY O 0 3.6050194466952235e-05
patients O 0 7.753992292691692e-08
with O 0 3.447068672168818e-11
female O 0 2.762749473639303e-10
phenotype O 0 4.240310769176858e-09
than O 0 7.441770116800583e-11
among O 0 1.8236226417833734e-10
46 O 0 2.5672419745603747e-09
, O 0 4.91025775595233e-10
XY O 0 0.00018448755145072937
patients O 0 3.2526870086257986e-07
with O 0 3.614026786169511e-11
sexual O 0 7.362935261490122e-10
ambiguity O 0 2.1363398161611258e-08
or O 0 4.2486654194817675e-09
male O 0 7.570508664400677e-10
phenotype O 0 5.267625780014384e-10
; O 0 1.2666962964646977e-11
and O 0 5.730014379645709e-11
( O 0 7.282701351696286e-12
3 O 0 5.437378325368059e-10
) O 0 5.982913383467681e-12
statistically O 0 4.2275790507195765e-11
significant O 0 3.6011454235262974e-11
evidence O 0 3.578224661016094e-10
that O 0 3.0006743617638776e-11
mutations O 0 2.671027177214569e-09
in O 0 1.5059379521176197e-08
exons O 0 1.128203450662113e-07
8 O 0 1.6644051470393606e-08
and O 0 2.469583704201028e-10
9 O 0 3.54352036602279e-09
preferentially O 0 2.5059740949018305e-09
affect O 0 7.347643049548935e-10
amino O 0 4.018351207335513e-10
acids O 0 9.083928748099268e-11
with O 0 5.699100479733543e-12
different O 0 4.642060000281667e-11
functions O 0 1.393954118800167e-10
. O 0 1.3409164889566227e-09
. O 0 2.1579300124585643e-08

The O 0 7.120919235603651e-06
185delAG O 0 8.907914161682129e-05
BRCA1 O 0 2.0911800220346777e-06
mutation O 0 3.6136307279832636e-09
originated O 0 7.834485837854288e-10
before O 0 6.864342427803649e-11
the O 0 9.671115470955005e-12
dispersion O 0 1.7355196169077658e-09
of O 0 2.294423540050161e-09
Jews O 0 4.797932273703509e-09
in O 0 9.999071709509977e-11
the O 0 2.5128843450517024e-10
diaspora O 0 3.220293198769042e-10
and O 0 7.445600559707888e-12
is O 0 1.8197431408961684e-12
not O 0 1.0600715617814505e-11
limited O 0 1.1323546544872443e-09
to O 0 4.4135504140285775e-09
Ashkenazim O 0 0.00026197993429377675
. O 0 5.755933898399235e-07

The O 0 1.7565402288255427e-07
185delAG O 0 2.370783477090299e-06
mutation O 0 3.80653446541146e-08
in O 0 4.828972777204399e-09
BRCA1 O 0 7.892052344971034e-09
is O 0 6.378430335990393e-12
detected O 0 5.710052430885071e-10
in O 0 9.426750352536928e-11
Ashkenazi O 0 3.1338228012600666e-08
Jews O 0 3.9358161174618544e-09
both O 0 1.5778466033733451e-10
in O 0 6.532067331477265e-09
familial B-Disease 1 0.99498450756073
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.7559907972142241e-09
in O 0 1.0419148183116178e-10
the O 0 2.896596018597819e-10
general O 0 8.862515166185858e-09
population O 0 1.7758555737046322e-10
. O 0 2.792056363887241e-09

All O 0 9.23581424672193e-08
tested O 0 3.2364451385547e-07
Ashkenazi O 0 4.0857446492736926e-07
mutation O 0 1.0568509622999045e-08
carriers O 0 3.930737513258009e-09
share O 0 2.5738497444471875e-10
the O 0 1.0344317069588271e-10
same O 0 1.9506785076117694e-10
allelic O 0 7.155735204378288e-08
pattern O 0 5.5360223072398185e-09
at O 0 7.218984521273342e-09
the O 0 3.0999899536254816e-08
BRCA1 O 0 4.11601092764613e-07
locus O 0 7.917640942878279e-08
. O 0 4.422256694169846e-08

Our O 0 4.880481583313667e-07
previous O 0 4.2961758595083666e-08
study O 0 1.6133222535685832e-09
showed O 0 6.860598894542491e-11
that O 0 4.638586064732719e-13
this O 0 6.117161638341528e-11
Ashkenazi O 0 2.630606843467831e-07
mutation O 0 2.080055017117388e-09
also O 0 5.6309423270006764e-12
occurs O 0 1.4264548743592176e-11
in O 0 5.448626359122466e-12
Iraqi O 0 5.325935872879661e-11
Jews O 0 3.2369257274567076e-10
with O 0 4.04958531985411e-12
a O 0 7.832808013308323e-11
similar O 0 3.2721614307007485e-09
allelic O 0 2.6495101792534115e-06
pattern O 0 4.058927629557729e-07
. O 0 1.5584107870836306e-07

We O 0 2.7409388536625556e-08
extended O 0 4.123160124436254e-08
our O 0 8.777689131100885e-10
analysis O 0 1.4600379238949301e-10
to O 0 3.415445010146456e-11
other O 0 1.8569319693018116e-10
non O 0 5.344627496128851e-08
- O 0 6.933684915111371e-08
Ashkenazi O 0 1.0605972988741996e-07
subsets O 0 2.0903012654116537e-08
354 O 0 5.7156781529954515e-09
of O 0 8.619837482681802e-11
Moroccan O 0 2.0416603963013813e-09
origin O 0 1.744519390056709e-10
, O 0 2.042889295228445e-11
200 O 0 4.899797789725824e-10
Yemenites O 0 2.5597483954697964e-07
and O 0 9.840858683496378e-11
150 O 0 6.351715819974402e-10
Iranian O 0 8.072305490713916e-09
Jews O 0 8.848398636018828e-08
. O 0 4.5608246068695735e-08

Heteroduplex O 0 5.747686736867763e-05
analysis O 0 2.5645809031971112e-08
complemented O 0 9.031887060473309e-08
by O 0 8.306397236701457e-10
direct O 0 2.2646411412807765e-09
DNA O 0 8.393342021406625e-09
sequencing O 0 2.7952497205774307e-08
of O 0 4.1703369646484134e-09
abnormally O 0 5.0966313835942856e-08
migrating O 0 6.661688534137511e-09
bands O 0 4.153745347679205e-09
were O 0 6.132023777638551e-10
employed O 0 1.1967974167248485e-08
. O 0 2.995320969034765e-08

Four O 0 5.948334802496902e-08
of O 0 1.0605260669649397e-08
Moroccan O 0 3.7760122495456017e-07
origin O 0 1.52656340901558e-08
( O 0 2.7082216677576376e-11
1 O 0 3.3650168762555666e-10
. O 0 7.669900305151689e-12
1 O 0 1.2623507794629063e-10
% O 0 2.5488684513713666e-12
) O 0 2.84273445711955e-13
and O 0 3.790688683086296e-12
none O 0 1.2153136830228561e-10
of O 0 4.5336731591127943e-10
the O 0 8.765614900596574e-09
Yemenites O 0 8.801268450042699e-06
or O 0 4.2984169001947237e-10
Iranians O 0 1.1242156094937172e-09
was O 0 1.8501160325978816e-10
a O 0 6.286396750376788e-12
carrier O 0 1.71529290771133e-10
of O 0 1.9466904477294378e-10
the O 0 2.7064430696555064e-09
185delAG O 0 1.2974008996025077e-06
mutation O 0 9.81434880031884e-08
. O 0 5.846426986977349e-08

BRCA1 O 0 0.00021011914941482246
allelic O 0 8.895015525922645e-06
patterns O 0 3.2695613327859974e-08
were O 0 2.8994500134160717e-09
determined O 0 4.1361605807033186e-10
for O 0 7.131581436503609e-11
four O 0 4.31291773128617e-11
of O 0 1.5396035835113508e-10
these O 0 2.1870191421746732e-11
individuals O 0 3.1730557851356034e-12
and O 0 7.0738931205738265e-12
for O 0 9.345557314133224e-12
12 O 0 7.270491847455318e-11
additional O 0 5.409962061664331e-11
non O 0 4.7242050271734115e-09
- O 0 6.7735936859492085e-09
Ashkenazi O 0 9.793924782286467e-09
185delAG O 0 1.3011744570690098e-08
mutation O 0 1.1500024266197784e-09
carriers O 0 1.9673704887424037e-09
who O 0 2.639685692251703e-10
had O 0 2.3809562321730482e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.4688495361479e-05

Six O 0 8.464999723400979e-07
non O 0 3.257453499827534e-06
- O 0 1.7562950915817055e-06
Ashkenazi O 0 5.936999514233321e-07
individuals O 0 2.4425958478069276e-10
shared O 0 5.290189952766866e-10
the O 0 2.068509391550677e-10
common O 0 7.194818962830141e-09
Ashkenazi O 0 6.8810784625839e-08
haplotype O 0 6.984106626362063e-09
, O 0 1.4043780027783725e-10
four O 0 1.0535573108372276e-10
had O 0 7.951241748349602e-11
a O 0 2.717447447619925e-11
closely O 0 1.7178924949234897e-10
related O 0 4.045731749613424e-09
pattern O 0 1.1780966424623784e-08
, O 0 5.8875203323705e-11
and O 0 8.918464577956087e-11
the O 0 2.2358337403716178e-09
rest O 0 1.2878120791981473e-08
( O 0 1.5866035915634846e-11
n O 0 3.315508423362701e-10
= O 0 2.86661999693294e-10
6 O 0 7.834187187860664e-10
) O 0 6.975349117754881e-12
displayed O 0 9.043480408976734e-10
a O 0 8.986771882213418e-10
distinct O 0 5.806287362020157e-08
BRCA1 O 0 1.0017886324931169e-06
allelic O 0 4.671227088692831e-06
pattern O 0 5.996920435791253e-07
. O 0 2.1896400426157925e-07

We O 0 2.289978517922009e-08
conclude O 0 2.5829605121430177e-08
that O 0 3.5781544394097864e-11
the O 0 3.744574428310443e-09
185delAG O 0 2.9607404030684847e-06
BRCA1 O 0 1.7598685531083902e-07
mutation O 0 3.9586189881646305e-10
occurs O 0 2.693390996344469e-11
in O 0 9.59900301605865e-12
some O 0 1.8876778612453293e-11
non O 0 2.4030647693962237e-08
- O 0 3.1730266414342623e-07
Ashkenazi O 0 3.346688970395917e-07
populations O 0 3.608456033976637e-10
at O 0 4.320888438713588e-11
rates O 0 4.1414635609804407e-11
comparable O 0 1.4069624632018218e-10
with O 0 1.131077111311829e-12
that O 0 8.312094935958303e-12
of O 0 1.7575230160105093e-08
Ashkenazim O 0 0.000358303397661075
. O 0 1.9220252056584286e-07

The O 0 1.0995449883921538e-07
majority O 0 3.0673805717640334e-09
of O 0 4.2932821742169835e-09
Jewish O 0 1.4869722519961215e-07
185delAG O 0 2.461202370795945e-07
mutation O 0 3.28587046460882e-09
carriers O 0 6.535017527120601e-10
have O 0 1.5590528867903686e-11
a O 0 2.1534286506752487e-11
common O 0 2.421356670723185e-09
allelic O 0 9.009021795236549e-08
pattern O 0 2.854672276342285e-09
, O 0 2.1156923435405872e-11
supporting O 0 2.6372386913164902e-11
the O 0 2.5935320557834984e-10
founder O 0 1.0033584629809411e-08
effect O 0 3.4560911910119785e-09
notion O 0 1.50356154193787e-08
, O 0 1.0943185593803584e-11
but O 0 1.1139626547584935e-11
dating O 0 3.697475103869863e-10
the O 0 8.680387658666078e-11
mutations O 0 1.347123888134627e-11
origin O 0 2.080255412373333e-11
to O 0 3.4609144976965878e-12
an O 0 2.41632804260164e-13
earlier O 0 8.129497075515246e-11
date O 0 2.1421664442300425e-08
than O 0 4.2978515191194333e-10
currently O 0 1.8558415915137516e-10
estimated O 0 2.0206232520525447e-10
. O 0 1.0378220061113552e-08

However O 0 5.058754126707754e-08
, O 0 2.4752755400925253e-10
the O 0 1.3462511661010979e-10
different O 0 1.227998813746467e-10
allelic O 0 9.30358368123052e-08
pattern O 0 3.3887013195510463e-09
at O 0 4.580498647044351e-09
the O 0 7.364231446871372e-09
BRCA1 O 0 3.82524696362907e-08
locus O 0 7.843292126885615e-10
even O 0 9.057165434311898e-11
in O 0 3.311202700917448e-11
some O 0 1.8005959570577268e-11
Jewish O 0 1.2657073167332555e-09
mutation O 0 5.589917764781127e-11
carriers O 0 1.417440470552478e-10
, O 0 9.143722237703322e-12
might O 0 5.827825722004576e-11
suggest O 0 9.504345921396151e-11
that O 0 2.6578960386769435e-12
the O 0 3.44991146761231e-10
mutation O 0 1.1961439616570146e-09
arose O 0 6.648031014577782e-09
independently O 0 3.438218598716958e-10
. O 0 1.0022830343459077e-09
. O 0 1.6534382751842713e-08

Crystal O 0 2.4657911126269028e-06
structure O 0 9.667850520145294e-08
of O 0 4.537986058039678e-07
the O 0 7.027133506198879e-06
hemochromatosis B-Disease 1 1.0
protein O 0 2.4325096092070453e-05
HFE O 0 0.010233387351036072
and O 0 3.592791064654932e-10
characterization O 0 4.113771101543762e-09
of O 0 1.724360432220351e-09
its O 0 8.045494825914545e-10
interaction O 0 2.399157317256595e-09
with O 0 8.139928731054624e-10
transferrin O 0 5.832776878378354e-06
receptor O 0 8.321865152538521e-07
. O 0 1.3053546865648968e-07

HFE O 1 0.999981164932251
is O 0 4.531974440169506e-08
an O 0 1.7236896354688724e-09
MHC O 0 0.0006390881608240306
- O 0 6.390325870597735e-05
related O 0 1.132884335675044e-06
protein O 0 2.5272139936305393e-09
that O 0 1.3295102865851227e-12
is O 0 6.918805806055417e-13
mutated O 0 2.72263683820384e-10
in O 0 3.4989754149616914e-11
the O 0 3.6205434206237896e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.34609895944595337

HFE O 0 0.0036353387404233217
binds O 0 7.104193286977534e-07
to O 0 2.4711551915856944e-08
transferrin O 0 4.301072749512969e-06
receptor O 0 4.6024032940295e-07
( O 0 1.2268522864289366e-09
TfR O 0 3.7851049228265765e-07
) O 0 3.290219485752033e-11
and O 0 1.2199114114708198e-11
reduces O 0 4.1436462594468537e-10
its O 0 1.5758676308319508e-10
affinity O 0 1.7608809965707906e-09
for O 0 6.913012384757167e-10
iron O 0 1.052390052791452e-05
- O 0 9.112711722991662e-07
loaded O 0 2.3256505699009722e-07
transferrin O 0 6.254368258851173e-07
, O 0 8.564171594116488e-10
implicating O 0 2.439335275994381e-07
HFE O 1 0.998272180557251
in O 0 1.817755901356577e-06
iron O 1 0.9992203712463379
metabolism O 0 0.00047114049084484577
. O 0 5.99435281856131e-07

The O 0 5.9437461459310725e-06
2 O 0 8.352400982403196e-06
. O 0 8.772707928983436e-07

6 O 0 9.378863069287036e-06
A O 0 8.888741831469815e-08
crystal O 0 5.318802323017735e-07
structure O 0 3.9502813820035954e-07
of O 0 8.445481398666743e-06
HFE O 1 0.999997615814209
reveals O 0 1.980771990872654e-08
the O 0 6.921377360136205e-10
locations O 0 3.166434447976485e-09
of O 0 6.604027191770001e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 1.1717891084117582e-06
and O 0 1.6036375782846335e-08
a O 0 2.031452117634558e-09
patch O 0 1.0418866622785572e-05
of O 0 7.167650619521737e-05
histidines O 1 0.9361239671707153
that O 0 7.21011514381864e-11
could O 0 3.9068300677902457e-11
be O 0 6.498802364307554e-12
involved O 0 9.774520602634507e-12
in O 0 1.3207840376949775e-10
pH O 0 9.501881663709355e-07
- O 0 2.1770397324871738e-06
dependent O 0 1.4891932664795604e-07
interactions O 0 3.1345400941518164e-08
. O 0 5.639552469460796e-08

We O 0 2.3124826498133189e-07
also O 0 1.8594493722545735e-09
demonstrate O 0 1.4429517580794027e-09
that O 0 1.047134462472954e-10
soluble O 0 3.494681732263416e-05
TfR O 0 5.435510684037581e-05
and O 0 1.2829014295334673e-08
HFE O 0 1.2461307960620616e-05
bind O 0 2.5266981840132985e-09
tightly O 0 4.491595095856837e-09
at O 0 4.3266798477326063e-10
the O 0 2.0123540334093803e-10
basic O 0 2.82657963701638e-09
pH O 0 1.9720713950732716e-08
of O 0 6.958815745861102e-09
the O 0 6.933441043521782e-10
cell O 0 1.1846004732696258e-10
surface O 0 9.158581532053844e-11
, O 0 2.4516950969388773e-12
but O 0 4.2879805609019606e-12
not O 0 4.231255536918388e-12
at O 0 3.0719110588606213e-10
the O 0 3.3604244387142046e-10
acidic O 0 5.85367985195262e-08
pH O 0 2.454894172387867e-07
of O 0 1.808263228042506e-08
intracellular O 0 1.3108394369965026e-08
vesicles O 0 2.6589569301904703e-07
. O 0 8.095962300558313e-08

TfR O 0 0.009621744975447655
HFE O 1 0.5543392300605774
stoichiometry O 0 6.285736890276894e-05
( O 0 2.006560961831383e-08
2 O 0 1.8464726636580053e-08
1 O 0 8.419589470065603e-09
) O 0 3.1736870076404244e-11
differs O 0 5.397454927447143e-09
from O 0 1.6610489650403792e-09
TfR O 0 2.308728426214657e-06
transferrin O 0 5.261180149318534e-07
stoichiometry O 0 3.502703975755139e-07
( O 0 1.5130420527587063e-10
2 O 0 8.855514654904084e-10
2 O 0 3.211307331163482e-10
) O 0 6.192737295185324e-12
, O 0 6.95779631826321e-12
implying O 0 8.935611278682032e-11
a O 0 1.4649803939392747e-11
different O 0 1.6870053964890275e-11
mode O 0 2.8529141271604885e-09
of O 0 1.013184536269307e-10
binding O 0 1.1642353747731704e-09
for O 0 2.664483522707428e-09
HFE O 0 0.0009298126678913832
and O 0 2.4953852317821656e-09
transferrin O 0 1.8230686293918552e-07
to O 0 1.6157610804867772e-09
TfR O 0 7.458619393219124e-07
, O 0 3.059495365387299e-11
consistent O 0 4.190715552354618e-10
with O 0 6.096657900744873e-12
our O 0 2.9176111526751924e-10
demonstration O 0 8.02034083591252e-09
that O 0 4.612335166576109e-11
HFE O 0 6.429440691135824e-05
, O 0 6.613916636588613e-10
transferrin O 0 4.1536137018738373e-07
, O 0 2.0004675693741092e-10
and O 0 1.4636654388500148e-10
TfR O 0 1.9753001367917022e-07
form O 0 2.769355023080067e-10
a O 0 4.001135534004163e-10
ternary O 0 1.495963147135626e-06
complex O 0 5.261563728709007e-06
. O 0 6.864155466246302e-07

Identification O 0 6.074708949199703e-07
of O 0 1.1182265780007583e-07
three O 0 3.5907652407018986e-09
novel O 0 1.9169101861393756e-08
mutations O 0 3.3837652124724116e-10
and O 0 2.162285801798891e-11
a O 0 1.0196474740931105e-11
high O 0 2.340149185542373e-10
frequency O 0 6.777528538393085e-11
of O 0 1.0058062716034044e-10
the O 0 1.7435323185210905e-09
Arg778Leu O 0 2.9265006560308393e-06
mutation O 0 2.529572107334843e-09
in O 0 1.7568274612855816e-10
Korean O 0 5.4727600229398377e-08
patients O 0 2.8487652237174643e-09
with O 0 4.6163135813959144e-11
Wilson B-Disease 0 3.9558156572638836e-07
disease I-Disease 0 6.664054126304109e-07
. O 0 1.4995096364600613e-07

Four O 0 1.618092539956706e-07
mutations O 0 4.897632521760897e-09
- O 0 1.7674770091957726e-08
- O 0 4.1846092813102587e-08
R778L O 0 3.6032503203387023e-07
, O 0 8.404547197082834e-11
A874V O 0 2.2161096069339692e-08
, O 0 2.744910722329852e-11
L1083F O 0 1.732233201323652e-08
, O 0 1.2069093120736785e-11
and O 0 9.164185903187683e-12
2304delC O 0 3.3644216301809138e-09
- O 0 5.047763540488859e-09
- O 0 1.6333773444898725e-08
in O 0 7.704877291736523e-10
the O 0 9.030294845224773e-10
copper O 0 2.3040815477770593e-08
- O 0 1.6253337564720027e-09
transporting O 0 5.340548892007746e-09
enzyme O 0 7.456864015153997e-10
, O 0 4.846813575487552e-11
P O 0 2.1782389580948802e-07
- O 0 4.174994927552689e-08
type O 0 1.0976632580650403e-07
ATPase O 0 2.3230079193581332e-08
( O 0 9.045580950939325e-11
ATP7B O 0 8.918951607483905e-06
) O 0 2.3726423603598334e-11
, O 0 4.6838054268416585e-12
were O 0 3.561826181219807e-11
identified O 0 1.467340485228341e-11
in O 0 2.8050778713706315e-11
Korean O 0 2.2822393930255203e-07
Patients O 0 1.838642482709929e-08
with O 0 9.128218320109127e-11
Wilson B-Disease 0 1.975713757929043e-06
disease I-Disease 0 7.12439668859588e-06
. O 0 5.002708007850742e-07

Arg778Leu O 0 0.0009878831915557384
, O 0 1.3854284830472352e-08
the O 0 8.599188028313165e-09
most O 0 1.6934808000357293e-09
frequently O 0 9.309180509786685e-11
reported O 0 2.955776248758646e-11
mutation O 0 5.4004873489832406e-11
of O 0 1.984612058025803e-10
this O 0 5.6548068311235156e-11
enzyme O 0 6.453574341591661e-10
, O 0 1.8742745203081945e-11
was O 0 2.0778891107742226e-10
found O 0 1.0246930907953367e-11
in O 0 9.60838093116978e-12
six O 0 3.206189133631021e-11
of O 0 3.158940609093719e-10
eight O 0 2.0198613892574713e-09
unrelated O 0 3.1962290591991405e-08
patients O 0 5.10110220730553e-09
studied O 0 2.7479818420772517e-10
, O 0 1.992294133487671e-12
an O 0 6.453047189484973e-13
allele O 0 4.6437870909743495e-11
frequency O 0 2.8359262160826404e-10
of O 0 2.5008171089524467e-09
37 O 0 1.2464849419302482e-07
. O 0 1.1981511249814503e-07

5 O 0 9.681964456831338e-07
% O 0 4.3607912836307605e-09
, O 0 4.950720736141001e-11
which O 0 5.706159503238162e-12
is O 0 2.6163650239385827e-12
considerably O 0 3.873607656856848e-09
higher O 0 9.020538094262065e-09
than O 0 5.344017936503853e-11
those O 0 4.0514102489508375e-11
in O 0 8.042421589804505e-11
other O 0 1.4893913879987508e-10
Asian O 0 3.2016824746960992e-09
populations O 0 7.914689459376234e-10
. O 0 1.1313054937289735e-09

The O 0 6.922572026724083e-08
novel O 0 3.206089971286019e-08
single O 0 7.477273245015681e-10
nucleotide O 0 1.937848548294596e-09
deletion O 0 2.8114226502395923e-09
, O 0 5.027724070405526e-11
2304delC O 0 4.450086166229994e-08
, O 0 1.4132615910877888e-10
was O 0 2.6605782021960067e-09
found O 0 2.2941951116628445e-10
in O 0 5.326334928668075e-10
one O 0 3.453995756075301e-09
patient O 0 1.8306993752048584e-06
. O 0 1.943246559221734e-07

Since O 0 9.682244694886322e-08
a O 0 1.6169295902201952e-09
mutation O 0 2.8170104027225307e-09
at O 0 3.847453022842728e-09
cDNA O 0 5.038243600097303e-08
nucleotide O 0 9.336077511079566e-08
2302 O 0 2.8889693567180075e-05
( O 0 2.1976748199037388e-10
2302insC O 0 4.33434941271571e-08
) O 0 1.250280989850694e-10
had O 0 3.993275154989817e-10
been O 0 1.0019078622303113e-10
previously O 0 1.316551034857838e-10
described O 0 2.1248655612815526e-10
, O 0 4.614937772207117e-12
this O 0 7.131427826739811e-12
region O 0 3.8077216379939216e-10
of O 0 8.054768518839239e-10
the O 0 1.0954061657741931e-08
ATP7B O 1 0.8588919043540955
gene O 0 6.944783637052865e-10
may O 0 1.4517323454477093e-10
be O 0 8.678997104327735e-11
susceptible O 0 1.0704398079042221e-07
to O 0 4.692340405121342e-10
gene O 0 5.088579158041284e-08
rearrangements O 0 0.02091795578598976
causing O 1 0.9824188351631165
Wilson B-Disease 0 0.19689463078975677
disease I-Disease 0 0.17097817361354828
. O 0 1.9271108158136485e-06

Disruption O 0 1.3560179468186107e-06
of O 0 2.2990244374909707e-08
splicing O 0 2.048147784705634e-08
regulated O 0 1.8326196116191795e-09
by O 0 2.7932467103197745e-11
a O 0 1.0811491285567243e-10
CUG O 0 0.0007437811582349241
- O 0 2.7735134722206567e-07
binding O 0 2.985197156135655e-08
protein O 0 1.0357520352499705e-07
in O 0 3.4860772046840793e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.942590461112559e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.857591456035152e-05
DM B-Disease 1 1.0
) O 0 1.9811496443367105e-08
is O 0 1.488002915328579e-10
caused O 0 5.708724049036107e-10
by O 0 1.8700047066388947e-10
a O 0 9.196378103482061e-10
CTG O 0 5.109818630444352e-06
expansion O 0 3.9295926512750157e-08
in O 0 2.4985991053938506e-10
the O 0 1.633734120209951e-10
3 O 0 8.84886219854053e-10
untranslated O 0 4.7202578912219906e-07
region O 0 1.2511541802595616e-10
of O 0 1.6958588699989008e-10
the O 0 3.9210721780591484e-08
DM B-Disease 1 1.0
gene O 0 2.8469416974985506e-06
. O 0 3.6559922023116087e-07

One O 0 5.851265694190033e-09
model O 0 5.883832532305178e-09
of O 0 1.8038113580587378e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9999997615814209
suggests O 0 1.7763891690947275e-08
that O 0 6.603561013979187e-12
RNAs O 0 5.220923693372015e-10
from O 0 2.2466854765479383e-11
the O 0 8.003675500134477e-11
expanded O 0 1.9376968918294324e-09
allele O 0 4.4094078388567937e-10
create O 0 7.394428125362396e-11
a O 0 9.84515802215924e-11
gain O 0 6.236247962476682e-09
- O 0 4.5603179010811346e-09
of O 0 5.868791674856766e-09
- O 0 3.1727096505562713e-09
function O 0 1.64821524484271e-11
mutation O 0 3.761885334491177e-12
by O 0 6.878935897465521e-13
the O 0 7.313492693394874e-12
inappropriate O 0 4.594572639016192e-11
binding O 0 1.323542941911171e-10
of O 0 9.232776765344397e-10
proteins O 0 2.921006145295557e-11
to O 0 1.0159944413556943e-10
the O 0 1.041578023830425e-08
CUG O 1 0.9872716069221497
repeats O 0 3.9230590687111544e-07
. O 0 2.2091930418355332e-07

Data O 0 1.1310939385111851e-07
presented O 0 4.3325972143293257e-08
here O 0 2.2144859279649154e-09
indicate O 0 3.7003394792733957e-10
that O 0 3.245862563103219e-12
the O 0 2.0206002149247837e-10
conserved O 0 1.8670057500003168e-08
heterogeneous O 0 1.1272925348748686e-07
nuclear O 0 9.136311405200104e-07
ribonucleoprotein O 0 6.595318609470269e-06
, O 0 1.876737432127129e-09
CUG O 0 2.111316644004546e-05
- O 0 5.74955443255476e-08
binding O 0 7.293165626975906e-09
protein O 0 1.5430261512960897e-09
( O 0 3.7023707016858864e-11
CUG O 0 0.0003190213465131819
- O 0 7.19818388006388e-07
BP O 0 3.837919848592719e-07
) O 0 4.4236930091257065e-11
, O 0 1.8059064660347346e-11
may O 0 1.5187552604434273e-10
mediate O 0 8.214856017652039e-10
the O 0 1.1768854779603544e-09
trans O 0 1.1655645337782516e-08
- O 0 1.5585163737341645e-07
dominant O 0 6.680076580778405e-08
effect O 0 6.1775282667042575e-09
of O 0 8.465482537189928e-09
the O 0 1.2300746199400692e-08
RNA O 0 3.633627443377918e-08
. O 0 1.3770166340520973e-08

CUG O 1 0.9999924898147583
- O 1 0.8699458837509155
BP O 0 0.00011804182577179745
was O 0 4.303245049186444e-08
found O 0 2.1465773603068783e-10
to O 0 8.125184552953968e-12
bind O 0 5.897511645702735e-11
to O 0 8.528680539576783e-11
the O 0 1.8440503568584177e-09
human O 0 3.912255408522469e-09
cardiac O 0 0.00027450965717434883
troponin O 0 0.0013068208936601877
T O 0 3.2527532312087715e-05
( O 0 3.348849808570975e-10
cTNT O 0 6.419745091079676e-08
) O 0 8.399178574869381e-11
pre O 0 3.403956156944332e-07
- O 0 1.1024534529724406e-07
messenger O 0 1.8233844656379006e-08
RNA O 0 1.001048799409432e-09
and O 0 5.704124672600841e-12
regulate O 0 6.938424140789934e-11
its O 0 5.0140204488346996e-11
alternative O 0 3.351063782019992e-08
splicing O 0 3.822228222816193e-07
. O 0 8.055022249209287e-08

Splicing O 0 2.0556802837745636e-07
of O 0 4.473028170082216e-08
cTNT O 0 2.06055319722509e-05
was O 0 8.045594768191222e-08
disrupted O 0 1.0477907608219539e-06
in O 0 4.310909673677088e-08
DM B-Disease 1 1.0
striated O 0 3.4761787901516072e-06
muscle O 0 2.3573389285047597e-07
and O 0 1.217031453393247e-08
in O 0 6.5985852337746564e-09
normal O 0 1.0056866983632062e-07
cells O 0 3.032275097680781e-09
expressing O 0 3.414274418744867e-10
transcripts O 0 8.172005849793607e-10
that O 0 1.110597985104489e-11
contain O 0 1.1680950429138193e-08
CUG O 0 0.01354145910590887
repeats O 0 4.797367409992148e-07
. O 0 2.051381642331762e-07

Altered O 0 4.166025064478163e-06
expression O 0 1.6984850503831694e-07
of O 0 4.74497738878199e-08
genes O 0 1.3515009555931101e-08
regulated O 0 5.5868031978434374e-08
posttranscriptionally O 0 7.83484210842289e-07
by O 0 1.908115265791821e-08
CUG O 1 1.0
- O 1 0.7658920884132385
BP O 0 2.073864197882358e-05
therefore O 0 6.2240084197640044e-09
may O 0 2.528644793553525e-10
contribute O 0 3.735398657056521e-10
to O 0 8.64747828899226e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9999957084655762
. O 0 1.571670509292744e-07
. O 0 1.203160593377106e-07

Identification O 0 7.05443667925465e-08
of O 0 8.654573058208825e-09
a O 0 9.892578978210054e-10
novel O 0 3.133774839625403e-08
nonsense O 0 4.6868532166399746e-08
mutation O 0 9.922531685191416e-10
and O 0 2.096519138850006e-11
a O 0 2.1837302799365688e-11
missense O 0 6.9008962988448275e-09
substitution O 0 2.5713008611205623e-08
in O 0 1.3720635738678766e-09
the O 0 1.4669669923250694e-09
vasopressin O 0 8.306195731222488e-09
- O 0 2.3872081200693174e-08
neurophysin O 0 2.0924608179484494e-06
II O 1 0.999982476234436
gene O 0 2.765281559291566e-09
in O 0 1.6775215938569232e-10
two O 0 2.1613870415659875e-11
Spanish O 0 1.4447445462195674e-09
kindreds O 0 8.232510140260274e-08
with O 0 1.965692886241044e-10
familial B-Disease 0 0.0001347243960481137
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 0 1.1242633263464086e-05

Familial B-Disease 1 0.9999994039535522
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.2599665524248849e-06
FNDI B-Disease 1 1.0
) O 0 2.4821082966752783e-09
is O 0 6.945601732644135e-11
an O 0 5.1560221370205994e-11
autosomal B-Disease 1 0.9999822378158569
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
caused O 0 0.0012509073130786419
by O 0 3.8834861015857314e-07
deficiency O 1 0.99687659740448
in O 0 5.89396726979885e-08
the O 0 9.357667352105636e-08
antidiuretic O 0 4.4928142983735597e-07
hormone O 0 3.755390665105551e-08
arginine O 0 4.551881715997297e-08
vasopressin O 0 1.2717765685010818e-07
( O 0 1.2385705794315527e-09
AVP O 0 7.083316404532525e-07
) O 0 2.020051834139558e-11
encoded O 0 4.18526567569355e-11
by O 0 6.649038264416873e-11
the O 0 6.4793064247226084e-09
AVP O 0 5.7667373766889796e-05
- O 0 2.909200929934741e-06
neurophysin O 0 0.45334890484809875
II O 1 1.0
( O 0 2.158852936418043e-07
AVP O 0 0.0008782511577010155
- O 0 5.701770987798227e-06
NPII O 0 0.0022056743036955595
) O 0 1.4207541809696522e-09
gene O 0 1.0854868115472982e-09
on O 0 3.720057151213041e-09
chromosome O 0 9.408221757212232e-09
20p13 O 0 5.182753739063628e-06
. O 0 5.18278056915733e-07

In O 0 1.9225014469270718e-08
this O 0 3.486678723518821e-10
study O 0 1.207076216758196e-09
, O 0 2.6131692296149645e-11
we O 0 1.678839532670562e-11
analyzed O 0 6.889950276978141e-10
two O 0 1.58376749215261e-11
families O 0 2.1452216739104024e-11
with O 0 1.63676485559483e-11
FNDI B-Disease 1 1.0
using O 0 2.948099542265936e-09
direct O 0 1.3990743008562845e-09
automated O 0 1.979865338341824e-08
fluorescent O 0 1.2001851068532687e-08
, O 0 5.84730744726536e-12
solid O 0 1.1029167162890374e-10
phase O 0 7.351288466850292e-10
, O 0 5.781521528885891e-12
single O 0 2.1118098589290035e-11
- O 0 1.9413545770952112e-10
stranded O 0 6.072455316363801e-10
DNA O 0 1.3226161485468957e-11
sequencing O 0 1.581763886537857e-10
of O 0 1.4264556202903123e-10
PCR O 0 7.777823611831991e-07
- O 0 3.140691478620283e-05
amplified O 0 3.6102181184105575e-05
AVP O 0 0.001119698747061193
- O 0 9.727427823236212e-06
NPII O 0 0.0017500376561656594
DNA O 0 1.0914415042861947e-06
. O 0 9.150788571332669e-08

In O 0 2.6310026157716493e-08
one O 0 1.476386513044048e-10
of O 0 2.2529474119625803e-10
the O 0 3.6150352156205656e-10
families O 0 5.007158576653126e-11
, O 0 3.3143160525078708e-12
affected O 0 7.986138833571133e-11
individuals O 0 1.5796457024375155e-12
presented O 0 5.045662776481663e-10
a O 0 1.1880399441999145e-10
novel O 0 1.2297861395893506e-08
nonsense O 0 1.4915762847067526e-08
mutation O 0 2.038111068802806e-10
in O 0 6.788408724034412e-11
exon O 0 1.0872210909340652e-09
3 O 0 2.304826607346655e-10
of O 0 8.838618725803826e-11
the O 0 2.0636228836856674e-10
gene O 0 6.471963243104284e-11
, O 0 1.0626546517733537e-11
consisting O 0 8.641434789957714e-11
in O 0 6.574257110925075e-11
a O 0 1.7931392481962405e-10
G O 0 6.831293148934492e-07
to O 0 2.9656617162032717e-09
T O 0 1.8018566549926618e-07
transition O 0 3.7002849673228866e-09
at O 0 3.1683011769700897e-09
nucleotide O 0 1.3144998867176128e-08
2101 O 0 3.2580314837105107e-06
, O 0 2.0038271389410944e-11
which O 0 9.969866729062082e-13
produces O 0 3.156064819209714e-12
a O 0 4.482653397780423e-12
stop O 0 8.803102691246067e-11
signal O 0 2.525271991515865e-09
in O 0 8.201298529186829e-10
codon O 0 6.784379991131573e-08
82 O 0 3.6783291079700575e-07
( O 0 1.7276129415932928e-09
Glu O 0 8.27495659905253e-06
) O 0 3.6652042512130834e-10
of O 0 1.4380563406746205e-08
NPII O 1 0.9984857439994812
. O 0 1.91262984117202e-06

The O 0 1.9301896827528253e-06
premature O 0 4.007229563285364e-06
termination O 0 4.02140727828737e-07
eliminates O 0 7.016421221806013e-08
part O 0 1.024940465832458e-09
of O 0 1.2336359711540013e-09
the O 0 1.9901928993704132e-09
C O 0 1.3421423545878497e-06
- O 0 9.950681167936182e-09
terminal O 0 2.2468817917342676e-08
domain O 0 7.934338741577562e-10
of O 0 3.086270128349611e-10
NPII O 0 0.00030782344401814044
, O 0 1.0714269055300818e-10
including O 0 3.5203024523200455e-11
a O 0 5.7810613934838884e-11
cysteine O 0 9.303593451193137e-10
residue O 0 3.364320733112436e-08
in O 0 4.4775649854500443e-10
position O 0 1.3591833214476878e-09
85 O 0 4.32282210027779e-09
, O 0 6.7636421637040645e-12
which O 0 1.1249325039194846e-12
could O 0 5.535295746067481e-12
be O 0 7.1202692179805904e-12
involved O 0 2.6526050453390404e-11
in O 0 4.379516541086481e-11
the O 0 2.814565247533096e-10
correct O 0 8.901682946316214e-09
folding O 0 7.764293030732006e-08
of O 0 5.009933801147781e-09
the O 0 6.50579750072211e-08
prohormone O 0 0.0027383179403841496
. O 0 8.133927735798352e-07

In O 0 2.239496765810145e-08
the O 0 6.012712105984974e-09
second O 0 3.520831626246945e-08
family O 0 2.18508558469388e-10
, O 0 6.102358635767802e-12
a O 0 5.764938006136422e-12
G279A O 0 3.86302723143217e-09
substitution O 0 5.525251811633325e-09
at O 0 9.176963633450441e-10
position O 0 1.865466114914227e-10
- O 0 2.521901576457708e-10
1 O 0 3.69678426759279e-10
of O 0 3.237134171829581e-11
the O 0 2.9154179070900454e-11
signal O 0 9.7579090641009e-11
peptide O 0 2.5817840920705493e-11
was O 0 5.429312902038852e-11
observed O 0 6.403177987834852e-11
in O 0 7.878147439965844e-11
all O 0 1.4030607231596548e-10
affected O 0 3.4434182172304872e-09
individuals O 0 3.6999445174323853e-10
. O 0 4.303720757548035e-08

This O 0 1.7022632903263002e-07
missense O 0 1.2430212336767e-05
mutation O 0 5.0157112241322466e-08
, O 0 2.7511073974473277e-10
which O 0 1.7291088005855215e-10
replaces O 0 1.39121902975603e-06
Ala O 0 8.059803076321259e-05
with O 0 3.7013578868538843e-09
Thr O 0 0.0018628209363669157
, O 0 8.782395366502271e-10
is O 0 3.65208314978549e-11
frequent O 0 5.773747036030841e-10
among O 0 7.527575007770793e-09
FNDI B-Disease 1 1.0
patients O 1 0.9998701810836792
and O 0 1.4148588967088926e-09
is O 0 3.1214218709774144e-11
thought O 0 8.581745730706913e-11
to O 0 9.190564975725124e-12
reduce O 0 1.5142112563815147e-10
the O 0 3.0395116978887415e-10
efficiency O 0 1.6662600188510623e-08
of O 0 1.3151261191168828e-09
cleavage O 0 1.5530414732012332e-09
by O 0 6.49105380556847e-10
signal O 0 3.1321256699357036e-08
peptidases O 0 7.698390618315898e-07
. O 0 4.782217732923755e-09
. O 0 3.745697441104312e-08

Genetic O 0 1.2906468782603042e-06
heterogeneity O 0 1.961320776899811e-06
of O 0 6.024274625815451e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.1285527507242108e-10
due O 0 1.957956641263081e-08
to O 0 1.1019226642261515e-09
TWIST O 0 0.008225413970649242
and O 0 4.0380015775554057e-07
FGFR O 1 0.9999972581863403
mutations O 0 3.1431848128704587e-06
. O 0 2.5939510805983446e-07

Thirty O 0 7.99241170170717e-05
- O 0 8.826972589304205e-06
two O 0 5.656721757674177e-09
unrelated O 0 4.6366960759769427e-07
patients O 0 9.075798779178967e-09
with O 0 2.9607514356877473e-12
features O 0 2.3124885339953494e-10
of O 0 5.746079523305525e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0307271008924701e-10
a O 0 7.529864926025809e-11
common O 0 1.923877448462008e-07
autosomal B-Disease 0 0.0010368518996983767
dominant I-Disease 0 9.815741941565648e-05
condition I-Disease 0 1.9092176444246434e-05
of O 0 0.016363075003027916
craniosynostosis B-Disease 1 1.0
and O 0 0.00038084687548689544
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9332760572433472
, O 0 4.852081847417367e-09
were O 0 1.8627231312962067e-08
screened O 0 3.8517502076729215e-08
for O 0 6.355266313207153e-10
mutations O 0 1.913351255211637e-09
in O 0 3.5635963069324816e-09
TWIST O 0 3.7860172596992925e-05
, O 0 4.907919404217864e-09
FGFR2 O 1 0.9987943172454834
, O 0 3.227957012796878e-09
and O 0 1.0992593502123782e-08
FGFR3 O 1 0.999859094619751
. O 0 2.3689324279985158e-06

Nine O 0 3.0821754535281798e-06
novel O 0 7.262033250299282e-07
and O 0 2.7999598195549424e-09
three O 0 2.4906967599491736e-09
recurrent O 0 3.551608926954941e-07
TWIST O 0 3.051794192288071e-05
mutations O 0 1.2360507284370215e-08
were O 0 1.5565230215841552e-09
found O 0 6.628246562723206e-11
in O 0 1.4212468701924053e-10
12 O 0 3.980683782600636e-09
families O 0 9.558088764904937e-10
. O 0 1.0306809627991242e-08

Seven O 0 5.677542276316672e-07
families O 0 5.9272209362859485e-09
were O 0 1.2146862404804892e-09
found O 0 6.169680044632031e-11
to O 0 2.3430597739793058e-11
have O 0 8.163558024021356e-11
the O 0 8.691960040607682e-09
FGFR3 O 1 0.9998518228530884
P250R O 0 9.242867236025631e-06
mutation O 0 5.069704656079921e-09
, O 0 1.6105627248519383e-11
and O 0 6.82319435327261e-12
one O 0 4.417746116841537e-12
individual O 0 9.000519947399699e-12
was O 0 1.585630238221114e-10
found O 0 2.29637402843208e-11
to O 0 1.47727021587718e-11
have O 0 6.3166520625213e-11
an O 0 6.14051795522208e-11
FGFR2 O 0 0.00213255500420928
VV269 O 0 2.4661114366608672e-05
- O 0 1.738489459057746e-06
270 O 0 2.2737276594853029e-07
deletion O 0 8.72568435283938e-08
. O 0 3.405647319709715e-08

To O 0 6.262292018277549e-09
date O 0 5.022862978876219e-07
, O 0 8.355879876909e-10
our O 0 1.8375152788241422e-10
detection O 0 2.734024562300874e-09
rate O 0 1.5802319175417523e-10
for O 0 1.0236734203361575e-11
TWIST O 0 5.529681743610126e-07
or O 0 1.846345831779672e-08
FGFR O 0 0.38622111082077026
mutations O 0 3.119151603669934e-09
is O 0 2.4301035142504368e-11
68 O 0 6.794941276311306e-10
% O 0 1.0387710656922788e-11
in O 0 2.7457485937687487e-11
our O 0 1.4940241266359067e-09
Saethre B-Disease 1 0.9988290667533875
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.3064460037858225e-05
, O 0 2.8854009459511332e-11
including O 0 1.320751286115751e-10
our O 0 1.7532465479419557e-09
five O 0 5.959605586802752e-10
patients O 0 6.189971646364256e-09
elsewhere O 0 7.724035855360967e-10
reported O 0 1.0351482171433446e-10
with O 0 1.4416029481267856e-10
TWIST O 0 0.0001227210450451821
mutations O 0 2.72604381734709e-07
. O 0 1.3983898838887399e-07

More O 0 1.4281640758895264e-08
than O 0 2.022359391062878e-09
35 O 0 7.674374025157249e-09
different O 0 9.151617796909761e-10
TWIST O 0 1.9060421436734032e-06
mutations O 0 7.728194972855817e-09
are O 0 1.0820857404558737e-10
now O 0 3.609445728414151e-11
known O 0 5.802713864966336e-11
in O 0 5.318799567444188e-11
the O 0 3.432479023235402e-10
literature O 0 2.4761186878663466e-08
. O 0 6.617554504373402e-09

The O 0 8.157107913575601e-07
most O 0 2.1269965344572483e-08
common O 0 8.795760564339616e-09
phenotypic O 0 1.98696241682228e-08
features O 0 2.9577871263342104e-09
, O 0 3.103635751178224e-11
present O 0 3.759383776502645e-11
in O 0 4.1668661576732546e-11
more O 0 1.2524852032250178e-12
than O 0 2.8797914573830408e-12
a O 0 1.065687035145535e-11
third O 0 2.9190541095402978e-09
of O 0 2.7457933704511106e-09
our O 0 9.165527892207592e-09
patients O 0 3.956484917466696e-09
with O 0 1.9928803399182904e-11
TWIST O 0 1.370383415633114e-06
mutations O 0 4.8933372909232276e-09
, O 0 4.813941259507182e-11
are O 0 5.806168046351701e-11
coronal B-Disease 0 1.3828947658112156e-06
synostosis I-Disease 0 4.071658622706309e-06
, O 0 9.47036671306023e-10
brachycephaly B-Disease 0 9.514599696558435e-06
, O 0 1.876903077402403e-08
low B-Disease 0 0.0001309783401666209
frontal I-Disease 1 0.9999849796295166
hairline I-Disease 1 0.9999997615814209
, O 0 5.602450983133167e-07
facial B-Disease 0 0.01583944447338581
asymmetry I-Disease 0 0.35130444169044495
, O 0 1.1216337014730016e-07
ptosis B-Disease 1 0.6447809934616089
, O 0 9.256515554056932e-09
hypertelorism B-Disease 0 2.307519389432855e-05
, O 0 2.716538105573818e-09
broad B-Disease 0 9.598793440090958e-06
great I-Disease 0 0.15605753660202026
toes I-Disease 0 7.204834400909021e-05
, O 0 3.4266980364350275e-09
and O 0 2.377846897161362e-08
clinodactyly B-Disease 0 0.05224987864494324
. O 0 4.495344001043122e-06

Significant O 0 5.6728244999249e-06
intra O 0 0.00014326437667477876
- O 0 0.00033565174089744687
and O 0 1.1939728494780866e-07
interfamilial O 0 3.888751598424278e-05
phenotypic O 0 1.2103826065867906e-06
variability O 0 2.2000848787229188e-07
is O 0 3.5898367611864046e-11
present O 0 1.3932410780626014e-11
for O 0 4.7136513442458394e-11
either O 0 3.886639898809108e-09
TWIST O 0 2.9748365705017932e-05
mutations O 0 2.3290442641155096e-07
or O 0 5.067213493248346e-08
FGFR O 1 0.9995119571685791
mutations O 0 1.1610889032453997e-06
. O 0 1.9380701132831746e-07

The O 0 2.979052169393981e-07
overlap O 0 3.5710691292933916e-08
in O 0 1.9412629281845284e-09
clinical O 0 5.953816994974659e-08
features O 0 6.918790540488828e-10
and O 0 1.3528717035526938e-10
the O 0 2.769318108164498e-10
presence O 0 6.768394872347372e-11
, O 0 1.5291663768568498e-11
in O 0 1.869418855826588e-11
the O 0 7.979926441858964e-11
same O 0 5.740834196910072e-11
genes O 0 2.7381548417526602e-11
, O 0 1.692787078046154e-12
of O 0 5.995996754659672e-11
mutations O 0 3.655846458894274e-11
for O 0 1.4892571550961797e-11
more O 0 9.321470678669286e-12
than O 0 7.151031850005651e-11
one O 0 1.035894772738466e-10
craniosynostotic B-Disease 0 1.3480953953148855e-07
condition I-Disease 0 2.996698000856668e-08
- O 0 1.1191948701139154e-08
such O 0 8.392457284678301e-10
as O 0 9.630224395706932e-10
Saethre B-Disease 0 1.5685814105381723e-06
- I-Disease 0 9.694995384279537e-08
Chotzen I-Disease 0 4.5531596697401255e-06
, I-Disease 0 3.686321248252966e-10
Crouzon I-Disease 0 2.622290594445076e-05
, I-Disease 0 2.2418378264887906e-09
and I-Disease 0 2.9654936284373434e-08
Pfeiffer I-Disease 0 0.01861306093633175
syndromes I-Disease 1 0.9999980926513672
- O 0 0.17723903059959412
support O 0 6.913361971783161e-08
the O 0 1.497528323568531e-08
hypothesis O 0 1.822136397322538e-08
that O 0 3.468792093841433e-12
TWIST O 0 6.393619145228513e-08
and O 0 1.8522061662196165e-10
FGFRs O 0 4.387910053083033e-07
are O 0 9.556401676935611e-12
components O 0 1.3021313194361284e-10
of O 0 7.594193329740762e-11
the O 0 7.575443744523014e-11
same O 0 6.253322165639119e-11
molecular O 0 6.638676275372291e-10
pathway O 0 1.5456647073364138e-10
involved O 0 2.3848093638756396e-12
in O 0 2.056359856700274e-12
the O 0 1.3343275269417365e-11
modulation O 0 3.7090754911872637e-09
of O 0 2.9571284088092398e-08
craniofacial O 1 1.0
and O 0 2.6134157451451756e-06
limb O 1 0.9999998807907104
development O 0 1.0789223097162903e-06
in O 0 4.868351055620224e-09
humans O 0 2.780311980643546e-09
. O 0 3.495401468267545e-10
. O 0 6.249751383080593e-09

Mutation O 0 3.013227711790023e-08
analysis O 0 9.113280130534918e-10
of O 0 1.9966881481536802e-08
UBE3A O 1 1.0
in O 1 0.9999905824661255
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9978262782096863
. O 0 2.6545382070253254e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.938057049410418e-05
AS B-Disease 1 1.0
) O 0 1.279076955462699e-09
is O 0 1.3897907998050574e-11
caused O 0 1.827944323684605e-10
by O 0 1.5101329908784322e-10
chromosome O 0 1.4516086110916149e-09
15q11 O 0 3.597814952627232e-07
- O 0 7.75341604253299e-08
q13 O 0 3.642093133748858e-07
deletions O 0 4.410251275288601e-09
of O 0 7.085783626514797e-10
maternal O 0 3.808624526868698e-09
origin O 0 1.5583996593182547e-10
, O 0 2.2205984880757645e-12
by O 0 4.77493045103472e-11
paternal O 0 1.1988623782599461e-06
uniparental B-Disease 1 0.9999326467514038
disomy I-Disease 1 0.9999985694885254
( O 0 3.42658950103214e-07
UPD B-Disease 1 1.0
) O 0 1.3092297246330986e-09
15 O 0 1.5157753940897578e-09
, O 0 9.998799531396596e-12
by O 0 1.3907248963551666e-10
imprinting O 0 3.259025788793224e-06
defects O 0 2.4189073883462697e-05
, O 0 4.098801853480438e-10
and O 0 1.2554689232668892e-10
by O 0 2.477830995939456e-10
mutations O 0 1.3353956829220692e-09
in O 0 1.184926490260807e-09
the O 0 6.579309541621114e-08
UBE3A O 0 0.0017207436030730605
gene O 0 1.354686247623249e-07
. O 0 1.9116639293770277e-07

UBE3A O 0 0.02568264678120613
encodes O 0 3.055978083921218e-07
a O 0 1.305086616554263e-08
ubiquitin O 0 1.047624891725718e-06
- O 0 4.026156602776609e-06
protein O 0 6.72396112122442e-08
ligase O 0 2.694824274840357e-07
and O 0 9.123545474665207e-09
shows O 0 5.094130894889304e-09
brain O 0 3.224580424898704e-08
- O 0 3.8716148509365667e-08
specific O 0 7.091008313864222e-08
imprinting O 0 2.418549956928473e-05
. O 0 4.4953259248359245e-07

Here O 0 6.028791403878131e-07
we O 0 1.442005981289185e-08
describe O 0 1.6091995291844796e-07
UBE3A O 0 0.000500520458444953
coding O 0 3.3551234537299024e-06
- O 0 7.615876711497549e-06
region O 0 7.778849209216787e-08
mutations O 0 1.5195905644915797e-09
detected O 0 2.4307178492222192e-09
by O 0 1.4163162309621669e-10
SSCP O 0 0.005321490112692118
analysis O 0 1.4941551329528124e-09
in O 0 9.647597165596267e-10
13 O 0 4.991325130987434e-09
AS B-Disease 1 0.9999891519546509
individuals O 0 1.819960154803013e-10
or O 0 1.2720701159096848e-09
families O 0 2.1744472888940436e-09
. O 0 1.2540604998889648e-08

Two O 0 6.599997703915506e-08
identical O 0 1.7066115276520577e-07
de O 0 2.332247248659769e-07
novo O 0 5.90053559790249e-07
5 O 0 2.3394179038405127e-07
- O 0 2.8886304903608107e-07
bp O 0 1.8410855773254298e-07
duplications O 0 2.2812733391219808e-07
in O 0 1.4364498923669089e-08
exon O 0 5.042940074417857e-07
16 O 0 2.0465270367253652e-08
were O 0 4.623552651850105e-09
found O 0 3.818443783387693e-09
. O 0 4.759952076938134e-08

Among O 0 1.1909415889022057e-06
the O 0 1.3854522862288832e-08
other O 0 3.929118363998896e-09
11 O 0 5.583476347936767e-09
unique O 0 1.249990777552057e-09
mutations O 0 5.198189101385253e-10
, O 0 8.055809491702703e-11
8 O 0 7.792790412963768e-09
were O 0 4.2139616240888245e-09
small O 0 7.713920613383607e-10
deletions O 0 8.067380541376679e-09
or O 0 9.18271148009353e-09
insertions O 0 3.1060537253324583e-07
predicted O 0 1.7055668877219432e-07
to O 0 1.5198196035015599e-09
cause O 0 1.4390775504580233e-07
frameshifts O 0 6.204214878380299e-05
, O 0 3.6503788880537513e-10
1 O 0 2.6904463101828924e-09
was O 0 3.4658195757764076e-10
a O 0 9.862914304714643e-12
mutation O 0 1.3699257006560828e-11
to O 0 6.668212423205366e-12
a O 0 3.256151251407324e-11
stop O 0 3.0697730468709494e-10
codon O 0 2.2662054455224734e-09
, O 0 2.78986035662232e-11
1 O 0 4.885780668928419e-10
was O 0 2.4892468641901644e-10
a O 0 7.834153464836291e-11
missense O 0 3.2052096088364124e-08
mutation O 0 5.676487058181579e-10
, O 0 1.2339218188883727e-11
and O 0 1.1816842643286307e-11
1 O 0 1.2987264597086323e-09
was O 0 1.1629813778668563e-09
predicted O 0 1.1761269735899305e-09
to O 0 3.6036191392030403e-11
cause O 0 4.082954530026939e-10
insertion O 0 2.8135898055836606e-09
of O 0 3.740248555317294e-09
an O 0 1.8317720604232868e-11
isoleucine O 0 7.095551701752356e-09
in O 0 1.0265207434079215e-10
the O 0 4.050377255815363e-10
hect O 0 1.5026246558136336e-07
domain O 0 2.515556651871975e-09
of O 0 6.091250615014587e-09
the O 0 3.8483353392848585e-08
UBE3A O 0 0.0002180390729336068
protein O 0 4.3651184888915395e-09
, O 0 1.2253730148625852e-11
which O 0 1.900603589441441e-12
functions O 0 6.704383576083828e-11
in O 0 8.031358356141993e-10
E2 O 0 2.4654550543345977e-06
binding O 0 1.3498625328622893e-08
and O 0 1.851532482888274e-09
ubiquitin O 0 2.0103847475638759e-07
transfer O 0 1.2972908507435932e-06
. O 0 6.189366104081273e-07

Eight O 0 6.833196408706499e-08
of O 0 1.7684741449031094e-09
the O 0 3.0511634885321826e-10
cases O 0 5.800514513154553e-10
were O 0 2.630629714062138e-09
familial O 0 4.3127354132366236e-08
, O 0 7.231397702867071e-10
and O 0 8.558179165341073e-10
five O 0 1.0357846802477866e-09
were O 0 5.759550614214959e-09
sporadic O 0 4.355486566964828e-07
. O 0 2.0591905069977656e-07

In O 0 4.000468720732897e-07
two O 0 3.2772018432325467e-09
familial O 0 9.910302622984091e-08
cases O 0 5.3285958756532636e-08
and O 0 1.2901772095119668e-08
one O 0 8.677081275720866e-10
sporadic O 0 1.7017610431935282e-08
case O 0 1.4808806625410398e-08
, O 0 6.907542871026351e-10
mosaicism O 0 8.479797543259338e-06
for O 0 1.628126966579657e-08
UBE3A O 0 0.00028872149414382875
mutations O 0 1.5517446216861686e-09
was O 0 2.0447030180115178e-10
detected O 0 2.2611007510775494e-10
in O 0 3.320246508287106e-11
the O 0 1.3650072738791152e-10
mother O 0 2.379459684842544e-10
of O 0 3.644889390308492e-10
three O 0 4.0089961905742655e-10
AS B-Disease 1 1.0
sons O 0 2.5907718281814596e-07
, O 0 8.042080022752085e-12
in O 0 9.479682663848799e-12
the O 0 1.1792082588168995e-10
maternal O 0 5.465413455141288e-09
grandfather O 0 3.241723689484388e-08
of O 0 3.823822591897397e-09
two O 0 5.032024796847168e-10
AS B-Disease 1 1.0
first O 0 2.148853184280597e-08
cousins O 0 4.006789122712462e-09
, O 0 7.268712541586009e-12
and O 0 6.146912839843921e-12
in O 0 8.836676182455427e-12
the O 0 9.729401312386088e-11
mother O 0 1.0655006044135718e-10
of O 0 1.3413863075850685e-10
an O 0 5.4396782217525086e-11
AS B-Disease 1 1.0
daughter O 0 1.0227448910882231e-05
. O 0 2.846649067578255e-07

The O 0 7.733284945743435e-08
frequencies O 0 5.245901046890822e-09
with O 0 2.3678772484436728e-11
which O 0 2.7562112314694076e-11
we O 0 2.4751893243357692e-11
detected O 0 4.773002548752459e-10
mutations O 0 2.7233795774073144e-10
were O 0 2.1741612954429e-09
5 O 0 1.337330357564781e-09
( O 0 5.7141973444641e-12
14 O 0 1.9625086278285409e-10
% O 0 3.036669223369093e-12
) O 0 3.771906289910809e-13
of O 0 8.67667951376383e-11
35 O 0 6.562734800041881e-10
in O 0 9.598385281028854e-11
sporadic O 0 9.365199282740377e-09
cases O 0 2.8601112589399236e-09
and O 0 1.538940752610074e-09
8 O 0 9.326997840730655e-09
( O 0 8.317455231499071e-12
80 O 0 1.641264346652349e-10
% O 0 1.8124136089495146e-12
) O 0 1.5438649978664204e-13
of O 0 1.4377963229728064e-11
10 O 0 1.1611742817274617e-10
in O 0 2.716433189497991e-10
familial O 0 1.4087309097021716e-08
cases O 0 2.8356204495594284e-08
. O 0 2.9333044437862554e-08
. O 0 1.2185057585156756e-07

The O 0 5.4532043577637523e-05
hemochromatosis B-Disease 1 1.0
845 O 0 4.5374323235591874e-05
G O 0 5.76027377974242e-06
- O 0 1.92884868965848e-07
- O 0 6.23365821184052e-08
> O 0 7.5620292250278e-08
A O 0 4.637215056391142e-09
and O 0 3.168745127402062e-11
187 O 0 8.149326768958076e-10
C O 0 3.965543005080008e-09
- O 0 8.606403367750204e-10
- O 0 6.716331490963512e-09
> O 0 9.255654020989823e-08
G O 0 6.087270207899564e-07
mutations O 0 5.344775177995587e-10
: O 0 2.0703081610173868e-11
prevalence O 0 8.273414175974381e-10
in O 0 5.272075484508143e-11
non O 0 3.8551238645823105e-08
- O 0 3.459780373304966e-07
Caucasian O 0 7.354520903390949e-08
populations O 0 3.2925266957306576e-09
. O 0 4.200681136268258e-09

Hemochromatosis B-Disease 1 0.9999985694885254
, O 0 5.3265026167537144e-08
the O 0 6.598453182959929e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.7481103614945823e-08
leads O 0 2.5647374002346623e-08
, O 0 8.699149733892853e-11
if O 0 1.4088269439938017e-09
untreated O 1 0.9999592304229736
, O 0 2.1835981633966384e-10
to O 0 1.6993113582941533e-09
progressive O 1 0.9999970197677612
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
and O 0 9.133505614045134e-07
premature B-Disease 0 6.288354597927537e-06
death I-Disease 0 1.1146740916956333e-06
. O 0 1.2523184977908386e-07

The O 0 2.7106063498649746e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.111618070761324e-06
, O 0 5.3998466142957113e-08
HFE O 1 0.9999971389770508
, O 0 1.4232556466708957e-08
recently O 0 1.951669270638945e-09
has O 0 6.197936695123696e-12
been O 0 9.996416021340604e-12
identified O 0 2.6240525377585477e-11
, O 0 1.978072436750744e-12
and O 0 5.1372114028003235e-12
characterization O 0 1.989589604178832e-09
of O 0 1.3935407494614083e-08
this O 0 1.8624133346634153e-09
gene O 0 1.377420399961693e-09
has O 0 1.4903567963076014e-11
shown O 0 5.318035942170063e-12
that O 0 2.8889884191515836e-13
it O 0 1.4150942787352627e-12
contains O 0 3.836252149280739e-11
two O 0 5.742802500902089e-12
mutations O 0 8.938862670893055e-12
that O 0 6.984145249980256e-13
result O 0 2.7458965656812495e-10
in O 0 4.0084915942095733e-10
amino O 0 4.672174869213563e-10
acid O 0 1.1672370847648494e-09
substitutions O 0 7.233345922230683e-09
- O 0 1.1287562884376712e-08
cDNA O 0 1.5630540417532757e-08
nucleotides O 0 5.158130034210728e-10
845 O 0 1.0233781821966659e-08
G O 0 9.424135249957999e-09
- O 0 2.0551551571657e-09
- O 0 3.538967785488012e-09
> O 0 9.508725362650239e-09
A O 0 6.4800849131074756e-09
( O 0 2.115385817902382e-11
C282Y O 0 1.4023237682181389e-08
) O 0 5.906446772646623e-12
and O 0 1.2214853260805736e-11
187 O 0 9.99154647907119e-10
C O 0 6.6987659863571025e-09
- O 0 1.9536583462098633e-09
- O 0 9.933500244585503e-09
> O 0 2.2809948063695629e-07
G O 0 9.107516234507784e-06
( O 0 1.2764254098129868e-09
H63D O 0 0.0006123643252067268
) O 0 6.86362922053263e-09
. O 0 6.891585968560321e-08

Although O 0 0.0003345221630297601
hemochromatosis B-Disease 1 1.0
is O 0 6.568977539700427e-08
common O 0 9.339604645219879e-08
in O 0 5.784265511010744e-09
Caucasians O 0 3.4065899967572477e-07
, O 0 8.314192390113107e-11
affecting O 0 5.18430687268534e-10
> O 0 5.978234351999845e-09
= O 0 6.432879229301136e-10
1 O 0 3.119103864079875e-09
/ O 0 1.1963356971733674e-09
300 O 0 1.1840402269758243e-10
individuals O 0 5.138541502025529e-13
of O 0 5.255089072231378e-11
northern O 0 5.81601322657832e-10
European O 0 1.557913020810986e-09
origin O 0 5.621526022459022e-10
, O 0 6.003775167989778e-12
it O 0 5.093770999615999e-13
has O 0 2.204640685505091e-13
not O 0 7.188481038720995e-13
been O 0 1.0866147391597192e-11
recognized O 0 1.2470585675217194e-10
in O 0 9.960013369614273e-11
other O 0 4.003402886976204e-10
populations O 0 2.8261430973230972e-09
. O 0 4.996173252891367e-09

The O 0 1.3556982025875186e-07
present O 0 8.983006338780797e-09
study O 0 7.034424154284125e-10
used O 0 9.941261008838964e-11
PCR O 0 4.6078579174491097e-08
and O 0 3.8558259363163927e-10
restriction O 0 2.4421044741984588e-08
- O 0 4.081726512339401e-09
enzyme O 0 4.3998138465894954e-10
digestion O 0 4.623208926801681e-09
to O 0 9.920458551859745e-12
analyze O 0 1.3118229592878894e-11
the O 0 3.90501042960012e-12
frequency O 0 2.136091997728684e-11
of O 0 6.718720718668081e-11
the O 0 5.990718476844847e-10
845 O 0 1.9826089214802778e-08
G O 0 3.887049970785483e-08
- O 0 5.951849679775023e-09
- O 0 5.893312060578637e-09
> O 0 6.745203950941914e-09
A O 0 9.43697231470253e-10
and O 0 1.3653034432181688e-11
187 O 0 2.396530751624937e-10
C O 0 1.8270633894701405e-09
- O 0 4.787974461351041e-10
- O 0 3.2010594175346796e-09
> O 0 6.828519616419726e-08
G O 0 5.954605626357079e-07
mutations O 0 8.501302439789526e-10
in O 0 7.469376228641522e-10
HLA O 0 3.967467137044878e-07
- O 0 5.9099857452338256e-08
typed O 0 1.9157468944541733e-09
samples O 0 1.896354323571714e-10
from O 0 4.8390732393377434e-11
non O 0 4.367992190168479e-09
- O 0 1.911061886517018e-08
Caucasian O 0 4.227293182168523e-09
populations O 0 8.174214777278976e-11
, O 0 2.1729018324229132e-12
comprising O 0 4.257479091496208e-11
Australian O 0 2.402646526178387e-09
Aboriginal O 0 3.393565206621929e-09
, O 0 6.7435991686626284e-12
Chinese O 0 9.049381799464129e-10
, O 0 3.353181274312611e-11
and O 0 4.367706474273092e-10
Pacific O 0 2.6692664079064343e-08
Islanders O 0 8.417134154115047e-07
. O 0 7.650963596006477e-08

Results O 0 1.369807250739541e-06
showed O 0 4.446530965651618e-08
that O 0 3.2638180352817514e-11
the O 0 2.6083912807450815e-09
845 O 0 1.7978675259655574e-07
G O 0 4.625239569122641e-07
- O 0 9.430755198991392e-08
- O 0 4.1727975741423506e-08
> O 0 3.7249577644615783e-08
A O 0 1.8918211441842914e-09
mutation O 0 5.304038805387101e-11
was O 0 2.548349552211615e-11
present O 0 7.053306289722672e-12
in O 0 2.1897530663728126e-11
these O 0 2.1995315291345463e-11
populations O 0 6.826123433861797e-12
( O 0 1.988163052159958e-13
allele O 0 3.0681425282341745e-12
frequency O 0 1.0490571085430833e-11
0 O 0 4.763078126357456e-11
. O 0 6.002710481456397e-12
32 O 0 5.5639631790782573e-11
% O 0 2.6369759240779667e-12
) O 0 2.2460961042469751e-13
, O 0 1.1068205813674625e-12
and O 0 5.344728999656656e-12
, O 0 5.339216482130871e-12
furthermore O 0 1.822742790036358e-10
, O 0 4.430073929223566e-12
it O 0 2.5247193658622935e-12
was O 0 1.1978243952270873e-09
always O 0 2.7655860934672205e-10
seen O 0 1.8251745947939213e-10
in O 0 4.698741395969819e-11
conjunction O 0 6.049127310170377e-10
with O 0 1.9942503204362083e-10
HLA O 0 0.00012521840108092874
haplotypes O 0 2.5523138447169913e-07
common O 0 1.68358784691236e-08
in O 0 7.569468940538115e-10
Caucasians O 0 3.145968108242414e-08
, O 0 1.2138072665035526e-11
suggesting O 0 1.0500424835191424e-10
that O 0 6.518963320545357e-12
845 O 0 3.802790260465372e-08
G O 0 6.535852321576385e-07
- O 0 1.6892933274448296e-07
- O 0 3.579259271191404e-07
> O 0 3.016249934262305e-07
A O 0 1.6521015666626226e-08
may O 0 3.983234020399351e-10
have O 0 1.1252806846051566e-11
been O 0 5.312581104199854e-12
introduced O 0 7.001718649313204e-11
into O 0 3.062940526210589e-11
these O 0 5.98728575398888e-12
populations O 0 8.387103511697802e-12
by O 0 2.891135768290365e-11
Caucasian O 0 9.762499253440637e-09
admixture O 0 1.6575849315358937e-07
. O 0 2.459269126120489e-07

187 O 0 4.37631888416945e-06
C O 0 6.162185854918789e-07
- O 0 2.6006880204931804e-08
- O 0 1.8346664631962994e-08
> O 0 5.023063920361892e-08
G O 0 1.3561637501879886e-07
was O 0 1.360593582244718e-10
present O 0 8.083972727335187e-12
at O 0 2.2819654152406166e-11
an O 0 1.6356303789676063e-13
allele O 0 1.6197553714958346e-11
frequency O 0 5.867017288663234e-11
of O 0 4.3876291488942343e-10
2 O 0 4.783323959145491e-08
. O 0 6.971731636440381e-08

68 O 0 2.7299020075588487e-06
% O 0 3.346099619605525e-09
in O 0 1.0779370451796666e-10
the O 0 1.8205224827649857e-10
two O 0 2.9214741736893757e-11
populations O 0 2.934940138143993e-11
analyzed O 0 5.108762857197746e-10
( O 0 2.458092236701237e-11
Australian O 0 3.5808227494271705e-08
Aboriginal O 0 2.6506871364517792e-08
and O 0 4.609644263520174e-11
Chinese O 0 3.266686254832507e-09
) O 0 2.676084354114039e-10
. O 0 1.2177558517123543e-08

In O 0 1.0975229969290012e-07
the O 0 1.524753656667599e-08
Australian O 0 9.72292113488038e-08
Aboriginal O 0 2.2887777006985743e-08
samples O 0 5.063517383163685e-10
, O 0 2.7838857954987084e-11
187 O 0 2.0440760195583607e-09
C O 0 1.6648431966359567e-08
- O 0 3.4897678080625383e-09
- O 0 2.3689560535444798e-08
> O 0 3.0751445478927053e-07
G O 0 3.370449803696829e-06
was O 0 1.2188706710603014e-09
found O 0 8.337881600428698e-12
to O 0 1.4972224848808224e-12
be O 0 6.5112095402886094e-12
associated O 0 4.823575983081696e-10
with O 0 6.988286616049777e-10
HLA O 0 0.3799072802066803
haplotypes O 0 1.7572858723724494e-07
common O 0 6.722662870828344e-09
in O 0 2.3228105550110456e-10
Caucasians O 0 9.407827405993885e-09
, O 0 5.458446195039102e-12
suggesting O 0 1.8572109128367487e-11
that O 0 1.8707653698726845e-13
it O 0 1.5988637280459073e-12
was O 0 2.0718420035148455e-10
introduced O 0 9.011488777410648e-10
by O 0 2.7200519614467566e-10
recent O 0 4.749737936293741e-09
admixture O 0 2.6301503908143786e-07
. O 0 8.445133659051862e-08

In O 0 4.0464431805276035e-08
the O 0 3.687237182248282e-09
Chinese O 0 6.339434310831393e-09
samples O 0 3.050348862387864e-10
analyzed O 0 3.6627023636270906e-10
, O 0 1.2318571510072651e-11
187 O 0 1.1750461714754579e-09
C O 0 1.0975728770290516e-08
- O 0 8.16806289272165e-10
- O 0 2.8112832062276993e-09
> O 0 2.2720406889220612e-08
G O 0 1.4250653634917398e-07
was O 0 1.9430586306601327e-10
present O 0 4.218284402335293e-11
in O 0 1.11288228632489e-10
association O 0 1.0518345916477045e-10
with O 0 2.9337240102511597e-12
a O 0 7.699922643933377e-11
wide O 0 9.02668340074797e-09
variety O 0 2.3066308862951246e-09
of O 0 5.919019052669228e-09
HLA O 0 0.00012717065692413598
haplotypes O 0 5.153405524538357e-08
, O 0 6.542971026091138e-11
showing O 0 2.4760204303531097e-11
this O 0 3.698684587771783e-12
mutation O 0 1.1798241203453408e-11
to O 0 5.0821668921841034e-12
be O 0 3.122261477139787e-11
widespread O 0 2.8167470578210896e-09
and O 0 2.0704672698546034e-10
likely O 0 1.9355730351833245e-09
to O 0 2.5233354294940114e-10
predate O 0 2.535851706397807e-07
the O 0 3.2491132007095302e-09
more O 0 2.462345050080472e-10
genetically O 0 1.598464471896932e-08
restricted O 0 9.639381737258645e-09
845 O 0 5.233451361164043e-08
G O 0 1.7703591481676995e-07
- O 0 7.174813987376183e-08
- O 0 1.0601826971878836e-07
> O 0 4.154259158895002e-07
A O 0 6.316504652659205e-08
mutation O 0 1.239804969799252e-08
. O 0 7.73739827764075e-09

Genotype O 0 0.00014031077444087714
- O 0 2.1360814571380615e-05
phenotype O 0 6.493544788099825e-06
correlations O 0 1.0523692708375165e-06
in O 0 8.483557678573561e-08
attenuated B-Disease 1 0.9976512789726257
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.00012195379531476647

Germ O 0 0.0036121513694524765
- O 0 1.9054486983804964e-05
line O 0 5.042699626756075e-07
mutations O 0 4.512168860770771e-09
of O 0 1.2124156123505259e-09
the O 0 3.809496273987634e-09
tumor B-Disease 0 1.5219037550195935e-06
suppressor O 0 4.634278866433306e-06
APC O 0 6.026675691828132e-08
are O 0 2.6921839757498844e-11
implicated O 0 1.7015946429665973e-09
in O 0 2.7770802546456252e-08
attenuated B-Disease 1 0.9999986886978149
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.7532513084006496e-05
AAPC B-Disease 1 1.0
) O 0 1.1721244808082787e-10
, O 0 2.4489841578267946e-12
a O 0 2.361904075098842e-12
variant O 0 4.545175613657193e-08
of O 0 6.655938705080189e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.529210061969934e-06
FAP B-Disease 0 0.0007561326492577791
) O 0 8.442069265868213e-09
. O 0 5.478942810555054e-08

AAPC B-Disease 1 1.0
is O 0 1.8117535915962435e-08
recognized O 0 1.2566363505328582e-09
by O 0 3.913423057833043e-11
the O 0 5.4589482240130494e-11
occurrence O 0 4.543324882977373e-10
of O 0 3.317647934153456e-09
< O 0 1.3346384548640344e-06
100 O 0 9.383154520037351e-08
colonic B-Disease 0 2.1092557290103287e-05
adenomas I-Disease 0 1.2413522654242115e-06
and O 0 6.338847502451728e-11
a O 0 2.193147226325909e-11
later O 0 9.522677091311493e-10
onset O 0 3.9246395317604765e-05
of O 1 0.5752720832824707
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.435395189490322e-11
age O 0 6.625293091921947e-10
> O 0 1.7688519537983893e-09
40 O 0 3.6637853861876124e-10
years O 0 1.1699467783454764e-10
) O 0 2.700032697422472e-10
. O 0 3.561335404356214e-08

The O 0 6.992719647769263e-08
aim O 0 1.943157101891302e-08
of O 0 5.64507829370342e-10
this O 0 7.53595727487344e-11
study O 0 1.6195274288310912e-10
was O 0 8.411506907668453e-11
to O 0 2.8281245401107213e-11
assess O 0 4.814637222239071e-08
genotype O 0 3.7367178720160155e-06
- O 0 6.395902346412186e-06
phenotype O 0 4.501933744904818e-06
correlations O 0 9.479227287556569e-07
in O 0 7.032686255570297e-08
AAPC B-Disease 1 1.0
families O 0 1.6085120080333581e-07
. O 0 1.2758704315274372e-07

By O 0 2.911876784139622e-08
protein O 0 1.770014002033804e-08
- O 0 3.6432666661312396e-08
truncation O 0 5.194324330659583e-07
test O 0 1.7385541468684096e-06
( O 0 1.0487180013285524e-09
PTT O 0 5.966423799463882e-08
) O 0 3.147306200379507e-12
assay O 0 5.595659491319793e-10
, O 0 9.83560021622365e-12
the O 0 4.884511198288699e-11
entire O 0 2.2021644230374449e-10
coding O 0 5.442171713276878e-10
region O 0 1.3409522381380157e-09
of O 0 1.488580547714946e-08
the O 0 3.2565168339715456e-07
APC B-Disease 0 2.7374261435397784e-07
gene O 0 5.672168845727299e-10
was O 0 8.088299474628968e-10
screened O 0 3.882439258973136e-09
in O 0 1.1203513811119947e-10
affected O 0 4.908281558968497e-10
individuals O 0 1.667624892343067e-11
from O 0 4.067357117776282e-09
11 O 0 1.0126775578100933e-06
AAPC B-Disease 1 1.0
kindreds O 0 0.0005104140727780759
, O 0 9.125611932780942e-10
and O 0 3.2267055694035207e-10
their O 0 4.974642364707904e-10
phenotypic O 0 5.498624489064241e-08
differences O 0 1.3313379554347193e-07
were O 0 5.203402793085843e-07
examined O 0 3.07038453684072e-06
. O 0 5.983666824249667e-07

Five O 0 2.8125029416514735e-07
novel O 0 1.978224020149355e-07
germ O 0 8.959069236880168e-05
- O 0 1.138912466558395e-05
line O 0 1.365393018204486e-05
APC B-Disease 0 5.112414100949536e-07
mutations O 0 2.2193993309826965e-09
were O 0 5.266771463396935e-10
identified O 0 5.89755966284855e-10
in O 0 1.0171233855160722e-09
seven O 0 2.514046926194169e-08
kindreds O 0 5.746004171669483e-05
. O 0 7.668523380743864e-07

Mutations O 0 6.134498562460067e-07
were O 0 3.3601008198047566e-08
located O 0 2.5393662728134814e-09
in O 0 4.557991484244184e-11
three O 0 8.799673663351104e-12
different O 0 1.6671032609938408e-11
regions O 0 5.491764265563859e-10
of O 0 8.120272809719609e-08
the O 0 1.0448397915752139e-05
APC B-Disease 0 2.1158384697628208e-06
gene O 0 1.4669642167675079e-09
( O 0 1.0581866979886279e-11
1 O 0 1.2028887885762174e-09
) O 0 2.9462567368437886e-12
at O 0 3.5061786807233375e-10
the O 0 3.5683217491921937e-10
5 O 0 1.8037051852104469e-09
end O 0 5.962530469361127e-09
spanning O 0 2.3161327078469185e-08
exons O 0 5.371410427557066e-09
4 O 0 1.758377221605656e-09
and O 0 7.130221413298443e-11
5 O 0 5.623670973342598e-10
, O 0 2.0228162894708746e-11
( O 0 5.591429229345746e-12
2 O 0 3.627011191387197e-10
) O 0 4.190575404044994e-12
within O 0 2.189495251769813e-10
exon O 0 4.047274959617653e-09
9 O 0 1.8694208403502444e-09
, O 0 1.8636373694258523e-11
and O 0 3.342243495851882e-11
( O 0 6.066371363577794e-12
3 O 0 3.2191077581344985e-10
) O 0 8.748893536719704e-13
at O 0 5.67632156556197e-11
the O 0 7.795027123780329e-11
3 O 0 7.491448017482583e-10
distal O 0 5.992664142695503e-09
end O 0 8.799585948793265e-09
of O 0 2.0802664479901978e-08
the O 0 5.687818216415508e-08
gene O 0 1.9281456431485822e-08
. O 0 3.958214733756904e-08

Variability O 0 5.521026650967542e-06
in O 0 5.7991127455636615e-09
the O 0 8.669669981919981e-10
number O 0 2.0585604332268304e-09
of O 0 2.037013018707512e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.004390301648527384
most O 0 7.016338177123771e-09
apparent O 0 1.1087836426781905e-08
in O 0 1.8424743675193866e-10
individuals O 0 5.82246707445111e-12
with O 0 2.2798945023549955e-11
mutations O 0 1.0859320109801729e-09
in O 0 1.5129274499869894e-09
region O 0 7.978869120961463e-09
1 O 0 4.707297662776e-08
, O 0 5.830360499947673e-11
and O 0 3.5152319943776433e-10
upper O 0 2.1510080841835588e-05
- O 0 1.791604154277593e-05
gastrointestinal O 1 0.6744807362556458
manifestations O 0 8.77871843840694e-06
were O 0 4.3445549380294324e-08
more O 0 1.7089576975770626e-10
severe O 0 1.4428208316985547e-07
in O 0 5.718371109963982e-09
them O 0 2.614074068318928e-09
. O 0 2.6322876323092714e-08

In O 0 6.974258326408744e-08
individuals O 0 3.4608785282053134e-10
with O 0 1.3913084573324852e-10
mutations O 0 1.3597640791118693e-09
in O 0 2.019711065059937e-09
either O 0 3.409798665643393e-09
region O 0 1.9606174461728187e-08
2 O 0 1.6108232969713754e-08
or O 0 3.083986954699469e-10
region O 0 2.1378510073333246e-09
3 O 0 1.5603366376737426e-09
, O 0 4.871111326798516e-12
the O 0 3.265200609892105e-11
average O 0 2.5843080453391565e-10
number O 0 1.183245584845949e-10
of O 0 3.388248792646209e-09
adenomas B-Disease 0 2.177272335757152e-06
tended O 0 6.218409964731109e-08
to O 0 8.048498673085547e-11
be O 0 1.313723990703508e-10
lower O 0 2.1246853165735047e-08
than O 0 3.426812306139837e-11
those O 0 2.6106434722339422e-11
in O 0 2.3719002456568106e-11
individuals O 0 2.6384497885112435e-12
with O 0 7.18921103204373e-12
mutations O 0 1.4532089420704608e-10
in O 0 8.292305037072012e-11
region O 0 3.6422206917130495e-10
1 O 0 8.962841024917623e-10
, O 0 1.3091628475736528e-12
although O 0 1.9179824395365586e-11
age O 0 4.6472717341039527e-10
at O 0 5.656222712424608e-10
diagnosis O 0 1.2257622472588992e-07
was O 0 8.563801223715473e-09
similar O 0 1.3114546781878289e-08
. O 0 1.413123413840367e-07

In O 0 3.2939769312179124e-07
all O 0 2.547335782310256e-07
AAPC B-Disease 1 1.0
kindreds O 0 2.9169128538342193e-05
, O 0 4.27712087969212e-10
a O 0 6.650281020315063e-11
predominance O 0 8.85478002032869e-08
of O 0 2.0911113551846938e-07
right O 0 0.44237375259399414
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9972800016403198
rectal B-Disease 1 1.0
polyp I-Disease 1 0.8792651295661926
sparing O 0 3.5059697438555304e-06
was O 0 2.459738368543185e-07
observed O 0 7.237323984554678e-08
. O 0 2.1034099972894182e-07

No O 0 5.587351552094333e-05
desmoid B-Disease 1 0.9999994039535522
tumors I-Disease 1 1.0
were O 0 6.636415150751418e-07
found O 0 5.238102396276645e-09
in O 0 1.6575834038690118e-09
these O 0 9.779943077603548e-09
kindreds O 0 3.149927215417847e-05
. O 0 4.141683689340425e-07

Our O 0 2.0267573574983544e-07
data O 0 1.8373340626709478e-09
suggest O 0 6.720570211449228e-10
that O 0 7.476566241115812e-12
, O 0 1.2012647820913713e-10
in O 0 2.3770397206135385e-08
AAPC B-Disease 1 1.0
families O 0 1.3414126476263277e-09
, O 0 1.5837063648341254e-12
the O 0 2.550998691799866e-12
location O 0 4.384062904372321e-11
of O 0 2.7455823725652806e-10
the O 0 7.406422497524545e-08
APC B-Disease 0 4.135402377869468e-06
mutation O 0 2.2368714880371954e-08
may O 0 6.952076248012418e-09
partially O 0 2.6523863994043495e-08
predict O 0 9.046487114972024e-09
specific O 0 3.776801982269262e-09
phenotypic O 0 7.030539563857019e-07
expression O 0 9.028276508615818e-07
. O 0 3.254517650930211e-07

This O 0 9.420109137181498e-09
should O 0 2.8394024909061955e-09
help O 0 3.4376942958935786e-10
in O 0 4.270402087502845e-11
the O 0 4.295103855911364e-11
design O 0 1.8245908117719978e-09
of O 0 7.24010629227223e-10
tailored O 0 8.131882367479193e-08
clinical O 0 4.224474139391532e-07
- O 0 4.6808139586573816e-08
management O 0 1.4725568542317546e-09
protocols O 0 3.992700214894285e-08
in O 0 1.2153322792585186e-10
this O 0 1.212358772401112e-11
subset O 0 1.963513129865646e-09
of O 0 1.814543515443745e-09
FAP B-Disease 0 9.581654740031809e-05
patients O 0 6.854957064206246e-07
. O 0 2.4382960095437056e-09
. O 0 2.3749777255943627e-08

Wilms B-Disease 1 0.9999998807907104
' I-Disease 0 0.09781809151172638
tumor I-Disease 0 1.5861825886531733e-05
1 O 0 1.1658541154702107e-07
and O 0 2.6308004663633255e-09
Dax O 0 0.1728552132844925
- O 0 5.673991836374626e-07
1 O 0 2.1269138983370794e-07
modulate O 0 2.4511153995376844e-08
the O 0 1.2916890668179803e-08
orphan O 0 2.594144064005377e-07
nuclear O 0 4.084142446458827e-08
receptor O 0 2.1745147904539408e-08
SF O 0 0.0022370917722582817
- O 0 8.904845572033082e-08
1 O 0 1.0968006058931223e-08
in O 0 6.119215550937085e-11
sex O 0 4.90314212842069e-11
- O 0 3.614249177719131e-10
specific O 0 4.5004427962069826e-10
gene O 0 1.1921900133771146e-09
expression O 0 7.150902980868068e-09
. O 0 1.548510830673422e-08

Products O 0 1.8186142369813751e-06
of O 0 4.4985549152443127e-07
steroidogenic O 1 0.9990697503089905
factor O 0 2.676881649676943e-06
1 O 0 1.9531847783582634e-07
( O 0 4.2218520346359867e-10
SF O 1 0.9999358654022217
- O 0 1.249342858500313e-06
1 O 0 1.0093552305079356e-07
) O 0 1.6257049872958618e-10
and O 0 3.0274900364446466e-09
Wilms B-Disease 1 0.9987585544586182
tumor I-Disease 0 0.00021132145775482059
1 O 0 8.814067768980749e-07
( O 0 1.1618506157162756e-09
WT1 O 0 6.646531801379751e-06
) O 0 6.557701603959742e-11
genes O 0 2.30955168184499e-11
are O 0 7.993247990584207e-13
essential O 0 4.6940028253228405e-11
for O 0 1.5094843777707645e-11
mammalian O 0 4.146813026295604e-08
gonadogenesis O 0 3.420885263949458e-07
prior O 0 1.992614215851063e-07
to O 0 5.288649074230989e-09
sexual O 0 1.2831387508072112e-08
differentiation O 0 1.1181352874700679e-06
. O 0 2.1978431163915957e-07

In O 0 4.8078650394245415e-08
males O 0 1.885563927217504e-09
, O 0 4.6245823837054445e-10
SF O 1 0.9999876022338867
- O 0 1.4914424355083611e-05
1 O 0 6.470046400863794e-07
participates O 0 5.405014213977211e-10
in O 0 1.5984314566397373e-11
sexual O 0 4.004162452997395e-12
development O 0 2.1075446943186193e-11
by O 0 6.55119708481422e-12
regulating O 0 8.014525709754139e-10
expression O 0 7.644578026155813e-11
of O 0 1.0683149503920575e-10
the O 0 1.1581048342534928e-09
polypeptide O 0 1.4314672114323912e-07
hormone O 0 3.217331112637112e-08
Mullerian O 0 3.7116112707735738e-06
inhibiting O 0 1.3598301507045107e-07
substance O 0 2.284385118400678e-06
( O 0 3.150339722424178e-08
MIS O 0 0.0007764908368699253
) O 0 1.6960546744826388e-08
. O 0 1.1879396311087476e-07

Here O 0 4.844792442781909e-07
, O 0 1.9980623822135612e-09
we O 0 1.8808646307100219e-10
show O 0 1.022953735607679e-10
that O 0 4.666686481691329e-11
WT1 O 0 0.00026655817055143416
- O 0 9.307116852141917e-05
KTS O 1 0.9987903237342834
isoforms O 0 5.897869073123729e-07
associate O 0 8.986261512688998e-09
and O 0 2.1333323996231002e-10
synergize O 0 1.7443788635773672e-07
with O 0 7.437148674682703e-10
SF O 1 1.0
- O 0 0.0005286219529807568
1 O 0 8.782937470641627e-07
to O 0 3.098469258944192e-09
promote O 0 1.0824423668509553e-07
MIS O 0 0.0005298018222674727
expression O 0 8.413380925276215e-08
. O 0 3.4230936307722004e-08

In O 0 1.8465119921984297e-07
contrast O 0 7.45544753044669e-07
, O 0 1.4778932211356732e-07
WT1 O 1 0.9809977412223816
missense O 0 0.00010480189666850492
mutations O 0 1.8933635104190216e-08
, O 0 2.6361723567958073e-11
associated O 0 1.2065876076050586e-10
with O 0 5.625577781387392e-11
male B-Disease 0 1.0996682675568081e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.9476678062346764e-05
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.920094967696969e-09
fail O 0 9.980488613337002e-08
to O 0 1.0100497105369755e-09
synergize O 0 4.958551926392829e-06
with O 0 2.708623725311554e-08
SF O 1 1.0
- O 0 0.37475550174713135
1 O 0 1.0021670277637895e-05
. O 0 6.74523263910487e-08

Additionally O 0 4.6411466314566496e-07
, O 0 1.1784780928891792e-09
the O 0 6.776820771214886e-10
X O 0 1.8970490600622725e-06
- O 0 2.019061611235884e-07
linked O 0 5.145508552573119e-08
, O 0 6.016995929281066e-11
candidate O 0 5.328285590522341e-10
dosage O 0 1.477081497114341e-07
- O 0 1.9887142599372964e-08
sensitive O 0 1.1602705285440607e-07
sex O 0 5.90200499583915e-10
- O 0 4.697456201796513e-09
reversal O 0 2.0741925510492365e-08
gene O 0 2.7644799782677865e-09
, O 0 8.465995127160397e-10
Dax O 1 0.9933019876480103
- O 0 7.430150503751065e-07
1 O 0 5.083030600872007e-07
, O 0 4.964103017535137e-10
antagonizes O 0 7.139103530562352e-08
synergy O 0 1.0094415081596253e-08
between O 0 4.8949990727464865e-09
SF O 1 0.9999468326568604
- O 0 9.297371548200317e-07
1 O 0 6.968035393128957e-08
and O 0 3.258942837813805e-10
WT1 O 0 1.6845262962306151e-06
, O 0 2.23612170446863e-11
most O 0 2.2912725536339273e-11
likely O 0 5.602138891669384e-11
through O 0 5.1901694747558125e-12
a O 0 1.6948870692340412e-12
direct O 0 1.0375513816163195e-11
interaction O 0 1.0036867170715169e-10
with O 0 2.9188579331318465e-10
SF O 1 1.0
- O 0 0.00010156376083614305
1 O 0 3.1050669804244535e-06
. O 0 4.525573871205779e-08

We O 0 5.7108859863319594e-08
propose O 0 1.1939660282678233e-07
that O 0 1.2643296409819982e-09
WT1 O 1 0.9796201586723328
and O 0 5.864060881322075e-07
Dax O 1 0.9999988079071045
- O 0 4.931549483444542e-06
1 O 0 2.2060791593503382e-07
functionally O 0 4.247417528802089e-09
oppose O 0 2.6102914274517275e-10
each O 0 2.335277804466074e-12
other O 0 1.647234779134088e-11
in O 0 3.0553506946695563e-10
testis O 0 3.728483832787788e-08
development O 0 1.1387151638286852e-10
by O 0 6.72227135067871e-11
modulating O 0 2.784833270652598e-07
SF O 1 0.9999265670776367
- O 0 2.0175154986645794e-06
1 O 0 3.043207641439949e-07
- O 0 4.241113771286109e-08
mediated O 0 8.001153162240371e-08
transactivation O 0 1.800946051844221e-06
. O 0 1.073352784430881e-08
. O 0 2.5508576584343245e-08

A O 0 3.9949901520230924e-07
mouse O 0 5.120396551205886e-08
model O 0 3.1597979788244857e-09
for O 0 1.2898573764630328e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999529123306274
centre O 0 0.00012150086695328355
mutations O 0 2.364591438208663e-07
. O 0 5.327051511017089e-08

Imprinting O 0 1.4826741789875086e-05
in O 0 1.662742477037682e-08
the O 0 4.630145156170329e-09
15q11 O 0 1.825578806347039e-06
- O 0 3.3703102531035256e-07
q13 O 0 1.1790731377914199e-06
region O 0 1.1936188704098072e-09
involves O 0 2.809523447222517e-10
an O 0 4.990574793695135e-12
imprinting O 0 1.1657495946337804e-07
centre O 0 4.4092112716498377e-07
( O 0 1.6109506784101058e-10
IC O 0 1.8414859368931502e-05
) O 0 5.033049671476775e-11
, O 0 6.831502377679932e-12
mapping O 0 5.6623723071469456e-11
in O 0 4.482176782505398e-11
part O 0 1.293980894656599e-10
to O 0 1.2839404539555233e-10
the O 0 4.958957244838302e-09
promoter O 0 5.929326789555489e-07
and O 0 2.499195961291889e-09
first O 0 2.230889251109147e-08
exon O 0 2.683842126316449e-07
of O 0 3.9712066524089096e-08
SNRPN O 1 0.9976056814193726
. O 0 3.3642870675976155e-06

Deletion O 0 6.547312523252913e-07
of O 0 1.764129109460555e-08
this O 0 4.223199123742916e-09
IC O 0 0.0006571214180439711
abolishes O 0 2.048161377388169e-06
local O 0 2.3294367323956067e-08
paternally O 0 7.364248233443504e-08
derived O 0 1.5015488852299086e-09
gene O 0 8.493064584946808e-11
expression O 0 1.3814813876189547e-11
and O 0 1.0417149998512287e-12
results O 0 8.02838281965812e-11
in O 0 1.3362194017929596e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.678080141544342
PWS B-Disease 1 1.0
) O 0 1.3418488720162713e-07
. O 0 1.2326950127317104e-07

We O 0 9.638796427680063e-08
have O 0 2.247810604316669e-09
created O 0 4.437488598796335e-09
two O 0 7.080163122452632e-10
deletion O 0 1.0235699932081843e-07
mutations O 0 1.5284221888123284e-08
in O 0 4.165360500962834e-09
mice O 0 1.0561255869845354e-08
to O 0 5.868575625456174e-10
understand O 0 1.1693097121678875e-06
PWS B-Disease 1 1.0
and O 0 2.0734489680762636e-08
the O 0 1.1987933978829801e-09
mechanism O 0 5.418990811634217e-10
of O 0 3.5575842272095315e-10
this O 0 1.124265014418313e-09
IC O 0 0.0009785271249711514
. O 0 3.9623853353987215e-07

Mice O 0 0.00017692083201836795
harbouring O 0 1.8491551600163803e-05
an O 0 8.863359823862993e-09
intragenic O 0 2.6002471713582054e-05
deletion O 0 6.01639726482972e-07
in O 0 4.350450311108034e-08
Snrpn O 0 0.0007399949245154858
are O 0 7.128515111531897e-09
phenotypically O 0 6.333651072054636e-06
normal O 0 2.5295349814768997e-08
, O 0 4.818893201141705e-11
suggesting O 0 3.248770419350677e-10
that O 0 1.665999369709903e-12
mutations O 0 2.4129784281790023e-10
of O 0 4.799542985267635e-09
SNRPN O 1 0.9999974966049194
are O 0 2.7511390388035295e-10
not O 0 4.571626063820666e-11
sufficient O 0 5.007851022753584e-09
to O 0 3.1634765917942786e-09
induce O 0 1.214902204083046e-05
PWS B-Disease 1 1.0
. O 0 3.302009281469509e-05

Mice O 0 4.776627974933945e-06
with O 0 6.529946028344114e-10
a O 0 8.395082407020027e-10
larger O 0 5.697304850116325e-09
deletion O 0 1.0282755980028924e-08
involving O 0 4.63716220977517e-09
both O 0 3.778005019938746e-09
Snrpn O 0 0.00010085104440804571
and O 0 1.5993479873799288e-09
the O 0 8.23001045091587e-09
putative O 0 3.803700792559539e-06
PWS O 1 1.0
- O 0 0.0002527186879888177
IC O 0 0.4132816791534424
lack O 0 8.297268294654714e-08
expression O 0 8.623821656783548e-10
of O 0 1.454903558739673e-10
the O 0 4.625711202965732e-10
imprinted O 0 4.207731407745996e-08
genes O 0 2.1465416111254854e-09
Zfp127 O 0 2.987452489833231e-06
( O 0 9.934935096822528e-10
mouse O 0 3.72993476105421e-08
homologue O 0 2.3411566019149177e-07
of O 0 5.157859916948837e-08
ZNF127 O 1 0.9999978542327881
) O 0 2.468357074292271e-08
, O 0 7.873963703275422e-09
Ndn O 0 6.800904657211504e-07
and O 0 7.805400770166671e-10
Ipw O 0 2.0162556211289484e-06
, O 0 5.841494510328005e-10
and O 0 4.591613755877688e-10
manifest O 0 3.270403325927873e-08
several O 0 8.35894020667638e-10
phenotypes O 0 3.2456065923724964e-07
common O 0 7.269088087014097e-08
to O 0 5.896316679354641e-07
PWS B-Disease 1 1.0
infants O 1 1.0
. O 0 2.514112793505774e-06

These O 0 3.115478719450948e-08
data O 0 3.3735267912504696e-09
demonstrate O 0 5.056934870850682e-10
that O 0 2.3393969053597807e-12
both O 0 1.4699371927995308e-11
the O 0 7.846685107226747e-11
position O 0 4.678872289609615e-10
of O 0 3.587751207234646e-10
the O 0 9.584925075856177e-10
IC O 0 0.03154951333999634
and O 0 3.0595903588448436e-10
its O 0 3.6082616061694495e-11
role O 0 3.4292051837025994e-11
in O 0 4.634425482263893e-11
the O 0 1.2221570977466456e-10
coordinate O 0 1.3898523998356893e-10
expression O 0 8.598445289109691e-10
of O 0 3.2979885489226035e-09
genes O 0 6.730113688568906e-10
is O 0 2.3525981510119642e-11
conserved O 0 5.549932180493045e-10
between O 0 3.0800720307588847e-10
mouse O 0 2.463832160515267e-08
and O 0 1.9436924292293156e-10
human O 0 1.721336406745877e-10
, O 0 2.347524084844732e-11
and O 0 1.6647964257154868e-11
indicate O 0 4.4812875632516125e-11
that O 0 1.9321105045738696e-12
the O 0 4.44078857020358e-10
mouse O 0 1.5491540272805082e-09
is O 0 1.1993337096019574e-12
a O 0 7.980222385683966e-13
suitable O 0 2.707779001021038e-10
model O 0 1.846069408451001e-10
system O 0 8.295552023085406e-10
in O 0 3.233628989574022e-11
which O 0 3.140578075377931e-12
to O 0 6.369871644040792e-12
investigate O 0 4.6281270482673165e-11
the O 0 1.2534112636686245e-10
molecular O 0 7.830287529486668e-10
mechanisms O 0 1.1168486135915145e-09
of O 0 1.7623625891971528e-09
imprinting O 0 3.451323493663949e-08
in O 0 1.852771547294907e-10
this O 0 3.826270203455273e-11
region O 0 1.1988253723060893e-09
of O 0 1.3614794847072176e-09
the O 0 4.047398860507201e-09
genome O 0 1.5849174195281535e-09
. O 0 5.179207618333237e-10
. O 0 9.542464596279387e-09

Mutations O 0 6.267563890105521e-07
of O 0 8.45041796537771e-08
the O 0 9.942147016772651e-08
ATM O 0 9.031075023813173e-06
gene O 0 2.9159099579345593e-09
detected O 0 4.366809136513439e-09
in O 0 9.380283216842145e-10
Japanese O 1 0.9867148995399475
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999977350234985
: O 0 2.903575296864247e-11
possible O 0 6.829135174024614e-11
preponderance O 0 1.2579414843116865e-08
of O 0 1.0345915790743732e-10
the O 0 1.591538706380291e-10
two O 0 5.672133249201572e-11
founder O 0 2.1345719858345547e-08
mutations O 0 2.3864967779729795e-09
4612del165 O 0 2.939014791536465e-07
and O 0 5.529395163961226e-09
7883del5 O 0 7.641761840204708e-06
. O 0 3.646976267646096e-07

The O 0 2.038511411228683e-06
ATM O 0 0.0018417274113744497
( O 0 4.6397392594599296e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.5784795692752596e-09
mutated O 0 7.135561475024588e-09
) O 0 3.9533726986507034e-11
gene O 0 1.1496553015133415e-10
on O 0 4.3178915998254297e-10
human O 0 4.233907668904635e-10
chromosome O 0 5.249504386739545e-09
11q22 O 0 4.079618520336226e-06
. O 0 6.132252110546688e-07

3 O 0 9.424815289094113e-06
has O 0 1.877231703417692e-09
recently O 0 1.1140828259925684e-09
been O 0 1.7282382469563373e-10
identified O 0 1.1324966658898816e-10
as O 0 2.8662959158931578e-11
the O 0 2.422532313639536e-11
gene O 0 7.989425093724023e-12
responsible O 0 2.1026611441571363e-12
for O 0 4.092415642475977e-12
the O 0 1.3004591847831648e-09
human O 0 2.0306009318460383e-08
recessive B-Disease 1 0.9995500445365906
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.010630762204527855
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.831712026501009e-08
. O 0 6.42187600874422e-08

In O 0 9.005995060817895e-09
order O 0 2.387120279223609e-09
to O 0 2.0913519527265834e-10
define O 0 6.423805931632387e-10
the O 0 1.5244842888062493e-10
types O 0 2.3558426320846593e-09
of O 0 3.79170694841946e-09
disease O 0 5.920573585171951e-06
- O 0 1.6645074083498912e-06
causing O 0 4.611424174072454e-06
ATM O 0 7.952158193802461e-05
mutations O 0 9.556302416058315e-10
in O 0 1.243472130818546e-10
Japanese O 0 4.6213773430281435e-07
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5116758731892332e-05
as O 0 9.213193402635156e-11
well O 0 2.4400474696317787e-11
as O 0 9.729246921996726e-12
to O 0 8.026847415909533e-12
look O 0 9.211365697980867e-11
for O 0 2.1335350153250943e-11
possible O 0 2.4602382353577923e-09
mutational O 0 3.590285587051767e-06
hotspots O 0 3.606151892654452e-07
, O 0 1.565466367647872e-10
reverse O 0 2.1637072133984248e-09
- O 0 5.470711883504009e-09
transcribed O 0 8.739099999210964e-10
RNA O 0 1.0389539922828206e-10
derived O 0 5.896094029678167e-11
from O 0 2.60448624472831e-11
ten O 0 1.2032788099247682e-09
patients O 0 1.1319680748300698e-09
belonging O 0 9.790049326774408e-11
to O 0 2.3669921925262294e-11
eight O 0 7.587464545544265e-10
unrelated O 0 3.00659692697991e-08
Japanese O 0 5.163241075933911e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 4.2670009192669056e-10
was O 0 6.17736903296695e-11
analyzed O 0 4.446736381891192e-11
for O 0 4.604316927725449e-12
mutations O 0 1.776285021848345e-11
by O 0 2.43045566311606e-11
the O 0 5.960503757229674e-10
restriction O 0 3.562877637364181e-08
endonuclease O 0 1.2774044932939432e-07
fingerprinting O 0 7.523372858031507e-08
method O 0 1.2575438290696184e-07
. O 0 6.124174234400925e-08

As O 0 3.333727249810181e-07
has O 0 3.5523292640782245e-10
been O 0 8.141197438416015e-11
reported O 0 2.4191247963156748e-11
by O 0 9.290466312927848e-11
others O 0 5.308991024577381e-10
, O 0 3.6153087468182576e-11
mutations O 0 7.813723279515017e-11
that O 0 5.691952117969912e-12
lead O 0 3.577066198801049e-09
to O 0 3.75924447126863e-09
exon O 0 1.3757031410932541e-05
skipping O 0 1.18428906716872e-05
or O 0 4.542425990905485e-09
premature O 0 1.7174814459508525e-08
protein O 0 4.3649248104848937e-10
truncation O 0 1.5782935847141744e-08
were O 0 1.389177328725566e-09
also O 0 1.4354459287879706e-10
predominant O 0 2.1499113245226908e-07
in O 0 3.7549163778294314e-09
our O 0 2.0861191885046537e-08
mutants O 0 2.9632553832925623e-07
. O 0 2.21975611225389e-08

Six O 0 4.6593160618613183e-07
different O 0 3.533046299963871e-09
mutations O 0 2.0369150810495285e-09
were O 0 4.3473769029134246e-10
identified O 0 1.3093288953047733e-10
on O 0 4.807667597361842e-10
12 O 0 2.926584252715969e-10
of O 0 3.074965004845609e-10
the O 0 4.904887163093008e-09
16 O 0 6.044069777999539e-08
alleles O 0 1.4606411191664392e-08
examined O 0 5.849739181940095e-07
. O 0 1.9401949202801916e-07

Four O 0 9.356435981544564e-08
were O 0 9.63397717157477e-09
deletions O 0 1.2129342863431702e-08
involving O 0 3.25742188778122e-09
a O 0 1.5599945779598556e-09
loss O 0 1.2456840181584994e-07
of O 0 2.0822679402954236e-07
a O 0 4.677099152416986e-09
single O 0 6.237818261922712e-09
exon O 0 4.149819332610605e-08
exon O 0 3.243925661422509e-08
7 O 0 1.0438791164801842e-08
, O 0 2.1155684148954634e-10
exon O 0 3.3291293277670775e-08
16 O 0 1.0021076413124774e-08
, O 0 9.44082478859798e-10
exon O 0 2.6801845365298504e-07
33 O 0 1.6558831816837483e-07
or O 0 2.9746596297286487e-08
exon O 0 5.857404630660312e-06
35 O 0 1.0935617638097028e-06
. O 0 3.0432454423134914e-07

The O 0 5.703086003450153e-07
others O 0 2.643537833080245e-08
were O 0 8.472363255407345e-09
minute O 0 4.6083851401590437e-08
deletions O 0 3.895258515740352e-08
, O 0 1.1578088487951277e-09
4649delA O 0 3.584099488307402e-07
in O 0 1.2954490813399389e-08
exon O 0 2.0164100078545744e-07
33 O 0 2.3368238899479366e-08
and O 0 6.93325563627667e-10
7883del5 O 0 1.4917034150130348e-06
in O 0 1.1845603609117461e-07
exon O 0 5.105644049763214e-06
55 O 0 9.759446584212128e-07
. O 0 2.6515169793128734e-07

The O 0 2.129451786458958e-06
mutations O 0 2.321227867696507e-07
4612del165 O 0 1.9797123513853876e-06
and O 0 5.625175880652478e-09
7883del5 O 0 1.3446020830087946e-06
were O 0 1.0560490260047573e-08
found O 0 1.3326419134873646e-10
in O 0 2.7977576852467045e-11
more O 0 4.139676448855489e-12
than O 0 1.4072651030594407e-11
two O 0 1.4833802589042655e-11
unrelated O 0 4.271220710450052e-09
families O 0 2.3472824378645285e-11
; O 0 7.44054644286063e-12
44 O 0 5.441134209860365e-10
% O 0 2.3438912269413414e-11
( O 0 1.2848112330987593e-12
7 O 0 3.880008814238778e-10
of O 0 6.505108673948712e-10
16 O 0 7.77879705093909e-10
) O 0 3.0778019022292824e-12
of O 0 1.2134004911956708e-10
the O 0 3.68639174741503e-10
mutant O 0 1.2563942108911874e-09
alleles O 0 8.266784479182832e-11
had O 0 4.3354177886589795e-11
one O 0 7.107378921511476e-12
of O 0 6.995111434537904e-11
the O 0 8.833129783170079e-10
two O 0 6.76607492255954e-10
mutations O 0 9.343093410052461e-09
. O 0 5.0793378392199884e-08

The O 0 1.561950625728059e-06
4612del165 O 0 1.4805645150772762e-05
mutations O 0 1.399705062965495e-08
in O 0 2.756796180225507e-10
three O 0 2.396218640177139e-11
different O 0 1.2007740288200175e-11
families O 0 1.0098000560732068e-11
were O 0 5.1794023930851196e-11
all O 0 7.6515183078385e-12
ascribed O 0 1.5882947179690632e-09
to O 0 3.136450821283887e-10
the O 0 3.863461994768613e-09
same O 0 2.1782662340541492e-09
T O 0 2.5178476192877497e-08
- O 0 2.017258804443145e-09
- O 0 7.607940943898939e-10
> O 0 1.1484876383249798e-09
A O 0 7.626446696384903e-11
substitution O 0 4.6432577227584204e-10
at O 0 8.729899442228017e-11
the O 0 5.35567076798138e-11
splice O 0 1.9429975850471237e-08
donor O 0 2.197747095422642e-09
site O 0 7.97238808303291e-09
in O 0 2.5484492294225447e-09
intron O 0 2.9623417958646314e-06
33 O 0 7.63251762236905e-07
. O 0 2.4315704649779946e-07

Microsatellite O 0 0.0014040612149983644
genotyping O 0 0.00019789398356806487
around O 0 6.538451913229437e-08
the O 0 3.2707777819496187e-08
ATM O 0 6.719218163198093e-06
locus O 0 1.141717564934197e-08
also O 0 3.405154977431657e-11
indicated O 0 2.1757479498618615e-11
that O 0 5.457267125176524e-13
a O 0 8.84234092196623e-12
common O 0 3.852958507799542e-10
haplotype O 0 3.927859371088971e-09
was O 0 2.2315138625828013e-09
shared O 0 6.522798273733699e-11
by O 0 5.060789027427903e-12
the O 0 7.469885127120435e-11
mutant O 0 2.413854449656583e-09
alleles O 0 5.023001459214527e-10
in O 0 2.4446467072891664e-10
both O 0 8.51993753325786e-10
mutations O 0 2.1343034006804373e-08
. O 0 8.119312866483597e-08

This O 0 3.669229542424546e-08
suggests O 0 2.191168491094686e-08
that O 0 4.599509315084127e-11
these O 0 1.9411028340243774e-10
two O 0 4.919819551751914e-10
founder O 0 9.679585843969107e-08
mutations O 0 4.99495111938586e-10
may O 0 5.847290984739573e-10
be O 0 2.7472743524548093e-10
predominant O 0 1.3694807421416044e-06
among O 0 1.5314213230865903e-09
Japanese O 0 6.158143150969408e-08
ATM O 0 2.0296599814173533e-06
mutant O 0 3.3164639035021537e-07
alleles O 0 1.1390350351803136e-07
. O 0 5.394401014768846e-08

W474C O 0 1.6181036698981188e-05
amino O 0 2.6070251735177408e-08
acid O 0 2.869816162487382e-09
substitution O 0 1.2276815120060292e-08
affects O 0 4.857329538587862e-10
early O 0 2.815468747030536e-09
processing O 0 1.7358573467518568e-09
of O 0 1.0133164307646325e-09
the O 0 1.4080961951989934e-09
alpha O 0 3.545595816945024e-09
- O 0 7.575592375630436e-10
subunit O 0 1.5921004792307514e-10
of O 0 6.425027870848865e-11
beta O 0 1.2283273287394536e-09
- O 0 6.724856227435794e-09
hexosaminidase O 0 6.501821303572797e-07
A O 0 5.048225837356313e-09
and O 0 2.4792100664083883e-11
is O 0 6.382613621652711e-13
associated O 0 2.6378824471984252e-11
with O 0 4.727607541554768e-11
subacute O 1 0.6468491554260254
G B-Disease 1 0.9999674558639526
( I-Disease 0 2.2398683796609475e-08
M2 I-Disease 0 0.0002199665759690106
) I-Disease 0 5.1195145900351235e-09
gangliosidosis I-Disease 0 1.473962765885517e-05
. O 0 5.754117751166632e-07

Mutations O 0 8.173257697308145e-07
in O 0 2.4213719029830827e-08
the O 0 5.620180942855768e-08
HEXA O 0 7.23199627827853e-05
gene O 0 2.0143520185200714e-09
, O 0 4.0851880905856675e-11
encoding O 0 4.9920179101548e-10
the O 0 1.374541369614235e-09
alpha O 0 8.098240411591462e-10
- O 0 2.6177252032688614e-10
subunit O 0 1.3266744647300044e-10
of O 0 3.411584209578322e-11
beta O 0 3.5734504244544496e-10
- O 0 2.599149118154287e-09
hexosaminidase O 0 2.3423854145221412e-06
A O 0 1.5020242472019163e-07
( O 0 1.865298887571143e-10
Hex O 0 1.3024263978422823e-07
A O 0 1.7345930247714136e-09
) O 0 4.192438063377324e-12
, O 0 1.530951797626412e-12
that O 0 8.317799574109053e-13
abolish O 0 1.9375685056388647e-08
Hex O 0 1.701252017483057e-06
A O 0 6.769486304847305e-09
enzyme O 0 5.951373172052854e-09
activity O 0 1.0989805510064343e-08
cause O 0 2.1862108042114414e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.5053635610561287e-08
TSD B-Disease 1 0.9999500513076782
) O 0 2.309394064869963e-10
, O 0 5.57814870683071e-11
the O 0 1.902158652811181e-09
fatal O 0 2.2715127556693915e-07
infantile B-Disease 0 8.664321882179138e-08
form I-Disease 0 4.006315279525552e-09
of I-Disease 0 1.1544024118848029e-06
G I-Disease 0 0.09551236033439636
( I-Disease 0 1.1825106449592226e-09
M2 I-Disease 0 5.8631831052480265e-06
) I-Disease 0 9.19858425540987e-11
gangliosidosis I-Disease 0 1.1248623366100219e-07
, I-Disease 0 1.1296122370829664e-10
Type I-Disease 0 9.211164275768624e-09
1 I-Disease 0 6.65273915956277e-08
. O 0 1.3805932397303877e-08

Less O 0 2.084999096041429e-06
severe O 0 0.00431158347055316
, O 0 5.094576067676826e-07
subacute O 1 0.9999998807907104
( O 0 2.784606856209848e-08
juvenile O 1 0.777548611164093
- O 0 7.444690481861471e-07
onset O 1 0.9999489784240723
) O 0 1.4076619869740625e-08
and O 0 3.0288029506664316e-07
chronic O 1 0.9999978542327881
( O 0 1.2641101498900298e-09
adult O 0 2.5113823909350685e-08
- O 0 5.5010342947525714e-09
onset O 0 9.415223303221865e-07
) O 0 7.742823049383674e-11
variants O 0 2.7731938967434644e-09
are O 0 3.1466596689400106e-11
characterized O 0 3.637824069757656e-11
by O 0 2.951562258490803e-11
a O 0 1.5940360142963073e-10
broad O 0 2.6459138879886268e-08
spectrum O 0 1.1354721607403917e-07
of O 0 2.026328438375913e-09
clinical O 0 7.02732307900078e-08
manifestations O 0 1.495319246203053e-08
and O 0 4.789296043083979e-11
are O 0 1.3544480207544618e-12
associated O 0 3.5380309792998332e-12
with O 0 1.0954623709882871e-12
residual O 0 2.1250095016966952e-08
levels O 0 2.5187986807395646e-08
of O 0 2.485933059404033e-08
Hex O 0 7.008180546108633e-06
A O 0 6.266799346121843e-08
enzyme O 0 3.3938842847192063e-08
activity O 0 2.4425142797213084e-08
. O 0 1.4001401815733061e-08

We O 0 6.568149757413266e-08
identified O 0 9.563199121487287e-09
a O 0 1.5106523809649275e-09
1422 O 0 6.2010922192712314e-06
G O 0 1.5404855275846785e-06
- O 0 1.4844360407550994e-07
- O 0 7.420987202522156e-08
> O 0 1.4226333178157802e-07
C O 0 1.2714612296349515e-07
( O 0 3.9728654394055596e-12
amino O 0 9.468370532061954e-12
acid O 0 2.9777545013098816e-11
W474C O 0 1.0745115908150638e-09
) O 0 2.6044636824811007e-13
substitution O 0 1.1565767094046109e-10
in O 0 3.023770470123033e-11
the O 0 2.8712150712539852e-11
first O 0 7.346154240472913e-11
position O 0 4.831826605489198e-10
of O 0 8.432056164409119e-10
exon O 0 1.4621128308078823e-08
13 O 0 7.825584624754356e-10
of O 0 2.2706359015245425e-09
HEXA O 0 0.0010330722434446216
of O 0 3.4245566382651305e-08
a O 0 1.8477752661283375e-09
non O 0 1.5898632454991457e-07
- O 0 1.3511845509128761e-07
Jewish O 0 1.2476718325160618e-07
proband O 0 6.137182481324999e-06
who O 0 3.928666836294781e-10
manifested O 0 5.6559881222995045e-09
a O 0 4.105256967701365e-10
subacute O 0 2.1050225313956616e-06
variant O 0 9.249623644791427e-07
of O 0 9.683529242465738e-06
G B-Disease 1 0.9787536859512329
( I-Disease 0 1.6151796344843206e-08
M2 I-Disease 0 0.00013032999413553625
) I-Disease 0 5.3865947258202596e-09
gangliosidosis I-Disease 0 1.820834404497873e-05
. O 0 2.5510556156405073e-07

On O 0 3.0905709991202457e-07
the O 0 1.758673207064021e-08
second O 0 1.2922920689106832e-07
maternally O 0 1.000925294647459e-06
inherited O 0 3.589089772049192e-07
allele O 0 8.685911545569525e-09
, O 0 2.4114866353786013e-11
we O 0 1.194826572750718e-12
identified O 0 6.485379507731315e-12
the O 0 6.594150225858186e-11
common O 0 1.400160954290186e-06
infantile O 0 0.014118742197751999
disease O 0 1.6084342860267498e-05
- O 0 1.1403730582060234e-07
causing O 0 5.4949655492464444e-08
4 O 0 4.886764415346079e-08
- O 0 7.684422875797736e-09
bp O 0 6.20554008179397e-09
insertion O 0 8.613847413130316e-09
, O 0 3.1926736254739296e-10
+ O 0 7.732825046957714e-09
TATC O 0 3.305614154669456e-05
1278 O 0 2.4695218598935753e-05
, O 0 5.317635221047112e-10
in O 0 3.4883034238930577e-09
exon O 0 4.897705707662681e-07
11 O 0 5.2201226452552874e-08
. O 0 5.8134684621791166e-08

Pulse O 0 3.658849163912237e-05
- O 0 9.583084192854585e-07
chase O 0 1.7019136322460326e-08
analysis O 0 1.5645826301202703e-10
using O 0 3.154160266305439e-10
proband O 0 1.90899277185963e-06
fibroblasts O 0 6.266500207630088e-08
revealed O 0 1.6813375136592867e-09
that O 0 3.3174784534045765e-12
the O 0 1.8489165753976522e-10
W474C O 0 2.3594909137614195e-08
- O 0 2.207312999047417e-09
containing O 0 1.0871340494489345e-09
alpha O 0 1.0968774777353474e-09
- O 0 2.103385104978983e-10
subunit O 0 2.7528029855616865e-10
precursor O 0 1.142431482747952e-09
was O 0 2.592097925191439e-10
normally O 0 2.0750205373398778e-11
synthesized O 0 4.87508478030918e-10
, O 0 3.2329740013575803e-12
but O 0 7.1088976719146935e-12
not O 0 1.4464056688479054e-11
phosphorylated O 0 1.9631732683933478e-08
or O 0 3.0528982120081594e-10
secreted O 0 4.926627994450428e-10
, O 0 1.0250606786998961e-11
and O 0 3.4240287688502846e-11
the O 0 8.129006356938362e-10
mature O 0 4.40691536596205e-08
lysosomal O 0 1.766771106304077e-06
alpha O 0 4.0296377790127735e-08
- O 0 1.2265907400887954e-08
subunit O 0 2.9109756827239153e-09
was O 0 1.7034326171838643e-09
not O 0 1.8422914582760797e-10
detected O 0 5.151252935320372e-08
. O 0 5.070799957707095e-08

When O 0 6.094181514981756e-08
the O 0 9.535877865118891e-09
W474C O 0 3.10147498794322e-07
- O 0 1.536917437761076e-08
containing O 0 3.5795644226510603e-09
alpha O 0 7.830157855437392e-09
- O 0 1.679340666527196e-09
subunit O 0 3.4105531732109284e-09
was O 0 5.1205306661472605e-09
transiently O 0 1.2177099506516242e-07
co O 0 3.607377507819365e-09
- O 0 3.2244618086707533e-09
expressed O 0 1.7684666231421176e-10
with O 0 3.887131068414096e-12
the O 0 5.2520227750152415e-11
beta O 0 1.099486751643397e-10
- O 0 1.0502668873479948e-10
subunit O 0 2.7575469685459097e-11
to O 0 3.537045873205913e-12
produce O 0 2.9676916479814963e-10
Hex O 0 3.079450152654317e-07
A O 0 1.782770375768905e-08
( O 0 1.2968272289359817e-10
alphabeta O 0 3.879709993270808e-07
) O 0 1.0492897523084466e-10
in O 0 6.733349433574176e-10
COS O 0 7.790347353875404e-07
- O 0 7.359586362554182e-08
7 O 0 3.8762681953130596e-09
cells O 0 2.693139287968105e-11
, O 0 9.078740905756055e-13
the O 0 2.229193045433231e-11
mature O 0 1.6052088824825006e-10
alpha O 0 9.543819901036699e-11
- O 0 5.81931690335491e-11
subunit O 0 2.173375368563768e-11
was O 0 1.2717292496855492e-11
present O 0 3.827071038547958e-12
, O 0 1.5737634719709126e-12
but O 0 2.117088188785532e-12
its O 0 1.6980387365292393e-12
level O 0 1.2002616955886225e-10
was O 0 9.019393565345979e-11
much O 0 4.675569306722416e-11
lower O 0 6.830649379452325e-10
than O 0 4.142267258366861e-12
that O 0 2.486339313687719e-13
from O 0 1.4256878663743144e-11
normal O 0 3.573900064779423e-10
alpha O 0 6.946956343512056e-10
- O 0 3.2895938750776565e-10
subunit O 0 2.456874981238144e-10
transfections O 0 6.50456621897888e-09
, O 0 2.046132577607218e-12
although O 0 8.632172233957736e-12
higher O 0 2.3985244346214074e-10
than O 0 9.333959820334581e-12
in O 0 6.271178715211434e-11
those O 0 4.6562306094122263e-11
cells O 0 1.926019066456064e-10
transfected O 0 3.036673801304346e-09
with O 0 1.150880606093363e-12
an O 0 1.2713161686578323e-12
alpha O 0 7.887502873060726e-10
- O 0 1.4914616208727693e-09
subunit O 0 1.8418497838013081e-09
associated O 0 1.2992096287689492e-09
with O 0 2.333531368137187e-09
infantile O 0 5.66509370401036e-05
TSD B-Disease 0 0.028083709999918938
. O 0 1.6616160110061173e-06

Furthermore O 0 3.4194630416095606e-07
, O 0 8.015197949795549e-10
the O 0 1.878971561675158e-10
precursor O 0 6.808527519552854e-09
level O 0 4.5918615576567845e-09
of O 0 1.2964470608167744e-09
the O 0 2.0599666417098206e-09
W474C O 0 9.758984020891148e-08
alpha O 0 4.704620248929814e-09
- O 0 6.158913379294972e-10
subunit O 0 2.751632255382219e-10
was O 0 1.758342776936317e-10
found O 0 1.2397085094595361e-11
to O 0 6.291650360423784e-12
accumulate O 0 8.705561271860063e-10
in O 0 2.8660990247786344e-11
comparison O 0 1.8186276096177068e-10
to O 0 1.3964708729663489e-11
the O 0 1.8655409161905112e-10
normal O 0 1.2349378186726767e-09
alpha O 0 6.291768439581347e-09
- O 0 2.4841544377096625e-09
subunit O 0 4.321453417333032e-09
precursor O 0 3.1910758480080403e-08
levels O 0 4.743701254028565e-08
. O 0 1.913994829294552e-08

We O 0 7.018214631671071e-08
conclude O 0 1.5055766766636225e-07
that O 0 1.7960555265261746e-10
the O 0 3.915308521840188e-09
1422 O 0 6.630799362028483e-06
G O 0 1.6819177517390926e-06
- O 0 1.4832798456154705e-07
- O 0 3.9426403475317784e-08
> O 0 4.9576925675864914e-08
C O 0 3.563849659826701e-08
mutation O 0 1.4534355489981277e-11
is O 0 5.985634893550945e-14
the O 0 8.144575508808871e-13
cause O 0 6.282899894793914e-11
of O 0 1.1932962173943906e-08
Hex B-Disease 1 0.9996716976165771
A I-Disease 1 0.9370185732841492
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.220826437835058e-09
the O 0 6.86804213501091e-09
proband O 0 8.110202543321066e-06
. O 0 2.0937594058523246e-07

The O 0 5.460654151079325e-08
resulting O 0 2.618856598246566e-08
W474C O 0 8.807160725154972e-07
substitution O 0 9.518452088741469e-07
clearly O 0 1.3175346147420441e-08
interferes O 0 2.423713230115254e-09
with O 0 3.0939542594587977e-11
alpha O 0 1.031955187968947e-09
- O 0 2.4253074548674647e-10
subunit O 0 9.834685843479463e-11
processing O 0 2.4328780656723836e-10
, O 0 2.2392786409863863e-12
but O 0 1.638691352751076e-12
because O 0 2.2965086863419026e-12
the O 0 7.409899083210547e-12
base O 0 6.021841358894164e-11
substitution O 0 2.454760128500766e-08
falls O 0 3.884752075578035e-08
at O 0 1.9629803338361285e-10
the O 0 3.6921948137758065e-11
first O 0 5.055090721017841e-11
position O 0 5.689722026858135e-10
of O 0 2.967019741006993e-09
exon O 0 6.464323121235793e-08
13 O 0 1.4729669706170512e-09
, O 0 2.602976688359515e-11
aberrant O 0 3.85918824674647e-10
splicing O 0 1.9907548942654785e-09
may O 0 4.212127868719051e-10
also O 0 1.9876267298712946e-11
contribute O 0 1.4079504229158601e-10
to O 0 3.5121174857266624e-09
Hex B-Disease 1 0.9999943971633911
A I-Disease 1 0.9081689715385437
deficiency I-Disease 1 0.9172910451889038
in O 0 1.057113063751558e-08
this O 0 2.520748720868937e-09
proband O 0 6.296588253462687e-06
. O 0 1.0903678848706022e-08
. O 0 4.0106524323846315e-08

Two O 0 1.7660438800248812e-07
frequent O 0 1.9175762133727403e-07
missense O 0 6.342286360450089e-05
mutations O 0 1.346963586001948e-06
in O 0 5.178648279979825e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00024764335830695927

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.2230519530476158e-07
an O 0 1.631765087495296e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.049948529427638e-06
by O 0 1.3450308422591206e-08
early O 1 0.9999998807907104
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999988079071045

A O 0 7.082290665039181e-08
century O 0 1.7608691393888876e-07
after O 0 7.255980261078321e-09
its O 0 8.172562626640456e-11
recognition O 0 5.972965455569579e-10
as O 0 8.529009720703584e-10
a O 0 3.9010833452479687e-10
syndrome O 0 1.9298012077229032e-08
by O 0 1.7790491302349665e-10
Vaughan O 0 7.32498083380051e-05
Pendred O 0 3.6344194086268544e-05
, O 0 6.245645667313227e-11
the O 0 2.6724730761706894e-10
disease O 0 1.4973398521078707e-08
gene O 0 1.6957627524405439e-09
( O 0 9.091733477184505e-10
PDS O 1 0.7988332509994507
) O 0 2.1696240637414377e-10
was O 0 3.403976434057654e-09
mapped O 0 1.087268830524124e-09
to O 0 2.5003532577727583e-10
chromosome O 0 5.630585775406871e-09
7q22 O 0 8.49632760946406e-06
- O 0 1.662384602241218e-05
q31 O 0 7.350009400397539e-05
. O 0 3.603652771744237e-07

1 O 0 1.9511253412929364e-06
and O 0 1.248059255942735e-08
, O 0 4.6553802479643025e-10
recently O 0 1.2489445033736502e-09
, O 0 3.345758045614211e-11
found O 0 2.890159986335128e-11
to O 0 3.4481598132352076e-11
encode O 0 3.147454963325913e-09
a O 0 6.753391623703919e-09
putative O 0 7.704171366640367e-06
sulfate O 0 2.23183033085661e-05
transporter O 0 6.963005580473691e-05
. O 0 1.0445063480801764e-06

We O 0 3.303789242181665e-08
performed O 0 2.0006061252075824e-09
mutation O 0 2.7162777582745434e-10
analysis O 0 9.170694759141895e-11
of O 0 7.720323824678132e-10
the O 0 3.613673982272303e-08
PDS B-Disease 1 0.9994730353355408
gene O 0 1.867739563010673e-08
in O 0 3.2053486531680164e-09
patients O 0 1.1772408825549974e-08
from O 0 2.472925753060906e-10
14 O 0 3.3773832619488076e-09
Pendred B-Disease 0 5.997148036840372e-06
families O 0 3.3418182110445116e-10
originating O 0 8.697561559856126e-10
from O 0 1.0483294787810848e-10
seven O 0 6.018350401371109e-11
countries O 0 5.8615334808109765e-12
and O 0 6.485432330061158e-11
identified O 0 1.8273561552817341e-09
all O 0 4.4795576137346416e-09
mutations O 0 2.075150362657041e-08
. O 0 4.1259298200202466e-08

The O 0 5.756581913374248e-07
mutations O 0 3.0915813908904966e-08
include O 0 1.61238389306817e-09
three O 0 3.409081628102939e-10
single O 0 7.150272041123173e-10
base O 0 8.101828541384748e-09
deletions O 0 5.578423056817883e-08
, O 0 1.5774923589617629e-09
one O 0 1.343743005755016e-09
splice O 0 1.6344670257240068e-06
site O 0 8.07847015948937e-08
mutation O 0 3.789147662303094e-09
and O 0 1.0566448827020736e-09
10 O 0 3.1252572085804786e-08
missense O 0 8.952569260145538e-06
mutations O 0 2.734647353008768e-07
. O 0 4.306234018258692e-07

One O 0 3.0936996608943446e-07
missense O 0 2.938736315627466e-06
mutation O 0 2.3703753626591606e-08
( O 0 2.491256367864736e-10
L236P O 0 1.2542213312372041e-07
) O 0 8.147659630308723e-11
was O 0 1.8356106634698222e-09
found O 0 6.961118487192053e-11
in O 0 4.396950858964743e-11
a O 0 3.420706426449094e-11
homozygous O 0 3.102340884186816e-10
state O 0 5.269271130536879e-11
in O 0 7.300478971350444e-11
two O 0 4.917884502408931e-11
consanguineous O 0 7.408265787489654e-07
families O 0 2.2248318465312167e-10
and O 0 4.1257108840397905e-11
in O 0 2.674201693420031e-10
a O 0 1.1311473979702669e-10
heterozygous O 0 2.535444632023598e-10
state O 0 1.7328916079861756e-11
in O 0 1.5662181621078908e-11
five O 0 1.7273574931531144e-11
additional O 0 2.582327129907469e-10
non O 0 2.962370899695088e-07
- O 0 4.238439032633323e-06
consanguineous O 0 0.0005594810354523361
families O 0 4.547811727206863e-08
. O 0 7.123923495555573e-08

Another O 0 8.536176778761728e-07
missense O 0 5.749779575126013e-06
mutation O 0 2.7300135485575083e-08
( O 0 3.4776395652080794e-10
T416P O 0 2.1103981850956188e-07
) O 0 1.1035584945862098e-10
was O 0 1.950448913490277e-09
found O 0 8.047516125708754e-11
in O 0 1.7722611572734692e-11
a O 0 1.0324620498824988e-11
homozygous O 0 8.185198352439471e-11
state O 0 3.903701667473669e-11
in O 0 1.6415366288491384e-10
one O 0 3.5833381401007e-11
family O 0 8.132719324371873e-12
and O 0 8.457561040398076e-12
in O 0 3.765476819239666e-11
a O 0 3.689554911590065e-11
heterozygous O 0 6.728134022138121e-11
state O 0 1.941472156652413e-11
in O 0 9.118403948571441e-11
four O 0 2.4134941267739407e-10
families O 0 4.83359630099045e-10
. O 0 1.2914081359838292e-08

Pendred B-Disease 1 0.99785977602005
patients O 0 0.002297778381034732
in O 0 1.5131300656889834e-08
three O 0 9.745192430798966e-10
non O 0 2.349705567894489e-07
- O 0 1.5663362091800082e-06
consanguineous O 0 0.019359329715371132
families O 0 3.089344335904798e-10
were O 0 1.2812226279912409e-10
shown O 0 4.141366936882829e-12
to O 0 1.0844732230286258e-12
be O 0 1.5252922189179507e-11
compound O 0 1.312716069179487e-08
heterozygotes O 0 4.886372906298675e-08
for O 0 5.882550557778643e-10
L236P O 0 6.3617125078963e-07
and O 0 5.5506448326525515e-09
T416P O 0 4.732707566290628e-06
. O 0 2.0078785212263028e-07

In O 0 2.6017991316962252e-08
total O 0 1.9229073888737958e-09
, O 0 1.6601486851897107e-10
one O 0 3.3138564808909976e-11
or O 0 4.264444006252255e-11
both O 0 4.188252175629792e-11
of O 0 4.501782280286193e-10
these O 0 1.199163268683634e-10
mutations O 0 1.2326779874616278e-10
were O 0 2.370436069654147e-10
found O 0 3.035003151574678e-11
in O 0 3.489418129443145e-11
nine O 0 1.1980065550698527e-10
of O 0 4.3948489292233717e-10
the O 0 3.8028682425306215e-09
14 O 0 1.0996871857571477e-08
families O 0 4.486352955801465e-10
analyzed O 0 9.517307830719801e-09
. O 0 1.6597766716586193e-08

The O 0 1.7528126505794717e-08
identification O 0 1.830014717540962e-08
of O 0 6.948523090244407e-09
two O 0 8.110916938086632e-10
frequent O 0 1.3074485494257715e-08
PDS B-Disease 1 0.8890745639801025
mutations O 0 1.1175651515316076e-08
will O 0 2.739304096055495e-11
facilitate O 0 1.9083716551460128e-10
the O 0 9.824636243438434e-11
molecular O 0 3.543641824421684e-09
diagnosis O 0 6.813524464632792e-07
of O 0 5.253215931588784e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.347408296074718e-05

Insertional O 0 0.0001546021521789953
mutation O 0 7.221328246487246e-08
by O 0 2.2272486077667963e-09
transposable O 0 2.4209714410972083e-06
element O 0 9.332392636451914e-08
, O 0 5.9562559329151554e-09
L1 O 0 3.6242324767954415e-06
, O 0 1.2346169919741357e-10
in O 0 3.2799077342993144e-10
the O 0 1.704649044143025e-08
DMD B-Disease 1 1.0
gene O 0 1.0524376925502565e-08
results O 0 1.8673405932645437e-08
in O 0 3.960607397601734e-09
X B-Disease 1 0.9993312358856201
- I-Disease 1 0.8850930333137512
linked I-Disease 0 0.003060364630073309
dilated I-Disease 1 0.7494889497756958
cardiomyopathy I-Disease 1 1.0
. O 0 1.861047167039942e-05

X B-Disease 1 0.9999599456787109
- I-Disease 1 0.999998927116394
linked I-Disease 1 0.9752087593078613
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 0 1.4622098660765914e-06
XLDCM B-Disease 1 0.9999998807907104
) O 0 3.161098327542078e-10
is O 0 9.02909778194294e-12
a O 0 1.492535782465776e-11
clinical O 0 1.2392115777970503e-08
phenotype O 0 3.604649023714046e-08
of O 0 9.162835823417481e-09
dystrophinopathy B-Disease 0 3.115089566563256e-05
which O 0 6.573630528805552e-11
is O 0 5.587953710861626e-12
characterized O 0 3.851546165334341e-11
by O 0 5.054762858280881e-11
preferential O 0 1.749126568029169e-07
myocardial B-Disease 0 7.320977147173835e-06
involvement I-Disease 0 2.7560562720907456e-09
without O 0 3.1092303731661275e-10
any O 0 2.6348467851988744e-10
overt O 0 6.145843833849085e-09
clinical O 0 1.0506369108043145e-07
signs O 0 1.2598965781762672e-07
of O 0 4.323502253100742e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9943051934242249

To O 0 1.8824879433054775e-09
date O 0 1.699308143088274e-07
, O 0 4.248809082341154e-10
several O 0 6.18477352665181e-11
mutations O 0 2.174247171193855e-10
in O 0 9.579588233776803e-10
the O 0 6.838262379460502e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.1534559428691864
, O 0 7.757097364446963e-07
DMD O 1 1.0
, O 0 1.2661588444373706e-09
have O 0 4.5428463074648207e-11
been O 0 4.0214772484281625e-11
identified O 0 1.0586576060234165e-10
in O 0 1.2920622904921686e-10
patients O 0 2.3295112505650195e-09
with O 0 2.655703261467135e-11
XLDCM B-Disease 1 0.9999998807907104
, O 0 4.1475051171246946e-10
but O 0 4.280220275432178e-11
a O 0 8.544534871313125e-12
pathogenic O 0 9.3302143788776e-10
correlation O 0 8.830176867480333e-11
of O 0 5.777732112188794e-11
these O 0 1.7165692478560146e-10
cardiospecific O 0 5.576634976023342e-07
mutations O 0 3.593971786841621e-09
in O 0 2.2761601492504724e-09
DMD O 1 0.9999998807907104
with O 0 3.273220861021997e-10
the O 0 4.2202700001325866e-08
XLDCM B-Disease 1 0.9999905824661255
phenotype O 0 1.7619453274164698e-06
has O 0 1.0931384269996514e-10
remained O 0 4.722961577385831e-09
to O 0 1.670107628581885e-11
be O 0 8.488469371847884e-10
elucidated O 0 9.340188626083545e-06
. O 0 3.7614452708112367e-07

We O 0 3.524984393266095e-08
report O 0 5.992283891309569e-10
here O 0 1.0248499965337388e-10
the O 0 1.477529383564491e-11
identification O 0 1.2121120773755933e-10
of O 0 5.949301468133328e-11
a O 0 6.90918641743643e-11
unique O 0 1.3893363126626923e-09
de O 0 2.7422043302749444e-08
novo O 0 4.521018581726821e-07
L1 O 0 6.846946689620381e-07
insertion O 0 1.5457665369922324e-08
in O 0 1.7852229694526045e-09
the O 0 1.8026183878916413e-09
muscle O 0 8.008814056381652e-09
exon O 0 1.3830739931108837e-07
1 O 0 6.035141808524713e-08
in O 0 1.1874067062933591e-08
DMD O 1 1.0
in O 0 6.526154550101637e-08
three O 0 4.247539209245588e-09
XLDCM B-Disease 1 0.9999935626983643
patients O 0 1.063771492226806e-06
from O 0 5.832154204021833e-10
two O 0 8.7017386352084e-11
unrelated O 0 3.934474790412423e-08
Japanese O 0 5.231016189100046e-07
families O 0 7.822380077016078e-09
. O 0 2.3211788047206028e-08

The O 0 2.4627308903291123e-07
insertion O 0 1.8531697776325018e-07
was O 0 5.663914848241802e-08
a O 0 5.867288876970633e-10
5 O 0 2.399779486239595e-09
- O 0 9.279845225584893e-10
truncated O 0 3.4722860142721856e-09
form O 0 2.489968786711927e-10
of O 0 1.4848197116279493e-09
human O 0 3.9643158200597384e-10
L1 O 0 5.33711990158281e-08
inversely O 0 9.414472401658713e-08
integrated O 0 1.124076920433481e-08
in O 0 1.0888620560756124e-10
the O 0 1.0605290950982393e-10
5 O 0 9.467170380972334e-10
- O 0 9.444233839417393e-09
untranslated O 0 0.00027358572697266936
region O 0 1.936688365233863e-09
in O 0 1.7832141319118477e-10
the O 0 6.134597274609632e-10
muscle O 0 2.706675106267653e-09
exon O 0 1.448409303606013e-08
1 O 0 4.609543413636175e-09
, O 0 5.239853689831264e-12
which O 0 1.9803713790372823e-12
affected O 0 8.74966973873903e-11
the O 0 5.5234442020157815e-11
transcription O 0 2.1509174996658942e-10
or O 0 1.6697350099792452e-11
the O 0 1.8998949635751217e-10
stability O 0 3.8891520559580783e-10
of O 0 8.352916136544764e-10
the O 0 7.717408379015467e-10
muscle O 0 6.248818129606093e-10
form O 0 2.2151787071322815e-09
of O 0 5.326320007270624e-08
dystrophin O 0 1.6226775301220187e-07
transcripts O 0 2.4590234293242474e-09
but O 0 8.558561845339874e-12
not O 0 1.589795677915673e-12
that O 0 4.962391717162895e-13
of O 0 1.3523305808504915e-09
the O 0 2.513169583551189e-08
brain O 0 2.7480092512632837e-07
or O 0 4.461829572477427e-09
Purkinje O 0 1.3781249208477675e-06
cell O 0 6.302169452965245e-09
form O 0 2.3653687342140017e-10
, O 0 5.1257432326368146e-11
probably O 0 1.240814562208925e-09
due O 0 2.4098028461594367e-08
to O 0 1.2526775450272254e-10
its O 0 1.5053190638436575e-10
unique O 0 1.8743612217875238e-10
site O 0 1.0312094511633063e-09
of O 0 1.171282626444281e-09
integration O 0 6.566133947671915e-08
. O 0 1.0391218552285864e-07

We O 0 5.521145851616893e-08
speculate O 0 4.209561765833314e-08
that O 0 4.305157359080214e-12
this O 0 1.1930212893973557e-11
insertion O 0 4.022294497474377e-09
of O 0 9.196821970647306e-09
an O 0 1.9892508473784432e-10
L1 O 0 4.551408778752375e-07
sequence O 0 5.07980768560401e-10
in O 0 1.23708310262316e-09
DMD O 1 1.0
is O 0 7.56597146045479e-11
responsible O 0 9.818393494065436e-12
for O 0 3.882603440141796e-12
some O 0 2.9022337918321872e-12
of O 0 1.8793360964663997e-11
the O 0 1.9110879545536363e-11
population O 0 3.1067241335926143e-13
of O 0 2.72811309133536e-12
Japanese O 0 9.551969881727018e-09
patients O 0 5.79508796505479e-09
with O 0 8.440837612200269e-11
XLDCM B-Disease 1 0.9825974106788635
. O 0 5.594021956767392e-08
. O 0 1.0136808015204224e-07

Severe O 0 0.0009334076894447207
early O 1 0.995032548904419
- O 1 0.9993438124656677
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 7.286153618224489e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.786225993782864e-07
red O 0 2.861225038941484e-05
hair O 0 2.7355238785276015e-07
pigmentation O 0 3.647018820629455e-05
caused O 0 1.0208905223407783e-06
by O 0 1.1543671689651092e-06
POMC O 1 1.0
mutations O 0 5.279807169245032e-07
in O 0 1.6529778434914988e-08
humans O 0 4.4605897642213677e-08
. O 0 2.7006585412436834e-08

Sequential O 0 2.0617922302790248e-07
cleavage O 0 1.4319013530439406e-07
of O 0 5.765290822523639e-08
the O 0 8.177747368165456e-09
precursor O 0 4.506941309045942e-08
protein O 0 3.0024747132983975e-09
pre O 0 9.796989388632937e-07
- O 0 3.7909575212324853e-07
pro O 0 1.3869046142644947e-06
- O 0 1.7806468122216756e-06
opiomelanocortin O 0 0.0028383322060108185
( O 0 6.332050883628426e-09
POMC O 0 3.510795795591548e-05
) O 0 1.1388237575182814e-10
generates O 0 1.5691133115058875e-10
the O 0 3.1684144197186015e-10
melanocortin O 0 1.23464155876718e-06
peptides O 0 5.338613551231219e-09
adrenocorticotrophin O 0 1.3315985825101961e-06
( O 0 6.087833015477884e-10
ACTH O 0 2.232571176818965e-07
) O 0 1.8503559795490787e-10
, O 0 3.8821554304568906e-10
melanocyte O 0 1.4638326319982298e-06
- O 0 9.475666047364939e-07
stimulating O 0 2.6013435672211926e-07
hormones O 0 3.411036431089087e-08
( O 0 4.88792450958897e-10
MSH O 0 2.113762457156554e-05
) O 0 2.1245737114039542e-10
alpha O 0 1.8026458104003495e-09
, O 0 9.285359807431615e-12
beta O 0 4.235763476079235e-11
and O 0 4.913812846202292e-12
gamma O 0 1.4359362310312207e-10
as O 0 2.31660159805136e-11
well O 0 2.9114169408650525e-11
as O 0 3.039556800699117e-11
the O 0 1.382336189958977e-10
opioid O 0 5.785581436157372e-08
- O 0 4.287523225343648e-08
receptor O 0 1.0064367117479378e-08
ligand O 0 1.1981292402651889e-07
beta O 0 4.070514307841222e-07
- O 0 7.801633046256029e-07
endorphin O 0 3.004441714438144e-05
. O 0 1.2516714775756554e-07

While O 0 5.6919422064538594e-08
a O 0 6.228565441190881e-10
few O 0 4.053453128705087e-10
cases O 0 1.3498154816105057e-09
of O 0 7.281434136530152e-06
isolated O 1 0.9999998807907104
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
have O 0 3.679207383200378e-09
been O 0 2.6572208877695402e-09
reported O 0 2.8648832195443674e-09
( O 0 1.0018873508599313e-09
OMIM O 0 0.0001710504584480077
201400 O 0 2.6140213549297187e-07
) O 0 3.507461335261475e-11
, O 0 1.3950971454457228e-11
an O 0 3.524501523965995e-11
inherited O 1 0.5629372000694275
POMC O 1 1.0
defect O 1 0.9642271995544434
has O 0 1.9812886886683145e-09
not O 0 1.2796107229373632e-10
been O 0 2.531154175144934e-10
described O 0 4.710076773051242e-10
so O 0 3.7303576894132107e-10
far O 0 1.4818667182225909e-08
. O 0 2.646802244044011e-08

Recent O 0 2.969552781451057e-07
studies O 0 9.660786837173418e-09
in O 0 1.234619351198063e-10
animal O 0 5.117774537488629e-10
models O 0 3.1368455055691413e-10
elucidated O 0 5.011102288676739e-08
a O 0 1.9544697804629863e-10
central O 0 1.1648484399273684e-09
role O 0 3.6224617749880395e-10
of O 0 7.063872597967702e-09
alpha O 0 1.3088674677419476e-07
- O 0 5.341418045645696e-07
MSH O 0 0.1345798522233963
in O 0 2.401958076880817e-10
the O 0 1.8516048069794344e-11
regulation O 0 9.317813187692536e-11
of O 0 6.636719385860745e-12
food O 0 7.467819418405242e-11
intake O 0 1.870178491236718e-11
by O 0 7.370216633176274e-13
activation O 0 6.023185422643351e-11
of O 0 4.264285369259824e-09
the O 0 7.304138449626407e-08
brain O 0 2.107600494127837e-07
melanocortin O 0 1.4091688171902206e-05
- O 0 1.1249079534536577e-06
4 O 0 2.592447572169476e-07
- O 0 3.473195064884749e-08
receptor O 0 7.33829175203482e-09
( O 0 2.062064824448484e-10
MC4 O 0 2.791129554680083e-05
- O 0 1.5609870729349495e-07
R O 0 5.480782760969305e-08
; O 0 1.2650261393964968e-10
refs O 0 6.886708536768538e-09
3 O 0 1.5119524521267635e-09
- O 0 8.264645079414379e-10
5 O 0 1.7636428428779993e-10
) O 0 1.107052817472809e-12
and O 0 3.019446455018726e-12
the O 0 8.981661248075312e-11
linkage O 0 3.790145086668417e-09
of O 0 2.094346918113388e-09
human O 0 7.981882710339505e-09
obesity B-Disease 1 0.9953290224075317
to O 0 4.0962308545111625e-10
chromosome O 0 1.9874228651683978e-10
2 O 0 2.897846629323908e-09
in O 0 3.208227850048928e-10
close O 0 1.7328999346588603e-09
proximity O 0 1.2214080413741613e-08
to O 0 4.938303099777386e-10
the O 0 4.753120563805169e-08
POMC O 0 6.106700311647728e-05
locus O 0 5.872285324670656e-09
, O 0 1.4961984776129533e-11
led O 0 4.725227500945728e-11
to O 0 2.9355931747965247e-12
the O 0 3.4962335110355625e-11
proposal O 0 5.885693044049845e-10
of O 0 1.309044261876835e-10
an O 0 4.3790132110699265e-12
association O 0 4.95523899690653e-10
of O 0 8.32683255680422e-09
POMC O 1 0.9997299313545227
with O 0 7.182808126060536e-09
human O 0 7.522941700699448e-07
obesity B-Disease 1 1.0
. O 0 1.2150875363658997e-06

The O 0 3.7108673467400877e-08
dual O 0 1.8692185577151577e-08
role O 0 8.42726866068233e-09
of O 0 1.3974273826988792e-07
alpha O 0 7.930916581244674e-06
- O 0 4.039746636408381e-05
MSH O 1 0.9998884201049805
in O 0 2.612867922024975e-09
regulating O 0 1.629089929622296e-08
food O 0 1.1558501711306235e-08
intake O 0 2.0446153214948026e-08
and O 0 6.708518740516922e-10
influencing O 0 7.142569415918842e-07
hair O 0 3.493789506592293e-07
pigmentation O 0 8.485156286042184e-05
predicts O 0 1.223212553469466e-08
that O 0 1.7334468929708358e-11
the O 0 5.610557018975726e-10
phenotype O 0 2.9698732362248847e-09
associated O 0 7.661934975367046e-11
with O 0 3.620330597808863e-12
a O 0 2.2352698858529862e-10
defect O 0 4.932207957608625e-07
in O 0 2.874447773137945e-07
POMC O 0 0.0028415757697075605
function O 0 6.052335854711544e-10
would O 0 5.1033840348102544e-11
include O 0 4.2083074802690135e-09
obesity B-Disease 1 0.9999994039535522
, O 0 1.3659344488825553e-10
alteration O 0 6.762409725524776e-07
in O 0 3.2086080636872794e-07
pigmentation O 1 0.9999997615814209
and O 0 0.0005824451218359172
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.999993085861206
. O 0 7.3980813795060385e-06

The O 0 5.4619146538925634e-08
observation O 0 2.428020593470137e-07
of O 0 4.088053007222925e-09
these O 0 8.225553571605815e-09
symptoms O 0 0.139823779463768
in O 0 2.7190486306949424e-08
two O 0 4.5572112750136284e-10
probands O 0 5.48759908269858e-06
prompted O 0 3.0292820696331546e-08
us O 0 7.283038755412363e-11
to O 0 5.3665918930967393e-11
search O 0 7.529380452453438e-10
for O 0 1.0497461233605065e-10
mutations O 0 2.254349817931711e-09
within O 0 5.238302236421077e-09
their O 0 6.391973528252493e-08
POMC O 1 0.5232037305831909
genes O 0 2.819528219788481e-07
. O 0 1.376755847104505e-07

Patient O 0 0.0004845711519010365
1 O 0 4.800983219865884e-07
was O 0 1.565011054083243e-08
found O 0 7.426768922069726e-11
to O 0 1.1994532103654088e-11
be O 0 4.959292698725193e-11
a O 0 1.0263719735226218e-10
compound O 0 2.65153161649323e-08
heterozygote O 0 1.7626702231154923e-07
for O 0 1.4458988173426945e-10
two O 0 8.88140810895166e-11
mutations O 0 2.8025337606152334e-10
in O 0 9.395861866323685e-10
exon O 0 6.064728808041764e-08
3 O 0 9.158030778166903e-09
( O 0 8.650438698687424e-11
G7013T O 0 3.6313414852884307e-07
, O 0 2.8985028266426127e-10
C7133delta O 0 7.391857934635482e-07
) O 0 2.5302258552239998e-11
which O 0 4.5494688745428835e-12
interfere O 0 1.0559709356927627e-11
with O 0 8.631608340407826e-13
appropriate O 0 1.3780504515281677e-10
synthesis O 0 2.048799130349721e-09
of O 0 1.142005068288654e-08
ACTH O 0 7.930622132334975e-07
and O 0 1.3435129453398531e-08
alpha O 0 9.694955451777787e-07
- O 0 2.760867346296436e-06
MSH O 0 0.004303860943764448
. O 0 6.10297036018892e-07

Patient O 0 0.00023641674488317221
2 O 0 1.4721594254751835e-07
was O 0 7.225072984340386e-09
homozygous O 0 1.0627632107684803e-09
for O 0 2.8437460719565877e-11
a O 0 4.199547307126572e-11
mutation O 0 3.088513611526622e-10
in O 0 7.335740903613441e-10
exon O 0 4.1134750716764756e-08
2 O 0 6.634881977163332e-09
( O 0 4.965795136202544e-11
C3804A O 0 8.188020927946127e-08
) O 0 8.062080864013055e-11
which O 0 4.710741796642992e-10
abolishes O 0 3.6701578665088164e-06
POMC O 0 0.002441400196403265
translation O 0 1.4939386119294795e-06
. O 0 3.2793266768749163e-07

These O 0 3.7833142840781875e-08
findings O 0 5.5570748003219705e-09
represent O 0 1.286516865262044e-10
the O 0 8.591866801355152e-11
first O 0 5.897106414298747e-11
examples O 0 3.42579464795989e-10
of O 0 3.8639538790796735e-10
a O 0 3.0473266132702292e-09
genetic B-Disease 1 0.9999996423721313
defect I-Disease 1 0.9999994039535522
within O 0 7.205245111663316e-08
the O 0 2.215931971250029e-08
POMC O 0 2.9328399250516668e-05
gene O 0 3.0220190239127476e-10
and O 0 1.1063061057525747e-11
define O 0 1.1671741351193532e-10
a O 0 1.1648300379807353e-10
new O 0 2.163413228117861e-05
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 0.0005605058395303786
resulting O 0 1.9609240453632992e-08
in O 0 5.360027421907887e-10
early O 0 7.905108759587165e-06
- O 0 1.2608388715307228e-05
onset O 1 0.9999988079071045
obesity B-Disease 1 1.0
, O 0 2.151740474687358e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.9315967253751296e-07
red O 0 3.731096148840152e-05
hair O 0 2.5824687099884613e-07
pigmentation O 0 4.5979991227795836e-06
. O 0 3.172820228769524e-08
. O 0 9.69105826698069e-08

A O 0 2.4562547196183004e-07
European O 0 2.0195700756175938e-07
multicenter O 0 2.5107867259066552e-05
study O 0 1.9549192487033906e-08
of O 0 8.06333559921768e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.0606749074356685e-09
classification O 0 4.911939299745427e-07
of O 0 2.764697626389534e-08
105 O 0 3.4790136282936146e-07
mutations O 0 3.0482028012812634e-10
and O 0 3.8696972709528765e-11
a O 0 3.0855859534106855e-11
general O 0 6.755530357338557e-09
system O 0 1.7826232712181422e-09
for O 0 8.591768962951107e-11
genotype O 0 1.2268248639202284e-08
- O 0 2.569269907937155e-09
based O 0 2.9914182242407605e-10
prediction O 0 4.357168492674646e-08
of O 0 1.7986275802073237e-09
metabolic O 0 2.1968800865579396e-05
phenotype O 0 2.2068734324420802e-06
. O 0 8.391952377451162e-08

Phenylketonuria B-Disease 1 0.999866247177124
( O 0 1.0447872682561865e-06
PKU B-Disease 1 0.9999798536300659
) O 0 6.3057163934843175e-09
and O 0 3.0387015126365213e-09
mild B-Disease 1 0.9999822378158569
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9739847183227539
MHP B-Disease 1 1.0
) O 0 3.6661589319919585e-08
are O 0 1.2690124506775646e-08
allelic B-Disease 1 0.965415894985199
disorders I-Disease 0 0.00037998342304490507
caused O 0 1.2182089115242434e-08
by O 0 1.0247880322111769e-09
mutations O 0 8.480378621555928e-10
in O 0 9.692356639501298e-11
the O 0 2.9070623686067165e-10
gene O 0 2.1517219950251132e-10
encoding O 0 2.3467039866886807e-08
phenylalanine O 0 1.4550053492712323e-05
hydroxylase O 0 0.0006664552493020892
( O 0 9.141961498926321e-08
PAH O 1 1.0
) O 0 5.5964552103660026e-08
. O 0 1.660155817262421e-07

Previous O 0 2.9921686746092746e-06
studies O 0 4.85367621649857e-08
have O 0 7.749723085481719e-11
suggested O 0 1.6856747941940142e-10
that O 0 6.281287881319819e-13
the O 0 7.389169137672624e-11
highly O 0 1.0539362271799746e-08
variable O 0 3.1331534700029806e-08
metabolic O 0 5.337138645700179e-05
phenotypes O 0 1.9532328224158846e-05
of O 0 5.6481447245460004e-05
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 2.559292988735251e-05
with O 0 5.564734806284832e-07
PAH O 1 1.0
genotypes O 1 0.9941861629486084
. O 0 3.4492950362619013e-06

We O 0 4.8731379820310394e-08
identified O 0 1.5665161612332668e-08
both O 0 2.0328863037377687e-09
causative O 0 1.4281987432696042e-06
mutations O 0 8.296319009559738e-08
in O 0 1.0294353813833368e-08
686 O 0 6.761785698472522e-06
patients O 0 3.905286973804323e-07
from O 0 1.8528644174509168e-09
seven O 0 1.6207459818673442e-09
European O 0 6.795335849574258e-08
centers O 0 2.816131541294453e-07
. O 0 4.9098410670467274e-08

On O 0 1.4843482176729594e-07
the O 0 1.8312220628757814e-09
basis O 0 7.167476612224277e-10
of O 0 3.105372070599799e-10
the O 0 3.213378174660164e-10
phenotypic O 0 2.335999482738771e-08
characteristics O 0 2.5470930609117204e-07
of O 0 4.1638975289970404e-07
297 O 0 1.9751976196857868e-06
functionally O 0 1.6663737767430575e-07
hemizygous O 0 4.015714694105554e-06
patients O 0 1.1670677935171625e-07
, O 0 4.039419840284886e-11
105 O 0 4.876919756924281e-09
of O 0 2.619298389294755e-10
the O 0 5.948578296610663e-10
mutations O 0 1.5885545656679767e-10
were O 0 1.7145536379548076e-10
assigned O 0 1.3935234910444905e-10
to O 0 2.3968769677362722e-11
one O 0 5.4299138102509303e-11
of O 0 3.462951869703801e-10
four O 0 4.135561337825777e-10
arbitrary O 0 5.674920533493832e-09
phenotype O 0 4.637952031316672e-07
categories O 0 1.7693919573957828e-07
. O 0 4.809598408428428e-08

We O 0 4.2554148649287526e-08
proposed O 0 5.507882860911195e-08
and O 0 7.357235376481697e-10
tested O 0 6.456360335249656e-09
a O 0 1.0241465314697606e-10
simple O 0 3.301889317519624e-10
model O 0 1.9627108271969007e-10
for O 0 1.6671128019729586e-11
correlation O 0 9.225308711391378e-11
between O 0 1.3661637099371404e-10
genotype O 0 3.768219869471068e-08
and O 0 8.534770112866852e-10
phenotypic O 0 1.6773176980677817e-07
outcome O 0 8.997943950816989e-06
. O 0 1.1211999435545295e-06

The O 0 1.8592362494018744e-07
observed O 0 5.4971778240542335e-08
phenotype O 0 2.332006943106535e-07
matched O 0 5.707531869347804e-08
the O 0 2.7522950585279204e-09
predicted O 0 2.143539745702583e-08
phenotype O 0 7.518309530496481e-08
in O 0 3.4616970401302183e-10
79 O 0 5.583561613065058e-09
% O 0 6.96919215045777e-12
of O 0 7.50558556278369e-12
the O 0 1.861505741218572e-11
cases O 0 3.629585521025547e-10
, O 0 7.635762161450899e-11
and O 0 7.906477555996716e-11
in O 0 9.172584219951929e-11
only O 0 1.7659781623158288e-11
5 O 0 5.158914614944443e-11
of O 0 4.0596099398770846e-11
184 O 0 1.678405747718159e-09
patients O 0 1.2230718660077855e-09
was O 0 1.3430657974655702e-10
the O 0 1.0109935805191483e-10
observed O 0 3.005819759760442e-10
phenotype O 0 6.330392876563451e-10
more O 0 4.72520677100019e-12
than O 0 5.6110437476886155e-12
one O 0 8.115240250627931e-12
category O 0 3.534176840069847e-10
away O 0 9.160310704414698e-11
from O 0 9.907864459424154e-12
that O 0 2.305030732258073e-12
expected O 0 2.8077158376049738e-08
. O 0 1.402074190082203e-07

Among O 0 6.502652354356542e-07
the O 0 6.042603750699982e-09
seven O 0 5.422837179303031e-10
contributing O 0 6.315751255314694e-10
centers O 0 2.841347379600734e-09
, O 0 7.000686922525867e-12
the O 0 3.284037625173042e-11
proportion O 0 3.382345514779672e-10
of O 0 7.177791139234557e-10
patients O 0 7.50752970901658e-09
for O 0 4.974668593726861e-11
whom O 0 4.585907487086871e-10
the O 0 3.7800793051268045e-10
observed O 0 6.06537153835518e-10
phenotype O 0 1.849728814562468e-09
did O 0 3.515712720947306e-11
not O 0 8.967414484584157e-12
match O 0 1.6746676267942462e-09
the O 0 4.902284689300984e-10
predicted O 0 2.1126580485031354e-09
phenotype O 0 2.3032018514612673e-09
was O 0 2.038647584079456e-10
4 O 0 1.2308784547165885e-10
% O 0 4.9488772455030805e-12
- O 0 8.205581353282199e-11
23 O 0 3.3609051652838673e-10
% O 0 3.045092303310959e-11
( O 0 9.914934324950497e-12
P O 0 3.235371082155325e-07
< O 0 1.962304807534565e-08
. O 0 1.7497045479153428e-10
0001 O 0 1.031285137287341e-07
) O 0 1.8280444866181078e-11
, O 0 3.9774373031264965e-12
suggesting O 0 3.143456328569272e-11
that O 0 1.4972853686068266e-12
differences O 0 5.106239320262773e-10
in O 0 5.905300554109871e-11
methods O 0 5.875172015556984e-10
used O 0 1.6808203440188407e-10
for O 0 1.1433900354296256e-10
mutation O 0 1.2109088176615046e-09
detection O 0 1.1636380037316485e-07
or O 0 1.057588572273005e-09
phenotype O 0 4.0508446375042695e-08
classification O 0 2.5890768640124406e-08
may O 0 1.923508019530118e-10
account O 0 1.2273260532880137e-11
for O 0 2.1363841685301255e-12
a O 0 7.33830878008046e-12
considerable O 0 5.175464501405713e-10
proportion O 0 1.7600985113830347e-09
of O 0 3.970417328247322e-09
genotype O 0 7.30939655113616e-06
- O 0 4.5643304474651814e-05
phenotype O 0 1.2116531252104323e-05
inconsistencies O 0 6.612080483137106e-07
. O 0 1.117567691721888e-07

Our O 0 2.4627050265735306e-07
data O 0 2.7825242110424142e-09
indicate O 0 8.416855545867463e-10
that O 0 7.243441523668848e-12
the O 0 5.450027984466033e-09
PAH O 1 1.0
- O 0 5.767595212091692e-05
mutation O 0 6.829897092330839e-09
genotype O 0 1.4879582010962622e-09
is O 0 1.945963464151934e-13
the O 0 4.608971082391278e-13
main O 0 9.123170968683425e-11
determinant O 0 2.914675611975781e-09
of O 0 1.0691615370816976e-09
metabolic O 0 0.031564295291900635
phenotype O 0 3.7373553141151206e-07
in O 0 1.598215865206143e-10
most O 0 3.986167784741923e-10
patients O 0 6.861812806846501e-08
with O 0 8.287082664537593e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.5675526261329651

In O 0 2.4521348507278162e-08
the O 0 1.5095117378294276e-09
present O 0 5.48585954440739e-10
study O 0 1.85058190993459e-10
, O 0 5.046658403673465e-12
the O 0 5.627380852968322e-11
classification O 0 4.614947002323788e-08
of O 0 4.129212527459458e-08
105 O 0 0.0002083382714772597
PAH O 1 1.0
mutations O 0 1.972801300098581e-08
may O 0 1.1348297301871924e-10
allow O 0 1.5760141455767318e-11
the O 0 5.887710458063466e-11
prediction O 0 5.169419559081234e-09
of O 0 1.3783343910667156e-10
the O 0 2.6726668100884865e-10
biochemical O 0 2.7469365448951066e-08
phenotype O 0 1.4110866253247423e-08
in O 0 1.4681811322247995e-10
> O 0 1.3254618735913937e-08
10 O 0 4.883833892854739e-10
, O 0 2.5553583554716042e-11
000 O 0 2.689599876148918e-09
genotypes O 0 1.397181659257285e-08
, O 0 7.291708035983557e-12
which O 0 1.559566711883953e-12
may O 0 1.718016180707327e-11
be O 0 6.41327095596278e-12
useful O 0 4.494007249666865e-11
for O 0 5.4461955778517535e-12
the O 0 1.481367944977663e-10
management O 0 1.0415377449390917e-09
of O 0 2.836814783080399e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.4919443148974096e-06
newborns O 0 2.2573196474695578e-05
. O 0 8.557207564763303e-08

Somatic O 0 7.020036719040945e-05
instability O 0 4.31169098646933e-07
of O 0 2.6482470616429055e-07
the O 0 5.170416898181429e-06
CTG O 1 0.9999874830245972
repeat O 0 8.208736289816443e-06
in O 0 9.77731744455923e-08
mice O 0 2.0380120702157e-08
transgenic O 0 2.4454791969219514e-08
for O 0 6.509399963494644e-11
the O 0 5.066556241217768e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 3.1729416605230654e-07
is O 0 2.3176802491087223e-11
age O 0 2.41567710279611e-10
dependent O 0 2.5701593631133335e-11
but O 0 1.3623684428851202e-12
not O 0 1.449968075294128e-12
correlated O 0 1.3450192348773982e-10
to O 0 1.0985618664749452e-11
the O 0 2.6880037085064146e-10
relative O 0 6.122796492036287e-08
intertissue O 0 2.4164435217244318e-06
transcription O 0 1.1037558067528153e-07
levels O 0 8.818206964633646e-08
and O 0 7.354741704546086e-09
proliferative O 0 0.0046475776471197605
capacities O 0 9.4147544587031e-06
. O 0 1.1226861715840641e-06

A O 0 1.92364113900112e-05
( O 0 8.292316522329202e-08
CTG O 0 8.390797302126884e-05
) O 0 1.5401564468220386e-09
nexpansion O 0 7.340449883486144e-07
in O 0 5.707961880929702e-10
the O 0 3.56887297492392e-10
3 O 0 4.293585043058101e-09
- O 0 3.527970804384495e-08
untranslated O 1 0.6366490125656128
region O 0 2.536453358459312e-08
( O 0 1.23673821184056e-10
UTR O 0 0.00702200923115015
) O 0 1.9606144832651218e-11
of O 0 3.9081884950498136e-10
the O 0 2.7024208648640524e-08
DM O 1 1.0
protein O 0 3.4947024118991976e-07
kinase O 0 2.230344797737871e-08
gene O 0 1.7276592378934197e-09
( O 0 1.1365279550812346e-10
DMPK O 0 0.04314255714416504
) O 0 6.437773231171562e-11
is O 0 5.741739982773053e-12
responsible O 0 2.8312767061389188e-11
for O 0 8.862607175919024e-11
causing O 0 1.313427128479816e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.5598254726210143e-06
DM B-Disease 1 1.0
) O 0 7.074783781035876e-08
. O 0 1.0502301961423655e-07

Major O 0 2.508671059331391e-05
instability O 0 2.620413681597711e-07
, O 0 9.530545241887012e-10
with O 0 6.27049662194068e-11
very O 0 7.412591651601019e-10
large O 0 4.753687443681542e-10
expansions O 0 1.0954270379670561e-08
between O 0 2.812581056943486e-09
generations O 0 1.936637517019335e-08
and O 0 6.182390710485208e-11
high O 0 1.0551163276417697e-09
levels O 0 4.138812348397636e-10
of O 0 3.186055308468383e-10
somatic O 0 1.0117180408997228e-06
mosaicism O 0 3.49373726749036e-06
, O 0 3.77990416744467e-11
is O 0 1.1852326411987413e-11
observed O 0 5.151955528859276e-10
in O 0 3.077102128656861e-09
patients O 0 2.5066069042622985e-07
. O 0 9.510144138857868e-08

There O 0 2.4722725200376772e-08
is O 0 2.58914806261501e-10
a O 0 1.620040351868468e-10
good O 0 7.536909985006446e-10
correlation O 0 1.1854459081028779e-10
between O 0 5.844210532179872e-11
repeat O 0 3.281096783158688e-10
size O 0 4.6517412144453374e-10
( O 0 5.002688367727881e-12
at O 0 6.83424289382728e-11
least O 0 2.8984833196771254e-12
in O 0 1.2376955363380127e-11
leucocytes O 0 3.2339301014872035e-08
) O 0 5.975978826372463e-12
, O 0 1.9639669664867077e-12
clinical O 0 1.9971432840826253e-10
severity O 0 7.042845417970511e-09
and O 0 1.8081615371645654e-10
age O 0 1.3762131878536366e-08
of O 0 1.4617000942962477e-08
onset O 0 0.00020528525055851787
. O 0 1.3355156625038944e-06

The O 0 3.818866753135808e-05
trinucleotide O 0 0.03327193111181259
repeat O 0 1.569760570419021e-06
instability O 0 1.850144997206371e-07
mechanisms O 0 1.0998910937587425e-07
involved O 0 2.528038445248626e-09
in O 0 6.108088257406052e-08
DM B-Disease 1 1.0
and O 0 1.0558173926256131e-06
other O 0 1.8259321166169684e-08
human O 0 5.858013096826653e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 9.872900275098573e-10
unknown O 0 7.635044596554508e-08
. O 0 1.8258729639342164e-08

We O 0 4.0193516070985424e-08
studied O 0 9.405408718521358e-08
somatic O 0 1.1848929943880648e-06
instability O 0 7.399740820090983e-09
by O 0 4.2779776943113745e-10
measuring O 0 3.187426784734271e-07
the O 0 1.335371422328535e-07
CTG O 0 3.0807081202510744e-05
repeat O 0 8.551037211645962e-09
length O 0 3.826870209611144e-10
at O 0 1.6735524077660102e-10
several O 0 1.286094147845418e-11
ages O 0 3.754613286943709e-10
in O 0 1.2936989153555789e-11
various O 0 7.316886679875623e-11
tissues O 0 3.0402032002996293e-09
of O 0 6.423171772240721e-09
transgenic O 0 6.91568175170687e-07
mice O 0 7.49969752966706e-10
carrying O 0 6.108662187198632e-11
a O 0 5.739202516008568e-11
( O 0 1.6533924229733543e-10
CTG O 0 3.163045903420425e-06
) O 0 4.905446049363604e-10
55expansion O 0 9.160635840999021e-07
surrounded O 0 7.6156396744409e-09
by O 0 8.898855957673035e-11
45 O 0 3.274896132055005e-09
kb O 0 3.527916803136577e-08
of O 0 3.079033916719709e-09
the O 0 2.108174967929699e-08
human O 0 2.113086239319273e-08
DM B-Disease 1 1.0
region O 0 1.7465561086282833e-07
, O 0 3.457729588762781e-11
using O 0 4.918109669516113e-11
small O 0 3.438133389099818e-10
- O 0 1.2371263125032783e-08
pool O 0 7.944310453922299e-08
PCR O 0 5.464633545670949e-07
. O 0 2.1385660886608093e-07

These O 0 2.716198196139885e-06
mice O 0 7.477735266547825e-07
have O 0 2.4163315792691265e-10
been O 0 2.519535968747988e-10
shown O 0 6.421867204675635e-11
to O 0 6.773250016411936e-11
reproduce O 0 2.5722610708101e-09
the O 0 2.5743518428100742e-09
intergenerational O 0 1.8933780765451047e-08
and O 0 2.2179763581320344e-10
somatic O 0 7.156827308563152e-08
instability O 0 1.4337611098369507e-09
of O 0 1.2065330956545495e-09
the O 0 5.485130127880211e-09
55 O 0 6.081374692712416e-08
CTG O 0 6.245902568480233e-06
repeat O 0 1.4187726549153012e-08
suggesting O 0 1.7012831143858875e-09
that O 0 6.6658852916623434e-12
surrounding O 0 2.951621613789257e-09
sequences O 0 4.658416014047262e-11
and O 0 2.6252439458418486e-11
the O 0 9.736937645055121e-11
chromatin O 0 7.609355634485837e-08
environment O 0 1.0223033086731448e-08
are O 0 1.3216830407891678e-11
involved O 0 3.037452928067452e-11
in O 0 4.156326949278366e-10
instability O 0 8.12485936307894e-08
mechanisms O 0 1.0352785011491505e-06
. O 0 4.358232956747088e-07

As O 0 5.342803177654787e-08
observed O 0 4.9941344393289455e-09
in O 0 2.2485642514613602e-10
some O 0 2.249940164733566e-11
of O 0 1.665372145742694e-10
the O 0 3.290472339045891e-10
tissues O 0 1.747205047308853e-08
of O 0 2.1158737695259333e-07
DM B-Disease 1 1.0
patients O 1 0.9999080896377563
, O 0 2.8064051083021013e-11
there O 0 4.376675237505179e-12
is O 0 1.1610425077954178e-12
a O 0 4.377835767510607e-12
tendency O 0 1.1353926826496163e-10
for O 0 3.4070777449324297e-11
repeat O 0 4.2839709557540573e-10
length O 0 3.2502023294966875e-10
and O 0 1.7766821347464656e-10
somatic O 0 1.0419201856848304e-07
mosaicism O 0 1.1229973040371988e-07
to O 0 8.156517995738799e-12
increase O 0 2.7307630982853492e-12
with O 0 1.0005853567571221e-12
the O 0 1.1104163422093194e-10
age O 0 1.6627131893542924e-09
of O 0 3.620817812244326e-10
the O 0 4.329010039327841e-09
mouse O 0 1.488902086066446e-07
. O 0 1.9010061080848573e-08

Furthermore O 0 9.477049047745822e-07
, O 0 1.9952328678130016e-09
we O 0 5.9146569586499e-11
observed O 0 4.449604226741677e-11
no O 0 8.373740936762353e-12
correlation O 0 1.0193324483098731e-11
between O 0 1.3057967034046936e-11
the O 0 4.774167727816803e-10
somatic O 0 4.653835787848948e-07
mutation O 0 2.4616981786351744e-09
rate O 0 1.4166303685669845e-09
and O 0 4.2994073579105674e-11
tissue O 0 1.399299254245534e-08
proliferation O 0 3.2684206985322817e-07
capacity O 0 9.778510445812572e-08
. O 0 1.0555118024058174e-07

The O 0 7.315578045563598e-07
somatic O 0 2.760552342806477e-05
mutation O 0 7.546252334122983e-08
rates O 0 2.4875015380843024e-09
in O 0 1.2851207077668736e-11
different O 0 7.797595902303556e-12
tissues O 0 8.649849170261348e-10
were O 0 2.710744961831324e-10
also O 0 5.0584540896292385e-12
not O 0 3.910376796673054e-12
correlated O 0 3.6094818800513906e-10
to O 0 2.3642398802592446e-11
the O 0 8.27634960565149e-10
relative O 0 2.2978197478096263e-07
inter O 0 2.9614503205266374e-07
- O 0 1.8871953955112986e-07
tissue O 0 4.017948995738152e-08
difference O 0 1.7517424177881935e-09
in O 0 6.454897380492319e-12
transcriptional O 0 2.1278707962313348e-10
levels O 0 3.6338523856649374e-10
of O 0 1.0912781095440138e-10
the O 0 1.876185318216983e-10
three O 0 7.202665547323406e-11
genes O 0 1.1319242765317483e-10
( O 0 2.1213373072037633e-11
DMAHP O 0 0.00235286564566195
, O 0 2.850504499107842e-09
DMPK O 1 0.7124525904655457
and O 0 5.874592812205037e-09
59 O 0 1.6359184229486345e-08
) O 0 4.234971748284799e-11
surrounding O 0 1.4728413155751241e-08
the O 0 5.176483686142319e-09
repeat O 0 2.2910706221068722e-08
. O 0 8.008845142626342e-09
. O 0 3.40788872676967e-08

A O 0 2.4827047582220985e-06
novel O 0 3.2507998639630387e-06
missense O 0 9.80946424533613e-06
mutation O 0 2.3257742398641312e-08
in O 0 1.0384195725521295e-09
patients O 0 1.7840664057189315e-08
from O 0 2.601201198881853e-10
a O 0 8.651631078215871e-10
retinoblastoma B-Disease 0 0.0008335444144904613
pedigree O 0 2.5022579848155146e-06
showing O 0 3.875055831770169e-09
only O 0 9.421034091738889e-11
mild O 0 4.5214409993832305e-08
expression O 0 1.4206512632952695e-09
of O 0 3.9067744594945e-09
the O 0 1.1030377500276245e-08
tumor B-Disease 0 5.871436314919265e-07
phenotype O 0 3.9981080135476077e-07
. O 0 2.00754097789968e-08

We O 0 6.995468027071183e-08
have O 0 4.0269290679795233e-10
used O 0 3.278406712770021e-10
single O 0 5.546715309279193e-10
strand O 0 1.010005412638293e-09
conformation O 0 8.420126401675887e-11
polymorphism O 0 3.4978676205499326e-11
analysis O 0 5.373052263529798e-12
to O 0 2.353485678910361e-12
study O 0 1.384280017002748e-11
the O 0 9.32431978850623e-11
27 O 0 1.2467435084317913e-08
exons O 0 1.0324005650375057e-08
of O 0 2.059298731538206e-09
the O 0 4.500387618122659e-08
RB1 O 0 1.648768738959916e-05
gene O 0 2.552008604439493e-10
in O 0 3.949024093841125e-11
individuals O 0 2.243066192855747e-12
from O 0 1.849498609818312e-10
a O 0 3.975416107415697e-10
family O 0 6.523074858044708e-10
showing O 0 2.880087057732794e-09
mild O 0 8.396833663937286e-07
expression O 0 5.02143535641153e-08
of O 0 8.508609994350991e-08
the O 0 2.832381085227098e-07
retinoblastoma B-Disease 0 0.00026018821517936885
phenotype O 0 4.829541467188392e-06
. O 0 1.1718825021489465e-07

In O 0 4.4772448859475844e-08
this O 0 1.52612023018861e-09
family O 0 2.83919665555743e-09
affected O 0 2.7922586465223276e-09
individuals O 0 1.5485505933110488e-10
developed O 0 2.892014663302689e-06
unilateral B-Disease 1 0.7581347823143005
tumors I-Disease 1 1.0
and O 0 2.1776936591777485e-06
, O 0 1.457867437881788e-10
as O 0 2.4805203030497935e-11
a O 0 2.3807691929000896e-12
result O 0 2.9374658955250155e-11
of O 0 1.2966541729220182e-10
linkage O 0 6.612996261701198e-10
analysis O 0 5.2832897778909427e-11
, O 0 1.073879440233183e-11
unaffected O 0 4.9425454839990834e-09
mutation O 0 1.647826319839396e-10
carriers O 0 5.029405780732077e-10
were O 0 1.5776961681535084e-10
also O 0 1.1515706790921065e-11
identified O 0 9.763197195145068e-11
within O 0 5.33752209097571e-10
the O 0 5.565422789288732e-09
pedigree O 0 2.558401774876984e-06
. O 0 2.2202436866791686e-07

A O 0 1.7637616167576198e-07
single O 0 6.735639157540163e-09
band O 0 5.352102316891205e-09
shift O 0 2.0996104854731357e-09
using O 0 1.5917580586943814e-09
SSCP O 0 0.004854255821555853
was O 0 4.400875752708089e-08
identified O 0 2.1125694527057703e-09
in O 0 9.80517222970434e-10
exon O 0 4.239989337406769e-08
21 O 0 1.4180037144484459e-09
which O 0 3.836798934120367e-12
resulted O 0 1.6110865974638955e-09
in O 0 5.909574496421044e-10
a O 0 1.3450558444816352e-09
missense O 0 2.1108188263951888e-07
mutation O 0 1.9850674437549287e-09
converting O 0 2.11036343955584e-08
a O 0 7.756973396944034e-10
cys O 0 1.7889822174765868e-06
- O 0 1.437294514516907e-07
- O 0 1.023772995267791e-07
> O 0 1.5569460742881347e-07
arg O 0 3.920010627211923e-08
at O 0 1.2341672128712844e-10
nucleotide O 0 3.280796467830527e-10
position O 0 4.659120311778508e-10
28 O 0 2.7688864534525237e-09
in O 0 6.002419117301372e-10
the O 0 1.6662824009472388e-08
exon O 0 1.5541378388661542e-06
. O 0 1.957303936706012e-07

The O 0 7.516272830798698e-07
mutation O 0 2.870568778234883e-07
destroyed O 0 4.5581765562019427e-07
an O 0 6.673665509104865e-10
NdeI O 0 4.3246476707281545e-05
restriction O 0 6.085254881327273e-06
enzyme O 0 8.183319550880697e-07
site O 0 2.7039425276598195e-07
. O 0 1.0032555053385295e-07

Analysis O 0 1.083067679985561e-08
of O 0 1.8836525228493883e-08
all O 0 5.762088584049252e-09
family O 0 2.312944058502353e-09
members O 0 3.769795586805458e-11
demonstrated O 0 4.2921904919168696e-10
that O 0 5.462445600012966e-12
the O 0 2.337545046415812e-09
missense O 0 1.2706590268862783e-06
mutation O 0 2.1487055690272427e-08
co O 0 1.1943391164948025e-08
- O 0 1.1299117659291369e-06
segregated O 0 1.3565919232405577e-07
with O 0 1.068349575472638e-10
patients O 0 2.1075995846331352e-06
with O 0 1.1771824404149811e-08
tumors B-Disease 1 1.0
or O 0 9.248265996575356e-05
who O 0 1.2319834929996887e-08
, O 0 2.0665720870671755e-11
as O 0 1.2760443743320415e-11
a O 0 1.4634546829581097e-12
result O 0 7.784548179678996e-12
of O 0 8.534245532487716e-11
linkage O 0 1.440882829717438e-10
analysis O 0 1.9104539131231668e-11
had O 0 2.3083361611053732e-11
been O 0 2.196161134893071e-11
predicted O 0 4.6473250248091347e-10
to O 0 4.5331779996438115e-11
carry O 0 5.086497334438889e-10
the O 0 4.903521588772719e-09
predisposing O 0 6.946869689272717e-06
mutation O 0 1.6136867486693518e-07
. O 0 8.183805277894862e-08

These O 0 3.246184832050858e-08
observations O 0 3.454221442211747e-08
point O 0 7.807101631840396e-09
to O 0 9.74489031135839e-11
another O 0 3.6476782705463506e-10
region O 0 5.262416724605146e-09
of O 0 2.34326442694055e-08
the O 0 2.5011198090396647e-07
RB1 O 0 6.510238017654046e-05
gene O 0 1.6577825778796296e-09
where O 0 5.543838166310877e-10
mutations O 0 1.1108908931634076e-10
only O 0 2.6383051993095208e-11
modify O 0 9.904417286321632e-10
the O 0 8.818651919817455e-10
function O 0 1.4037968010249813e-10
of O 0 2.228608630971962e-09
the O 0 1.6119534596015228e-09
gene O 0 4.0216177610297166e-10
and O 0 1.3954065680721328e-10
raise O 0 6.32607188855161e-10
important O 0 4.199356973266788e-10
questions O 0 7.179708494398085e-10
for O 0 2.7808713665145035e-11
genetic O 0 4.277212806158559e-09
counseling O 0 2.4932063080740363e-09
in O 0 1.8740672208528153e-11
families O 0 5.088617027748654e-12
with O 0 1.5934933494249348e-12
these O 0 1.3502680917820697e-10
distinctive O 0 1.351400502613842e-08
phenotypes O 0 3.768270460113854e-07
. O 0 1.2166369245392161e-08
. O 0 4.813195531028214e-08

Maternal B-Disease 0 0.0001218305915244855
disomy I-Disease 0 0.0006650817231275141
and O 0 3.992719030065928e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 9.158154716715217e-05
with O 0 6.817529318858817e-10
gamete O 0 4.669417990044167e-07
complementation O 0 0.0016779453726485372
in O 0 5.945719472322253e-10
a O 0 2.845156749087252e-11
case O 0 8.97046881220831e-10
of O 0 2.9025608583310714e-08
familial O 0 1.059690930560464e-06
translocation O 0 1.3080430107947905e-06
( O 0 1.1086725287823285e-10
3 O 0 8.413356678005357e-10
; O 0 1.0923958786157595e-11
15 O 0 2.316629527099323e-10
) O 0 8.177516823415498e-12
( O 0 1.738347139845775e-11
p25 O 0 8.626675906953096e-08
; O 0 1.2326992204769738e-10
q11 O 0 9.790697674816329e-08
. O 0 7.642161903298472e-10
2 O 0 9.4610372869397e-09
) O 0 5.563944305286839e-10
. O 0 2.0495976471579525e-08

Maternal B-Disease 1 0.7290679216384888
uniparental I-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999998807907104
( I-Disease 0 1.3065783605270553e-05
UPD I-Disease 1 1.0
) I-Disease 0 1.2263475568374815e-08
for I-Disease 0 1.2825288608908636e-09
chromosome I-Disease 0 3.1169256065055606e-10
15 I-Disease 0 3.6133529501825024e-10
is O 0 3.457655169125662e-12
responsible O 0 1.2445273978034521e-11
for O 0 2.3725880635150354e-11
an O 0 3.104332546230437e-12
estimated O 0 2.1835302663197886e-11
30 O 0 2.9121167283152616e-11
% O 0 7.073187521799973e-13
of O 0 6.930957544004634e-13
cases O 0 2.1129058572211257e-11
of O 0 3.885700650130275e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.2862125039100647
PWS B-Disease 1 1.0
) O 0 3.596675313133346e-08
. O 0 7.54082805087819e-08

We O 0 3.327738795633195e-08
report O 0 9.510588983019375e-10
on O 0 5.581801687526422e-10
an O 0 2.357016491705277e-12
unusual O 0 1.910323843556938e-10
case O 0 9.748055695979474e-10
of O 0 9.503413167522012e-09
maternal B-Disease 0 5.849879016750492e-06
disomy I-Disease 0 0.4112743139266968
15 I-Disease 0 5.040906216891017e-07
in O 0 1.5990735846571624e-07
PWS B-Disease 1 1.0
that O 0 1.366924767820521e-10
is O 0 2.0687214094539108e-11
most O 0 4.646445034284241e-11
consistent O 0 2.703820500826737e-10
with O 0 2.741900673522424e-12
adjacent O 0 2.2178210379308894e-09
- O 0 4.527436203716206e-09
1 O 0 9.68172386706101e-09
segregation O 0 1.0462885002837652e-09
of O 0 1.4464725250906696e-10
a O 0 1.2243130120825896e-10
paternal O 0 1.1184954473719699e-07
t O 0 5.34800026485982e-09
( O 0 1.2471721572149264e-11
3 O 0 3.1230909525170603e-10
; O 0 1.0703662782496348e-11
15 O 0 1.8780542399010614e-10
) O 0 1.0751049356327869e-11
( O 0 2.5276693932374528e-11
p25 O 0 4.983736801023042e-08
; O 0 4.989959140333511e-11
q11 O 0 1.9531151806972957e-08
. O 0 5.212423895284424e-11
2 O 0 1.513908026717914e-10
) O 0 1.0068781745864452e-12
with O 0 1.3280579977750784e-12
simultaneous O 0 2.938010668085411e-10
maternal O 0 5.732985997042306e-08
meiotic O 0 2.881143473132397e-06
nondisjunction O 0 1.6352922102669254e-05
for O 0 2.6745256676008466e-08
chromosome O 0 1.4301184236842346e-08
15 O 0 3.8789401912708854e-08
. O 0 5.842057504423792e-08

The O 0 2.0554364255076507e-06
patient O 0 2.6472687750356272e-05
( O 0 1.1479314165896426e-09
J O 0 1.4344452665682184e-06
. O 0 2.804244891851937e-10
B O 0 4.211738158232947e-08
. O 0 2.758055719573327e-12
) O 0 4.439223782407714e-13
, O 0 9.159672803224495e-13
a O 0 3.9728047240839e-12
17 O 0 1.1497385682401884e-10
- O 0 2.680758670603467e-10
year O 0 8.617737634608602e-10
- O 0 1.7975994026642184e-08
old O 0 6.788858541995069e-08
white O 0 1.0037790598715901e-09
male O 0 1.2176804009556008e-10
with O 0 1.568107102500882e-11
PWS B-Disease 1 1.0
, O 0 1.614273270611477e-09
was O 0 3.910143764329632e-09
found O 0 1.0860081584018744e-10
to O 0 6.041560307590288e-11
have O 0 1.9116140614894306e-10
47 O 0 5.7271578590700756e-09
chromosomes O 0 6.346384529010152e-11
with O 0 3.2534864559397025e-12
a O 0 1.9853088617516335e-10
supernumerary O 0 2.2684437226416776e-06
, O 0 4.200158276734811e-10
paternal O 0 3.0923339977562136e-07
der O 0 6.384717607943458e-07
( O 0 2.4443050014588685e-11
15 O 0 1.5656186069801237e-10
) O 0 7.567450355586147e-13
consisting O 0 1.2039846550293554e-11
of O 0 3.601447959300508e-11
the O 0 4.566713118769883e-10
short O 0 7.979355842735458e-09
arm O 0 2.521205466621268e-09
and O 0 1.3412969346315862e-10
the O 0 4.536053754833347e-09
proximal O 0 0.00019098373013548553
long O 0 3.756566115953319e-07
arm O 0 1.3727840197930163e-08
of O 0 3.0918689830627955e-09
chromosome O 0 3.04289343722175e-10
15 O 0 7.243144972690629e-10
, O 0 6.453251127913617e-11
and O 0 1.2660044124146452e-09
distal O 0 3.966573785874061e-06
chromosome O 0 1.2671883951043128e-06
arm O 0 2.340966420888435e-05
3p O 1 0.5117653012275696
. O 0 6.766939804947469e-06

The O 0 1.1687719052133616e-05
t O 0 3.4013828553725034e-07
( O 0 2.4475063642448447e-10
3 O 0 6.124239448901392e-10
; O 0 6.5907136519161025e-12
15 O 0 4.20459639327575e-11
) O 0 7.627486424584273e-13
was O 0 9.647722204464415e-11
present O 0 4.0963534647664446e-11
in O 0 8.049772654006304e-11
the O 0 1.484241479721149e-10
balanced O 0 8.154842773278048e-11
state O 0 3.813358049470361e-12
in O 0 2.65548932669446e-12
the O 0 6.302536270652581e-11
patients O 0 5.977869310669348e-09
father O 0 9.07551755968683e-10
and O 0 5.501808453267643e-10
a O 0 1.8151155245504924e-08
sister O 0 2.4951166324171936e-06
. O 0 5.57138832846249e-07

Fluorescent O 0 3.5195316741010174e-05
in O 0 5.733062735657768e-08
situ O 0 4.1508573644932767e-07
hybridization O 0 4.279408383212058e-09
analysis O 0 6.057856438701492e-10
demonstrated O 0 3.1563629487862954e-10
that O 0 5.898892485589613e-12
the O 0 1.4680705540115468e-08
PWS B-Disease 1 1.0
critical O 0 0.0003630383580457419
region O 0 7.723895123490365e-08
resided O 0 4.599217717782267e-08
on O 0 1.5214235427052358e-09
the O 0 4.1313194532044406e-10
derivative O 0 1.0254963989098087e-08
chromosome O 0 5.5323006592500334e-11
3 O 0 1.744918792789818e-10
and O 0 3.5714159494354414e-12
that O 0 5.549225900840227e-13
there O 0 1.2139692896762089e-11
was O 0 1.4191908759286775e-10
no O 0 5.388025095531823e-12
deletion O 0 4.308971235378323e-11
of O 0 3.9650721594952643e-10
the O 0 3.801136827519258e-08
PWS B-Disease 1 1.0
region O 0 2.257380060655123e-08
on O 0 1.0616791890072363e-09
the O 0 5.976506789462377e-11
normal O 0 1.0160506463963159e-10
pair O 0 7.759647785432477e-11
of O 0 1.470529670255516e-10
15s O 0 1.1170328662046813e-07
present O 0 2.361358220070997e-09
in O 0 1.9233413084407402e-08
J O 0 0.00019282539142295718
. O 0 4.681479026658053e-07

B O 0 0.022817708551883698
. O 0 1.3665289770870004e-05

Methylation O 0 1.0306263931170179e-07
analysis O 0 9.381486698600838e-09
at O 0 3.22636424243683e-08
exon O 0 1.685162800413309e-07
alpha O 0 4.570584355434448e-09
of O 0 4.75162020840969e-10
the O 0 1.6683328052380375e-09
small O 0 5.494069643674493e-10
nuclear O 0 3.880553123281061e-08
ribonucleoprotein O 0 1.1923085594389704e-06
- O 0 2.076773775172569e-08
associated O 0 7.2709700482676e-09
polypeptide O 0 6.375182692863746e-08
N O 0 7.861316930757312e-08
( O 0 2.6688359855420174e-10
SNRPN O 0 0.00012132696429034695
) O 0 4.299999523116327e-10
gene O 0 4.7025366933795e-10
showed O 0 1.8276269386774402e-10
a O 0 1.1771986163644499e-11
pattern O 0 2.9452090766213246e-10
characteristic O 0 7.714391347946048e-10
of O 0 7.946909241773881e-10
only O 0 1.0242676845573229e-10
the O 0 3.9295811049555596e-10
maternal O 0 4.814175724732195e-09
chromosome O 0 1.3835126100314454e-10
15 O 0 8.173688392787426e-10
in O 0 1.329730436872012e-09
J O 0 6.0868853324791417e-05
. O 0 3.0270211937022395e-07

B O 0 0.02416350319981575
. O 0 1.0113368261954747e-05

Maternal B-Disease 0 0.000237688742345199
disomy I-Disease 0 0.00032985949655994773
was O 0 7.696542070334544e-08
confirmed O 0 3.01631408738956e-09
by O 0 1.5185062929301552e-10
polymerase O 0 3.317179864126274e-09
chain O 0 6.048908041123013e-10
reaction O 0 2.1449116094363063e-10
analysis O 0 2.7428292970199664e-10
of O 0 1.5659059604544723e-09
microsatellite O 0 1.7597864143681363e-07
repeats O 0 6.263626839420056e-10
at O 0 3.202315912442799e-10
the O 0 1.16061188437655e-10
gamma O 0 2.925391484609463e-09
- O 0 6.166321675493691e-09
aminobutyric O 0 1.954382895519302e-07
acid O 0 9.675409806675361e-09
receptor O 0 4.142431286879855e-09
beta3 O 0 1.3348061145279644e-07
subunit O 0 1.4118889168912574e-08
( O 0 5.046692508337003e-10
GABRB3 O 0 4.126753628952429e-05
) O 0 6.9053598394930304e-09
locus O 0 1.1013374745516558e-07
. O 0 6.181065970167765e-08

A O 0 0.0001065945252776146
niece O 0 0.0009802337735891342
( O 0 1.3382035923825697e-08
B O 0 3.827637556241825e-06
. O 0 1.706104563181654e-10
B O 0 1.4822229665867326e-08
. O 0 2.504450639928546e-12
) O 0 3.6840241144156516e-13
with O 0 6.999508394764375e-13
45 O 0 9.545330498239579e-11
chromosomes O 0 1.0595621602327299e-11
and O 0 9.071025180995562e-12
the O 0 8.643578214284631e-11
derivative O 0 1.6221066712063248e-09
3 O 0 2.207172777879407e-10
but O 0 6.046099385037529e-12
without O 0 8.138371920818344e-11
the O 0 1.115856407274407e-09
der O 0 2.0345908069430152e-07
( O 0 1.6556258100597354e-11
15 O 0 1.8722101646773126e-10
) O 0 8.257703548730788e-12
demonstrated O 0 7.313722960589075e-10
a O 0 8.11261405275765e-11
phenotype O 0 1.9223216796149245e-08
consistent O 0 1.4542965720565348e-09
with O 0 1.0380733815942844e-12
that O 0 2.2965819784087627e-13
reported O 0 5.889482911775046e-12
for O 0 1.7528903675789742e-11
haploinsufficiency O 0 6.956375955269323e-07
of O 0 1.8543083513122838e-07
distal O 0 3.611950160120614e-05
3 O 0 2.0510819012997672e-05
p O 0 1.4164186723064631e-05
. O 0 2.8960724307580676e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999997615814209
associated O 0 1.5944685856084106e-06
with O 0 1.020801043694064e-08
unbalanced O 0 2.992120244016405e-06
segregation O 0 3.026377441983641e-07
of O 0 6.419451636929807e-08
non O 0 4.128014552406967e-06
- O 0 5.187163878872525e-06
Robertsonian O 0 0.062287840992212296
translocations O 0 1.9737324237212306e-06
has O 0 1.0920468973552033e-09
been O 0 5.584677165160201e-10
reported O 0 2.700387968790352e-10
previously O 0 5.257969060146195e-10
but O 0 7.135553953263596e-11
has O 0 4.68869431127783e-12
not O 0 2.8842770186110478e-12
, O 0 7.40503838803086e-12
to O 0 1.4234054906969718e-11
our O 0 2.2305339519856915e-10
knowledge O 0 7.05819902524496e-10
, O 0 2.531112689233006e-12
been O 0 3.2655972110468e-12
observed O 0 1.2801838582265912e-11
in O 0 9.171985219935674e-12
a O 0 2.953330635602214e-11
case O 0 9.830025682333599e-09
of O 0 8.319960898006684e-07
PWS B-Disease 1 1.0
. O 0 0.000130224390886724

Furthermore O 0 5.270061137707671e-06
, O 0 9.483313689884199e-09
our O 0 2.933963294537989e-09
findings O 0 1.259280346666003e-09
are O 0 1.9826815536583275e-11
best O 0 1.6708731620518336e-10
interpreted O 0 8.999361811312667e-10
as O 0 2.0453388982488718e-10
true O 0 1.9027828201956254e-09
gamete O 0 1.180207860329574e-07
complementation O 0 5.050066647527274e-06
resulting O 0 2.4961291700265065e-08
in O 0 1.0356034252367863e-08
maternal B-Disease 0 2.1530029698624276e-05
UPD I-Disease 1 1.0
15 I-Disease 0 7.220337283797562e-05
and O 0 8.928678653319366e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9996472597122192
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.8626684322953224e-05
2 I-Disease 0 2.0309521175931877e-07
and O 0 7.85993048424416e-10
Stuve B-Disease 1 0.9999643564224243
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.2905253254924531e-10
a O 0 1.6737559255242118e-11
case O 0 1.1048263692803317e-10
for O 0 7.70653402204502e-11
" O 0 2.174347812911037e-09
lumping O 0 2.1290867735501706e-08
" O 0 1.490384704538883e-08
. O 0 1.0496691515982093e-08

Recent O 0 9.898835173771658e-08
studies O 0 3.558325856189981e-09
demonstrated O 0 2.0864403538212173e-09
the O 0 2.3704091467458e-10
existence O 0 4.1033465514317413e-10
of O 0 4.627864758077749e-10
a O 0 3.7200834079875733e-10
genetically O 0 4.384370981824759e-07
distinct O 0 6.034158173129356e-10
, O 0 2.1074953848038147e-12
usually O 0 1.0046739915697822e-12
lethal O 0 4.319726520929379e-11
form O 0 6.657918140418051e-12
of O 0 5.156327101407676e-11
the O 0 3.2878624822707536e-10
Schwartz B-Disease 0 1.0554509799476364e-06
- I-Disease 0 0.004765336401760578
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999749660491943
( O 0 3.810295634565364e-09
SJS B-Disease 1 0.99997878074646
) O 0 2.4434916312543464e-09
of O 0 2.233483655800228e-06
myotonia B-Disease 1 1.0
and O 0 2.1055358956800774e-05
skeletal B-Disease 1 0.9999889135360718
dysplasia I-Disease 1 1.0
, O 0 3.2122049020699706e-08
which O 0 1.2083869460610686e-09
we O 0 6.726315060490151e-10
called O 0 3.933752434903681e-09
SJS B-Disease 1 0.8621124029159546
type I-Disease 0 1.2132245501561556e-05
2 I-Disease 0 1.71463102560665e-06
. O 0 6.761501225582833e-08

This O 0 1.8474314344985032e-07
disorder O 0 0.005888722836971283
is O 0 8.359227754439758e-10
reminiscent O 0 2.5178411533488543e-07
of O 0 1.162835516765881e-08
another O 0 2.0796732391747952e-10
rare O 0 3.979770957229789e-10
condition O 0 1.551750505868199e-09
, O 0 3.4414433108809206e-12
the O 0 3.0570704301347007e-10
Stuve B-Disease 1 0.9995262622833252
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.446915449487278e-06
SWS B-Disease 1 0.9999490976333618
) O 0 1.0629268298867345e-10
, O 0 1.666257583299302e-11
which O 0 1.580683327284671e-11
comprises O 0 2.3239760116311459e-10
campomelia B-Disease 0 3.458470700934413e-07
at O 0 4.0225501152235665e-08
birth O 0 1.710882429506455e-06
with O 0 3.1816178580612586e-09
skeletal B-Disease 0 0.05038590729236603
dysplasia I-Disease 1 0.9999995231628418
, O 0 2.5567468142639882e-08
contractures B-Disease 0 0.0033371038734912872
, O 0 7.13290426723745e-10
and O 0 1.4307718898542987e-10
early B-Disease 0 9.827367364323436e-08
death I-Disease 0 1.7632200410844234e-07
. O 0 8.949933771873475e-08

To O 0 1.254199322175964e-08
test O 0 2.751928995792241e-08
for O 0 3.3281738476276246e-10
possible O 0 1.859929099623514e-08
nosologic O 0 0.11999760568141937
identity O 0 2.0644515430490173e-08
between O 0 1.2928886850005483e-09
these O 0 6.417514519796441e-09
disorders O 0 9.694783329905476e-06
, O 0 6.136186003757871e-11
we O 0 1.868306724606139e-11
reviewed O 0 1.5712853240756885e-09
the O 0 2.6206375958182093e-10
literature O 0 2.9095309495019706e-10
and O 0 8.674933059220347e-13
obtained O 0 6.747394309947197e-12
a O 0 1.5214357551585067e-12
follow O 0 4.1192004668344495e-11
- O 0 9.4403207473448e-10
up O 0 8.617190294657462e-11
of O 0 5.2300705433161454e-11
the O 0 2.1426371094035446e-11
only O 0 3.888866225570942e-12
two O 0 1.821806160789974e-12
surviving O 0 1.279321715230708e-08
patients O 0 8.362835757225184e-09
, O 0 1.5318872906289194e-11
one O 0 2.663982749673277e-11
with O 0 4.44250643216737e-11
SJS B-Disease 0 0.04468463733792305
type I-Disease 0 1.6609346857876517e-06
2 I-Disease 0 1.3038525814579316e-08
at O 0 2.7568436422598097e-10
age O 0 3.1732949601348537e-10
10 O 0 8.235493884067857e-12
years O 0 5.526434344871323e-12
and O 0 5.7850842172246786e-12
another O 0 5.953365578292846e-11
with O 0 1.647593728115737e-10
SWS B-Disease 0 7.336303951888112e-06
at O 0 3.1073585926577607e-09
age O 0 8.861534617210509e-09
7 O 0 6.095202120803833e-09
years O 0 2.7030226945612412e-09
. O 0 2.2255681741967237e-08

Patients O 0 0.00010728816414484754
reported O 0 7.08490821565988e-09
as O 0 7.665271195556045e-10
having O 0 1.2214912414876267e-09
either O 0 9.158471669934443e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.9972379207611084
SWS B-Disease 0 0.05147735774517059
presented O 0 8.557363151417974e-10
a O 0 6.460169205135813e-12
combination O 0 3.164778439312954e-10
of O 0 1.9713999876991295e-10
a O 0 4.983624624088634e-11
severe O 0 9.174291903946141e-07
, O 0 3.4696971962233647e-09
prenatal O 1 0.999977707862854
- O 1 0.9999982118606567
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.6247879557340639e-06
with O 0 0.00031772497459314764
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9554276466369629
respiratory O 1 1.0
and O 0 3.0535698897438124e-05
feeding O 0 0.008101784624159336
difficulties O 0 1.315791450906545e-06
, O 0 3.486678723518821e-10
tendency O 0 1.867111576459024e-09
to O 0 4.2031231273220726e-10
hyperthermia B-Disease 0 0.2103651463985443
, O 0 2.949127053675227e-10
and O 0 5.5983256225244915e-11
frequent O 0 3.552964519815127e-11
death O 0 1.3309864321797704e-09
in O 0 1.0162857222439925e-09
infancy O 0 7.748359820425321e-08
) O 0 1.053660739387674e-12
with O 0 5.612667990963216e-13
a O 0 2.607856465497438e-11
distinct O 0 2.0592005878228292e-09
campomelic B-Disease 0 0.0005696816951967776
- I-Disease 1 0.7043163180351257
metaphyseal I-Disease 1 0.9999589920043945
skeletal I-Disease 1 0.9723686575889587
dysplasia I-Disease 1 0.9999997615814209
. O 0 9.549893729854375e-05

The O 0 3.1178561954448014e-08
similarity O 0 2.21334683914165e-08
of O 0 2.3145251049072613e-08
the O 0 3.672765558349056e-08
clinical O 0 1.0516880593058886e-06
and O 0 1.0740690559174482e-09
radiographic O 0 0.0002603393222671002
findings O 0 5.980380706205324e-07
is O 0 3.019910155277472e-10
so O 0 4.156031768731694e-11
extensive O 0 5.317909446134195e-10
that O 0 1.2132100879469476e-11
these O 0 1.2283818406899627e-08
disorders O 0 0.000981051241979003
appear O 0 1.2228579038264797e-08
to O 0 5.3872160205026276e-11
be O 0 8.919587984879129e-11
a O 0 2.1825863338875706e-10
single O 0 2.5483131160797257e-09
entity O 0 2.4884757365839505e-08
. O 0 1.2297701346142276e-07

The O 0 9.064903139233138e-08
follow O 0 1.5819948018247487e-08
- O 0 4.205204362506265e-08
up O 0 4.314722190645881e-10
observation O 0 3.5577829571309394e-09
of O 0 3.8539268998327714e-11
an O 0 1.067985869011856e-12
identical O 0 1.1374127334429218e-10
and O 0 1.2212896492724834e-11
unique O 0 5.672230740660922e-11
pattern O 0 1.4621093225031245e-09
of O 0 2.6607602876538294e-07
progressive O 1 0.9999969005584717
bone B-Disease 1 0.9999984502792358
dysplasia I-Disease 1 0.9999994039535522
in O 0 1.0751193713076646e-07
the O 0 1.1743321870483214e-08
two O 0 6.531989393820936e-10
patients O 0 2.956547540122756e-08
( O 0 4.731962217896513e-12
one O 0 1.9067190534793887e-11
with O 0 2.151630436320051e-11
SJS B-Disease 0 0.0004075853794347495
type I-Disease 0 6.836754664618638e-07
2 I-Disease 0 2.8584878464243957e-08
, O 0 9.384711757709496e-12
one O 0 8.17062563440718e-12
with O 0 3.897808811825776e-11
SWS B-Disease 0 1.3531075637729373e-06
) O 0 6.264520152621245e-11
surviving O 0 4.368285644318348e-08
beyond O 0 1.2564397877667943e-07
infancy O 0 1.5516661733272485e-07
adds O 0 1.3666380527244115e-10
to O 0 2.361238635173457e-11
the O 0 4.5942659399056396e-11
evidence O 0 1.9093548964121965e-10
in O 0 5.984331780117813e-11
favor O 0 5.93346483057644e-09
of O 0 1.5770952321858545e-09
identity O 0 8.111198823712584e-09
. O 0 2.2883805073092844e-08

The O 0 6.280015441006981e-07
hypothesis O 0 6.2016770243644714e-06
that O 0 4.6238790574193445e-09
SWS B-Disease 0 0.37868499755859375
and O 0 7.151015068984634e-08
SJS B-Disease 1 0.9999994039535522
type I-Disease 0 0.00014364520029630512
2 I-Disease 0 3.30977826479284e-07
are O 0 3.104718912516624e-11
the O 0 2.1507576275503482e-10
same O 0 3.995440867043953e-09
disorder O 0 7.368771548499353e-07
should O 0 9.842572312734887e-10
be O 0 4.1733902444995863e-10
testable O 0 5.180971385243538e-08
by O 0 2.75749423295224e-11
molecular O 0 2.2622440032371571e-10
methods O 0 1.6203440811324299e-09
. O 0 1.490503276357913e-09
. O 0 2.374796537196744e-08

A O 0 1.9144188456721167e-07
mouse O 0 2.9093007114511238e-08
model O 0 3.9159189779702785e-10
of O 0 6.246649308927488e-10
severe O 1 0.9931500554084778
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 3.9333490349235944e-06
defects O 0 8.779217750998214e-05
in O 0 6.510824590577613e-08
hemostasis O 0 0.027621068060398102
and O 0 1.1188623716407164e-07
thrombosis B-Disease 1 0.9999799728393555
. O 0 1.3521217624656856e-05

von B-Disease 0 0.169453427195549
Willebrand I-Disease 1 0.9999912977218628
factor I-Disease 0 0.020636891946196556
( I-Disease 0 1.8457441228747484e-06
vWf I-Disease 1 0.9999822378158569
) I-Disease 0 5.27083511769888e-06
deficiency I-Disease 1 0.9999970197677612
causes O 0 0.00013827215298078954
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.0005204163608141243
humans O 0 4.985353143638349e-07
. O 0 2.9122375622137042e-08

We O 0 2.749814420610619e-08
generated O 0 3.7186522749976803e-09
a O 0 2.346370597816616e-10
mouse O 0 1.4071377396618345e-09
model O 0 7.993697370700659e-11
for O 0 9.523285805779214e-12
this O 0 7.857618028461744e-11
disease O 0 3.0227818026418163e-09
by O 0 1.1435296459749722e-10
using O 0 6.10315631366376e-10
gene O 0 1.0603273814524528e-09
targeting O 0 1.1348221917728551e-08
. O 0 3.854785290968721e-08

vWf B-Disease 1 0.9999828338623047
- I-Disease 1 1.0
deficient I-Disease 1 1.0
mice O 0 4.97879500471754e-06
appeared O 0 1.8275791990873813e-09
normal O 0 1.408772404287717e-10
at O 0 1.6810512704079628e-10
birth O 0 7.806234547658164e-10
; O 0 1.2702600256375707e-11
they O 0 1.7977477145825205e-11
were O 0 4.916348994576936e-10
viable O 0 1.96348040049088e-08
and O 0 7.813324987004933e-10
fertile O 0 9.061624837158888e-07
. O 0 3.104327106484561e-08

Neither O 0 4.237317989463918e-05
vWf O 0 0.00037493251147679985
nor O 0 1.0529473001952283e-05
vWf O 0 0.0003030051593668759
propolypeptide O 0 0.00045418035006150603
( O 0 7.711295069157131e-08
von B-Disease 0 0.0017609994392842054
Willebrand I-Disease 0 0.010455731302499771
antigen O 0 8.134632480505388e-06
II O 1 1.0
) O 0 2.006667276788221e-09
were O 0 2.70631383969544e-09
detectable O 0 5.645880918336843e-08
in O 0 2.6554866638939245e-10
plasma O 0 1.7107529615145722e-08
, O 0 2.88780145629719e-11
platelets O 0 5.858055374119431e-09
, O 0 2.487902418801813e-11
or O 0 1.3466203846457248e-11
endothelial O 0 2.226616002687365e-09
cells O 0 1.3463000159141814e-10
of O 0 1.6057355445298072e-10
the O 0 3.686576377504025e-09
homozygous O 0 4.6525090624527365e-07
mutant O 0 1.8868332745114458e-06
mice O 0 3.2914081771195924e-07
. O 0 2.0703982528402776e-08

The O 0 1.0725732863647863e-05
mutant O 0 6.617092731175944e-05
mice O 0 1.2624190048882156e-06
exhibited O 0 5.419389381700057e-08
defects O 0 1.2521995813585818e-06
in O 0 4.354451732524467e-08
hemostasis O 0 1.7485173884779215e-05
with O 0 1.0985393844586966e-10
a O 0 1.2211907041148606e-09
highly O 0 2.2441442979470594e-06
prolonged O 0 0.14355427026748657
bleeding O 0 0.0006409253692254424
time O 0 4.634865646835351e-08
and O 0 1.6042616124423148e-08
spontaneous O 0 2.580400746410305e-07
bleeding O 0 4.819157339852609e-08
events O 0 7.282426744970039e-11
in O 0 1.701592859670864e-11
approximately O 0 6.8871310564266874e-12
10 O 0 2.4558990258105595e-11
% O 0 2.0311634318925798e-11
of O 0 4.088284710768164e-10
neonates O 0 8.483838200845639e-07
. O 0 1.7225228532424808e-07

As O 0 4.522268781670391e-08
in O 0 7.746697172628103e-10
the O 0 2.6632424043881997e-10
human O 0 7.540946339590349e-11
disease O 0 1.57527946242908e-09
, O 0 5.1016881691401395e-12
the O 0 7.737390589346305e-11
factor O 0 3.980030971462156e-09
VIII O 1 0.9999364614486694
level O 0 8.846776040627446e-07
in O 0 9.865521732876914e-10
these O 0 1.3881037985719047e-10
mice O 0 1.699077128991533e-10
was O 0 3.886940075359391e-11
reduced O 0 6.018261999862773e-10
strongly O 0 1.3188129754926337e-10
as O 0 2.7980992522991244e-11
a O 0 5.202568410800357e-12
result O 0 7.148576869342449e-11
of O 0 3.431366024653215e-10
the O 0 2.7146515590992237e-10
lack O 0 1.4827821193108548e-09
of O 0 1.1824671797278086e-10
protection O 0 2.793355990959867e-09
provided O 0 5.004774372707743e-10
by O 0 1.7672098229226663e-09
vWf O 0 9.214782949129585e-06
. O 0 3.0916083915144554e-07

Defective O 1 0.9999043941497803
thrombosis B-Disease 1 1.0
in O 0 9.3704320534016e-06
mutant O 0 6.110953563620569e-06
mice O 0 1.970781760007867e-08
was O 0 2.008664901076429e-10
also O 0 3.804908211418878e-12
evident O 0 2.680581090430678e-09
in O 0 7.542140523231211e-11
an O 0 7.815206272930586e-13
in O 0 1.3845625167208109e-11
vivo O 0 1.4290153782514636e-10
model O 0 2.640360430294919e-10
of O 0 1.1955060941204465e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.0006474623223766685

In O 0 2.7373430189214787e-09
this O 0 2.2997929949308826e-11
model O 0 4.2244216458264816e-10
, O 0 2.6210362005785193e-11
the O 0 2.8025123888220094e-10
exteriorized O 0 3.372588025740697e-06
mesentery O 0 2.531753125367686e-05
was O 0 1.0427552155078956e-07
superfused O 0 7.107078545232071e-06
with O 0 1.9589119215623896e-09
ferric O 0 2.9612672733492218e-05
chloride O 0 6.32880528428359e-07
and O 0 4.033557488014594e-09
the O 0 2.9822817548819103e-09
accumulation O 0 5.560947613503231e-08
of O 0 1.030311480576529e-08
fluorescently O 0 4.089906724402681e-06
labeled O 0 4.341357495718512e-08
platelets O 0 3.0718261712081585e-08
was O 0 5.215260445723402e-10
observed O 0 2.164820683825397e-10
by O 0 5.294076288464566e-10
intravital O 0 3.7641398193954956e-06
microscopy O 0 2.9190946406743024e-06
. O 0 9.385317412125005e-07

We O 0 8.587914379631911e-08
conclude O 0 1.222845611437151e-07
that O 0 9.592602406849338e-11
these O 0 2.4722570657331744e-09
mice O 0 3.5130504727476364e-08
very O 0 7.261763967925106e-10
closely O 0 1.6960676418875664e-08
mimic O 0 2.7413540010456927e-05
severe O 1 0.9999746084213257
human O 1 0.9805307388305664
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 2.3249448588558153e-08
will O 0 3.2163074287216986e-11
be O 0 1.1532278604287072e-11
very O 0 2.5729832760917892e-12
useful O 0 5.4396136033030285e-12
for O 0 7.791674206877874e-13
investigating O 0 5.1201539535972174e-11
the O 0 6.678729791431692e-11
role O 0 1.0521777199512528e-10
of O 0 2.9340530005583787e-09
vWf O 0 1.3531049489756697e-06
in O 0 2.078888838852322e-09
normal O 0 4.9396927437328486e-08
physiology O 0 8.475406332308921e-08
and O 0 3.673649925928224e-11
in O 0 1.796912202367551e-10
disease O 0 5.223715238145132e-09
models O 0 4.537767051004948e-09
. O 0 4.045715762401869e-09
. O 0 4.256616747966291e-08

Oral O 0 0.0007836176082491875
contraceptives O 0 4.1942923417082056e-05
and O 0 6.621364012637798e-10
the O 0 1.7447466804654255e-09
risk O 0 1.4199130760061962e-07
of O 0 6.238393689272925e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.449684876017272e-05

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.30126598477363586
Study O 0 1.3260641651413607e-07
Group O 0 4.839982636895002e-09
. O 0 1.476863964455788e-08

BACKGROUND O 0 6.652421870967373e-05
Women O 0 1.6094780619368976e-08
with O 0 2.6364438410197977e-11
mutations O 0 3.855487595849638e-10
in O 0 2.904967377759249e-10
either O 0 1.5639688433211063e-09
the O 0 3.50983562213969e-08
BRCA1 O 0 1.0753634427373981e-07
or O 0 1.0808735018130733e-09
the O 0 2.844216950848022e-08
BRCA2 O 0 2.1340916589451808e-08
gene O 0 2.3885525501921023e-11
have O 0 8.423651858512071e-13
a O 0 2.7674564029300797e-12
high O 0 7.468511142860734e-09
lifetime O 0 2.907647633776378e-08
risk O 0 6.088558848205139e-07
of O 0 0.00044142096885479987
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6401788798248162e-06

Oral O 1 0.9999885559082031
contraceptives O 1 0.9999995231628418
protect O 0 0.00025565153919160366
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.038276214477719e-08
general O 0 1.1069452021672532e-08
, O 0 2.2117061654336467e-11
but O 0 1.1212743407373882e-11
it O 0 9.021139412736245e-13
is O 0 2.440487048560591e-13
not O 0 4.834142526381757e-13
known O 0 2.3820830724607944e-11
whether O 0 4.335830999790957e-11
they O 0 6.946290070919403e-11
also O 0 1.991877149332133e-11
protect O 0 1.2637986490648956e-10
against O 0 2.7134208213652755e-09
hereditary B-Disease 1 0.9776426553726196
forms I-Disease 1 0.9935874938964844
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.188062116052606e-07

METHODS O 0 1.015908219414996e-05
We O 0 9.696808689341196e-08
enrolled O 0 3.0910365467207157e-07
207 O 0 1.010037067317171e-07
women O 0 8.281387242625726e-10
with O 0 9.232160036454218e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.364376777170719e-09
161 O 0 4.102589823418157e-09
of O 0 1.271757144039043e-09
their O 0 2.8048023903437524e-09
sisters O 0 3.829311090441934e-09
as O 0 5.1210917451083304e-11
controls O 0 2.701336099253382e-10
in O 0 5.589811252759702e-11
a O 0 3.1905599690018605e-11
case O 0 2.8838742505143955e-09
- O 0 3.407934201504759e-08
control O 0 1.5481800730299256e-08
study O 0 3.376848578540148e-09
. O 0 3.9988257150014306e-09

All O 0 3.652311519886098e-08
the O 0 1.0029260977262311e-08
patients O 0 3.0645095350223528e-09
carried O 0 4.494572769520033e-11
a O 0 9.608931705873403e-12
pathogenic O 0 9.453876792520077e-09
mutation O 0 4.17843404321161e-09
in O 0 9.695726443936792e-10
either O 0 5.353103293970207e-09
BRCA1 O 0 2.324492598404504e-08
( O 0 2.112309459290085e-11
179 O 0 1.1437445657236367e-08
women O 0 9.389084648647739e-11
) O 0 1.0932086833004284e-11
or O 0 3.443549667636603e-09
BRCA2 O 0 1.7557994169692392e-06
( O 0 4.671622533258812e-10
28 O 0 2.585891820672259e-07
women O 0 1.6981578365715677e-09
) O 0 2.3273384608391012e-10
. O 0 2.0458363891862064e-08

The O 0 4.2000621647275693e-07
control O 0 1.7797475493352977e-07
women O 0 1.0703837816095074e-09
were O 0 6.872205582375557e-10
enrolled O 0 1.3920471442219196e-09
regardless O 0 1.9984312815690686e-10
of O 0 2.1485066503679207e-10
whether O 0 2.2562371415624227e-10
or O 0 1.9793272576507093e-10
not O 0 2.4371510365384097e-10
they O 0 2.8054963907564456e-10
had O 0 1.4895511490919944e-09
either O 0 6.96726232263245e-09
mutation O 0 3.5287918365156656e-08
. O 0 5.3357965157374565e-08

Lifetime O 0 1.5154086213442497e-05
histories O 0 2.0103570932406e-06
of O 0 1.3292331857428508e-07
oral O 0 9.022923222801182e-06
- O 0 1.0901120504058781e-06
contraceptive O 0 1.117405076911382e-06
use O 0 7.866435280945439e-11
were O 0 4.701986716648676e-11
obtained O 0 1.2192832681001686e-11
by O 0 1.8099823723138897e-11
interview O 0 4.192184446805136e-11
or O 0 5.274808801553066e-12
by O 0 9.484710759843917e-12
written O 0 4.484554047556877e-11
questionnaire O 0 1.1785854237000848e-10
and O 0 2.6395320391198185e-12
were O 0 2.465426647557667e-11
compared O 0 9.981046544815797e-11
between O 0 1.1103443858795359e-10
patients O 0 1.2434335872058e-07
and O 0 1.8698263770655643e-10
control O 0 6.137693020491497e-08
women O 0 1.562179274827713e-10
, O 0 1.6078116485754301e-12
after O 0 4.4647025659871886e-11
adjustment O 0 9.533073219714083e-10
for O 0 8.609284292415698e-12
year O 0 9.904128212001595e-11
of O 0 3.253266267488897e-10
birth O 0 1.9407716322916713e-08
and O 0 1.3150734945455156e-09
parity O 0 3.374323966909287e-07
. O 0 5.2613451373417774e-08

RESULTS O 0 1.1824541616078932e-05
The O 0 1.3294487644088804e-07
adjusted O 0 4.976992045158113e-07
odds O 0 3.100598632954643e-06
ratio O 0 1.124804953178682e-06
for O 0 1.7819226059145876e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.831182177587266e-09
with O 0 9.472742035221415e-12
any O 0 4.234567557714897e-11
past O 0 1.6095562382911766e-10
use O 0 8.042698451671271e-11
of O 0 1.9895021186044914e-09
oral O 0 2.726163529587211e-06
contraceptives O 0 1.249662204827473e-06
was O 0 1.516481695773564e-08
0 O 0 3.35243832694232e-08
. O 0 1.1479669659308911e-08

5 O 0 3.026608055733959e-06
( O 0 1.1665564514373727e-08
95 O 0 2.445869768052944e-06
percent O 0 5.770153421735813e-08
confidence O 0 3.8185184791927895e-08
interval O 0 2.359157846854032e-08
, O 0 1.1511714498313452e-10
0 O 0 4.5180226226904097e-10
. O 0 4.093976893604356e-12
3 O 0 3.048416380435626e-11
to O 0 3.481252829409809e-12
0 O 0 3.7475017533594723e-10
. O 0 3.2128494309446864e-11
8 O 0 1.3422163380738539e-09
) O 0 1.1163582558371132e-10
. O 0 7.886513664345784e-09

The O 0 5.892056265111023e-07
risk O 0 9.294875269461045e-08
decreased O 0 4.9463366735835734e-09
with O 0 1.4205305334802354e-11
increasing O 0 2.3176371932720485e-10
duration O 0 4.694760136203513e-09
of O 0 8.320732436395417e-10
use O 0 1.2955423400740074e-09
( O 0 2.1727050714126506e-10
P O 0 8.369731290258642e-07
for O 0 4.495003813609344e-10
trend O 0 7.788926836838073e-09
, O 0 5.379963835538959e-12
< O 0 2.9461644235340145e-10
0 O 0 2.324960224342476e-10
. O 0 1.1659541387931682e-11
001 O 0 1.359644730136722e-09
) O 0 1.3083883477517377e-13
; O 0 1.6160845177273092e-13
use O 0 1.967183794332472e-12
for O 0 1.397376745565504e-11
six O 0 1.0103130138050531e-10
or O 0 2.2580742831124212e-11
more O 0 4.2931526389455854e-12
years O 0 2.533181130137674e-11
was O 0 6.016583065093783e-11
associated O 0 2.08600862278141e-11
with O 0 1.2723155862204294e-12
a O 0 2.758335920782784e-11
60 O 0 3.6822031534988753e-10
percent O 0 3.936991010977664e-11
reduction O 0 1.42313005824235e-09
in O 0 3.977344675831773e-09
risk O 0 1.4767547895644384e-07
. O 0 5.262137747763518e-08

Oral O 0 0.0037814462557435036
- O 0 0.00023572212376166135
contraceptive O 0 0.0033530485816299915
use O 0 1.208461810620065e-07
protected O 0 0.011572310701012611
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 6.352540160570186e-10
for O 0 4.767995720467155e-11
carriers O 0 2.2254090237261437e-10
of O 0 5.06753694562434e-10
the O 0 5.524060764372507e-09
BRCA1 O 0 8.986073218864021e-09
mutation O 0 1.886325678990275e-10
( O 0 4.598419301587997e-12
odds O 0 3.2508862268798566e-09
ratio O 0 3.955735738969679e-10
, O 0 2.13341995979055e-12
0 O 0 2.0017643792558104e-11
. O 0 1.7884988195299156e-12
5 O 0 1.9575691762030445e-11
; O 0 6.918307940417812e-12
95 O 0 1.1697403934363138e-08
percent O 0 8.244649407629367e-10
confidence O 0 1.4417769200747443e-09
interval O 0 2.4039072954451512e-09
, O 0 5.006508749239025e-11
0 O 0 1.6441781269804778e-10
. O 0 3.862726544873185e-12
3 O 0 2.6322234322750937e-11
to O 0 5.087423537997182e-12
0 O 0 1.892719037055457e-10
. O 0 1.0363487845665986e-11
9 O 0 1.3031302426025348e-10
) O 0 4.801474430722596e-13
and O 0 1.6142768545501784e-12
for O 0 1.6419577286361231e-12
carriers O 0 1.5392687124915483e-10
of O 0 5.855348983452302e-10
the O 0 3.356667477305564e-08
BRCA2 O 0 1.4850363072582695e-07
mutation O 0 9.42538824766359e-10
( O 0 1.5688731563878733e-11
odds O 0 1.3658342012945468e-08
ratio O 0 1.8476589147553568e-09
, O 0 5.08049982292369e-12
0 O 0 5.79654102494942e-11
. O 0 2.548882979680478e-12
4 O 0 4.533748723667408e-11
; O 0 1.332079585525392e-11
95 O 0 3.211996713048393e-08
percent O 0 1.4073283649551627e-09
confidence O 0 2.4676118925981427e-09
interval O 0 3.031442430412312e-09
, O 0 1.9248724142384432e-11
0 O 0 1.4327215802634186e-10
. O 0 2.9465436167386283e-12
2 O 0 2.0457045779576077e-11
to O 0 2.324722879476493e-12
1 O 0 3.0413907503579196e-10
. O 0 4.2542726286232124e-11
1 O 0 3.976510232206465e-09
) O 0 2.2967518165106782e-10
. O 0 1.2993615072787179e-08

CONCLUSIONS O 0 0.0001868297258624807
Oral O 0 0.000175523673533462
- O 0 3.2286350233334815e-06
contraceptive O 0 1.5400123629660811e-06
use O 0 1.459748294463381e-10
may O 0 7.717345512636697e-11
reduce O 0 7.835647408693802e-11
the O 0 2.6249749596196637e-10
risk O 0 9.64122364166542e-08
of O 0 0.014616506174206734
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.0914248111125744e-09
women O 0 5.3790301206280144e-12
with O 0 3.0295977857495993e-13
pathogenic O 0 2.8136435403780524e-09
mutations O 0 1.5236945039021066e-09
in O 0 4.5125453373984215e-10
the O 0 2.2518499065427022e-08
BRCA1 O 0 8.367321129298944e-07
or O 0 1.4305977913409151e-07
BRCA2 O 0 1.1331900168443099e-05
gene O 0 5.488669785336242e-07

A O 0 4.3670283389474207e-07
Japanese O 0 4.921584149997216e-06
family O 0 4.7549044701611365e-09
with O 0 1.3398631093508584e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 6.75638034408621e-09
a O 0 1.106620217683485e-08
codon O 0 2.900727338328579e-07
291 O 0 2.5419598870257687e-08
deletion O 0 1.509923519549261e-09
: O 0 8.082553723531838e-12
a O 0 1.0953689344450623e-11
clinical O 0 4.025656252792942e-09
, O 0 1.3131647678965574e-11
biochemical O 0 3.843215523602339e-08
, O 0 1.1727283033557967e-10
pathological O 0 4.966630967828678e-06
, O 0 3.751914334770845e-10
and O 0 5.146671422373572e-10
genetic O 0 4.3003403504826565e-08
report O 0 5.825586235630453e-09
. O 0 9.330505434945735e-08

We O 0 8.822459207635802e-09
report O 0 1.4447300300535204e-10
a O 0 6.166691463027618e-11
Japanese O 0 4.811387555037072e-08
family O 0 8.431686460141918e-10
with O 0 2.6630710969755e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.010351153090596199
ALD B-Disease 1 1.0
) O 0 9.770914077833481e-10
with O 0 3.076218793585106e-11
a O 0 5.740253411490315e-11
three O 0 4.765795397210226e-11
base O 0 1.219147338638038e-09
pair O 0 2.2514192732359106e-09
deletion O 0 3.4338427656877e-09
( O 0 8.607942136862334e-11
delGAG O 0 5.27100326053187e-07
291 O 0 7.178260652551671e-09
) O 0 1.7515234054799045e-11
in O 0 3.5937094966520533e-10
the O 0 8.687290176112583e-08
ALD B-Disease 1 1.0
gene O 0 5.043338205723558e-06
. O 0 1.2676960068347398e-06

A O 0 2.839415458311123e-07
variety O 0 1.9591521294159975e-08
of O 0 7.205283925060257e-09
phenotypes O 0 1.9067624634772073e-07
were O 0 7.25896620590305e-10
observed O 0 2.4226168293672856e-10
within O 0 2.2417297185217677e-10
this O 0 2.5084020971455345e-10
family O 0 4.1697800767792614e-09
. O 0 4.737914238717167e-08

While O 0 4.56889601707644e-08
the O 0 3.5171936474398535e-08
proband O 1 0.5815786719322205
( O 0 1.2163074103455074e-08
patient O 0 1.6501229538334883e-06
1 O 0 2.2497376406249714e-08
) O 0 2.024093739838584e-11
was O 0 4.657494390158945e-10
classified O 0 9.062889327893231e-10
as O 0 2.3901763901434947e-10
having O 0 1.5021697774564302e-10
a O 0 3.6675520259654704e-11
rare O 0 6.177831579634585e-10
intermediate O 0 8.257121208998797e-08
type O 0 3.1945088796447862e-09
of O 0 8.151239683229505e-10
adult O 0 2.51641574244843e-09
cerebral O 0 4.255348073911591e-09
and O 0 3.836619910657646e-10
cerebello O 0 1.1268242815276608e-05
- O 0 3.5420905533101177e-06
brain O 0 2.0165485636880476e-07
stem O 0 5.174490169679302e-09
forms O 0 4.135750630851476e-10
, O 0 1.3687660380123923e-11
his O 0 1.8995036099589413e-10
younger O 0 5.666984037588918e-08
brother O 0 7.916840871757813e-08
( O 0 1.1618610934460705e-10
patient O 0 2.9124766598442875e-08
2 O 0 4.692474742107322e-10
) O 0 4.685324177244876e-12
and O 0 1.752102352092777e-10
nephew O 0 1.336518380412599e-05
( O 0 7.340975605174549e-10
patient O 0 9.781623475646484e-07
3 O 0 3.503493273271374e-09
) O 0 1.0414592799268263e-11
had O 0 2.0697486780019148e-10
a O 0 1.2537203497586802e-09
childhood O 0 1.3085360478726216e-05
ALD B-Disease 1 1.0
type O 0 0.024895798414945602
. O 0 2.262482894366258e-06

Another O 0 4.807558070751838e-06
nephew O 1 0.946820080280304
( O 0 5.4920423764315274e-08
patient O 0 1.8926086340798065e-05
4 O 0 2.7462764506935855e-08
) O 0 3.2668139027247634e-11
of O 0 3.838818152246404e-09
patient O 0 7.732296012363804e-07
1 O 0 3.23327036255705e-08
was O 0 3.1337255013141885e-09
classified O 0 9.384847343696379e-10
as O 0 2.755108918783833e-10
having O 0 6.841823774195177e-10
an O 0 5.336745281803168e-11
adolescent O 0 2.939807330903932e-08
form O 0 3.6340344067298247e-09
. O 0 7.833596527007103e-08

The O 0 6.918955364199064e-08
tau O 0 2.9395661016451413e-08
level O 0 6.071532165918825e-09
in O 0 2.0274137924047864e-10
the O 0 9.056150274133756e-10
cerebrospinal O 0 3.2590705245638674e-08
fluid O 0 4.344331614447583e-07
( O 0 8.220220948373935e-09
CSF O 0 7.196045044111088e-05
) O 0 5.494006360962089e-10
in O 0 1.1030082625040905e-08
patient O 0 2.488125801392016e-06
1 O 0 5.2358878122049646e-08
was O 0 1.2249683045695292e-08
as O 0 5.343552267333962e-10
high O 0 7.318080363916124e-09
as O 0 6.9342409418637896e-12
that O 0 1.710859644059315e-13
of O 0 6.32006322276446e-11
patients O 0 4.047630230985533e-09
with O 0 5.818187598372049e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 0 0.13036082684993744
( O 0 8.845487675657182e-10
AD B-Disease 0 1.338540300821478e-06
) O 0 1.3596603842813693e-09
. O 0 1.648978731338957e-08

His O 0 3.283978685431066e-06
brain O 0 5.710149935111986e-07
magnetic O 0 3.424296153298201e-07
resonance O 0 9.120336699197651e-07
image O 0 1.2848809092247393e-06
( O 0 4.932509156674314e-08
MRI O 1 0.9999960660934448
) O 0 1.033898211488804e-08
showed O 0 1.462291354670242e-08
abnormalities B-Disease 0 4.767757388890459e-08
in I-Disease 0 4.5940579118664004e-10
the I-Disease 0 5.9029874321936404e-09
bilateral I-Disease 0 1.8132361219613813e-05
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.5870556831359863
and O 0 7.779190269729952e-08
brain O 0 3.497845924016474e-08
stem O 0 2.6219040272223992e-09
, O 0 2.7593342107751218e-12
but O 0 3.5932261940180288e-12
not O 0 3.6638934074184615e-12
in O 0 4.6678615833739556e-11
the O 0 2.1659854465561068e-10
cerebral O 0 2.364151985290164e-09
white O 0 1.5538703657114183e-10
matter O 0 2.784343866579775e-10
, O 0 6.839765299276879e-13
where O 0 4.140408719002786e-13
marked O 0 6.225649336333294e-12
reductions O 0 4.096715189305655e-10
of O 0 1.251923342771022e-09
the O 0 2.393215625673406e-09
cerebral O 0 1.7205241675810612e-08
blood O 0 3.2756706236369837e-09
flow O 0 1.20023024852145e-09
and O 0 6.992229711899611e-11
oxygen O 0 4.4617958216974785e-09
metabolism O 0 7.358418319114435e-09
were O 0 4.002043973994063e-10
clearly O 0 6.324479273622785e-10
demonstrated O 0 1.8747903229865415e-10
by O 0 1.0475140199694977e-10
positron O 0 2.9614813001899165e-07
emission O 0 5.541602376979426e-07
tomography O 0 2.9060315682727378e-06
( O 0 4.681168785936052e-09
PET O 0 1.025291840051068e-05
) O 0 1.7509473870802594e-09
. O 0 1.607207877896144e-08

In O 0 7.69640109865577e-07
patients O 0 1.1737362228814163e-06
2 O 0 2.1737934119414604e-08
and O 0 2.9568378301370046e-10
3 O 0 6.36672314868747e-09
, O 0 1.8673911375555186e-11
the O 0 2.2225923879126697e-10
autopsy O 0 5.662035107434349e-08
findings O 0 1.538724347938114e-08
showed O 0 4.916998364024039e-09
massive O 0 1.009218593139849e-07
demyelination B-Disease 1 1.0
of I-Disease 0 0.0003567603707779199
the I-Disease 0 8.476131370116491e-07
cerebral I-Disease 0 2.0933300959313783e-07
white I-Disease 0 5.522098889265692e-10
matter I-Disease 0 5.296954541655907e-10
with O 0 1.9386514962804746e-12
sparing O 0 1.6748497033702847e-09
of O 0 1.1576041458738473e-08
the O 0 9.19733338378137e-08
U O 0 8.981241990113631e-05
- O 0 9.96355879578914e-07
fibers O 0 4.750700810518538e-08
, O 0 7.847762717450024e-11
compatible O 0 1.5694732180548954e-09
with O 0 3.825479863439618e-12
the O 0 7.860766204625946e-11
findings O 0 1.114911829525056e-09
of O 0 1.3803667542333642e-08
childhood O 0 4.435752271092497e-05
ALD B-Disease 1 1.0
. O 0 2.027381742664147e-05

Oleic O 0 0.0021998772863298655
and O 0 2.4069422579486854e-06
erucic O 0 0.006452355999499559
acids O 0 9.92533841781551e-07
( O 0 4.747500614854516e-09
Lorenzos O 0 1.6325340766343288e-05
Oil O 0 3.308462055429118e-07
) O 0 1.682321365548134e-10
were O 0 1.382695513640897e-09
administered O 0 9.664045119706088e-10
to O 0 4.042504941903502e-10
patients O 0 9.327001038172966e-08
1 O 0 1.7261186258110683e-08
and O 0 4.996056901518386e-10
4 O 0 3.215648414212069e-09
, O 0 4.259572295578495e-12
but O 0 6.500351906052471e-12
sufficient O 0 2.9163982340207895e-10
effectiveness O 0 1.9236960913104895e-09
was O 0 6.775269789649485e-10
not O 0 6.756502995974856e-11
obtained O 0 5.5055480174814875e-09
. O 0 3.110123358851524e-08

The O 0 2.3744462396280142e-07
findings O 0 3.492666067472783e-08
in O 0 4.430433520052901e-10
this O 0 1.3241564789101545e-10
family O 0 6.088480414279118e-11
suggest O 0 3.02394324858124e-11
that O 0 3.81549501195233e-13
delGAG291 O 0 6.80622935789188e-09
is O 0 7.365484090693375e-12
part O 0 1.476864464056149e-11
of O 0 7.680487495997923e-11
the O 0 1.8715889948950348e-10
cause O 0 7.315424932485826e-10
of O 0 6.3804845851223035e-09
Japanese O 0 0.0002108778280671686
ALD B-Disease 1 1.0
with O 0 9.776958798113355e-09
phenotypic O 0 1.8481376855561393e-06
variations O 0 1.2838415386795532e-05
. O 0 1.0792938383019646e-06

Moreover O 0 6.277159059209225e-07
, O 0 4.676508069678675e-10
although O 0 1.1079030748373242e-10
the O 0 4.584724613843072e-11
scale O 0 1.7687779019226468e-09
of O 0 7.713052974089862e-10
the O 0 2.9163149672939426e-10
study O 0 2.4812159271636602e-11
is O 0 2.9491957920929623e-13
limited O 0 1.1813552740214117e-11
, O 0 1.5982752231066821e-12
there O 0 2.9972977225178887e-12
is O 0 2.1293058462268366e-12
a O 0 9.76768058796873e-12
possibility O 0 1.6974583960660539e-09
that O 0 1.934723076191247e-10
PET O 0 0.0015902079176157713
can O 0 1.0038498921005612e-09
detect O 0 6.995307444412902e-08
an O 0 3.140419591041166e-10
insidious B-Disease 0 7.0982591751089785e-06
lesion I-Disease 0 8.952783900895156e-06
which O 0 4.834592171043539e-10
is O 0 4.3157158402529205e-11
undetectable O 0 2.216717254199807e-09
by O 0 9.549373791717386e-11
computed O 0 7.129278856154997e-08
tomogram O 0 0.00019544664246495813
( O 0 4.360067418218705e-09
CT O 0 8.094956865534186e-05
) O 0 2.5289390026550507e-10
or O 0 1.7570453425541643e-10
MRI O 0 6.266691343626007e-08
analysis O 0 7.714461014440843e-11
, O 0 3.2192640480460666e-12
and O 0 9.112693238888525e-13
that O 0 2.333188438459477e-13
the O 0 2.0928115143648007e-11
higher O 0 7.74329989017275e-10
level O 0 4.2959746870963045e-10
of O 0 7.232690835135003e-11
tau O 0 5.571718086905264e-10
reflects O 0 4.281068902156626e-11
the O 0 6.925767685045381e-12
process O 0 2.2946500255471847e-10
of O 0 4.433428291150676e-09
neuronal B-Disease 0 2.5140116122202016e-05
degeneration I-Disease 1 0.9999927282333374
in O 0 1.296865775657352e-05
ALD B-Disease 1 1.0
. O 0 2.5188017389154993e-05

Lorenzos O 0 0.00020498460798989981
Oil O 0 3.020282690613385e-07
should O 0 3.092775757718158e-10
be O 0 1.0330963515214897e-11
given O 0 4.6111919838054405e-11
in O 0 3.163304340692008e-11
the O 0 4.994682098469205e-11
early O 0 1.1965052060247672e-08
stage O 0 1.7281509556710262e-08
. O 0 1.1708403135912704e-09
. O 0 6.8787002760473115e-09

Nonsense O 0 1.685072129475884e-05
mutation O 0 1.5401417385874083e-07
in O 0 8.064488632442135e-09
exon O 0 3.230647678265086e-07
4 O 0 1.0819424467456429e-08
of O 0 5.955935189483341e-10
human O 0 3.817291205354678e-10
complement O 0 6.052999168559836e-08
C9 O 1 0.9999991655349731
gene O 0 2.3049155917220787e-09
is O 0 4.919758610916203e-12
the O 0 1.037519722912883e-11
major O 0 4.707166878503699e-10
cause O 0 2.2849544478731332e-10
of O 0 1.9199022371907404e-09
Japanese O 0 2.552085334173171e-06
complement B-Disease 0 2.2299114789348096e-05
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.7115832567214966
. O 0 1.1535879593793652e-06

Deficiency B-Disease 0 0.26636287569999695
of I-Disease 0 4.614045337802963e-06
the I-Disease 0 2.516749191272538e-06
ninth I-Disease 0 0.00034178997157141566
component I-Disease 0 7.715780725447985e-07
of I-Disease 0 3.722443508991091e-08
human I-Disease 0 3.105770307598732e-09
complement I-Disease 0 1.310377513163985e-07
( O 0 3.849228935592919e-09
C9 O 1 0.9999974966049194
) O 0 6.716849992871587e-11
is O 0 3.1236894581371244e-12
the O 0 1.2657036876917438e-11
most O 0 7.12820844017692e-11
common O 0 3.054314277051162e-07
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.42651648668857e-09
Japan O 0 1.5894705551744437e-09
but O 0 2.8901709150930266e-11
is O 0 5.323100033677308e-12
rare O 0 1.5410313303210188e-10
in O 0 6.25666254916446e-11
other O 0 1.9974175091697077e-10
countries O 0 3.6358627220067774e-10
. O 0 2.473682947368161e-08

We O 0 6.159021737062176e-09
studied O 0 2.9655147226748113e-09
the O 0 1.2172624019868294e-10
molecular O 0 5.5380683372519e-10
basis O 0 2.3674642246618305e-09
of O 0 5.827744757880282e-07
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999990463256836
in O 0 2.1550839335304772e-08
four O 0 5.219609189310859e-10
Japanese O 0 2.2280789835349424e-07
C9 B-Disease 1 1.0
- I-Disease 1 0.9944175481796265
deficient I-Disease 1 0.9598276019096375
patients O 0 6.719590146531118e-06
who O 0 3.8652361866731155e-10
had O 0 1.9994768063469337e-09
suffered O 0 1.145428541349247e-06
from O 0 6.966166984057054e-05
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.983079740370158e-06

Direct O 0 9.423113311868292e-08
sequencing O 0 2.864481132291985e-07
of O 0 6.160786369946436e-08
amplified O 0 2.718069026741432e-06
C9 O 0 0.0010493366280570626
cDNA O 0 2.860375616364763e-07
and O 0 4.462355207568436e-10
DNA O 0 1.6885007836364707e-09
revealed O 0 1.061500998211784e-09
a O 0 1.2221920697719213e-10
nonsense O 0 2.214892624863296e-08
substitution O 0 3.01506759115e-07
( O 0 4.589792712561547e-10
CGA O 0 4.509409379238605e-08
- O 0 1.319481057748817e-08
- O 0 1.5584488366471305e-08
> O 0 3.130208625634623e-08
TGA O 0 3.174818345996755e-07
) O 0 5.5680821064996167e-11
at O 0 3.3064082027856045e-10
codon O 0 1.7653534190031905e-09
95 O 0 8.296125564299928e-09
in O 0 3.6326325281166305e-10
exon O 0 1.2754136413661854e-08
4 O 0 1.358449797095318e-09
in O 0 6.317917716769372e-11
the O 0 6.444816347261906e-10
four O 0 4.519463914220978e-09
C9 B-Disease 1 0.9999998807907104
- I-Disease 0 0.13547249138355255
deficient I-Disease 0 1.7312084310106002e-05
individuals O 0 1.8328363271535864e-09
. O 0 3.129504122512117e-08

An O 0 1.4443677365250096e-08
allele O 0 5.326157292984135e-08
- O 0 2.0246375243004877e-08
specific O 0 2.09736095158064e-09
polymerase O 0 1.8293553338821766e-08
chain O 0 2.2296673396482447e-09
reaction O 0 4.528366570610842e-10
system O 0 2.7324187357180563e-09
designed O 0 2.82739387458264e-09
to O 0 2.136345683689811e-10
detect O 0 2.2299819768534235e-09
exclusively O 0 4.544780940474169e-10
only O 0 1.2633134989503692e-11
one O 0 6.062265273110157e-12
of O 0 4.185968238701321e-11
the O 0 1.2066175836267234e-10
normal O 0 8.466995993217097e-10
and O 0 5.6336092041364694e-11
mutant O 0 4.5317621877316583e-10
alleles O 0 1.5768681499439552e-11
indicated O 0 1.2182139845495765e-11
that O 0 2.4735869277349443e-13
all O 0 5.001066401277843e-12
the O 0 5.51713744134652e-11
four O 0 3.742885168467325e-11
patients O 0 4.0371267440164615e-10
were O 0 7.554536163301151e-11
homozygous O 0 4.776114573279422e-11
for O 0 3.992953190312676e-11
the O 0 5.142157810666959e-10
mutation O 0 2.774313834219555e-10
in O 0 4.5407952398157647e-10
exon O 0 7.581117955623995e-09
4 O 0 9.257375421789504e-10
and O 0 8.472593286679153e-12
that O 0 4.323142592608381e-13
the O 0 1.7070095337246016e-10
parents O 0 9.473216655564443e-11
of O 0 5.464785290953955e-10
patient O 0 2.423802811790665e-07
2 O 0 2.2575264324586897e-08
were O 0 1.1138071798200144e-08
heterozygous O 0 2.604435600517263e-08
. O 0 1.321942288967648e-08

The O 0 1.3025108103192906e-07
common O 0 4.2956841639352206e-08
mutation O 0 7.280295477585241e-09
at O 0 5.4378168634627855e-09
codon O 0 2.400238408029054e-08
95 O 0 3.780587576329708e-08
in O 0 1.3719457792049639e-09
exon O 0 4.253345764482219e-08
4 O 0 1.3772786244814483e-09
might O 0 4.151634591664788e-11
be O 0 3.227047101761471e-12
responsible O 0 1.1894313658999955e-11
for O 0 2.532891257844838e-11
most O 0 2.882554417382721e-09
Japanese O 0 0.00037756378878839314
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.03365490213036537
. O 0 1.8740413665341293e-08
. O 0 2.7712651728961646e-08

BRCA1 O 0 8.214071272050205e-07
required O 0 2.180731595302632e-09
for O 0 5.171172379192512e-10
transcription O 0 2.7687460146808007e-07
- O 0 1.3880624010198517e-06
coupled O 0 1.0887634971368243e-06
repair O 0 8.511976830050116e-07
of O 0 6.739317370829667e-08
oxidative O 0 6.193864464876242e-06
DNA O 0 2.125566425092984e-06
damage O 0 1.1669174455164466e-05
. O 0 7.238344892357418e-07

The O 0 1.8826536688720807e-05
breast B-Disease 1 0.9999971389770508
and I-Disease 1 0.9992417097091675
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.995854377746582
gene O 0 3.7820021248080593e-07
BRCA1 O 0 1.6441413208667655e-07
encodes O 0 7.564849857644163e-10
a O 0 5.605979014333684e-10
zinc O 0 8.668336022310541e-07
finger O 0 6.150935405457858e-08
protein O 0 5.256076907045326e-09
of O 0 1.1943162903094162e-08
unknown O 0 1.9482826019157073e-07
function O 0 7.821917336059414e-09
. O 0 1.4840221496115191e-08

Association O 0 3.9887925140646985e-07
of O 0 9.813150825266348e-08
the O 0 1.946804246699685e-07
BRCA1 O 0 3.584300500847348e-08
protein O 0 2.2342638850147978e-10
with O 0 1.0386047057109327e-11
the O 0 9.388355648454194e-10
DNA O 0 1.4822568950023651e-08
repair O 0 3.318517087791406e-07
protein O 0 2.057682202405431e-08
Rad51 O 0 1.7743684566084994e-07
and O 0 5.823847654129466e-11
changes O 0 1.0592292321032204e-10
in O 0 7.466551682488998e-11
the O 0 3.3002885146959926e-11
phosphorylation O 0 4.5632389533700746e-10
and O 0 1.1895635865233345e-10
cellular O 0 2.1100796110395947e-10
localization O 0 1.797317517038266e-09
of O 0 3.258097402980553e-10
the O 0 2.44328529630522e-10
protein O 0 2.064307891291861e-10
after O 0 3.0252504945593728e-09
exposure O 0 3.37252501481089e-08
to O 0 1.433930058025723e-10
DNA O 0 5.67522340233495e-09
- O 0 1.8604010776357427e-08
damaging O 0 2.1938031835588845e-08
agents O 0 5.144943915347255e-10
are O 0 1.658236395418733e-11
consistent O 0 3.970988815549248e-11
with O 0 5.649377992321403e-13
a O 0 1.3752349953266574e-11
role O 0 2.2712065561591999e-10
for O 0 4.396209174473142e-09
BRCA1 O 0 3.368035379480716e-07
in O 0 4.6308956669349755e-09
DNA O 0 1.1630123708528117e-07
repair O 0 3.7623524349328363e-06
. O 0 5.874802582184202e-07

Here O 0 2.623286547986936e-07
, O 0 4.881365867070997e-10
it O 0 1.2602162369201864e-11
is O 0 1.4531694424169128e-11
shown O 0 3.0916064847064106e-11
that O 0 1.8163699710971315e-11
mouse O 0 3.819764415879945e-08
embryonic O 0 4.727641567114915e-07
stem O 0 2.3251382685884892e-07
cells O 0 3.7581923351126534e-08
deficient B-Disease 0 6.887867698424088e-08
in I-Disease 0 8.467544998502774e-10
BRCA1 I-Disease 0 3.634173184607903e-09
are O 0 1.6261134799799848e-11
defective O 0 1.0322037446997001e-08
in O 0 7.554195047276835e-10
the O 0 1.2323025933014264e-09
ability O 0 1.3166012724497023e-10
to O 0 3.410634275002877e-11
carry O 0 2.0724387483905815e-10
out O 0 1.2777645608252897e-10
transcription O 0 3.767033973645084e-08
- O 0 1.8604301033064985e-07
coupled O 0 8.946636853579548e-07
repair O 0 2.524621720567666e-07
of O 0 9.060819650130725e-09
oxidative O 0 1.694665030527176e-07
DNA O 0 4.5988844732391954e-08
damage O 0 3.812682081161256e-08
, O 0 4.9922725675610735e-11
and O 0 7.522659578595992e-11
are O 0 1.0527618360400837e-10
hypersensitive O 0 1.8285813041529764e-07
to O 0 6.332059321323413e-10
ionizing O 0 4.576013452606276e-06
radiation O 0 7.966727935126983e-06
and O 0 1.2795089432415807e-09
hydrogen O 0 7.26401481188077e-08
peroxide O 0 1.2194373084639665e-06
. O 0 1.37521524834483e-07

These O 0 4.468304481974883e-08
results O 0 4.4142172583860884e-08
suggest O 0 5.5213881466897874e-08
that O 0 9.678322587802768e-10
BRCA1 O 0 1.0205580736055708e-07
participates O 0 1.8320385486436663e-10
, O 0 3.8828185458528175e-12
directly O 0 8.837973755615458e-12
or O 0 1.137221219971174e-11
indirectly O 0 5.555246540556169e-11
, O 0 1.0524119770094487e-11
in O 0 1.153195525183115e-10
transcription O 0 1.1918908882080359e-07
- O 0 8.133066558002611e-07
coupled O 0 7.15881981250277e-07
repair O 0 1.9357057112756593e-07
of O 0 1.1973338764903474e-08
oxidative O 0 5.93252821090573e-07
DNA O 0 3.112435251750867e-07
damage O 0 4.1610513790146797e-07
. O 0 7.1353163377807505e-09
. O 0 4.3058228982317814e-08

Truncation O 0 4.999680459150113e-05
mutations O 0 3.7592147350551386e-07
in O 0 2.3741113519548662e-09
the O 0 3.805995518746386e-09
transactivation O 0 2.1665596250386443e-06
region O 0 1.4755800137322694e-08
of O 0 3.889882904672959e-08
PAX6 O 1 0.5446596741676331
result O 0 2.535941234782513e-07
in O 0 4.009214293887453e-08
dominant O 0 2.2796473331254674e-06
- O 0 4.924378345094738e-07
negative O 0 1.9942224582791823e-07
mutants O 0 1.1103888937213924e-06
. O 0 3.555518901521282e-08

PAX6 O 1 0.9993925094604492
is O 0 2.5073331855196557e-08
a O 0 1.9367401016268104e-09
transcription O 0 2.5702908246216793e-08
factor O 0 6.89366075334874e-09
with O 0 2.066946613865639e-11
two O 0 1.6957027795805324e-11
DNA O 0 4.4590706127500823e-10
- O 0 3.839198736699245e-09
binding O 0 7.788778511041983e-09
domains O 0 1.6432142757594193e-08
( O 0 9.829134728356337e-11
paired O 0 3.5225897754287416e-09
box O 0 2.4551720656518228e-08
and O 0 3.9875364121755297e-10
homeobox O 0 4.255609908909719e-08
) O 0 1.2380590476424036e-11
and O 0 5.81362596951962e-11
a O 0 9.44074887709867e-11
proline O 0 9.10176733981416e-09
- O 0 3.54329223739569e-08
serine O 0 2.2499850160784263e-07
- O 0 4.68096573058574e-07
threonine O 0 3.8113299183351046e-07
( O 0 5.920980927776043e-10
PST O 0 3.0040464480407536e-05
) O 0 5.734511199229075e-10
- O 0 6.152543363668883e-08
rich O 0 2.15558539906624e-08
transactivation O 0 4.119971436011838e-06
domain O 0 1.4137111747913877e-07
. O 0 7.495671638935164e-08

PAX6 O 1 0.9999991655349731
regulates O 0 0.000615963654126972
eye O 1 0.9998588562011719
development O 0 1.7726816849972238e-06
in O 0 5.5292157519204466e-09
animals O 0 2.2993784654090632e-09
ranging O 0 7.666328016853186e-09
from O 0 1.921763637113827e-09
jellyfish O 0 2.769463414153961e-08
to O 0 1.7667952656452712e-09
Drosophila O 0 8.322056999077176e-08
to O 0 1.8879029450857843e-09
humans O 0 5.9682442099529e-08
. O 0 1.2209065403112618e-07

Heterozygous O 0 1.505918953625951e-05
mutations O 0 9.647146725910716e-08
in O 0 1.0773538727804066e-09
the O 0 4.258953190117154e-09
human O 0 6.7690475447079734e-09
PAX6 O 1 0.9892578721046448
gene O 0 9.408688050882574e-09
result O 0 3.935703762891762e-09
in O 0 3.4881156296684424e-10
various O 0 3.8337524821407953e-10
phenotypes O 0 1.5748716108987537e-08
, O 0 1.6326833982005517e-11
including O 0 2.469786042347266e-10
aniridia B-Disease 1 1.0
, O 0 9.873624406964154e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.1713054526296673e-08
autosomal B-Disease 0 2.0359610061859712e-05
dominant I-Disease 0 0.00021411993657238781
keratitis I-Disease 1 0.9998201727867126
, O 0 1.792450277093849e-08
and O 0 8.724985178787392e-08
familial B-Disease 1 0.9999805688858032
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999963045120239

It O 0 4.7892734222898525e-09
is O 0 2.2274984634584882e-10
believed O 0 3.3327413051509325e-10
that O 0 1.275566891695279e-12
the O 0 1.013795367099668e-10
mutated O 0 6.5682854710757965e-09
allele O 0 6.029870380785951e-09
of O 0 1.2725220877030097e-08
PAX6 O 1 0.9349933862686157
produces O 0 1.8859738215581956e-09
an O 0 9.784406791724098e-12
inactive O 0 3.5406693132955525e-09
protein O 0 3.878987964167635e-10
and O 0 4.663698871532063e-10
aniridia B-Disease 1 1.0
is O 0 1.7783037264962331e-09
caused O 0 2.571693258346386e-08
due O 0 4.4192387349539786e-07
to O 0 9.914288057188969e-09
genetic O 0 8.860251909936778e-07
haploinsufficiency O 0 0.00012072270328644663
. O 0 1.1174615792697296e-06

However O 0 6.610132459172746e-07
, O 0 2.6565265542899397e-09
several O 0 7.391047773808168e-10
truncation O 0 4.326185489844647e-07
mutations O 0 3.850477270361807e-09
have O 0 7.41253169955769e-11
been O 0 6.33055899368351e-11
found O 0 1.2008335298352435e-11
to O 0 5.6469464521091695e-12
occur O 0 5.959204657512984e-11
in O 0 1.1386391135514984e-10
the O 0 6.08049888217721e-10
C O 0 2.7225001986153075e-07
- O 0 5.624875232257409e-09
terminal O 0 3.0699869313366435e-08
half O 0 3.4433772500008786e-10
of O 0 5.345876519236015e-10
PAX6 O 0 0.00010999502410413697
in O 0 1.0794147797810183e-09
patients O 0 2.8685467334810255e-09
with O 0 2.633805326612837e-11
Aniridia B-Disease 1 1.0
resulting O 0 7.83888538080646e-07
in O 0 5.362442934142564e-09
mutant O 0 2.48906317779074e-09
proteins O 0 1.3470647340640962e-11
that O 0 2.1469152410719117e-12
retain O 0 7.475419172564557e-10
the O 0 2.4365467976572575e-10
DNA O 0 1.0870386812911192e-09
- O 0 1.741368715890701e-09
binding O 0 8.275624074904897e-10
domains O 0 4.0002426371366084e-10
but O 0 7.613323166344443e-11
have O 0 1.978269457969528e-11
lost O 0 1.0046276033293111e-09
most O 0 1.6070644814902835e-11
of O 0 1.3711654034409548e-10
the O 0 3.528130232410831e-09
transactivation O 0 1.9368242192285834e-06
domain O 0 1.1535072985680017e-07
. O 0 9.724849547865233e-08

It O 0 1.4376250190295536e-09
is O 0 2.4181975866177652e-11
not O 0 3.740399916879467e-12
clear O 0 8.290565456370302e-11
whether O 0 2.227701183243891e-11
such O 0 1.0656779902973312e-09
mutants O 0 1.850672379077878e-05
really O 0 4.307310064177727e-08
behave O 0 3.872674680938104e-10
as O 0 8.338299495314061e-11
loss O 0 7.074386076943995e-10
- O 0 2.843011381870042e-09
of O 0 4.7812145353987034e-09
- O 0 2.887403738327521e-08
function O 0 3.833313666490312e-10
mutants O 0 2.4557329503238634e-09
as O 0 4.5442934137884805e-11
predicted O 0 1.020956319486288e-09
by O 0 9.659253397131806e-10
haploinsufficiency O 0 9.751145262271166e-05
. O 0 1.182321739179315e-06

Contrary O 0 3.0890976177033735e-07
to O 0 2.767686357874055e-10
this O 0 1.1582545339505756e-10
theory O 0 8.183477007150941e-08
, O 0 1.2325206133478872e-10
our O 0 1.4980180984558444e-10
data O 0 6.952188824627115e-11
showed O 0 3.586168861868799e-11
that O 0 2.1356905772953322e-13
these O 0 1.2732800924730725e-11
mutants O 0 3.4784970459611486e-09
are O 0 4.727138472326864e-11
dominant O 0 1.2026117879315734e-08
- O 0 1.126751492108724e-08
negative O 0 4.1719121490757516e-09
in O 0 5.51377388191554e-10
transient O 0 4.889652238659892e-09
transfection O 0 3.1125726440706103e-09
assays O 0 1.1915898268100023e-09
when O 0 2.191366949011453e-10
they O 0 4.0220757280273745e-11
are O 0 1.591653371602053e-11
coexpressed O 0 9.402879186382052e-08
with O 0 5.032879113464617e-10
wild O 0 4.035559413750889e-06
- O 0 1.39036228574696e-06
type O 0 1.0121376362803858e-05
PAX6 O 1 0.954373836517334
. O 0 1.2731164815704687e-06

We O 0 9.082119944991973e-09
found O 0 2.1024867957741833e-10
that O 0 3.5584898742946347e-12
the O 0 5.414816373061626e-10
dominant O 0 1.9629004555099527e-07
- O 0 4.318571455996789e-08
negative O 0 3.0717308696637247e-09
effects O 0 7.053505779452962e-09
result O 0 1.707856966959298e-09
from O 0 3.225930356176576e-10
the O 0 1.537778099303111e-10
enhanced O 0 4.784249663103424e-10
DNA O 0 1.3112688712624276e-09
binding O 0 9.448679616497202e-10
ability O 0 6.90049739571208e-10
of O 0 2.248912611690912e-09
these O 0 7.185452677305193e-09
mutants O 0 6.317606562333822e-07
. O 0 4.2907707609174395e-08

Kinetic O 0 2.259246457469999e-06
studies O 0 7.540450930321185e-09
of O 0 7.74358077659798e-10
binding O 0 7.23042159478382e-09
and O 0 3.5297189615590696e-09
dissociation O 0 2.6374136652407287e-08
revealed O 0 2.105192242751741e-09
that O 0 3.6525270655229924e-12
various O 0 2.3013342620448185e-10
truncation O 0 2.4026141431932047e-07
mutants O 0 5.639122235834293e-08
have O 0 1.355702772265488e-10
3 O 0 4.6546699827842986e-10
- O 0 4.6360101868536674e-10
5 O 0 5.220187060395176e-10
- O 0 7.012026514985337e-10
fold O 0 9.160804337327022e-10
higher O 0 3.043811869218871e-09
affinity O 0 3.013385652117506e-10
to O 0 2.210171108629755e-11
various O 0 5.485323653631191e-11
DNA O 0 1.8147468250351295e-10
- O 0 2.0090711039255638e-10
binding O 0 9.470362688501766e-11
sites O 0 6.577920153016947e-11
when O 0 1.1101764472998266e-11
compared O 0 6.257271090159833e-11
with O 0 1.479446339741619e-12
the O 0 7.511651300973199e-10
wild O 0 2.344132354892281e-07
- O 0 1.0193927124646507e-07
type O 0 1.2508974123193184e-06
PAX6 O 0 0.015584846027195454
. O 0 6.688426879009057e-07

These O 0 1.4461596364867546e-08
results O 0 2.997902814882991e-09
provide O 0 2.0903630215673985e-10
a O 0 3.4537286225377883e-11
new O 0 9.272502210500022e-10
insight O 0 1.5248690088398575e-09
into O 0 5.24846797966827e-11
the O 0 1.8421606254315215e-11
role O 0 5.284418388984413e-11
of O 0 5.164430549875476e-10
mutant O 0 6.233610179151583e-07
PAX6 O 1 0.9995536208152771
in O 0 4.8913058492416894e-08
causing O 0 5.503271722773206e-07
aniridia B-Disease 1 1.0
. O 0 2.680951638467377e-07
. O 0 2.217463048737045e-07

Reversal O 0 8.165177860064432e-06
of O 0 1.8364471543463878e-06
severe O 1 0.9999624490737915
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.321369745710399e-05
excellent O 0 2.9899814535383484e-07
neuropsychologic O 0 1.1401743904571049e-06
outcome O 0 7.136659405659884e-07
in O 0 1.0985944376429302e-09
very B-Disease 0 1.0377695924823627e-10
- I-Disease 0 5.855281814959312e-10
long I-Disease 0 2.5018895288830834e-10
- I-Disease 0 8.512790472536835e-10
chain I-Disease 0 9.76849157119375e-10
acyl I-Disease 0 4.010698262391088e-08
- I-Disease 0 8.289928388194312e-08
coenzyme I-Disease 0 1.98425894382126e-07
A I-Disease 0 4.6987759105832083e-07
dehydrogenase I-Disease 0 4.219194124743808e-06
deficiency I-Disease 0 0.00022316387912724167
. O 0 3.790306379869435e-07

Very B-Disease 0 1.7957289344394667e-07
- I-Disease 0 1.287397424221126e-07
long I-Disease 0 5.5043511970609416e-09
- I-Disease 0 4.246397011797853e-09
chain I-Disease 0 6.915201744561728e-10
acyl I-Disease 0 4.947563247981179e-09
- I-Disease 0 2.1557982066156e-09
coenzyme I-Disease 0 3.012869731477963e-09
A I-Disease 0 1.3842127444263497e-09
dehydrogenase I-Disease 0 2.236268947797271e-09
( I-Disease 0 3.190232800154291e-10
VLCAD I-Disease 1 0.9999910593032837
) I-Disease 0 8.778195947911627e-09
deficiency I-Disease 0 1.637468926674046e-06
is O 0 6.041456224181729e-11
a O 0 2.583726566030009e-10
disorder O 0 8.083916327450424e-06
of O 0 6.825186119385762e-06
fatty O 0 6.502033556898823e-06
acid O 0 4.268022379960712e-08
beta O 0 1.1984367942474705e-09
oxidation O 0 3.603847775757174e-10
that O 0 1.948580186095228e-11
reportedly O 0 1.0873766331798151e-09
has O 0 4.564845029753073e-12
high O 0 1.0094429736540178e-09
rates O 0 7.192976214653868e-10
of O 0 2.265435061765686e-10
morbidity O 0 5.52552307908627e-07
and O 0 3.2383049575201994e-09
mortality O 0 2.8245935368431674e-07
. O 0 2.7053088658135493e-08

We O 0 3.220964384098579e-09
describe O 0 7.236475307870194e-10
the O 0 4.5040751683878e-10
outcome O 0 2.3766316914475283e-08
of O 0 7.145748881498548e-09
a O 0 1.0140855516427294e-10
5 O 0 4.286569987854705e-10
- O 0 1.5359430394212836e-10
year O 0 3.185162134045072e-10
- O 0 9.712278092877114e-09
old O 0 2.3026544226922852e-07
girl O 0 8.75647376830102e-09
with O 0 6.626910131757313e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 9.191402305930296e-09
was O 0 1.0520557758297855e-09
first O 0 1.6970463923016155e-10
seen O 0 1.171755747986225e-10
at O 0 8.074283602832466e-11
5 O 0 2.3884432626131158e-11
months O 0 2.6187762895701905e-12
of O 0 1.1156679746715525e-11
age O 0 5.774209999032109e-10
with O 0 2.023916104154644e-11
severe O 0 1.4367163203132804e-05
hypertrophic B-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 1.0
, O 0 5.429583688965067e-05
hepatomegaly B-Disease 1 1.0
, O 0 2.4026676328503527e-06
encephalopathy B-Disease 0 0.4284162223339081
, O 0 3.749471488845302e-08
and O 0 1.4944073711831152e-07
hypotonia B-Disease 1 0.9999184608459473
. O 0 0.0002416121424175799

Biochemical O 0 3.074470805586316e-05
studies O 0 6.465685373768792e-07
indicated O 0 0.00034119741758331656
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 3.2637349249853287e-06
by O 0 1.031541851936879e-09
a O 0 4.3818168538045654e-10
stable O 0 8.134892226507873e-08
yet O 0 2.6211651515950507e-08
inactive O 0 4.693576158842916e-07
enzyme O 0 2.554731679538236e-07
. O 0 1.5153359811392875e-07

Molecular O 0 2.329401809220144e-07
genetic O 0 4.70510475025776e-09
analysis O 0 5.327391305876006e-10
of O 0 2.6192662261337318e-08
her O 0 2.989590086599492e-08
VLCAD O 1 1.0
gene O 0 6.776284067200322e-08
revealed O 0 1.9522772731761506e-08
a O 0 3.729184183676182e-10
T1372C O 0 5.440879817797395e-07
( O 0 2.417336331106412e-10
F458L O 0 1.1863149040891585e-07
) O 0 2.7907770538959653e-10
missense O 0 7.346795172225029e-08
mutation O 0 6.571126975885022e-10
and O 0 5.64003878322783e-11
a O 0 1.5448933243789043e-09
1668 O 0 0.00032525003189221025
ACAG O 1 0.9999892711639404
1669 O 0 0.003571040229871869
splice O 0 4.336073834565468e-05
site O 0 7.4788192705455e-07
mutation O 0 1.4776112777781236e-07
. O 0 2.694638467914956e-08

After O 0 3.369786156781629e-07
initial O 0 4.080176267962088e-07
treatment O 0 2.0922332168993307e-06
with O 0 1.1365719476685854e-09
intravenous O 0 2.134590886271326e-07
glucose O 0 2.752399552718998e-07
and O 0 2.3057937503789816e-10
carnitine O 0 1.62832591854567e-08
, O 0 5.364913374661384e-11
the O 0 1.249380598977723e-09
patient O 0 2.0210730156122736e-07
has O 0 9.096412512121788e-11
thrived O 0 1.4307842022276418e-08
on O 0 4.471223946644898e-10
a O 0 4.692015873053457e-11
low O 0 3.4565147188914125e-08
- O 0 1.3569045442807237e-08
fat O 0 1.2927124259931588e-07
diet O 0 4.5293994332951115e-08
supplemented O 0 5.644948952721052e-10
with O 0 5.0236000255499125e-12
medium O 0 8.52241583970681e-08
- O 0 7.209352226311694e-09
chain O 0 1.7286481135414533e-09
triglyceride O 0 8.769799109131782e-08
oil O 0 4.664733488368711e-09
and O 0 7.655200778833304e-11
carnitine O 0 1.15664846589425e-08
and O 0 7.876704843923221e-11
avoidance O 0 7.610183416772998e-08
of O 0 2.1105487135741896e-08
fasting O 0 2.6349257495894562e-06
. O 0 3.105109271928086e-07

Her O 0 1.2896482985524926e-05
ventricular O 0 0.02940615452826023
hypertrophy O 1 0.8568705320358276
resolved O 0 9.338989184470847e-05
significantly O 0 5.284563258101116e-07
over O 0 2.2629831342158013e-09
1 O 0 2.469909832214512e-09
year O 0 2.2921828324307114e-10
, O 0 1.2809800963020646e-11
and O 0 1.456105652719586e-10
cognitively O 0 5.610787638943293e-07
, O 0 2.9662695910648296e-11
she O 0 1.9334373511925573e-12
is O 0 6.836817353569891e-13
in O 0 9.147037294265914e-12
the O 0 1.4026273198464168e-10
superior O 0 8.108386850835814e-08
range O 0 6.578067512919006e-08
for O 0 1.8816408431376885e-09
age O 0 5.534039360099996e-07
. O 0 1.9608798140779982e-07

Clinical O 0 2.4842636776156723e-05
recognition O 0 5.580382094194647e-06
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 4.372378725747694e-08
important O 0 3.711198459654952e-09
because O 0 7.73603264780931e-11
it O 0 1.7326097154213294e-12
is O 0 9.298097231394409e-13
one O 0 1.3850346650828849e-12
of O 0 2.0316359705674358e-11
the O 0 1.3370389517763925e-10
few O 0 9.325570315965592e-10
directly O 0 2.38523623075082e-09
treatable O 0 0.012878154404461384
causes O 0 4.407627596236807e-09
of O 0 6.468467006470746e-08
cardiomyopathy B-Disease 1 1.0
in O 0 0.09373096376657486
children O 0 8.350785840605113e-09
. O 0 3.4931488257505805e-10
. O 0 5.180968543072595e-09

Cloning O 0 4.429289219842758e-07
of O 0 2.892986517011309e-09
a O 0 1.6035502092837106e-10
novel O 0 6.2669163192197175e-09
member O 0 5.784314693890735e-11
of O 0 9.652360161149787e-11
the O 0 2.7448859851730845e-10
low O 0 4.285601562514785e-08
- O 0 1.2329379295294984e-08
density O 0 4.3812779182417216e-08
lipoprotein O 0 1.5927489585010335e-05
receptor O 0 1.6571469814152806e-06
family O 0 1.2060504595012844e-08
. O 0 6.612282987816798e-08

A O 0 1.3267863607779873e-07
gene O 0 3.6523863933268785e-09
encoding O 0 2.669638021757237e-08
a O 0 1.0006217188163191e-08
novel O 0 4.5017526417723275e-07
transmembrane O 0 9.857362925913549e-09
protein O 0 4.1597850164443173e-10
was O 0 1.2148085315466517e-10
identified O 0 1.337864714845427e-11
by O 0 1.2593937394680954e-12
DNA O 0 1.385476542520303e-11
sequence O 0 1.2674327733164237e-12
analysis O 0 2.8526757778896128e-12
within O 0 3.5827028843637976e-11
the O 0 5.960105742275346e-10
insulin B-Disease 0 8.01633286755532e-05
- I-Disease 1 0.9994370341300964
dependent I-Disease 1 0.9589830040931702
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 7.381246280857567e-09
IDDM B-Disease 0 0.0002041782281594351
) O 0 5.243057654702454e-10
locus O 0 9.690148239371865e-09
IDDM4 O 0 3.5251939607405802e-06
on O 0 2.7427377702338163e-08
chromosome O 0 1.2689373996011e-08
11q13 O 0 3.680722784338286e-06
. O 0 1.635338833239075e-07

Based O 0 2.2367269991718786e-07
on O 0 2.1761328738989505e-08
its O 0 7.991232675585991e-10
chromosomal O 0 1.497751078716192e-08
position O 0 6.179274691930914e-08
, O 0 9.499633024656617e-11
this O 0 4.6528034897130865e-11
gene O 0 6.2407155831945e-11
is O 0 1.6178092936483535e-12
a O 0 3.4840758750265266e-12
candidate O 0 3.922511759846259e-10
for O 0 8.909300380777196e-11
conferring O 0 5.356966994440882e-07
susceptibility O 0 4.17196933995001e-05
to O 0 4.6261924069312954e-08
diabetes B-Disease 1 0.9999990463256836
. O 0 6.12913436270901e-06

The O 0 3.75299237020954e-07
gene O 0 1.0500915692546187e-08
, O 0 3.461472497523488e-10
termed O 0 6.586966527777349e-09
low O 0 2.6329360025556525e-07
- O 0 2.793874465112367e-08
density O 0 2.11748414358226e-08
lipoprotein O 0 4.3463950305522303e-07
receptor O 0 4.880884141300612e-09
related O 0 1.7899827176037775e-09
protein O 0 2.953771671698746e-10
5 O 0 4.91751195319523e-10
( O 0 1.2249804469399717e-11
LRP5 O 0 7.671942512388341e-06
) O 0 6.27269833297639e-11
, O 0 1.644597652505908e-11
encodes O 0 6.1479211478643325e-12
a O 0 7.471149567062074e-12
protein O 0 3.2609076550116356e-10
of O 0 4.251794472054371e-09
1615 O 0 1.232468548550969e-05
amino O 0 3.127248504597446e-08
acids O 0 2.3840263096985836e-09
that O 0 1.7543619335036453e-11
contains O 0 5.842627770480391e-11
conserved O 0 5.750524501024756e-10
modules O 0 3.4753716571245263e-10
which O 0 7.46859551200435e-13
are O 0 5.619706089365906e-13
characteristic O 0 1.4199346559662374e-11
of O 0 2.9896828068753933e-11
the O 0 1.7746604186186232e-10
low O 0 1.4760219713139122e-08
- O 0 1.871297339306466e-09
density O 0 3.4523621739168675e-09
lipoprotein O 0 4.250840390795929e-07
( O 0 1.4035004269885576e-09
LDL O 0 4.885934231424471e-06
) O 0 2.5507447265482597e-09
receptor O 0 3.843032203576513e-08
family O 0 3.5022773570148047e-09
. O 0 1.9999660594294255e-08

These O 0 5.5850875924079446e-08
modules O 0 1.5783952278525248e-07
include O 0 7.315121397510893e-09
a O 0 1.3662295739180763e-09
putative O 0 9.732235639603459e-08
signal O 0 5.214875198333857e-09
peptide O 0 3.749875687741877e-10
for O 0 2.36251799373699e-11
protein O 0 1.4273265902531307e-10
export O 0 9.79910108611648e-09
, O 0 1.5773291006659917e-10
four O 0 2.5116766999566664e-10
epidermal O 0 7.204816299122285e-09
growth O 0 1.1320846482476554e-09
factor O 0 1.0192835020461644e-08
( O 0 2.2878193783881784e-10
EGF O 0 2.3728752296392486e-07
) O 0 5.539639580387501e-11
repeats O 0 1.0765460745076894e-10
with O 0 5.481691489617191e-12
associated O 0 1.8840216053916947e-09
spacer O 0 6.939771424185892e-08
domains O 0 2.063030635213181e-08
, O 0 6.001319996506993e-10
three O 0 8.710776544518239e-10
LDL O 0 4.130885372433113e-06
- O 0 2.7906687591894297e-06
receptor O 0 1.057940508530919e-07
( O 0 3.7288497289900135e-10
LDLR O 0 0.00013672688510268927
) O 0 7.518800165806638e-11
repeats O 0 5.842226702412745e-11
, O 0 3.4948183669919475e-12
a O 0 1.7776780047995544e-11
single O 0 4.3222919687835315e-10
transmembrane O 0 1.7424685028188946e-09
spanning O 0 1.1449443615418886e-09
domain O 0 9.716498716727529e-10
, O 0 2.88527986225251e-11
and O 0 4.306243556184697e-11
a O 0 3.7898398308477965e-10
cytoplasmic O 0 2.444224733721967e-08
domain O 0 4.064900238631708e-08
. O 0 2.6242867434689288e-08

The O 0 7.686285812269489e-07
encoded O 0 6.025870646908515e-08
protein O 0 6.6674594734195125e-09
has O 0 2.5492441491081763e-11
a O 0 1.9448226015739145e-11
unique O 0 2.07248218586642e-10
organization O 0 4.833218270050565e-10
of O 0 6.150441045349453e-09
EGF O 0 4.04413731303066e-05
and O 0 3.2280510708915244e-08
LDLR O 1 0.5601330995559692
repeats O 0 1.2749752364982214e-09
; O 0 1.7783392813885968e-11
therefore O 0 3.953578298077076e-10
, O 0 3.601131892683185e-11
LRP5 O 0 4.7132100007729605e-05
likely O 0 1.611354782937724e-08
represents O 0 6.220133436096731e-11
a O 0 7.13292445941871e-12
new O 0 6.184502215900167e-11
category O 0 4.3023215545723303e-10
of O 0 2.066545407020115e-10
the O 0 3.1605453809646633e-09
LDLR O 1 0.9999878406524658
family O 0 1.2928579451454425e-07
. O 0 1.0632486890926884e-07

Both O 0 5.344882652025262e-07
human O 0 4.955726140565275e-08
and O 0 5.314852558058192e-08
mouse O 0 3.6790768263017526e-06
LRP5 O 1 0.9994235038757324
cDNAs O 0 0.0005425281706266105
have O 0 3.798467762550217e-09
been O 0 4.005008769070173e-09
isolated O 0 7.003289059781537e-09
and O 0 3.984297614056942e-10
the O 0 3.968327444425768e-09
encoded O 0 1.3446666002892016e-08
mature O 0 1.2938366822368152e-08
proteins O 0 3.0458358057927626e-11
are O 0 5.796814851050103e-12
95 O 0 2.8045227251638494e-10
% O 0 3.3180860403020374e-12
identical O 0 1.1517990554377189e-11
, O 0 9.957382141045912e-13
indicating O 0 1.8443720509186967e-11
a O 0 2.7266982075002666e-12
high O 0 4.172323875284434e-10
degree O 0 1.012350647755511e-09
of O 0 2.7100779953492804e-10
evolutionary O 0 1.1894695006731126e-08
conservation O 0 8.808738627408275e-09
. O 0 3.0142938145516496e-10
. O 0 7.818933944747641e-09

The O 0 3.9629512684769e-06
APC B-Disease 0 8.296132364193909e-06
variants O 0 5.312045345817751e-07
I1307K O 0 7.3620813054731116e-06
and O 0 4.177621359957584e-09
E1317Q O 0 1.0254913149765343e-06
are O 0 2.9677879598288825e-10
associated O 0 2.4205132120869166e-08
with O 0 2.155511174350977e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.825298880930859e-07
but O 0 8.084166114308289e-10
not O 0 5.4624898354616036e-11
always O 0 5.121511895134212e-11
with O 0 1.486387293629654e-12
a O 0 6.512927003266e-11
family O 0 2.374835050833468e-10
history O 0 8.381231708654013e-09
. O 0 1.2044665709254332e-08

Classical O 0 0.0014544270234182477
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.1915439245058224e-05
FAP B-Disease 0 0.10936632752418518
) O 0 3.507456269868925e-10
is O 0 1.4582949431352077e-11
a O 0 8.802868156632115e-11
high O 0 3.993213613284752e-05
- O 1 0.9999996423721313
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.977575421333313
that O 0 3.4488720213055046e-10
predisposes O 0 1.1833488144930016e-07
to O 0 4.0505473974938866e-10
hundreds O 0 1.94830707123117e-09
or O 0 1.3105481977415678e-10
thousands O 0 2.508709462389902e-09
of O 0 1.3615080206363928e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999971389770508
carcinoma I-Disease 1 1.0
and O 0 1.114286773962192e-09
that O 0 6.23635735066963e-12
results O 0 8.69455951679754e-10
from O 0 3.0173785692255706e-09
truncating O 0 1.298828067319846e-07
mutations O 0 1.74852454737362e-09
in O 0 4.968043754161044e-10
the O 0 1.6910478350951053e-08
APC B-Disease 0 1.037624087985023e-06
gene O 0 4.6404647235931407e-08
. O 0 6.618326864327173e-08

A O 0 9.801497213857147e-08
variant O 0 8.418723496106395e-07
of O 0 7.305691269721137e-07
FAP B-Disease 1 0.9665749073028564
is O 0 2.448634859320009e-07
attenuated B-Disease 1 0.9998446702957153
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 4.915113649417435e-09
which O 0 2.982745300750267e-11
results O 0 3.4171149243533705e-10
from O 0 6.242313888016326e-10
germ O 0 3.20255130645819e-05
- O 0 9.45311057876097e-07
line O 0 9.522301525066723e-07
mutations O 0 4.457157698478653e-10
in O 0 6.993590428994167e-11
the O 0 9.425167590837447e-11
5 O 0 1.0939393141340403e-10
and O 0 5.980026803603655e-12
3 O 0 1.824248807569262e-10
regions O 0 1.182086095674606e-10
of O 0 9.331458938888204e-10
the O 0 1.1599009752671918e-07
APC B-Disease 0 1.3010636621402227e-06
gene O 0 6.21109634835193e-08
. O 0 1.2059635423611326e-07

Attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 2.3482309430278292e-08
" O 0 1.1377111697186137e-08
multiple O 0 5.7215160609302984e-08
" O 0 0.0007093322928994894
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.340062505406081e-09
typically O 0 2.1769694380502358e-10
fewer O 0 7.238169091872138e-11
than O 0 7.36469739359702e-12
100 O 0 3.1436599851053515e-11
) O 0 3.7631106997865205e-13
without O 0 1.6382483911114853e-11
the O 0 2.509349672497052e-10
florid O 0 1.320142359872989e-07
phenotype O 0 2.7165032889797658e-08
of O 0 3.8762535403691345e-09
classical O 0 5.447161584015703e-07
FAP B-Disease 0 1.741928281262517e-05
. O 0 1.1631798457756304e-07

Another O 0 2.6592104518385895e-07
group O 0 1.5209709047780962e-09
of O 0 4.708300860301051e-09
patients O 0 1.0995595545182368e-07
with O 0 9.641729636911123e-10
multiple O 0 1.248528769792756e-05
adenomas B-Disease 1 0.9999998807907104
has O 0 6.393263252135739e-09
no O 0 5.756088383712665e-10
mutations O 0 3.572557527586895e-10
in O 0 4.1305237008515405e-10
the O 0 4.092070682304438e-09
APC B-Disease 0 1.3101971063633755e-08
gene O 0 1.2250089831411515e-10
, O 0 1.694105793148548e-11
and O 0 8.662392331215685e-11
their O 0 3.697983030903629e-10
phenotype O 0 1.1232946128814092e-08
probably O 0 4.554256971545101e-10
results O 0 6.464856427967902e-11
from O 0 2.241878384323659e-11
variation O 0 1.5982075662890338e-09
at O 0 2.3897750445200927e-10
a O 0 2.1894272853040242e-11
locus O 0 2.2573605484854653e-10
, O 0 5.438845988164909e-12
or O 0 2.966484696775851e-11
loci O 0 3.024846595423014e-09
, O 0 4.0980260851419814e-11
elsewhere O 0 8.345940605281044e-10
in O 0 1.579659320016802e-10
the O 0 3.793906078186637e-09
genome O 0 1.0913999481942938e-08
. O 0 1.600789367728339e-08

Recently O 0 6.992639782765764e-07
, O 0 8.189449673956517e-10
however O 0 7.701527193759716e-10
, O 0 3.87886771313628e-11
a O 0 4.3250108355818995e-11
missense O 0 2.0250082499728705e-08
variant O 0 1.3732599768445652e-07
of O 0 6.761353233741829e-06
APC B-Disease 0 1.4890690181346145e-05
( O 0 6.490409876214187e-10
I1307K O 0 1.0313082157153985e-06
) O 0 4.471247677662049e-11
was O 0 5.195790464540551e-10
described O 0 6.860048640255911e-11
that O 0 1.7602333436325668e-12
confers O 0 5.384003798347692e-10
an O 0 2.2921282927246267e-12
increased O 0 1.016754902494199e-09
risk O 0 2.2795616416715347e-07
of O 0 0.10750322043895721
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.9698973946779006e-08
including O 0 2.9363371734092425e-09
multiple O 0 3.577409302124579e-08
adenomas B-Disease 0 0.0001767813810147345
, O 0 2.3403019522305613e-09
in O 0 6.339884350836655e-08
Ashkenazim O 0 0.0013698223046958447
. O 0 3.2746640954428585e-07

We O 0 1.1356601881118422e-08
have O 0 6.85340534323231e-11
studied O 0 9.258647182264212e-10
a O 0 2.028840116741204e-11
set O 0 1.8442251892292205e-10
of O 0 6.886743952883023e-10
164 O 0 1.9694351749421912e-07
patients O 0 3.55569511611975e-08
with O 0 1.9162868514221998e-10
multiple O 0 0.0001985094859264791
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7548105120658875
/ I-Disease 1 0.9162973761558533
or I-Disease 0 9.924383448378649e-06
carcinoma I-Disease 1 1.0
and O 0 8.556094499567735e-09
analyzed O 0 1.6069718000721878e-08
codons O 0 1.3759060557561043e-08
1263 O 0 4.232135779602686e-07
- O 0 1.978740371555432e-08
1377 O 0 1.2734661822833004e-06
( O 0 1.0081749879375934e-09
exon O 0 8.142777829789338e-08
15G O 0 8.09273501545249e-08
) O 0 2.3822921066396496e-11
of O 0 5.489753651666263e-10
the O 0 6.884856684763463e-09
APC B-Disease 0 1.295803002676621e-07
gene O 0 1.0830670804651277e-09
for O 0 7.341843799579806e-10
germ O 0 0.000291626580292359
- O 0 6.070039944461314e-06
line O 0 5.517784302355722e-06
variants O 0 1.0432639783175546e-06
. O 0 2.4416905830548785e-07

Three O 0 3.072438801154931e-07
patients O 0 5.24126306800099e-08
with O 0 3.481540056249344e-11
the O 0 1.8272235946525939e-09
I1307K O 0 1.8999682538378693e-07
allele O 0 1.2915749580955094e-09
were O 0 4.6980693640952254e-11
detected O 0 8.164616205341702e-11
, O 0 8.585961260541841e-13
each O 0 6.744212935512472e-13
of O 0 3.949493232457968e-10
Ashkenazi O 0 7.634097300979192e-07
descent O 0 5.913695417802955e-07
. O 0 1.8273836133175791e-07

Four O 0 1.98395355255343e-06
patients O 0 1.8357677618041635e-06
had O 0 4.288461585844061e-09
a O 0 9.399176992275216e-10
germ O 0 8.140862337313592e-05
- O 0 2.1029977688158397e-06
line O 0 4.74742637379677e-06
E1317Q O 0 6.366485649778042e-06
missense O 0 2.6005844233623066e-07
variant O 0 6.546725472844628e-08
of O 0 4.342094328535495e-08
APC O 0 2.061245041318216e-08
that O 0 3.5502393126024545e-12
was O 0 1.9607726553516613e-10
not O 0 4.9196267719320286e-12
present O 0 4.8733163338088303e-11
in O 0 5.9328250645585e-11
controls O 0 1.932606158439043e-10
; O 0 1.6024181981322272e-11
one O 0 1.8752685168599292e-11
of O 0 5.527828542128965e-11
these O 0 2.6666210906078902e-11
individuals O 0 5.068498138555144e-12
had O 0 8.080769386964448e-11
an O 0 3.6690477045464576e-12
unusually O 0 1.7720263034703976e-09
large O 0 8.585281791040345e-11
number O 0 1.404264812071565e-11
of O 0 5.283715687198764e-10
metaplastic B-Disease 0 4.5233780838316306e-05
polyps I-Disease 0 1.3312617852534459e-07
of I-Disease 0 5.042531370236247e-08
the I-Disease 0 8.108695936925869e-08
colorectum I-Disease 0 5.214241173234768e-05
. O 0 3.98061814621542e-07

There O 0 3.350328725559848e-08
is O 0 1.5238972583819788e-10
increasing O 0 1.3101483786748247e-10
evidence O 0 2.874432913912983e-10
that O 0 4.382104488304117e-12
there O 0 3.8886532882642655e-11
exist O 0 2.9871705109485447e-10
germ O 0 2.6428025989844173e-07
- O 0 6.903002613967146e-09
line O 0 7.212612285201203e-09
variants O 0 2.157015455139799e-09
of O 0 2.8334730117762774e-09
the O 0 4.197549419160396e-09
APC B-Disease 0 1.3881608751376007e-08
gene O 0 3.6762082961105946e-11
that O 0 1.6643700306850917e-12
predispose O 0 3.970295647803823e-09
to O 0 6.451429668263842e-11
the O 0 1.5109404838398177e-09
development O 0 1.1335891336727855e-08
of O 0 1.0615080725528969e-07
multiple O 1 0.9987863898277283
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
, O 0 7.92659438086929e-10
but O 0 7.651128342001101e-11
without O 0 2.2325216675334048e-10
the O 0 6.138553554357884e-10
florid O 0 8.399895534694224e-08
phenotype O 0 3.384489799529433e-09
of O 0 5.600016006468422e-10
classical O 0 8.016016295187e-08
FAP B-Disease 0 6.166324055811856e-07
, O 0 2.2942463900887944e-11
and O 0 4.60187617179475e-12
possibly O 0 3.6246852741506075e-11
with O 0 2.0212265021413156e-12
importance O 0 1.5643722761637946e-08
for O 0 2.7497442260937532e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 3.428315267228754e-07
in O 0 9.71713768477267e-12
the O 0 1.0643626605078005e-11
general O 0 3.265613057745753e-10
population O 0 2.5601782846496057e-11
. O 0 1.4728426811494444e-10
. O 0 5.044491047101474e-09

Genomic O 0 8.073386936757743e-08
structure O 0 4.409763665336186e-09
of O 0 3.7054619372867137e-09
the O 0 5.752593068564238e-08
human O 0 1.6835048199936864e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 5.850377056049183e-05
CLD B-Disease 1 0.999998927116394
) O 0 2.522414099814796e-08
gene O 0 4.188945368355235e-08
. O 0 4.593764657556676e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.002064392203465104
CLD B-Disease 1 1.0
) O 0 1.136693295045177e-09
is O 0 2.525077022474953e-11
caused O 0 2.704563240030211e-10
by O 0 1.401397192735132e-10
mutations O 0 4.020045407671091e-10
in O 0 1.531420545930473e-10
a O 0 6.828040910455968e-11
gene O 0 6.662062568274507e-11
which O 0 2.0432008515647304e-11
encodes O 0 1.2902914847678915e-10
an O 0 2.6189625121353366e-11
intestinal O 0 4.201855517749209e-06
anion O 0 6.0147726799186785e-06
transporter O 0 9.067079190572258e-06
. O 0 3.1192308824756765e-07

We O 0 6.973792920916821e-08
report O 0 2.3745370114625075e-09
here O 0 3.8164177373900543e-10
the O 0 6.54830217827751e-11
complete O 0 3.8480527098094797e-10
genomic O 0 2.573615542900143e-09
organization O 0 7.097723797588884e-11
of O 0 1.347443268073789e-10
the O 0 4.967136035816111e-09
human O 0 1.8637964060985723e-08
CLD B-Disease 1 0.9992714524269104
gene O 0 1.845395303234909e-08
which O 0 2.608743498999644e-10
spans O 0 1.071202682112471e-09
approximately O 0 7.9581452538946e-11
39kb O 0 2.2336487859320187e-07
, O 0 2.3497026546692723e-10
and O 0 8.470000256721733e-10
comprises O 0 4.6429677880155396e-09
21 O 0 4.7282007642479584e-08
exons O 0 2.2799204657530936e-07
. O 0 4.74821852947116e-08

All O 0 1.0095533298226655e-06
exon O 0 1.4516608644044027e-05
/ O 0 1.6423845181634533e-06
intron O 0 2.0282047898945166e-06
boundaries O 0 1.399705062965495e-08
conform O 0 8.57838333701011e-09
to O 0 3.620445054863808e-10
the O 0 1.2466056631410538e-08
GT O 0 0.0038569166790694
/ O 0 3.460219886619598e-05
AG O 0 0.2474556416273117
rule O 0 7.718637789366767e-06
. O 0 1.1071457493017078e-06

An O 0 6.161236104640366e-11
analysis O 0 1.2523812542575286e-10
of O 0 1.1558892731855508e-09
the O 0 1.6206509911853573e-08
putative O 0 5.849087301612599e-06
promoter O 0 3.0552776024705963e-06
region O 0 1.0850836673625963e-08
sequence O 0 2.1186777332538043e-10
shows O 0 2.2849021286130977e-10
a O 0 4.918055962477297e-10
putative O 0 2.2124442693893798e-05
TATA O 1 0.9997562766075134
box O 0 5.485804649651982e-06
and O 0 2.402133381096405e-09
predicts O 0 5.935796743017363e-09
multiple O 0 7.537369617338641e-10
transcription O 0 2.5167961936745087e-08
factor O 0 9.144399903959766e-09
binding O 0 1.6962067306280915e-08
sites O 0 9.621162888606705e-08
. O 0 7.382629974017618e-08

The O 0 4.870861403105664e-07
genomic O 0 2.1860886079139163e-07
structure O 0 4.7168065009373095e-08
was O 0 2.5081797971893138e-08
determined O 0 6.304008426383234e-09
using O 0 3.911648782661814e-10
DNA O 0 2.9807236678891513e-09
from O 0 2.3469257093289286e-10
several O 0 6.287983328467917e-11
sources O 0 5.754244303268763e-10
including O 0 8.523834416074294e-11
multiple O 0 5.514646517212896e-10
large O 0 1.2205533472808838e-08
- O 0 1.097628341995005e-06
insert O 0 8.845291290526802e-07
libaries O 0 0.0001280858414247632
and O 0 6.7572827333606256e-09
genomic O 0 4.7099173450249054e-09
DNA O 0 4.8851123146675945e-09
from O 0 2.03698502510008e-09
Finnish O 0 0.0003064115880988538
CLD B-Disease 1 1.0
patients O 0 0.16221696138381958
and O 0 1.97901215415186e-08
controls O 0 4.0071660123430775e-07
. O 0 4.364138987966726e-07

Exon O 0 4.4470569264376536e-05
- O 0 5.783562073702342e-07
specific O 0 2.9719657845816982e-08
primers O 0 7.81795165494259e-07
developed O 0 3.548493054950086e-08
in O 0 2.645265118061957e-10
this O 0 4.7620879461973686e-11
study O 0 5.947328046707057e-11
will O 0 1.3691256245049188e-12
facilitate O 0 6.637228960881814e-11
mutation O 0 4.133918554694027e-11
screening O 0 5.404746095116764e-10
studies O 0 2.8571641580432683e-11
of O 0 2.413502037112991e-11
patients O 0 2.196565374035231e-09
with O 0 2.2400404448008615e-11
the O 0 8.3445797827153e-08
disease O 0 0.00023973576026037335
. O 0 7.722052828285086e-07

Genomic O 0 2.2878158745243127e-07
sequencing O 0 1.7795099438444595e-07
of O 0 3.233214584952293e-08
a O 0 6.32150616297622e-08
BAC O 1 0.9843263030052185
clone O 0 7.345357880694792e-05
H O 1 1.0
_ O 0 7.107880861667581e-08
RG364P16 O 0 1.2827611328702915e-07
revealed O 0 2.778046959139857e-10
the O 0 1.1943486130649994e-11
presence O 0 2.9628077335280834e-12
of O 0 6.522947459952633e-11
another O 0 1.6824433513029646e-10
, O 0 4.175840923048568e-11
highly O 0 8.407998186577004e-10
homologous O 0 5.812350600820082e-11
gene O 0 7.942557028739472e-11
3 O 0 5.547604042810406e-10
of O 0 2.194195491966866e-09
the O 0 1.1946198696932697e-07
CLD B-Disease 1 0.943627119064331
gene O 0 1.0817958973063924e-08
, O 0 3.937208892246247e-11
with O 0 2.1576089439395707e-12
a O 0 1.0056656896129113e-11
similar O 0 1.1335404143109074e-10
genomic O 0 7.626770326396581e-10
structure O 0 6.80826450771832e-10
, O 0 6.997643350187266e-12
recently O 0 2.946589847119263e-11
identified O 0 1.1306205971450822e-11
as O 0 1.5189922236702458e-11
the O 0 1.694318463307809e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.2273164290709246e-07
( O 0 1.4702442596714604e-09
PDS B-Disease 0 0.0010074519086629152
) O 0 5.215767817645656e-10
. O 0 2.817939881438747e-09
. O 0 3.501891399082524e-08

The O 0 1.3890065702071297e-06
APCI1307K O 1 0.8143488168716431
allele O 0 1.0386615940660704e-06
and O 0 6.637668548137299e-08
cancer B-Disease 0 2.800517358991783e-05
risk O 0 1.3733969517204514e-08
in O 0 2.004768573371507e-10
a O 0 8.161300107945024e-11
community O 0 5.360269519916194e-11
- O 0 1.9126351891163296e-10
based O 0 5.4127691911931564e-11
study O 0 2.663789674950401e-11
of O 0 4.368354289407961e-11
Ashkenazi O 0 3.923937796912469e-08
Jews O 0 6.445473843541549e-08
. O 0 4.28835740251543e-08

Mutations O 0 3.957274657295784e-06
in O 0 3.865468656272242e-08
APC O 0 5.065484174338053e-07
are O 0 1.830913615163965e-10
classically O 0 1.7971400367855495e-08
associated O 0 3.4118998737397987e-09
with O 0 1.7338363633712106e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.8300570445717312e-06
FAP B-Disease 0 7.987048593349755e-05
) O 0 5.826314430912305e-11
, O 0 7.569201342094711e-12
a O 0 5.707109437813607e-11
highly O 0 0.0002493815845809877
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.996696949005127
by O 0 1.65488054335583e-05
multiple O 0 0.0026936964131891727
intestinal O 1 1.0
polyps B-Disease 0 4.016565071651712e-06
and O 0 1.3916914287648297e-09
, O 0 1.0677990609775367e-11
without O 0 7.861425399546818e-11
surgical O 0 1.1737507747966447e-06
intervention O 0 2.1122672499984674e-09
, O 0 7.927070458380037e-12
the O 0 6.252892648106467e-11
development O 0 4.4962922274294215e-09
of O 0 0.0008430278394371271
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.73615647378756e-07
CRC B-Disease 1 0.9772114753723145
) O 0 7.624708864284457e-09
. O 0 1.357572898541548e-07

APC B-Disease 0 9.662987577030435e-05
is O 0 9.098365616466708e-09
a O 0 6.043963551860543e-09
tumour O 1 0.9999998807907104
- O 0 1.212658935401123e-05
suppressor O 0 1.872897996690881e-06
gene O 0 9.371359244170208e-10
, O 0 2.1581819664717727e-11
and O 0 1.8171712745651547e-10
somatic O 0 4.752498716698028e-05
loss O 0 7.600827757414663e-06
occurs O 0 1.5408013496198691e-06
in O 0 2.5487531729595503e-06
tumours B-Disease 1 1.0
. O 0 9.181870154861826e-06

The O 0 7.500378615077352e-06
germline O 0 1.3268804650579114e-05
T O 0 1.1636418548732763e-06
- O 0 2.310127733551326e-08
to O 0 3.0597305245017026e-10
- O 0 7.666240087189635e-09
A O 0 3.944315984938385e-09
transversion O 0 8.407284468603393e-08
responsible O 0 9.975754944324677e-11
for O 0 2.5244896451059873e-11
the O 0 1.622261325273655e-09
APC O 0 8.756712333024552e-08
I1307K O 0 2.79477035292075e-07
allele O 0 4.1873140510517715e-09
converts O 0 2.2545303401955152e-09
the O 0 1.7460706491778666e-10
wild O 0 1.6716900086422015e-09
- O 0 1.1745841799193357e-10
type O 0 2.566780399337887e-10
sequence O 0 1.585115372293444e-11
to O 0 1.102383982709565e-11
a O 0 1.0738415712197025e-09
homopolymer O 1 0.9999997615814209
tract O 1 0.9999992847442627
( O 0 4.244558482469074e-09
A8 O 0 9.167671350951423e-07
) O 0 7.884697235394089e-12
that O 0 1.328501436463625e-12
is O 0 2.1843759440143273e-11
genetically O 0 9.19642175745139e-08
unstable O 0 3.3483394190625404e-07
and O 0 2.6603039771089243e-09
prone O 0 5.65175753308722e-07
to O 0 4.461846447867401e-09
somatic O 0 4.587877992889844e-05
mutation O 0 3.942768955766951e-07
. O 0 1.0052705334828715e-07

The O 0 3.4337568877162994e-07
I1307K O 0 8.285522199003026e-06
allele O 0 8.501926629378431e-08
was O 0 1.7290446407969284e-08
found O 0 1.2014143013772127e-09
in O 0 1.3493058892422027e-09
6 O 0 1.8355893871557782e-07
. O 0 5.7873364767146995e-08

1 O 0 5.381938876780623e-07
% O 0 6.366795535228675e-09
of O 0 7.962722925469734e-09
unselected O 0 0.2828008830547333
Ashkenazi O 0 2.650273245308199e-06
Jews O 0 2.4885089544568473e-08
and O 0 9.163910602572045e-11
higher O 0 1.9195289802098614e-09
proportions O 0 1.3544990684621894e-09
of O 0 2.979916535750249e-09
Ashkenazim O 0 9.043899808602873e-06
with O 0 7.397503443140607e-11
family O 0 7.895717413219927e-11
or O 0 2.234851019522477e-11
personal O 0 2.975384161274519e-09
histories O 0 9.539810719161324e-08
of O 0 3.574531774575007e-06
CRC B-Disease 1 1.0
( O 0 3.845750384812163e-09
ref O 0 1.963276417882298e-06
. O 0 1.9577504062340267e-09
2 O 0 8.265437223542449e-09
) O 0 2.846450020133062e-10
. O 0 1.2326792919736818e-08

To O 0 2.702709345214771e-08
evaluate O 0 3.5697272693369086e-08
the O 0 2.429480172594367e-09
role O 0 1.8035984927777804e-09
of O 0 1.5048870594114305e-08
I1307K O 0 9.394661901751533e-05
in O 0 4.832052624692551e-08
cancer B-Disease 0 3.680104612158175e-07
, O 0 3.5380330609680044e-11
we O 0 7.107436861275573e-11
genotyped O 0 9.662298907642253e-07
5 O 0 3.0032037301452874e-08
, O 0 9.264689015964223e-10
081 O 0 3.177776306984015e-06
Ashkenazi O 0 2.2379879283107584e-07
volunteers O 0 7.248731836995148e-09
in O 0 1.6669322866480485e-10
a O 0 3.4207606192104834e-10
community O 0 4.281065280054008e-09
survey O 0 4.451832680274492e-09
. O 0 1.6652085932378213e-08

Risk O 0 2.2498707039630972e-05
of O 0 2.296151023983839e-06
developing O 1 0.9994755387306213
colorectal B-Disease 1 1.0
, I-Disease 1 0.9809995889663696
breast I-Disease 1 1.0
and I-Disease 0 5.332867090146465e-07
other I-Disease 0 4.017873038719699e-07
cancers I-Disease 1 0.9882956743240356
were O 0 1.0321765842036257e-07
compared O 0 1.9624655678285308e-08
between O 0 1.307757901969353e-08
genotyped O 0 0.00040573696605861187
I1307K O 0 1.4407297612706316e-06
carriers O 0 5.238841804811045e-09
and O 0 1.358254758665467e-10
non O 0 8.972539378149236e-10
- O 0 6.366428495496734e-10
carriers O 0 2.4499305362191137e-10
and O 0 9.399885383953865e-12
their O 0 8.41280257263266e-12
first O 0 1.0227176744370681e-10
- O 0 1.565831242444915e-09
degree O 0 2.9274135115997524e-08
relatives O 0 1.0205537748220195e-08
. O 0 7.640985622003882e-09

Sperm O 0 6.618112280420974e-08
DNA O 0 2.210367444632766e-09
analysis O 0 2.568269208413909e-10
in O 0 3.1994218385733575e-10
a O 0 6.8771393024746885e-09
Friedreich B-Disease 1 0.9999990463256836
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 0 5.996456093271263e-05
suggests O 0 1.7103279503771773e-07
both O 0 2.5210562526467584e-09
meiotic O 0 1.0258171414534445e-06
and O 0 3.3238045649142123e-09
mitotic O 0 1.489613623562036e-07
expansion O 0 6.283028142206604e-07
in O 0 5.495644384012621e-09
the O 0 3.316131369501818e-08
FRDA B-Disease 0 0.0032772051636129618
gene O 0 2.848661608823022e-07
. O 0 1.5218937221561646e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 8.383377547716009e-08
usually O 0 8.11215805640586e-09
caused O 0 2.0320722882161135e-09
by O 0 3.9768931203720825e-11
an O 0 3.1097967083393296e-12
expansion O 0 2.670976106955436e-09
of O 0 5.078763631871652e-09
a O 0 8.84405793044607e-09
GAA O 0 1.9271328710601665e-06
trinucleotide O 0 8.53818255563965e-06
repeat O 0 2.6162402022578135e-08
in O 0 3.011151994414263e-09
intron O 0 2.9384452204794798e-08
1 O 0 1.2099945490007258e-09
of O 0 6.025751009275382e-10
the O 0 1.3372723373095141e-08
FRDA B-Disease 0 0.12948863208293915
gene O 0 5.324014296093083e-07
. O 0 3.858637001030729e-07

Occasionally O 0 4.443928389719076e-07
, O 0 2.6788025131452287e-09
a O 0 1.2317903363978644e-09
fully O 0 1.4231009259901839e-08
expanded O 0 2.054438930088054e-08
allele O 0 1.038352603899284e-08
has O 0 3.726274150350761e-11
been O 0 2.9038190255126217e-11
found O 0 1.2777078006731557e-11
to O 0 6.921026685785536e-12
arise O 0 1.7726449197397187e-09
from O 0 1.9539442286387043e-10
a O 0 7.743177626862163e-11
premutation O 0 2.162364012292528e-07
of O 0 5.602497132883855e-09
100 O 0 3.4259726167107374e-09
or O 0 1.6432878668926065e-10
less O 0 1.4507622658754826e-08
triplet O 0 1.5483949482586468e-06
repeats O 0 1.2978424024367996e-07
. O 0 1.701777989637776e-07

We O 0 9.317719218415732e-08
have O 0 6.263220497793043e-10
examined O 0 1.7975926525082286e-08
the O 0 6.659512385986943e-10
sperm O 0 5.414672044068425e-10
DNA O 0 1.9249761507023067e-10
of O 0 8.177614835291891e-11
a O 0 6.429886068026747e-10
premutation O 0 0.00014290117542259395
carrier O 0 3.2135767469299026e-06
. O 0 4.888368039246416e-07

This O 0 8.988750721528049e-08
mans O 0 5.209037408349104e-05
leucocyte O 0 8.814220564090647e-06
DNA O 0 9.491604657796415e-08
showed O 0 1.7561013754274768e-09
one O 0 9.896192372516044e-12
normal O 0 4.6905843792410806e-11
allele O 0 1.2443546193452448e-10
and O 0 8.872616183430715e-12
one O 0 6.023814259903393e-12
allele O 0 7.607298818657071e-11
of O 0 1.1296639318425505e-10
approximately O 0 1.4881250398612877e-10
100 O 0 1.538931870825877e-09
repeats O 0 3.3352101080907914e-09
. O 0 2.2365002294577607e-08

His O 0 8.015394428184663e-07
sperm O 0 6.641163707854503e-08
showed O 0 8.375697357898559e-10
an O 0 2.8038352889447893e-12
expanded O 0 2.857220293694951e-10
allele O 0 5.93452564867647e-10
in O 0 2.135306931272396e-10
a O 0 1.963931517412476e-10
tight O 0 1.5062961722378532e-07
range O 0 8.057757128199228e-08
centering O 0 3.016695160340532e-08
on O 0 3.1491229068869586e-10
a O 0 1.0424509346018684e-11
size O 0 8.391363992554801e-11
of O 0 4.3586853570865003e-10
approximately O 0 2.218476735649233e-09
320 O 0 6.650176231914884e-08
trinucleotide O 0 7.632148481206968e-06
repeats O 0 7.379448163646884e-08
. O 0 2.007049602070765e-07

His O 0 3.94760263588978e-06
affected O 0 1.556547977088485e-05
son O 0 3.8076228520367295e-05
has O 0 4.2994008353502977e-10
repeat O 0 2.0345658491294216e-09
sizes O 0 9.45301081856087e-09
of O 0 4.52256854188704e-09
1040 O 0 1.5935823682866612e-07
and O 0 4.709935552682509e-09
540 O 0 2.3528087922386476e-07
. O 0 2.6145992038095756e-08

These O 0 2.5481735832499908e-08
data O 0 3.969084616528562e-09
suggest O 0 5.413339776438875e-10
that O 0 2.5700110442561375e-12
expansion O 0 3.051456198832625e-09
occurs O 0 1.5230371130936504e-10
in O 0 1.9972717923977257e-11
two O 0 1.5637695131853757e-12
stages O 0 3.8119801759606275e-10
, O 0 1.0178243881400761e-12
the O 0 5.62760341799029e-12
first O 0 8.954356353618742e-12
during O 0 8.494523140445409e-11
meiosis O 0 1.286607625994307e-10
followed O 0 1.5282342058497989e-10
by O 0 3.5075813781260123e-11
a O 0 4.2925489551759455e-11
second O 0 2.1392583260393394e-09
mitotic O 0 7.49126982668713e-08
expansion O 0 5.082570169179235e-07
. O 0 1.5147060139497626e-07

We O 0 1.7828698162247747e-07
also O 0 2.2600026294838926e-09
show O 0 9.45422698461762e-11
that O 0 8.048382923661612e-13
in O 0 2.2994946224930146e-11
all O 0 3.316151520049715e-11
informative O 0 7.709434757252609e-10
carrier O 0 2.796702591734146e-10
father O 0 4.259065045086885e-10
to O 0 7.745807467651744e-11
affected O 0 4.51124186895413e-08
child O 0 7.728814033214348e-09
transmissions O 0 2.4991864133738773e-09
, O 0 3.916467844478078e-12
with O 0 5.444406319006501e-13
the O 0 2.8434098825469434e-11
notable O 0 7.215980035724101e-10
exception O 0 3.346563859363272e-10
of O 0 1.9547419238818975e-10
the O 0 3.5176667134706463e-10
premutation O 0 5.2067676392653084e-08
carrier O 0 9.743259532513093e-10
, O 0 8.838833311097805e-12
the O 0 4.2057832910780135e-11
expansion O 0 1.790050996319792e-09
size O 0 5.417812309893577e-10
decreases O 0 7.3992896254537754e-09
. O 0 2.436055357435407e-09
. O 0 2.5436525774580332e-08

The O 0 1.370354283380948e-07
R496H O 0 1.3622643564303871e-06
mutation O 0 8.47501446799015e-09
of O 0 3.9852876554391514e-09
arylsulfatase O 0 0.0005175432306714356
A O 0 5.163687433196174e-07
does O 0 6.930809259841908e-10
not O 0 1.1737134597566978e-09
cause O 0 1.8620715991346515e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.770909526996547e-06

Deficiency B-Disease 0 0.001920922426506877
of I-Disease 0 2.0965956082363846e-06
arylsulfatase I-Disease 1 0.9999996423721313
A I-Disease 1 0.9988206028938293
( O 0 6.972608730393404e-07
ARSA O 1 0.998526930809021
) O 0 8.188200673053814e-10
enzyme O 0 1.2771079305196054e-08
activity O 0 8.316134447738932e-09
causes O 0 1.0524902194219976e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 6.82489883274684e-07
MLD B-Disease 1 1.0
) O 0 1.0797204907930791e-07
. O 0 2.0911113551846938e-07

A O 0 3.384030549113959e-07
number O 0 1.2279579131302398e-08
of O 0 1.077739142374412e-07
ARSA O 0 0.04120807349681854
gene O 0 5.861019758413022e-08
mutations O 0 4.787766627600831e-09
responsible O 0 7.084107744859125e-10
for O 0 8.133818063527087e-09
MLD B-Disease 1 1.0
have O 0 1.0412030349016277e-07
been O 0 5.451452178562022e-09
identified O 0 7.989011230336018e-09
. O 0 2.022838607729227e-08

Recently O 0 2.165186998581703e-07
, O 0 8.902816261979751e-10
the O 0 8.943168428032777e-10
R496H O 0 3.7044043210698874e-07
mutation O 0 7.0478978209109755e-09
of O 0 2.090771644702727e-08
ARSA O 0 0.001898444490507245
was O 0 9.640631404295164e-09
proposed O 0 2.2682724587497205e-09
to O 0 4.29752969322017e-11
be O 0 2.740438084791741e-11
a O 0 2.923163100465587e-11
cause O 0 1.4868177800053672e-09
of O 0 1.1545132139190173e-07
MLD B-Disease 1 1.0
( O 0 2.0471205175454088e-08
Draghia O 0 1.4680932508781552e-05
et O 0 7.3242243381344e-09
al O 0 9.519010024661156e-10
. O 0 3.3988478698177005e-11
, O 0 2.3239925608931067e-11
1997 O 0 2.433037105120661e-09
) O 0 1.714829167553944e-09
. O 0 9.053930227764795e-08

We O 0 1.1582362446915795e-07
have O 0 1.2447018971073476e-09
investigated O 0 6.91747414904853e-09
the O 0 6.234464056120714e-09
R496H O 0 8.428789897152456e-07
mutation O 0 2.3322366260458693e-09
and O 0 3.2373072972324834e-11
found O 0 5.438213247777046e-12
this O 0 3.787436943930578e-12
mutation O 0 2.2285256973120227e-11
at O 0 6.81809816938106e-11
a O 0 7.603117788135272e-12
relatively O 0 1.1367404934015113e-10
high O 0 1.1464013766060432e-10
frequency O 0 1.9747559490412847e-11
in O 0 5.767181437271729e-12
an O 0 3.217715536293214e-13
African O 0 4.296256926605846e-12
American O 0 5.4340759322868415e-12
population O 0 5.765396840495818e-13
( O 0 6.537962445735124e-13
f O 0 8.386952243810697e-10
= O 0 1.1314149617192015e-10
0 O 0 4.2246953158020517e-10
. O 0 2.052043257538827e-11
09 O 0 2.9260944778286557e-09
, O 0 2.5360382197026077e-11
n O 0 8.001435625182296e-10
= O 0 4.281547116846696e-09
61 O 0 3.5668076492356704e-08
subjects O 0 2.9403681267581305e-08
) O 0 2.136318233425527e-09
. O 0 8.967978715190839e-08

The O 0 8.684793283464387e-05
ARSA O 0 0.00801762379705906
enzyme O 0 7.238207189175228e-08
activity O 0 7.184205230714724e-09
in O 0 1.9607127033083316e-10
subjects O 0 1.2112367775429789e-09
with O 0 1.8805831458051925e-12
and O 0 2.410603661129329e-11
without O 0 1.955879486148504e-10
the O 0 1.73606262698911e-09
R496H O 0 1.041828738834738e-07
mutation O 0 3.0994132260708795e-10
was O 0 1.9905412040888137e-10
determined O 0 1.7479033498357666e-10
and O 0 3.9596437240163596e-11
found O 0 3.843063367536814e-11
to O 0 3.406096585334417e-11
be O 0 8.440197984960207e-10
normal O 0 3.155692525069753e-07
. O 0 1.660407491499427e-07

It O 0 4.3871040134035866e-09
is O 0 1.7586042344586161e-10
therefore O 0 3.7872238678460235e-10
concluded O 0 4.691007027268768e-10
that O 0 2.4791475296270793e-12
the O 0 2.916798746976923e-10
R496H O 0 1.0000134409438033e-07
mutation O 0 2.170287283220773e-09
of O 0 7.829202175457795e-09
ARSA O 0 2.541787580412347e-05
does O 0 1.919235048664092e-10
not O 0 7.954943648247337e-11
negatively O 0 3.396103620545432e-09
influence O 0 3.4410545524110603e-09
the O 0 4.5985026897454873e-10
activity O 0 1.922350056915434e-09
of O 0 1.6619940979012426e-08
ARSA O 1 0.6090537309646606
and O 0 6.606213354132251e-10
is O 0 1.5492353927504254e-11
not O 0 6.487185354869807e-12
a O 0 6.847159644829404e-11
cause O 0 1.266357685381081e-08
of O 0 9.264853133572615e-07
MLD B-Disease 1 1.0

Down O 0 2.1436394490592647e-06
- O 0 2.45440503476857e-07
regulation O 0 2.2009558620084135e-07
of O 0 5.3009827638561546e-08
transmembrane O 0 5.148414743416652e-07
carbonic O 0 8.501476258970797e-05
anhydrases O 0 0.0033184983767569065
in O 0 7.1976473918766715e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 1.107836624214542e-06
lines O 0 1.027093188277206e-09
by O 0 2.403080789914469e-10
wild O 0 2.57544911619334e-07
- O 0 2.3912365421097093e-08
type O 0 4.550658161406318e-07
von B-Disease 1 0.9995074272155762
Hippel I-Disease 1 0.9992474317550659
- I-Disease 0 0.0019156273920089006
Lindau I-Disease 0 0.004579927772283554
transgenes O 0 7.348979124799371e-05
. O 0 4.17308427813623e-07

To O 0 1.2887720401977276e-07
discover O 0 2.0170672243580157e-08
genes O 0 5.798467817008657e-10
involved O 0 1.2879236566121222e-10
in O 0 7.623614517449084e-10
von B-Disease 1 0.999997615814209
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 3.951961957682215e-07
VHL B-Disease 1 0.9999994039535522
) O 0 5.975532069157907e-09
- O 0 3.4148843042203225e-07
mediated O 0 1.517943672979527e-07
carcinogenesis O 0 0.00018979325250256807
, O 0 3.217217325879318e-10
we O 0 1.1495961127483412e-10
used O 0 7.649705757728498e-09
renal B-Disease 1 1.0
cell I-Disease 1 0.9999972581863403
carcinoma I-Disease 1 1.0
cell O 0 2.8350146749289706e-05
lines O 0 8.986162924884411e-08
stably O 0 1.465350919716002e-06
transfected O 0 1.4226699818209454e-07
with O 0 7.190942979962145e-11
wild O 0 1.6912760258946946e-07
- O 0 4.917066576126672e-08
type O 0 6.171201221150113e-07
VHL O 1 0.9890120029449463
- O 0 1.772850373527035e-05
expressing O 0 2.618916994379106e-07
transgenes O 0 2.500876689737197e-05
. O 0 2.072010687470538e-07

Large O 0 1.1752875934689655e-06
- O 0 7.769460808049189e-07
scale O 0 8.027091098483652e-07
RNA O 0 8.998648581837188e-08
differential O 0 3.6960617677550545e-08
display O 0 2.0173203107987092e-09
technology O 0 2.9727877048912887e-08
applied O 0 3.101851220321805e-09
to O 0 6.528685231321774e-11
these O 0 5.776674277813143e-11
cell O 0 4.494661032250491e-10
lines O 0 6.603904229018909e-11
identified O 0 2.1882124584537976e-11
several O 0 3.8885270003952144e-11
differentially O 0 3.208836929502468e-08
expressed O 0 2.9150523661591876e-10
genes O 0 1.2763273771199124e-10
, O 0 3.0923597016396798e-12
including O 0 2.5040889500838048e-11
an O 0 2.7118659748359697e-11
alpha O 0 5.2720434240427494e-08
carbonic O 0 3.9085721255105454e-06
anhydrase O 0 1.2999141290492844e-05
gene O 0 1.5260045671539046e-08
, O 0 1.4337830922528383e-09
termed O 0 7.484705975002726e-07
CA12 O 1 0.9991374015808105
. O 0 7.75666194385849e-06

The O 0 1.1259377430405948e-07
deduced O 0 5.7632568939425255e-08
protein O 0 9.439744541595019e-10
sequence O 0 6.632976806697499e-11
was O 0 1.3187625991228913e-10
classified O 0 1.4802889469756053e-10
as O 0 6.118748563377352e-11
a O 0 6.488549975092184e-11
one O 0 5.771215172423183e-10
- O 0 1.0374429848525324e-06
pass O 0 0.0011862771352753043
transmembrane O 0 1.2080508895451203e-06
CA O 0 3.297166983884381e-07
possessing O 0 6.272177888178021e-09
an O 0 3.790445041174095e-11
apparently O 0 5.933883606701329e-09
intact O 0 8.301871190496968e-09
catalytic O 0 5.798979962889916e-09
domain O 0 9.62663015968701e-09
in O 0 1.2841615548708774e-09
the O 0 1.0075660306085865e-08
extracellular O 0 3.2865185062291857e-07
CA O 0 3.105265932390466e-05
module O 0 3.5295365705678705e-06
. O 0 1.1374056896329421e-07

Reintroduced O 0 2.8592063245014288e-05
wild O 0 9.583227438270114e-06
- O 0 9.136712151303072e-07
type O 0 1.42234591749002e-06
VHL B-Disease 1 0.5282690525054932
strongly O 0 3.149942884306256e-08
inhibited O 0 1.4625814337421161e-08
the O 0 6.843742239581729e-10
overexpression O 0 9.548545065740655e-09
of O 0 3.6248809509586977e-10
the O 0 1.085894818508848e-09
CA12 O 0 4.140562305110507e-05
gene O 0 7.539914803622594e-10
in O 0 1.1133833438536911e-10
the O 0 3.300128170735661e-09
parental O 0 1.420785702066496e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.006135733798146248
lines O 0 6.118004876043415e-07
. O 0 4.854977646573388e-07

Similar O 0 2.8903958337878066e-08
results O 0 7.975673455007382e-09
were O 0 9.910974263505068e-10
obtained O 0 2.4489679728567637e-10
with O 0 6.325948098684364e-11
CA9 O 0 0.00010674241639208049
, O 0 1.2593477372035977e-09
encoding O 0 4.790737762050412e-08
another O 0 4.4733354798154323e-08
transmembrane O 0 1.2397357807003573e-07
CA O 0 1.0574159858833809e-07
with O 0 2.005792580639376e-11
an O 0 2.348088563863815e-11
intact O 0 1.571067542727178e-08
catalytic O 0 3.423015471071267e-08
domain O 0 2.061241843875905e-07
. O 0 1.490689527372524e-07

Although O 0 3.092115719027788e-07
both O 0 2.7528199719739632e-09
domains O 0 8.253668859481422e-09
of O 0 1.882675704223402e-08
the O 0 1.5295748312382784e-07
VHL B-Disease 1 0.9806350469589233
protein O 0 2.0719387094914055e-08
contribute O 0 1.7594699308620676e-10
to O 0 2.1661826846153254e-11
regulation O 0 9.059575312164725e-09
of O 0 1.8139804325301156e-08
CA12 O 1 0.9999350309371948
expression O 0 5.947582870646784e-09
, O 0 1.081940786962221e-11
the O 0 4.7793404650553484e-11
elongin O 0 1.9722971700275593e-08
binding O 0 2.7727073970140736e-09
domain O 0 1.6461630281128237e-08
alone O 0 3.079068999767287e-09
could O 0 8.042625454507402e-10
effectively O 0 4.96232814839459e-08
regulate O 0 1.1199250593563193e-06
CA9 O 0 0.009611857123672962
expression O 0 5.374172360461671e-06
. O 0 1.057477106769511e-06

We O 0 4.099260308976227e-07
mapped O 0 1.930219241330633e-06
CA12 O 1 0.7237456440925598
and O 0 1.0121677860297495e-06
CA9 O 0 0.005168470554053783
loci O 0 2.500399659766117e-06
to O 0 6.668349872285262e-09
chromosome O 0 8.286953345759684e-09
bands O 0 4.07285511982991e-08
15q22 O 0 1.1204868997083395e-06
and O 0 1.4725239694257652e-08
17q21 O 0 2.1455769456224516e-05
. O 0 7.369109198407386e-07

2 O 0 2.427506444746541e-07
respectively O 0 1.7193233503576266e-08
, O 0 8.553381336540156e-10
regions O 0 2.5757433519402184e-08
prone O 0 4.492964364999352e-07
to O 0 6.582366318674815e-10
amplification O 0 1.489532041887287e-05
in O 0 3.47130111322258e-08
some O 0 6.880117364715943e-09
human O 0 5.125946600514908e-08
cancers B-Disease 0 0.00024068258062470704
. O 0 6.742402547388338e-07

Additional O 0 4.2744748185441495e-08
experiments O 0 5.171848371787746e-08
are O 0 5.434110106339318e-11
needed O 0 6.196052004803221e-10
to O 0 3.505795653779842e-11
define O 0 3.7066544278374636e-10
the O 0 2.957260825109387e-10
role O 0 9.977015880124895e-10
of O 0 1.3532387299619586e-07
CA O 0 0.0009778261883184314
IX O 1 1.0
and O 0 1.1705817541951546e-06
CA O 0 7.2506054493715055e-06
XII O 0 0.0015978821320459247
enzymes O 0 1.010664330003408e-09
in O 0 9.269066764128198e-11
the O 0 1.240318698442211e-11
regulation O 0 2.603841864345924e-10
of O 0 5.925598900446971e-11
pH O 0 2.031964640991646e-08
in O 0 3.493921818531476e-10
the O 0 3.9786174355072035e-10
extracellular O 0 1.4967108663554995e-09
microenvironment O 0 2.864617840714345e-07
and O 0 6.706813576728976e-11
its O 0 9.729846095485328e-11
potential O 0 5.739131836435263e-09
impact O 0 2.0994879434965696e-07
on O 0 1.3735483435084461e-06
cancer B-Disease 0 1.0289082638337277e-05
cell O 0 6.023297771662328e-08
growth O 0 1.721259401676889e-08
. O 0 2.2128615384531258e-08

A O 0 4.2126785615437257e-07
gene O 0 1.3511195717796909e-08
encoding O 0 1.3231446871486696e-07
a O 0 1.5455954738285982e-08
transmembrane O 0 7.512833377631978e-08
protein O 0 2.8810154262259857e-09
is O 0 5.623668197785037e-11
mutated O 0 4.806917974775615e-09
in O 0 2.311884156336319e-10
patients O 0 1.1902275609543267e-08
with O 0 1.841048979933646e-09
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9995881915092468
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.1287131229664737e-08
. O 0 3.5386253927072175e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.269582420121878e-05
WFS B-Disease 1 0.9999810457229614
; O 0 8.570664817852958e-07
OMIM O 1 0.9999918937683105
222300 O 0 1.575925125507638e-05
) O 0 2.790005448893851e-10
is O 0 5.455493001793599e-11
an O 0 5.679194337027127e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 3.056094044495694e-08
by O 0 4.2756385099096406e-09
young O 0 2.0289773772219633e-07
- O 0 2.3442380552296527e-06
onset O 1 1.0
non O 1 1.0
- O 1 1.0
immune O 1 0.8267635107040405
insulin B-Disease 1 0.63326096534729
- I-Disease 0 6.915249105077237e-05
dependent I-Disease 0 2.714970605666167e-06
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.7078373275580816e-06
progressive O 1 0.9996229410171509
optic B-Disease 1 0.9999954700469971
atrophy I-Disease 0 0.055271223187446594
. O 0 5.541537393582985e-05

Linkage O 0 4.985931809642352e-06
to O 0 6.85098111574689e-09
markers O 0 6.561739240851239e-08
on O 0 1.385423242794559e-08
chromosome O 0 8.93246721034302e-09
4p O 0 0.0012665758840739727
was O 0 1.3914346119747734e-08
confirmed O 0 5.477310160983961e-09
in O 0 1.8996604289611696e-09
five O 0 8.705428045097108e-10
families O 0 7.735977969325347e-10
. O 0 7.0770749260873345e-09

On O 0 9.382814170066922e-08
the O 0 2.1628161483988606e-09
basis O 0 5.784133172426209e-09
of O 0 5.823886262135147e-09
meiotic O 0 0.1537083238363266
recombinants O 1 0.9999992847442627
and O 0 1.9881191803960974e-07
disease O 0 3.127719310214161e-06
- O 0 2.175900704060041e-08
associated O 0 1.616961142758555e-08
haplotypes O 0 8.881827540108134e-08
, O 0 2.3201714161036335e-10
the O 0 6.514201178475787e-09
WFS B-Disease 0 1.7002033928292803e-05
gene O 0 1.4573064976985961e-09
was O 0 1.8834647175225427e-09
localized O 0 8.48271231035369e-09
to O 0 6.788101747368103e-10
a O 0 2.7195881102670683e-08
BAC O 0 0.10553169995546341
/ O 0 3.958128218073398e-06
P1 O 0 6.167586434457917e-06
contig O 0 9.214626857101393e-07
of O 0 1.71276004490295e-09
less O 0 2.374464624921302e-09
than O 0 7.869620510803088e-10
250 O 0 2.4361726858046495e-08
kb O 0 1.4075377521294286e-06
. O 0 1.9335138290443865e-07

Mutations O 0 3.8142826497278293e-07
in O 0 4.8250048401143886e-09
a O 0 1.1706862146354524e-09
novel O 0 3.025205685958099e-08
gene O 0 2.9342543950150457e-09
( O 0 3.5481378946045083e-10
WFS1 O 0 0.0013422517804428935
) O 0 5.598242980298096e-10
encoding O 0 2.3582535035870933e-08
a O 0 1.0917267978527434e-08
putative O 0 4.347344315647206e-07
transmembrane O 0 4.571473866121778e-09
protein O 0 2.357963269083996e-10
were O 0 1.094638546472737e-10
found O 0 9.29051453824048e-12
in O 0 1.6528303031781988e-11
all O 0 3.205870985345527e-11
affected O 0 6.380529438132498e-10
individuals O 0 1.1745117031725094e-11
in O 0 3.0323503708018507e-09
six O 0 3.0710475584783126e-07
WFS B-Disease 1 0.9999984502792358
families O 0 2.0504957731759532e-09
, O 0 1.586718603729942e-11
and O 0 8.863870575026578e-12
these O 0 1.2685483739838244e-11
mutations O 0 4.8117565487615366e-11
were O 0 6.375611844022799e-11
associated O 0 1.0588394050436989e-10
with O 0 5.243295034262907e-11
the O 0 2.7540170322026825e-07
disease O 0 0.00024085243057925254
phenotype O 0 1.7496884538559243e-05
. O 0 3.783931958878384e-07

WFS1 O 1 0.9989005327224731
appears O 0 2.939149510439165e-07
to O 0 5.145120440808171e-10
function O 0 6.861806123303893e-10
in O 0 1.865488430397022e-09
survival O 0 2.02720116249111e-06
of O 0 1.2102883140130416e-08
islet O 0 9.895189805320115e-07
beta O 0 1.1659363963190117e-07
- O 0 1.623157430685751e-07
cells O 0 2.6193447411060333e-09
and O 0 1.0367467301319877e-10
neurons O 0 4.194513902877617e-10
. O 0 1.6312896866654825e-10
. O 0 6.537302255082977e-09

Stable O 0 3.2383177313022316e-06
interaction O 0 3.78285047730742e-09
between O 0 2.762970963132716e-10
the O 0 2.243646241018027e-10
products O 0 2.5562982841620396e-08
of O 0 2.956197953096762e-08
the O 0 2.812038815136475e-07
BRCA1 O 0 8.555377917218721e-07
and O 0 1.642744251739714e-08
BRCA2 O 0 6.179523097671336e-07
tumor B-Disease 0 2.6616484660735296e-07
suppressor O 0 2.502188465314248e-07
genes O 0 3.3833197354837807e-10
in O 0 7.171657018245625e-11
mitotic O 0 4.247460339001918e-08
and O 0 1.173631325457336e-08
meiotic O 0 1.6437978047179058e-05
cells O 0 1.4598356301576132e-06
. O 0 2.385606592270051e-07

BRCA1 O 0 0.003941428381949663
and O 0 1.5809231399543933e-06
BRCA2 O 0 2.024865352723282e-06
account O 0 6.696562054875344e-11
for O 0 3.2976000402529237e-12
most O 0 6.158754062290939e-12
cases O 0 1.0299208534625404e-11
of O 0 1.5564509403542814e-10
familial O 0 3.9839370913341554e-08
, O 0 5.824539184295929e-10
early O 0 1.1389298379071988e-05
onset O 1 0.999998927116394
breast B-Disease 1 0.999995231628418
and I-Disease 0 5.8651468862080947e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.043358815484453e-09
encode O 0 3.0305735698732406e-10
products O 0 1.5731235203375604e-09
that O 0 6.872946222563625e-12
each O 0 2.001859789046989e-11
interact O 0 1.5850436241304777e-10
with O 0 1.0719296977823589e-10
hRAD51 O 0 1.102452984014235e-06
. O 0 1.742766073675739e-07

Results O 0 8.560372179999831e-07
presented O 0 7.072738981150906e-07
here O 0 3.527674508063683e-08
show O 0 1.4077095045195165e-09
that O 0 9.811939455373064e-11
BRCA1 O 0 2.479060867699445e-07
and O 0 2.6448489620634064e-08
BRCA2 O 0 4.614111730916193e-06
coexist O 0 1.274810568219209e-08
in O 0 8.496434111826545e-11
a O 0 1.6416860926238286e-11
biochemical O 0 7.374773236534793e-09
complex O 0 3.346860566466603e-08
and O 0 1.110527003689299e-09
colocalize O 0 1.4525597180181649e-05
in O 0 6.795491458433389e-08
subnuclear O 0 0.0006987043307162821
foci O 0 1.3345404113351833e-05
in O 0 3.961853956013783e-09
somatic O 0 1.5468023661924235e-07
cells O 0 2.8888166858642705e-10
and O 0 5.62428749406596e-12
on O 0 1.8573528132170836e-11
the O 0 5.89012345841855e-12
axial O 0 1.3777640139878145e-10
elements O 0 4.694273858518727e-10
of O 0 4.143142273704825e-09
developing O 0 2.791363726828422e-07
synaptonemal O 0 9.937089635059237e-05
complexes O 0 3.1679062431066995e-06
. O 0 4.387922274418088e-07

Like O 0 8.528385660611093e-05
BRCA1 O 0 0.00012897010310553014
and O 0 6.279188369262556e-07
RAD51 O 1 0.9996058344841003
, O 0 1.8955263385578291e-06
BRCA2 O 0 4.562032700050622e-05
relocates O 0 5.061263550487638e-07
to O 0 1.3699905210273755e-08
PCNA O 0 3.0265615350799635e-05
+ O 0 1.0605949007924664e-08
replication O 0 4.692859434385355e-10
sites O 0 2.4783638682968068e-11
following O 0 3.5240511897516313e-11
exposure O 0 3.840385343067965e-09
of O 0 2.47746823056616e-09
S O 0 2.8870460937469034e-06
phase O 0 1.4993896684245556e-06
cells O 0 3.692022687573626e-09
to O 0 4.786604446138654e-10
hydroxyurea O 0 5.603193926617678e-07
or O 0 1.240240088407063e-08
UV O 0 0.18349234759807587
irradiation O 0 0.0001396046718582511
. O 0 8.512601539223397e-07

Thus O 0 3.318116569062113e-06
, O 0 1.2247632241724205e-07
BRCA1 O 0 8.57732061376737e-07
and O 0 1.2788678560582412e-08
BRCA2 O 0 3.207087502232753e-07
participate O 0 7.310180238917496e-10
, O 0 1.4492997947590514e-11
together O 0 6.344517359396784e-12
, O 0 3.756199778298663e-12
in O 0 1.3363548982681106e-11
a O 0 2.276023119973658e-11
pathway O 0 2.02127203863256e-09
( O 0 1.1003422131783402e-11
s O 0 6.163226040634129e-10
) O 0 2.3648431303480155e-12
associated O 0 8.512233279356352e-11
with O 0 5.2633119217160296e-12
the O 0 9.419021812506756e-11
activation O 0 5.474070086108895e-10
of O 0 1.9996675426625643e-09
double O 0 1.0315320819742624e-09
- O 0 6.005527808383704e-08
strand O 0 1.1416740441916318e-08
break O 0 2.0556256696835362e-09
repair O 0 2.0156289082251533e-08
and O 0 1.144627836957568e-09
/ O 0 4.900784134065361e-08
or O 0 3.493950462285511e-09
homologous O 0 7.309988614423446e-09
recombination O 0 4.991013824451329e-08
. O 0 3.124595338022118e-08

Dysfunction O 0 0.012317202985286713
of O 0 1.170666564576095e-06
this O 0 3.915069157756079e-09
pathway O 0 1.6365707011800623e-08
may O 0 3.580284332893591e-11
be O 0 4.189696332923543e-12
a O 0 5.968164764474926e-12
general O 0 6.083282766411457e-10
phenomenon O 0 1.5492663818506003e-09
in O 0 1.5209722370457257e-11
the O 0 1.9220475905301626e-11
majority O 0 1.7094089815525293e-12
of O 0 6.016947357023739e-12
cases O 0 1.0185906285098412e-10
of O 0 1.9068819412382254e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9990904331207275
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.702450150442019e-08
. O 0 6.516713568771593e-08

A O 0 1.7105919596360764e-06
novel O 0 1.3059366210654844e-06
Arg362Ser O 0 1.0535970432101749e-05
mutation O 0 1.1687725454123665e-08
in O 0 2.7007279745916435e-10
the O 0 3.593531305856601e-10
sterol O 0 3.004290078933991e-07
27 O 0 1.7344541447528172e-07
- O 0 1.301953176380266e-07
hydroxylase O 0 4.359988906799117e-06
gene O 0 9.63717550206411e-09
( O 0 2.8463742474116316e-10
CYP27 O 1 0.9995098114013672
) O 0 2.817600042170909e-10
: O 0 2.9570845772042276e-11
its O 0 4.9599737511618613e-11
effects O 0 1.1515696174413392e-09
on O 0 5.748279185979754e-09
pre O 0 4.989757940165873e-07
- O 0 9.567636283236425e-08
mRNA O 0 1.6050909934506308e-08
splicing O 0 5.702795125017701e-09
and O 0 7.433358095720877e-11
enzyme O 0 2.1669741556706867e-09
activity O 0 2.459581649461029e-09
. O 0 1.1541230193756746e-08

A O 0 5.207353979130858e-07
novel O 0 3.4523120007179386e-07
C O 0 7.90764829616819e-07
to O 0 1.3886732042056593e-10
A O 0 1.2582623831747242e-09
mutation O 0 2.9655131128514256e-10
in O 0 2.475718068051247e-11
the O 0 1.500008173227485e-10
sterol O 0 1.1436141278409195e-07
27 O 0 5.398497648911871e-08
- O 0 5.624771048928778e-08
hydroxylase O 0 5.248843990557361e-06
gene O 0 1.558969131565391e-08
( O 0 2.5889751453789245e-10
CYP27 O 1 0.5342583060264587
) O 0 1.96323873824511e-10
was O 0 1.2551176764574734e-09
identified O 0 1.1851926384753853e-10
by O 0 6.534665170088161e-11
sequencing O 0 5.056573826323074e-08
amplified O 0 2.544924768699275e-07
CYP27 O 0 5.629496445180848e-05
gene O 0 1.8075210217460835e-09
products O 0 5.748301390440247e-09
from O 0 1.8380447164290104e-10
a O 0 5.834098482093708e-11
patient O 0 6.349914372094645e-09
with O 0 1.5618813187234792e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.6174199402030354e-07
CTX B-Disease 0 0.10503940284252167
) O 0 7.635565957286872e-09
. O 0 3.647000212936291e-08

The O 0 1.8984792404808104e-07
mutation O 0 3.192305797483641e-08
changed O 0 1.94059754932141e-08
the O 0 3.3318148240368828e-09
adrenodoxin O 0 7.785690172568138e-07
cofactor O 0 9.086090813070768e-08
binding O 0 7.653617295488857e-09
residue O 0 1.277527559295777e-07
362Arg O 0 8.256775174686481e-08
to O 0 6.645694550222458e-10
362Ser O 0 5.364742037272663e-07
( O 0 2.9720153005285965e-09
CGT O 0 1.3631683941639494e-05
362Arg O 0 1.299949872191064e-06
to O 0 1.733089227684559e-08
AGT O 0 0.0004898171755485237
362Ser O 0 9.205968609649062e-08
) O 0 3.479156893138047e-11
, O 0 5.266525496955277e-12
and O 0 5.586142225871837e-12
was O 0 2.6061372504493363e-10
responsible O 0 4.423678090503813e-10
for O 0 2.0558971414175176e-08
deficiency O 1 0.8118555545806885
in O 0 4.409782405900842e-08
the O 0 1.1437794711355309e-08
sterol O 0 5.580391189141665e-07
27 O 0 6.407585573242613e-08
- O 0 1.2379618219426902e-08
hydroxylase O 0 2.7261947366241657e-07
activity O 0 2.688333111677821e-09
, O 0 6.337369431314022e-12
as O 0 6.634972953001306e-12
confirmed O 0 2.4333686107769203e-11
by O 0 3.4798473130814855e-11
expression O 0 1.7374165994787916e-10
of O 0 2.320211245354642e-10
mutant O 0 3.3101266172508303e-09
cDNA O 0 4.5250279079311895e-09
into O 0 3.405996373828657e-09
COS O 0 3.173315462845494e-06
- O 0 5.614597853309533e-07
1 O 0 1.9203744727747107e-07
cells O 0 1.1791150278384066e-08
. O 0 3.87739218510319e-09

Quantitative O 0 4.559902606615651e-07
analysis O 0 2.655761610625973e-09
showed O 0 8.346147661875136e-10
that O 0 2.0707101398148575e-12
the O 0 1.0939560368683487e-10
expression O 0 6.409009434271695e-10
of O 0 3.6315674911691076e-09
CYP27 O 0 0.00012575520668178797
gene O 0 1.059736964847957e-09
mRNA O 0 4.3943795824397114e-10
in O 0 1.7972264301779894e-11
the O 0 9.956973440194972e-11
patient O 0 5.901658717277769e-09
represented O 0 3.053668429231493e-09
52 O 0 2.003183112719853e-07
. O 0 1.4381103596861067e-07

5 O 0 8.813867680146359e-08
% O 0 6.198935809109685e-10
of O 0 4.045714041556181e-10
the O 0 1.1093204133061363e-09
normal O 0 4.6809745413156634e-08
level O 0 3.8323460671563225e-07
. O 0 1.0951684004112394e-07

As O 0 3.5835213907375874e-08
the O 0 3.68093422409288e-09
mutation O 0 6.090364879085541e-10
occurred O 0 3.5697460543104853e-09
at O 0 4.763762162518503e-10
the O 0 3.114940527737531e-10
penultimate O 0 2.981493025799864e-07
nucleotide O 0 2.794022124774642e-09
of O 0 1.1478968886535768e-08
exon O 0 7.395878043325865e-08
6 O 0 1.2102582935824557e-08
( O 0 1.6277302422595952e-11
- O 0 2.9037834359257886e-09
2 O 0 2.780333296925619e-09
position O 0 1.1576102298960222e-09
of O 0 4.4479371297256876e-09
exon O 0 7.099385612718834e-08
6 O 0 5.2799634886468993e-08
- O 0 2.5306985662609804e-07
intron O 0 1.334247826889623e-06
6 O 0 4.8842949240679445e-08
splice O 0 1.1021381141063102e-07
site O 0 3.2929601267994713e-09
) O 0 4.255512175282972e-12
of O 0 1.537414362484668e-10
the O 0 6.236934302350505e-10
gene O 0 2.606246607417262e-10
, O 0 3.8296431997819624e-11
we O 0 5.928549318134912e-11
hypothesized O 0 7.777699040367736e-10
that O 0 2.015132852251078e-12
the O 0 3.494561862105172e-10
mutation O 0 4.93050988925603e-10
may O 0 6.553003140119529e-10
partially O 0 3.626424938119044e-09
affect O 0 6.54910514708007e-10
the O 0 1.838928315178734e-10
normal O 0 2.73243289106162e-10
splicing O 0 1.3367310591760884e-09
efficiency O 0 2.8402487473044857e-08
in O 0 1.0572053232849044e-09
exon O 0 2.6461965063617754e-08
6 O 0 1.4626587718780115e-09
and O 0 1.4034239916027591e-11
cause O 0 1.0808069716983226e-10
alternative O 0 3.524054825732037e-09
splicing O 0 2.8746756086661662e-09
elsewhere O 0 9.658220889718905e-10
, O 0 7.352847714373056e-13
which O 0 1.762144033121138e-13
resulted O 0 2.0464235861439306e-10
in O 0 1.5370391071023448e-10
decreased O 0 8.584242650044871e-09
transcript O 0 1.6388501666853017e-09
in O 0 9.040889564770893e-11
the O 0 2.1986990006439555e-09
patient O 0 2.9694055569962075e-07
. O 0 5.6352408961402034e-08

Transfection O 0 1.526874621049501e-05
of O 0 1.8510449706354848e-07
constructed O 0 4.648944013752043e-06
minigenes O 0 7.987734716152772e-05
, O 0 1.998415877224602e-10
with O 0 5.597468669127359e-12
or O 0 2.876038296406591e-11
without O 0 2.2405158284222182e-10
the O 0 3.39939382199006e-10
mutation O 0 1.7981190147953185e-10
, O 0 1.8943723326114714e-11
into O 0 7.798020007498963e-10
COS O 0 1.4880249636917142e-06
- O 0 2.3680439653617213e-07
1 O 0 8.02496202823022e-09
cells O 0 7.0783774674954e-11
confirmed O 0 1.4990807206682888e-11
that O 0 2.1183995855232618e-13
the O 0 4.2007647360620126e-11
mutant O 0 3.1828317759163838e-09
minigene O 0 9.105035303491604e-08
was O 0 1.0616811874086807e-09
responsible O 0 1.1625039125773284e-10
for O 0 9.823530183750151e-11
a O 0 3.41566858130804e-10
mRNA O 0 6.762891580081032e-09
species O 0 3.536271969695193e-11
alternatively O 0 6.929457702087305e-11
spliced O 0 8.355274250249067e-10
at O 0 8.188185129931469e-10
an O 0 3.71690421496762e-11
activated O 0 1.3431641718852916e-06
cryptic O 0 6.658057714048482e-07
5 O 0 1.9462245148815782e-08
splice O 0 5.946904479969817e-07
site O 0 1.0809671380229702e-07
88 O 0 1.818917922946639e-07
bp O 0 9.541354373254762e-09
upstream O 0 3.2672096139663154e-09
from O 0 1.4887438504196382e-10
the O 0 3.26709576059514e-10
3 O 0 1.903436075423315e-09
end O 0 3.200113507517699e-09
of O 0 1.853522846317901e-08
exon O 0 1.0479286629561102e-06
6 O 0 2.600155539767002e-07
. O 0 4.807543874107978e-08

Our O 0 9.100121189931087e-08
data O 0 2.016073974431265e-09
suggest O 0 4.3978001795785815e-10
that O 0 2.2708577639835026e-12
the O 0 3.3077202088449553e-10
C O 0 3.909449048933311e-07
to O 0 8.121066319421999e-11
A O 0 7.510104205188384e-10
mutation O 0 1.4716126928160378e-10
at O 0 1.4905508771700937e-10
the O 0 5.173498088262285e-11
penultimate O 0 1.0028786334714823e-07
nucleotide O 0 9.150361024445886e-10
of O 0 1.8955741420967342e-09
exon O 0 9.352114638261355e-09
6 O 0 1.2016962980254675e-09
of O 0 4.1894604452252793e-10
the O 0 2.357991357726519e-09
CYP27 O 0 6.493719411082566e-05
gene O 0 2.872059812197847e-10
not O 0 1.5137831960165826e-11
only O 0 7.623654485477971e-11
causes O 0 3.5693512590029286e-09
the O 0 2.0006833523211753e-08
deficiency B-Disease 0 9.321369134340785e-07
in I-Disease 0 2.775321084058646e-09
the I-Disease 0 3.2734348565099936e-09
sterol I-Disease 0 1.8677523883070535e-07
27 I-Disease 0 2.2129247767566085e-08
- I-Disease 0 6.976650368528681e-09
hydroxylase I-Disease 0 1.2391151926749444e-07
activity I-Disease 0 1.7768220228475684e-09
, O 0 1.5341504108756787e-11
but O 0 5.956068971357809e-11
also O 0 5.116688669981606e-11
partially O 0 1.3407016608013578e-09
leads O 0 7.936484108794772e-11
to O 0 7.49109801967407e-12
alternative O 0 1.7730507062552192e-09
pre O 0 1.673704019822253e-08
- O 0 8.499388970406585e-10
mRNA O 0 2.570048063255115e-10
splicing O 0 1.651186409823424e-10
of O 0 5.282453641175522e-11
the O 0 3.091065459148723e-10
gene O 0 1.6849779349570326e-09
. O 0 1.1166745750301743e-08

To O 0 2.0992590776813813e-08
our O 0 5.916061862620836e-09
knowledge O 0 3.5103426831994966e-09
, O 0 1.1275516978437317e-11
this O 0 1.875160400219289e-12
is O 0 1.864717148053474e-12
the O 0 1.9714216370481097e-11
first O 0 7.008773422745307e-11
report O 0 1.6944742484148456e-11
regarding O 0 9.769535180836897e-10
effects O 0 1.5965380129046025e-09
on O 0 2.9857309957748157e-09
pre O 0 4.044367685196448e-08
- O 0 1.6793215706911724e-09
mRNA O 0 1.1022437823582365e-10
splicing O 0 9.70001301503487e-11
of O 0 2.6802254859958907e-11
a O 0 1.4032305048830573e-12
mutation O 0 2.98325578650116e-12
at O 0 2.9468483209171836e-11
the O 0 8.687112140748354e-11
- O 0 2.5873374553953e-09
2 O 0 1.2809960869830661e-09
position O 0 2.712984559227749e-10
of O 0 1.9939308537608724e-10
a O 0 8.36129998571522e-10
5 O 0 2.47066491709802e-08
splice O 0 5.794526600766403e-07
site O 0 9.500679709617543e-08
. O 0 2.886550376501873e-08

ATM O 0 0.0014883929397910833
germline O 0 5.187553324503824e-05
mutations O 0 8.280652252778964e-08
in O 0 1.8013672775651912e-09
classical O 0 0.0015228914562612772
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 4.1533652073155736e-09
the O 0 1.8155924541574109e-09
Dutch O 0 5.732887302656309e-07
population O 0 3.490578104337061e-10
. O 0 3.393533010154215e-09

Germline O 0 0.0013672442873939872
mutations O 0 5.034353307564743e-07
in O 0 3.843704465822384e-09
the O 0 3.6661849112107348e-09
ATM O 0 1.9102243697943777e-07
gene O 0 5.062597563387783e-11
are O 0 2.344313708001894e-13
responsible O 0 6.496394676543116e-13
for O 0 7.496443570065292e-12
the O 0 4.139875090913847e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.0933794328593649e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.441872812956717e-08
. O 0 3.0377245252566354e-07

In O 0 1.2229061496782379e-07
our O 0 2.831344270148861e-09
study O 0 2.6112523254795406e-10
, O 0 7.409983217299132e-12
we O 0 2.2683901198389256e-12
have O 0 1.790372537724405e-12
determined O 0 1.7864142110024517e-10
the O 0 7.439560079092189e-10
ATM O 0 2.0175527026822238e-07
mutation O 0 1.452311937377715e-09
spectrum O 0 3.250769964324718e-08
in O 0 1.398321319845408e-10
19 O 0 9.864975503148798e-10
classical O 0 4.2531030430836836e-07
A B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.3668841246690135e-06
, O 0 2.192560369373986e-12
including O 0 9.895169536186521e-13
some O 0 8.800832458633057e-12
immigrant O 0 5.220764376367981e-10
populations O 0 1.9131449896514496e-11
, O 0 9.613069888725345e-13
as O 0 1.0722645861493962e-11
well O 0 5.065794658754008e-11
as O 0 7.198572987698881e-11
12 O 0 1.4336894171851355e-10
of O 0 1.4421695782029786e-10
Dutch O 0 6.52571827686188e-08
ethnic O 0 2.587770553397206e-10
origin O 0 6.4065073246410975e-09
. O 0 2.1166199459798918e-08

Both O 0 2.2225012941134992e-08
the O 0 4.1782031168224876e-09
protein O 0 1.0198488720192245e-09
truncation O 0 1.0417949880547894e-07
test O 0 1.024324319587322e-06
( O 0 1.9853552135629116e-09
PTT O 0 7.247082294270513e-07
) O 0 6.072869290774108e-11
and O 0 5.010998907484243e-11
the O 0 8.776211701810865e-11
restriction O 0 1.3838200807470002e-08
endonuclease O 0 3.2477583999934723e-07
fingerprinting O 0 6.686169626846095e-07
( O 0 6.652238759841111e-10
REF O 0 1.0311105143046007e-06
) O 0 2.1769516744818418e-11
method O 0 7.100475762911174e-10
were O 0 1.3221426731213626e-10
used O 0 4.394167668619886e-11
and O 0 3.315791391456102e-11
compared O 0 8.128509532134842e-10
for O 0 4.617933813122477e-11
their O 0 4.0826023117723764e-11
detection O 0 2.3759325618044613e-09
efficiency O 0 1.3559782630068185e-08
, O 0 2.1834178562385453e-11
identifying O 0 3.4788139036123766e-10
76 O 0 6.5289285089420446e-09
% O 0 1.9645224683118023e-11
and O 0 5.493330183098388e-12
60 O 0 5.585537588004286e-11
% O 0 4.736341527311616e-12
of O 0 4.865505220941202e-11
the O 0 2.019722611379393e-09
mutations O 0 4.2805998745620855e-09
, O 0 1.0326187682707655e-09
respectively O 0 1.1047899306504405e-07
. O 0 1.9777732518377888e-07

Most O 0 9.988217470890959e-07
patients O 0 7.490118605346652e-07
were O 0 6.1770810688699385e-09
found O 0 1.842228314341554e-10
to O 0 8.451776778439779e-11
be O 0 1.163032448125989e-09
compound O 0 3.744208925127168e-06
heterozygote O 0 0.00015431524661835283
. O 0 4.7007299031065486e-07

Seventeen O 0 1.1822353371826466e-05
mutations O 0 7.282924485707554e-08
were O 0 9.276593715412673e-09
distinct O 0 3.84571957612323e-10
, O 0 2.675582845557134e-11
of O 0 1.9987132782173234e-10
which O 0 3.4235652507375036e-11
10 O 0 2.351316363835565e-10
were O 0 3.1532698674396897e-10
not O 0 4.70928400442272e-11
reported O 0 9.437836068215688e-10
previously O 0 1.2229186552303872e-08
. O 0 6.885726122618507e-08

Mutations O 0 8.541733222955372e-06
are O 0 9.211550633381194e-09
small O 0 1.0176322895460999e-08
deletions O 0 4.011176883977896e-07
or O 0 3.2582070730313717e-07
point O 0 4.3841060687555e-05
mutations O 0 4.1859823340928415e-07
frequently O 0 4.475981185692035e-08
affecting O 0 3.814690217041061e-07
splice O 0 3.5323020711075515e-05
sites O 0 1.436465709048207e-06
. O 0 4.6564241529267747e-07

Moreover O 0 1.002667977445526e-05
, O 0 1.860862397506935e-08
a O 0 1.570306373821495e-08
16 O 0 5.810651941828837e-07
. O 0 3.7355735571509285e-07

7 O 0 1.0737165212049149e-05
- O 0 3.7022537071607076e-06
kb O 0 4.761486707138829e-06
genomic O 0 5.413789594399532e-08
deletion O 0 1.1670660882145967e-08
of O 0 1.9515288940397113e-08
the O 0 3.3880873662184285e-09
3 O 0 2.7929938362092344e-09
end O 0 8.635310244642369e-10
of O 0 1.0016637519427718e-09
the O 0 3.8482728115241116e-10
gene O 0 5.0834104287078574e-11
, O 0 6.49201309030345e-12
most O 0 2.1033199487652254e-11
likely O 0 2.0876336770392356e-10
a O 0 1.107792677035313e-11
result O 0 1.2793276160660838e-10
of O 0 6.272940500373636e-10
recombination O 0 2.1894451529558268e-10
between O 0 9.75904496103297e-11
two O 0 7.822566205906156e-11
LINE O 0 5.890600505153998e-07
elements O 0 3.2559372975526912e-09
, O 0 2.9036986703978585e-10
was O 0 6.36524166708341e-09
identified O 0 1.461382392875521e-08
. O 0 1.8574406013271982e-08

The O 0 5.230522788224334e-07
most O 0 1.1283343148704716e-08
frequently O 0 9.386315058534933e-10
found O 0 5.7667884356682464e-11
mutation O 0 7.074193314471344e-11
, O 0 1.1525550479285496e-11
identified O 0 9.355567015534305e-11
in O 0 1.1696968393870577e-10
three O 0 7.595366696699912e-11
unrelated O 0 3.1313951431855003e-09
Turkish O 0 1.0615627132892769e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 5.589150323115355e-11
, O 0 2.9622933880174562e-12
was O 0 4.496185021518606e-11
previously O 0 2.1650922374383264e-11
described O 0 7.701138338145341e-12
to O 0 2.143003873314453e-12
be O 0 7.185962328654094e-12
a O 0 2.496330225865151e-11
Turkish O 0 5.7513535267617044e-08
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999986886978149
T I-Disease 1 1.0
founder O 0 5.6105318435584195e-06
mutation O 0 9.308695325671579e-08
. O 0 1.955418937882314e-08

The O 0 8.031044274048327e-08
presence O 0 3.1265015021375575e-09
of O 0 1.8960450987037802e-08
a O 0 1.3931633624508777e-08
founder O 0 1.4199632687450503e-06
mutation O 0 1.6667241808931976e-08
among O 0 9.620733099069412e-10
relatively O 0 3.526796354957895e-10
small O 0 1.095458793121118e-11
ethnic O 0 2.4484797869761543e-12
population O 0 9.21646981823232e-13
groups O 0 3.2000031964518616e-13
in O 0 3.636941442453079e-12
Western O 0 2.189980863320784e-09
Europe O 0 2.557544176440274e-10
could O 0 4.371421627458183e-11
indicate O 0 9.74808705977992e-11
a O 0 1.4667361075693108e-11
high O 0 4.667338737718296e-10
carrier O 0 8.371126014594665e-11
frequency O 0 1.0034895137067679e-10
in O 0 4.0397123146629355e-11
such O 0 4.899555205994943e-10
communities O 0 4.4280872302238095e-09
. O 0 3.3739983251734884e-08

In O 0 2.5558748006915266e-07
patients O 0 2.2500965712879406e-07
of O 0 5.162404281833233e-09
Dutch O 0 4.015607828478096e-06
ethnic O 0 3.134788262304511e-10
origin O 0 3.4227640166584195e-10
, O 0 3.5392459362543205e-12
however O 0 5.160892893596447e-11
, O 0 3.3144743460250536e-12
no O 0 7.960979965526693e-12
significant O 0 6.367399385531769e-10
founder O 0 1.7416553532711987e-08
effect O 0 4.6537311781946755e-09
could O 0 1.9836670084316665e-09
be O 0 1.856798492738676e-09
identified O 0 2.8511367489159056e-08
. O 0 7.317944294982226e-08

The O 0 1.7622517134441296e-07
observed O 0 6.434075316974486e-08
genetic O 0 1.1591596127402681e-08
heterogeneity O 0 3.290582384352092e-08
including O 0 7.589303074873044e-10
the O 0 1.5052881163768461e-09
relative O 0 2.998954187205527e-07
high O 0 5.481566063281207e-07
percentage O 0 8.493105774221021e-09
of O 0 6.806147867521872e-10
splice O 0 3.6119140531809535e-06
- O 0 1.7441738009438268e-06
site O 0 1.4533468117861048e-07
mutations O 0 1.4177278240268265e-09
had O 0 1.9653478844361416e-10
no O 0 6.230558430297961e-11
reflection O 0 1.4904207867871833e-09
on O 0 3.3094573748115863e-09
the O 0 9.220709529245141e-09
phenotype O 0 6.971823722778936e-07
. O 0 7.322090311845386e-08

All O 0 1.2271949856312858e-07
patients O 0 4.916278939504082e-08
manifested O 0 2.3693628392607025e-08
classical O 0 1.8858149815059733e-06
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.9999983310699463
T I-Disease 1 1.0
and O 0 2.0538071243692002e-09
increased O 0 6.056426915534985e-09
cellular O 0 1.769453739086657e-08
radioresistant O 0 2.0503352970990818e-07
DNA O 0 2.4227116313113584e-08
synthesis O 0 1.0317868515130613e-07
. O 0 6.506355276769682e-08

Determination O 0 7.624994964317011e-07
of O 0 1.6948646930359246e-08
the O 0 1.7528853923920451e-09
genomic O 0 1.784882464050952e-09
structure O 0 1.0697979169194127e-09
of O 0 7.640427734934008e-10
the O 0 3.785853408544426e-09
COL4A4 O 0 0.14472880959510803
gene O 0 1.159125795346938e-09
and O 0 1.4236199892547763e-11
of O 0 7.196297446832034e-10
novel O 0 4.326205953475437e-07
mutations O 0 4.3227868218309595e-07
causing O 0 1.0703804946388118e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.071024785749614e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.11042741668399e-09
a O 0 4.226194671996808e-10
progressive O 0 3.507332439767197e-05
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0077390605583786964
by O 0 1.3436097106023226e-05
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999998807907104
membrane I-Disease 0 1.9785704807873117e-06
abnormalities I-Disease 0 6.211878371686907e-07
and O 0 3.612057597468521e-10
associated O 0 4.083392735054758e-09
with O 0 9.231914122054263e-10
mutations O 0 8.30446911237459e-09
in O 0 4.448148960278786e-09
either O 0 1.6950318926234331e-09
the O 0 9.776958798113355e-09
COL4A3 O 1 0.999756395816803
or O 0 6.00274230322384e-09
the O 0 2.283479716425063e-08
COL4A4 O 0 0.0013593968469649553
gene O 0 4.2275971612326657e-10
, O 0 4.361142523501282e-12
which O 0 2.370980798846456e-12
encode O 0 8.320537314698839e-11
the O 0 4.3510436920080053e-10
alpha3 O 0 5.753437335442868e-07
and O 0 2.0421004887083427e-09
alpha4 O 0 4.320390416978626e-06
type O 0 8.641678505227901e-06
IV O 1 1.0
collagen O 0 6.50462752673775e-05
chains O 0 6.04155786732008e-07
, O 0 2.515705421757275e-09
respectively O 0 8.793818295771416e-08
. O 0 9.395134981105002e-08

To O 0 3.9588323730299635e-09
date O 0 1.3040632040883793e-07
, O 0 2.907045715261347e-10
mutation O 0 9.615719331890205e-11
screening O 0 3.256924729910793e-09
in O 0 4.4224798823044864e-10
the O 0 2.4800024256421693e-09
two O 0 3.610294563305416e-10
genes O 0 4.352737059676315e-10
has O 0 7.974444889147225e-12
been O 0 4.781637932826932e-11
hampered O 0 2.8485393954724714e-07
by O 0 5.462721386351177e-10
the O 0 3.4316949282242604e-09
lack O 0 1.8798408163434033e-08
of O 0 7.886374886467706e-10
genomic O 0 1.7904879801022844e-09
structure O 0 1.0005487549591408e-09
information O 0 1.0123371030346107e-09
. O 0 1.5645007067632832e-08

We O 0 1.7369941929246124e-08
report O 0 4.96124474835824e-10
here O 0 1.4808199111371323e-10
the O 0 3.615046803573385e-11
complete O 0 8.261299283551793e-11
characterization O 0 1.4434416995001698e-09
of O 0 8.89058104913687e-10
the O 0 1.2087765233204095e-09
48 O 0 4.1618424262424014e-09
exons O 0 8.935019391032029e-10
of O 0 3.3826358381006116e-10
the O 0 5.21886533988436e-09
COL4A4 O 0 0.3197579085826874
gene O 0 3.1962399393847818e-09
, O 0 2.9481639352013644e-11
a O 0 3.193457651096132e-11
comprehensive O 0 7.771208565543475e-09
gene O 0 1.508477648348716e-10
screen O 0 1.525919279821153e-09
, O 0 1.509754994633017e-11
and O 0 5.702720847627907e-12
the O 0 5.464050219228245e-12
subsequent O 0 3.5579626050941116e-11
detection O 0 6.665549223683342e-10
of O 0 1.222502238329426e-10
10 O 0 2.0412427303995173e-10
novel O 0 1.0830650820636833e-09
mutations O 0 1.3104782536910164e-10
in O 0 5.017224830039524e-11
eight O 0 2.2060795412670586e-09
patients O 0 2.498318565358204e-07
diagnosed O 0 1.2918517313664779e-05
with O 0 7.82691131462343e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.7545526134199463e-05

Furthermore O 0 7.740781029497157e-07
, O 0 4.4659334008656515e-09
we O 0 5.980557715723478e-10
identified O 0 8.39458613732802e-10
a O 0 9.210311679996863e-11
glycine O 0 6.094295734726529e-09
to O 0 3.113841684498908e-10
alanine O 0 1.2939847415793793e-08
substitution O 0 9.449225331081834e-07
in O 0 1.626178125491151e-08
the O 0 8.929605499474746e-09
collagenous O 0 6.251094646358979e-07
domain O 0 3.390225322696949e-10
that O 0 7.36230629412582e-13
is O 0 2.6128840844436008e-12
apparently O 0 3.1907379516304957e-10
silent O 0 7.742797514254107e-10
in O 0 1.9114525934282867e-11
the O 0 8.979554599886086e-11
heterozygous O 0 3.948333326952991e-10
carriers O 0 7.025104942215421e-10
, O 0 3.3184611308856304e-11
in O 0 5.071210673612825e-10
11 O 0 1.8823632430553516e-08
. O 0 6.825784737429785e-08

5 O 0 1.7677119501513516e-07
% O 0 8.047781330233761e-10
of O 0 2.4823013089481094e-10
all O 0 2.0261447034042313e-11
control O 0 4.071258885574025e-10
individuals O 0 1.1865898888463455e-11
, O 0 2.7879878961023508e-11
and O 0 1.063563612180296e-10
in O 0 5.376573630755388e-10
one O 0 8.001996287809732e-11
control O 0 2.404910159903295e-10
individual O 0 2.1020045079533922e-11
homozygous O 0 4.414960064202944e-11
for O 0 1.1728148834044827e-11
this O 0 1.1955549050757242e-10
glycine O 0 1.543362415645788e-08
substitution O 0 1.2995767519896617e-06
. O 0 6.19588092831691e-07

There O 0 3.020644712137255e-08
has O 0 1.7808247931849763e-10
been O 0 3.8632735899213344e-11
no O 0 2.3900565554457742e-11
previous O 0 1.6375190092787761e-09
finding O 0 1.871639954131865e-09
of O 0 2.488397543576326e-10
a O 0 4.328576039269727e-11
glycine O 0 2.787680919436042e-10
substitution O 0 1.6642273337197366e-08
that O 0 8.756911862306538e-12
is O 0 8.963032139402971e-13
not O 0 4.0094717910360567e-13
associated O 0 9.342972576154018e-12
with O 0 1.4597914890779329e-12
any O 0 1.1329027299611383e-10
obvious O 0 1.4656141189561822e-08
phenotype O 0 2.974137558453549e-08
in O 0 3.4356359424059235e-10
homozygous O 0 5.620263809902326e-09
individuals O 0 1.6845594363879002e-10
. O 0 9.772446851741279e-09

Founder O 1 0.7484772801399231
BRCA1 O 0 0.00039221940096467733
and O 0 8.847037520354206e-07
BRCA2 O 0 2.4378662146773422e-06
mutations O 0 2.9046640648289213e-09
in O 0 2.1984589149148803e-10
French O 0 8.45135303961797e-08
Canadian O 0 1.7623235180508345e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7521745121484855e-06
. O 0 3.9131307971729257e-07

We O 0 2.9302290371902018e-08
have O 0 5.484342979755752e-10
identified O 0 1.5892764881897392e-09
four O 0 1.7302437260724446e-10
mutations O 0 1.2380668712452803e-10
in O 0 2.5922201885020257e-11
each O 0 8.7314279070827e-12
of O 0 2.218299099965293e-09
the O 0 3.702235972014023e-06
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9989249110221863
- O 1 0.9861569404602051
susceptibility O 1 0.9761896133422852
genes O 0 1.4657670988071914e-07
, O 0 1.7079547776077675e-09
BRCA1 O 0 4.7315477758047564e-08
and O 0 1.1346680262036557e-09
BRCA2 O 0 1.2187364895055453e-08
, O 0 1.9994813096890773e-12
in O 0 4.737407948568473e-12
French O 0 1.3752783356579812e-09
Canadian O 0 6.959800202821498e-08
breast B-Disease 0 2.0439607396838255e-05
cancer I-Disease 0 3.2283671771438094e-06
and O 0 1.6339779904228635e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.9774802240135614e-08
from O 0 3.457937269857325e-09
Quebec O 0 2.524484443711117e-07
. O 0 4.927628793893746e-08

To O 0 1.7446650701913313e-07
identify O 0 6.851695957266202e-07
founder O 0 1.3667766324942932e-05
effects O 0 1.4272200132836588e-05
, O 0 5.807547331926344e-09
we O 0 6.221156922947557e-10
examined O 0 8.31619839658515e-09
independently O 0 2.5738497444471875e-10
ascertained O 0 5.563568095112714e-08
French O 0 7.01783946510659e-08
Canadian O 0 4.157544992722251e-07
cancer B-Disease 0 8.033355243242113e-07
families O 0 2.4877601714767827e-11
for O 0 3.917140049825019e-12
the O 0 3.313407534455415e-11
distribution O 0 1.5920852136641628e-10
of O 0 7.295443693600134e-10
these O 0 1.6916922307430582e-09
eight O 0 1.54381289974026e-08
mutations O 0 1.060764809324155e-08
. O 0 5.0483631497399983e-08

Mutations O 0 3.9725708234072954e-07
were O 0 1.32543149788944e-08
found O 0 2.41946740420218e-10
in O 0 1.7459174384004683e-10
41 O 0 9.016788204974091e-09
of O 0 5.362688515475611e-09
97 O 0 7.978307621669956e-06
families O 0 1.2983878860950426e-08
. O 0 4.338037840057041e-08

Six O 0 1.954095836254055e-07
of O 0 2.0526178090563008e-08
eight O 0 7.533291324079983e-09
mutations O 0 1.2203409394118125e-09
were O 0 5.028503724524569e-10
observed O 0 6.20752560465121e-10
at O 0 2.490449846348497e-09
least O 0 1.396869175884774e-09
twice O 0 3.360947076203047e-08
. O 0 9.182539884022844e-08

The O 0 8.960001650848426e-06
BRCA1 O 0 8.056393198785372e-06
C4446T O 0 5.02556940773502e-06
mutation O 0 1.5607273695650292e-08
was O 0 1.2269739668724355e-09
the O 0 1.0846004649955887e-10
most O 0 3.5409831317112506e-11
common O 0 2.4392529662797813e-10
mutation O 0 1.143651770507681e-10
found O 0 2.890402327204722e-11
, O 0 2.8401345945200385e-12
followed O 0 1.2197630405719195e-10
by O 0 6.529198848248541e-10
the O 0 1.1043223224760368e-07
BRCA2 O 0 3.0896976568328682e-06
8765delAG O 0 1.1569748039619299e-06
mutation O 0 9.268833167652701e-08
. O 0 3.1645583931094734e-08

Together O 0 2.5658488311819383e-07
, O 0 2.5163437999964344e-09
these O 0 3.651903779378074e-10
mutations O 0 7.075465768835443e-10
were O 0 1.1382553788408245e-09
found O 0 1.3431529499730033e-10
in O 0 7.002372987008343e-11
28 O 0 3.1528206712039264e-09
of O 0 1.9581125609846595e-09
41 O 0 2.1415454298789882e-08
families O 0 3.9974263482678296e-11
identified O 0 3.5199669567997915e-11
to O 0 2.653151483233973e-11
have O 0 1.3466826265240428e-10
a O 0 2.492360096084667e-09
mutation O 0 1.5285409915577475e-07
. O 0 1.2118964320961823e-07

The O 0 1.5613755977028632e-07
odds O 0 1.4491753574930044e-07
of O 0 4.2383194176487393e-10
detection O 0 4.6913761764244555e-09
of O 0 3.980484830634623e-10
any O 0 9.625188146511476e-11
of O 0 6.112724104667677e-09
the O 0 3.277484594832458e-08
four O 0 1.54538906116386e-08
BRCA1 O 0 4.703070644040963e-08
mutations O 0 9.614807838786987e-10
was O 0 4.264643305162963e-09
18 O 0 2.155149481097851e-08
. O 0 9.473319551034365e-08

7x O 0 0.0006381563143804669
greater O 0 2.219087775756634e-07
if O 0 6.140524089204291e-09
one O 0 4.487671068087451e-10
or O 0 4.829907307435377e-11
more O 0 5.703297643183669e-12
cases O 0 7.019225756188519e-10
of O 0 0.09014227986335754
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 9.03693297971131e-09
also O 0 3.9217075767372656e-12
present O 0 1.2168555225955391e-11
in O 0 1.3094338113806003e-10
the O 0 2.6958810739330374e-09
family O 0 1.8572660076543457e-09
. O 0 1.4457294028602519e-08

The O 0 1.761527528287843e-07
odds O 0 1.76099675286423e-07
of O 0 5.221600929417036e-10
detection O 0 1.087066170413209e-08
of O 0 8.784590277421955e-10
any O 0 1.9745234614010343e-10
of O 0 5.079442200184303e-09
the O 0 2.6930971230854084e-08
four O 0 4.457952940128962e-08
BRCA2 O 0 8.464095344606903e-07
mutations O 0 2.0784132193085725e-09
was O 0 2.2613274808236383e-08
5 O 0 6.601243995874029e-08
. O 0 5.857633667005757e-08

3x O 0 3.582504177757073e-06
greater O 0 1.1660737264662657e-08
if O 0 2.042469526841728e-10
there O 0 9.703084863366129e-11
were O 0 2.5696411665165897e-10
at O 0 1.4316044183448895e-10
least O 0 3.291460853871442e-12
five O 0 1.2080832211339154e-12
cases O 0 1.842143104724414e-11
of O 0 1.5008167153496288e-08
breast B-Disease 1 0.999362051486969
cancer I-Disease 0 5.753685763920657e-05
in O 0 4.549197907266489e-09
the O 0 3.626820799240704e-08
family O 0 2.17142193115194e-09
. O 0 1.355745560260857e-08

Interestingly O 0 1.8217699562228518e-06
, O 0 2.606680649108739e-09
the O 0 6.034446276004246e-10
presence O 0 4.8555143239426e-10
of O 0 1.6014245929341087e-08
a O 0 1.5948518239383702e-07
breast B-Disease 1 0.6507334113121033
cancer I-Disease 0 1.2198119065942592e-06
case O 0 8.995814759771292e-09
< O 0 5.762487376159697e-08
36 O 0 1.794043358316344e-09
years O 0 3.498107706279008e-11
of O 0 3.962446690208843e-11
age O 0 6.097803928462042e-10
was O 0 1.0381932813441352e-10
strongly O 0 8.020572921096925e-12
predictive O 0 1.3746796756475277e-10
of O 0 5.668920888268758e-11
the O 0 1.8148012606578057e-11
presence O 0 3.028611649663615e-12
of O 0 6.8489068583144075e-12
any O 0 1.4425952619967486e-11
of O 0 5.177330786310108e-10
the O 0 2.9234448195580853e-09
eight O 0 4.6070645076667915e-09
mutations O 0 2.202228621683844e-09
screened O 0 9.71067066757314e-08
. O 0 4.538574671641982e-08

Carriers O 0 3.4123874570468615e-07
of O 0 1.6491515708594306e-08
the O 0 2.625627271157782e-09
same O 0 5.892488719183575e-10
mutation O 0 1.353692435923648e-10
, O 0 1.2848212077587462e-12
from O 0 6.98388265621408e-12
different O 0 2.1806086450415485e-11
families O 0 1.637292558476222e-11
, O 0 6.023377543268316e-12
shared O 0 6.142977793111015e-11
similar O 0 2.2485771578040215e-10
haplotypes O 0 1.1436486424543091e-08
, O 0 5.651313098042898e-11
indicating O 0 2.7720395423536104e-10
that O 0 3.1987110443026934e-12
the O 0 2.1322260623790612e-10
mutant O 0 1.1899228269385276e-09
alleles O 0 1.0308490172583618e-10
were O 0 1.6167188421345458e-10
likely O 0 1.0919672110976109e-10
to O 0 7.031063665313697e-12
be O 0 9.87477287439642e-12
identical O 0 1.1935681609731574e-10
by O 0 2.5257995348026974e-11
descent O 0 3.629987144204705e-10
for O 0 1.3200857941486621e-11
a O 0 1.943072612531349e-11
mutation O 0 1.5194566438392343e-10
in O 0 7.203146412670947e-11
the O 0 2.1769497315915487e-09
founder O 0 1.1534203991914183e-07
population O 0 3.0315680521475485e-10
. O 0 7.496083753721905e-09

The O 0 5.151525428459536e-09
identification O 0 5.809430714265318e-09
of O 0 9.353417596003055e-09
common O 0 2.2346202968037687e-05
BRCA1 O 0 0.0008029646123759449
and O 0 8.272433547062974e-07
BRCA2 O 0 1.6201121297854115e-06
mutations O 0 6.961413667738725e-10
will O 0 8.998219704070554e-12
facilitate O 0 1.3991616198971712e-10
carrier O 0 1.6932634461230833e-10
detection O 0 2.385559305650986e-09
in O 0 1.2449220820887064e-10
French O 0 5.3128662358403744e-08
Canadian O 0 3.821616019195062e-07
breast B-Disease 0 5.3251555073074996e-05
cancer I-Disease 0 7.869552064221352e-06
and O 0 2.7931775548495352e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.088522942424788e-08
. O 0 1.5918136142545336e-08

Are O 0 1.1094694229996094e-07
Dp71 O 0 0.0001455267920391634
and O 0 9.374335263601097e-08
Dp140 O 0 7.321050361497328e-05
brain O 0 2.0549073269648943e-06
dystrophin O 0 1.0968468814098742e-05
isoforms O 0 8.138753742059635e-07
related O 0 4.4555389422384906e-07
to O 0 9.760879216003104e-09
cognitive B-Disease 0 0.0005614249967038631
impairment I-Disease 1 0.9999997615814209
in O 1 0.9996391534805298
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999980926513672

Molecular O 0 1.7905268805407104e-06
study O 0 7.768422349840876e-09
and O 0 9.820234209145795e-11
neuropsychological O 0 2.637886709067061e-08
analysis O 0 5.38759925561294e-10
were O 0 7.971548421359387e-10
performed O 0 1.0113927750854401e-10
concurrently O 0 2.0485010909787604e-10
on O 0 5.097328781289434e-09
49 O 0 4.9178169092556345e-08
patients O 0 1.2771876356509893e-07
with O 0 3.903729606236084e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0002582835440989584
DMD B-Disease 1 1.0
) O 0 1.1071953770480647e-10
in O 0 1.9534103501417377e-11
order O 0 2.2826227019656642e-11
to O 0 3.7415270534579825e-12
find O 0 1.140194622745172e-11
a O 0 5.950361731121845e-13
molecular O 0 3.2174488767688914e-11
explanation O 0 4.067003678276393e-11
for O 0 1.3969130539803754e-11
the O 0 2.2156310119925138e-09
cognitive B-Disease 0 1.632222506486869e-06
impairment I-Disease 0 2.7680277980834944e-06
observed O 0 1.6488151288740482e-08
in O 0 8.318038702270769e-09
most O 0 1.4745130272331153e-07
DMD B-Disease 1 1.0
patients O 1 0.9741966724395752
. O 0 8.406504434788076e-07

Complete O 0 3.8843744221139787e-08
analysis O 0 2.3568313967103904e-09
of O 0 4.270340969725339e-09
the O 0 1.0893305812942344e-08
dystrophin O 0 1.9756514575419715e-06
gene O 0 9.777928688947668e-09
was O 0 1.2514751013270597e-08
performed O 0 4.032263134501335e-10
to O 0 2.2982230701851236e-11
define O 0 8.273209339826337e-10
the O 0 6.326771329057124e-10
localization O 0 4.049747914791624e-08
of O 0 2.4057695835466575e-09
deletions O 0 2.57479393361848e-09
and O 0 1.9617976687591465e-10
duplications O 0 6.616683645432886e-09
in O 0 2.2102565611081815e-10
relation O 0 5.325451191140473e-10
to O 0 8.338362639248587e-11
the O 0 3.6437792783061695e-09
different O 0 6.543017150306696e-08
DMD B-Disease 1 1.0
promoters O 0 0.02373676747083664
. O 0 1.2983651913600625e-06

Qualitative O 0 4.154746591211733e-07
analysis O 0 6.3832596985946566e-09
of O 0 4.438295064801423e-08
the O 0 1.8665024015263043e-07
Dp71 O 0 0.00025974775780923665
transcript O 0 3.5916571050620405e-08
and O 0 1.8480342256488314e-11
testing O 0 8.227585279740879e-11
for O 0 4.665277712756488e-12
the O 0 2.0158258742797308e-11
specific O 0 5.649664069906635e-11
first O 0 6.055268508831091e-10
exon O 0 4.849278312235583e-09
of O 0 9.799208111616053e-10
Dp140 O 0 6.622746013817959e-07
were O 0 6.327403045958135e-09
also O 0 1.1639394309481688e-10
carried O 0 8.616718449871996e-10
out O 0 7.085512732096788e-10
. O 0 1.1292557999809105e-08

Neuropsychological O 0 3.505168933770619e-05
analysis O 0 5.173880879283388e-08
assessed O 0 1.7477736946602818e-06
verbal O 0 1.029300847221748e-06
and O 0 2.0394741895302104e-08
visuospatial O 0 2.3877446437836625e-06
intelligence O 0 4.276250464840814e-09
, O 0 1.2602127119620832e-09
verbal O 0 8.544752745365258e-07
memory O 1 0.9999005794525146
, O 0 3.1720457371875455e-08
and O 0 2.4792942809881424e-08
reading O 0 0.0001649269979679957
skills O 0 2.755409013843746e-06
. O 0 9.676115553247655e-08

Comparison O 0 1.5230683629852138e-06
of O 0 1.1211204054006885e-07
molecular O 0 6.234632792256889e-07
and O 0 6.352215642380088e-09
psychometric O 0 5.6747885537333786e-05
findings O 0 3.0164540021360153e-07
demonstrated O 0 6.507025318569504e-08
that O 0 6.385444950574026e-11
deletions O 0 1.1076126682496579e-08
and O 0 8.979713084222851e-10
duplications O 0 1.3928286968223347e-08
that O 0 2.6328609431525152e-11
were O 0 1.187899889565358e-09
localized O 0 6.105266958655875e-09
in O 0 3.004283766205873e-10
the O 0 8.574076448830681e-10
distal O 0 7.702872295567431e-08
part O 0 6.227974580497175e-09
of O 0 7.903895493655e-08
the O 0 7.093687059978038e-08
gene O 0 3.562590666916776e-09
seemed O 0 9.859769889430936e-09
to O 0 9.931116692896147e-12
be O 0 1.707816180140931e-11
preferentially O 0 1.1955966217058744e-09
associated O 0 7.581403282941324e-10
with O 0 1.1333117777567736e-09
cognitive B-Disease 0 0.00040708601591177285
impairment I-Disease 1 0.9992296695709229
. O 0 5.013712143409066e-05

Two O 0 2.940055026101618e-07
altered O 0 2.660042127899942e-06
Dp71 O 0 0.0008385995752178133
transcripts O 0 2.2861634079163196e-06
and O 0 6.942866725978547e-09
two O 0 8.437155973872734e-10
deleted O 0 1.1520952192256573e-08
Dp140 O 0 1.0253617688249506e-07
DNA O 0 5.78998071709691e-10
sequences O 0 1.818820961896339e-11
were O 0 3.654856625678882e-11
found O 0 5.63526135477499e-12
in O 0 1.659850208668434e-11
four O 0 9.305772125101086e-11
patients O 0 4.513459828103805e-09
with O 0 5.350527798597682e-10
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.00047689079656265676

These O 0 2.836927990301774e-07
findings O 0 4.087345217840266e-08
suggest O 0 4.4958121669935736e-09
that O 0 9.79882494589468e-12
some O 0 2.1015874804297674e-11
sequences O 0 2.113381344925891e-11
located O 0 1.4690101912684383e-10
in O 0 4.2041797126968206e-11
the O 0 7.888300568303919e-10
distal O 0 9.01627643656866e-08
part O 0 8.71696315130066e-09
of O 0 5.676655234765349e-08
the O 0 4.7971728811546654e-09
gene O 0 7.394061751764269e-11
and O 0 1.8203272222905298e-11
, O 0 2.0257768986592373e-12
in O 0 3.5226786765374385e-12
particular O 0 4.516279711319626e-11
, O 0 3.2412844110096817e-12
some O 0 3.002735560198033e-11
DMD B-Disease 1 0.9999982118606567
isoforms O 0 1.2174139385479066e-07
expressed O 0 4.7734780572739055e-09
in O 0 1.3162679834977098e-09
the O 0 2.0185286775387112e-09
brain O 0 1.7060500789867206e-09
may O 0 2.6894484903006166e-11
be O 0 1.5598621352919118e-11
related O 0 2.7470190566702968e-09
to O 0 2.026551843004043e-10
the O 0 7.421567715937272e-08
cognitive B-Disease 0 5.8187910326523706e-05
impairment I-Disease 0 6.955578282941133e-05
associated O 0 6.546587769662437e-07
with O 0 1.1284498668828746e-07
DMD B-Disease 1 1.0
. O 0 1.4237111827242188e-06
. O 0 2.5670090053608874e-07

I1307K O 0 0.0004848578537348658
APC O 0 1.3408488484856207e-05
and O 0 1.2066625032502998e-08
hMLH1 O 0 6.526577749355056e-07
mutations O 0 3.162293982228448e-09
in O 0 1.4524996483356034e-10
a O 0 4.5856863445381535e-11
non O 0 1.740107968828397e-08
- O 0 2.777679064536187e-08
Jewish O 0 9.752821661379585e-09
family O 0 2.2941938279674723e-11
with O 0 3.7695849046393004e-12
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00010907628893619403

We O 0 5.87766413318036e-09
describe O 0 1.1406831035287723e-09
a O 0 1.646670161337127e-10
French O 0 2.282804700826091e-08
Canadian O 0 8.950084975367645e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.580846962198848e-06
HNPCC B-Disease 1 1.0
) O 0 7.902113630109397e-09
kindred O 0 6.16824195276422e-07
which O 0 7.127066298240337e-11
carries O 0 7.906360566245496e-10
a O 0 6.24947038563306e-11
novel O 0 8.215613078732531e-09
truncating O 0 9.716247006963386e-08
mutation O 0 4.82985695882121e-09
in O 0 1.3522377662056329e-09
hMLH1 O 0 7.265295494107704e-07
. O 0 8.101739723542778e-08

Interestingly O 0 3.669083525892347e-06
, O 0 5.694904103847875e-09
the O 0 1.0263730310100527e-08
I1307K O 0 5.947788849880453e-06
APC O 0 4.4333120285955374e-07
polymorphism O 0 3.036206308593137e-08
, O 0 9.47806000350937e-11
associated O 0 1.5557356791706667e-10
with O 0 5.2651090952371415e-12
an O 0 1.7305291314523297e-12
increased O 0 1.3540909504783372e-09
risk O 0 8.894505754142301e-07
of O 1 0.9969689249992371
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 6.316622336299815e-09
is O 0 1.2002015700729451e-11
also O 0 1.083080023236982e-12
present O 0 5.877923581892874e-12
in O 0 5.467159364114238e-11
this O 0 3.08541664439943e-10
family O 0 2.715730085256496e-09
. O 0 1.1369714947306875e-08

The O 0 1.2020037729598698e-06
I1307K O 0 1.0887440112128388e-05
polymorphism O 0 4.1482536516923574e-07
has O 0 1.6793015589211535e-10
previously O 0 1.605113819636017e-10
only O 0 7.351758091189708e-12
been O 0 2.2246610803522415e-11
identified O 0 4.385769178383292e-11
in O 0 1.1355133847090748e-11
individuals O 0 1.7678577785701366e-12
of O 0 6.47743636505993e-10
self O 0 1.0627174873434342e-07
- O 0 4.6673255837959005e-07
reported O 0 8.307193155587811e-09
Ashkenazi O 0 3.576679432626406e-07
Jewish O 0 4.779083440098475e-08
origins O 0 1.0309605613656458e-07
. O 0 1.834908047726458e-08

In O 0 2.0686890422894066e-08
addition O 0 2.902692308737187e-09
, O 0 5.989767015712744e-11
in O 0 3.201697587607022e-11
this O 0 3.1255206756064524e-11
family O 0 6.589950113378151e-11
, O 0 2.610532666771914e-12
there O 0 3.6909746092828044e-12
appears O 0 3.001510151534603e-11
to O 0 1.977800735686319e-12
be O 0 1.4140130906448167e-11
no O 0 5.064490493644769e-11
relationship O 0 3.33817244679846e-11
between O 0 1.319593045945311e-10
the O 0 1.26519805743186e-09
I1307K O 0 1.627428325434721e-08
polymorphism O 0 5.796853552730852e-10
and O 0 6.548398975847469e-12
the O 0 9.162053928035707e-12
presence O 0 1.5396350860896746e-11
or O 0 1.1098425650724053e-10
absence O 0 9.164011061102428e-08
of O 0 4.931004013997153e-07
cancer B-Disease 0 2.8074910005670972e-05
. O 0 3.7033776045802824e-09
. O 0 2.019966238719917e-08

Identification O 0 1.0051594045989987e-07
of O 0 2.8601003787542822e-09
a O 0 1.3971589163386255e-10
novel O 0 4.934727293459673e-09
mutation O 0 5.242777323388736e-10
of O 0 1.897965340447172e-09
the O 0 5.4969678586758164e-08
CPO O 0 4.1167266317643225e-05
gene O 0 7.042532668144474e-10
in O 0 8.506536447461244e-11
a O 0 1.5993838198280486e-10
Japanese O 0 1.1981788929915638e-06
hereditary B-Disease 1 0.9999949932098389
coproporphyria I-Disease 1 0.9999984502792358
family O 0 5.122003585711354e-07
. O 0 2.0131570011017175e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 0.005563096143305302
HCP B-Disease 1 1.0
) O 0 4.412043619339556e-09
is O 0 1.877359379065524e-10
an O 0 1.7460706491778666e-10
autosomal B-Disease 1 0.9999897480010986
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9935715198516846
characterized O 0 1.094767032583377e-08
by O 0 6.460680879172287e-10
a O 0 6.726700307879696e-10
deficiency B-Disease 0 1.9159178918926045e-06
of I-Disease 0 3.3607554428272124e-07
coproporphyrinogen I-Disease 1 0.9685009717941284
oxidase I-Disease 0 5.37039613845991e-06
( O 0 4.999106684167032e-10
CPO O 0 7.926360012788791e-08
) O 0 1.1983070785648309e-12
caused O 0 1.0998553630348074e-11
by O 0 3.252754185792406e-12
a O 0 1.945757617527466e-11
mutation O 0 4.133589581734043e-10
in O 0 1.0048230025816451e-09
the O 0 6.402112973091789e-08
CPO O 0 0.00033432160853408277
gene O 0 4.8223572690631045e-08
. O 0 8.839761278522928e-08

Only O 0 7.545835245537091e-08
11 O 0 1.9856894795111657e-08
mutations O 0 1.4656358349185439e-09
of O 0 3.3380356256884625e-09
the O 0 8.37736369163622e-09
gene O 0 1.6462500251890333e-09
have O 0 8.102067627913101e-11
been O 0 3.627599054478736e-10
reported O 0 1.3540960575042504e-09
in O 0 7.226591947073757e-08
HCP B-Disease 1 1.0
patients O 1 0.9991676807403564
. O 0 1.7836091501521878e-06

We O 0 1.3955570032919695e-08
report O 0 3.417089111668048e-10
another O 0 1.5082016191492187e-10
mutation O 0 2.581854452454735e-10
in O 0 4.5917956936758486e-11
a O 0 1.2819729999780094e-10
Japanese O 0 9.83249265118502e-07
family O 0 7.726027817511749e-09
. O 0 3.159624739623723e-08

Polymerase O 0 8.000372986316506e-07
chain O 0 3.194449504917429e-08
reaction O 0 1.3988776359497024e-08
- O 0 9.127813882514602e-08
single O 0 1.4876658793738784e-09
strand O 0 1.0303856656790344e-09
conformational O 0 7.318352174268128e-11
polymorphism O 0 1.0994238852646276e-10
and O 0 1.8739911965964806e-12
direct O 0 6.231517905852524e-12
sequence O 0 8.803013873404097e-12
analyses O 0 5.8620733267567e-11
demonstrated O 0 2.409565880157061e-10
a O 0 1.0703565811454041e-10
C O 0 1.8473009788522177e-07
to O 0 2.878696170327544e-10
T O 0 9.281778901026883e-09
substitution O 0 1.497048529586209e-08
in O 0 8.035035414799552e-10
exon O 0 2.30040941850973e-09
1 O 0 3.5599601044822293e-10
of O 0 3.7889288928560916e-10
the O 0 4.939397779679666e-09
CPO O 0 1.2562807114591124e-06
gene O 0 2.4874388659945623e-10
at O 0 4.352520843742269e-10
nucleotide O 0 1.433236196390908e-09
position O 0 6.049915235450953e-09
85 O 0 1.1343158412557841e-08
, O 0 2.6305570569040704e-11
which O 0 2.609916623097508e-11
lies O 0 6.349741288325106e-10
in O 0 5.461687352381617e-11
the O 0 6.584802147990843e-10
putative O 0 2.9249688893173698e-08
presequence O 0 1.4766942513233516e-07
for O 0 4.1370445957866764e-10
targeting O 0 1.5592033220102053e-09
to O 0 1.6825661974806394e-09
mitochondria O 0 7.052162231957482e-07
. O 0 1.0819098150705031e-07

This O 0 3.1602922501150488e-09
mutation O 0 9.137856582519532e-10
changes O 0 2.4361007655571143e-10
the O 0 1.1328405991051227e-09
codon O 0 6.131091190297866e-09
for O 0 1.5182195778340457e-10
glutamine O 0 1.313173680905777e-09
to O 0 2.5391213437364613e-11
a O 0 6.861056861540149e-11
termination O 0 1.7659337103737016e-08
codon O 0 2.1580618181360478e-08
at O 0 5.637162292515541e-09
amino O 0 1.0586419518787693e-09
acid O 0 5.0107651361486205e-09
position O 0 2.1696427765505177e-08
29 O 0 1.5775029282849573e-07
. O 0 1.2220539247209672e-07

MaeI O 0 0.00011365431419108063
restriction O 0 4.6296617028929177e-07
analysis O 0 1.799040028060972e-08
showed O 0 8.982453669759138e-10
two O 0 1.4076865541279293e-11
other O 0 3.4981479518636505e-11
carriers O 0 2.2493673590417984e-09
in O 0 9.503208220351667e-10
the O 0 1.4905154444022628e-08
family O 0 7.726661976903415e-09
. O 0 2.4955484789757065e-08

The O 0 1.1621102657954907e-06
C O 0 0.0001587640872457996
- O 0 3.2520612876396626e-05
T O 0 1.8107192545357975e-06
mutation O 0 1.7183751088722943e-09
is O 0 6.418777401956399e-12
located O 0 4.486470570053136e-11
within O 0 1.904280205744513e-11
a O 0 9.694311325914029e-12
recently O 0 9.75009517567571e-11
proposed O 0 2.4702064838066917e-09
putative O 0 2.992317149619339e-08
alternative O 0 2.7296490401340634e-08
translation O 0 1.4803801517970783e-09
initiation O 0 4.256963670457026e-09
codon O 0 6.053654910687101e-09
( O 0 3.9716702149306116e-11
TIC O 0 2.2664301546626575e-09
- O 0 2.5292246075281355e-09
1 O 0 6.540142316602271e-10
) O 0 3.4504740644564214e-12
, O 0 6.178155209646263e-12
supporting O 0 1.6753719939144318e-11
that O 0 4.659177557653216e-12
TIC O 0 9.119457189399327e-09
- O 0 8.284175123662862e-08
1 O 0 4.221944749360773e-08
is O 0 1.5579650416985835e-11
the O 0 2.2814834743645207e-10
real O 0 6.020825171759725e-09
TIC O 0 1.10524265295453e-08
rather O 0 6.351728032427673e-10
than O 0 5.055758589556092e-10
TIC O 0 1.2998391696328326e-07
- O 0 2.0314149651312619e-07
2 O 0 2.373288587875777e-08
. O 0 4.2577166792234777e-10
. O 0 4.759541205601181e-09

Human B-Disease 0 4.7516429901861557e-08
complement I-Disease 0 1.105175215343479e-06
factor I-Disease 0 0.003460536478087306
H I-Disease 1 1.0
deficiency I-Disease 1 0.9962201714515686
associated O 0 2.284777110617142e-06
with O 0 9.766599760041572e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8473051190376282

This O 0 1.2037454588664787e-08
study O 0 7.199238982735778e-09
reports O 0 5.043468975785004e-10
on O 0 5.125159185936923e-10
six O 0 1.634750251833239e-10
cases O 0 1.7487946646355113e-09
of O 0 1.4714928511239123e-06
deficiency B-Disease 1 0.9999873638153076
in I-Disease 0 4.115861074183158e-08
the I-Disease 0 1.3966001688459073e-09
human I-Disease 0 1.7976790195328718e-11
complement I-Disease 0 8.292747738503081e-11
regulatory I-Disease 0 1.1302723201822573e-09
protein I-Disease 0 7.009205438279764e-10
Factor I-Disease 0 2.02019361239536e-08
H I-Disease 1 0.9999947547912598
( O 0 2.1146284723272402e-10
FH O 0 6.633643465647765e-07
) O 0 3.720179112681743e-12
in O 0 1.0069837758780453e-12
the O 0 1.2653891606415058e-12
context O 0 1.703469830471871e-11
of O 0 2.959736622454301e-11
an O 0 1.1708620184514018e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.1438204637670424e-05

Five O 0 9.312211801670855e-08
of O 0 2.322200209903258e-09
the O 0 4.2363715313520345e-10
cases O 0 3.330866416018097e-10
were O 0 1.5400204722570976e-10
observed O 0 1.1230170959830588e-10
in O 0 3.401195297625392e-11
children O 0 6.127153905771676e-12
presenting O 0 1.3260015307992035e-10
with O 0 3.3032562796186937e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00011012904724339023
HUS B-Disease 1 1.0
) O 0 7.01008033843209e-08
. O 0 1.9788107863405457e-07

Two O 0 3.701950967993639e-09
of O 0 4.6313988200097356e-09
the O 0 2.0396997868488143e-08
children O 0 1.741395361243292e-09
exhibited O 0 4.784206364405463e-09
a O 0 6.687761455737018e-09
homozygous O 0 4.253104634699412e-06
deficiency O 0 2.252663762192242e-05
characterized O 0 4.97519581088568e-09
by O 0 5.66522717626583e-10
the O 0 7.595476247956867e-09
absence O 0 5.965615201830587e-08
of O 0 1.212309896914121e-08
the O 0 1.0893923541033246e-09
150 O 0 1.7603628277296224e-10
- O 0 5.514780646032058e-11
kD O 0 1.8183580197117521e-09
form O 0 2.3257307538160354e-11
of O 0 5.584144258108381e-10
Factor O 0 1.3104095586413678e-08
H O 1 0.5035018920898438
and O 0 9.368673892229396e-11
the O 0 1.1478426716060586e-11
presence O 0 3.622499435834703e-12
, O 0 9.016322844584979e-13
upon O 0 5.926853452464798e-11
immunoblotting O 0 4.888134697011992e-08
, O 0 2.6880843037591085e-11
of O 0 1.0444556330924115e-10
the O 0 2.945287902456073e-10
42 O 0 1.833346807700309e-09
- O 0 2.235978735498634e-09
kD O 0 1.0751131895858634e-07
Factor O 0 6.945253261392281e-08
H O 1 0.9999971389770508
- O 0 6.003696171319461e-07
like O 0 9.42229627654001e-10
protein O 0 6.367084082192775e-10
1 O 0 5.235685218707431e-09
( O 0 8.356799974240658e-11
FHL O 0 7.517328867834294e-06
- O 0 6.79422100802185e-08
1 O 0 1.2549794092819866e-08
) O 0 1.1203679477211903e-11
and O 0 1.9941655965416416e-11
other O 0 1.1273178918136395e-10
FH O 0 7.4042577580257785e-06
- O 0 7.728198170298128e-08
related O 0 5.9483120651293575e-08
protein O 0 8.596400036253726e-09
( O 0 2.1305267272619943e-10
FHR O 0 7.018162432359532e-05
) O 0 1.0246981041461822e-09
bands O 0 4.700460820572516e-08
. O 0 3.122099201391393e-08

Southern O 0 2.9008067485847278e-06
blot O 0 1.2855894055974204e-06
and O 0 3.207102083901958e-10
PCR O 0 8.353048031040089e-09
analysis O 0 1.257024068168633e-10
of O 0 7.952288133550311e-11
DNA O 0 7.662873668934367e-10
of O 0 1.5446428580645488e-09
one O 0 7.681854041763359e-10
patient O 0 2.9697085324187356e-07
with O 0 1.3818755029149088e-09
homozygous O 0 2.133632187906187e-05
deficiency O 0 0.0005085565499030054
ruled O 0 2.205622706696886e-07
out O 0 2.3798862880397564e-10
the O 0 2.7956185977284775e-11
presence O 0 4.906826247402796e-12
of O 0 2.8775417812432202e-11
a O 0 1.5602309375029044e-11
large O 0 7.507178906296375e-11
deletion O 0 8.54162296448635e-11
of O 0 1.1420785428484237e-09
the O 0 6.5778138491623395e-09
FH O 0 1.1613753486017231e-05
gene O 0 3.233605883057322e-10
as O 0 3.332408654577179e-11
the O 0 2.210770871924339e-10
underlying O 0 7.979603111607503e-08
defect O 0 2.1859756671460673e-08
for O 0 2.8378539518314483e-09
the O 0 3.3375777093169745e-06
deficiency O 1 0.9997280240058899
. O 0 4.818789875571383e-06

The O 0 1.3473307092226605e-07
other O 0 3.923486868728787e-09
four O 0 1.0985565790377905e-09
children O 0 2.3905047386030276e-10
presented O 0 1.4735120901221421e-09
with O 0 3.5173126633480933e-09
heterozygous O 0 5.2490195230348036e-05
deficiency O 0 0.02019837498664856
and O 0 2.2286554823836013e-09
exhibited O 0 7.772068322253745e-09
a O 0 1.8769798215689804e-10
normal O 0 7.396833812123305e-09
immunoblotting O 0 2.657428126440209e-07
pattern O 0 1.2718760489249803e-09
of O 0 1.4359444189260273e-10
proteins O 0 6.8610924233714066e-12
of O 0 1.0846955972310113e-10
the O 0 1.07167332785707e-08
FH O 0 0.0029857701156288385
family O 0 3.270602988436622e-08
. O 0 2.7107114775049013e-08

Factor B-Disease 1 0.9999998807907104
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999979734420776
is O 0 2.617600303178591e-10
the O 0 2.2790783149595484e-10
only O 0 1.2258090098526964e-09
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
associated O 0 2.5279418878199067e-06
with O 0 1.9341796075877937e-07
HUS B-Disease 1 1.0
. O 0 0.00046714034397155046

These O 0 2.883919947294089e-08
observations O 0 1.4542807846851247e-08
suggest O 0 1.7954228104244407e-09
a O 0 7.741199348210159e-11
role O 0 3.7670516706000967e-10
for O 0 1.120384007791131e-09
FH O 1 0.999962568283081
and O 0 7.487569320119292e-08
/ O 0 1.9331666862854036e-06
or O 0 3.496338507602559e-08
FH O 0 2.474415668984875e-05
receptors O 0 1.6480596887191723e-09
in O 0 2.6363987382094223e-11
the O 0 2.1378050718556807e-10
pathogenesis O 0 1.4974018540669931e-06
of O 0 2.4162510214864596e-08
idiopathic O 1 0.9999979734420776
HUS B-Disease 1 1.0
. O 0 4.315393198339734e-07
. O 0 8.923650796077709e-08

Further O 0 1.3168989454470648e-08
evidence O 0 3.4163607498527426e-09
for O 0 1.3365340778559442e-10
a O 0 1.6286565152068277e-10
major O 0 1.854962050629183e-08
ancient O 0 7.0053079070930835e-06
mutation O 0 2.2348003767547198e-06
underlying O 0 0.0008754163281992078
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 9.589999194759002e-08
linkage O 0 1.06730631443952e-07
disequilibrium O 0 3.043233789412625e-07
studies O 0 9.627060953976141e-11
in O 0 5.242832210039516e-12
the O 0 4.279673143647855e-11
Japanese O 0 2.0897431340927142e-08
population O 0 8.973544129986522e-11
. O 0 1.689099971002861e-09

The O 0 9.099760063691065e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7335640905002947e-06
DM B-Disease 1 1.0
) O 0 3.000625525828582e-09
mutation O 0 1.0887442059015484e-09
is O 0 1.3531755577167459e-11
an O 0 6.455008402794782e-12
unstable O 0 3.3809951105467917e-07
( O 0 3.6433343009178998e-09
CTG O 0 1.937116394401528e-05
) O 0 1.9037908749464094e-10
n O 0 4.568629641266142e-10
repeat O 0 1.3600131021362927e-09
, O 0 1.1887531757570624e-11
present O 0 2.942938948091722e-11
at O 0 2.434642210058513e-10
a O 0 6.220153298680531e-12
copy O 0 2.538110832617235e-10
number O 0 4.846324036522631e-11
of O 0 1.6264181668113054e-10
5 O 0 1.1641598796074959e-09
- O 0 5.996677376884918e-09
37 O 0 4.333123637678682e-09
repeats O 0 7.451968903060546e-11
on O 0 2.2049678749525015e-10
normal O 0 3.0848576471065314e-10
chromosomes O 0 8.843020066207075e-11
but O 0 8.93443513616532e-11
amplified O 0 1.5688925714130164e-09
to O 0 1.3046522195914179e-10
50 O 0 2.6772599692748145e-09
- O 0 6.398423568754197e-09
3000 O 0 8.95850416071653e-09
copies O 0 1.0814796835845186e-09
on O 0 2.1102025016261905e-08
DM B-Disease 1 0.9999997615814209
chromosomes O 0 4.679225185100222e-07
. O 0 1.400984928068283e-07

Previous O 0 1.6541296190553112e-06
findings O 0 1.3317048797034658e-07
in O 0 5.021796756210506e-09
Caucasian O 0 4.868889735831772e-09
populations O 0 6.676972169605833e-11
of O 0 8.971182824391022e-11
a O 0 4.583391000068104e-09
DM B-Disease 1 1.0
founder O 1 0.998994767665863
chromosome O 0 3.862120845354866e-09
raise O 0 2.315578007117125e-10
a O 0 5.912217763970329e-12
question O 0 7.953487174416907e-11
about O 0 6.98990290561724e-13
the O 0 4.974922817452265e-12
molecular O 0 7.292295933769566e-11
events O 0 4.20746640653058e-12
involved O 0 1.201364962372109e-11
in O 0 4.4785706393435376e-11
the O 0 1.1476424255363327e-09
expansion O 0 3.046116887617245e-07
mutation O 0 5.222084098477353e-08
. O 0 5.698960237054962e-08

To O 0 1.9524671657222825e-08
investigate O 0 2.6127596086666927e-08
whether O 0 1.2375605429326697e-08
a O 0 6.430453503014633e-09
founder O 0 1.3497600548362243e-07
chromosome O 0 2.976790480779812e-10
for O 0 7.397193274583103e-11
the O 0 1.3173064417060232e-07
DM B-Disease 1 1.0
mutation O 0 4.461048774828669e-08
exists O 0 1.0432490288314611e-10
in O 0 1.9997866210208493e-12
the O 0 2.714276069529231e-12
Japanese O 0 5.141039816081161e-10
population O 0 8.536906533247735e-13
, O 0 1.2018870057181608e-12
we O 0 9.457126054490672e-12
genotyped O 0 7.598855233936774e-08
families O 0 7.598974227640554e-11
using O 0 3.6874513859030955e-11
polymorphic O 0 4.6513086715549434e-09
markers O 0 7.897232201514726e-09
near O 0 4.870712544402522e-08
the O 0 1.1750379336206151e-08
( O 0 1.1492743423602292e-09
CTG O 0 5.273208444123156e-06
) O 0 2.469597859544592e-10
n O 0 3.436174900173228e-09
repeat O 0 1.4145952853539256e-08
region O 0 1.4398238157298238e-08
and O 0 2.0127697286653756e-09
constructed O 0 7.038362355160643e-07
haplotypes O 0 1.587896349519724e-06
. O 0 1.8716289673648134e-07

Six O 0 1.944219718552631e-07
different O 0 4.716003143556691e-09
haplotypes O 0 1.3279243660235807e-07
were O 0 2.505261997853836e-09
found O 0 3.787592184334443e-10
and O 0 9.933438516185333e-10
DM B-Disease 1 1.0
alleles O 0 2.8520946671051206e-07
were O 0 3.230952216881633e-08
always O 0 3.57841067888387e-09
haplotype O 0 3.708136375735194e-08
A O 0 6.55323404430419e-08
. O 0 5.4146674699495634e-08

To O 0 1.2318872144589932e-08
find O 0 1.0341146827741454e-09
an O 0 1.261446784701914e-12
origin O 0 6.581308414910225e-11
of O 0 4.3777984015669347e-10
the O 0 5.49991208131928e-09
( O 0 6.624635284779856e-10
CTG O 0 5.837451681145467e-06
) O 0 7.887228370417887e-11
n O 0 4.1594674926592745e-10
repeat O 0 1.087337220262441e-09
mutation O 0 1.3241616136916434e-10
and O 0 8.811194829316804e-12
to O 0 3.5607645304525093e-12
investigate O 0 5.3977378122738173e-11
the O 0 2.2139061417458805e-10
mechanism O 0 1.0958403073857426e-09
of O 0 8.331403900108114e-10
the O 0 2.2769580665382705e-10
expansion O 0 3.783882540631112e-09
mutation O 0 3.67763909603358e-11
in O 0 3.206756258103405e-12
the O 0 1.2048300725153727e-11
Japanese O 0 1.2012287831097979e-09
population O 0 5.295795269324999e-13
we O 0 5.788160749309323e-13
have O 0 4.47790838697254e-13
studied O 0 7.044235333930615e-11
90 O 0 2.0744914119852353e-10
Japanese O 0 6.704738098051166e-08
DM B-Disease 1 1.0
families O 0 1.9364150283252e-09
comprising O 0 1.2104002522494994e-10
190 O 0 1.6365128696627096e-10
affected O 0 7.208025842864174e-11
and O 0 9.249075810791041e-11
130 O 0 1.3266757470375978e-08
unaffected O 0 8.979289418675762e-07
members O 0 3.089110300891207e-09
. O 0 4.6456634095193294e-08

The O 0 2.456451397847559e-07
results O 0 4.643944606641526e-08
suggest O 0 7.149347780455173e-09
that O 0 1.9488702318604112e-11
a O 0 1.593880860628616e-10
few O 0 2.2080581807415456e-09
common O 0 2.6845835776612148e-08
ancestral O 0 4.06407906439199e-07
mutations O 0 4.290768629289232e-09
in O 0 6.036748323445806e-10
both O 0 3.563750960999812e-10
Caucasian O 0 1.8903605347730945e-09
and O 0 1.5460951963142122e-10
Japanese O 0 4.317221282690298e-07
populations O 0 2.2108004316123697e-10
have O 0 2.882951473034967e-12
originated O 0 4.3127782595187014e-11
by O 0 8.173493999674708e-12
expansion O 0 1.7587461487167388e-09
of O 0 3.249954194650684e-10
an O 0 5.917226778007212e-12
ancestral O 0 1.0204189715423695e-09
n O 0 2.8345470415303e-10
= O 0 1.87130699824678e-10
5 O 0 2.0253924926105782e-10
repeat O 0 7.474745128410731e-11
to O 0 4.1115392340751455e-11
n O 0 1.5434677980152856e-09
= O 0 3.4057690001532137e-09
19 O 0 1.6661712010090923e-08
- O 0 4.0965787206914683e-08
37 O 0 3.7807755148833166e-08
copies O 0 1.703716101530972e-08
. O 0 2.8102231652837872e-08

These O 0 1.070645616607635e-08
data O 0 1.7143287900367454e-09
support O 0 6.672112862204926e-10
multistep O 0 3.011949729625485e-07
models O 0 5.057325935808876e-08
of O 0 4.5745466081825725e-07
triplet O 0 3.886956619680859e-06
repeat O 0 1.9680959084666938e-08
expansion O 0 3.444260698870494e-08
that O 0 4.417796857503209e-12
have O 0 1.9530219455554665e-12
been O 0 1.961668241040604e-12
proposed O 0 2.1414198539404516e-11
for O 0 1.809754603121494e-11
both O 0 1.617021960775844e-09
DM B-Disease 1 1.0
and O 0 5.102486966279685e-07
Friedreichs B-Disease 1 0.9904012084007263
ataxia I-Disease 1 0.6986225843429565
. O 0 1.2868819965206058e-07
. O 0 1.5741396452995104e-07

The O 0 1.0567623220936184e-08
molecular O 0 1.2556905737426405e-08
basis O 0 2.4876642967797125e-08
of O 0 0.0063255843706429005
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.823215935649387e-09
the O 0 3.3889968609202015e-10
western O 0 1.322905118783524e-09
Cape O 0 1.5566188338311804e-08
, O 0 1.852883818598272e-11
South O 0 7.733469975512719e-10
Africa O 0 1.2419391071105679e-09
. O 0 4.067209236069402e-09

Deficiency B-Disease 0 0.03444734215736389
of I-Disease 0 3.631006165960571e-06
the I-Disease 0 7.845482059565256e-07
sixth I-Disease 0 5.8731504395836964e-05
component I-Disease 0 2.6537054509390146e-07
of I-Disease 0 2.4258095976392724e-08
human I-Disease 0 1.1134326793893479e-09
complement I-Disease 0 1.3108787300097902e-07
( O 0 4.565296141123554e-09
C6 O 0 0.00011853893374791369
) O 0 4.960144101007202e-11
has O 0 8.029236130135953e-12
been O 0 9.956000433797296e-12
reported O 0 6.921423070099797e-12
in O 0 7.38712303133271e-12
a O 0 3.4274902794423356e-12
number O 0 8.48311958873138e-12
of O 0 1.559383004667847e-11
families O 0 1.7841410857380446e-12
from O 0 3.3898983880370492e-12
the O 0 2.578014884901947e-11
western O 0 1.1147927025945137e-09
Cape O 0 2.6012036968836583e-08
, O 0 5.723307938687583e-11
South O 0 2.585689884426756e-09
Africa O 0 1.655112935594616e-09
. O 0 4.5775112589296896e-09

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999985694885254
is O 0 8.36178326579784e-09
endemic O 0 8.885698843386081e-10
in O 0 6.20816245633371e-11
the O 0 4.012668253228213e-10
Cape O 0 5.755501319981704e-08
and O 0 1.878103575436718e-11
almost O 0 6.205341362280903e-12
all O 0 2.0755578245684747e-12
pedigrees O 0 8.074519386447321e-10
of O 0 1.1217845541366955e-09
total O 0 3.709336169777089e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.3115900305015202e-09
C6Q0 O 0 9.612781286705285e-05
) O 0 1.747442468502669e-11
have O 0 2.3557581666638905e-12
been O 0 1.1016063929114583e-11
ascertained O 0 1.2388428949350327e-08
because O 0 6.245732264709147e-10
of O 0 2.4961769540254863e-08
recurrent O 0 0.00012939989392179996
disease O 0 0.0012061760062351823
. O 0 1.620757984710508e-06

We O 0 4.5112845015182756e-08
have O 0 7.859030648482701e-10
sequenced O 0 9.23072196457042e-09
the O 0 7.689066050531324e-10
expressed O 0 1.3993252112598498e-09
exons O 0 3.278009685914185e-08
of O 0 1.0795471183655536e-08
the O 0 6.636630445200353e-08
C6 O 0 2.3700784367974848e-05
gene O 0 1.765844276357953e-10
from O 0 2.832270529218306e-11
selected O 0 4.4788631137215873e-10
cases O 0 4.649414533930418e-11
and O 0 2.949868127544164e-11
have O 0 2.3719184602533083e-11
found O 0 8.951390323419517e-11
three O 0 8.766458392539533e-11
molecular O 0 1.5893491536189686e-06
defects O 0 0.08561015874147415
leading O 0 0.00032951816683635116
to O 0 4.692918054161055e-08
total O 0 2.083029357891064e-05
deficiency O 1 0.9998489618301392
879delG O 0 7.88981924415566e-05
, O 0 2.280121785824818e-10
which O 0 1.243115766574876e-11
is O 0 2.785148413980698e-12
the O 0 8.53769763220491e-11
common O 0 3.641639212403902e-09
defect O 0 1.3175572632917465e-08
in O 0 1.1300610447406712e-09
the O 0 2.160078782509345e-09
Cape O 0 7.466491069862968e-08
and O 0 1.2071216248799033e-10
hitherto O 0 1.4966831329843444e-08
unreported O 0 3.202403231483686e-09
, O 0 1.8174199992171403e-11
and O 0 2.49157812437506e-11
1195delC O 0 2.083609906833317e-08
and O 0 5.042901096707908e-10
1936delG O 0 7.099561827317302e-08
, O 0 4.344224979746514e-11
which O 0 8.662983524976298e-12
have O 0 2.2357208098733317e-11
been O 0 1.709603153488004e-10
previously O 0 3.303502194018648e-10
reported O 0 1.2573932173243207e-10
in O 0 3.3951952360666837e-10
African O 0 9.943617040875097e-10
- O 0 7.993523176708095e-09
Americans O 0 1.7330122892289523e-09
. O 0 6.839739885577956e-09

We O 0 2.160908536552597e-07
also O 0 1.5119696605836452e-09
show O 0 1.2865782050841545e-10
that O 0 2.1714019471374968e-12
the O 0 2.7372268340819517e-10
879delG O 0 3.563564803243935e-07
and O 0 2.6134461261762e-09
1195delC O 0 6.234827196749393e-06
defects O 0 9.370506859340821e-07
are O 0 6.940754221362866e-11
associated O 0 3.881385768345069e-10
with O 0 4.954908150445192e-10
characteristic O 1 0.9939143061637878
C6 O 1 1.0
/ O 1 0.999996542930603
C7 O 0 0.185674250125885
region O 0 6.243450911824766e-08
DNA O 0 2.1893722390586845e-08
marker O 0 1.8238262455838594e-08
haplotypes O 0 4.374228090853194e-09
, O 0 8.739625342868429e-12
although O 0 4.894088259654872e-11
small O 0 5.2658249288795034e-11
variations O 0 2.9198392592633127e-09
were O 0 5.6499280809418906e-09
observed O 0 2.229243101226075e-08
. O 0 1.4047496676994342e-07

The O 0 4.897055987385102e-07
1936delG O 0 9.221113032253925e-06
defect O 0 1.0566735682004946e-06
was O 0 3.5073394855089646e-08
observed O 0 1.2097590706972028e-09
only O 0 6.347243564075455e-11
once O 0 1.8403388535315202e-10
in O 0 2.6669567596004917e-11
the O 0 2.3324445153072304e-10
Cape O 0 5.2168079633929665e-08
, O 0 5.978110801524439e-12
but O 0 3.30659393095456e-12
its O 0 6.0726809865407905e-12
associated O 0 3.831281958355248e-10
haplotype O 0 1.3809883014914703e-08
could O 0 2.378693908511309e-09
be O 0 4.6483732418778345e-09
deduced O 0 1.4167006838761154e-06
. O 0 1.8927070755125897e-07

The O 0 8.509032056736032e-08
data O 0 3.765099787500503e-09
from O 0 7.474350027791843e-10
the O 0 3.413012983344288e-09
haplotypes O 0 2.8799400197954128e-08
indicate O 0 7.365716925278321e-10
that O 0 1.984360375670291e-12
these O 0 4.071947987127622e-11
three O 0 9.350108187700101e-11
molecular O 0 4.915144558026441e-08
defects O 0 1.0194413135877767e-07
account O 0 1.8736069640201691e-10
for O 0 3.753073962720066e-10
the O 0 4.161845197359071e-07
defects O 0 0.014866015873849392
in O 0 2.256346931517328e-08
all O 0 5.797163304954722e-10
the O 0 1.9488535230038906e-09
38 O 0 7.969651605321815e-09
unrelated O 0 2.534625132000201e-08
C6Q0 O 0 0.00012219020572956651
individuals O 0 1.3012672883672138e-10
we O 0 5.229591759636776e-11
have O 0 6.907311961984464e-12
studied O 0 3.6247010948287084e-10
from O 0 8.037331217236598e-11
the O 0 1.8142631841300272e-09
Cape O 0 6.441110826926888e-07
. O 0 3.062296727307512e-08

We O 0 5.969052807586195e-08
have O 0 3.6742545117540715e-10
also O 0 1.4534688556888664e-11
observed O 0 1.1342454753204834e-10
the O 0 5.103211186963108e-10
879delG O 0 3.421844496642734e-07
defect O 0 6.068686531079948e-08
in O 0 2.9129305634256752e-09
two O 0 1.3103887974708073e-09
Dutch O 1 0.9999898672103882
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 7.408142209897051e-06
, O 0 2.2206673999658477e-11
but O 0 1.3130596436539133e-11
the O 0 1.8914379784629176e-10
879delG O 0 6.84656953353624e-08
defect O 0 2.8107967509072296e-08
in O 0 5.714170248083406e-10
the O 0 1.6040588857180182e-09
Cape O 0 1.5771824735111295e-07
probably O 0 7.408930691177318e-10
did O 0 1.8671455007113202e-11
not O 0 2.8471094839360722e-12
come O 0 2.565389047026745e-11
from O 0 3.0690981006609164e-11
The O 0 2.352545658279581e-10
Netherlands O 0 4.222143967780312e-09
. O 0 5.721608742348394e-10
. O 0 1.138290706137468e-08

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.537175861216383e-08
seven O 0 1.8191420592117424e-09
further O 0 9.919144394743284e-10
molecular O 0 1.3847936486399703e-07
defects O 0 1.0350662478231243e-06
and O 0 2.1790891313600014e-09
their O 0 3.5188560953969272e-09
associated O 0 8.278378516024532e-08
marker O 0 4.0086247281578835e-06
haplotypes O 0 4.137477390031563e-06
. O 0 2.3329657494741696e-07

Seven O 0 2.4980247204098305e-08
further O 0 1.1021077384043565e-09
molecular O 0 1.5073604586746114e-08
bases O 0 1.9540840057175046e-08
of O 0 0.35210099816322327
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.850736156138737e-08
described O 0 3.86289649156879e-08
. O 0 3.447139462764426e-08

All O 0 1.9603183076810637e-08
these O 0 9.273368739570742e-10
new O 0 3.454996955198908e-09
molecular O 0 6.470651214840473e-08
defects O 0 1.849722686131372e-08
involve O 0 6.084721615451372e-10
single O 0 1.6558550086642754e-09
- O 0 1.1039933411893799e-08
nucleotide O 0 6.317321332716119e-09
events O 0 3.8092615173290767e-10
, O 0 2.127155396269842e-11
deletions O 0 7.446743777173026e-10
and O 0 2.1927634707985533e-10
substitutions O 0 7.854255024142276e-09
, O 0 3.594351899449677e-11
some O 0 2.104487764609253e-11
of O 0 2.2106276531541624e-10
which O 0 7.89202800333122e-11
alter O 0 1.553107509266738e-08
splice O 0 1.1049560271203518e-06
sites O 0 1.3326306280703193e-08
, O 0 1.4036870277234215e-10
and O 0 3.109343060803127e-10
others O 0 2.6600250890851385e-09
codons O 0 1.513588330226412e-07
. O 0 2.7024498194805346e-07

They O 0 3.396876024908124e-08
are O 0 1.927819986979884e-10
distributed O 0 1.6382992185093315e-10
along O 0 6.912591055119321e-10
the O 0 4.075440873663183e-09
C7 O 0 3.708398935486912e-06
gene O 0 3.651910718271978e-10
, O 0 7.991102571325293e-12
but O 0 9.430125083587093e-12
predominantly O 0 5.181052809000164e-11
towards O 0 5.948861958593454e-10
the O 0 7.088270526089957e-10
3 O 0 1.1258019405602226e-08
end O 0 3.20880637616483e-08
. O 0 9.239567333452214e-08

All O 0 2.8230413562368994e-08
were O 0 5.932899060923091e-09
found O 0 4.493529714988398e-10
in O 0 6.223174198183301e-10
compound O 0 1.9227110215069843e-07
heterozygous O 0 6.003180175184752e-08
individuals O 0 7.938334989354701e-10
. O 0 3.919681290653898e-08

The O 0 0.0002264559589093551
C6 O 1 0.9999964237213135
/ O 1 0.8555830717086792
C7 O 0 0.0037819254212081432
marker O 0 2.097695642078179e-06
haplotypes O 0 7.982373517734231e-08
associated O 0 4.939341380350015e-09
with O 0 8.876043788852428e-10
most O 0 2.8758756798197282e-06
C7 B-Disease 1 1.0
defects I-Disease 0 0.16876953840255737
are O 0 9.895490649114436e-09
tabulated O 0 5.625499852612847e-07
. O 0 6.3414655748772475e-09
. O 0 3.5608803017339596e-08

A O 0 5.635677553073037e-06
genome O 0 2.0578281123562192e-07
- O 0 2.632469033869711e-07
wide O 0 7.161866477645162e-08
search O 0 1.9659938121918685e-09
for O 0 1.0265129024578101e-10
chromosomal O 0 1.636994397813396e-07
loci O 0 2.5338047180412104e-06
linked O 0 2.3593074729433283e-06
to O 0 2.5156202454468257e-08
mental O 1 1.0
health O 1 1.0
wellness O 1 0.9999954700469971
in O 0 4.730029257160595e-09
relatives O 0 8.539036699950486e-10
at O 0 7.258214862471135e-11
high O 0 5.164669580892678e-09
risk O 0 5.232909661145868e-09
for O 0 2.8559373532743848e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.7879033088684082
the O 0 1.970361296343981e-07
Old O 0 6.678828299300221e-07
Order O 0 1.0301172892468458e-07
Amish O 0 2.1427626961667556e-06
. O 0 3.2191234566880667e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999535083770752
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.8781642552312405e-07
is O 0 5.002998570979855e-10
characterized O 0 7.50978890184939e-10
by O 0 2.9936556011911364e-10
episodes O 0 4.898389249774482e-09
of O 0 3.4690970096562523e-08
mania B-Disease 0 0.00017041197861544788
and O 0 8.313501886902941e-09
/ O 0 5.769690574197739e-07
or O 0 1.5368062378229297e-08
hypomania B-Disease 0 2.997858473463566e-06
interspersed O 0 1.1722659509771916e-09
with O 0 1.7894235355628285e-12
periods O 0 1.2125503268123339e-08
of O 0 2.561530365596809e-08
depression B-Disease 0 0.0006376249948516488
. O 0 5.232553235146042e-07

Compelling O 0 3.3466549211880192e-06
evidence O 0 2.6564975996734574e-08
supports O 0 9.651518473319243e-10
a O 0 8.363305881164962e-11
significant O 0 1.3437275736549736e-09
genetic O 0 2.3898186540805e-08
component O 0 2.3626617462468857e-07
in O 0 2.044084013164138e-09
the O 0 1.0915956139001537e-08
susceptibility O 0 4.218188678350998e-06
to O 0 1.5666566710592633e-08
develop O 0 5.356912879506126e-05
BPAD B-Disease 1 1.0
. O 1 0.9046435952186584

To O 0 4.883602855443314e-09
date O 0 4.2167502556367253e-07
, O 0 8.94871399204078e-10
however O 0 1.8012779046117089e-09
, O 0 1.1162858137847564e-10
linkage O 0 7.99300448051099e-09
studies O 0 2.595749171163675e-10
have O 0 9.19384360309472e-12
attempted O 0 2.7342279551589854e-09
only O 0 1.1213647371777213e-10
to O 0 2.460485704069981e-10
identify O 0 7.0009114061519995e-09
chromosomal O 0 2.3461026898985438e-07
loci O 0 6.062427928554825e-07
that O 0 5.294691907131721e-10
cause O 0 8.285815589204049e-09
or O 0 4.5504343348934384e-11
increase O 0 6.570847338460695e-11
the O 0 4.0942310652880565e-10
risk O 0 4.0610541596208805e-09
of O 0 1.2407370242328852e-08
developing O 0 2.6134330255445093e-05
BPAD B-Disease 1 1.0
. O 0 0.000176376779563725

To O 0 1.7895670723078183e-08
determine O 0 1.9424973629611486e-08
whether O 0 5.9517359929373015e-09
there O 0 1.4521734925665442e-09
could O 0 6.806848973361923e-10
be O 0 6.262014240476788e-10
protective O 0 9.065903441296541e-07
alleles O 0 2.363701234742166e-09
that O 0 6.590839419368111e-12
prevent O 0 1.5996218238889526e-10
or O 0 3.836932854772712e-11
reduce O 0 1.9251450433799278e-10
the O 0 7.55201901014857e-10
risk O 0 3.651961399953052e-09
of O 0 9.845355641857623e-09
developing O 0 2.3322879769693827e-06
BPAD B-Disease 1 1.0
, O 0 7.934096712958194e-10
similar O 0 1.8766219134214168e-10
to O 0 1.7182325007247812e-11
what O 0 1.2140850824682303e-11
is O 0 1.7196675940883699e-12
observed O 0 2.355283156008081e-11
in O 0 6.567013599578786e-11
other O 0 1.0507908321244486e-08
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.887357380438772e-10
we O 0 4.1651734145053965e-11
used O 0 1.1566418933739442e-08
mental O 1 0.9999992847442627
health O 1 1.0
wellness O 1 0.9999982118606567
( O 0 6.523320078555273e-11
absence O 0 3.885661570279808e-09
of O 0 1.3021170808258375e-09
any O 0 1.118055603654966e-08
psychiatric B-Disease 1 1.0
disorder I-Disease 0 0.11352621018886566
) O 0 1.990852621647221e-10
as O 0 5.358279375755615e-10
the O 0 1.6946343217583149e-09
phenotype O 0 2.0995553740021933e-08
in O 0 1.060396104257677e-09
our O 0 1.2553762473999086e-09
genome O 0 4.388683583211872e-10
- O 0 3.0542743889583335e-09
wide O 0 2.755122352482431e-08
linkage O 0 1.0088505142391568e-08
scan O 0 2.9057570571922042e-08
of O 0 7.600867490964447e-09
several O 0 1.0043728071451596e-09
large O 0 2.80907497263172e-09
multigeneration O 0 1.130120836023707e-06
Old O 0 1.8218520381196868e-07
Order O 0 4.8555744314171534e-08
Amish O 0 5.056882628196036e-07
pedigrees O 0 4.324902036501044e-08
exhibiting O 0 1.0962144525450412e-09
an O 0 1.963974555901915e-12
extremely O 0 9.428624547780373e-10
high O 0 6.780159544916842e-09
incidence O 0 3.628287714718681e-08
of O 0 1.9199038092665432e-07
BPAD B-Disease 1 1.0
. O 0 0.00033509155036881566

We O 0 2.2227033014132758e-07
have O 0 2.3419095551702185e-09
found O 0 3.5180491853026297e-10
strong O 0 1.7152994302715996e-10
evidence O 0 2.478663108096413e-10
for O 0 5.110962694732102e-11
a O 0 1.0109028891758243e-10
locus O 0 1.63251701046363e-09
on O 0 1.5005268139134387e-09
chromosome O 0 8.771430248799561e-10
4p O 0 9.80718141363468e-06
at O 0 2.5151644322818356e-08
D4S2949 O 0 5.395366997618112e-07
( O 0 7.23369766864046e-11
maximum O 0 6.688501308360628e-09
GENEHUNTER O 0 6.556441076099873e-05
- O 0 3.023040449079417e-07
PLUS O 0 1.8601637918891356e-07
nonparametric O 0 2.1070619027341309e-07
linkage O 0 3.832336226139432e-09
score O 0 1.215434863865994e-09
= O 0 7.312463828901272e-11
4 O 0 1.5322561275343816e-10
. O 0 1.354600979996956e-11
05 O 0 4.762213379194691e-08
, O 0 2.4266588738441897e-10
P O 0 2.5132925429716124e-07
= O 0 4.6355416727372756e-10
5 O 0 2.406534693744078e-10
. O 0 4.805920418571308e-12
22 O 0 1.0206481493302277e-10
x O 0 2.3568493823233894e-09
10 O 0 8.202612478136473e-10
( O 0 4.022658942059998e-11
- O 0 1.013340167332899e-08
4 O 0 3.3110230113209127e-09
) O 0 8.440994431202498e-12
; O 0 5.7926066721059044e-11
SIBPAL O 0 1.3744572243012954e-05
Pempirical O 0 9.049162486007845e-07
value O 0 6.9129506563569976e-09
< O 0 3.8026430893012275e-09
3 O 0 5.24393750644947e-10
x O 0 1.5151798704593489e-09
10 O 0 2.1493960777885235e-10
( O 0 7.421185194145252e-12
- O 0 3.28391558390706e-09
5 O 0 1.567486807019236e-09
) O 0 7.655561948261003e-12
) O 0 6.91566985969172e-12
and O 0 3.2266609523157186e-11
suggestive O 0 3.6815994697292354e-10
evidence O 0 6.40267769358438e-11
for O 0 1.3991583065753321e-11
a O 0 1.9337269285824021e-10
locus O 0 6.047146339227538e-09
on O 0 1.31701956007646e-08
chromosome O 0 5.364530153428859e-09
4q O 0 2.0190020677546272e-07
at O 0 9.503974496283263e-09
D4S397 O 0 2.9857383765374834e-07
( O 0 7.506835431048131e-11
maximum O 0 9.308070758606846e-09
GENEHUNTER O 0 8.897701627574861e-05
- O 0 5.680635126736888e-07
PLUS O 0 4.00525976829158e-07
nonparametric O 0 3.8877843167028914e-07
linkage O 0 2.151412203943437e-08
score O 0 5.003726322172497e-09
= O 0 9.369102715872657e-11
3 O 0 1.6589046802906182e-10
. O 0 9.428686997825508e-12
29 O 0 1.2833143436807859e-09
, O 0 7.456846251585603e-11
P O 0 2.644241874349973e-07
= O 0 5.695987570497607e-10
2 O 0 5.98575022880965e-10
. O 0 1.2909973437502664e-11
57 O 0 4.289358868092563e-10
x O 0 3.0674216500159446e-09
10 O 0 1.029242469030578e-09
( O 0 2.4107415716456693e-11
- O 0 7.0256986894889906e-09
3 O 0 2.1267763106180837e-09
) O 0 5.759113238384961e-12
; O 0 3.976476092848458e-11
SIBPAL O 0 1.2674877325480338e-05
Pempirical O 0 8.778507094575616e-07
value O 0 5.900308241990615e-09
< O 0 4.794748598158094e-09
1 O 0 1.3412182475747159e-09
x O 0 4.927165786483556e-09
10 O 0 3.724897335022348e-10
( O 0 1.9858758734669912e-11
- O 0 7.862078099662995e-09
3 O 0 2.2699431223571764e-09
) O 0 2.7104167434760518e-12
) O 0 3.7648194024103576e-13
that O 0 1.0348386508601468e-13
are O 0 3.0904376280282975e-12
linked O 0 1.0349118229058263e-09
to O 0 3.0698272812657024e-09
mental O 1 0.9999992847442627
health O 1 0.9999982118606567
wellness O 1 0.9999476671218872
. O 0 1.4296570043370593e-06

These O 0 3.536014503424667e-08
findings O 0 1.4508508172639267e-08
are O 0 2.0023419033954326e-10
consistent O 0 1.941103944247402e-09
with O 0 1.391031907715945e-11
the O 0 4.717772839057943e-10
hypothesis O 0 4.806807840651572e-09
that O 0 1.2935008966707962e-12
certain O 0 5.830774751913737e-10
alleles O 0 1.451658349083118e-09
could O 0 3.6009001336267943e-10
prevent O 0 9.503952069778165e-10
or O 0 2.890227501772813e-10
modify O 0 5.60873036903331e-09
the O 0 1.2617855649210696e-09
clinical O 0 4.971963107891497e-08
manifestations O 0 1.0453479148964107e-07
of O 0 1.8457231476531888e-07
BPAD B-Disease 1 1.0
and O 0 6.594508938917443e-09
perhaps O 0 2.2356803075496146e-09
other O 0 2.8919922012704546e-10
related O 0 2.3874916223576292e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 0.005282606463879347

Segregation O 0 0.00017053323972504586
distortion O 0 0.00012084906484233215
in O 0 1.3703893273486756e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0005694585270248353

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5741580128669739
DM B-Disease 1 1.0
) O 0 1.5392988927942497e-07
is O 0 1.160470719518969e-09
an O 0 1.5469504843768078e-10
autosomal B-Disease 1 0.9016995429992676
dominant I-Disease 1 0.9997963309288025
disease I-Disease 1 0.9585340619087219
which O 0 2.6500829308773177e-10
, O 0 8.030951771653694e-12
in O 0 1.3049204078408039e-11
the O 0 2.4302424656008625e-11
typical O 0 9.890164243131494e-10
pedigree O 0 3.774490053842783e-09
, O 0 7.906141887004114e-12
shows O 0 5.019816593648807e-12
a O 0 1.249341168713114e-11
three O 0 1.8093758435977492e-10
generation O 0 1.442569327991805e-06
anticipation O 0 1.3477766515279654e-05
cascade O 0 2.9467457807186292e-06
. O 0 1.3623379402361024e-07

This O 0 3.3189138104461335e-09
results O 0 4.65377780756171e-08
in O 0 5.327082064354727e-08
infertility B-Disease 1 0.9678028225898743
and O 0 1.9618109945440665e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3982528344058665e-06
CDM B-Disease 0 3.0171009711921215e-05
) O 0 4.23221614004321e-12
with O 0 5.374750666232997e-13
the O 0 5.544766382148403e-11
disappearance O 0 1.0884577683611951e-09
of O 0 3.092171496632545e-08
DM B-Disease 1 1.0
in O 0 6.45023305878567e-07
that O 0 8.510127602612272e-10
pedigree O 0 3.0083066349106957e-07
. O 0 1.5877080983273117e-08

The O 0 4.7016623483386866e-08
concept O 0 9.159624880794581e-08
of O 0 1.4250159274808993e-08
segregation O 0 1.2512393254837662e-07
distortion O 0 4.918238971640676e-08
, O 0 1.859419215821667e-11
where O 0 4.072326243581559e-12
there O 0 3.6517867180695107e-13
is O 0 2.1363913784745725e-13
preferential O 0 3.7407887898410763e-10
transmission O 0 5.174810580044209e-11
of O 0 2.4810596285784747e-11
the O 0 2.1152930101964174e-11
larger O 0 6.496946036715912e-11
allele O 0 4.8613682523956925e-11
at O 0 1.458996812253588e-10
the O 0 1.2731308229874116e-09
DM B-Disease 1 1.0
locus O 0 1.5039804068806006e-08
, O 0 3.2752175971317854e-11
has O 0 2.2677066387893907e-12
been O 0 7.1562404439784455e-12
put O 0 1.4566861605835868e-10
forward O 0 3.947010274174545e-09
to O 0 2.0557892888017903e-10
explain O 0 2.146169020278421e-09
partially O 0 2.291248746288943e-09
the O 0 1.356321027712326e-10
maintenance O 0 3.405270376788394e-08
of O 0 2.2078052097640466e-07
DM B-Disease 1 1.0
in O 0 1.273552072689199e-07
the O 0 3.812250959356334e-09
population O 0 7.03941349655679e-11
. O 0 7.13000714025469e-10

In O 0 3.398833570145143e-08
a O 0 5.543469017155189e-10
survey O 0 2.8416979880319104e-10
of O 0 1.7285425313318115e-09
DM B-Disease 1 1.0
in O 0 1.2948360108566703e-06
Northern O 0 4.535199593647121e-07
Ireland O 0 1.8971810789025767e-08
, O 0 3.0994251609683943e-10
59 O 0 1.2364893109406694e-08
pedigrees O 0 5.39136699728715e-08
were O 0 3.4927110093008196e-09
ascertained O 0 7.621497388754506e-07
. O 0 1.8720020023010875e-07

Sibships O 0 8.673049887875095e-05
where O 0 1.005109151464012e-08
the O 0 7.385890232747272e-10
status O 0 2.5406063919319877e-09
of O 0 1.9009906981892755e-09
all O 0 1.1786190079465797e-10
the O 0 7.295860582345881e-10
members O 0 1.3850062589859657e-11
had O 0 2.437391261045363e-11
been O 0 1.3068531500015634e-11
identified O 0 2.870284218636776e-11
were O 0 2.4336624382392813e-10
examined O 0 2.261938858438839e-09
to O 0 2.8647383076840782e-11
determine O 0 6.1010030361075e-10
the O 0 6.80352607584922e-10
transmission O 0 3.5730158831626113e-09
of O 0 1.8899279918827006e-09
the O 0 1.3384619990119972e-07
DM B-Disease 1 1.0
expansion O 0 1.6271871572826058e-05
from O 0 9.623178698348056e-09
affected O 0 8.579806198838469e-09
parents O 0 2.1108122194579693e-10
to O 0 7.462636064659023e-11
their O 0 2.861693992883829e-09
offspring O 0 1.9904413761651085e-07
. O 0 3.338075416081665e-08

Where O 0 4.796662622652548e-08
the O 0 9.011098534017492e-09
transmitting O 0 8.264477742159215e-07
parent O 0 9.079400342670851e-09
was O 0 2.0727293659206225e-08
male O 0 8.085156544268557e-09
, O 0 4.995351354786237e-10
58 O 0 7.382587341453473e-08
. O 0 5.006783965200157e-08

3 O 0 3.1702225555818586e-07
% O 0 1.532975968387973e-09
of O 0 5.891421239745398e-10
the O 0 1.3157935851992875e-09
offspring O 0 1.6909961431110787e-08
were O 0 1.0759368951340775e-09
affected O 0 4.270876430290116e-10
, O 0 8.033280637920193e-12
and O 0 9.102361225865607e-12
in O 0 2.626726613996766e-11
the O 0 4.122721608545987e-11
case O 0 9.257724448152871e-11
of O 0 8.906649723305904e-11
a O 0 9.006192319693795e-11
female O 0 3.231521994440101e-10
transmitting O 0 1.3456260994360036e-08
parent O 0 8.489732805649908e-10
, O 0 6.05643479811846e-10
68 O 0 3.2150833817468083e-07
. O 0 1.7340339297788887e-07

7 O 0 3.11164171762357e-06
% O 0 2.8079513825218783e-08
were O 0 9.099319520089466e-09
affected O 0 7.405222390843846e-08
. O 0 2.0349303042621614e-07

Studies O 0 5.96361417137814e-07
on O 0 5.984306028494757e-08
meiotic O 0 1.5085867744346615e-05
drive O 0 3.250316240155371e-06
in O 0 4.3479292344272835e-07
DM B-Disease 1 1.0
have O 0 2.6150468457331044e-09
shown O 0 2.2428876464419822e-11
increased O 0 1.1679841122047563e-11
transmission O 0 1.564110473084579e-11
of O 0 4.2128145590070165e-12
the O 0 1.1963961071836948e-11
larger O 0 6.18811252239837e-11
allele O 0 2.5052356023014255e-11
at O 0 8.315730742891603e-11
the O 0 7.402137236489637e-10
DM B-Disease 1 1.0
locus O 0 1.1096446428382478e-08
in O 0 5.193134811065647e-10
non O 0 5.0723770073091146e-08
- O 0 8.498568604409229e-07
DM O 1 1.0
heterozygotes O 0 7.775215635774657e-06
for O 0 2.2438367608401677e-08
CTGn O 0 7.131516031222418e-05
. O 0 2.685992797069048e-07

This O 0 1.8648064425974553e-08
study O 0 4.518602381153869e-09
provides O 0 1.9870731796101104e-11
further O 0 6.481323290563612e-12
evidence O 0 9.93944163085736e-11
that O 0 8.047481084294539e-12
the O 0 3.314361052275672e-08
DM B-Disease 1 1.0
expansion O 1 0.9471825957298279
tends O 0 1.9109184279386682e-07
to O 0 1.3862967718214492e-10
be O 0 3.950804128294294e-10
transmitted O 0 1.3271263199499117e-08
preferentially O 0 1.4346569798817654e-07
. O 0 8.3945302264965e-08

Diagnosis O 1 0.9986822009086609
of O 0 0.003905192483216524
hemochromatosis B-Disease 1 1.0
. O 1 0.9845371246337891

If O 0 3.226160697522573e-05
untreated O 1 1.0
, O 0 2.115047664119629e-06
hemochromatosis B-Disease 1 1.0
can O 0 8.711754730938992e-07
cause O 0 0.062122929841279984
serious O 0 0.01676999405026436
illness O 0 0.24546626210212708
and O 0 1.1592446447217242e-10
early B-Disease 0 1.8883074659470367e-08
death I-Disease 0 1.200472943274633e-09
, O 0 1.0794667026567395e-12
but O 0 3.315732454226006e-12
the O 0 8.74334771250318e-11
disease O 0 1.2831186113615445e-09
is O 0 3.281869567772766e-12
still O 0 1.6746819209156882e-11
substantially O 0 1.4460596053922359e-09
under O 0 3.715457239650277e-07
- O 0 0.22070395946502686
diagnosed O 1 0.7906764149665833
. O 0 1.2645034530578414e-06

The O 0 8.568540010855941e-07
cornerstone O 0 3.647029370767996e-05
of O 0 1.6662029977965176e-08
screening O 0 6.341649623209378e-07
and O 0 2.665808962465377e-10
case O 0 2.472840543443766e-10
detection O 0 4.210844561924887e-09
is O 0 3.2147357692524636e-12
the O 0 1.3406592676290519e-11
measurement O 0 1.3390097919341315e-09
of O 0 5.670134917146186e-10
serum O 0 7.709864746630046e-09
transferrin O 0 6.704060240281251e-08
saturation O 0 5.103090217062345e-08
and O 0 3.4627933853670356e-10
the O 0 7.671121515784307e-10
serum O 0 3.538679393955135e-08
ferritin O 0 1.2995234328627703e-06
level O 0 2.551106490500388e-07
. O 0 5.712563577731089e-08

Once O 0 1.0531242651268258e-06
the O 0 1.9550235208498634e-08
diagnosis O 0 9.008821507450193e-06
is O 0 4.933558006570138e-10
suspected O 0 1.6336889174795033e-08
, O 0 4.75405881328328e-10
physicians O 0 1.305602026491215e-08
must O 0 4.923161323056036e-10
use O 0 1.4809562465245563e-09
serum O 0 2.684018625132012e-07
ferritin O 0 1.5610537957400084e-05
levels O 0 6.0012342828486e-07
and O 0 1.0575971209902946e-08
hepatic O 0 0.015570808202028275
iron O 0 0.23192362487316132
stores O 0 5.227854558143008e-07
on O 0 4.962716104728315e-08
liver O 0 2.586490950307052e-07
biopsy O 0 3.517099855798733e-08
specimens O 0 2.172847013426349e-09
to O 0 1.6996532653523744e-11
assess O 0 9.842295867201756e-09
patients O 0 5.606794140078364e-09
for O 0 1.6248856427036884e-11
the O 0 2.3131854764990578e-10
presence O 0 2.972251889055144e-10
of O 0 2.3737232623943783e-08
iron B-Disease 1 0.9995515942573547
overload I-Disease 0 0.0016372411046177149
. O 0 1.1267921991020557e-06

Liver O 1 0.9996579885482788
biopsy O 0 0.44126051664352417
is O 0 8.579970511846113e-09
also O 0 9.982949883413639e-11
used O 0 7.862865220031878e-11
to O 0 3.743927737276387e-11
establish O 0 4.047473745050212e-10
the O 0 2.345242888779353e-10
presence O 0 8.811636836858483e-11
or O 0 3.6885647314299774e-10
absence O 0 1.7577349353814498e-07
of O 0 7.440276021952741e-07
cirrhosis B-Disease 1 1.0
, O 0 1.2433654106303038e-10
which O 0 3.864804743597405e-12
can O 0 1.908567401343042e-11
affect O 0 2.2324172732623992e-08
prognosis O 1 0.9999960660934448
and O 0 7.838289661776798e-08
management O 0 5.194854679757555e-07
. O 0 1.1784678832782447e-07

A O 0 5.856147140548273e-07
DNA O 0 7.276702973513238e-08
- O 0 2.5726892616262376e-08
based O 0 1.7656901496465593e-09
test O 0 5.77568881610091e-09
for O 0 2.6845758949178844e-10
the O 0 1.3160251555177638e-08
HFE O 0 0.0006483852048404515
gene O 0 1.139767502600364e-09
is O 0 4.85154711543645e-12
commercially O 0 1.8563088566292407e-10
available O 0 5.568716494874781e-12
, O 0 2.2711510677762142e-13
but O 0 8.119557001577682e-13
its O 0 1.1603096955470349e-12
place O 0 4.529962516208741e-11
in O 0 4.355506406927834e-12
the O 0 3.943800147565568e-11
diagnosis O 0 7.19486266120839e-08
of O 0 6.652802397866253e-08
hemochromatosis B-Disease 1 1.0
is O 0 1.5217958448943136e-08
still O 0 2.601633797283398e-09
being O 0 2.0006289958018897e-09
evaluated O 0 2.4689884980944043e-07
. O 0 9.250394583659727e-08

Currently O 0 2.8358208226109127e-08
, O 0 2.287003642020835e-10
the O 0 2.6911381456606875e-10
most O 0 1.000147534235829e-10
useful O 0 4.0225994757392414e-10
role O 0 2.925366199280077e-11
for O 0 1.5850066051315004e-11
this O 0 1.2902243509693712e-11
test O 0 2.4091719730279237e-09
is O 0 3.0438887087952393e-12
in O 0 1.4392936712251392e-12
the O 0 2.5051768385436768e-12
detection O 0 2.703414381244329e-09
of O 0 1.3074685334402147e-08
hemochromatosis B-Disease 1 1.0
in O 0 4.0110239751811605e-07
the O 0 5.6719258623161295e-08
family O 0 1.0661247579202282e-10
members O 0 1.3571760902608698e-12
of O 0 9.758766017498033e-11
patients O 0 7.029465010077729e-09
with O 0 9.112644666631198e-12
a O 0 7.462497841892457e-10
proven O 0 8.27263235692044e-08
case O 0 9.103642284458147e-09
of O 0 3.164479878137172e-08
the O 0 2.417300208890083e-07
disease O 0 1.7512306840217207e-06
. O 0 5.8532222624307906e-08

It O 0 1.9287844654769515e-09
is O 0 2.0919464771562701e-10
crucial O 0 2.08953601088524e-08
to O 0 3.0200617562314847e-09
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.008549878373742104
because O 0 1.3505557205917285e-07
phlebotomy O 1 0.9665822982788086
therapy O 0 4.54192741017323e-06
can O 0 6.307468991550991e-10
avert O 0 3.495785131235607e-05
serious O 1 0.9999494552612305
chronic O 1 1.0
disease O 0 0.026284288614988327
and O 0 2.7061214380452725e-10
can O 0 6.328201417743484e-12
even O 0 4.141416029557199e-11
lead O 0 1.0125741217725803e-10
to O 0 2.136303807465101e-11
normal O 0 8.335382162272253e-09
life O 0 1.970115404148487e-09
expectancy O 0 8.381326743744921e-09
. O 0 3.521365421477185e-10
. O 0 6.9346079989429654e-09

Prevalence O 0 1.1598888704611454e-05
of O 0 8.554336261568096e-08
the O 0 3.160158712489647e-07
I1307K O 0 0.0005138928536325693
APC B-Disease 0 3.7270694974722574e-06
gene O 0 2.6963904442567355e-09
variant O 0 1.0945665707140506e-08
in O 0 2.016319056163951e-10
Israeli O 0 1.2894236789406932e-09
Jews O 0 4.005556719643977e-10
of O 0 2.745356025846135e-11
differing O 0 2.8994148748573423e-10
ethnic O 0 1.5377655745996144e-11
origin O 0 1.3562174994152798e-10
and O 0 1.2452261444195756e-10
risk O 0 9.918259991081868e-09
for O 0 2.5707154804877064e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0003189356066286564

BACKGROUND O 0 0.0005727179814130068
& O 0 9.903866157401353e-06
AIMS O 0 3.733579205800197e-07
Israeli O 0 1.9134690276700894e-08
Jews O 0 3.2232503333062823e-09
of O 0 2.8881225189181237e-10
European O 0 2.600001769437199e-09
birth O 0 1.0080970014314516e-07
, O 0 6.646831696155431e-11
i O 0 4.402548464677025e-11
. O 0 6.077883855926114e-12
e O 0 1.3532890953682486e-11
. O 0 2.653220958909186e-12
, O 0 4.822081102473508e-12
Ashkenazim O 0 5.444565687184877e-08
, O 0 8.443119467460569e-12
have O 0 1.1270980676547637e-11
the O 0 2.065545734453167e-09
highest O 1 0.9996083378791809
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 9.064557104920823e-08
of O 0 2.9478675056537895e-10
any O 0 2.0118552657155675e-10
Israeli O 0 2.909655982819004e-08
ethnic O 0 1.895516188454849e-09
group O 0 7.540001401018515e-10
. O 0 2.8428703835459146e-09

The O 0 1.644448616389127e-06
I1307K O 0 0.0001572476903675124
APC B-Disease 0 5.177946604817407e-06
gene O 0 1.2565314122525706e-08
variant O 0 1.5852349122269516e-07
was O 0 7.181769490216539e-08
found O 0 1.776574665157682e-09
in O 0 3.376043666847295e-09
6 O 0 5.762003070231003e-07
. O 0 1.3495051121026336e-07

1 O 0 2.5129523351097305e-07
% O 0 8.063623102572137e-10
of O 0 1.7450718647893382e-10
American O 0 2.487585692989569e-10
Jews O 0 1.107394509425319e-09
, O 0 1.1217470528845919e-11
28 O 0 7.011197178385942e-10
% O 0 3.176539586924321e-11
of O 0 3.6216465937322084e-10
their O 0 4.384705789561849e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 9.093204425880685e-06
, O 0 3.0587195970488423e-11
but O 0 9.493976785290847e-12
not O 0 8.140012969226618e-12
in O 0 7.507350990865191e-11
non O 0 1.3267921872284205e-08
- O 0 2.5971337080932244e-08
Jews O 0 5.6915514079491913e-08
. O 0 1.5026097699433194e-08

We O 0 1.2357352829894808e-07
assessed O 0 8.648444804748578e-07
the O 0 3.7278010012187224e-08
I1307K O 0 3.4871527532231994e-06
prevalence O 0 3.2918187287123146e-08
in O 0 3.832873254894231e-11
Israeli O 0 2.584603919775219e-10
Jews O 0 2.033618273777904e-10
of O 0 1.814247536924274e-11
differing O 0 2.4822444100180974e-10
ethnic O 0 6.066220876316253e-12
origin O 0 6.828938803327134e-11
and O 0 4.4110628344418146e-11
risk O 0 5.38982147801903e-09
for O 0 1.9291154274014843e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00021255512547213584

METHODS O 0 7.2806774369382765e-06
DNA O 0 1.860713894075161e-07
samples O 0 1.7710304334173088e-08
from O 0 1.3548762112236545e-09
500 O 0 1.1092695650916085e-09
unrelated O 0 1.4447472107548265e-09
Jews O 0 1.3035709178765842e-09
of O 0 5.85103965278222e-10
European O 0 1.9207311297009255e-08
or O 0 1.4794767633219408e-09
non O 0 1.52836410194368e-08
- O 0 1.181735154176522e-09
European O 0 2.0793242128114287e-10
origin O 0 6.281162395760376e-11
, O 0 2.4864957098511e-13
with O 0 3.135511327575363e-14
or O 0 1.292405960896803e-12
without O 0 5.6649865354252427e-11
a O 0 3.0833266495555733e-11
personal O 0 6.845599642701927e-09
and O 0 2.640190732705605e-09
/ O 0 2.8940212359884754e-07
or O 0 3.854209840170597e-09
family O 0 8.13607514693615e-11
history O 0 1.8265676471340697e-10
of O 0 3.010392490843117e-10
neoplasia B-Disease 0 9.242543228538125e-07
, O 0 4.5707191503874256e-11
were O 0 1.0752962409377176e-10
examined O 0 8.61883897584903e-10
for O 0 2.7675422717421405e-11
the O 0 7.371366295139126e-10
I1307K O 0 3.836755624320176e-08
variant O 0 3.363138434409052e-09
by O 0 9.526161109940645e-11
the O 0 1.1711547009962686e-10
allele O 0 8.065525330946954e-11
- O 0 1.5512703621656243e-10
specific O 0 2.0345766738039117e-10
oligonucleotide O 0 6.547024611336383e-08
( O 0 6.636941551896314e-10
ASO O 0 9.733794286148623e-06
) O 0 8.406523255288789e-10
method O 0 9.014728163947439e-08
. O 0 5.1829779579293245e-08

RESULTS O 0 2.260648034280166e-05
In O 0 2.0794374222532497e-08
persons O 0 1.0718158582889714e-09
at O 0 5.455557672284783e-10
average O 0 1.1872430816239898e-09
risk O 0 3.433167972133333e-09
for O 0 1.0827149310443929e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1662466192774446e-07
I1307K O 0 1.9021269963559462e-06
was O 0 6.57274723536716e-09
found O 0 2.9236385534758824e-10
in O 0 5.693337468137827e-10
5 O 0 2.7386917622607143e-08
. O 0 1.873648081129886e-08

0 O 0 3.6017939919474884e-07
% O 0 9.389394817205243e-10
of O 0 3.8381056666203506e-10
120 O 0 3.0829767627693627e-09
European O 0 6.902502125427645e-09
and O 0 3.111308322090167e-09
1 O 0 6.811971502429515e-07
. O 0 1.8218780439838156e-07

6 O 0 2.8676647616521223e-06
% O 0 6.2605125528136796e-09
of O 0 2.7584912132283534e-09
188 O 0 5.113544787604951e-08
non O 0 3.693637395940641e-08
- O 0 1.2222540313189256e-08
European O 0 2.7179648753872243e-08
Jews O 0 2.622500439031228e-08
( O 0 8.683599672654196e-11
P O 0 1.8016126546172018e-07
= O 0 7.448448524627338e-10
0 O 0 1.4510631585196165e-09
. O 0 1.0588676463418878e-10
08 O 0 2.7237252453460314e-08
) O 0 4.64594251958772e-10
. O 0 1.1518403120192033e-08

It O 0 1.2976946628384667e-08
occurred O 0 3.9798175066607655e-07
in O 0 2.1402062344577644e-08
15 O 0 8.891370129049392e-08
. O 0 8.509324800343165e-08

4 O 0 3.592754183046054e-07
% O 0 2.0982813264680544e-09
of O 0 9.8800023717871e-10
52 O 0 1.7977228594645567e-08
Ashkenazi O 0 6.548773257009088e-08
Israelis O 0 1.507903846231784e-08
with O 0 8.933383477405243e-10
familial O 0 0.0007402857299894094
cancer B-Disease 1 0.9999986886978149
( O 0 1.6820751458368477e-09
P O 0 2.863120471374714e-06
= O 0 2.930919118515618e-10
0 O 0 2.59669979962851e-10
. O 0 8.949473974395605e-12
02 O 0 1.564481988403088e-09
) O 0 1.191560738966757e-12
and O 0 3.645782894329264e-12
was O 0 1.2520803838178551e-10
not O 0 1.466792139137585e-11
detected O 0 2.124477482823295e-09
in O 0 7.838820703653937e-10
51 O 0 5.242660083837336e-09
non O 0 9.449657945026502e-09
- O 0 5.664819280326583e-09
European O 0 3.413937355034591e-09
Jews O 0 1.3886791716544167e-09
at O 0 4.822380272884175e-10
increased O 0 3.717609997622162e-09
cancer B-Disease 0 2.9906601639595465e-07
risk O 0 2.7846228434214026e-08
. O 0 4.488479987685423e-08

Colorectal B-Disease 1 0.9999988079071045
neoplasia I-Disease 1 0.9991612434387207
occurred O 0 0.00011168576747877523
personally O 0 7.794012191197908e-08
or O 0 3.9138428609142295e-10
in O 0 1.5775396267070363e-10
the O 0 2.702531531895147e-10
families O 0 1.4038042429886932e-11
of O 0 7.849319805242061e-11
13 O 0 1.6169655892017687e-10
of O 0 4.0631756292874854e-10
20 O 0 1.5048862156419318e-09
Ashkenazi O 0 1.1875336269895342e-08
I1307K O 0 5.0280291929993837e-08
carriers O 0 1.7534004248531687e-09
, O 0 2.3787504951910954e-11
8 O 0 3.0898747449548125e-10
of O 0 1.0518851345509006e-09
whom O 0 1.7032312227271973e-09
also O 0 5.029114971688564e-11
had O 0 1.7299367494061357e-10
a O 0 8.781972371529889e-11
personal O 0 9.963899039178159e-09
or O 0 3.6384573132153264e-10
family O 0 1.3296561074405133e-10
history O 0 4.102258810423365e-10
of O 0 2.4472321946689135e-09
noncolonic O 0 0.00010226678568869829
neoplasia B-Disease 0 0.045357950031757355
. O 0 1.0944694395220722e-06

CONCLUSIONS O 0 1.640844129724428e-05
The O 0 6.917792916283361e-07
I1307K O 0 8.749757398618385e-05
APC O 0 5.483696440933272e-06
variant O 0 1.7252303905479494e-06
may O 0 8.942289753122168e-08
represent O 0 6.322890655496849e-09
a O 0 3.1126021760030653e-09
susceptibility O 0 1.1344109225319698e-06
gene O 0 1.0311214992952955e-08
for O 0 2.4755470562354276e-08
colorectal B-Disease 1 1.0
, I-Disease 0 2.6284303658030694e-06
or I-Disease 0 4.6021401090001746e-07
other I-Disease 0 6.724165757532319e-08
, I-Disease 0 3.348672450442791e-09
cancers I-Disease 0 2.3800488634151407e-05
in O 0 1.1821865264494136e-08
Ashkenazi O 0 4.1527979988131847e-07
Jews O 0 3.482262656007151e-08
, O 0 1.1606605954117555e-10
and O 0 3.9076217261957424e-10
partially O 0 7.483283326337187e-09
explains O 0 1.3422514488770076e-10
the O 0 3.716067731307504e-11
higher O 0 2.4286881394885995e-09
incidence O 0 1.0315503118363267e-08
of O 0 2.524433853068331e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.319942956802606e-09
European O 0 7.027990633901027e-09
Israelis O 0 5.111279843816874e-09
. O 0 5.291060034551265e-09

Systematic O 0 9.976907300313087e-09
analysis O 0 1.3908263429840417e-09
of O 0 8.657973893377857e-09
coproporphyrinogen O 0 0.0007122212555259466
oxidase O 0 9.84897997113876e-05
gene O 0 1.0524496474317857e-06
defects O 0 6.069455139368074e-06
in O 0 2.3889116462783022e-08
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 1.0
and O 0 3.6545773127727443e-06
mutation O 0 3.69440613212646e-07
update O 0 1.0492547062312951e-06
. O 0 4.58496742794523e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.249113458674401e-05
HC B-Disease 1 1.0
) O 0 3.231932055314246e-08
is O 0 6.125407403523297e-10
an O 0 2.0340489015335805e-10
acute O 1 0.9959509372711182
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 2.6412882903059653e-07
autosomal O 1 0.999991774559021
dominant O 1 0.9999821186065674
inheritance O 0 3.624257806222886e-05
caused O 0 4.2518614407072164e-08
by O 0 2.360924511446427e-10
deficient B-Disease 0 1.0260950311646866e-08
activity I-Disease 0 1.504589924872235e-10
of I-Disease 0 2.0739374106959474e-10
coproporphyrinogen I-Disease 0 7.496252237615408e-06
III I-Disease 1 1.0
oxidase I-Disease 0 0.00033747422276064754
( O 0 2.5358922073337453e-08
CPO O 0 1.593427987245377e-05
) O 0 1.6159553695160866e-09
. O 0 2.4698639577991344e-08

Clinical O 0 0.0013278445694595575
manifestations O 0 4.6843753807479516e-05
of O 0 1.0712103630794445e-06
the O 0 6.323200523183914e-07
disease O 0 0.0004471544816624373
are O 0 1.7234182830838662e-11
characterized O 0 2.602797838369142e-11
by O 0 8.333747754385445e-12
acute O 0 1.5467537650692975e-06
attacks O 0 7.823585113087006e-10
of O 0 0.00033999697188846767
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 3.0170291154263396e-08
precipitated O 0 2.7214390740937233e-09
by O 0 5.206442568739256e-11
drugs O 0 3.2244558134664203e-09
, O 0 1.4355410957178627e-11
fasting O 0 1.6705625327517737e-08
, O 0 3.0492436353668495e-10
cyclical O 0 1.712446191959316e-06
hormonal O 0 2.1058143317986833e-07
changes O 0 7.588293549076752e-09
, O 0 1.8702945858706244e-09
or O 0 2.584498872693075e-07
infectious B-Disease 0 0.3163605332374573
diseases I-Disease 0 7.338538125623018e-05
. O 0 4.295995665870578e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 2.1380868929554708e-05
also O 0 4.141531118051489e-09
be O 0 7.141330304882842e-10
present O 0 1.2400083626573633e-08
. O 0 8.681277563482581e-08

The O 0 7.624769295944134e-07
seven O 0 8.05231863409972e-08
exons O 0 1.0260014704499554e-07
, O 0 3.4570518669951866e-10
the O 0 3.437945261808295e-09
exon O 0 2.6120554252884176e-07
/ O 0 8.402122375628096e-08
intron O 0 3.6087629950998235e-07
boundaries O 0 5.098573119255434e-09
and O 0 2.769122708912164e-10
part O 0 4.4932466081171185e-10
of O 0 4.6631498662463855e-09
3 O 0 7.39092476109704e-09
noncoding O 0 2.2343586980611008e-09
sequence O 0 2.6020284885075462e-11
of O 0 9.771324860352593e-10
the O 0 2.3374793656216752e-08
CPO O 0 1.5481615491808043e-06
gene O 0 6.823344111950291e-10
were O 0 5.664838043095699e-10
systematically O 0 1.4113328561382588e-10
analyzed O 0 1.0529706967465913e-10
by O 0 4.31879566831217e-11
an O 0 1.8138912247223082e-11
exon O 0 8.828384245873622e-09
- O 0 3.510336021861349e-09
by O 0 3.45284290048653e-09
- O 0 1.2060893368470715e-06
exon O 0 9.708371635497315e-07
denaturing O 0 5.167350536794402e-06
gradient O 0 3.314396224141092e-07
gel O 0 1.1039516323307907e-07
electrophoresis O 0 2.0747346951566215e-08
( O 0 3.90041388076412e-10
DGGE O 0 2.1293166355462745e-05
) O 0 1.0832090779899772e-10
strategy O 0 1.1612413253203613e-09
followed O 0 6.988683243225324e-11
by O 0 6.170971286051374e-12
direct O 0 9.366601938509689e-11
sequencing O 0 6.6416681043790504e-09
in O 0 5.591050400433062e-10
seven O 0 1.7937832330616743e-09
unrelated O 0 1.6252189993792854e-07
heterozygous O 0 1.4184581687004538e-07
HC B-Disease 1 0.9999932050704956
patients O 0 3.646834102255525e-06
from O 0 1.3597043491131444e-09
France O 0 2.0580028792238636e-09
, O 0 7.654455541628025e-11
Holland O 0 3.479991761423662e-08
, O 0 6.401199709182848e-11
and O 0 1.705642571625532e-10
Czech O 0 2.7599986651694053e-07
Republic O 0 1.882252576024257e-07
. O 0 1.0428501582282479e-06

Seven O 0 2.0666482214437565e-06
novel O 0 5.046188107371563e-07
mutations O 0 1.290822115862511e-08
and O 0 3.527092506949714e-10
two O 0 8.25660581571519e-11
new O 0 3.3241596142374874e-09
polymorphisms O 0 1.251691656989351e-07
were O 0 1.4737630671390889e-08
detected O 0 4.290112372018484e-07
. O 0 1.5859016855301888e-07

Among O 0 8.321857194459881e-07
these O 0 9.722528560018873e-09
mutations O 0 1.89283189122591e-09
two O 0 1.9321859390242224e-10
are O 0 2.89165025257887e-10
missense O 0 2.644822245656542e-07
( O 0 2.0408573442320943e-10
G197W O 0 7.878441579123319e-07
, O 0 1.7494108939253294e-10
W427R O 0 4.8872770719299297e-08
) O 0 1.60211253985576e-11
, O 0 7.478734645460783e-12
two O 0 6.105560067942717e-12
are O 0 2.122806444515568e-11
nonsense O 0 1.187175779904237e-08
( O 0 5.749095643992064e-11
Q306X O 0 1.0233806335691042e-07
, O 0 8.332257800391929e-11
Q385X O 0 2.6512635642461646e-08
) O 0 2.410180735545886e-11
, O 0 1.0428785439386967e-11
two O 0 2.798813047641402e-12
are O 0 6.304576652405025e-12
small O 0 3.2233948149551495e-11
deletions O 0 1.696474516421631e-09
( O 0 1.4292171612861893e-10
662de14bp O 0 2.830026346600789e-07
; O 0 9.576647252984571e-10
1168del3bp O 0 9.148412232207193e-07
removing O 0 1.1946767131121305e-07
a O 0 9.189732863568167e-10
glycine O 0 1.8527088752051668e-09
at O 0 1.0030484887124658e-08
position O 0 4.039162337932112e-09
390 O 0 4.123968277980339e-09
) O 0 5.712856836898039e-12
, O 0 3.9292622974751445e-12
and O 0 3.908586995726715e-12
one O 0 3.5210259187457016e-12
is O 0 1.4427072817652098e-12
a O 0 1.3123810198301111e-11
splicing O 0 3.930932468421133e-09
mutation O 0 1.204482069638857e-09
( O 0 3.420216887484173e-11
IVS1 O 0 2.8803194709325908e-06
- O 0 2.4503162165956383e-08
15c O 0 3.504361245632026e-07
- O 0 6.379535122391644e-09
- O 0 3.5305605106117355e-09
> O 0 1.213216549444951e-08
g O 0 3.920957780678691e-09
) O 0 4.803684360010774e-12
which O 0 8.31001760459582e-12
creates O 0 7.580473748713956e-11
a O 0 4.022658942059998e-11
new O 0 3.263783909801532e-09
acceptor O 0 2.4942357867985265e-07
splice O 0 5.462520675791893e-06
site O 0 3.528290903886955e-07
. O 0 5.7030486999565255e-08

The O 0 8.399687345672646e-08
pathological O 0 7.957593197716051e-07
significance O 0 8.232055392909388e-08
of O 0 2.5341950760093823e-08
the O 0 1.7058003010106404e-08
point O 0 2.1592599708242233e-08
mutations O 0 7.546461233687296e-10
G197W O 0 7.48084616475353e-08
, O 0 1.338309463250198e-10
W427R O 0 1.979041002186932e-07
, O 0 1.7197480939312726e-10
and O 0 1.5620005289207484e-10
the O 0 8.347580404688415e-10
in O 0 9.849013826723763e-10
- O 0 6.247129036296428e-09
frame O 0 1.1098880925430876e-08
deletion O 0 2.712344571165204e-09
390delGly O 0 8.234752435498649e-09
were O 0 1.8334858631341433e-10
assessed O 0 5.048522155881585e-10
by O 0 6.284074649531846e-11
their O 0 3.3441516222865175e-10
respective O 0 3.5469418513400797e-09
expression O 0 4.57607757242684e-10
in O 0 3.471666704113474e-11
a O 0 2.1247548859237853e-11
prokaryotic O 0 1.1378999076328e-08
system O 0 8.148720587186631e-10
using O 0 1.9442226995014522e-10
site O 0 6.211934966415811e-09
- O 0 1.2036834640127836e-08
directed O 0 6.095457916188707e-09
mutagenesis O 0 1.1870875823660754e-05
. O 0 8.194332679067884e-08

These O 0 1.1745359351778006e-08
mutations O 0 2.615405891859268e-09
resulted O 0 3.3333402704727177e-09
in O 0 2.0769419517563392e-10
the O 0 2.889703754060946e-10
absence O 0 1.2209375732652461e-08
or O 0 1.0162018448944821e-10
a O 0 2.829133628756697e-11
dramatic O 0 7.046899175300325e-10
decrease O 0 1.744793998170735e-08
of O 0 1.0711407867347589e-06
CPO O 0 0.003712986595928669
activity O 0 3.196504110292153e-07
. O 0 5.434958083583297e-08

The O 0 2.6146099685320223e-07
two O 0 7.11061698410731e-09
polymorphisms O 0 1.5184042467808467e-07
were O 0 7.69821184576358e-09
localized O 0 9.963940783563885e-08
in O 0 3.7884828607559484e-09
noncoding O 0 1.430282736691879e-07
part O 0 1.2086681655532061e-09
of O 0 9.957363822366005e-09
the O 0 5.0264925555154605e-09
gene O 0 8.861120170955417e-11
1 O 0 7.447639172042386e-10
) O 0 2.4655147715102466e-12
a O 0 4.655147101129131e-11
C O 0 1.0095054392422753e-07
/ O 0 4.156289534762436e-09
G O 0 3.904764867002086e-08
polymorphism O 0 1.3437275736549736e-09
in O 0 8.315428901006783e-11
the O 0 1.2663375903443352e-09
promotor O 0 7.118883331713732e-07
region O 0 7.0387220496570535e-09
, O 0 2.66827615558185e-10
142 O 0 1.609441113714638e-08
bp O 0 4.1448027232604545e-09
upstream O 0 2.7603281882448982e-09
from O 0 7.60587703929616e-11
the O 0 1.7247971106915116e-10
transcriptional O 0 2.077688954216228e-08
initiation O 0 2.0960424507165953e-08
site O 0 8.259291028878124e-09
( O 0 2.051487452137124e-11
- O 0 4.912939388646009e-09
142C O 0 3.85521246926146e-07
/ O 0 3.730788478151226e-08
G O 0 6.550635021085327e-07
) O 0 5.7976470846377026e-11
, O 0 1.7067415189475632e-11
and O 0 4.3442083264011444e-11
2 O 0 9.845106951900107e-10
) O 0 1.65708557986477e-11
a O 0 2.3589663555867446e-10
6 O 0 6.200570723535748e-09
bp O 0 3.240281820637847e-09
deletion O 0 5.656891621796944e-10
polymorphism O 0 1.2768296420162528e-09
in O 0 1.362671364635304e-10
the O 0 2.203462828864744e-10
3 O 0 1.0477984035972554e-09
noncoding O 0 8.27094126520933e-09
part O 0 2.1858399812391127e-10
of O 0 4.703372802339345e-09
the O 0 3.2603486488369526e-07
CPO O 0 3.683685645228252e-05
gene O 0 8.641443116630398e-09
, O 0 9.847717086231e-10
574 O 0 1.3190866354761965e-07
bp O 0 9.37165012260266e-09
downstream O 0 6.000246965953693e-09
of O 0 2.4161148082235684e-10
the O 0 7.891802489279343e-11
last O 0 7.685719422001469e-11
base O 0 1.7102162741533533e-10
of O 0 1.0499384001105838e-10
the O 0 1.894965850901542e-10
normal O 0 1.8305723603617707e-09
termination O 0 4.3443144193133776e-08
codon O 0 3.700781192605973e-08
( O 0 5.81283021716672e-10
+ O 0 1.2733718968149788e-08
574 O 0 1.423329507588278e-07
delATTCTT O 0 7.575092695333296e-07
) O 0 2.6711697298509307e-09
. O 0 7.071019325621819e-08

Five O 0 2.1313799152267165e-06
intragenic O 0 8.135398093145341e-05
dimorphisms O 0 6.820353155490011e-05
are O 0 2.517577479821398e-09
now O 0 2.4306007206931213e-10
well O 0 7.675479002378083e-11
characterized O 0 1.3140297183689142e-10
and O 0 3.205375895265483e-11
the O 0 1.6844406425242653e-10
high O 0 3.6069374154124034e-09
degree O 0 2.407610333321486e-09
of O 0 1.981859343302972e-09
allelic O 0 3.527318881424435e-07
heterogeneity O 0 1.8794830225488113e-07
in O 0 4.566811373507562e-09
HC B-Disease 1 0.9957435727119446
is O 0 1.2274139482570945e-09
demonstrated O 0 1.5344913117942838e-09
with O 0 8.20082109859177e-12
seven O 0 3.145237542634405e-11
new O 0 2.837417974188572e-11
different O 0 8.44324870435953e-12
mutations O 0 1.3536350859655322e-11
making O 0 1.2425397516446779e-11
a O 0 4.3162569872412515e-12
total O 0 2.3611935323630817e-11
of O 0 2.9977484938825683e-09
nineteen O 0 0.00010398322774562985
CPO O 1 0.6593405604362488
gene B-Disease 0 3.9246830851880077e-07
defects I-Disease 0 2.104737404806656e-06
reported O 0 1.9258583616732494e-09
so O 0 6.211090530783281e-10
far O 0 5.890210985626254e-09
. O 0 1.7039005761887438e-09
. O 0 2.8338094537616598e-08

Coincidence O 0 2.1509051748580532e-06
of O 0 3.368262824210433e-08
two O 0 1.4018336491616878e-09
novel O 0 4.469429626396959e-08
arylsulfatase O 0 2.4380171907978365e-06
A O 0 5.7658958496631385e-08
alleles O 0 9.525334299098631e-09
and O 0 4.107778561746045e-10
mutation O 0 2.035575263903411e-09
459 O 0 1.0813193895842232e-08
+ O 0 2.008458954705361e-09
1G O 0 1.3485135923474445e-06
> O 0 1.549864059313677e-08
A O 0 2.125146059128724e-09
within O 0 4.289391897227546e-10
a O 0 8.003079449148132e-11
family O 0 5.115205134464951e-11
with O 0 1.4820066007725785e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 8.631851899920662e-10
molecular O 0 1.2055806353217235e-09
basis O 0 2.12703493707167e-10
of O 0 1.7378938566015023e-10
phenotypic O 0 3.4064990472870704e-07
heterogeneity O 0 2.397979005763773e-05
. O 0 3.539892077242257e-06

In O 0 4.729698233063573e-08
a O 0 2.7032855953734725e-09
family O 0 3.344024224194442e-10
with O 0 2.2463727059052196e-11
three O 0 1.1243679320926958e-09
siblings O 0 5.1107857501619947e-08
, O 0 1.7028656262851882e-11
one O 0 7.467246439241126e-12
developed O 0 3.0232527592488623e-10
classical O 0 1.1206136463215444e-07
late O 0 0.0001266243343707174
infantile O 1 0.6163619756698608
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.1622389979067975e-09
MLD B-Disease 1 1.0
) O 0 3.0774999215665844e-10
, O 0 3.669448078724713e-11
fatal O 0 2.127003462248922e-09
at O 0 1.3187558822735923e-09
age O 0 7.521002487465012e-09
5 O 0 4.840275402706595e-10
years O 0 6.972971505758707e-11
, O 0 5.411156765722236e-12
with O 0 2.841902581318667e-11
deficient O 0 2.2926917608856456e-06
arylsulfatase O 0 0.0002549916098359972
A O 0 1.4146663488645572e-05
( O 0 4.205482628805157e-09
ARSA O 0 1.0681931598810479e-05
) O 0 2.322707477742103e-11
activity O 0 8.26736804016015e-11
and O 0 8.422194365531599e-12
increased O 0 1.8615573527114293e-09
galactosylsulfatide O 0 9.028865315485746e-05
( O 0 5.300780259176463e-08
GS O 1 1.0
) O 0 9.657268762452986e-09
excretion O 0 7.231017207232071e-07
. O 0 6.925134243829234e-08

The O 0 1.203694210971662e-07
two O 0 9.99505367360598e-10
other O 0 1.3552122757332086e-09
siblings O 0 1.982427875191206e-07
, O 0 4.1141534623534426e-10
apparently O 0 1.0644742332033275e-07
healthy O 0 7.643583899152873e-08
at O 0 1.5582109824663348e-08
12 O 0 6.4248144582279565e-09
( O 0 1.6883059186789673e-11
1 O 0 1.4767767453349734e-08
/ O 0 3.6544420822792745e-09
2 O 0 1.6828165527726924e-09
) O 0 4.423387003904544e-12
and O 0 1.7924885534204016e-11
15 O 0 3.027995215676427e-11
years O 0 2.4016637636958826e-11
, O 0 2.3103081947528636e-12
respectively O 0 6.107531841381686e-11
, O 0 3.6066911176385608e-12
and O 0 6.251386994865493e-12
their O 0 2.910090050878278e-11
father O 0 5.516582746167842e-10
, O 0 5.859524671025795e-11
apparently O 0 5.55811352498381e-09
healthy O 0 8.109756199914386e-10
as O 0 1.855904319114643e-11
well O 0 4.983567378213927e-11
, O 0 3.6869309688603025e-11
presented O 0 3.190333686120539e-08
ARSA O 0 0.00028025504434481263
and O 0 1.706604280116153e-08
GS O 1 0.9999991655349731
values O 0 6.6060281689317435e-09
within O 0 2.2997677373570724e-10
the O 0 6.365453303347479e-11
range O 0 5.587151630237486e-09
of O 0 2.299770152092151e-08
MLD B-Disease 1 1.0
patients O 1 0.9993311166763306
. O 0 1.0893139688050724e-06

Mutation O 0 2.18751949887519e-07
screening O 0 1.1230808638629242e-07
and O 0 3.0032354381148707e-10
sequence O 0 3.919996965917605e-11
analysis O 0 3.7554064025169254e-11
disclosed O 0 9.198483086336751e-10
the O 0 4.331634217979996e-10
involvement O 0 6.179151634810864e-10
of O 0 3.752711030813316e-09
three O 0 2.7411257708109815e-09
different O 0 1.618081135745797e-08
ARSA O 0 0.0007453226135112345
mutations O 0 2.768352880266889e-09
being O 0 1.8109674870814274e-10
the O 0 5.1778713261452225e-11
molecular O 0 2.788584918533843e-10
basis O 0 3.422072070158322e-10
of O 0 7.826689296663858e-10
intrafamilial O 0 1.549678563605994e-05
phenotypic O 0 2.372471135458909e-05
heterogeneity O 0 9.791604679776356e-05
. O 0 2.994183887494728e-06

The O 0 9.100416775709164e-08
late O 0 4.2925821617245674e-05
infantile O 0 0.00013102192315272987
patient O 0 6.404918167390861e-06
inherited O 0 1.131089106820582e-06
from O 0 5.33517585665777e-08
his O 0 3.439573603714052e-08
mother O 0 5.4091313650417305e-09
the O 0 4.002639053535262e-10
frequent O 0 3.3871358495751736e-10
0 O 0 1.8962251768783744e-09
- O 0 1.1857765880307625e-09
type O 0 6.2938805278633936e-09
mutation O 0 3.046675578488589e-09
459 O 0 3.667667725082424e-09
+ O 0 2.7358590393156135e-10
1G O 0 9.333246708820297e-08
> O 0 1.3017297240125458e-09
A O 0 4.896584249181046e-10
, O 0 4.4023448081409455e-12
and O 0 3.9661420848935425e-12
from O 0 4.5117513891579364e-11
his O 0 3.1024890989606035e-10
father O 0 8.949584962003598e-10
a O 0 4.481578302906186e-11
novel O 0 1.405547123134454e-09
, O 0 1.2147312669630317e-11
single O 0 1.0022825625011222e-10
basepair O 0 8.675351637066342e-08
microdeletion O 0 2.5993273311542e-07
of O 0 7.851543415426931e-09
guanine O 0 1.9921763794172875e-08
at O 0 3.5121374697411056e-09
nucleotide O 0 2.538552479336431e-09
7 O 0 3.471405163324448e-09
in O 0 3.7360969873390104e-10
exon O 0 3.635048528849438e-08
1 O 0 1.8145549063319777e-08
( O 0 2.693053280378166e-10
7delG O 0 6.151018396849395e-07
) O 0 4.570532396996896e-09
. O 0 8.364881409761438e-08

The O 0 2.2779731523314695e-07
two O 0 2.8295747966922136e-08
clinically O 0 0.0006221172516234219
unaffected O 0 6.883648893563077e-05
siblings O 0 1.847664066190191e-07
carried O 0 6.412983477588341e-10
the O 0 8.104684146026386e-10
maternal O 0 2.9210218244202224e-08
mutation O 0 3.817380633819312e-09
459 O 0 6.457151613403767e-08
+ O 0 3.730615816266436e-09
1G O 0 1.1316468544464442e-06
> O 0 1.265116722493076e-08
A O 0 1.2935126303403877e-09
and O 0 2.3327770271031056e-11
, O 0 2.7673930855232065e-12
on O 0 7.216967301548749e-11
their O 0 4.041623979933462e-11
paternal O 0 1.7345930247714136e-09
allele O 0 2.113987179752641e-10
, O 0 6.024411872140867e-12
a O 0 2.3017062214525374e-11
novel O 0 1.4531902348124959e-09
cytosine O 0 6.92576163086045e-10
to O 0 7.546917951684051e-11
thymidine O 0 4.1677068907119974e-08
transition O 0 4.181360147015312e-09
at O 0 6.363809035292434e-09
nucleotide O 0 4.202277992249037e-08
2435 O 0 8.196986527764238e-06
in O 0 5.597487806596746e-09
exon O 0 9.731510886012984e-08
8 O 0 2.7040076844286887e-09
, O 0 1.0809362085972829e-11
resulting O 0 9.513287380080726e-11
in O 0 2.6032844283041534e-11
substitution O 0 7.615422070728073e-09
of O 0 1.3217903438444978e-09
alanine O 0 9.088843455629103e-09
464 O 0 3.3945770638865724e-08
by O 0 2.646725061339339e-09
valine O 0 9.427281497664808e-07
( O 0 2.477657412569556e-09
A464V O 0 2.661724693098222e-06
) O 0 4.091485372725856e-09
. O 0 5.472488595614777e-08

The O 0 4.179145776106452e-07
fathers O 0 4.3320480358488567e-07
genotype O 0 1.448052273644862e-07
thus O 0 5.983356032857046e-09
was O 0 1.6963847215833994e-08
7delG O 0 3.6647227261710213e-06
/ O 0 5.913604127272265e-06
A464V O 0 5.2247683925088495e-05
. O 0 6.115047312960087e-07

Mutation O 0 1.875015868790797e-06
A464V O 0 6.700961876049405e-06
was O 0 1.0899915636741753e-08
not O 0 3.458013042578756e-11
found O 0 2.7108832539868288e-11
in O 0 2.7314988812476848e-11
18 O 0 1.4224217359526392e-09
unrelated O 0 2.485346385583398e-06
MLD B-Disease 1 1.0
patients O 1 0.9999748468399048
and O 0 9.58025125896711e-09
50 O 0 1.6393073565268423e-08
controls O 0 5.191555985106788e-08
. O 0 2.50960169978498e-07

A464V O 0 4.669981717597693e-05
, O 0 6.699430343815038e-09
although O 0 8.973279008728241e-09
clearly O 0 3.620130684112155e-08
modifying O 0 1.0795545676955953e-05
ARSA O 1 0.9999995231628418
and O 0 3.0939054340706207e-06
GS O 1 1.0
levels O 0 2.7063879315392114e-06
, O 0 1.6191013807453913e-10
apparently O 0 6.940572561120462e-10
bears O 0 2.2276185340786014e-09
little O 0 3.955929681054293e-11
significance O 0 2.2329603444060098e-10
for O 0 3.391019062770617e-11
clinical O 0 6.357670390144676e-09
manifestation O 0 5.8467389152383475e-08
of O 0 1.3909111373777705e-07
MLD B-Disease 1 1.0
, O 0 1.0757937651817429e-08
mimicking O 0 1.0743178080474536e-07
the O 0 1.0974891218040739e-08
frequent O 0 9.246337384638537e-08
ARSA O 0 0.0010836325818672776
pseudodeficiency O 0 0.00026074767811223865
allele O 0 1.0046473107649945e-05
. O 0 1.1262325187999522e-06

Our O 0 2.6312542900086555e-07
results O 0 2.4287354349894485e-08
demonstrate O 0 2.846017199686912e-09
that O 0 2.7845002779219863e-12
in O 0 2.3045045038916356e-11
certain O 0 1.9383540605932836e-10
genetic O 0 7.3862604921259845e-09
conditions O 0 3.063262192881666e-05
MLD B-Disease 1 1.0
- O 1 0.9999995231628418
like O 0 3.191446467099013e-06
ARSA O 1 0.9998599290847778
and O 0 2.5459048202947088e-08
GS O 1 1.0
values O 0 3.174434715091934e-09
need O 0 7.015005937249796e-11
not O 0 2.080869331011481e-12
be O 0 3.4505529943745783e-12
paralleled O 0 8.830012832028444e-10
by O 0 7.95658261498744e-11
clinical O 0 1.3093010693410179e-06
disease O 0 6.720166112472725e-08
, O 0 8.825963397629533e-12
a O 0 8.099189721666455e-12
finding O 0 1.9142740170785544e-10
with O 0 6.576988086093305e-12
serious O 0 1.720406039851241e-08
diagnostic O 0 1.3396740541793406e-05
and O 0 2.237660723380941e-08
prognostic O 1 0.9999887943267822
implications O 0 7.446989184245467e-05
. O 0 3.81247531322515e-07

Moreover O 0 9.007936569105368e-06
, O 0 3.428556638596092e-08
further O 0 3.3980822422563506e-07
ARSA O 0 0.005625202786177397
alleles O 0 4.4266664644965203e-07
functionally O 0 3.625458333544884e-08
similar O 0 3.879394583350404e-10
to O 0 2.7550350889526953e-10
A464V O 0 8.583024282415863e-07
might O 0 3.4515654778743965e-09
exist O 0 1.395161625117325e-10
which O 0 8.021858351192623e-12
, O 0 6.649999127750217e-12
together O 0 2.2214797276015608e-12
with O 0 2.0070774469499453e-12
0 O 0 9.132163469871557e-09
- O 0 2.467886162094146e-08
type O 0 7.730615436685184e-08
mutations O 0 2.4118111952020627e-09
, O 0 3.005760917940137e-11
may O 0 4.200769065931809e-09
cause O 0 7.635087513335748e-07
pathological O 1 0.9999783039093018
ARSA O 1 0.999996542930603
and O 0 1.742069741794694e-07
GS O 1 1.0
levels O 0 5.6837080819605035e-08
, O 0 2.2519484107336174e-12
but O 0 1.2274870789946712e-12
not O 0 8.958230207981033e-13
clinical O 0 4.2060585569991815e-10
outbreak O 0 1.4215132404515884e-09
of O 0 1.1420436818454505e-09
the O 0 9.370899611838013e-09
disease O 0 1.653088901321098e-07
. O 0 9.845012582943014e-10
. O 0 1.2160057849541772e-08

Human O 0 0.001425404567271471
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.0004593113553710282
to O 0 3.8351427633642743e-07
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 0.9999997615814209
and O 0 3.1743672934680944e-07
neurofibromatosis B-Disease 1 0.9997557997703552
type I-Disease 0 2.7837104425998405e-05
1 I-Disease 0 2.7261447030468844e-05
. O 0 3.0621919222539873e-07

Heterozygous O 0 1.2596266287800972e-06
germ O 0 4.08004671044182e-05
- O 0 8.357583851648087e-07
line O 0 1.5289886334812763e-07
mutations O 0 1.3883190153052283e-09
in O 0 9.336492690081855e-11
the O 0 6.389151430141737e-10
DNA O 0 3.54429943172363e-08
mismatch O 0 0.0002772053994704038
repair O 0 1.162786065833643e-05
genes O 0 3.979023688316374e-08
lead O 0 2.580862634715686e-08
to O 0 2.1040614583967e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006012780359014869

The O 0 5.436750711851346e-07
disease O 0 8.800914201856358e-07
susceptibility O 0 8.693619975019828e-07
of O 0 1.2664160919939604e-07
individuals O 0 3.3046443359552313e-09
who O 0 3.5089100514085203e-09
constitutionally O 0 1.7822237907694216e-07
lack O 0 3.1554627639707178e-06
both O 0 3.1034255165707236e-09
wild O 0 7.775052068836885e-08
- O 0 2.6229542982036946e-09
type O 0 7.554731062953124e-09
alleles O 0 1.4581378326994354e-09
is O 0 3.133220419226923e-11
unknown O 0 6.972686428241559e-09
. O 0 4.511429008147161e-09

We O 0 4.86813043210077e-08
have O 0 5.647038392453396e-10
identified O 0 1.2958042416855164e-09
three O 0 1.0585142484753618e-10
offspring O 0 3.4736968856918793e-09
in O 0 1.435199598054382e-10
a O 0 2.7435631544392436e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0001060283393599093
who O 0 1.0521500337645762e-09
developed O 0 1.7810853591981868e-07
hematological B-Disease 1 0.9999983310699463
malignancy I-Disease 1 0.999771773815155
at O 0 2.7323210360918893e-08
a O 0 3.998959149931203e-11
very O 0 2.90737694336185e-11
early O 0 7.400926538281283e-09
age O 0 2.564863210707813e-09
, O 0 4.453830533546199e-12
and O 0 6.658121536745609e-12
at O 0 8.593752098828844e-11
least O 0 1.0327239931273713e-11
two O 0 3.355546743244453e-12
of O 0 5.300246699868616e-11
them O 0 1.4894275049415207e-11
displayed O 0 4.958482513472973e-10
signs O 0 1.4004413184665054e-09
of O 0 3.0677143048052358e-09
neurofibromatosis B-Disease 0 7.45662473491393e-05
type I-Disease 0 5.092666697237291e-07
1 I-Disease 0 8.136006499626092e-07
( O 0 3.4077312083269362e-09
NF1 B-Disease 0 0.00014628797362092882
) O 0 8.065134338153257e-09
. O 0 1.3426016209905356e-07

DNA O 0 6.376690464549029e-08
sequence O 0 6.201537616767894e-10
analysis O 0 1.0762093299865327e-10
and O 0 4.1011853635364304e-11
allele O 0 2.0726680094451666e-10
- O 0 1.9848808707756405e-10
specific O 0 6.967029730908791e-11
amplification O 0 1.0426552954356794e-08
in O 0 3.412699012272924e-10
two O 0 1.9300053222259805e-10
siblings O 0 1.3436205925643208e-08
revealed O 0 2.405039944974874e-09
a O 0 1.161990170750471e-09
homozygous O 0 3.575772495878482e-07
MLH1 O 0 0.0018975927960127592
mutation O 0 3.305812157350374e-08
( O 0 6.740052960196863e-11
C676T O 0 6.002687769068871e-08
- O 0 3.0411442253353016e-08
- O 0 6.448720313301237e-08
> O 0 3.9487821368311415e-07
Arg226Stop O 0 9.354754183732439e-06
) O 0 2.1036310471345132e-09
. O 0 1.1899324192654603e-08

Thus O 0 2.501635094631638e-07
, O 0 1.3729247738680783e-09
a O 0 6.705921928862324e-10
homozygous O 0 4.9179291750078846e-08
germ O 0 0.0002084181469399482
- O 0 1.3983614735479932e-05
line O 0 2.0415625840541907e-05
MLH1 O 1 0.9807524085044861
mutation O 0 1.7267086604988435e-07
and O 0 1.1490574047812174e-09
consequent O 0 0.1525810807943344
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9993894100189209
results O 0 3.0849142262923124e-07
in O 0 4.559926658487257e-09
a O 0 1.6431161986574239e-09
mutator O 0 0.0010955370962619781
phenotype O 0 1.64514204925581e-07
characterized O 0 7.264534529483058e-10
by O 0 2.21488175022877e-10
leukemia B-Disease 1 0.9999998807907104
and O 0 1.706191369521548e-06
/ O 1 0.9999994039535522
or O 1 0.6025470495223999
lymphoma B-Disease 1 1.0
associated O 0 1.6692600183887407e-05
with O 0 2.5717914908796047e-08
neurofibromatosis B-Disease 1 0.9999978542327881
type I-Disease 0 4.973290288035059e-06
1 I-Disease 0 8.977372090157587e-07
. O 0 9.525880528826747e-09
. O 0 2.9724532168984297e-08

Missense O 0 0.0012431778013706207
mutations O 0 3.2707563946132723e-07
in O 0 2.826854750281882e-09
the O 0 1.8725576644840203e-09
most O 0 4.559002342308105e-10
ancient O 0 1.235975322089189e-08
residues O 0 7.86309861666723e-09
of O 0 3.7096412608406126e-09
the O 0 2.383791120053047e-08
PAX6 O 0 0.029117649421095848
paired O 0 6.164606958236618e-08
domain O 0 8.90524898267131e-09
underlie O 0 2.367835882921554e-08
a O 0 1.4384662905264634e-10
spectrum O 0 3.522377483022865e-07
of O 0 4.076305515354761e-08
human O 0 1.9555774997570552e-05
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0025536289904266596

Mutations O 0 3.518335347507673e-07
of O 0 1.2936393289919579e-08
the O 0 1.1583042969220969e-08
human O 0 1.6707918604197403e-08
PAX6 O 1 0.9986889958381653
gene O 0 8.248713356806547e-07
underlie O 1 0.9868812561035156
aniridia B-Disease 1 1.0
( O 0 0.10768602043390274
congenital B-Disease 1 1.0
absence I-Disease 1 0.5893892049789429
of I-Disease 0 0.0007845781510695815
the I-Disease 0 1.167063828688697e-06
iris I-Disease 0 1.166088622994721e-05
) O 0 1.8190570577614196e-11
, O 0 3.2551064708258304e-12
a O 0 1.2070198139590982e-11
rare O 0 3.5708922041521873e-08
dominant O 0 0.05551236495375633
malformation B-Disease 1 0.9999998807907104
of I-Disease 1 0.9965830445289612
the I-Disease 1 0.891975998878479
eye I-Disease 1 0.9999617338180542
. O 0 2.2828583041700767e-06

The O 0 1.9893084868272126e-07
spectrum O 0 5.421205969469156e-06
of O 0 7.397408126053051e-07
PAX6 O 1 0.9999986886978149
mutations O 0 1.3523903135137516e-06
in O 0 6.479110936652432e-08
aniridia B-Disease 1 1.0
patients O 0 0.0027578400913625956
is O 0 5.6848161594791335e-11
highly O 0 2.4820610011744293e-09
biased O 0 1.0638928626960364e-09
, O 0 8.523829211903866e-12
with O 0 2.5467156595376794e-12
92 O 0 2.4600753434356193e-08
% O 0 2.874574016320519e-11
of O 0 1.0065739214359937e-10
all O 0 8.028627762612928e-11
reported O 0 3.4798225412302486e-10
mutations O 0 5.862075824758506e-10
leading O 0 2.9255420308516022e-09
to O 0 9.096828845756022e-11
premature O 0 2.2147403910821595e-08
truncation O 0 5.3952966538872715e-08
of O 0 1.833886287272435e-08
the O 0 2.7595594698226478e-09
protein O 0 1.1533325405821415e-09
( O 0 1.708207186812416e-11
nonsense O 0 1.462800991447466e-09
, O 0 9.867128815399528e-12
splicing O 0 5.819231208015196e-10
, O 0 1.5069469977424532e-11
insertions O 0 7.141739422067417e-10
and O 0 4.2317257337165515e-11
deletions O 0 8.389416383813852e-10
) O 0 4.630431801877499e-11
and O 0 8.946990370795049e-10
just O 0 1.949370220799551e-09
2 O 0 3.5212868176870415e-09
% O 0 1.9561208555729515e-11
leading O 0 3.3846671992909805e-11
to O 0 8.873542092086018e-13
substitution O 0 3.274227777794181e-09
of O 0 2.0211639029099615e-09
one O 0 4.658380278743657e-11
amino O 0 1.1471160826781457e-11
acid O 0 1.8493177475487066e-11
by O 0 3.2431907853736064e-11
another O 0 7.367908505528931e-10
( O 0 5.876113484681866e-10
missense O 0 3.6907647427142365e-07
) O 0 1.0725398347233295e-09
. O 0 4.0041399529400223e-08

The O 0 2.5163160444208188e-08
extraordinary O 0 1.0524054516736214e-08
conservation O 0 2.1302119179722467e-08
of O 0 4.945259202138175e-10
the O 0 3.2584535070157017e-09
PAX6 O 0 3.325260695419274e-05
protein O 0 2.8258466677755223e-09
at O 0 3.47140344247876e-10
the O 0 1.3031699330756652e-10
amino O 0 4.3040285224726915e-10
acid O 0 9.124729416498667e-09
level O 0 3.1278636924980674e-07
amongst O 0 6.022849561304611e-07
vertebrates O 0 7.239863748509379e-07
predicts O 0 1.2954886940974575e-08
that O 0 1.7711164479461416e-10
pathological O 0 5.656175926560536e-05
missense O 0 1.529544715594966e-05
mutations O 0 1.0447774201338689e-08
should O 0 4.383647334016416e-10
in O 0 1.8597393069974544e-10
fact O 0 8.60239449118616e-11
be O 0 3.4333612342063446e-11
common O 0 7.452199968227546e-10
even O 0 1.3104956009257762e-10
though O 0 1.1287292628336942e-10
they O 0 6.88927300623865e-12
are O 0 6.75760749441201e-12
hardly O 0 2.4133754994437595e-09
ever O 0 1.0296253849517711e-09
seen O 0 3.6752165755160604e-09
in O 0 1.2762849443959112e-08
aniridia B-Disease 1 1.0
patients O 0 0.313275545835495
. O 0 5.488669785336242e-07

This O 0 3.3044866842857346e-09
indicates O 0 9.206663209582189e-10
that O 0 1.2457284552860881e-12
there O 0 2.66447953110871e-12
is O 0 9.161279590844118e-13
a O 0 5.375091864656678e-12
heavy O 0 2.6892072924056265e-07
ascertainment O 0 4.9495753046358004e-05
bias O 0 1.430407614577689e-08
in O 0 6.098777732832517e-11
the O 0 3.006724383358694e-11
selection O 0 4.252135088478326e-09
of O 0 5.146357229257603e-10
patients O 0 3.94788379765032e-09
for O 0 2.3609605936947275e-10
PAX6 O 0 2.1563542759395204e-05
mutation O 0 8.074519386447321e-10
analysis O 0 5.860485707831486e-11
and O 0 8.31764518371969e-12
that O 0 4.715464997639973e-12
the O 0 4.663825770023777e-09
missing O 0 2.5096594526985427e-06
PAX6 O 1 0.999996542930603
missense O 0 0.0005496054654940963
mutations O 0 1.3591248659849953e-07
frequently O 0 3.465371767319425e-09
may O 0 4.586985458132631e-09
underlie O 0 1.1313339882690343e-06
phenotypes O 0 7.824955901014619e-07
distinct O 0 4.049854229748462e-09
from O 0 3.6970539962766225e-09
textbook O 0 4.010994962300174e-05
aniridia B-Disease 1 1.0
. O 0 7.836531949578784e-06

Here O 0 2.170243504906466e-07
we O 0 1.3211096661081e-09
present O 0 1.1713965353266076e-09
four O 0 3.3803158050460524e-09
novel O 0 1.148163960351667e-06
PAX6 O 1 0.9995573163032532
missense O 0 8.78270948305726e-05
mutations O 0 5.993558715999825e-08
, O 0 2.2666840626683893e-10
two O 0 3.321392813560031e-11
in O 0 1.6536416680423827e-10
association O 0 4.569762623862772e-10
with O 0 2.170773630294498e-11
atypical O 0 1.4936971638235264e-05
phenotypes O 0 0.0005805043620057404
ectopia B-Disease 1 0.6325575709342957
pupillae I-Disease 1 0.7454808950424194
( O 0 1.1670633348614956e-09
displaced B-Disease 0 5.7917173279520284e-09
pupils I-Disease 0 3.381329705121061e-08
) O 0 2.720415004375809e-10
and O 0 5.5401656595677196e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9998701810836792
( O 0 6.866601509614156e-09
searching B-Disease 0 5.806287362020157e-08
gaze I-Disease 0 5.504603439732136e-09
) O 0 3.180047588105528e-12
, O 0 5.508480824256701e-12
and O 0 9.220678040544605e-12
two O 0 1.0706664721471526e-11
in O 0 1.2543152627664256e-10
association O 0 2.1814584860724295e-10
with O 0 1.5352276741542603e-11
more O 0 4.4194783943574123e-10
recognizable O 0 3.943140200135531e-06
aniridia B-Disease 1 1.0
phenotypes O 0 0.00012470496585592628
. O 0 8.982356121123303e-07

Strikingly O 0 3.4672026231419295e-05
, O 0 1.3188948599918149e-08
all O 0 3.086224609205601e-09
four O 0 9.745749762757328e-10
mutations O 0 7.662376844130847e-10
are O 0 1.9077156521163374e-11
located O 0 3.213390387113435e-10
within O 0 4.730495994920147e-10
the O 0 2.584399538818616e-08
PAX6 O 1 0.9996423721313477
paired O 0 1.628522170449287e-07
domain O 0 3.3325264769956675e-09
and O 0 7.936908075212301e-11
affect O 0 2.067937487915117e-10
amino O 0 1.7947336672374803e-10
acids O 0 1.0842033520974681e-10
which O 0 5.583414806886733e-12
are O 0 1.8708064611350217e-11
highly O 0 6.416311926216167e-10
conserved O 0 1.4355726607462316e-09
in O 0 1.087577319869304e-10
all O 0 1.6986365092286348e-10
known O 0 7.49736983607363e-09
paired O 0 2.613721505895228e-08
domain O 0 1.6422116999592618e-08
proteins O 0 1.821808814916892e-09
. O 0 1.4330400865958381e-08

Our O 0 1.1235757568783811e-07
results O 0 7.830515791340531e-09
support O 0 7.503889176696532e-10
the O 0 3.173301066361489e-10
hypothesis O 0 1.3301463264170366e-09
that O 0 4.458466676903437e-14
the O 0 2.342629779397698e-12
under O 0 8.200981560513299e-11
- O 0 1.1821927881072725e-09
representation O 0 1.3664562814597048e-09
of O 0 8.128157702458338e-09
missense O 0 1.3672165550815407e-06
mutations O 0 1.9445500765158386e-09
is O 0 1.327694031105775e-11
caused O 0 4.95739449490884e-10
by O 0 8.353744362921134e-10
ascertainment O 0 0.0004722913436125964
bias O 0 7.014279646000432e-08
and O 0 1.193686538503158e-10
suggest O 0 1.1195246812922832e-10
that O 0 4.5206189052543477e-13
a O 0 4.925786341314353e-12
substantial O 0 1.206063693359738e-09
burden O 0 3.821718053131917e-07
of O 0 6.94909545018163e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9958754181861877
related I-Disease 1 0.9853222370147705
disease I-Disease 1 0.9972636699676514
remains O 0 3.443236096245528e-08
to O 0 1.6862206075884956e-11
be O 0 6.215756381822146e-11
uncovered O 0 2.7112909251059136e-08
. O 0 3.1144313794584377e-09
. O 0 2.2376267949653084e-08

The O 0 5.570522887410334e-08
chromosomal O 0 4.782922502499787e-08
order O 0 1.6516290557433422e-08
of O 0 2.5130049152721767e-07
genes O 0 3.464012010567785e-08
controlling O 0 5.228173449722817e-08
the O 0 3.306852747186895e-08
major O 0 0.02725667878985405
histocompatibility O 1 1.0
complex O 0 0.021811066195368767
, O 0 7.723976458429149e-10
properdin O 0 3.6883369602946914e-07
factor O 0 4.36002842718608e-08
B O 0 2.131722249032464e-05
, O 0 4.1074244699901286e-11
and O 0 1.4148419935633427e-10
deficiency B-Disease 0 7.29350304595755e-08
of I-Disease 0 2.4050549995990878e-08
the I-Disease 0 4.72305394794148e-08
second I-Disease 0 1.2531668858173362e-07
component I-Disease 0 6.846347133659947e-08
of I-Disease 0 1.4047331298172594e-08
complement I-Disease 0 1.5468481251446065e-07
. O 0 3.344831895901734e-07

The O 0 9.52962722067241e-08
relationship O 0 3.2876132927128765e-09
of O 0 1.8911043397906724e-08
the O 0 6.4837073487922225e-09
genes O 0 4.240955642220712e-10
coding O 0 1.4916493595862335e-09
for O 0 3.6608446829511365e-10
HLA O 0 3.335289875394665e-05
to O 0 8.66413218947315e-10
those O 0 3.3826036416328975e-10
coding O 0 6.05496819350293e-10
for O 0 1.0755300816622793e-10
properdin O 0 2.9313815730347415e-07
Factor O 0 5.60392159343337e-08
B O 0 3.951715825678548e-06
allotypes O 0 1.1092874530049812e-07
and O 0 5.590301485614013e-11
for O 0 1.2283267458723657e-10
deficiency B-Disease 0 2.3749603883516102e-07
of I-Disease 0 5.4234426727362006e-08
the I-Disease 0 1.8484319852518638e-08
second I-Disease 0 2.3773752744205012e-08
component I-Disease 0 8.746441793050508e-09
of I-Disease 0 4.12840694963279e-09
complement I-Disease 0 1.1302383917666248e-08
( O 0 3.636917156324415e-10
C2 O 0 5.165125571693352e-08
) O 0 1.9500739998484784e-12
was O 0 3.195419623347462e-11
studied O 0 1.201869853639792e-10
in O 0 7.732562853912661e-12
families O 0 7.869612947408733e-12
of O 0 9.483267643384252e-11
patients O 0 4.115994656217481e-08
with O 0 6.511716499346676e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 1.8247421394335106e-05

Patients O 0 9.0850553533528e-05
were O 0 4.983698431715311e-08
selected O 0 1.574180963359595e-08
because O 0 3.292770223151109e-10
they O 0 3.431770145834179e-11
were O 0 1.018093831461897e-09
heterozygous O 0 2.347956273851537e-09
or O 0 1.8902586440550095e-10
homozygous O 0 1.457032823282134e-07
for O 0 3.5462344385450706e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.1502964955288917e-05

12 O 0 1.3750805010204203e-06
families O 0 8.751414704022409e-09
with O 0 2.588135816772308e-10
15 O 0 9.832707092982673e-09
matings O 0 3.648490064733778e-06
informative O 0 2.3982947823242284e-06
for O 0 3.4794359180523315e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.4043183682588278e-07
found O 0 7.909713772846771e-09
. O 0 3.7822896814532214e-08

Of O 0 5.0532075874798466e-06
57 O 0 3.629088269008207e-06
informative O 0 2.5066572106879903e-07
meioses O 0 3.029475465154974e-06
, O 0 4.531918174066618e-10
two O 0 3.941634518778159e-11
crossovers O 0 1.6402698088668899e-09
were O 0 4.735244418796469e-10
noted O 0 2.1648001446994414e-10
between O 0 3.2581985998092478e-09
the O 1 0.9679035544395447
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 3.638556345109123e-09
and O 0 2.4343355109479603e-10
the O 0 2.839169344071024e-09
HLA O 0 5.195563062443398e-05
- O 0 0.0059103346429765224
B O 0 0.0002307820541318506
gene O 0 7.805427137963505e-11
, O 0 4.366483845504032e-13
with O 0 1.6738753395514894e-13
a O 0 2.274073724467529e-12
recombinant O 0 7.00654478880125e-10
fraction O 0 1.9967176800861353e-09
of O 0 5.4033471030834335e-09
0 O 0 6.569478472329138e-08
. O 0 1.466156529517093e-08

035 O 0 0.04637321084737778
. O 0 6.515982386190444e-05

A O 0 1.528707230136206e-06
lod O 0 0.00018977929721586406
score O 0 1.100214106486419e-07
of O 0 4.6758414917746904e-09
13 O 0 9.646512477701208e-10
was O 0 8.779392490776416e-11
calculated O 0 2.091703060758121e-10
for O 0 8.597948741861927e-11
linkage O 0 8.831290756461385e-07
between O 0 0.1374979466199875
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 8.560338216057062e-09
HLA O 0 3.884118086716626e-06
- O 0 6.645110488534556e-07
B O 0 1.6926925354709965e-06
at O 0 3.824649971728711e-11
a O 0 2.4644134931535444e-13
maximum O 0 8.429377855445619e-12
likelihood O 0 8.862590522573655e-11
value O 0 1.636225738232966e-10
of O 0 6.489565135270325e-11
the O 0 1.2231926582728647e-10
recombinant O 0 1.2088225975759315e-09
fraction O 0 1.6105796696308516e-09
of O 0 2.3215049882452377e-09
0 O 0 7.758771403132414e-08
. O 0 2.6325336577315284e-08

04 O 0 0.03724397346377373
. O 0 5.865756611456163e-05

18 O 0 1.2834199196731788e-06
families O 0 7.4059536281367855e-09
with O 0 1.6042692174700335e-10
21 O 0 1.8876953333801794e-08
informative O 0 5.750593334852283e-09
matings O 0 9.806242928789288e-09
for O 0 1.1616527878510752e-10
both O 0 4.6500556183382e-10
properdin O 0 2.517920847822097e-06
Factor O 0 5.521982870959619e-07
B O 0 8.006983080122154e-06
allotype O 0 3.4938460657940595e-07
and O 0 8.530425255059981e-10
HLA O 0 1.4229160115064587e-05
- O 0 3.166213718941435e-05
B O 0 0.00032674026442691684
were O 0 2.1776431768927296e-09
found O 0 7.729222817332015e-10
. O 0 6.938775776177408e-09

Of O 0 5.553682967729401e-06
72 O 0 6.241037681320449e-06
informative O 0 4.6950714249760495e-07
meioses O 0 1.6350551959476434e-05
, O 0 8.708317955630207e-10
three O 0 2.797983233993051e-10
recombinants O 0 1.3916171610617312e-06
were O 0 8.678691543195782e-09
found O 0 1.4547120452679252e-10
, O 0 7.711662038112355e-12
giving O 0 2.7751594425251547e-11
a O 0 1.3686172854743273e-11
recombinant O 0 3.490506550463124e-09
fraction O 0 8.77593642201191e-09
of O 0 8.69078320420158e-09
0 O 0 1.699471710026046e-07
. O 0 2.4713294521916396e-08

042 O 0 0.006971565540879965
. O 0 5.55169208382722e-05

A O 0 1.6883362832231796e-06
lod O 0 0.00020554767979774624
score O 0 3.413416038711148e-07
of O 0 2.0999399552579234e-08
16 O 0 1.631957324832456e-08
between O 0 1.8617278829680117e-09
HLA O 0 0.0059265755116939545
- O 0 0.0002443504345137626
B O 0 6.473984103649855e-05
and O 0 7.163385856712168e-11
Factor O 0 1.0420742047045906e-09
B O 0 2.7235124377966713e-08
allotypes O 0 5.456914031753968e-09
was O 0 3.273194215669406e-11
calculated O 0 3.45817159630446e-11
at O 0 3.300559131558245e-11
a O 0 1.1065165710782976e-12
maximum O 0 7.188556694348591e-11
likelihood O 0 2.5482729815173855e-10
value O 0 6.644642613906626e-10
of O 0 1.826456069720095e-10
the O 0 3.513221102924291e-10
recombinant O 0 2.8739464141835924e-09
fraction O 0 2.555648359603424e-09
of O 0 1.872197064045622e-09
0 O 0 7.87545459957073e-08
. O 0 1.7600221724478615e-08

04 O 0 0.045636944472789764
. O 0 6.55279727652669e-05

A O 0 6.945332415853045e-07
crossover O 0 3.2010373729463026e-07
was O 0 1.2110756841821058e-08
shown O 0 2.605580751158243e-10
to O 0 5.57454325755824e-11
have O 0 4.1534879702265215e-11
occurred O 0 5.435400574071991e-09
between O 0 1.6636290955940325e-10
genes O 0 4.4737043930487275e-11
for O 0 1.8583272073935397e-11
Factor O 0 9.618114304998926e-09
B O 0 7.35223352421599e-07
and O 0 1.1596824889270607e-10
HLA O 0 6.668961987088551e-07
- O 0 3.575387836463051e-06
D O 0 7.884063393248653e-07
, O 0 5.6012628563140154e-11
in O 0 4.296751149324152e-11
which O 0 4.3256627446641716e-11
HLA O 0 1.8705381990002934e-06
- O 0 1.7819120330386795e-05
D O 0 1.348112391497125e-06
segregared O 0 5.573747898779402e-07
with O 0 1.9446455556959563e-10
HLA O 0 9.641578799346462e-05
- O 0 6.839103662059642e-06
A O 0 5.640181370836217e-07
and O 0 1.4787609359245835e-08
B O 0 1.3779336768493522e-05
. O 0 1.566405671837856e-08

These O 0 3.739052090168116e-08
studies O 0 5.329101604445441e-09
suggest O 0 2.1431859065224046e-10
that O 0 1.5645601134095521e-12
the O 0 5.816698164795575e-11
genes O 0 3.132431813934744e-11
for O 0 1.647552060057844e-11
Factor O 0 1.2632403922907542e-06
B O 1 0.9999998807907104
and O 0 2.1126404590177117e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.041291940508728e-10
located O 0 2.809127097602726e-10
outside O 0 3.133843740066311e-10
those O 0 1.5554826524044607e-11
for O 0 1.270983041035123e-10
HLA O 0 2.368582681810949e-05
, O 0 5.32060541458268e-11
that O 0 2.2807884053621663e-13
the O 0 4.9853710569480736e-12
order O 0 3.887948643588324e-11
of O 0 1.041935093759605e-09
genese O 0 5.507167770701926e-07
is O 0 6.486681330963862e-11
HLA O 0 9.416663004913062e-08
- O 0 1.349641109982258e-08
A O 0 3.453942909459329e-09
, O 0 1.797061978392467e-11
- O 0 1.1539244004765692e-09
B O 0 1.2222497502989427e-07
, O 0 7.458719405994962e-12
- O 0 6.253563777924853e-10
D O 0 2.505954999065807e-09
, O 0 8.590011514597595e-12
Factor O 0 7.143296176792546e-09
B O 0 2.2965252355788834e-05
allotype O 0 0.0004486726247705519
, O 0 1.129807174038433e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 9.702048886506276e-11
that O 0 1.5524409015255092e-12
the O 0 2.56550780619591e-10
genes O 0 5.765636856835954e-10
coding O 0 7.5237025498609e-08
for O 0 1.456973336644296e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 8.801566586669196e-09
Factor O 0 8.935572992641028e-08
B O 0 8.540989142602484e-07
allotypes O 0 4.418732757471844e-08
are O 0 8.157576177059145e-12
approximately O 0 1.97342597992034e-12
3 O 0 3.455217709169567e-11
- O 0 3.659867131577954e-10
- O 0 8.33118551923917e-09
5 O 0 3.4070228860372254e-09
centimorgans O 0 9.003920098393792e-08
from O 0 3.3355454509553795e-10
the O 0 1.0285732265913339e-09
HLA O 0 1.4894276318955235e-06
- O 0 2.1955408158191858e-07
A O 0 4.951549925635845e-08
and O 0 6.152185982877256e-10
HLA O 0 1.8055548025586177e-06
- O 0 9.329987165074272e-07
B O 0 1.1680971283567487e-06
loci O 0 7.282291436538912e-10
, O 0 6.146124733284741e-13
and O 0 6.0308556109126e-14
that O 0 9.16917231160927e-15
the O 0 2.105317873160595e-12
apparent O 0 2.2523888310033158e-10
lack O 0 1.639400393216306e-09
of O 0 8.371321968958512e-10
recombinants O 0 1.2844492403019103e-07
between O 0 1.9607201973137478e-10
the O 0 9.27108778636665e-10
Factor O 0 7.27005797784841e-08
B O 0 0.0001147500443039462
gene O 0 5.5858016878573835e-08
and O 0 1.4258798728405964e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.4836032846687885e-08
suggests O 0 5.136482350565075e-10
that O 0 1.3049346759413938e-12
these O 0 2.1943606653973546e-11
two O 0 4.110128209999786e-11
genes O 0 3.3215846739764743e-10
lie O 0 1.1462597537814645e-09
in O 0 4.973368938898659e-11
close O 0 7.023056025623475e-10
proximity O 0 3.326133324321745e-08
to O 0 1.0971955566319025e-09
one O 0 4.98419971961539e-09
another O 0 1.87819235719644e-08
. O 0 1.2741497812385205e-07

Distribution O 0 4.2678191647382846e-08
of O 0 1.984190234338712e-08
emerin O 0 0.0001385176001349464
and O 0 6.998924817480656e-08
lamins O 0 0.0002742441138252616
in O 0 2.5469477638040416e-09
the O 0 1.1048648662637106e-09
heart O 0 2.5349104149086088e-08
and O 0 1.432688828684192e-10
implications O 0 1.4827827854446696e-08
for O 0 2.2156265711004153e-09
Emery B-Disease 0 0.0006362481508404016
- I-Disease 1 0.9999983310699463
Dreifuss I-Disease 1 0.999995231628418
muscular I-Disease 1 0.9999991655349731
dystrophy I-Disease 1 1.0
. O 0 0.00030458479886874557

Emerin O 0 0.2729882597923279
is O 0 2.4693177280710188e-08
a O 0 2.3267092696954705e-09
nuclear O 0 2.9811945978508447e-07
membrane O 0 3.9941170371093904e-08
protein O 0 7.212182517868371e-10
which O 0 9.616686787172757e-12
is O 0 1.924035583633632e-11
missing O 0 1.7329594426129802e-09
or O 0 2.5738056130819587e-10
defective O 0 5.829418228131544e-07
in O 0 4.343883475144139e-08
Emery B-Disease 0 0.031196575611829758
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 0.9999996423721313
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.888886102591641e-06
EDMD B-Disease 1 1.0
) O 0 1.930987423293118e-07
. O 0 3.5918085927733046e-07

It O 0 1.2983797370580419e-09
is O 0 1.0731326244295403e-10
one O 0 5.149899257039792e-11
member O 0 2.2971451130171516e-11
of O 0 1.6123768986631148e-10
a O 0 1.6080127507311914e-10
family O 0 2.365824203209854e-10
of O 0 5.2413406947948715e-09
lamina O 1 0.9999988079071045
- O 0 5.611813685391098e-05
associated O 0 3.925749325617289e-08
proteins O 0 9.826304353532933e-11
which O 0 4.189976057084044e-12
includes O 0 5.736794719823912e-11
LAP1 O 0 3.6260520573705435e-05
, O 0 1.5001633268951764e-09
LAP2 O 0 0.02778322994709015
and O 0 8.346744806431161e-08
lamin O 0 4.5628679799847305e-05
B O 0 8.085707668215036e-05
receptor O 0 3.4813336924344185e-07
( O 0 4.627064065232389e-09
LBR O 0 1.707129558781162e-05
) O 0 6.478256153741313e-09
. O 0 1.0827541530034068e-07

A O 0 1.2808400242647622e-06
panel O 0 8.734426160117437e-08
of O 0 1.847705810575917e-08
16 O 0 5.17542062539178e-08
monoclonal O 0 6.23196967808326e-07
antibodies O 0 1.247262559900264e-07
( O 0 7.990485495490418e-10
mAbs O 0 3.9988285038816684e-07
) O 0 9.587699384416837e-11
has O 0 1.18342566648999e-11
been O 0 4.090794369915329e-11
mapped O 0 3.7951636278066303e-10
to O 0 1.1952221157240928e-10
six O 0 4.74280115181358e-10
specific O 0 6.066886992783793e-10
sites O 0 6.05543348797255e-09
throughout O 0 2.8490367842692876e-09
the O 0 1.811987559996453e-09
emerin O 0 9.042451551977138e-07
molecule O 0 2.077212402085138e-09
using O 0 1.3448814284444666e-09
phage O 0 3.354075772676879e-08
- O 0 2.439091373318547e-09
displayed O 0 2.5050566065942803e-09
peptide O 0 6.949208986029021e-10
libraries O 0 9.274979118067961e-10
and O 0 2.212697733372515e-11
has O 0 1.6311325120449416e-12
been O 0 5.561031669876204e-12
used O 0 2.678176430626067e-11
to O 0 2.038258867242959e-10
localize O 0 8.31342447327188e-07
emerin O 0 3.5362048947717994e-05
in O 0 1.0972170727541197e-08
human O 0 3.246771518305991e-09
and O 0 1.0668764538479536e-08
rabbit O 0 3.4003455766651314e-06
heart O 0 1.9533445083652623e-06
. O 0 1.9807158935236657e-07

Several O 0 1.2063723033861606e-06
mAbs O 0 2.5318544430774637e-05
against O 0 1.0611072553956546e-07
different O 0 2.8737616730722948e-08
emerin O 0 2.6767083909362555e-05
epitopes O 0 1.65789947459416e-06
did O 0 1.7629476767311303e-09
not O 0 1.4109452495247865e-10
recognize O 0 4.1456227339864427e-10
intercalated O 0 6.53857000543212e-07
discs O 0 1.249320860097214e-07
in O 0 9.204766948656129e-10
the O 0 1.9586430255458254e-09
heart O 0 1.3189048964079575e-08
, O 0 9.75254599300257e-12
though O 0 3.48219092449753e-11
they O 0 8.507344134711659e-12
recognized O 0 2.0495681540833033e-10
cardiomyocyte O 0 1.7968956456115848e-07
nuclei O 0 1.0962380336820843e-08
strongly O 0 4.07891498355184e-10
, O 0 1.7463228779712736e-11
both O 0 1.4535020756434314e-11
at O 0 1.3420063948998973e-09
the O 0 5.2194528699089915e-09
rim O 0 6.436665245246331e-08
and O 0 3.948965876521271e-10
in O 0 3.909964796378063e-09
intranuclear O 0 0.00010414418647997081
spots O 0 1.134537455982354e-06
or O 0 6.556307052818511e-09
channels O 0 1.8724835015859753e-08
. O 0 2.7646816391779794e-08

A O 0 8.282489034172613e-06
polyclonal O 0 0.00017894503253046423
rabbit O 0 6.835413387307199e-06
antiserum O 0 3.544428864188376e-06
against O 0 1.0738179412328464e-07
emerin O 0 0.00011232135148020461
did O 0 4.985143675639847e-08
recognize O 0 7.152975989299648e-09
both O 0 7.309344240979954e-10
nuclear O 0 4.1288028995722925e-08
membrane O 0 4.475278814197736e-09
and O 0 5.093542948531038e-11
intercalated O 0 1.4541864601369525e-08
discs O 0 1.6037070560415145e-09
but O 0 9.95389742852737e-11
, O 0 9.85652098134393e-12
after O 0 1.2844696140046352e-10
affinity O 0 1.006351779686554e-09
purification O 0 4.1649254711728645e-08
against O 0 7.883892982896157e-10
a O 0 1.2420262041068497e-10
pure O 0 2.3145604544083653e-08
- O 0 1.252884196389914e-08
emerin O 0 6.351067440846236e-07
band O 0 2.6974653621891775e-09
on O 0 1.558806972390414e-10
a O 0 2.3332086263039287e-11
western O 0 2.6949096287864904e-09
blot O 0 1.9030417774956732e-07
, O 0 4.239586459675593e-11
it O 0 7.34784628975138e-12
stained O 0 2.401218424097351e-08
only O 0 1.8384373190460934e-10
the O 0 8.976527854365202e-10
nuclear O 0 1.4874132148179342e-07
membrane O 0 8.136242257705817e-08
. O 0 1.238261759795023e-08

These O 0 3.785783064813586e-08
results O 0 7.93655274833327e-09
would O 0 4.28054869328065e-10
not O 0 4.182919635664639e-11
be O 0 1.0089361984766398e-10
expected O 0 5.105667444382789e-09
if O 0 6.307854238940536e-10
immunostaining O 0 3.5670198030857136e-06
at O 0 1.1902161034527126e-08
intercalated O 0 2.6013012188741413e-07
discs O 0 1.0477188894242317e-08
were O 0 5.03120933803558e-10
due O 0 7.96551891113495e-09
to O 0 1.2637625668165953e-10
a O 0 8.965281295125749e-11
product O 0 1.8341442808988973e-09
of O 0 5.398011371227085e-09
the O 0 8.86461126725635e-09
emerin O 0 9.463817605137592e-07
gene O 0 3.2389640969299194e-10
and O 0 3.732633299668997e-11
, O 0 4.060428642621572e-12
therefore O 0 4.1798248889834966e-11
, O 0 8.052517853907037e-12
cast O 0 1.0488374752037899e-10
some O 0 2.639583517038968e-11
doubt O 0 8.141543550443942e-10
upon O 0 2.3915261437856827e-10
the O 0 2.3258918402380147e-10
hypothesis O 0 1.0956652474192197e-08
that O 0 1.701969294665151e-11
cardiac B-Disease 0 2.285103801114019e-05
defects I-Disease 0 1.389372755511431e-05
in O 0 8.363212486983684e-07
EDMD B-Disease 1 1.0
are O 0 1.5944905840115098e-08
caused O 0 5.082872789330395e-09
by O 0 1.681840083866959e-10
absence O 0 1.0472717804077547e-07
of O 0 5.1333138628706365e-08
emerin O 0 0.0002245724172098562
from O 0 2.1796687121877767e-07
intercalated O 0 3.5256958653917536e-05
discs O 0 3.0433777737925993e-06
. O 0 3.968447117586038e-07

Although O 0 5.703928991351859e-07
emerin O 0 5.749375486630015e-05
was O 0 1.7714670264012966e-07
abundant O 0 5.0334026724385694e-08
in O 0 3.367816303612159e-10
the O 0 2.1670930328010485e-10
membranes O 0 2.6467844582711564e-10
of O 0 5.291522220396416e-10
cardiomyocyte O 0 8.125228987410082e-07
nuclei O 0 3.876639809163862e-08
, O 0 1.622804494949559e-11
it O 0 9.935716529033134e-13
was O 0 2.121536696320092e-10
absent O 0 1.4197762965295624e-09
from O 0 6.941442559638134e-11
many O 0 9.101167736114135e-11
non O 0 1.175820329990529e-08
- O 0 5.7546671428099216e-08
myocyte O 0 4.581362645694753e-06
cells O 0 1.5999460645232944e-09
in O 0 1.0997679156243834e-10
the O 0 1.4383491064862142e-09
heart O 0 7.72697461570715e-08
. O 0 6.493883120128885e-08

This O 0 2.736163517980117e-09
distribution O 0 3.5407230480899443e-09
of O 0 5.580782946879026e-09
emerin O 0 2.4381573894061148e-05
was O 0 1.6684161607827264e-08
similar O 0 1.930933329896689e-10
to O 0 1.144065744917988e-11
that O 0 8.090477615109448e-13
of O 0 1.1013091549827436e-09
lamin O 0 1.0268369123878074e-06
A O 0 1.0714034992531651e-08
, O 0 1.4312897221591125e-11
a O 0 2.1403252434271103e-11
candidate O 0 1.876479860385416e-09
gene O 0 4.639917963733531e-11
for O 0 1.3434007378743118e-11
an O 0 1.0204334773000756e-11
autosomal O 0 9.89447102028862e-09
form O 0 3.807696558055795e-08
of O 0 0.001223857863806188
EDMD B-Disease 1 1.0
. O 0 0.0014599693240597844

In O 0 1.33713257355339e-07
contrast O 0 4.932716137773241e-07
, O 0 6.29809804308934e-08
lamin O 0 0.0025421336758881807
B1 O 0 0.2732461094856262
was O 0 8.098155035440868e-08
absent O 0 1.6729977403429075e-07
from O 0 3.829442540848049e-09
cardiomyocyte O 0 1.3337616110220551e-05
nuclei O 0 2.0605355075531406e-06
, O 0 1.2544809635528509e-09
showing O 0 3.4375122748286913e-09
that O 0 8.18292378301777e-10
lamin O 0 0.2988392412662506
B1 O 0 0.011097596026957035
is O 0 2.661930745273544e-11
not O 0 3.9244835679796974e-12
essential O 0 9.993389449292067e-11
for O 0 1.3239437324230607e-11
localization O 0 1.0872962974417533e-08
of O 0 2.8344024904924936e-09
emerin O 0 1.103216618503211e-06
to O 0 6.015943854187356e-10
the O 0 9.193261263362729e-09
nuclear O 0 5.4408346841228195e-06
lamina O 1 0.9645420908927917
. O 0 6.684193181172304e-07

Lamin O 1 0.9999666213989258
B1 O 1 0.9993926286697388
is O 0 7.54384554824128e-09
also O 0 7.005956925709711e-10
almost O 0 1.9007295737338836e-09
completely O 0 3.974335882617197e-08
absent O 0 3.8765369936299976e-07
from O 0 2.663793630119926e-08
skeletal O 0 5.750410309701692e-06
muscle O 0 8.761381650401745e-06
nuclei O 0 0.0016177662182599306
. O 0 8.285182047984563e-06

In O 0 9.254644623979402e-07
EDMD B-Disease 1 1.0
, O 0 3.3455824777206544e-09
the O 0 3.431706585566019e-10
additional O 0 2.488572958814217e-10
absence O 0 5.071351338870045e-08
of O 0 2.9041339075774886e-06
lamin O 1 0.9999996423721313
B1 O 1 0.9999998807907104
from O 0 7.078508588165278e-07
heart O 1 0.9172354340553284
and O 0 3.987822481121839e-07
skeletal O 0 0.044850874692201614
muscle O 0 0.002475649816915393
nuclei O 1 0.9993775486946106
which O 0 5.9074952929449864e-08
already O 0 6.604883395766592e-08
lack O 0 9.612026588001754e-07
emerin O 0 1.754781806084793e-05
may O 0 4.3304799746124445e-09
offer O 0 3.3655367381868473e-10
an O 0 1.4938422677676644e-12
alternative O 0 1.510493841117011e-09
explanation O 0 8.753713864884105e-10
of O 0 2.546645394563285e-10
why O 0 3.069784981768464e-10
these O 0 3.51604821646756e-11
tissues O 0 1.1323502135951458e-09
are O 0 6.649748807152633e-11
particularly O 0 2.4621302774363585e-09
affected O 0 2.4934869724546616e-09
. O 0 3.477899968018505e-09
. O 0 6.333007718239969e-08

Genetic O 0 1.765942840847856e-07
mapping O 0 9.735797057430773e-09
of O 0 1.2119075520899969e-08
the O 0 3.3942214372473245e-07
copper B-Disease 1 0.5852328538894653
toxicosis I-Disease 1 0.9999752044677734
locus O 0 2.238272827526089e-06
in O 0 6.424694021234245e-08
Bedlington O 0 6.2066355894785374e-06
terriers O 0 1.0082967492053285e-06
to O 0 5.614967935052562e-10
dog O 0 1.0165304153986199e-08
chromosome O 0 1.911916736041519e-10
10 O 0 1.790535081314104e-10
, O 0 9.032955806953513e-12
in O 0 3.437941598072314e-11
a O 0 1.2724699072208523e-10
region O 0 2.115937647317878e-08
syntenic O 0 5.152853191248141e-06
to O 0 1.0007433770553575e-09
human O 0 1.4868886122343383e-09
chromosome O 0 2.0214183660272056e-09
region O 0 5.916039658160344e-09
2p13 O 0 1.39419944389374e-06
- O 0 1.7666970961727202e-06
p16 O 0 4.358284513727995e-06
. O 0 2.0216860718846874e-07

Abnormal O 1 0.8340965509414673
hepatic B-Disease 1 0.9999964237213135
copper I-Disease 0 4.900621570413932e-05
accumulation I-Disease 0 9.93495973489189e-07
is O 0 1.0070270312079188e-10
recognized O 0 1.615781813901762e-10
as O 0 7.927648815186927e-11
an O 0 1.382868958232919e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.12080651521682739
man O 0 8.40337861518492e-07
, O 0 3.3478916861007235e-10
mouse O 0 2.6845221157145716e-08
, O 0 5.461971430698043e-10
rat O 0 2.3374136617348995e-06
and O 0 2.0634359998439322e-08
dog O 0 1.122389585361816e-05
. O 0 4.4851768166154216e-07

The O 0 1.516308714144543e-07
major O 0 6.282854769779078e-07
cause O 0 1.9196292555534455e-07
of O 0 9.827704161580186e-06
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9358310699462891
accumulation I-Disease 0 0.009201989509165287
in O 0 5.634950994704013e-08
man O 0 7.689613390482464e-09
is O 0 4.0242014581748364e-11
a O 0 2.266601906164567e-10
dysfunctional O 0 2.331784543230242e-07
ATP7B O 1 0.9999104738235474
gene O 0 3.5228065797809904e-08
, O 0 1.578984581973586e-10
causing O 0 7.694193726592857e-08
Wilson B-Disease 0 1.5754683772684075e-05
disease I-Disease 0 0.0021237682085484266
( O 0 2.247816155431792e-08
WD B-Disease 1 0.9941410422325134
) O 0 3.4373698554190923e-08
. O 0 2.2296308088698424e-07

Mutations O 0 8.515174840795225e-07
in O 0 1.5771171035794396e-08
the O 0 3.7843538081006045e-08
ATP7B O 1 0.9999709129333496
genes O 0 2.1068645494892735e-08
have O 0 1.0199709132852064e-10
also O 0 2.6413616086018443e-11
been O 0 1.5936924002701858e-10
demonstrated O 0 8.53060910799286e-09
in O 0 1.3701525247711288e-08
mouse O 0 1.3911103451391682e-06
and O 0 2.0039907511204547e-08
rat O 0 8.781623364484403e-06
. O 0 1.1200196325944489e-07

The O 0 1.0297347216692287e-05
ATP7B O 1 0.9970088601112366
gene O 0 1.0446742493286365e-07
has O 0 1.142243452600944e-10
been O 0 1.750832812064118e-10
excluded O 0 3.977465912186062e-09
in O 0 5.576457351441633e-11
the O 0 5.295396413029785e-11
much O 0 4.5725875863489307e-10
rarer O 0 0.00011474239727249369
human O 0 3.7242978123686044e-07
copper B-Disease 1 0.9845501780509949
overload I-Disease 1 0.9993059635162354
disease O 1 0.5770070552825928
non B-Disease 0 1.3394623010754003e-06
- I-Disease 0 6.262497720399551e-08
Indian I-Disease 0 5.7291900112943495e-09
childhood I-Disease 0 1.0455832466504944e-07
cirrhosis I-Disease 0 0.006035653408616781
, O 0 3.245667623552606e-10
indicating O 0 9.33370625233465e-09
genetic O 0 5.227964550158504e-08
heterogeneity O 0 1.6120346799652907e-06
. O 0 2.859224537132832e-07

By O 0 3.982126628443439e-09
investigating O 0 1.2528365012087761e-08
the O 0 1.250730718993509e-08
common O 0 4.243947842041962e-06
autosomal O 1 0.9981216788291931
recessive O 1 0.9999970197677612
copper B-Disease 1 0.9999997615814209
toxicosis I-Disease 1 0.9999998807907104
( O 0 2.0923515364756895e-08
CT B-Disease 0 0.0405641533434391
) O 0 1.1686627221507706e-09
in O 0 1.39460167858374e-08
Bedlington O 0 3.147209781673155e-06
terriers O 0 5.006697847420583e-07
, O 0 8.545317231600791e-12
we O 0 4.6472313844359014e-12
have O 0 1.3726295490859575e-12
identified O 0 3.833419692789164e-12
a O 0 7.095550817910745e-13
new O 0 3.620801922177286e-11
locus O 0 2.389752284948088e-10
involved O 0 2.0036283396307475e-11
in O 0 4.773432760174501e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.866677490004804e-06

We O 0 5.5640029472669994e-08
examined O 0 1.1131916011208887e-07
whether O 0 1.0732073896235761e-08
the O 0 1.9685093377574958e-07
WD B-Disease 1 0.99980229139328
gene O 0 1.1392983196856221e-06
ATP7B O 1 0.9999998807907104
was O 0 2.1540692785038118e-07
also O 0 1.497561102903333e-10
causative O 0 1.0278736084501361e-08
for O 0 4.968478961586698e-10
CT B-Disease 0 2.147052100553992e-06
by O 0 5.035577510525968e-10
investigating O 0 2.522778430602557e-09
the O 0 5.0168189602572966e-09
chromosomal O 0 8.157996944646584e-08
co O 0 1.0359792668168666e-07
- O 0 4.564536482121184e-07
localization O 0 5.06709102410241e-06
of O 0 3.471430716217583e-07
ATP7B O 1 0.9992015957832336
and O 0 3.0041420462367796e-09
C04107 O 0 3.87857745920428e-08
, O 0 1.4929628713855614e-11
using O 0 9.59975328396201e-12
fluorescence O 0 1.1583168868511962e-09
in O 0 7.356955045167979e-10
situ O 0 9.974075254604031e-08
hybridization O 0 4.56171171947517e-08
( O 0 8.184359301388611e-10
FISH O 0 8.822208314995805e-07
) O 0 5.340882180959738e-10
. O 0 1.677062577698507e-08

C04107 O 0 0.00014622909657191485
is O 0 7.1615491314958035e-09
an O 0 1.8622665909351355e-10
anonymous O 0 8.419107189183705e-09
microsatellite O 0 1.6214676179515664e-06
marker O 0 3.228630305329716e-07
closely O 0 1.1328131321874935e-08
linked O 0 7.938191259881933e-08
to O 0 4.352077098701557e-08
CT B-Disease 1 0.9999992847442627
. O 0 4.6311321057146415e-05

However O 0 1.2745786079904065e-05
, O 0 8.240442070928111e-07
BAC O 0 0.012780413031578064
clones O 0 7.728204764134716e-06
containing O 0 1.6833750748901366e-07
ATP7B O 0 0.2878245413303375
and O 0 8.190782274652975e-09
C04107 O 0 4.3528743276510795e-07
mapped O 0 5.098505173606327e-09
to O 0 2.7782962042088855e-10
the O 0 5.1741544382366556e-09
canine O 0 1.0884421897117136e-07
chromosome O 0 4.6405688181039295e-09
regions O 0 7.211883534807839e-09
CFA22q11 O 0 7.797261787345633e-06
and O 0 4.068792414102518e-09
CFA10q26 O 0 3.1466966902371496e-05
, O 0 1.370971947078914e-10
respectively O 0 7.145690705812058e-10
, O 0 2.2615914349599642e-11
demonstrating O 0 3.423234196109348e-10
that O 0 1.9489370187142363e-11
WD B-Disease 0 1.3169526482670335e-06
cannot O 0 8.217567737389686e-10
be O 0 1.615794026355033e-10
homologous O 0 8.605615664514232e-10
to O 0 4.013918086798185e-09
CT B-Disease 0 0.00021536543499678373
. O 0 6.563241186086088e-07

The O 0 3.0132391657389235e-06
copper O 0 7.507255759264808e-06
transport O 0 1.6206405462071416e-06
genes O 0 1.51076619658852e-07
CTR1 O 0 0.12145061790943146
and O 0 2.9694895431475743e-08
CTR2 O 1 0.9999834299087524
were O 0 1.4429338079935405e-07
also O 0 3.8770425758727356e-10
excluded O 0 1.35301760906259e-08
as O 0 1.7908432514701644e-09
candidate O 0 1.2900886581235227e-08
genes O 0 2.618793792930063e-10
for O 0 1.4653554758492504e-10
CT B-Disease 0 2.6119079848285764e-05
since O 0 2.5179724971735595e-08
they O 0 4.267944886393593e-10
both O 0 2.0457718852284756e-10
mapped O 0 1.4763028577391424e-09
to O 0 2.038827329187143e-09
canine O 0 7.379967996712367e-07
chromosome O 0 1.0060666255640172e-07
region O 0 2.8502350346570893e-07
CFA11q22 O 0 0.0025704400613904
. O 0 2.633651774885948e-06

2 O 0 2.1600571926683187e-05
- O 0 1.3257218597573228e-05
22 O 0 1.7594082919458742e-06
. O 0 2.0298038805321994e-07

5 O 0 6.37145058135502e-05
. O 0 4.494298082136083e-06

A O 0 8.214078661694657e-07
transcribed O 0 1.9396836137275386e-08
sequence O 0 3.283901484074647e-10
identified O 0 3.656238922733479e-10
from O 0 1.271142913150669e-10
the O 0 8.429804632115179e-10
C04107 O 0 1.0042508620244917e-06
- O 0 1.796844344426063e-07
containing O 0 1.009139651841906e-07
BAC O 0 0.00015006129979155958
was O 0 7.469964202755364e-09
found O 0 7.288764036772477e-11
to O 0 1.1311404070346587e-11
be O 0 2.644068297641411e-11
homologous O 0 8.851508415119724e-11
to O 0 2.5047400264988084e-10
a O 0 4.761273042497294e-10
gene O 0 9.672342926592137e-10
expressed O 0 4.0209424678749883e-10
from O 0 2.7804059055114294e-10
human O 0 1.8029337744973617e-10
chromosome O 0 1.961187739984993e-10
2p13 O 0 8.394449935167358e-08
- O 0 4.4048899638937655e-08
p16 O 0 2.43019986356785e-08
, O 0 2.7605201111113864e-11
a O 0 2.156618460202875e-11
region O 0 4.5065073894789975e-10
devoid O 0 8.720954625118793e-09
of O 0 1.05889998158748e-10
any O 0 6.758413828578114e-10
positional O 0 9.058746854861965e-07
candidate O 0 7.205161978163233e-07
genes O 0 5.485624754442142e-08
. O 0 5.2493671631737016e-08

Molecular O 0 1.1750938888610563e-08
analysis O 0 1.0397275262974404e-09
of O 0 5.575154560233386e-09
the O 0 6.393936047288662e-08
APC B-Disease 0 4.915580120723462e-07
gene O 0 1.4028902484142236e-09
in O 0 8.105843218864095e-10
205 O 0 1.7183399592113346e-08
families O 0 1.0230961217105872e-10
: O 0 1.2034153187845398e-11
extended O 0 4.972330547303727e-09
genotype O 0 1.7385229966748739e-07
- O 0 2.694754925869347e-07
phenotype O 0 1.1057133519898343e-07
correlations O 0 1.8279425972878016e-08
in O 0 4.2327288896082393e-10
FAP B-Disease 0 9.186427973872924e-08
and O 0 7.599579819606017e-12
evidence O 0 6.978742670554761e-12
for O 0 1.6735760997518834e-12
the O 0 2.902401582960401e-11
role O 0 5.133795472067604e-11
of O 0 3.5780627349879524e-09
APC B-Disease 0 7.079454178438027e-08
amino O 0 1.2845485786172617e-09
acid O 0 3.1689237900422995e-09
changes O 0 3.694765027262292e-08
in O 0 0.000847955874633044
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 6.797089008614421e-05

BACKGROUND O 0 0.0008867363212630153
/ O 0 8.187605271814391e-05
AIMS O 0 1.7289871721004602e-06
The O 0 9.103329645654412e-09
development O 0 1.5260976482522892e-08
of O 0 1.5881325907685095e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.206831632520448e-10
a O 0 4.812910920498625e-12
variable O 0 2.1603030128658496e-11
range O 0 5.842260702992874e-11
of O 0 3.4457797726261674e-11
extracolonic O 0 1.004239265967044e-06
manifestations O 0 2.960904112114804e-06
in O 0 1.5897796856734203e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.7007208792138044e-08
FAP B-Disease 0 8.10176061349921e-06
) O 0 1.5875087702732493e-11
is O 0 6.025120723521238e-13
the O 0 5.571114858500537e-13
result O 0 2.275505738696948e-12
of O 0 2.1441376452102645e-11
the O 0 2.1203190592178345e-10
dominant O 0 3.508771229121521e-08
inheritance O 0 6.579560363206838e-08
of O 0 2.986621439049486e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999969005584717
coli I-Disease 1 1.0
( O 0 2.0085259677671274e-07
APC B-Disease 0 2.5547833502059802e-06
) O 0 7.941050483850631e-09
gene O 0 2.742758908880205e-08
mutations O 0 8.385360672491515e-08
. O 0 1.708580441572849e-07

In O 0 1.1605113314772098e-08
this O 0 1.7802846696834962e-10
study O 0 8.204940199485478e-11
, O 0 1.3051138945605056e-12
direct O 0 2.2493556496583356e-12
mutation O 0 1.2816515427074848e-12
analysis O 0 3.723735729488364e-12
of O 0 2.471312876561882e-10
the O 0 2.5802474823422017e-08
APC B-Disease 0 4.990095590073906e-07
gene O 0 2.349658911882102e-09
was O 0 1.0022682239707592e-08
performed O 0 8.45582770470088e-10
to O 0 1.346338596164287e-10
determine O 0 8.877301560517026e-09
genotype O 0 8.778800406616938e-07
- O 0 8.073369031080802e-07
phenotype O 0 1.147889818753356e-07
correlations O 0 7.656916878318043e-09
for O 0 5.0092218567554525e-11
nine O 0 8.034514720201003e-10
extracolonic O 0 7.411594538098143e-07
manifestations O 0 1.2898910028980026e-07
and O 0 1.2069420463056701e-10
to O 0 1.3957625853711075e-11
investigate O 0 6.414020703449097e-11
the O 0 1.0321041937766395e-10
incidence O 0 2.7621818166068124e-09
of O 0 4.922844798471715e-09
APC B-Disease 0 1.505034106230596e-07
mutations O 0 2.5693189797948435e-09
in O 0 7.2752155411137664e-09
non O 1 0.6445856690406799
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.28062547952868e-06

METHODS O 0 1.1900255231012125e-05
The O 0 1.4349951698022778e-06
APC B-Disease 0 1.8905075194197707e-06
gene O 0 3.0924411920096873e-09
was O 0 2.083473615854814e-09
analysed O 0 1.3177531954511323e-08
in O 0 4.41565284337031e-10
190 O 0 1.175571462397329e-08
unrelated O 0 2.5318229290860472e-08
FAP B-Disease 0 5.18904380442109e-06
and O 0 2.3045640951124824e-09
15 O 0 6.296560428609155e-08
non O 0 0.13316480815410614
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.567971250755363e-06
using O 0 7.962294157337624e-10
denaturing O 0 1.2032849099341547e-06
gradient O 0 1.0614999013114357e-07
gel O 0 8.604951062807231e-08
electrophoresis O 0 9.665745537290604e-09
, O 0 1.2765756507437942e-10
the O 0 2.466500059750132e-10
protein O 0 5.27045962428474e-10
truncation O 0 1.7089918813439908e-08
test O 0 1.323337350811471e-08
, O 0 1.21692586563249e-10
and O 0 6.778497901871461e-11
direct O 0 8.152187813692535e-10
sequencing O 0 2.50780487931479e-07
. O 0 8.289422481766451e-08

RESULTS O 0 0.00016453336866106838
Chain O 0 1.0636618981152424e-06
terminating O 0 2.04157828420648e-07
signals O 0 8.070058399312074e-09
were O 0 6.087833015477884e-10
only O 0 1.0057328234114316e-11
identified O 0 4.1194048172599196e-11
in O 0 7.070308227774547e-11
patients O 0 2.563474321704007e-09
belonging O 0 9.556370278440696e-11
to O 0 1.853696710019115e-11
the O 0 3.3291737366880625e-08
FAP B-Disease 1 0.9999754428863525
group O 0 3.732281150803374e-09
( O 0 7.255778616821473e-11
105 O 0 2.0206702799896448e-07
patients O 0 4.570011569171584e-08
) O 0 5.119961121735628e-10
. O 0 4.323417357454673e-08

Amino O 0 1.7345732317153306e-07
acid O 0 1.3411241894800696e-08
changes O 0 3.2977245378873477e-09
were O 0 4.456088831261695e-09
identified O 0 4.829790456462035e-10
in O 0 1.317302100733997e-10
four O 0 1.8675523627553758e-10
patients O 0 2.2630091134345776e-09
, O 0 6.160058140664004e-12
three O 0 1.4927266020481333e-11
of O 0 1.2573514673874797e-08
whom O 0 1.2510956715061639e-08
belonged O 0 2.643285768044734e-08
to O 0 4.7258943286498933e-11
the O 0 8.584537525280211e-09
non O 0 1.0438678145874292e-05
- O 0 0.0001452707074349746
FAP O 0 0.0008934633806347847
group O 0 2.20207740930789e-09
of O 0 2.1360631308198208e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.8870739936828613
. O 0 2.840314436980407e-07

Genotype O 0 0.002147550927475095
- O 0 0.0005094080115668476
phenotype O 0 1.2972046533832327e-05
correlations O 0 4.784272960023372e-07
identified O 0 3.494616818144891e-09
significant O 0 2.7884268227751363e-09
differences O 0 9.67804947293871e-09
in O 0 1.6493489907176695e-09
the O 0 7.743565788587148e-10
nature O 0 3.3335995075489677e-10
of O 0 7.590760658926499e-11
certain O 0 1.9111410232142134e-09
extracolonic O 0 2.630952440085821e-05
manifestations O 0 1.1035385796276387e-06
in O 0 1.8491759234962046e-08
FAP B-Disease 0 2.9652290322701447e-05
patients O 0 5.5632710882491665e-08
belonging O 0 1.7930400220134146e-10
to O 0 3.032746276332432e-11
three O 0 9.455836114113936e-10
mutation O 0 1.636730644349882e-07
subgroups O 0 2.775513621600112e-06
. O 0 9.15241216148388e-08

CONCLUSIONS O 0 2.372595736233052e-05
Extended O 0 4.593511221173685e-06
genotype O 0 1.3138555914338212e-05
- O 0 4.287328920327127e-06
phenotype O 0 3.9411560237567755e-07
correlations O 0 4.067389980377811e-08
made O 0 2.0942579614935397e-10
in O 0 1.519264575255974e-11
this O 0 3.6199025547911656e-12
study O 0 1.9415536886557838e-11
may O 0 3.045301510962162e-11
have O 0 1.570591573463176e-11
the O 0 1.0752838897065686e-10
potential O 0 1.3855935843132272e-10
to O 0 1.2090012151133589e-11
determine O 0 2.1180192322223235e-10
the O 0 1.8422845193821757e-10
most O 0 9.390643124218556e-11
appropriate O 0 7.424463821514848e-10
surveillance O 0 5.8586810958161095e-09
and O 0 1.018194861757138e-09
prophylactic O 0 0.24954427778720856
treatment O 0 0.30250903964042664
regimens O 0 5.3413950809044763e-05
for O 0 1.2628649237456102e-08
those O 0 4.232249040114766e-08
patients O 0 7.60411822398055e-08
with O 0 3.000399581565283e-11
mutations O 0 3.7284372811363653e-10
associated O 0 5.620839904629804e-10
with O 0 4.0153785851870794e-10
life O 0 8.886657099083095e-08
threatening O 0 2.9357057229617567e-08
conditions O 0 0.00014366547111421824
. O 0 8.395729196308821e-07

This O 0 1.56952797425447e-08
study O 0 3.4546281391101274e-09
also O 0 5.9878677537150704e-12
provided O 0 8.955739795590834e-12
evidence O 0 4.679789195050077e-11
for O 0 3.9453652150855945e-11
the O 0 4.022540078807424e-09
pathological O 0 6.862158898002235e-06
nature O 0 1.3537603260616038e-09
of O 0 3.1929967003740956e-10
amino O 0 1.1660881982233917e-10
acid O 0 1.768655499834182e-10
changes O 0 5.01248376139074e-10
in O 0 7.626512754654868e-09
APC O 0 2.342200922100801e-08
associated O 0 6.721903589301803e-10
with O 0 8.423339803442786e-11
both O 0 3.245471447144155e-09
FAP B-Disease 0 0.00022395895211957395
and O 0 7.218987718715653e-08
non O 1 0.9999043941497803
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.00019559654174372554
. O 0 1.9944490503576162e-09
. O 0 1.802564320030342e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.13927826285362244
cancer B-Disease 1 0.9794584512710571
risk O 0 2.9329465078831163e-08
of O 0 7.87752441056e-09
the O 0 7.98794772549627e-08
APC O 0 2.8492368073784746e-06
I1307K O 0 6.571116045961389e-06
polymorphism O 0 6.11121151905536e-07
. O 0 1.0447937626167914e-07

Germ O 0 0.0014382037334144115
- O 0 9.280175618187059e-06
line O 0 1.047481987370702e-06
and O 0 4.560239741380201e-09
somatic O 0 5.2846638709525e-07
truncating O 0 1.9674753559684177e-07
mutations O 0 1.360355494917087e-09
of O 0 8.718588628831014e-10
the O 0 8.190453648637686e-09
APC B-Disease 0 8.312903077012379e-08
gene O 0 4.005212828062099e-10
are O 0 4.534795455812812e-11
thought O 0 4.1385914140157354e-10
to O 0 2.5951005233615376e-10
initiate O 0 1.2536234805793356e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.0309640821069479
formation O 0 1.4394086065294687e-06
in O 0 2.2594813344767317e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.4716227926546708e-06
sporadic O 0 0.04807133227586746
colorectal O 1 1.0
carcinogenesis O 1 0.9999997615814209
, O 0 4.660955710278358e-08
respectively O 0 6.254547315620584e-07
. O 0 4.887491513727582e-07

Recently O 0 7.621970894433616e-07
, O 0 2.3791248970894685e-09
an O 0 1.1632802360272976e-10
isoleucine O 0 9.340673301494462e-08
- O 0 1.4743343967893452e-07
- O 0 1.7304756738667493e-07
> O 0 2.4982733748402097e-07
lysine O 0 3.146706362144869e-08
polymorphism O 0 1.2714927999368797e-09
at O 0 3.518089153331516e-10
codon O 0 3.0287490293545716e-09
1307 O 0 1.6349224551959196e-07
( O 0 4.979234732860327e-11
I1307K O 0 3.7014729059592355e-08
) O 0 2.512298528933865e-11
of O 0 1.2030951790364952e-09
the O 0 3.3269518695533407e-08
APC B-Disease 0 2.5194745489898196e-07
gene O 0 8.007557950051591e-10
has O 0 1.5960125582248352e-11
been O 0 4.22963608581739e-11
identified O 0 5.879945141895604e-11
in O 0 9.480229795633122e-11
6 O 0 1.461916920852957e-09
% O 0 1.85454915313521e-11
- O 0 1.8134044266204796e-10
7 O 0 3.109479618235156e-10
% O 0 4.718902352207621e-12
of O 0 1.2065801482941119e-11
the O 0 2.9993368899638995e-10
Ashkenazi O 0 7.796004553028979e-08
Jewish O 0 2.6665388119795352e-08
population O 0 1.7029248844391276e-10
. O 0 2.4986908098156846e-09

To O 0 3.4839418017185153e-09
assess O 0 3.7591959767269145e-08
the O 0 9.827152425145869e-10
risk O 0 4.964140765117975e-10
of O 0 9.078421348007737e-11
this O 0 7.184636219292884e-11
common O 0 3.987114283177107e-08
APC B-Disease 0 1.0210228538198862e-06
allelic O 0 1.528965299257834e-06
variant O 0 3.6341864415589953e-06
in O 0 8.401719924222562e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999991655349731
, O 0 5.2387818527677155e-09
we O 0 1.9908069637253334e-10
have O 0 1.6422717352693184e-11
analyzed O 0 9.412627621774305e-11
a O 0 3.686443945244422e-12
large O 0 6.745660974250001e-11
cohort O 0 6.8526539998003955e-09
of O 0 6.229230464782631e-10
unselected O 0 0.00020525610307231545
Ashkenazi O 0 8.471363912576635e-07
Jewish O 0 3.5002820197860274e-08
subjects O 0 5.7217999227532346e-08
with O 0 4.669938880041968e-10
adenomatous B-Disease 0 3.697548891068436e-05
polyps I-Disease 0 1.5138019762162003e-06
and O 0 5.492521548688956e-09
. O 0 2.6757502880059292e-08
or O 0 0.11439697444438934
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.2797138904119265e-09
for O 0 2.651493469230104e-10
the O 0 2.3397944914904656e-08
APC O 0 3.2917569114943035e-07
I1307K O 0 1.3894861012886395e-06
polymorphism O 0 5.344617761693371e-07
. O 0 1.4522231595037738e-07

The O 0 3.257633579778485e-06
APC O 0 8.287631317216437e-06
I1307K O 0 3.970907528128009e-06
allele O 0 1.578715291827848e-08
was O 0 5.480382814226914e-09
identified O 0 3.6815783754917675e-10
in O 0 2.358152284553938e-10
48 O 0 7.1497847642376655e-09
( O 0 2.7315196979293965e-11
10 O 0 6.138222569118668e-11
. O 0 5.355198923195914e-12
1 O 0 3.031776218964666e-10
% O 0 1.1109369500716948e-11
) O 0 1.8116945660687223e-12
of O 0 3.964270578471485e-10
476 O 0 2.750198063949938e-06
patients O 0 4.514849933912046e-06
. O 0 1.6190465146337374e-07

Compared O 0 1.658310679886199e-07
with O 0 1.0111150111624667e-10
the O 0 1.9785195704002945e-10
frequency O 0 7.800727286344511e-10
in O 0 8.241767684991075e-11
two O 0 6.519461186182962e-12
separate O 0 5.814388033542617e-12
population O 0 8.523045008472507e-13
control O 0 3.4573798685100243e-11
groups O 0 2.7135459677862794e-12
, O 0 6.8350737396360994e-12
the O 0 1.4183173524529025e-09
APC O 0 1.4670803238914232e-07
I1307K O 0 2.322303913615542e-07
allele O 0 7.47974071568791e-10
is O 0 1.6140613151582883e-12
associated O 0 4.39573290961226e-12
with O 0 2.977296957151071e-13
an O 0 1.426880667657407e-13
estimated O 0 1.5312028988495596e-12
relative O 0 6.440858957290629e-10
risk O 0 6.883317249517518e-10
of O 0 3.5184670732490986e-09
1 O 0 7.984464787114121e-07
. O 0 9.019062474635575e-08

5 O 0 6.662117812084034e-06
- O 0 3.7222955597826513e-06
1 O 0 1.2863546317021246e-06
. O 0 1.2774628999068227e-07

7 O 0 3.4311583476664964e-06
for O 0 1.777403326741478e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
( O 0 4.813728082808666e-08
both O 0 2.9200524664929617e-08
P O 0 6.579815817531198e-05
= O 0 1.513759428917183e-08
. O 0 1.335591970352823e-09
01 O 0 1.6111081890812784e-07
) O 0 4.867791170148905e-10
. O 0 1.3921593655652487e-08

Furthermore O 0 6.785129471609253e-07
, O 0 1.9929280448138798e-09
compared O 0 5.318388840436228e-09
with O 0 3.846797880235897e-10
noncarriers O 0 0.0008517315145581961
, O 0 3.0000723683087926e-08
APC O 0 9.320347089669667e-07
I1307K O 0 1.4184879546519369e-06
carriers O 0 1.0560328611575187e-08
had O 0 7.188131340152282e-11
increased O 0 6.722220696753212e-11
numbers O 0 2.1770399372122995e-10
of O 0 2.788129060959932e-09
adenomas B-Disease 1 0.9304493069648743
and O 0 1.3954691894468851e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 1.5291931049432606e-05
patient O 0 0.0006157112075015903
( O 0 1.4585684049439607e-10
P O 0 1.7635377957958553e-07
= O 0 1.5038238709852436e-10
. O 0 2.7628429058457193e-11
03 O 0 1.5471284253720796e-09
) O 0 2.204099533095749e-12
, O 0 1.6040380829140943e-12
as O 0 7.050751042042558e-12
well O 0 2.5094487252075304e-11
as O 0 2.3441684357528025e-11
a O 0 7.866375606457865e-11
younger O 0 1.4184046825960195e-08
age O 0 1.829330820157793e-08
at O 0 1.802846050225071e-08
diagnosis O 0 5.754694939241745e-06
. O 0 1.8766674259040883e-07

We O 0 6.588376066929413e-08
conclude O 0 1.6021324711346097e-07
that O 0 2.644341967616981e-10
the O 0 1.5803450992279977e-08
APC O 0 2.38326492763008e-06
I1307K O 0 7.134003681130707e-06
variant O 0 1.2501088349381462e-05
leads O 0 8.681426066914355e-08
to O 0 4.883097814989412e-10
increased O 0 7.201741425433283e-08
adenoma B-Disease 1 1.0
formation O 0 1.1409488251956645e-06
and O 0 1.290890283556223e-09
directly O 0 7.442086391584724e-10
contributes O 0 3.419486568900787e-11
to O 0 6.227869782382545e-12
3 O 0 3.314395424780514e-10
% O 0 1.1223719002806387e-11
- O 0 9.321475535895019e-11
4 O 0 7.241593436013716e-11
% O 0 9.673952177519096e-13
of O 0 1.7081965182630388e-12
all O 0 2.954186895109956e-11
Ashkenazi O 0 1.0167145774175879e-06
Jewish O 0 8.69863506522961e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.7298514194408199e-06

The O 0 8.123991079855841e-08
estimated O 0 4.298664979529576e-09
relative O 0 8.8883858495592e-08
risk O 0 7.480514874202981e-09
for O 0 2.186048425611986e-10
carriers O 0 9.958085023242802e-09
may O 0 1.1967601354356816e-09
justify O 0 1.8628574238732654e-09
specific O 0 4.3677231276184614e-10
clinical O 0 5.259225499543163e-09
screening O 0 4.477823445370177e-09
for O 0 1.0996378113636851e-10
the O 0 1.9606987144982213e-09
360 O 0 5.566919369925927e-09
, O 0 2.0792834468097432e-11
000 O 0 2.828363376838894e-10
Americans O 0 2.718752740299424e-12
expected O 0 2.433044044014565e-11
to O 0 2.1705293812290805e-11
harbor O 0 1.9876068790836143e-08
this O 0 5.473806130584791e-11
allele O 0 3.3440752944535745e-10
, O 0 4.160891683285817e-12
and O 0 1.5623802165215528e-12
genetic O 0 5.451693350227993e-12
testing O 0 4.572428546900653e-11
in O 0 7.836689630558169e-12
the O 0 3.065932924206649e-11
setting O 0 1.3323859793246129e-09
of O 0 2.6642787975816873e-10
long O 0 1.0028944341655688e-10
- O 0 9.24343768193836e-10
term O 0 2.3437964458139504e-08
- O 0 5.068892416915105e-09
outcome O 0 1.5661488106388788e-08
studies O 0 8.149400598789214e-11
may O 0 1.0278995536683322e-11
impact O 0 4.976882239660085e-10
significantly O 0 1.251389676326653e-07
on O 1 0.919540524482727
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.02341633103787899
in O 0 2.609668869890669e-10
this O 0 4.2717707843253905e-11
population O 0 4.5200631432207317e-11
. O 0 1.2450200870262051e-09

Localization O 0 6.4067448874993715e-06
of O 0 1.7451277756208583e-07
human O 0 5.553726367679701e-09
BRCA1 O 0 6.51969713771905e-08
and O 0 3.929700731486463e-10
its O 0 2.4770324680289946e-10
loss O 0 3.663488357119604e-08
in O 0 2.9464692907765766e-09
high O 0 2.831135930136952e-07
- O 0 2.2910969121880953e-08
grade O 0 5.567595735556097e-07
, O 0 9.421789043395634e-11
non B-Disease 0 3.558640457868023e-07
- I-Disease 0 6.867211777716875e-05
inherited I-Disease 1 0.999980092048645
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.00015588125097565353

Although O 0 4.454485136307085e-08
the O 0 2.6393245367017926e-09
link O 0 2.839694701606277e-09
between O 0 8.32508550985267e-09
the O 0 1.1608475460889167e-06
BRCA1 O 0 1.0622007721394766e-05
tumour B-Disease 1 1.0
- O 0 4.95058557135053e-05
suppressor O 0 5.739753760281019e-06
gene O 0 3.88731491440808e-09
and O 0 2.1163040209160044e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 4.798524910754054e-10
established O 0 7.407305879780779e-10
, O 0 1.4427844769598908e-12
the O 0 1.6945776379340138e-11
role O 0 1.5225395597062708e-11
, O 0 1.507296999887775e-12
if O 0 7.701471838733598e-13
any O 0 7.078144494132577e-12
, O 0 1.065743934075547e-11
of O 0 6.660948459469296e-10
BRCA1 O 0 1.503555857595984e-08
in O 0 1.274284788799207e-09
non B-Disease 0 3.3415810321457684e-05
- I-Disease 0 0.37456563115119934
familial I-Disease 0 0.3664974570274353
cancers I-Disease 1 0.9998615980148315
is O 0 5.267859481961068e-09
unclear O 0 3.9458345213461143e-07
. O 0 1.3173453794479428e-07

BRCA1 O 0 0.0002159761788789183
mutations O 0 1.3307895585512597e-07
are O 0 3.595738984341068e-10
rare O 0 4.252313612340686e-09
in O 0 3.5857417035600747e-09
sporadic B-Disease 0 7.558275228802813e-06
cancers I-Disease 0 0.3148233890533447
, O 0 1.2307851404713688e-09
but O 0 7.388951672737676e-09
loss O 0 3.2574100714555243e-06
of O 0 8.013437764020637e-06
BRCA1 O 0 1.0199625677387303e-07
resulting O 0 2.863075332371068e-09
from O 0 1.1577994812883574e-10
reduced O 0 1.6699787108720443e-09
expression O 0 1.408772404287717e-10
or O 0 3.922135879963484e-11
incorrect O 0 1.9590165045713093e-09
subcellular O 0 4.109459794676695e-08
localization O 0 1.4841693207756634e-08
is O 0 9.429172720398782e-12
postulated O 0 3.4450325925305947e-10
to O 0 2.5048138476563286e-12
be O 0 4.438828211245083e-12
important O 0 3.0764846226105647e-10
in O 0 4.800181918618307e-10
non B-Disease 0 2.1917553567618597e-06
- I-Disease 0 0.0004204314900562167
familial I-Disease 1 0.9997077584266663
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0004396974400151521

Epigenetic O 0 0.23573103547096252
loss O 0 0.00038846954703330994
, O 0 8.15590794900345e-09
however O 0 7.350212438694825e-09
, O 0 2.443540335350658e-11
has O 0 5.351867495180518e-13
not O 0 4.621991266280656e-13
received O 0 1.7208760458298222e-11
general O 0 3.317482122344728e-10
acceptance O 0 1.161224272294703e-08
due O 0 6.289344600673985e-09
to O 0 6.442957278807171e-11
controversy O 0 4.256208274711071e-09
regarding O 0 1.6726724449966923e-09
the O 0 6.822394316152725e-10
subcellular O 0 3.7402580232992477e-07
localization O 0 6.153435947453545e-07
of O 0 7.909354593493845e-08
BRCA1 O 0 2.8628745596392946e-08
proteins O 0 1.9724295113876522e-11
, O 0 5.0231498648078965e-12
reports O 0 8.946264735965048e-12
of O 0 7.162415799344402e-11
which O 0 2.199481222153743e-11
have O 0 4.9787882150376106e-11
ranged O 0 3.120135261269752e-07
from O 0 3.664575032313877e-10
exclusively O 0 1.0814379253210049e-10
nuclear O 0 2.0483186258246633e-09
, O 0 1.4572829054593228e-11
to O 0 8.062584454238131e-12
conditionally O 0 4.330455105616693e-09
nuclear O 0 2.0530015021336112e-08
, O 0 2.6957139645511496e-11
to O 0 2.267240908904178e-11
the O 0 4.920516438744471e-09
ER O 0 9.825406596064568e-05
/ O 0 5.020908488972964e-08
golgi O 0 3.0885144042258617e-07
, O 0 6.50550238678882e-11
to O 0 5.5462259784810897e-11
cytoplasmic O 0 5.530618185645153e-09
invaginations O 0 4.3634813096105063e-07
into O 0 6.132682361936759e-09
the O 0 5.151230553224195e-09
nucleus O 0 9.352832108788789e-08
. O 0 4.166983202935626e-08

In O 0 4.3073509203850335e-08
an O 0 9.257406646812072e-11
attempt O 0 4.6280521637243055e-09
to O 0 2.576905355766712e-10
resolve O 0 7.335450913359409e-09
this O 0 2.4066171278036563e-10
issue O 0 1.1079760220411572e-08
, O 0 3.5089067068616586e-11
we O 0 2.261634629574516e-11
have O 0 3.831045897184637e-11
comprehensively O 0 1.386699324257279e-07
characterized O 0 9.672531220417113e-09
19 O 0 1.334836667865602e-07
anti O 0 1.4185599866323173e-05
- O 0 0.003929260652512312
BRCA1 O 0 2.1432695120893186e-06
antibodies O 0 1.1073088757029836e-07
. O 0 6.463521629029856e-08

These O 0 6.542318686797444e-08
reagents O 0 3.4619363304955186e-06
detect O 0 1.9805496265234979e-07
a O 0 5.061878471934733e-09
220 O 0 1.9510308391090803e-07
- O 0 4.196838858661067e-07
kD O 0 5.08568655277486e-06
protein O 0 1.644672309453199e-08
localized O 0 3.4554929584373895e-08
in O 0 1.0506840952828611e-09
discrete O 0 1.1092278207058826e-08
nuclear O 0 1.9072899704042356e-07
foci O 0 2.8439108064048924e-06
in O 0 9.923345478668466e-10
all O 0 1.5369423789213243e-10
epithelial O 0 1.9641731796582462e-08
cell O 0 1.6121655121992262e-09
lines O 0 7.310734656540419e-11
, O 0 7.180190686809085e-13
including O 0 4.304303441449164e-12
those O 0 2.1158578361601954e-11
derived O 0 7.633774501414337e-09
from O 0 5.0556192121575805e-08
breast B-Disease 0 4.094019459444098e-05
malignancies I-Disease 0 3.185409150319174e-05
. O 0 2.3164115248164308e-07

Immunohistochemical O 0 7.726832700427622e-05
staining O 0 1.183727817988256e-05
of O 0 6.924981335032498e-07
human O 0 1.4745523913006764e-07
breast O 0 3.522187762428075e-05
specimens O 0 8.138637781485158e-07
also O 0 4.423233335160148e-09
revealed O 0 3.2053813470156456e-07
BRCA1 O 0 2.180601086365641e-06
nuclear O 0 1.3889283536627772e-06
foci O 0 7.193386409198865e-06
in O 0 8.724348354860467e-09
benign O 0 0.10378480702638626
breast O 0 0.044964637607336044
, O 0 3.925854130670814e-08
invasive B-Disease 1 0.9999991655349731
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999994039535522
and O 0 1.5573990594930365e-06
low B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999988079071045
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 7.866963642300107e-06

Conversely O 0 1.60479212354403e-05
, O 0 7.89554803759529e-08
BRCA1 O 0 1.4831313421836967e-07
expression O 0 6.906265004325007e-10
was O 0 4.748684778732581e-10
reduced O 0 6.66084631895103e-10
or O 0 4.979937642812793e-11
undetectable O 0 4.2739265460056686e-09
in O 0 3.3211586258907744e-11
the O 0 3.6237936262839554e-11
majority O 0 9.952373994370767e-12
of O 0 1.342584238228639e-10
high O 0 6.311735205599689e-07
- O 0 2.0778848011104856e-06
grade O 0 0.04322108253836632
, O 0 2.405513654935021e-08
ductal B-Disease 1 0.9999874830245972
carcinomas I-Disease 1 1.0
, O 0 1.077530620285927e-09
suggesting O 0 1.0435978747835861e-09
that O 0 1.3922342445571445e-11
absence O 0 5.1598277650555247e-08
of O 0 1.9339084644798277e-07
BRCA1 O 0 4.822974020157744e-08
may O 0 1.236068331023077e-10
contribute O 0 1.5739924988378284e-11
to O 0 7.908872341755302e-12
the O 0 2.0287330149137972e-10
pathogenesis O 0 3.4939628790198185e-07
of O 0 2.051402381297862e-10
a O 0 3.8500768545501884e-11
significant O 0 1.2179875996665146e-09
percentage O 0 1.6069872543766905e-08
of O 0 2.9202864126887107e-08
sporadic B-Disease 1 0.6700659990310669
breast I-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9439229369163513
. O 0 2.3606122567798593e-07
. O 0 4.199721672648593e-07

